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INTRODUCTION ● xxvii
Introduction
● HOW TO USE THIS BOOK
NANDA International (NANDA-I) describes its purpose as 
follows:
NANDA International exists to develop, reﬁ ne and promote ter-
minology that accurately reﬂ ects nurses’ clinical judgments. This 
unique, evidence-based perspective includes social, psychological 
and spiritual dimensions of care  (NANDA-I, 2009).
Standardization of nursing actions and common terminol-
ogy is important in the provision of consistent care over time, 
among nurses, across shifts, and even between different health-
care agencies. This text incorporates the nomenclature of 
Taxonomy II that has been adopted by NANDA-I.
There are those individuals who believe that NANDA’s list 
is incomplete. My intent is not to judge the completeness of this 
list but rather to suggest the need for clinical testing of what is 
available. NANDA encourages nurses to submit new diagnoses 
for consideration, after testing and research of that diagnosis has 
been conducted in the clinical setting.
There are three essential components in a nursing diagnosis, 
which comprise the PES format. The “P” identiﬁ es the prob-
lem (or human issue of concern), the “E” represents the etiol-
ogy (or cause) of the problem, and the “S” describes a cluster of 
signs and symptoms, or what has come to be known as “deﬁ ning 
characteristics.” These three parts are combined into one state-
ment by the use of “connecting words.” The diagnosis would 
then be written in this manner: Problem (or issue of concern) 
“related to” etiology “evidenced by” signs and symptoms (deﬁ n-
ing characteristics).
The problem can be identiﬁ ed as the human response to 
actual or potential health problems as assessed by the nurse. The 
etiology may be represented by past experiences of the individ-
ual, genetic inﬂ uences, current environmental factors, or patho-
physiological changes. The deﬁ ning characteristics describe 
what the client says and what the nurse observes that indicate 
the existence of a particular problem.
Nursing diagnoses, then, become the basis for the care plan. 
This book may be used as a guide in the construction of care 
plans for various psychiatric clients. The concepts are presented 
xxvii
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in such a manner that they may be applied to various types of 
health care settings: inpatient hospitalization, outpatient clinic, 
home health, partial hospitalization, and private practice, to 
name a few. Major divisions in the book are identiﬁ ed by psychi-
atric diagnostic categories, according to the order in which they 
appear in the Diagnostic and Statistical Manual of Mental Disor-
ders, Fourth Edition, Text Revision (DSM-IV-TR, APA, 2000). 
The use of this format is not to imply that nursing diagnoses are 
based on, or ﬂ ow from, medical diagnoses; it is meant only to 
enhance the usability of the book. In addition, I am not suggest-
ing that those nursing diagnoses presented with each psychiatric 
category are all-inclusive.
It is valid, however, to state that certain nursing diagnoses 
are indeed common to individuals with speciﬁ c psychiatric dis-
orders. The diagnoses presented in this book are intended to be 
used as guidelines for construction of care plans that must be 
individualized for each client, based on the nursing assessment. 
The interventions can also be used in areas in which interdisci-
plinary treatment plans take the place of the nursing care plan.
Each chapter in Unit II begins with an overview of informa-
tion related to the medical diagnostic category, which may be 
useful to the nurse as background assessment data. This section 
includes:
 1. The Disorder: A deﬁ nition and common types or categories 
that have been identiﬁ ed.
 2. Predisposing Factors: Information regarding theories of 
etiology, which the nurse may use in formulating the “re-
lated to” portion of the nursing diagnosis, as it applies to the 
client.
 3. Symptomatology: Subjective and objective data identifying 
behaviors common to the disorder. These behaviors, as they 
apply to the individual client, may be pertinent to the “evi-
denced by” portion of the nursing diagnosis.
Information presented with each nursing diagnosis includes 
the following:
 1. Defi nition: The approved NANDA deﬁ nition is included 
for each of the accepted NANDA nursing diagnoses. Any 
additions or alterations made by the author to the NANDA 
deﬁ nition are identiﬁ ed by brackets [ ].
 2. Possible Etiologies (“related to”): This section suggests 
possible causes for the problem identiﬁ ed. Those not ap-
proved by NANDA are identiﬁ ed by brackets [ ]. Related/
Risk Factors are given for diagnoses for which the client 
is at risk. Note: Defi ning characteristics are replaced by 
“related/risk factors” for the “Risk for” diagnoses. 
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 3. Defi ning Characteristics (“evidenced by”): This section in-
cludes signs and symptoms that may be evident to indicate that 
the problem exists. Again, as with deﬁ nitions and etiologies, 
those not approved by NANDA are identiﬁ ed by brackets [ ].
 4. Goals/Objectives: These statements are made in client behav-
ioral objective terminology. They are measurable, short- and 
long-term goals, to be used in evaluating the effectiveness of 
the nursing interventions in alleviating the identiﬁ ed problem. 
There may be more than one short-term goal, and they may 
be considered “stepping stones” to fulﬁ llment of the long-term 
goal. For purposes of this book, “long-term,” in most instances, 
is designated as “by discharge from treatment,” whether the 
client is in an inpatient or outpatient setting.
 5. Interventions with Selected Rationales: Only those inter-
ventions that are appropriate to a particular nursing diagno-
sis within the context of the psychiatric setting are presented. 
Rationales for selected interventions are included to provide 
clariﬁ cation beyond fundamental nursing knowledge, and to 
assist in the selection of appropriate interventions for indi-
vidual clients. Important interventions related to communi-
cation may be identiﬁ ed with the icon.
 6. Outcome Criteria: These are behavioral changes that can 
be used as criteria to determine the extent to which the nurs-
ing diagnosis has been resolved.
To use this book in the preparation of psychiatric nursing 
care plans, ﬁ nd the section in the text applicable to the client’s 
psychiatric diagnosis. Review background data pertinent to the 
diagnosis, if needed. Complete a biopsychosocial history and as-
sessment on the client. Select and prioritize nursing diagnoses 
appropriate to the client. Using the list of NANDA-approved 
nursing diagnoses, be sure to include those that are client-
speciﬁ c, and not just those that have been identiﬁ ed as “common” 
to a particular medical diagnosis. Select nursing interventions 
and outcome criteria appropriate to the client for each nursing 
diagnosis identiﬁ ed. Include all of this information on the care 
plan, along with a date for evaluating the status of each problem. 
On the evaluation date, document success of the nursing inter-
ventions in achieving the goals of care, using the desired client 
outcomes as criteria. Modify the plan as required.
Unit III deals with client populations with special psychiatric 
nursing needs. These include victims of abuse or neglect, clients 
with premenstrual dysphoric disorder or HIV disease, clients 
who are homeless, and clients who are experiencing bereave-
ment. Topics related to forensic nursing, psychiatric home nurs-
ing care, and complementary therapies are also included.
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Unit IV, Psychotropic Medications, has been updated to in-
clude new medications that have been approved by the U.S. Food 
and Drug Administration (FDA) since the last edition. This 
information should facilitate use of the book for nurses adminis-
tering psychotropic medications and also for nurse practitioners 
with prescriptive authority. The major categories of psychotropic 
medications are identiﬁ ed by chemical class. Information is pre-
sented related to indications, actions, contraindications and pre-
cautions, interactions, route and dosage, and adverse reactions 
and side effects. Examples of medications in each chemical class 
are presented by generic and trade name, along with information 
about half-life, controlled and pregnancy categories, and avail-
able forms of the medication. Therapeutic plasma level ranges 
are provided, where appropriate. Nursing diagnoses related to 
each category, along with nursing interventions, and client and 
family education are included in each chapter.
Another helpful feature of this text is the table in Appendix N, 
which lists some client behaviors commonly observed in the 
psychiatric setting and the most appropriate nursing diagnosis 
for each. It is hoped that this information will broaden the un-
derstanding of the need to use a variety of nursing diagnoses in 
preparing the client treatment plan.
This book helps to familiarize the nurse with the current 
NANDA-approved nursing diagnoses and provides suggestions 
for their use within the psychiatric setting. The book is de-
signed to be used as a quick reference in the preparation of care 
plans, with the expectation that additional information will be 
required for each nursing diagnosis as the nurse individualizes 
care for psychiatric clients.
 MCT
●  NANDA-I NURSING DIAGNOSES
TAXONOMY II (2009–2011)
Domain 1: Health Promotion
Ineffective health maintenance
Ineffective self health management
Impaired home maintenance
Readiness for enhanced immunization status
Self neglect
Readiness for enhanced nutrition
Ineffective family therapeutic regimen management
Readiness for enhanced self health management
Domain 2: Nutrition
Ineffective infant feeding pattern
Impaired swallowing
Imbalanced nutrition: Less than body requirements
xxx ● INTRODUCTION
2506_FM_i-xxxvi.indd   xxx 10/4/10   3:53:27 PM
Imbalanced nutrition: More than body requirements
Risk for imbalanced nutrition: More than body requirements
Risk for unstable blood glucose level
Neonatal jaundice
Risk for impaired liver function
Risk for electrolyte imbalance
Deﬁ cient fl uid volume
Risk for deﬁ cient fl uid volume
Excess fl uid volume
Risk for imbalanced fl uid volume
Readiness for enhanced fl uid balance
Domain 3: Elimination and Exchange
Impaired urinary elimination
Urinary retention
Functional urinary incontinence
Stress urinary incontinence
Urge urinary incontinence
Reﬂ ex urinary incontinence
Risk for urge urinary incontinence
Readiness for enhanced urinary elimination
Overﬂ ow urinary incontinence
Bowel incontinence
Diarrhea
Constipation
Risk for constipation
Perceived constipation
Dysfunctional gastrointestinal motility
Risk for dysfunctional gastrointestinal motility
Impaired gas exchange
Domain 4: Activity/Rest
Insomnia
Disturbed sleep pattern
Sleep deprivation
Readiness for enhanced sleep
Risk for disuse syndrome
Impaired physical mobility
Impaired bed mobility
Impaired wheelchair mobility
Impaired transfer ability
Impaired walking
Deﬁ cient diversional activity
Delayed surgical recovery
Sedentary lifestyle
Disturbed energy ﬁ eld
Fatigue
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Decreased cardiac output
Ineffective breathing pattern
Activity intolerance
Risk for activity intolerance
Risk for bleeding
Impaired spontaneous ventilation
Dysfunctional ventilatory weaning response
Ineffective peripheral tissue perfusion 
Risk for decreased cardiac tissue perfusion
Risk for ineffective cerebral tissue perfusion
Risk for ineffective gastrointestinal perfusion
Risk for ineffective renal perfusion
Risk for shock
Readiness for enhanced self-care
Dressing self-care deﬁ cit
Bathing self-care deﬁ cit
Feeding self-care deﬁ cit
Toileting self-care deﬁ cit
Domain 5: Perception/Cognition
Unilateral neglect
Impaired environmental interpretation syndrome
Wandering
Disturbed sensory perception (specify: visual, auditory, 
kinesthetic, gustatory, tactile, olfactory)
Deﬁ cient knowledge (specify)
Readiness for enhanced knowledge (specify)
Acute confusion
Chronic confusion
Impaired memory
Risk for acute confusion
Readiness for enhanced decision-making
Ineffective activity planning
Impaired verbal communication
Readiness for enhanced communication
Domain 6: Self-Perception
Disturbed personal identity
Powerlessness
Risk for powerlessness
Readiness for enhanced power
Hopelessness
Readiness for enhanced hope
Risk for loneliness
Readiness for enhanced self-concept  
Chronic low self-esteem
Situational low self-esteem
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Risk for situational low self-esteem
Risk for compromised human dignity
Disturbed body image
Domain 7: Role Relationships
Caregiver role strain
Risk for caregiver role strain
Impaired parenting
Risk for impaired parenting
Readiness for enhanced parenting
Interrupted family processes
Readiness for enhanced family processes
Dysfunctional family processes
Risk for impaired attachment
Effective breastfeeding
Ineffective breastfeeding
Interrupted breastfeeding
Ineffective role performance
Parental role confl ict
Impaired social interaction
Readiness for enhanced relationship
Domain 8: Sexuality
Sexual dysfunction
Ineffective sexuality pattern
Readiness for enhanced childbearing process
Risk for disturbed maternal/fetal dyad
Domain 9: Coping/Stress Tolerance
Relocation stress syndrome
Risk for relocation stress syndrome
Rape-trauma syndrome
Post-trauma syndrome
Risk for post-trauma syndrome
Fear
Anxiety
Death anxiety
Chronic sorrow
Ineffective denial
Grieving
Complicated grieving
Risk for complicated grieving
Impaired individual resilience
Readiness for enhanced resilience
Risk for compromised resilience
Risk-prone health behavior
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Ineffective coping
Stress overload
Disabled family coping
Compromised family coping
Defensive coping
Ineffective community coping
Readiness for enhanced coping 
Readiness for enhanced family coping
Readiness for enhanced community coping
Autonomic dysreﬂ exia
Risk for autonomic dysreﬂ exia
Disorganized infant behavior
Risk for disorganized infant behavior
Readiness for enhanced organized infant behavior
Decreased intracranial adaptive capacity
Domain 10: Life Principles
Readiness for enhanced spiritual well-being
Readiness for enhanced hope
Spiritual distress
Risk for spiritual distress
Decisional confl ict 
Noncompliance 
Risk for impaired religiosity
Impaired religiosity
Readiness for enhanced religiosity
Moral distress
Domain 11: Safety/Protection
Risk for infection
Impaired oral mucous membrane
Risk for injury
Risk for perioperative positioning injury
Risk for falls
Risk for trauma
Risk for vascular trauma
Impaired skin integrity
Risk for impaired skin integrity
Impaired tissue integrity
Impaired dentition
Risk for suffocation
Risk for aspiration
Ineffective airway clearance
Risk for peripheral neurovascular dysfunction
Ineffective protection
Risk for sudden infant death syndrome
Risk for self-mutilation
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Self-mutilation
Risk for other-directed violence
Risk for self-directed violence
Risk for suicide
Risk for poisoning
Latex allergy response
Risk for latex allergy response
Risk for imbalanced body temperature
Ineffective thermoregulation
Hypothermia
Hyperthermia
Readiness for enhanced immunization status
Risk for contamination
Contamination
Domain 12: Comfort
Acute pain
Chronic pain
Nausea
Impaired comfort
Readiness for enhanced comfort
Social isolation
Domain 13: Growth/Development
Delayed growth and development
Risk for disproportionate growth
Adult failure to thrive
Risk for delayed development
Source: NANDA International nursing diagnoses: Deﬁ nitions and clas-
siﬁ cation 2009-2011. (2009). Hoboken, NJ: Wiley-Blackwell. With 
permission. 
 INTERNET REFERENCES
 • http://www.apna.org
 • http://www.nanda.org
 • http://www.nursecominc.com
INTRODUCTION ● xxxv
2506_FM_i-xxxvi.indd   xxxv 10/4/10   3:53:29 PM
2506_FM_i-xxxvi.indd   xxxvi 10/4/10   3:53:30 PM
1Nursing has struggled for many years to achieve recognition as a 
profession. Out of this struggle has emerged an awareness of the 
need to do the following:
 1. Deﬁ ne the boundaries of nursing (What is nursing?).
 2. Identify a scientiﬁ c method for delivering nursing care. 
In its statement on social policy, the American Nurses 
Association (ANA) presented the following deﬁ nition: 
Nursing is the protection, promotion, and optimization of health 
and abilities, prevention of illness and injury, alleviation of suffer-
ing through the diagnosis and treatment of human response, and 
advocacy in the care of individuals, families, communities, and 
populations (ANA, 2010, p. 10). 
The nursing process has been identiﬁ ed as nursing’s scien-
tiﬁ c methodology for the delivery of nursing care. The curricula 
of most nursing schools include nursing process as a component 
of their conceptual frameworks. The National Council of State 
Boards of Nursing (NCSBN) has integrated the nursing proc-
ess throughout the test plan for the National Council Licensure 
Examination for Registered Nurses (NCSBN, 2010). Questions 
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that relate to nursing behaviors in a variety of client situations 
are presented according to the steps of the nursing process:
 1. Assessment: Establishing a database on a client
 2. Diagnosis: Identifying the client’s health care needs and 
selecting goals of care
 3. Outcome identifi cation: Establishing criteria for measuring 
achievement of desired outcomes
 4. Planning: Designing a strategy to achieve the goals established 
for client care
 5. Implementation: Initiating and completing actions necessary 
to accomplish the goals
 6. Evaluation: Determining the extent to which the goals of 
care have been achieved 
By following these six steps, the nurse has a systematic frame-
work for decision-making and problem-solving in the delivery of 
nursing care. The nursing process is dynamic, not static. It is an 
ongoing process that continues for as long as the nurse and client 
have interactions directed toward change in the client’s physical 
or behavioral responses. Figure 1-1 presents a schematic of the 
ongoing nursing process.
Diagnosis is an integral part of the nursing process. In this 
step, the nurse identiﬁ es the human responses to actual or 
potential health problems. In some states, diagnosing is identi-
ﬁ ed within the Nurse Practice Acts as a legal responsibility of 
Figure 1-1: The ongoing nursing process.
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the professional nurse. Nursing diagnosis provides the basis 
for prescribing the speciﬁ c interventions for which the nurse 
is accountable.
As an inherent part of the nursing process, nursing diagno-
sis is included in the ANA Standards of Practice. These stand-
ards provide one broad basis for evaluating practice and reﬂ ect 
recognition of the rights of the person receiving nursing care 
(ANA, 2010).
● CONCEPT MAPPING
Concept mapping is a diagrammatic teaching and learning strat-
egy that allows students and faculty to visualize interrelation-
ships between medical diagnoses, nursing diagnoses, assessment 
data, and treatments. The concept map care plan is an innovative 
approach to planning and organizing nursing care. Basically, it 
is a diagram of client problems and interventions. Compared 
to the commonly used column-format care plans, concept map 
care plans are more succinct. They are practical, realistic, and 
time-saving, and they serve to enhance critical-thinking skills 
and clinical reasoning ability.
The nursing process is foundational to developing and us-
ing the concept map care plan, just as it is with all types of 
nursing care plans. Client data are collected and analyzed, 
nursing diagnoses are formulated, outcome criteria are identi-
ﬁ ed, nursing actions are planned and implemented, and the 
success of the interventions in meeting the outcome criteria 
is evaluated.
The concept map care plan may be presented in its entirety 
on one page, or the assessment data and nursing diagnoses may 
appear in diagram format on one page, with outcomes, inter-
ventions, and evaluation written on a second page. Additionally, 
the diagram may appear in circular format, with nursing diag-
noses and interventions branching off the “client” in the center 
of the diagram. Or, it may begin with the “client” at the top 
of the diagram, with branches emanating in a linear fashion 
downward.
As stated previously, the concept map care plan is based 
on the components of the nursing process. Accordingly, the 
diagram is assembled in the nursing process stepwise fashion, 
beginning with the client and his or her reason for needing 
care, nursing diagnoses with subjective and objective clinical 
evidence for each, nursing interventions, and outcome criteria 
for evaluation.
Various colors may be used in the diagram to designate vari-
ous components of the care plan. Lines are drawn to connect 
the various components to indicate any relationships that exist. 
For example, there may be a relationship between two nursing 
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diagnoses (e.g., there may be a relationship between the nursing 
diagnoses of pain or anxiety and disturbed sleep pattern). A line 
between these nursing diagnoses should be drawn to show the 
relationship. 
Concept map care plans allow for a great deal of creativity on 
the part of the user, and they permit viewing the “whole picture” 
without generating a great deal of paperwork. Because they re-
ﬂ ect the steps of the nursing process, concept map care plans 
also are valuable guides for the documentation of client care. 
Doenges, Moorhouse, and Murr (2008) state, 
As students, you are asked to develop plans of care that often con-
tain more detail than what you see in the hospital plans of care. 
This is to help you learn how to apply the nursing process and 
create individualized client care plans. However, even though 
much time and energy may be spent focusing on ﬁ lling the col-
umns of traditional clinical care plan forms, some students never 
develop a holistic view of their clients and fail to visualize how 
each client need interacts with other identiﬁ ed needs. A new tech-
nique or learning tool [concept mapping] has been developed to 
assist you in visualizing the linkages, enhance your critical think-
ing skills, and to facilitate the creative process of planning client 
care (p. 35). 
An example of one format for a concept map care plan is 
presented in Figure 1-2.
The purpose of this book is to assist students and staff nurses 
as they endeavor to provide high-quality nursing care to their 
psychiatric clients. The following is an example of a nursing his-
tory and assessment tool that may be used to gather informa-
tion about the client during the assessment phase of the nursing 
process. 
●  NURSING HISTORY AND ASSESSMENT TOOL
 I. General Information
Client name:  Allergies: 
Room number:  Diet: 
Doctor:  Height/weight: 
Age:  Vital signs:  TPR/BP 
Sex:  Name and phone no. of
  signiﬁ cant other: 
Race: 
Dominant language:  City of residence: 
Marital status:  Diagnosis (admitting 
  & current): 
Chief complaint:  
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Outcomes Outcomes
Medication
Nursing Actions Nursing Actions
Nursing
Diagnosis
Nursing
Diagnosis
Signs and
Symptoms
Signs and
Symptoms
Medical Diagnosis
Figure 1-2:  Example of a format for a concept map care plan.
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 II. Conditions of admission
Date:  Time: 
Accompanied by: 
Route of admission (wheelchair; ambulatory; cart): 
Admitted from: 
III. Predisposing Factors
 A. Genetic Inﬂ uences
 1. Family conﬁ guration (use genograms):
 Family of origin:  Present family: 
  Family dynamics (describe signiﬁ cant 
relationships between family members): 
 2. Medical/psychiatric history:
 a. Client:
 b. Family member 
    
    
 3.  Other genetic inﬂ uences affecting present 
adaptation. This might include effects speciﬁ c to 
gender, race, appearance, such as genetic physical 
defects, or any other factor related to genetics that 
is affecting the client’s adaptation that has not been 
mentioned elsewhere in this assessment.
 
 
 B. Past Experiences
 1. Cultural and social history:
 a.  Environmental factors (family living arrange-
ments, type of neighborhood, special working
conditions): 
 b.  Health beliefs and practices (personal responsibility 
 for health; special self-care practices):
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 c.  Religious beliefs and practices: 
 d.  Educational background: 
 e.  Signiﬁ cant losses/changes (include dates): 
 f.  Peer/friendship relationships: 
 g.  Occupational history: 
 h.  Previous pattern of coping with stress: 
 i.   Other lifestyle factors contributing to present 
adaptation: 
 C. Existing Conditions
 1. Stage of development (Erikson):
 a. Theoretically: 
 b. Behaviorally: 
 c. Rationale: 
  
  
 2. Support systems: 
 3. Economic security: 
 4. Avenues of productivity/contribution:
 a. Current job status: 
 b.  Role contributions and responsibility for others: 
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IV. Precipitating Event
Describe the situation or events that precipitated this illness/
hospitalization: 
 V. Client’s Perception of the Stressor
Client’s or family member’s understanding or description of 
stressor/illness and expectations of hospitalization: 
VI. Adaptation Responses
 A. Psychosocial
 1.  Anxiety level (circle level, and check the 
behaviors that apply):
Mild Moderate Severe Panic
Calm  Friendly  Passive 
Alert  Perceives environment correctly 
Cooperative  Impaired attention  
“Jittery”  Unable to concentrate 
Hypervigilant  Tremors  Rapid speech 
Withdrawn  Confused 
Disoriented  Fearful  Hyperventilating 
Misinterpreting the environment 
(hallucinations or delusions)  
Depersonalization  Obsessions  
Compulsions  Somatic complaints  
Excessive hyperactivity  Other 
 2. Mood/affect (circle as many as apply):  
Happiness Sadness Dejection Despair
Elation Euphoria Suspiciousness
Apathy (little emotional tone) Anger/hostility
 3.  Ego defense mechanisms (describe how used 
by client):
Projection 
Suppression 
Undoing 
Displacement 
Intellectualization 
Rationalization 
Denial 
Repression 
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Isolation 
Regression 
Reaction formation 
Splitting 
Religiosity 
Sublimation 
Compensation 
 4.  Level of self-esteem (circle one):
low moderate  high
Things client likes about self 
Things client would like to change about self 
Nurse’s objective assessment of self-esteem:
Eye contact 
General appearance 
Personal hygiene 
Participation in group activities and interactions 
with others 
 5. Stage and manifestations of grief (circle one):
Denial Anger Bargaining Depression 
Acceptance
Describe the client’s behaviors that are associated 
with this stage of grieving in response to loss or 
change. 
 6. Thought processes (circle as many as apply): 
Clear Logical Easy to follow Relevant
Confused Blocking Delusional Rapid ﬂ ow 
    of thoughts
Slowness in thought association Suspicious
Recent memory: Loss Intact
Remote memory: Loss Intact
Other: 
 7.  Communication patterns (circle as many as 
apply):
Clear Coherent Slurred  Incoherent
   speech
Neologisms Loose  Flight of 
 associations ideas
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Aphasic  Perseveration Rumination
Tangential  Loquaciousness
speech
Slow, impoverished speech
Speech impediment (describe) 
Other 
 8.  Interaction patterns (describe client’s pattern of 
interpersonal interactions with staff and peers on 
the unit, e.g., manipulative, withdrawn, isolated, 
verbally or physically hostile, argumentative, passive, 
assertive, aggressive, passive-aggressive, other): 
 9. Reality orientation (check those that apply):
Oriented to: Time  Person 
 Place  Situation 
 10.  Ideas of destruction to self/others?   Yes   No
If yes, consider plan; available means 
 B. Physiological
 1.  Psychosomatic manifestations (describe any somatic 
complaints that may be stress-related): 
 2. Drug history and assessment:
Use of prescribed drugs:
   PRESCRIBED 
NAME DOSAGE FOR RESULTS
Use of over-the-counter drugs:
NAME DOSAGE USED FOR RESULTS
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Use of street drugs or alcohol:
  HOW WHEN
 AMOUNT OFTEN LAST EFFECTS
NAME USED USED USED PRODUCED
 3. Pertinent physical assessments:
 a. Respirations: Normal  Labored 
  Rate  Rhythm 
 b. Skin: Warm  Dry  Moist 
  Cool  Clammy  Pink 
  Cyanotic  Poor turgor  Edematous 
  Evidence of: Rash  Bruising 
  Needle tracks  Hirsutism  Loss of hair 
  Other 
 c. Musculoskeletal status: Weakness  
  Tremors 
  Degree of range of motion (describe limitations)  
  
  Pain (describe) 
  Skeletal deformities (describe) 
  Coordination (describe limitations) 
 d. Neurological status:
  History of (check all that apply):
  Seizures (describe method of control) 
  
  Headaches (describe location and frequency) 
  Fainting spells  Dizziness 
  Tingling/numbness (describe location) 
 e. Cardiovascular:  B/P  Pulse 
  History of (check all that apply):
  Hypertension  Palpitations 
  Heart murmur  Chest pain 
  Shortness of breath  Pain in legs 
  Phlebitis  Ankle/leg edema 
  Numbness/tingling in extremities 
  Varicose veins 
 f. Gastrointestinal:
  Usual diet pattern: 
  Food allergies: 
  Dentures? Upper  Lower 
  Any problems with chewing or 
  swallowing? 
  Any recent change in weight? 
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  Any problems with:
  Indigestion/heartburn? 
  Relieved by 
  Nausea/vomiting? 
  Relieved by 
  History of ulcers? 
  Usual bowel pattern 
  Constipation?  Diarrhea? 
   Type of self-care assistance provided for either of 
the above problems 
 g. Genitourinary/Reproductive:
  Usual voiding pattern 
   Urinary hesitancy?  
Frequency? 
  Nocturia?  Pain/burning? 
  Incontinence? 
  Any genital lesions? 
  Discharge?  Odor? 
  History of sexually transmitted disease? 
  If yes, please explain: 
  Any concerns about sexuality/sexual activity? 
  Method of birth control used 
  Females:
  Date of last menstrual cycle 
  Length of cycle 
  Problems associated with menstruation? 
  Breasts:  Pain/tenderness? 
  Swelling?  Discharge?
  Lumps?  Dimpling? 
  Practice breast self-examination? 
  Frequency? 
  Males:
  Penile discharge? 
  Prostate problems?
 h. Eyes:
 Yes No Explain
Glasses?   
Contacts?   
Swelling?   
Discharge?   
Itching?   
Blurring?   
Double vision?   
12 ● THE FOUNDATION FOR PLANNING PSYCHIATRIC NURSING CARE
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  i. Ears:
 Yes No Explain
Pain?   
Drainage?   
 Difﬁ culty 
hearing?             
Hearing aid?   
Tinnitus?   
 j. Medication side effects:
   What symptoms is the client experiencing that 
may be attributed to current medication usage? 
 k. Altered lab values and possible signiﬁ cance: 
  
 l. Activity/rest patterns:
  Exercise (amount, type, frequency) 
  Leisure time activities: 
  Patterns of sleep:  Number of hours per night 
  Use of sleep aids? 
  Pattern of awakening during the night? 
  Feel rested upon awakening? 
 m. Personal hygiene/activities of daily living:
Patterns of self-care: Independent 
Requires assistance with: 
 Mobility 
 Hygiene 
 Toileting 
 Feeding 
 Dressing 
 Other 
Statement describing personal hygiene and 
general appearance 
 n. Other pertinent physical assessments:  
  
VII. Summary of Initial Psychosocial/
Physical Assessment:
Knowledge Deﬁ cits Identiﬁ ed: 
Nursing Diagnoses Indicated: 
Nursing Process: One Step to Professionalism ● 13
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● BACKGROUND ASSESSMENT DATA
Several common psychiatric disorders may arise or become 
evident during infancy, childhood, or adolescence. Essential fea-
tures of many disorders are identical, regardless of the age of the 
individual. Examples include the following:
There are, however, several disorders that appear during the 
early developmental years and are identiﬁ ed according to the 
child’s ability or inability to perform age-appropriate tasks or 
intellectual functions. Selected disorders are presented here. It 
Cognitive disorders
Schizophrenia
Schizophreniform disorder
Adjustment disorder
Sexual disorders
Personality disorders
Substance-related disorders
Mood disorders
Somatoform disorders
Psychological factors affect-
ing medical condition
U N I T  T W O
ALTERATIONS IN 
PSYCHOSOCIAL 
ADAPTATION
C H A P T E R  2
Disorders Usually 
First Diagnosed in 
Infancy, Childhood, or 
Adolescence
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is essential that the nurse working with these clients understand 
normal behavior patterns characteristic of the infant, childhood, 
and adolescent years.
● MENTAL RETARDATION
Deﬁ ned
Mental retardation is deﬁ ned by deﬁ cits in general intellectual 
functioning and adaptive functioning and measured by an indi-
vidual’s performance on intelligence quotient (IQ) tests (American 
Psychiatric Association [APA], 2000).  Mental retardation is cod-
ed on Axis II in the APA (2000) Diagnostic and Statistical Manual 
of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR) 
Classiﬁ cation (see Appendix L). Mental retardation is further 
categorized (by IQ level) as follows:
Mild (IQ of 50–70)
Moderate (IQ of 35–49)
Severe (IQ of 20–34)
Profound (IQ below 20)
Predisposing Factors
 1. Physiological
 a. About 5% of cases of mental retardation are caused by 
hereditary factors, such as Tay-Sachs disease, phenylke-
tonuria, and hyperglycinemia. Chromosomal disorders, 
such as Down syndrome and Klinefelter syndrome, have 
also been implicated.
 b. Events that occur during the prenatal period (e.g., fetal 
malnutrition, viral and other infections, maternal ingestion 
of alcohol or other drugs, and uncontrolled diabetes) and 
the perinatal period (e.g., birth trauma or premature sepa-
ration of the placenta) can result in mental retardation. 
 c. Mental retardation can occur as an outcome of childhood 
illnesses, such as encephalitis or meningitis, or be the 
result of poisoning or physical trauma in childhood. 
 2. Psychosocial
 a. From 15% to 20% of cases of mental retardation are attrib-
uted to deprivation of nurturance and social, linguistic, and 
other stimulation and to severe mental disorders, such as 
autistic disorder (APA, 2000). 
Symptomatology (Subjective and Objective Data)
 1. At the mild level (IQ of 50–70), the individual can live in-
dependently but with some assistance. He or she is capable 
of sixth-grade–level work and can learn a vocational skill. 
Social skills are possible, but the individual functions best in 
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a structured, sheltered setting. Coordination may be slightly 
affected.
 2. At the moderate level (IQ of 35–49), the individual can per-
form some activities independently but requires supervision. 
Academic skill can be achieved to about the second-grade 
level. The individual may experience some limitation in 
speech communication and in interactions with others. 
Motor development may be limited to gross motor ability.
 3. The severe level of mental retardation (IQ of 20–34) is charac-
terized by the need for complete supervision. Systematic habit 
training may be accomplished, but the individual does not 
have the ability for academic or vocational training. Verbal 
skills are minimal and psychomotor development is poor.
 4. The profoundly mentally retarded individual (IQ of less than 
20) has no capacity for independent living. Constant aid and 
supervision are required. No ability exists for academic or vo-
cational training. There is a lack of ability for speech develop-
ment, socialization skills, or ﬁ ne or gross motor movements. 
The individual requires constant supervision and care. 
Common Nursing Diagnoses and 
Interventions for the Client with Mental 
Retardation
(Interventions are applicable to various health care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.) 
●
 RISK FOR INJURY
Deﬁ nition: At risk of injury as a result of environmental 
conditions interacting with the individual’s adaptive and 
defensive resources
Related/Risk Factors (“related to”)
Altered physical mobility
[Aggressive behavior]
Goals/Objectives
Short-/Long-term Goal
Client will not experience injury.
Interventions with Selected Rationales
 1. To ensure client safety: 
 a. Create a safe environment for client. Remove small items 
from the area where client will be ambulating and move 
sharp items out of his or her reach.
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 b. Store items that client uses frequently within easy reach.
 c. Pad side rails and headboard of client with history of 
seizures.
 d. Prevent physical aggression and acting out behaviors 
by learning to recognize signs that client is becoming 
agitated. 
Outcome Criteria
 1. Client has experienced no physical harm.
 2. Client responds to attempts to inhibit agitated behavior. 
●
 SELF-CARE DEFICIT
Deﬁ nition: Impaired ability to perform or complete [activities of 
daily living] for self 
Possible Etiologies (“related to”)
Musculoskeletal impairment
Cognitive impairment
Deﬁ ning Characteristics (“evidenced by”)
Inability to wash body 
Inability to put on clothing
Inability to bring food from receptacle to mouth
[Inability to toilet self without assistance] 
Goals/Objectives
Short-term Goal
Client will be able to participate in aspects of self-care.
Long-term Goal
Client will have all self-care needs met.
Interventions with Selected Rationales
 1. Identify aspects of self-care that may be within client’s 
capabilities. Work on one aspect of self-care at a time. 
Provide simple, concrete explanations. Because clients’ 
capabilities vary so widely, it is important to know each 
client individually and to ensure that no client is set up 
to fail.
 2. Offer positive feedback for efforts at assisting with own 
self-care. Positive reinforcement enhances self-esteem and 
encourages repetition of desirable behaviors.
 3. When one aspect of self-care has been mastered to the 
best of client’s ability, move on to another. Encourage inde-
pendence but intervene when client is unable to perform. Cli-
ent comfort and safety are nursing priorities. 
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Outcome Criteria
 1. Client assists with self-care activities to the best of his or her 
ability.
 2. Client’s self-care needs are being met. 
●
 IMPAIRED VERBAL COMMUNICATION
Deﬁ nition: Decreased, delayed, or absent ability to receive, pro-
cess, transmit, and use a system of symbols [to communicate] 
Possible Etiologies (“related to”)
[Developmental alteration]
Deﬁ ning Characteristics (“evidenced by”)
Speaks or verbalizes with difﬁ culty
Difﬁ culty forming words or sentences
Difﬁ culty expressing thought verbally
Inappropriate verbalization
Does not or cannot speak 
Goals/Objectives
Short-term Goal
Client will establish trust with caregiver and a means of com-
municating needs.
Long-term Goals
 1. Client’s needs are being met through established means of 
communication.
 2. If client cannot speak or communicate by other means, needs 
are met by caregiver’s anticipation of client’s needs.
Interventions with Selected Rationales
 1. Maintain consistency of staff assignment over time. This 
facilitates trust and the ability to understand client’s ac-
tions and communication.
 2. Anticipate and fulﬁ ll client’s needs until satisfactory com-
munication patterns are established. Learn (from family, 
if possible) special words client uses that are different from 
the norm.
 3. Identify nonverbal gestures or signals that client may use 
to convey needs if verbal communication is absent. Practice 
these communication skills repeatedly. Some children with 
mental retardation, particularly at the severe level, can 
only learn by systematic habit training. 
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Outcome Criteria
 1. Client is able to communicate with consistent caregiver.
 2. (For client who is unable to communicate): Client’s needs, as 
anticipated by caregiver, are being met.
●
 IMPAIRED SOCIAL INTERACTION
Deﬁ nition: Insuffi cient or excessive quantity or ineffective qual-
ity of social exchange
Possible Etiologies (“related to”)
[Speech deﬁ ciencies]
[Difﬁ culty adhering to conventional social behavior (because of 
delayed maturational development)]
Deﬁ ning Characteristics (“evidenced by”)
Use of unsuccessful social interaction behaviors
Dysfunctional interaction with others
[Observed] discomfort in social situations
Goals/Objectives
Short-term Goal
Client will attempt to interact with others in the presence of 
trusted caregiver.
Long-term Goal
Client will be able to interact with others using behaviors that 
are socially acceptable and appropriate to developmental level.
Interventions with Selected Rationales
 1. Remain with client during initial interactions with others. 
The presence of a trusted individual provides a feeling of 
security.
 2. Explain to other clients the meaning of some of client’s 
nonverbal gestures and signals. Others may be more accepting 
of client’s differentness if they have a better understanding of 
his or her behavior.
 3. Use simple language to explain to client which behaviors 
are acceptable and which are not. Establish a procedure for 
behavior modiﬁ cation that offers rewards for appropriate be-
haviors and renders an aversive reinforcement in response to 
the use of inappropriate behaviors. Positive, negative, and 
aversive reinforcements can contribute to desired changes in 
behavior. The privileges and penalties are individually deter-
mined as caregiver learns the likes and dislikes of client.
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Outcome Criterion
 1. Client interacts with others in a socially appropriate manner.
● AUTISTIC DISORDER 
Deﬁ ned
Autistic disorder is characterized by a withdrawal of the child 
into the self and into a fantasy world of his or her own creation. 
Activities and interests are restricted and may be considered 
somewhat bizarre. In 2009, the Centers for Disease Control 
and Prevention reported that in the United States 1.1% of chil-
dren aged 3 to 17 years had an autism spectrum disorder (ASD). 
ASD includes several disorders with similar symptoms based 
on level of severity. These include autistic disorder, Rett’s disor-
der, childhood disintegrative disorder, pervasive developmen-
tal disorder not otherwise speciﬁ ed, and Asperger’s disorder.
Autistic disorder occurs about four times more often in boys than 
in girls. Onset of the disorder occurs before age 3, and in most cases 
it runs a chronic course, with symptoms persisting into adulthood. 
Predisposing Factors
 1. Physiological
 a. Genetics. An increased risk of autistic disorder exists 
among siblings of individuals with the disorder (APA, 
2000). Studies with both monozygotic and dizygotic twins 
have also provided evidence of a genetic involvement.
 b. Neurological Factors. Abnormalities in brain structures 
or functions have been correlated with autistic disorder 
(National Institute of Mental Health [NIMH], 2009). 
Certain developmental problems, such as postnatal neu-
rological infections, congenital rubella, phenylketonuria, 
and fragile X syndrome, also have been implicated.
Symptomatology (Subjective and Objective 
Data)
 1. Failure to form interpersonal relationships, characterized by 
unresponsiveness to people; lack of eye contact and facial re-
sponsiveness; indifference or aversion to affection and physical 
contact. In early childhood, there is a failure to develop coop-
erative play and friendships.
 2. Impairment in communication (verbal and nonverbal) char-
acterized by absence of language or, if developed, often an 
immature grammatical structure, incorrect use of words, 
echolalia, or inability to use abstract terms. Accompanying 
nonverbal expressions may be inappropriate or absent.
 3. Bizarre responses to the environment, characterized by resis-
tance or extreme behavioral reactions to minor occurrences; 
abnormal, obsessive attachment to peculiar objects; ritualis-
tic behaviors.
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 4. Extreme fascination for objects that move (e.g., fans, trains). 
Special interest in music, playing with water, buttons, or 
parts of the body.
 5. Unreasonable insistence on following routines in precise 
detail (e.g., insisting that exactly the same route always be 
followed when shopping).
 6. Marked distress over changes in trivial aspects of environ-
ment (e.g., when a vase is moved from its usual position).
 7. Stereotyped body movements (e.g., hand ﬂ icking or 
twisting, spinning, head banging, complex whole-body 
movements). 
Common Nursing Diagnoses and 
Interventions for the Client with 
Autistic Disorder
(Interventions are applicable to various health care settings, such as in-
patient and partial hospitalization, community outpatient clinic, home 
health, and private practice.)
●
 RISK FOR SELF-MUTILATION
Deﬁ nition: At risk for deliberate self-injurious behavior causing 
tissue damage with the intent of causing nonfatal injury to attain 
relief of tension 
Related/Risk Factors (“related to”)
[Neurological alterations]
[History of self-mutilative behaviors in response to increasing 
anxiety]
[Obvious indifference to environment or hysterical reactions to 
changes in the environment] 
Goals/Objectives
Short-term Goal
Client will demonstrate alternative behavior (e.g., initiating in-
teraction between self and nurse) in response to anxiety within 
speciﬁ ed time. (Length of time required for this objective will 
depend on severity and chronicity of the disorder.)
Long-term Goal
Client will not inﬂ ict harm on self.
Interventions with Selected Rationales
 1. Intervene to protect child when self-mutilative behaviors, 
such as head banging or other hysterical behaviors, become 
evident. The nurse is responsible for ensuring client safety.
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 2. A helmet may be used to protect against head banging, 
hand mitts to prevent hair pulling, and appropriate pad-
ding to protect extremities from injury during hysterical 
movements.
 3. Try to determine if self-mutilative behaviors occur in response 
to increasing anxiety and, if so, to what the anxiety may be 
attributed. Mutilative behaviors may be averted if the cause 
can be determined.
 4. Work on one-to-one basis with child to establish trust.
 5. Offer self to child during times of increasing anxiety, in or-
der to decrease need for self-mutilative behaviors and provide 
feelings of security. 
Outcome Criteria
 1. Anxiety is maintained at a level at which client feels no need 
for self-mutilation.
 2. When feeling anxious, client initiates interaction between 
self and nurse. 
● IMPAIRED SOCIAL INTERACTION
Deﬁ nition: Insuffi cient or excessive quantity or ineffective 
quality of social exchange 
Possible Etiologies (“related to”)
Self-concept disturbance
Absence of [available] signiﬁ cant others
[Unfulﬁ lled tasks of trust versus mistrust]
[Neurological alterations]
Deﬁ ning Characteristics (“evidenced by”)
[Lack of responsiveness to, or interest in, people]
[Failure to cuddle]
[Lack of eye contact and facial responsiveness]
[Indifference or aversion to affection and physical contact]
[Failure to develop cooperative play and peer friendships]
Goals/Objectives
Short-term Goal
Client will demonstrate trust in one caregiver (as evidenced 
by facial responsiveness and eye contact) within speciﬁ ed time 
(depending on severity and chronicity of disorder).
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Long-term Goal
Client will initiate social interactions (physical, verbal, nonver-
bal) with caregiver by discharge from treatment.
Interventions with Selected Rationales
 1. Function in a one-to-one relationship with child. Consisten-
cy of staff–client interaction enhances the establishment of 
trust.
 2. Provide child with familiar objects (favorite toys, blanket). 
These items will offer security during times when child feels 
distressed.
 3. Convey a manner of warmth, acceptance, and availability as cli-
ent attempts to fulﬁ ll basic needs. These characteristics enhance 
establishment and maintenance of a trusting relationship.
 4. Go slowly. Do not force interactions. Begin with positive 
reinforcement for eye contact. Gradually introduce touch, 
smiling, hugging. The autistic client may feel threatened by 
an onslaught of stimuli to which he or she is unaccustomed.
 5. Support client with your presence as he or she endeavors 
to relate to others in the environment. The presence of 
an individual with whom a trusting relationship has been 
established provides a feeling of security. 
Outcome Criteria
 1. Client initiates interactions between self and others.
 2. Client uses eye contact, facial responsiveness, and other 
nonverbal behaviors in interactions with others.
 3. Client does not withdraw from physical contact. 
●
 IMPAIRED VERBAL 
COMMUNICATION
Deﬁ nition: Decreased, delayed, or absent ability to receive, pro-
cess, transmit, and use a system of symbols [to communicate] 
Possible Etiologies (“related to”)
[Inability to trust]
[Withdrawal into the self]
[Neurological alterations]
Deﬁ ning Characteristics (“evidenced by”)
Does not or cannot speak.
[Immature grammatical structure]
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[Echolalia]
[Pronoun reversal]
[Inability to name objects]
[Inability to use abstract terms]
[Absence of nonverbal expression (e.g., eye contact, facial 
responsiveness, gestures)]
Goals/Objectives
Short-term Goal
Client will establish trust with one caregiver (as evidenced by 
facial responsiveness and eye contact) by speciﬁ ed time (depend-
ing on severity and chronicity of disorder).
Long-term Goal
Client will have established a means for communicating (verbally 
or nonverbally) needs and desires to staff by time of discharge 
from treatment.
Interventions with Selected Rationales
 1. Maintain consistency in assignment of caregivers. Consistency 
facilitates trust and enhances caregiver’s ability to under-
stand child’s attempts to communicate.
 2. Anticipate and fulﬁ ll client’s needs until satisfactory com-
munication patterns are established. Anticipating needs 
helps to minimize frustration while child is learning com-
munication skills.
 3. Use the techniques of consensual validation and seeking 
clariﬁ cation to decode communication patterns. (Examples: 
“I think you must have meant...” or “Did you mean to say 
that...?”) (see Appendix E). These techniques work to verify 
the accuracy of the message received, or to clarify any hid-
den meanings within the message. Take caution not to “put 
words into client’s mouth.”
 4. Use “en face” approach (face-to-face, eye-to-eye) to convey cor-
rect nonverbal expressions by example. Eye contact expresses 
genuine interest in, and respect for, the individual. 
Outcome Criteria
 1. Client is able to communicate in a manner that is understood 
by others.
 2. Client’s nonverbal messages are congruent with verbalizations.
 3. Client initiates verbal and nonverbal interaction with others. 
●
 DISTURBED PERSONAL IDENTITY 
Deﬁ nition: Inability to maintain an integrated and complete 
perception of self 
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Possible Etiologies (“related to”)
[Unfulﬁ lled tasks of trust versus mistrust]
[Neurological alterations]
[Inadequate sensory stimulation]
Deﬁ ning Characteristics (“evidenced by”)
[Inability to separate own physiological and emotional needs 
from those of others]
[Increased levels of anxiety resulting from contact with others]
[Inability to differentiate own body boundaries from those of 
others]
[Repeating words he or she hears others say or mimicking move-
ments of others]
Goals/Objectives
Short-term Goal
Client will name own body parts and body parts of caregiver within 
speciﬁ ed time (depending on severity and chronicity of disorder).
Long-term Goal
Client will develop ego identity (evidenced by ability to recog-
nize physical and emotional self as separate from others) by time 
of discharge from treatment.
Interventions with Selected Rationales 
 1. Function in a one-to-one relationship with child. Consisten-
cy of staff–client interaction enhances the establishment of 
trust.
 2. Assist child to recognize separateness during self-care activi-
ties, such as dressing and feeding. These activities increase 
child’s awareness of self as separate from others.
 3. Point out and assist child in naming own body parts. This 
activity may increase child’s awareness of self as separate 
from others.
 4. Gradually increase amount of physical contact, using touch 
to point out differences between client and nurse. Be cautious 
with touch until trust is established, because this gesture may 
be interpreted by client as threatening.
 5. Use mirrors and drawings or pictures of child to reinforce 
child’s learning of body parts and boundaries. 
Outcome Criteria
 1. Client is able to differentiate own body parts from those of 
others.
 2. Client communicates ability to separate self from environ-
ment by discontinuing use of echolalia (repeating words 
heard) and echopraxia (imitating movements seen). 
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● DISRUPTIVE BEHAVIOR DISORDERS
Attention-Deﬁ cit/Hyperactivity Disorder 
Deﬁ ned
Attention-deﬁ cit/hyperactivity disorder (ADHD) is character-
ized by a “persistent pattern of inattention and/or hyperactivity- 
impulsivity that is more frequent and severe than is typically 
observed in individuals at a comparable level of development” 
(APA, 2000). The disorder is frequently not diagnosed until 
the child begins school because, prior to that time, childhood 
behavior is much more variable than that of older children. 
ADHD is 4 to 9 times more common in boys than in girls and may 
occur in as many as 3% to 7% of school-age children. The course 
can be chronic, persisting into adulthood. The DSM-IV-TR 
further categorizes the disorder into the following subtypes: com-
bined type, predominantly inattentive type, and predominantly 
hyperactive-impulsive type.
Predisposing Factors
 1. Physiological
 a. Genetics. A number of studies have indicated that heredi-
tary factors may be implicated in the predisposition to 
ADHD. Siblings of hyperactive children are more likely 
than normal children to have the disorder.
 b. Biochemical. Abnormal levels of the neurotransmitters 
dopamine, norepinephrine, and possibly serotonin have 
been suggested as a causative factor.
 c. Prenatal, Perinatal, and Postnatal Factors. Maternal 
smoking during pregnancy has been linked to ADHD in 
offspring (Linnet et al., 2005). Intrauterine exposure to 
toxic substances, including alcohol, can produce effects on 
behavior. Premature birth, fetal distress, precipitated or 
prolonged labor, and perinatal asphyxia have also been im-
plicated. Postnatal factors include cerebral palsy, epilepsy, 
and other central nervous system abnormalities resulting 
from trauma, infections, or other neurological disorders.
 2. Psychosocial
 a. Environmental Infl uences. Disorganized or chaotic en-
vironments or a disruption in family equilibrium may 
predispose some individuals to ADHD. A high degree of 
psychosocial stress, maternal mental disorder, paternal 
criminality, low socioeconomic status, poverty, growing up 
in an institution, and unstable foster care are factors that 
have been implicated (Dopheide, 2001; Voeller, 2004).
Symptomatology (Subjective and Objective Data)
 1. Difﬁ culties in performing age-appropriate tasks. 
 2. Highly distractible. 
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 3. Extremely limited attention span.
 4. Shifts from one uncompleted activity to another.
 5. Impulsivity, or deﬁ cit in inhibitory control, is common.
 6. Difﬁ culty forming satisfactory interpersonal relationships.
 7. Disruptive and intrusive behaviors inhibit acceptable social 
interaction.
 8. Difﬁ culty complying with social norms.
 9. Some children with ADHD are very aggressive or op-
positional. Others exhibit more regressive and immature 
behaviors. 
10. Low frustration tolerance and outbursts of temper are 
common.
11.  Boundless energy, exhibiting excessive levels of activity, 
restlessness, and ﬁ dgeting
12. Often described as “perpetual motion machines,” continu-
ously running, jumping, wiggling, or squirming 
13. They experience a greater than average number of 
accidents, from minor mishaps to more serious incidents 
that may lead to physical injury or the destruction of 
property. 
Conduct Disorder 
Deﬁ ned
The DSM-IV-TR describes the essential feature of this disor-
der as a “repetitive and persistent pattern of conduct in which 
the basic rights of others or major age-appropriate societal 
norms or rules are violated” (APA, 2000).  The conduct is more 
serious than the ordinary mischief and pranks of children and 
adolescents. The disorder is more common in boys than in 
girls, and the behaviors may continue into adulthood, often 
meeting the criteria for antisocial personality disorder. Con-
duct disorder is divided into two subtypes based on the age at 
onset: childhood-onset type (onset of symptoms before age 10 
years) and adolescent-onset type (absence of symptoms before 
age 10 years).
Predisposing Factors
 1. Physiological
 a. Birth Temperament. The term temperament refers to 
personality traits that become evident very early in 
life and may be present at birth. Evidence suggests a 
genetic component in temperament and an association 
between temperament and behavioral problems later 
in life.
 b. Genetics. Twin studies have revealed a signiﬁ cantly higher 
number of conduct disorders among those who have family 
members with the disorder.
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 2. Psychosocial
 a. Peer Relationships. Social groups have a signiﬁ cant im-
pact on a child’s development. Peers play an essential 
role in the socialization of interpersonal competence, 
and skills acquired in this manner affect the child’s long-
term adjustment. Studies have shown that poor peer re-
lations during childhood were consistently implicated in 
the etiology of later deviance (Ladd, 1999). Aggression 
was found to be the principal cause of peer rejection, thus 
contributing to a cycle of maladaptive behavior.
 b. Theory of Family Dynamics. The following factors related 
to family dynamics have been implicated as contributors 
in the predisposition to this disorder (Foley et al., 2004; 
Popper et al., 2003; Sadock & Sadock, 2007): 
● Parental rejection
● Inconsistent management with harsh discipline
● Early institutional living
● Frequent shifting of parental ﬁ gures
● Large family size
● Absent father
● Parents with antisocial personality disorder and/or 
alcohol dependence
● Association with a delinquent subgroup
● Marital conﬂ ict and divorce
● Inadequate communication patterns
● Parental permissiveness
Symptomatology (Subjective and Objective Data)
 1. Uses physical aggression in the violation of the rights of 
others. 
 2. The behavior pattern manifests itself in virtually all areas of 
the child’s life (home, school, with peers, and in the commu-
nity). 
 3. Stealing, ﬁ ghting, lying, and truancy are common prob-
lems. 
 4. There is an absence of feelings of guilt or remorse.
 5. The use of tobacco, liquor, or nonprescribed drugs, as well 
as the participation in sexual activities, occurs earlier than 
the peer group’s expected age. 
 6. Projection is a common defense mechanism.
 7. Low self-esteem is manifested by a “tough guy” image. 
Often threatens and intimidates others.
 8. Characteristics include poor frustration tolerance, irritabil-
ity, and frequent temper outbursts. 
 9. Symptoms of anxiety and depression are not uncommon. 
10. Level of academic achievement may be low in relation to age 
and IQ.
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11. Manifestations associated with ADHD (e.g., attention difﬁ -
culties, impulsiveness, and hyperactivity) are very common 
in children with conduct disorder.
Oppositional Deﬁ ant Disorder 
Deﬁ ned
The DSM-IV-TR deﬁ nes this disorder as a pattern of negativistic, 
deﬁ ant, disobedient, and hostile behavior toward authority ﬁ gures 
that occurs more frequently than is typically observed in individu-
als of comparable age and developmental level (APA, 2000). The 
disorder typically begins by 8 years of age and usually not later 
than early adolescence. The disorder is more prevalent in boys 
than in girls and is often a developmental antecedent to conduct 
disorder.
Predisposing Factors
 1. Physiological
 a. Refer to this section under Conduct Disorder.
 2. Psychosocial
 a. Theory of Family Dynamics. It is thought that some par-
ents interpret average or increased levels of developmen-
tal oppositionalism as hostility and a deliberate effort on 
the part of the child to be in control. If power and con-
trol are issues for parents, or if they exercise authority 
for their own needs, a power struggle can be established 
between the parents and the child that sets the stage for 
the development of oppositional deﬁ ant disorder.
Symptomatology (Subjective and Objective Data)
 1. Characterized by passive-aggressive behaviors such as stub-
bornness, procrastination, disobedience, carelessness, nega-
tivism, testing of limits, resistance to directions, deliberately 
ignoring the communication of others, and unwillingness to 
compromise.
 2. Other symptoms that may be evident are running away, school 
avoidance, school underachievement, temper tantrums, ﬁ ght-
ing, and argumentativeness.
 3. In severe cases, there may be elective mutism, enuresis, en-
copresis, or eating and sleeping problems.
 4. Blames others for mistakes and misbehavior.
 5. Has poor peer relationships. 
Common Nursing Diagnoses and 
Interventions for Clients with Disruptive 
Behavior Disorders
(Interventions are applicable to various health care settings, such as in-
patient and partial hospitalization, community outpatient clinic, home 
health, and private practice.) 
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●
 RISK FOR SELF-DIRECTED OR 
OTHER-DIRECTED VIOLENCE
Deﬁ nition: At risk for behaviors in which an individual demon-
strates that he or she can be physically, emotionally, and/or sexu-
ally harmful [either to self or to others] 
Related/Risk Factors (“related to”)
[Unsatisfactory parent–child relationship]
[Neurological alteration related to premature birth, fetal 
distress, precipitated or prolonged labor]
[Dysfunctional family system]
[Disorganized or chaotic environments]
[Child abuse or neglect]
[Birth temperament]
Body language (e.g., rigid posture, clenching of ﬁ sts and jaw, 
hyperactivity, pacing, breathlessness, threatening stances) 
[History or threats of violence toward self or others or of 
destruction to the property of others]
Impulsivity
[History of] cruelty to animals
Suicidal ideation, plan [available means]
Goals/Objectives
Short-term Goals
 1. Client will seek out staff at any time if thoughts of harming 
self or others should occur.
 2. Client will not harm self or others. 
Long-term Goal
Client will not harm self or others.
Interventions with Selected Rationales
 1. Observe client’s behavior frequently. Do this through rou-
tine activities and interactions to avoid appearing watchful 
and suspicious. Clients at high risk for violence require 
close observation to prevent harm to self or others.
 2. Observe for suicidal behaviors: verbal statements, such as 
“I’m going to kill myself” or “Very soon my mother won’t 
have to worry herself about me any longer,” or nonverbal be-
haviors, such as giving away cherished items or mood swings. 
Most clients who attempt suicide have communicated their 
intent, either verbally or nonverbally.
 3. Determine suicidal intent and available means. Ask, “Do 
you plan to kill yourself?” and “How do you plan to do it?” 
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Direct, closed-ended questions are appropriate in this in-
stance. The client who has a usable plan is at higher risk 
than one who does not.
 4. Obtain verbal or written contract from client agreeing not to 
harm self and agreeing to seek out staff in the event that such 
ideation occurs. Discussion of suicidal feelings with a trusted 
individual provides a degree of relief to client. A contract 
gets the subject out in the open and places some of the re-
sponsibility for his or her safety with client. An attitude of 
acceptance of client as a worthwhile individual is conveyed.
 5. Help client to recognize when anger occurs and to accept those 
feelings as his or her own. Have client keep an “anger note-
book,” in which a record of anger experienced on a 24-hour 
basis is kept. Information regarding source of anger, behav-
ioral response, and client’s perception of the situation should 
also be noted. Discuss entries with client, suggesting alterna-
tive behavioral responses for those identiﬁ ed as maladaptive.
 6. Act as a role model for appropriate expression of angry feel-
ings, and give positive reinforcement to client for attempting 
to conform. It is vital that client express angry feelings, be-
cause suicide and other self-destructive behaviors are often 
viewed as a result of anger turned inward on the self.
 7. Remove all dangerous objects from client’s environment. 
Client’s physical safety is a nursing priority.
 8. Try to redirect violent behavior with physical outlets for 
client’s anxiety (e.g., punching bag, jogging, volleyball). 
Anxiety and tension can be relieved safely and with benefi t 
to client in this manner.
 9. Be available to stay with client as anxiety level and tensions 
begin to rise. The presence of a trusted individual provides 
a feeling of security.
 10. Staff should maintain and convey a calm attitude to client. 
Anxiety is contagious and can be communicated from staff 
to client and vice versa. A calm attitude conveys a sense of 
control and a feeling of security to client.
 11.  Have sufﬁ cient staff available to indicate a show of strength 
to client if it becomes necessary. This conveys to client an 
evidence of control over the situation and provides some 
physical security for staff.
 12. Administer tranquilizing medications as ordered by physi-
cian, or obtain an order if necessary. Monitor medication 
for effectiveness and for adverse side effects. Short-term use 
of antianxiety medications (e.g., chlordiazepoxide, alpra-
zolam, lorazepam) provides relief from the immobilizing 
effects of anxiety and facilitates client’s cooperation with 
therapy.
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13. Mechanical restraints or isolation room may be required 
if less restrictive interventions are unsuccessful. It is 
client’s right to expect the use of techniques that ensure 
the safety of client and others by the least restrictive 
means. 
Outcome Criteria
 1. Anxiety is maintained at a level at which client feels no need 
for aggression.
 2. Client seeks out staff to discuss true feelings.
 3. Client recognizes, verbalizes, and accepts possible conse-
quences of own maladaptive behaviors.
 4. Client does not harm self or others. 
● DEFENSIVE COPING
Deﬁ nition: Repeated projection of falsely positive self-evaluation 
based on a self-protective pattern that defends against underlying 
perceived threats to positive self-regard
Possible Etiologies (“related to”)
[Low self-esteem]
[Negative role models]
[Lack of positive feedback]
[Repeated negative feedback, resulting in feelings of 
diminished self-worth]
[Unsatisfactory parent–child relationship]
[Disorganized or chaotic environments]
[Child abuse or neglect]
[Dysfunctional family system]
[Neurological alteration related to premature birth, fetal 
distress, precipitated or prolonged labor]
Deﬁ ning Characteristics (“evidenced by”)
Denial of obvious problems or weaknesses
Projection of blame or responsibility
Rationalization of failures
Hypersensitivity to criticism
Grandiosity
Superior attitude toward others
Difﬁ culty establishing or maintaining relationships
Hostile laughter or ridicule of others
Difﬁ culty in perception of reality testing
Lack of follow-through or participation in treatment or therapy
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Goals/Objectives
Short-term Goal
Client will verbalize personal responsibility for difﬁ culties 
experienced in interpersonal relationships.
Long-term Goal
Client will demonstrate ability to interact with others with-
out becoming defensive, rationalizing behaviors, or expressing 
grandiose ideas.
Interventions with Selected Rationales
 1. Recognize and support basic ego strengths. Focusing on 
positive aspects of the personality may help to improve self-
concept.
 2. Encourage client to recognize and verbalize feelings of 
inadequacy and need for acceptance from others and to 
recognize how these feelings provoke defensive behaviors, 
such as blaming others for own behaviors. Recognition of 
the problem is the fi rst step in the change process toward 
resolution.
 3. Provide immediate, matter-of-fact, nonthreatening feed-
back for unacceptable behaviors. Client may lack knowledge 
about how he or she is being perceived by others. Providing 
this information in a nonthreatening manner may help to 
eliminate these undesirable behaviors. 
CLINICAL PEARL           Say to the client, “When you say those things to people, 
they don’t like it, and they don’t want to be around you. Try to think how you would 
feel if someone said those things to you.”
 4. Help client identify situations that provoke defensiveness 
and practice through role-play more appropriate responses. 
Role-playing provides confi dence to deal with diffi cult situ-
ations when they actually occur.
 5. Provide immediate positive feedback for acceptable behav-
iors. Positive feedback enhances self-esteem and encourages 
repetition of desirable behaviors.
 6. Help client set realistic, concrete goals and determine 
appropriate actions to meet those goals. Success increases 
self-esteem.
 7. With client, evaluate the effectiveness of the new behaviors 
and discuss any modiﬁ cations for improvement. Because of 
limited problem-solving ability, assistance may be required 
to reassess and develop new strategies in the event that some 
new coping methods prove ineffective. 
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Outcome Criteria
 1. Client verbalizes and accepts responsibility for own behavior.
 2. Client verbalizes correlation between feelings of inadequacy 
and the need to defend the ego through rationalization and 
grandiosity.
 3. Client does not ridicule or criticize others.
 4. Client interacts with others in group situations without 
taking a defensive stance. 
● IMPAIRED SOCIAL INTERACTION
Deﬁ nition: Insuffi cient or excessive quantity or ineffective qual-
ity of social exchange  
Possible Etiologies (“related to”)
Self-concept disturbance
 [Neurological alterations related to premature birth, fetal dis-
tress, precipitated or prolonged labor]
[Dysfunctional family system]
[Disorganized or chaotic environments]
[Child abuse or neglect]
[Unsatisfactory parent–child relationship]
[Negative role models]
Deﬁ ning Characteristics (“evidenced by”)
[Verbalized or observed] discomfort in social situations
[Verbalized or observed] inability to receive or communicate 
a satisfying sense of belonging, caring, interest, or shared 
history
[Observed] use of unsuccessful social interaction behaviors
Dysfunctional interaction with others
[Behavior unacceptable for appropriate age by dominant 
cultural group]
Goals/Objectives
Short-term Goal
Client will interact in age-appropriate manner with nurse in 
one-to-one relationship within 1 week.
Long-term Goal
Client will be able to interact with staff and peers, by the time of 
discharge from treatment, with no indication of discomfort.
Interventions with Selected Rationales
 1. Develop trusting relationship with client. Be honest; keep 
all promises; convey acceptance of the person, separate from 
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unacceptable behaviors (“It is not you, but your behavior, that 
is unacceptable.”) Acceptance of client increases his or her 
feelings of self-worth.
 2. Offer to remain with client during initial interactions with 
others. Presence of a trusted individual provides a feeling of 
security.
 3. Provide constructive criticism and positive reinforcement for 
client’s efforts. Positive feedback enhances self-esteem and 
encourages repetition of desirable behaviors.
 4. Confront client and withdraw attention when interactions 
with others are manipulative or exploitative. Attention to the 
unacceptable behavior may reinforce it.
 5. Act as a role model for client through appropriate interac-
tions with other clients and staff members.
 6. Provide group situations for client. It is through these group 
interactions that client will learn socially acceptable behavior, 
with positive and negative feedback from his or her peers. 
Outcome Criteria
 1. Client seeks out staff member for social, as well as therapeutic, 
interaction.
 2. Client has formed and satisfactorily maintained one inter-
personal relationship with another client.
 3. Client willingly and appropriately participates in group 
activities.
 4. Client verbalizes reasons for past inability to form close 
interpersonal relationships. 
●
 INEFFECTIVE COPING
Deﬁ nition: Inability to form a valid appraisal of the stressors, in-
adequate choices of practiced responses, and/or inability to use 
available resources 
Possible Etiologies (“related to”)
Situational crisis
Maturational crisis
[Inadequate support systems]
[Inadequate coping strategies]
[Negative role models]
[Neurological alteration related to premature birth, fetal 
distress, precipitated or prolonged labor]
[Low self-esteem]
[Dysfunctional family system]
[Disorganized or chaotic environments]
[Child abuse or neglect]
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Deﬁ ning Characteristics (“evidenced by”)
Inability to meet [age-appropriate] role expectations
Inadequate problem solving
Poor concentration
Risk taking
[Manipulation of others in the environment for purposes of ful-
ﬁ lling own desires]
[Verbal hostility toward staff and peers]
[Hyperactivity, evidenced by excessive motor activity, easily dis-
tracted, short attention span]
[Unable to delay gratiﬁ cation]
[Oppositional and deﬁ ant responses to adult requests or rules]
Goals/Objectives
Short-term Goal
Within 7 days, client will demonstrate ability and willingness to 
follow rules of the treatment setting.
Long-term Goal
By discharge from treatment, client will develop, and use, age-
appropriate, socially acceptable coping skills.
Interventions with Selected Rationales
 1. If client is hyperactive, make environment safe for continuous 
large-muscle movement. Rearrange furniture and other objects 
to prevent injury. Client physical safety is a nursing priority.
 2. Provide large motor activities in which client may partici-
pate. Nurse may join in some of these activities to facilitate 
relationship development. Tension is released safely and 
with benefi t to client through physical activities.
 3. Provide frequent, nutritious snacks that client may “eat on 
the run,” to ensure adequate calories to offset client’s exces-
sive use of energy. 
CLINICAL PEARL          Set limits on manipulative behavior.
Say, “I understand why you are saying these things (or doing these things) 
and I will not tolerate these behaviors from you.” Take caution not to reinforce 
manipulative behaviors by providing desired attention.
 4. Identify for client the consequences of manipulative behavior. 
All staff must follow through and be consistent. Client may 
try to play one staff member against another, so consistency 
is vital if intervention is to be successful. Aversive reinforce-
ment may work to decrease unacceptable behaviors.
 5. Do not debate, argue, rationalize, or bargain with client. 
Ignoring these attempts may work to decrease manipulative 
behaviors.
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 6. Caution should be taken to avoid reinforcing manipulative 
behaviors by providing desired attention. Attention provides 
positive reinforcement and encourages repetition of the 
undesirable behavior.
 7. Confront client’s use of manipulative behaviors and explore 
their damaging effects on interpersonal relationships. Manip-
ulative clients often deny responsibility for their behaviors.
 8. Encourage discussion of angry feelings. Help client identify 
the true object of the hostility. Dealing with the feelings 
honestly and directly will discourage displacement of the 
anger onto others.
 9. Explore with client alternative ways of handling frustration 
that would be most suited to his or her lifestyle. Provide sup-
port and positive feedback to client as new coping strategies 
are tried. Positive feedback encourages use of the acceptable 
behaviors. 
Outcome Criteria
 1. Client is able to delay gratiﬁ cation, without resorting to ma-
nipulation of others.
 2. Client is able to express anger in a socially acceptable manner.
 3. Client is able to verbalize alternative, socially acceptable, and 
lifestyle-appropriate coping skills he or she plans to use in 
response to frustration. 
●
 LOW SELF-ESTEEM 
Deﬁ nition:  Negative self-evaluating/feelings about self or self-
capabilities 
Possible Etiologies (“related to”)
[Negative role models]
Lack of approval
Repeated negative reinforcement
[Unsatisfactory parent–child relationship]
[Disorganized or chaotic environments]
[Child abuse or neglect]
[Dysfunctional family system]
Deﬁ ning Characteristics (“evidenced by”)
Lack of eye contact
Exaggerates negative feedback about self
Expressions of shame or guilt
Evaluation of self as unable to deal with events
Rejects positive feedback about self
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Hesitant to try new things or situations
[Denial of problems obvious to others]
[Projection of blame or responsibility for problems]
[Rationalization of personal failures]
[Hypersensitivity to criticism]
[Grandiosity]
Goals/Objectives
Short-term Goal
Client will independently direct own care and activities of daily 
living within 1 week.
Long-term Goal
By time of discharge from treatment, client will exhibit increased 
feelings of self-worth as evidenced by verbal expression of positive 
aspects about self, past accomplishments, and future prospects.
Interventions with Selected Rationales
 1. Ensure that goals are realistic. It is important for client to 
achieve something, so plan for activities in which the pos-
sibility for success is likely. Success enhances self-esteem.
 2. Convey unconditional positive regard for client. Commu-
nication of your acceptance of him or her as a worthwhile 
human being increases self-esteem.
 3. Spend time with client, both on a one-to-one basis and in 
group activities. This conveys to client that you feel he or she 
is worth your time.
 4. Assist client in identifying positive aspects of self and in 
developing plans for changing the characteristics he or she 
views as negative.
 5. Help client decrease use of denial as a defense mechanism. 
Give positive reinforcement for problem identiﬁ cation and 
development of more adaptive coping behaviors. Positive 
reinforcement enhances self-esteem and increases client’s 
use of acceptable behaviors.
 6. Encourage and support client in confronting the fear of fail-
ure by having client attend therapy activities and undertake 
new tasks. Offer recognition of successful endeavors and 
positive reinforcement for attempts made. Recognition and 
positive reinforcement enhance self-esteem. 
Outcome Criteria
 1. Client verbalizes positive perception of self.
 2. Client participates in new activities without exhibiting 
extreme fear of failure. 
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● ANXIETY (MODERATE TO SEVERE)
Deﬁ nition: Vague uneasy feeling of discomfort or dread accom-
panied by an autonomic response (the source often nonspecifi c 
or unknown to the individual); a feeling of apprehension caused 
by anticipation of danger. It is an alerting signal that warns of im-
pending danger and enables the individual to take measures to 
deal with threat. 
Possible Etiologies (“related to”)
Situational and maturational crises
Threat to self-concept [perceived or real]
Threat of death
Unmet needs
[Fear of failure]
[Dysfunctional family system]
[Unsatisfactory parent–child relationship]
[Innately, easily agitated temperament since birth]
Deﬁ ning Characteristics (“evidenced by”)
Overexcited
Fearful
Feelings of inadequacy
Fear of unspeciﬁ ed consequences
Restlessness
Insomnia
Poor eye contact
Focus on self
[Continuous attention-seeking behaviors]
Difﬁ culty concentrating
Impaired attention
Increased respiration and pulse
Goals/Objectives
Short-term Goals 
 1. Within 7 days, client will be able to verbalize behaviors that 
become evident as anxiety starts to rise.
 2. Within 7 days, client will be able to verbalize strategies to 
interrupt escalation of anxiety.
Long-term Goal
By time of discharge from treatment, client will be able to main-
tain anxiety below the moderate level as evidenced by absence of 
disabling behaviors in response to stress.
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Interventions with Selected Rationales
 1. Establish a trusting relationship with client. Be honest, con-
sistent in responses, and available. Show genuine positive 
regard. Honesty, availability, and acceptance promote trust 
in the nurse–client relationship.
 2. Provide activities geared toward reduction of tension and 
decreasing anxiety (walking or jogging, volleyball, musical 
exercises, housekeeping chores, group games). Tension and 
anxiety are released safely and with benefi t to client through 
physical activities.
 3. Encourage client to identify true feelings, and to acknowl-
edge ownership of those feelings. Anxious clients often deny 
a relationship between emotional problems and their anxi-
ety. Use of the defense mechanisms of projection and dis-
placement is exaggerated.
 4. Nurse must maintain an atmosphere of calmness; anxiety 
is easily transmitted from one person to another.
 5. Offer support during times of elevated anxiety. Reassure 
client of physical and psychological safety. Client safety is a 
nursing priority.
 6. Use of touch is comforting to some clients. However, nurse 
must be cautious with its use, because anxiety may foster 
suspicion in some individuals who might misinterpret touch 
as aggression.
 7. As anxiety diminishes, assist client to recognize speciﬁ c 
events that preceded its onset. Work on alternative responses 
to future occurrences. A plan of action provides client with 
a feeling of security for handling a diffi cult situation more 
successfully, should it recur.
 8. Help client recognize signs of escalating anxiety, and explore 
ways client may intervene before behaviors become disabling.
 9. Administer tranquilizing medication, as ordered. Assess for 
effectiveness, and instruct client regarding possible adverse 
side effects. Short-term use of antianxiety medications (e.g., 
lorazepam, chlordiazepoxide, alprazolam) provides relief 
from the immobilizing effects of anxiety and facilitates 
client’s cooperation with therapy. 
Outcome Criteria
 1. Client is able to verbalize behaviors that become evident 
when anxiety starts to rise, and takes appropriate action to 
interrupt progression of the condition.
 2. Client is able to maintain anxiety at a manageable level. 
●
 NONCOMPLIANCE
Deﬁ nition: Behavior of person and/or caregiver that fails to 
coincide with a health-promoting or therapeutic plan agreed on 
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by the person [or caregiver] and health care professional. In the 
presence of an agreed-on, health-promoting or therapeutic plan, 
person’s or caregiver’s behavior is fully or partially nonadher-
ent and may lead to clinically ineffective or partially ineffective 
outcomes. 
Possible Etiologies (“related to”)
[Biochemical alteration]
[Neurological alteration related to premature birth, fetal 
distress, precipitated or prolonged labor]
[Negative temperament]
[Dysfunctional family system]
[Negative role models]
[Retarded ego development]
[Low frustration tolerance and short attention span]
[Denial of problems]
Deﬁ ning Characteristics (“evidenced by”)
Behavior indicative of failure to adhere [to treatment regimen]
[Inability to sit still long enough to complete a task]
[Expression of opposition to requests for participation]
[Refusal to follow directions or suggestions of treatment team]
Goals/Objectives
Short-term Goal
Client will participate in and cooperate during therapeutic 
activities.
Long-term Goal
Client will complete assigned tasks willingly and independently 
or with a minimum of assistance.
Interventions with Selected Rationales
For the client with inattention and hyperactivity:
 1. Provide an environment for task efforts that is as free of dis-
tractions as possible. Client is highly distractible and is unable 
to perform in the presence of even minimal stimulation.
 2. Provide assistance on a one-to-one basis, beginning with 
simple, concrete instructions. Client lacks the ability to 
assimilate information that is complicated or has abstract 
meaning.
 3. Ask that instructions be repeated to determine client’s level 
of comprehension.
 4. Establish goals that allow client to complete a part of the task, 
rewarding completion of each step with a break for physical 
activity. Short-term goals are not so overwhelming to client 
with such a short attention span. The positive reinforcement 
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(physical activity) increases self-esteem and provides incen-
tive for client to pursue the task to completion.
 5. Gradually decrease the amount of assistance given to task 
performance, while assuring client that assistance is still 
available if deemed necessary. This encourages client to per-
form independently while providing a feeling of security 
with the presence of a trusted individual. 
For the client with oppositional tendencies:
 6. Set forth a structured plan of therapeutic activities. Start 
with minimum expectations and increase as client begins 
to manifest evidence of compliance. Structure provides 
security, and one or two activities may not seem as over-
whelming as the whole schedule of activities presented at 
one time.
 7. Establish a system of rewards for compliance with therapy 
and consequences for noncompliance. Ensure that the re-
wards and consequences are concepts of value to client. Posi-
tive and negative reinforcements can contribute to desired 
changes in behavior.
 8. Convey acceptance of client separate from the undesirable 
behaviors being exhibited. (“It is not you, but your behavior, 
that is unacceptable.”) Unconditional acceptance enhances 
self-worth and may contribute to a decrease in the need for 
passive-aggressive behavior toward others. 
Outcome Criteria
 1. Client cooperates with staff in an effort to complete assigned 
tasks.
 2. Client complies with treatment by participating in therapies 
without negativism.
 3. Client takes direction from staff without becoming defensive. 
● TOURETTE’S DISORDER 
Deﬁ ned
Tourette’s disorder is characterized by the presence of multiple 
motor tics and one or more vocal tics that may appear simulta-
neously or at different periods during the illness (APA, 2000). 
Onset of the disorder can be as early as 2 years, but it occurs 
most commonly during childhood (around age 6 to 7 years). 
Tourette’s disorder is more common in boys than in girls. The 
duration of the disorder may be lifelong, although there may 
be periods of remission that last from weeks to years (APA, 
2000). The symptoms usually diminish during adolescence and 
adulthood and, in some cases, disappear altogether by early 
adulthood.
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Predisposing Factors
 1. Physiological
 a. Genetics. Family studies have shown that Tourette’s dis-
order is more common in relatives of individuals with 
the disorder than in the general population. It may 
be transmitted in an autosomal pattern intermediate 
between dominant and recessive (Sadock & Sadock, 
2007). 
 b. Brain Alterations. Altered levels of neurotransmitters 
and dysfunction in the area of the basal ganglia have been 
implicated in the etiology of Tourette’s disorder.
 c. Biochemical Factors. Abnormalities in levels of dopa-
mine, serotonin, dynorphin, gamma-aminobutyric acid 
(GABA), acetylcholine, and norepinephrine have been 
associated with Tourette’s disorder (Popper et al., 2003).
 2. Psychosocial
 a. The genetic predisposition to Tourette’s disorder may 
be reinforced by certain factors in the environ-
ment, such as complications of pregnancy (e.g., severe 
nausea and vomiting or excessive stress), low birth 
weight, head trauma, carbon monoxide poisoning, and 
encephalitis.
Symptomatology (Subjective and Objective 
Data)
Signs and symptoms of Tourette’s disorder are as follows (APA, 
2000; Popper et al., 2003):
 1. The disorder may begin with a single motor tic, such as eye 
blinking, neck jerking, shoulder shrugging, facial grimacing, 
or coughing.
 2. Complex motor tics may follow and include touching, squat-
ting, hopping, skipping, deep knee bends, retracing steps, 
and twirling when walking.
 3. Vocal tics include various words or sounds such as clicks, 
grunts, yelps, barks, sniffs, snorts, coughs; in about 10% of 
cases, a complex vocal tic involves uttering obscenities.
 4. Vocal tics may include repeating certain words or phrases out 
of context, repeating one’s own sounds or words (palilalia), or 
repeating what others say (echolalia).
 5. The movements and vocalizations are experienced as compul-
sive and irresistible, but they can be suppressed for varying 
lengths of time.
 6. Tics are exacerbated by stress and attenuated during periods in 
which the individual becomes totally absorbed by an activity.
 7. Tics are markedly diminished during sleep. 
2506_Ch02_014-053.indd   Sec1:43 10/1/10   9:33:24 AM
44 ●  ALTERATIONS IN PSYCHOSOCIAL ADAPTATION
Common Nursing Diagnoses and Interventions 
for the Client with Tourette’s Disorder
(Interventions are applicable to various health care settings, such as in-
patient and partial hospitalization, community outpatient clinic, home 
health, and private practice.)
●
 RISK FOR SELF-DIRECTED OR 
OTHER-DIRECTED VIOLENCE
Deﬁ nition: At risk for behaviors in which an individual demon-
strates that he or she can be physically, emotionally, and/or sexually 
harmful [either to self or to others] 
Related/Risk Factors (“related to”)
[Low tolerance for frustration]
[Abnormalities in brain neurotransmitters]
Body language (e.g., rigid posture, clenching of ﬁ sts and jaw, hy-
peractivity, pacing, breathlessness, and threatening stances)
[History or threats of violence toward self or others or of 
destruction to the property of others]
Impulsivity
Suicidal ideation, plan, [available means]
Goals/Objectives
Short-term Goals
 1. Client will seek out staff or support person at any time if 
thoughts of harming self or others should occur.
 2. Client will not harm self or others. 
Long-term Goal
Client will not harm self or others.
Interventions with Selected Rationales
 1. Observe client’s behavior frequently through routine activities 
and interactions. Become aware of behaviors that indicate a rise 
in agitation. Stress commonly increases tic behaviors. Recog-
nition of behaviors that precede the onset of aggression may 
provide the opportunity to intervene before violence occurs.
 2. Monitor for self-destructive behavior and impulses. A 
staff member may need to stay with client to prevent self-
mutilation. Client safety is a nursing priority.
 3. Provide hand coverings and other restraints that prevent 
client from self-mutilative behaviors. Provide immediate ex-
ternal controls against self-aggressive behaviors.
 4. Redirect violent behavior with physical outlets for frustra-
tion. Excess energy is released through physical activities 
and a feeling of relaxation is induced.
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 5. Administer medication as ordered by physician. Several 
medications have been used to treat Tourette’s disorder. The 
most common ones include the following: 
 a. Haloperidol (Haldol). Haloperidol has been the drug of 
choice for Tourette’s disorder. Children on this medica-
tion must be monitored for adverse effects associated with 
most antipsychotic medications (see Chapter 28). Because 
of the potential for adverse effects, haloperidol should 
be reserved for children with severe symptoms or with 
symptoms that interfere with their ability to function. 
Usual dosage for children 3 to 12 years of age is 0.05 to 
0.075 mg/kg/day in two or three divided doses.
 b. Pimozide (Orap). The response rate and side effect pro-
ﬁ le of pimozide are similar to those of haloperidol. It is 
used in the management of severe motor or vocal tics that 
have failed to respond to more conventional treatment. 
It is not recommended for children younger than age 
12 years. Dosage is initiated at 0.05 mg/kg at bedtime; 
dosage may be increased every third day to a maximum of 
0.2 mg/kg, not to exceed 10 mg/day.
 c. Clonidine (Catapres). Clonidine is an antihyperten-
sive medication, the efﬁ cacy of which in the treatment of 
Tourette’s disorder has been mixed. Some physicians like 
it and use it as a drug of ﬁ rst choice because of its rela-
tive safety and few side effects. Recommended dosage is 
150 to 200 mcg/day.
 d. Atypical Antipsychotics. Atypical antipsychotics are 
less likely to cause extrapyramidal side effects than are 
the older antipsychotics (e.g., haloperidol and pimo-
zide). Risperidone, the most studied atypical antipsy-
chotic in Tourette’s disorder, has been shown to re-
duce symptoms by 21% to 61% compared with placebo 
(results that are similar to those of pimozide and cloni-
dine) (Dion et al., 2002). Both olanzapine and ziprasi-
done have demonstrated effectiveness in decreasing tic 
symptoms of Tourette’s disorder. However, weight gain 
and abnormal glucose tolerance may be troublesome 
side effects, and ziprasidone has been associated with 
increased risk of QTc interval prolongation (Zinner, 
2004). 
Outcome Criteria
 1. Anxiety is maintained at a level at which client feels no need 
for aggression.
 2. Client seeks out staff or support person for expression of true 
feelings.
 3. Client has not harmed self or others. 
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●
 IMPAIRED SOCIAL INTERACTION
Deﬁ nition: Insuffi cient or excessive quantity or ineffective qual-
ity of social exchange 
Possible Etiologies (“related to”)
Self-concept disturbance
[Low tolerance for frustration]
[Impulsiveness]
[Oppositional behavior]
[Aggressive behavior]
Deﬁ ning Characteristics (“evidenced by”)
[Verbalized or observed] discomfort in social situations
[Verbalized or observed] inability to receive or communicate 
a satisfying sense of belonging, caring, interest, or shared 
history
[Observed] use of unsuccessful social interaction behaviors
Dysfunctional interaction with others
Goals/Objectives
Short-term Goal
Client will develop a one-to-one relationship with nurse or sup-
port person within 1 week.
Long-term Goal
Client will be able to interact with staff and peers using age-
appropriate, acceptable behaviors.
Interventions with Selected Rationales
 1. Develop a trusting relationship with client. Conveyac-
ceptance of the person separate from the unacceptable 
behavior. Unconditional acceptance increases feelings of 
self-worth.
 2. Discuss with client which behaviors are and are not accept-
able. Describe in matter-of-fact manner the consequences of 
unacceptable behavior. Follow through. Aversive reinforce-
ment can alter undesirable behaviors.
 3. Provide group situations for client. Appropriate social behav-
ior is often learned from the positive and negative feedback of 
peers.
 4. Act as a role model for client through appropriate interac-
tions with others. Role modeling of a respected individual is 
one of the strongest forms of learning. 
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Outcome Criteria
 1. Client seeks out staff or support person for social, as well as 
for therapeutic, interaction.
 2. Client verbalizes reasons for past inability to form close 
interpersonal relationships.
 3. Client interacts with others using age-appropriate, acceptable 
behaviors. 
●
 LOW SELF-ESTEEM
Deﬁ nition: Negative self-evaluating/feelings about self or self-
capabilities
Possible Etiologies (“related to”)
[Shame associated with tic behaviors]
Deﬁ ning Characteristics (“evidenced by”)
Lack of eye contact
Self-negating verbalizations
Expressions of shame or guilt
Hesitant to try new things or situations
[Manipulation of others]
Goals/Objectives
Short-term Goal
Client will verbalize positive aspects about self not associated 
with tic behaviors.
Long-term Goal
Client will exhibit increased feeling of self-worth as evidenced 
by verbal expression of positive aspects about self, past accom-
plishments, and future prospects.
Interventions with Selected Rationales
 1. Convey unconditional acceptance and positive regard. Com-
munication of client as worthwhile human being may increase 
self-esteem.
 2. Set limits on manipulative behavior. Take caution not to re-
inforce manipulative behaviors by providing desired atten-
tion. Identify the consequences of manipulation. Administer 
consequences matter-of-factly when manipulation occurs. 
Aversive reinforcement may work to decrease unacceptable 
behaviors.
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 3. Help client understand that he or she uses this behavior in or-
der to try to increase own self-esteem. Interventions should 
reﬂ ect other actions to accomplish this goal. When client feels 
better about self, the need to manipulate others will diminish.
 4. If client chooses to suppress tics in the presence of others, 
provide a speciﬁ ed “tic time,” during which client “vents” 
tics, feelings, and behaviors (alone or with staff). Allows for 
release of tics and assists in sense of control and manage-
ment of symptoms.
 5. Ensure that client has regular one-to-one time with staff or 
support person. One-to-one time gives nurse the opportu-
nity to provide client with information about the illness and 
healthy ways to manage it. Exploring feelings about the illness 
helps client incorporate the illness into a healthy sense of self. 
Outcome Criteria
 1. Client verbalizes positive perception of self.
 2. Client willingly participates in new activities and situations. 
● SEPARATION ANXIETY DISORDER 
Deﬁ ned
The APA (2000) deﬁ nes separation anxiety disorder as “exces-
sive anxiety concerning separation from the home or from those 
to whom the person is attached.” Onset may occur as early as 
preschool age, rarely as late as adolescence, but always before age 
18, and is more common in girls than in boys.
Predisposing Factors
 1. Physiological
 a. Genetics. The results of studies indicate that a greater 
number of children with relatives who manifest anxiety 
problems develop anxiety disorders themselves than do 
children with no such family patterns.
 b. Temperament. Studies have shown that differences in 
temperamental characteristics at birth may be correlated 
to the acquisition of fear and anxiety disorders in child-
hood. This may denote an inherited vulnerability or pre-
disposition toward developing these disorders.
 2. Psychosocial
 a. Stressful Life Events. Studies indicate that children who 
are predisposed to anxiety disorders may be affected 
signiﬁ cantly by stressful life events.
 b. Family Infl uences. Several theories exist that relate 
the development of separation anxiety to the following 
dynamics within the family:
✈ An overattachment to the mother (primary caregiver)
✈ Separation conﬂ icts between parent and child
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✈ Enmeshment of members within a family
✈ Overprotection of the child by the parents
✈ Transfer of parents’ fears and anxieties to the children 
through role modeling
Symptomatology (Subjective and Objective Data)
Symptoms of separation anxiety disorder include the following:
 1. In most cases the child has difﬁ culty separating from the 
mother, although occasionally the separation reluctance is 
directed toward the father, siblings, or other signiﬁ cant indi-
vidual to whom the child is attached.
 2. Anticipation of separation may result in tantrums, crying, 
screaming, complaints of physical problems, and clinging 
behaviors.
 3. Reluctance or refusal to attend school is especially common 
in adolescence.
 4. Younger children may “shadow” or follow around the person 
from whom they are afraid to be separated.
 5. During middle childhood or adolescence he or she may re-
fuse to sleep away from home (e.g., at a friend’s house or 
at camp).
 6. Worrying is common and relates to the possibility of harm 
coming to self or to the attachment ﬁ gure. Younger children 
may have nightmares to this effect.
 7. Speciﬁ c phobias may be present.
 8. Depressed mood is frequently present and often precedes the 
onset of the anxiety symptoms, which commonly occur fol-
lowing a major stressor. 
Common Nursing Diagnoses and 
Interventions for the Client with Separation 
Anxiety Disorder
(Interventions are applicable to various health care settings, such as in-
patient and partial hospitalization, community outpatient clinic, home 
health, and private practice.)
●
 ANXIETY (SEVERE)
Deﬁ nition: Vague uneasy feeling of discomfort or dread accom-
panied by an autonomic response (the source is often nonspecifi c 
or unknown to the individual); a feeling of apprehension caused by 
anticipation of danger. It is an alerting signal that warns of impend-
ing danger and enables the individual to take measures to deal with 
threat. 
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Possible Etiologies (“related to”)
Heredity
[Birth temperament]
[Overattachment to parent]
[Negative role modeling]
Deﬁ ning Characteristics (“evidenced by”)
[Excessive distress when separated from attachment ﬁ gure]
[Fear of anticipation of separation from attachment ﬁ gure]
[Fear of being alone or without attachment ﬁ gure]
[Reluctance or refusal to go to school or anywhere else without 
attachment ﬁ gure]
[Nightmares about being separated from attachment ﬁ gure]
[Somatic symptoms occurring as a result of fear of separation]
Goals/Objectives
Short-term Goal
Client will discuss fears of separation with trusted individual.
Long-term Goal
Client will maintain anxiety at no higher than moderate level in 
the face of events that formerly have precipitated panic.
Interventions with Selected Rationales
 1. Establish an atmosphere of calmness, trust, and genuine pos-
itive regard. Trust and unconditional acceptance are neces-
sary for satisfactory nurse–client relationship. Calmness is 
important because anxiety is easily transmitted from one 
person to another.
 2. Assure client of his or her safety and security. Symptoms of 
panic anxiety are very frightening.
 3. Explore child’s or adolescent’s fears of separating from par-
ents. Explore with parents possible fears they may have of 
separation from child. Some parents may have an underly-
ing fear of separation from child, of which they are un-
aware and which they are unconsciously transferring to 
child.
 4. Help parents and child initiate realistic goals (e.g., 
child to stay with sitter for 2 hours with minimal anxi-
ety or child to stay at friend’s house without parents until 
9:00 pm without experiencing panic anxiety). Parents may 
be so frustrated with child’s clinging and demanding 
behaviors that assistance with problem solving may be 
required.
 5. Give, and encourage parents to give, positive reinforcement 
for desired behaviors. Positive reinforcement encourages 
repetition of desirable behaviors. 
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Outcome Criteria
 1. Client and parents are able to discuss their fears regarding 
separation.
 2. Client experiences no somatic symptoms from fear of 
separation.
 3. Client maintains anxiety at moderate level when separation 
occurs or is anticipated. 
●
 INEFFECTIVE COPING
Deﬁ nition:  Inability to form a valid appraisal of the stressors, in-
adequate choices of practiced responses, and/or inability to use 
available resources 
Possible Etiologies (“related to”)
[Unresolved separation conﬂ icts]
[Inadequate coping skills]
Deﬁ ning Characteristics (“evidenced by”)
[Somatic complaints in response to occurrence or anticipation 
of separation from attachment ﬁ gure]
Goals/Objectives
Short-term Goal
Client will verbalize correlation of somatic symptoms to fear of 
separation.
Long-term Goal
Client will demonstrate use of more adaptive coping strategies 
(than physical symptoms) in response to stressful situations.
Interventions with Selected Rationales
 1. Encourage child or adolescent to discuss speciﬁ c situations 
in life that produce the most distress and describe his or her 
response to these situations. Include parents in the discus-
sion. Client and family may be unaware of the correlation 
between stressful situations and the exacerbation of physical 
symptoms.
 2. Help child or adolescent who is perfectionistic to recognize 
that self-expectations may be unrealistic. Connect times 
of unmet self-expectations to the exacerbation of physical 
symptoms. Recognition of maladaptive patterns is the fi rst 
step in the change process.
 3. Encourage parents and child to identify more adaptive cop-
ing strategies that child could use in the face of anxiety that 
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feels overwhelming. Practice through role-play. Practice fa-
cilitates the use of the desired behavior when individual is 
actually faced with the stressful situation. 
Outcome Criteria
 1. Client and family verbalize the correlation between separa-
tion anxiety and somatic symptoms.
 2. Client verbalizes the correlation between unmet self-
expectations and somatic symptoms.
 3. Client responds to stressful situations without exhibiting 
physical symptoms. 
●
 IMPAIRED SOCIAL INTERACTION
Deﬁ nition: Insuffi cient or excessive quantity or ineffective quality 
of social exchange 
Possible Etiologies (“related to”)
[Reluctance to be away from attachment ﬁ gure]
Deﬁ ning Characteristics (“evidenced by”)
[Symptoms of severe anxiety]
[Verbalized or observed] discomfort in social situations
[Verbalized or observed] inability to receive or communicate 
a satisfying sense of belonging, caring, interest, or shared 
history
[Observed] use of unsuccessful social interaction behaviors
Dysfunctional interaction with others
Goals/Objectives
Short-term Goal
Client will spend time with staff or other support person, with-
out presence of attachment ﬁ gure, without excessive anxiety.
Long-term Goal
Client will be able to spend time with others (without presence 
of attachment ﬁ gure) without excessive anxiety.
Interventions with Selected Rationales
 1. Develop a trusting relationship with client. This is the fi rst 
step in helping client learn to interact with others.
 2. Attend groups with child and support efforts to interact 
with others. Give positive feedback. Presence of a trusted 
individual provides security during times of distress. Positive 
feedback encourages repetition.
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Movie Connections
Bill (MR) • Bill: On His Own (MR) • Sling Blade (MR) 
• Forrest Gump (MR) • Rain Man (autistic disorder) • Mercury Rising 
(autistic disorder) • Niagara, Niagara (Tourette’s disorder) • Toughlove 
(conduct disorder)
 3. Convey to the child the acceptability of his or her not par-
ticipating in group in the beginning. Gradually encourage 
small contributions until client is able to participate more 
fully. Small successes will gradually increase self-confi dence 
and decrease self-consciousness, so that client will feel less 
anxious in the group situation.
 4. Help client set small personal goals (e.g., “Today I will speak 
to one person I don’t know.”). Simple, realistic goals provide 
opportunities for success that increase self-confi dence and 
may encourage client to attempt more diffi cult objectives in 
the future. 
Outcome Criteria
 1. Client spends time with others using acceptable, age-
appropriate behaviors.
 2. Client is able to interact with others away from the attach-
ment ﬁ gure without excessive anxiety. 
 INTERNET REFERENCES 
● Additional information about attention-deﬁ cit/hyperactivity 
disorder may be located at the following websites: 
 a. http://www.chadd.org
 b. http://www.nimh.nih.gov/health/topics/attention-deﬁ cit- 
hyperactivity-disorder-adhd/index.shtml
● Additional information about autism may be located at the 
following websites: 
 a. http://www.autism-society.org
 b. http://www.nimh.nih.gov/health/topics/autism-spectrum-
disorders-pervasive-developmental-disorders/index.shtml
● Additional information about medications to treat attention-
deﬁ cit/hyperactivity disorder may be located at the following 
websites: 
 a. http://www.fadavis.com/townsend
 b. http://www.drugs.com/condit ion/attention-def icit-
disorder.html
 c. http://www.nimh.nih.gov/health/publications/medica-
tions/complete-publication.shtml
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● BACKGROUND ASSESSMENT DATA
Delirium
Deﬁ ned
The American Psychiatric Association (APA, 2000) Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition, Text 
Revision (DSM-IV-TR) deﬁ nes “delirium” as a disturbance of 
consciousness and a change in cognition that develop rapidly 
over a short period. The symptoms of delirium usually begin 
quite abruptly, and the duration is usually brief (e.g., 1 week; 
rarely more than 1 month). The disorder subsides completely 
on recovery from the underlying determinant. If the underly-
ing condition persists, the delirium may gradually shift to the 
syndrome of dementia or progress to coma. The individual then 
recovers, becomes chronically vegetative, or dies.
Predisposing Factors to Delirium
The DSM-IV-TR differentiates among the disorders of 
delirium by their etiology, although they share a common 
symptom presentation. Categories of delirium include the 
following:
 1. Delirium Due to a General Medical Condition. Certain 
medical conditions, such as systemic infections, metabolic 
disorders, ﬂ uid and electrolyte imbalances, liver or kidney 
disease, thiamine deﬁ ciency, postoperative states, hyperten-
sive encephalopathy, postictal states, and sequelae of head 
trauma, can cause the symptoms of delirium.
 2. Substance-Induced Delirium. The symptoms of delirium 
can be induced by the exposure to a toxin or the ingestion 
of medications, such as anticonvulsants, neuroleptics, anx-
iolytics, antidepressants, cardiovascular medications, anti-
neoplastics, analgesics, antiasthmatic agents, antihistamines, 
antiparkinsonian drugs, corticosteroids, and gastrointestinal 
medications.
54
C H A P T E R  3
Delirium, Dementia, 
and Amnestic Disorders
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 3. Substance-Intoxication Delirium. Delirium symptoms can 
occur in response to taking high doses of cannabis, cocaine, 
hallucinogens, alcohol, anxiolytics, or narcotics.
 4. Substance-Withdrawal Delirium. Reduction or termina-
tion of long-term, high-dose use of certain substances, such 
as alcohol, sedatives, hypnotics, or anxiolytics, can result in 
withdrawal delirium symptoms.
 5. Delirium Due to Multiple Etiologies. Symptoms of delir-
ium may be related to more than one general medical condi-
tion or to the combined effects of a general medical condition 
and substance use.
Symptomatology (Subjective and Objective Data) 
The following symptoms have been identiﬁ ed with the syndrome 
of delirium:
 1. Altered consciousness ranging from hypervigilance to stupor 
or semicoma.
 2. Extreme distractibility with difﬁ culty focusing attention.
 3. Disorientation to time and place.
 4. Impaired reasoning ability and goal-directed behavior.
 5. Disturbance in the sleep-wake cycle.
 6. Emotional instability as manifested by fear, anxiety, 
depression, irritability, anger, euphoria, or apathy.
 7. Misperceptions of the environment, including illusions and 
hallucinations.
 8. Autonomic manifestations, such as tachycardia, sweating, 
ﬂ ushed face, dilated pupils, and elevated blood pressure.
 9. Incoherent speech.
 10. Impairment of recent memory.
Dementia
Deﬁ ned
“Dementia” is deﬁ ned by a loss of previous levels of cogni-
tive, executive, and memory function in a state of full alertness 
(Bourgeois, Seaman, & Servis, 2008). The disease usually has a 
slow, insidious onset and is chronic, progressive, and irreversible.
Predisposing Factors to Dementia
Following are major etiologic categories for the syndrome of 
dementia:
 1. Dementia of the Alzheimer’s Type. The exact cause of 
Alzheimer’s disease (AD) is unknown, but several theories 
have been proposed, such as reduction in brain acetylcholine, 
the formation of plaques and tangles, serious head trauma, 
and genetic factors. Pathologic changes in the brain include 
atrophy, enlarged ventricles, and the presence of numerous 
neuroﬁ brillary plaques and tangles. Deﬁ nitive diagnosis is 
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by biopsy or autopsy examination of brain tissue, although 
reﬁ nement of diagnostic criteria and new diagnostic tools 
now enable clinicians to use speciﬁ c clinical features to iden-
tify the disease at an accuracy rate of 70% to 90% (Bourgeois, 
Seaman, & Servis, 2008).
 2. Vascular Dementia. This type of dementia is caused by 
signiﬁ cant cerebrovascular disease. The client suffers the 
equivalent of small strokes caused by arterial hypertension 
or cerebral emboli or thrombi, which destroy many areas of 
the brain. The onset of symptoms is more abrupt than in 
AD and runs a highly variable course, progressing in steps 
rather than as a gradual deterioration.
 3. Dementia Due to HIV Disease. The immune dysfunction 
associated with human immunodeﬁ ciency virus (HIV) dis-
ease can lead to brain infections by other organisms. HIV 
also appears to cause dementia directly.
 4. Dementia Due to Head Trauma. The syndrome of symp-
toms associated with dementia can be brought on by a 
traumatic brain injury.
 5. Dementia Due to Lewy Body Disease. Clinically, Lewy 
body disease is fairly similar to AD; however, it tends to 
progress more rapidly, and there is an earlier appearance 
of visual hallucinations and parkinsonian features (Rabins, 
et al., 2006). This disorder is distinctive by the presence of 
Lewy bodies—eosinophilic inclusion bodies—seen in the 
cerebral cortex and brainstem (Andreasen & Black, 2006). 
 6. Dementia Due to Parkinson’s Disease. Parkinson’s dis-
ease is caused by a loss of nerve cells in the substantia nigra 
of the basal ganglia. The symptoms of dementia associated 
with Parkinson’s disease closely resemble those of AD.
 7. Dementia Due to Huntington’s Disease. This disease is 
transmitted as a Mendelian dominant gene, and damage oc-
curs in the areas of the basal ganglia and the cerebral cortex. 
The average duration of the disease is based on age at onset. 
One study concluded that juvenile-onset and late-onset cli-
ents have the shortest duration (Foroud et al., 1999). In this 
study, the median duration of the disease was 21.4 years.
 8. Dementia Due to Pick’s Disease. Pathology occurs from 
atrophy in the frontal and temporal lobes of the brain. 
Symptoms are strikingly similar to those of AD, and Pick’s 
disease is often misdiagnosed as AD.
 9. Dementia Due to Creutzfeldt-Jakob Disease. This form 
of dementia is caused by a transmissible agent known as a 
“slow virus” or prion. The clinical presentation is typical of 
the syndrome of dementia, and the course is extremely rapid, 
with progressive deterioration and death within 1 year after 
onset.
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 10. Dementia Due to Other General Medical Conditions. A 
number of other general medical conditions can cause demen-
tia. Some of these include endocrine conditions (e.g., hypogly-
cemia, hypothyroidism), pulmonary disease, hepatic or renal 
failure, cardiopulmonary insufﬁ ciency, ﬂ uid and electrolyte 
imbalances, nutritional deﬁ ciencies, frontal or temporal lobe 
lesions, central nervous system (CNS) or systemic infections, 
uncontrolled epilepsy, and other neurological conditions such 
as multiple sclerosis (APA, 2000).
 11. Substance-Induced Persisting Dementia. This type of 
dementia is related to the persisting effects of substances 
such as alcohol, inhalants, sedatives, hypnotics, anxiolyt-
ics, other medications, and environmental toxins. The term 
“persisting” is used to indicate that the dementia persists 
long after the effects of substance intoxication or substance 
withdrawal have subsided.
Symptomatology (Subjective and Objective Data) 
The following symptoms have been identiﬁ ed with the syndrome 
of dementia:
 1. Memory impairment (impaired ability to learn new informa-
tion or to recall previously learned information).
 2. Impairment in abstract thinking, judgment, and impulse 
control.
 3. Impairment in language ability, such as difﬁ culty naming 
objects. In some instances, the individual may not speak at 
all (aphasia).
 4. Personality changes are common.
 5. Impaired ability to perform motor activities despite intact 
motor abilities (apraxia).
 6. Disorientation.
 7. Wandering.
 8. Delusions are common (particularly delusions of persecution).
Amnestic Disorders
Deﬁ ned
Amnestic disorders are characterized by an inability to learn 
new information (short-term memory deﬁ cit) despite normal at-
tention and an inability to recall previously learned information 
(long-term memory deﬁ cit). No other cognitive deﬁ cits exist.
Predisposing Factors to Amnestic Disorders
The DSM-IV-TR identiﬁ es the following categories as etiologies 
for the syndrome of symptoms known as amnestic disorders:
 1. Amnestic Disorder Due to a General Medical Condi-
tion. The symptoms may be associated with head trauma, 
cerebrovascular disease, cerebral neoplastic disease, cerebral 
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anoxia, herpes simplex encephalitis, poorly controlled in-
sulin dependent diabetes, and surgical intervention to the 
brain (APA, 2000; Bourgeois, Seaman, & Servis, 2008). 
Transient amnestic syndromes can also occur from epi-
leptic seizures, electroconvulsive therapy, severe migraine, 
and drug overdose.
 2. Substance-Induced Persisting Amnestic Disorder. This 
type of amnestic disorder is related to the persisting effects 
of substances such as alcohol, sedatives, hypnotics, anxiolyt-
ics, other medications, and environmental toxins. The term 
“persisting” is used to indicate that the symptoms persist 
long after the effects of substance intoxication or substance 
withdrawal have subsided.
Symptomatology (Subjective and Objective Data) 
The following symptoms have been identiﬁ ed with amnestic 
disorder:
 1. Disorientation to place and time may occur with profound 
amnesia.
 2. There is an inability to recall events from the recent past and 
events from the remote past. (Events from the very remote past 
are often more easily recalled than recently occurring ones.)
 3. The individual is prone to confabulation. That is, the in-
dividual may create imaginary events to ﬁ ll in the memory 
gaps.
 4. Apathy, lack of initiative, and emotional blandness are 
common.
Common Nursing Diagnoses and 
Interventions for Delirium, Dementia, 
and Amnestic Disorders
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.) 
●
 RISK FOR TRAUMA
Deﬁ nition: [The client has] accentuated risk of accidental tissue 
injury (e.g., wound, burn, fracture).
Related/Risk Factors (“related to”) 
[Chronic alteration in structure or function of brain tissue, 
secondary to the aging process, multiple infarcts, HIV dis-
ease, head trauma, chronic substance abuse, or progressively 
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dysfunctional physical condition resulting in the following 
symptoms:
Disorientation; confusion
Weakness
Muscular incoordination
Seizures
Memory impairment
Poor vision
Extreme psychomotor agitation observed in the late stages 
of delirium]
[Frequent shufﬂ ing of feet and stumbling]
[Falls, caused by muscular incoordination or seizures]
[Bumping into furniture]
[Exposing self to frigid conditions with insufﬁ cient protective 
clothing]
[Cutting self when using sharp instruments]
[History of attempting to light burner or oven and leaving gas 
on in house]
[Smoking and leaving burning cigarettes in various places; 
smoking in bed; falling asleep sitting on couch or chair with 
lighted cigarette in hand]
[Purposeless, thrashing movements; hyperactivity that is out of 
touch with the environment] 
Goals/Objectives
Short-term Goals
 1. Client will accept assistance when ambulating or carrying 
out other activities.
 2. Client will not experience physical injury.
Long-term Goal
Client will not experience physical injury.
Interventions with Selected Rationales
 1. Assess client’s level of disorientation and confusion to deter-
mine speciﬁ c requirements for safety. Knowledge of client’s 
level of functioning is necessary to formulate appropriate 
plan of care.
 2. Institute appropriate safety measures, such as the following: 
 a. Place furniture in room in an arrangement that best 
accommodates client’s disabilities.
 b. Observe client behaviors frequently; assign staff on one-
to-one basis if condition warrants; accompany and assist 
client when ambulating; use wheelchair for transporting 
long distances.
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 c. Store items that client uses frequently within easy access.
 d. Remove potentially harmful articles from client’s room: 
cigarettes, matches, lighters, sharp objects.
 e. Remain with client while he or she smokes.
 f. Pad side rails and headboard of client with seizure disor-
der. Institute seizure precautions as described in procedure 
manual of individual institution.
 g. If client is prone to wander, provide an area within which 
wandering can be carried out safely. 
 3. Frequently orient client to reality and surroundings. Disori-
entation may endanger client safety if he or she unknowingly 
wanders away from safe environment.
 4. Use tranquilizing medications and soft restraints, as pre-
scribed by physician, for client’s protection during periods 
of excessive hyperactivity. Use restraints judiciously, because 
they can increase agitation. They may be required, however, 
to provide for client safety.
 5. Teach prospective caregivers methods that have been successful 
in preventing client injury. These caregivers will be responsible 
for client’s safety after discharge from the hospital. Sharing 
successful interventions may be helpful.
Outcome Criteria
 1. Client is able to accomplish daily activities within the envi-
ronment without experiencing injury.
 2. Prospective caregivers are able to verbalize means of provid-
ing safe environment for client.
●
 RISK FOR SELF-DIRECTED OR 
OTHER-DIRECTED VIOLENCE
Deﬁ nition: At risk for behaviors in which an individual demon-
strates that he or she can be physically, emotionally, and/or sexually 
harmful [either to self or to others]. 
Related/Risk Factors (“related to”)
[Chronic alteration in structure or function of brain tissue, 
secondary to the aging process, multiple infarcts, HIV dis-
ease, head trauma, chronic substance abuse, or progressively 
dysfunctional physical condition resulting in the following 
symptoms: 
Delusional thinking
Suspiciousness of others
Hallucinations
Illusions
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Disorientation or confusion
Impairment of impulse control]
[Inaccurate perception of the environment]
Body language—rigid posture, clenching of ﬁ sts and jaw, hyper-
activity, pacing, breathlessness, and threatening stances
Suicidal ideation, plan, available means
Cognitive impairment
[Depressed mood] 
Goals/Objectives
Short-term Goals
 1. Client will maintain agitation at manageable level so as not to 
become violent.
 2. Client will not harm self or others.
Long-term Goal
Client will not harm self or others.
Interventions with Selected Rationales
 1. Assess client’s level of anxiety and behaviors that indicate 
the anxiety is increasing. Recognizing these behaviors, nurse 
may be able to intervene before violence occurs.
 2. Maintain low level of stimuli in client’s environment (low 
lighting, few people, simple decor, low noise level). Anxiety 
increases in a highly stimulating environment.
 3. Remove all potentially dangerous objects from client’s en-
vironment. In a disoriented, confused state, client may use 
these objects to harm self or others.
 4. Have sufﬁ cient staff available to execute a physical confronta-
tion, if necessary. Assistance may be required from others to 
provide for physical safety of client or primary nurse or both.
 5. Maintain a calm manner with client. Attempt to prevent 
frightening client unnecessarily. Provide continual reas-
surance and support. Anxiety is contagious and can be 
transferred to client.
 6. Interrupt periods of unreality and reorient. Client safety is 
jeopardized during periods of disorientation. Correcting 
misinterpretations of reality enhances client’s feelings of 
self-worth and personal dignity.
 7. Use tranquilizing medications and soft restraints, as pre-
scribed by physician, for protection of client and others during 
periods of elevated anxiety. Use restraints judiciously, because 
agitation sometimes increases; however, they may be required 
to ensure client safety.
 8. Sit with client and provide one-to-one observation if assessed 
to be actively suicidal. Client safety is a nursing priority, 
and one-to-one observation may be necessary to prevent a 
suicidal attempt.
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 9. Teach relaxation exercises to intervene in times of increas-
ing anxiety.
 10. Teach prospective caregivers to recognize client behaviors 
that indicate anxiety is increasing and ways to intervene 
before violence occurs.
Outcome Criteria
 1. Prospective caregivers are able to verbalize behaviors 
that indicate an increasing anxiety level and ways they 
may assist client to manage the anxiety before violence 
occurs.
 2. With assistance from caregivers, client is able to control 
impulse to perform acts of violence against self or others.
● CHRONIC CONFUSION
Deﬁ nition: Irreversible, long-standing, and/or progressive dete-
rioration of intellect and personality characterized by decreased 
ability to interpret environmental stimuli; decreased capacity for 
intellectual thought processes; and manifested by disturbances of 
memory, orientation, and behavior. 
Possible Etiologies (“related to”)
[Alteration in structure/function of brain tissue, secondary to 
the following conditions: 
Advanced age
Vascular disease
Hypertension
Cerebral hypoxia
Long-term abuse of mood- or behavior-altering 
substances
Exposure to environmental toxins
Various other physical disorders that predispose to 
cerebral abnormalities (see Predisposing Factors)]
Deﬁ ning Characteristics (“evidenced by”)
Altered interpretation
Altered personality
Altered response to stimuli
Clinical evidence of organic impairment
Impaired long-term memory
Impaired short-term memory
Impaired socialization
Longstanding cognitive impairment
No change in level of consciousness
Progressive cognitive impairment
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Goals/Objectives
Short-term Goal
Client will accept explanations of inaccurate interpretations 
within the environment.
Long-term Goal
With assistance from caregiver, client will be able to interrupt 
non–reality-based thinking.
Interventions with Selected Rationales
 1. Frequently orient client to reality and surroundings. Allow 
client to have familiar objects around him or her. Use oth-
er items, such as a clock, a calendar, and daily schedules, to 
assist in maintaining reality orientation. Client safety is 
jeopardized during periods of disorientation. Maintaining 
reality orientation enhances client’s sense of self-worth and 
personal dignity.
 2. Teach prospective caregivers how to orient client to time, 
person, place, and circumstances, as required. These care-
givers will be responsible for client safety after discharge 
from the hospital. Sharing successful interventions may be 
helpful.
 3. Give positive feedback when thinking and behavior are appro-
priate, or when client verbalizes that certain ideas expressed 
are not based in reality. Positive feedback increases self-esteem 
and enhances desire to repeat appropriate behaviors.
 4. Use simple explanations and face-to-face interaction when 
communicating with client. Do not shout message into cli-
ent’s ear. Speaking slowly and in a face-to-face position is 
most effective when communicating with an elderly indi-
vidual experiencing a hearing loss. Visual cues facilitate 
understanding. Shouting causes distortion of high-pitched 
sounds and in some instances creates a feeling of discomfort 
for client.
 5. Express reasonable doubt if client relays suspicious beliefs 
in response to delusional thinking. Discuss with client the 
potential personal negative effects of continued suspicious-
ness of others. Reinforce accurate perception of people and 
situations. Expressions of doubt by a trusted individual may 
foster similar uncertainties about delusion on the part of 
client.
 6. Do not permit rumination of false ideas. When this begins, 
talk to client about real people and real events. Reality ori-
entation increases client’s sense of self-worth and personal 
dignity.
 7. Close observation of client’s behavior is indicated if delusion-
al thinking reveals an intention for violence. Client safety is 
a nursing priority.
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Outcome Criteria
 1. With assistance from caregiver, client is able to distinguish 
between reality-based and non–reality-based thinking.
 2. Prospective caregivers are able to verbalize ways in which to 
orient client to reality, as needed.
●
 SELF-CARE DEFICIT
Deﬁ nition: Impaired ability to perform or complete [activities of 
daily living (ADLs)] for self. 
Possible Etiologies (“related to”)
Cognitive impairment
Deﬁ ning Characteristics (“evidenced by”)
Inability to wash body 
Inability to put on clothing
Inability to bring food from receptacle to mouth
[Inability to toilet self without assistance] 
Goals/Objectives
Short-term Goal
Client will participate in ADLs with assistance from caregiver.
Long-term Goal
Client will accomplish ADLs to the best of his or her ability. 
Unfulﬁ lled needs will be met by caregiver.
Interventions with Selected Rationales
 1. Provide a simple, structured environment to minimize 
confusion: 
 a. Identify self-care deﬁ cits and provide assistance as 
required.
 b. Allow plenty of time for client to perform tasks.
 c. Provide guidance and support for independent actions by 
talking client through the task one step at a time.
CLINICAL PEARL           Medications for Alzheimer’s disease. Cholinesterase 
inhibitors are used for mild to moderate cognitive impairment in clients with 
Alzheimer’s disease. Examples include tacrine (Cognex), donepezil (Aricept), 
rivastigmine (Exelon), and galantamine (Razadyne). Common side effects include 
dizziness, headache, and gastrointestinal upset. Memantine (Namenda), an NMDA 
receptor antagonist, is used for treatment of moderate to severe cognitive impairment 
in clients with Alzheimer’s disease. Common side effects of memantine include 
dizziness, headache, and constipation. These medications do not stop or reverse the 
disease process but may slow down the progression of the decline in functionality. 
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 d. Provide a structured schedule of activities that does not 
change from day to day.
 e. Ensure that ADLs follow home routine as closely as 
possible.
 f. Provide for consistency in assignment of daily caregivers.
 2. In planning for discharge:
 a. Perform ongoing assessment of client’s ability to fulﬁ ll 
nutritional needs, ensure personal safety, follow medi-
cation regimen, and communicate need for assistance 
with those activities that he or she cannot accomplish 
independently. Client safety and security are nursing 
priorities.
 b. Assess prospective caregivers’ ability to anticipate and 
fulﬁ ll client’s unmet needs. Provide information to assist 
caregivers with this responsibility. Ensure that caregivers 
are aware of available community support systems from 
which they can seek assistance when required. This will 
facilitate transition to discharge from treatment center.
 c. National support organizations can provide information:
National Parkinson Foundation, Inc.
1501 NW 9th Ave.
Miami, FL 33136-1494
1-800-327-4545
Alzheimer’s Association
225 N. Michigan Ave., Fl. 17
Chicago, IL 60601-7633
1-800-272-3900
Outcome Criteria
 1. Client willingly participates in ADLs.
 2. Client accomplishes ADLs to the best of his or her ability.
 3. Client’s unfulﬁ lled needs are met by caregivers.
● DISTURBED SENSORY PERCEPTION 
(Specify)
Deﬁ nition: Change in the amount or patterning of incoming stimuli 
[either internally or externally initiated] accompanied by a diminished, 
exaggerated, distorted, or impaired response to such stimuli. 
Possible Etiologies (“related to”)
[Alteration in structure/function of brain tissue, secondary to 
the following conditions: 
Advanced age
Vascular disease
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Hypertension
Cerebral hypoxia
Abuse of mood- or behavior-altering substances
Exposure to environmental toxins
Various other physical disorders that predispose to cere-
bral abnormalities (see Predisposing Factors)]
Deﬁ ning Characteristics (“evidenced by”)
Poor concentration
Sensory distortions
Hallucinations
[Disorientation to time, place, person, or circumstances]
[Inappropriate responses]
[Talking and laughing to self]
[Suspiciousness] 
Goals/Objectives
Short-term Goal
With assistance from caregiver, client will maintain orientation 
to time, place, person, and circumstances for speciﬁ ed period 
of time.
Long-term Goal
Client will demonstrate accurate perception of the environ-
ment by responding appropriately to stimuli indigenous to the 
surroundings.
Interventions with Selected Rationales
 1. Decrease the amount of stimuli in client’s environment 
(e.g., low noise level, few people, simple decor). This de-
creases the possibility of client’s forming inaccurate sensory 
perceptions.
 2. Do not reinforce the hallucination. Let client know that you 
do not share the perception. Maintain reality through re-
orientation and focus on real situations and people. Reality 
orientation decreases false sensory perceptions and enhances 
client’s sense of self-worth and personal dignity.
 3. Provide reassurance of safety if client responds with fear to 
inaccurate sensory perception. Client safety and security are 
nursing priorities.
 4. Correct client’s description of inaccurate perception, and de-
scribe the situation as it exists in reality. Explanation of and 
participation in real situations and real activities interfere 
with the ability to respond to hallucinations.
 5. Allow for care to be given by same personnel on a regular 
basis, if possible, to provide a feeling of security and stability 
in client’s environment.
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 6. Teach prospective caregivers how to recognize signs and 
symptoms of client’s inaccurate sensory perceptions. Explain 
techniques they may use to restore reality to the situation.
Outcome Criteria
 1. With assistance from caregiver, client is able to recognize 
when perceptions within the environment are inaccurate.
 2. Prospective caregivers are able to verbalize ways in which 
to correct inaccurate perceptions and restore reality to the 
situation.
●
 LOW SELF-ESTEEM 
Deﬁ nition: Negative self-evaluating/feelings about self or self-
capabilities. 
Possible Etiologies (“related to”)
[Loss of independent functioning]
[Loss of capacity for remembering]
[Loss of capability for effective verbal communication] 
Deﬁ ning Characteristics (“evidenced by”)
[Withdraws into social isolation]
Lack of eye contact
[Excessive crying alternating with expressions of anger]
[Refusal to participate in therapies]
[Refusal to participate in own self-care activities]
[Becomes increasingly dependent on others to perform 
ADLs]
Expressions of shame or guilt
Goals/Objectives
Short-term Goal
Client will voluntarily spend time with staff and peers in day-
room activities (time dimension to be individually determined).
Long-term Goal
Client will exhibit increased feelings of self-worth as evidenced 
by voluntary participation in own self-care and interaction 
with others (time dimension to be individually determined).
Interventions with Selected Rationales
 1. Encourage client to express honest feelings in relation to 
loss of prior level of functioning. Acknowledge pain of loss. 
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Support client through process of grieving. Client may be 
fi xed in anger stage of grieving process, which is turned 
inward on the self, resulting in diminished self-esteem.
 2. Devise methods for assisting client with memory deﬁ cit. 
These aids may assist client to function more independently, 
thereby increasing self-esteem. Examples follow:
 a. Name sign on door identifying client’s room.
 b. Identifying sign on outside of dining room door.
 c. Identifying sign on outside of restroom door.
 d. Large clock, with oversized numbers and hands, appropri-
ately placed.
 e. Large calendar, indicating one day at a time, with month, 
day, and year identiﬁ ed in bold print.
 f. Printed, structured daily schedule, with one copy for client 
and one posted on unit wall.
 g. “News board” on unit wall where current national and 
local events may be posted.
 3. Encourage client’s attempts to communicate. If verbalizations 
are not understandable, express to client what you think he or 
she intended to say. It may be necessary to reorient client fre-
quently. The ability to communicate effectively with others 
may enhance self-esteem.
 4. Encourage reminiscence and discussion of life review. Also 
discuss present-day events. Sharing picture albums, if pos-
sible, is especially good. Reminiscence and life review help 
client resume progression through the grief process associ-
ated with disappointing life events and increase self-esteem 
as successes are reviewed.
 5. Encourage participation in group activities. Caregiver may 
need to accompany client at ﬁ rst, until he or she feels secure 
that group members will be accepting, regardless of limita-
tions in verbal communication. Positive feedback from group 
members will increase self-esteem.
 6. Offer support and empathy when client expresses embar-
rassment at inability to remember people, events, and places. 
Focus on accomplishments to lift self-esteem.
 7. Encourage client to be as independent as possible in self-care 
activities. Provide written schedule of tasks to be performed. 
Intervene in areas where client requires assistance. The abil-
ity to perform independently preserves self-esteem.
Outcome Criteria
 1. Client initiates own self-care according to written schedule 
and willingly accepts assistance as needed.
 2. Client interacts with others in group activities, maintaining 
anxiety at minimal level in response to difﬁ culties with ver-
bal communication.
2506_Ch03_054-070.indd   68 10/1/10   9:33:42 AM
Delirium, Dementia, and Amnestic Disorders ● 69
● CAREGIVER ROLE STRAIN
Deﬁ nition: Diffi culty in performing family caregiver role. 
Possible Etiologies (“related to”)
Severity of care receiver’s illness
Chronicity of care receiver’s illness
[Lack of respite and recreation for caregiver]
Caregiver’s competing role commitments
Inadequate physical environment for providing care
Family or caregiver isolation
Complexity and amount of caregiving activities
Deﬁ ning Characteristics (“evidenced by”)
Apprehension about possible institutionalization of care receiver
Apprehension about future regarding care receiver’s health and 
caregiver’s ability to provide care
Difﬁ culty performing and/or completing required tasks
Apprehension about care receiver’s care if caregiver unable to 
provide care
Goals/Objectives
Short-term Goal
Caregivers will verbalize understanding of ways to facilitate the 
caregiver role.
Long-term Goal
Caregivers will demonstrate effective problem-solving skills and 
develop adaptive coping mechanisms to regain equilibrium.
Interventions with Selected Rationales
 1. Assess caregivers’ ability to anticipate and fulﬁ ll client’s un-
met needs. Provide information to assist caregivers with this 
responsibility. Caregivers may be unaware of what client will 
realistically be able to accomplish. They may be unaware of 
the progressive nature of the illness.
 2. Ensure that caregivers are aware of available community 
support systems from which they can seek assistance when 
required. Examples include adult day-care centers, house-
keeping and homemaker services, respite-care services, 
and a local chapter of the Alzheimer’s Association. This 
organization sponsors a nationwide 24-hour hot line to 
provide information and link families who need assistance 
with nearby chapters and afﬁ liates. The hotline number is 
1-800-272-3900. Caregivers require relief from the pressures 
and strain of providing 24-hour care for their loved ones. 
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Studies show that elder abuse arises out of caregiving situa-
tions that place overwhelming stress on caregivers.
 3. Encourage caregivers to express feelings, particularly anger. 
Release of these emotions can serve to prevent psychopathol-
ogy, such as depression or psychophysiological disorders, 
from occurring.
 4. Encourage participation in support groups composed of 
members with similar life situations. Hearing others who are 
experiencing the same problems discuss ways in which they 
have coped may help caregiver adopt more adaptive strate-
gies. Individuals who are experiencing similar life situations 
provide empathy and support for each other.
Outcome Criteria
 1. Caregivers are able to problem solve effectively regarding 
care of elderly client.
 2. Caregivers demonstrate adaptive coping strategies for dealing 
with stress of caregiver role.
 3. Caregivers express feelings openly.
 4. Caregivers express desire to join support group of other 
caregivers.
 INTERNET REFERENCES
● Additional information about Alzheimer’s disease may be 
located at the following websites:
 a. http://www.alz.org
 b. http://www.nia.nih.gov/
 c. http://www.ninds.nih.gov/disorders/alzheimersdisease/
alzheimersdisease.htm
● Information on caregiving can be located at the following 
website:
 a. http://www.aarp.org
● Additional information about medications to treat Alzheimer’s 
disease may be located at the following websites:
 a. http://www.fadavis.com/townsend
 b. http://www.nimh.nih.gov/publicat/medicate.cfm
 c. http://www.drugs.com/condition/alzheimer-s-disease 
html.
 d. http://www.nlm.nih.gov/medlineplus/druginformation 
html. 
Movie Connections
The Notebook (Alzheimer’s disease) • Away from Her 
(Alzheimer’s disease) • Iris (Alzheimer’s disease)
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Substance-Related 
Disorders
● BACKGROUND ASSESSMENT DATA
The substance-related disorders are composed of two groups: 
the substance-use disorders (dependence and abuse) and the 
substance-induced disorders (intoxication and withdrawal). 
Other substance-induced disorders (delirium, dementia, am-
nesia, psychosis, mood disorder, anxiety disorder, and sexual 
dysfunction) are included in the chapters with which they share 
symptomatology (e.g., substance-induced anxiety disorder is 
included in Chapter 8; substance-induced sexual dysfunction is 
included in Chapter 11, etc.).
● SUBSTANCE-USE DISORDERS
Substance Abuse 
Deﬁ ned
The American Psychiatric Association (APA, 2000) Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition, Text 
Revision (DSM-IV-TR) deﬁ nes “substance abuse” as “a mal-
adaptive pattern of substance use manifested by recurrent and 
signiﬁ cant adverse consequences related to repeated use of the 
substance.” Symptoms include use of substances in physically 
harmful circumstances, impaired role performance (school, 
work, or home), repeated encounters with the legal system for 
substance-related conduct, and experiencing personal problems 
related to substance use.
Substance Dependence 
Deﬁ ned
“Dependence” is deﬁ ned as a compulsive or chronic requirement. 
The need is so strong as to generate distress (either physical or 
psychological) if left unfulﬁ lled (Townsend, 2009). Dependence 
on substances is identiﬁ ed by the appearance of unpleasant 
effects characteristic of a withdrawal syndrome when a drug is 
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discontinued. Dependence on substances can also be associated 
with tolerance, in which there is a need for increasingly larger 
or more frequent doses of a substance to obtain the desired 
effects originally produced by a lower dose. The individual who 
is dependent on substances continues to increase the amount 
consumed to achieve the desired effect and to relieve or avoid 
withdrawal symptoms.
● SUBSTANCE-INDUCED DISORDERS
Substance Intoxication 
Deﬁ ned
“Intoxication” is deﬁ ned as a physical and mental state of exhila-
ration and emotional frenzy or lethargy and stupor (Townsend, 
2009). With substance intoxication, the individual experiences 
a reversible syndrome of symptoms that occur with ingestion of 
a substance and that are speciﬁ c to the substance ingested. The 
behavior changes can be attributed to the physiological effects 
of the substance on the central nervous system (CNS).
Substance Withdrawal 
Deﬁ ned
“Withdrawal” is deﬁ ned as the physiological and mental read-
justment that accompanies the discontinuation of an addictive 
substance (Townsend, 2009). The symptoms of withdrawal 
are speciﬁ c to the substance that has been ingested and oc-
cur after prolonged or heavy use of the substance. The effects 
are of sufﬁ cient signiﬁ cance to interfere with usual role 
performance.
● CLASSIFICATION OF SUBSTANCES
Alcohol
Although alcohol is a CNS depressant, it is considered sepa-
rately because of the complex effects and widespread nature 
of its use. Low to moderate consumption produces a feeling 
of well-being and reduced inhibitions. At higher concentra-
tions, motor and intellectual functioning are impaired, mood 
becomes very labile, and behaviors characteristic of depres-
sion, euphoria, and aggression are exhibited. The only medical 
use for alcohol (with the exception of its inclusion in a number 
of pharmacological concentrates) is as an antidote for methanol 
consumption.
EXAMPLES: Beer, wine, bourbon, scotch, gin, vodka, rum, tequila, liqueurs.
Common substances containing alcohol and used by some 
dependent individuals to satisfy their need include liquid cough 
medications, liquid cold preparations, mouthwashes, isopropyl 
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rubbing alcohol, nail polish removers, colognes, and aftershave 
and preshave preparations.
Opioids
Opioids have a medical use as analgesics, antitussives, and an-
tidiarrheals. They produce the effects of analgesia and euphoria 
by stimulating the opiate receptors in the brain, thereby mim-
icking the naturally occurring endorphins.
EXAMPLES: Opium, morphine, codeine, heroin, hydrocodone, oxycodone, meperidine, methadone.
COMMON STREET NAMES: Horse, junk, H (heroin); black stuff, poppy, big O (opium); M, morph 
(morphine); dollies (methadone); terp (terpin hydrate or cough syrup with codeine); oxy, O.C. 
(oxycodone); Vike (hydrocodone).
CNS Depressants
CNS depressants have a medical use as antianxiety agents, seda-
tives, hypnotics, anticonvulsants, and anesthetics. They depress 
the action of the CNS, resulting in an overall calming, relax-
ing effect on the individual. At higher dosages they can induce 
sleep.
EXAMPLES: Benzodiazepines, barbiturates, chloral hydrate, meprobamate, fl unitrazepam. 
COMMON STREET NAMES: Peter, Mickey (chloral hydrate); green and whites, roaches (Librium); 
blues (Valium, 10 mg); yellows (Valium, 5 mg); candy, tranks (other benzodiazepines); red 
birds, red devils (secobarbital); downers (barbiturates; tranquilizers); rophies, forget-me pill, 
R2 (fl unitrazepam [Rohypnol]). 
CNS Stimulants
CNS stimulants have a medical use in the management of 
hyperkinesia, narcolepsy, and weight control. They stimulate 
the action of the CNS, resulting in increased alertness, excita-
tion, euphoria, increased pulse rate and blood pressure, insom-
nia, and loss of appetite.
EXAMPLES: Amphetamines, methylphenidate (Ritalin), phendimetrazine (Bontril), cocaine, 
hydrochloride cocaine, caffeine, tobacco, methylenedioxymethamphetamine (MDMA). 
COMMON STREET NAMES: Bennies, wake-ups, uppers, speed (amphetamines); coke, snow, gold 
dust, girl (cocaine); crack, rock (hydrochloride cocaine); speedball (mixture of heroin and 
cocaine); Adam, ecstasy, XTC (MDMA). 
Hallucinogens
Hallucinogens act as sympathomimetic agents, producing 
effects resembling those resulting from stimulation of the 
sympathetic nervous system (e.g., excitation, increased energy, 
distortion of the senses). Therapeutic medical uses for lysergic 
acid diethylamide (LSD) have been proposed in the treatment 
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of chronic alcoholism and in the reduction of intractable pain, 
such as terminal malignant disease and phantom limb sensa-
tions. At this time there is no real evidence of the safety and 
efﬁ cacy of the drug in humans.
EXAMPLES: LSD, mescaline, phencyclidine (PCP), psilocybin. 
COMMON STREET NAMES: Acid, cube, big D, California sunshine (LSD); angel dust, hog, peace pill, 
crystal (PCP); cactus, mescal, mesc (mescaline); magic mushroom, shrooms (psilocybin). 
Cannabinols
Cannabinols depress higher centers in the brain and consequently 
release lower centers from inhibitory inﬂ uence. They produce an 
anxiety-free state of relaxation characterized by a feeling of ex-
treme well-being. Large doses of the drug can produce hallucina-
tions. Marijuana has been used therapeutically in the relief of nau-
sea and vomiting associated with antineoplastic chemotherapy.
EXAMPLES: Marijuana, hashish. 
COMMON STREET NAMES: Joints, reefers, pot, grass, Mary Jane (marijuana); hash (hashish). 
Inhalants
Inhalant disorders are induced by inhaling the aliphatic 
and aromatic hydrocarbons found in substances such as fuels, 
solvents, adhesives, aerosol propellants, and paint thinners. 
Inhalants are absorbed through the lungs and reach the CNS 
very rapidly. Inhalants generally act as a CNS depressant. The 
effects are relatively brief, lasting from several minutes to a 
few hours, depending on the speciﬁ c substance and amount 
consumed.
EXAMPLES: Gasoline, varnish remover, lighter fl uid, airplane glue, rubber cement, cleaning fl uid, 
spray paint, shoe conditioner, typewriter correction fl uid. 
A proﬁ le summary of these psychoactive substances is 
presented in Table 4-1.
●  PREDISPOSING FACTORS FOR 
SUBSTANCE-RELATED DISORDERS
 1. Physiological
 a. Genetics. A genetic link may be involved in the develop-
ment of substance-related disorders. This is especially 
evident with alcoholism, and less so with other substanc-
es. Children of alcoholics are three times more likely than 
are other children to become alcoholics (Harvard Medical 
School, 2001). Studies with monozygotic and dizygotic 
twins have also supported the genetic hypothesis. 
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 b. Biochemical. A second physiological hypothesis relates 
to the possibility that alcohol may produce morphine-
like substances in the brain that are responsible for alco-
hol addiction. This occurs when the products of alcohol 
metabolism react with biologically active amines.
 2. Psychosocial
 a. Psychodynamic Theory. The psychodynamic approach  to 
the etiology of substance abuse focuses on a punitive super-
ego and ﬁ xation at the oral stage of psychosexual develop-
ment (Sadock & Sadock, 2007). Individuals with punitive 
superegos turn to alcohol to diminish unconscious anxi-
ety and increase feelings of power and self-worth. Sadock 
and Sadock (2007) stated, “As a form of self-medication, 
alcohol may be used to control panic, opioids to diminish 
anger, and amphetamines to alleviate depression” (p. 386).
 b. Social Learning Theory. The effects of modeling, imita-
tion, and identiﬁ cation on behavior can be observed from 
early childhood onward. In relation to drug consumption, 
the family appears to be an important inﬂ uence. Various 
studies have shown that children and adolescents are more 
likely to use substances if they have parents who provide a 
model for substance use. Peers often exert a great deal of 
inﬂ uence in the life of the child or adolescent who is being 
encouraged to use substances for the ﬁ rst time. Modeling 
may continue to be a factor in the use of substances once 
the individual enters the work force. This is particularly 
true in the work setting that provides plenty of leisure 
time with coworkers and where drinking is valued and is 
used to express group cohesiveness.
●  COMMON PATTERNS OF USE IN 
SUBSTANCE-RELATED DISORDERS
Symptomatology (Subjective and Objective 
Data) 
Alcohol Abuse/Dependence
 1. Begins with social drinking that provides feeling of 
relaxation and well-being. Soon requires more and more to 
produce the same effects.
 2. Drinks in secret; hides bottles of alcohol; drinks ﬁ rst thing 
in the morning (to “steady my nerves”) and at any other 
opportunity that arises during the day.
 3. As the disease progresses, the individual may drink in binges. 
During a binge, drinking continues until the individual is 
too intoxicated or too sick to consume any more. Behavior 
borders on the psychotic, with the individual wavering in and 
out of reality.
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 4. Begins to have blackouts. Periods of amnesia occur (in the 
absence of intoxication or loss of consciousness) during 
which the individual is unable to remember periods of time 
or events that have occurred.
 5. Experiences multisystem physiological impairments from 
chronic use that include (but are not limited to) the following:
 a. Peripheral Neuropathy: Numbness, tingling, pain in 
extremities (caused by thiamine deﬁ ciency).
 b. Wernicke-Korsakoff Syndrome: Mental confusion, agita-
tion, diplopia (caused by thiamine deﬁ ciency).  Without 
immediate thiamine replacement, rapid deterioration to 
coma and death will occur.
 c. Alcoholic Cardiomyopathy: Enlargement of the heart 
caused by an accumulation of excess lipids in myocardial 
cells. Symptoms of tachycardia, dyspnea, and arrhythmias 
may be evident.
 d. Esophagitis: Inﬂ ammation of, and pain in, the esophagus.
 e. Esophageal Varices: Distended veins in the esophagus, 
with risk of rupture and subsequent hemorrhage.
 f. Gastritis: Inﬂ ammation of lining of stomach caused by 
irritation from the alcohol, resulting in pain, nausea, 
vomiting, and possibility of bleeding because of erosion of 
blood vessels.
 g. Pancreatitis: Inﬂ ammation of the pancreas, resulting in 
pain, nausea and vomiting, and abdominal distention. 
With progressive destruction to the gland, symptoms of 
diabetes mellitus could occur.
 h. Alcoholic Hepatitis: Inﬂ ammation of the liver, resulting 
in enlargement, jaundice, right upper quadrant pain, and 
fever.
 i. Cirrhosis of the Liver: Fibrous and degenerative 
changes occurring in response to chronic accumulation 
of large amounts of fatty acids in the liver. In cirrhosis, 
symptoms of alcoholic hepatitis progress to include the 
following:
 •  Portal Hypertension: Elevation of blood pressure through 
the portal circulation resulting from defective blood fl ow 
through the cirrhotic liver.
 •  Ascites: An accumulation of serous fl uid in the peritoneal 
cavity.
 •  Hepatic Encephalopathy: Liver disorder caused by in-
ability of the liver to convert ammonia to urea (the body’s 
natural method of discarding excess ammonia); as serum 
ammonia levels rise, confusion occurs, accompanied by 
restlessness, slurred speech, fever, and, without interven-
tion, an eventual progression to coma and death.
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Alcohol Intoxication
 1. Symptoms of alcohol intoxication include disinhibition 
of sexual or aggressive impulses, mood lability, impaired 
judgment, impaired social or occupational functioning, 
slurred speech, incoordination, unsteady gait, nystagmus, 
and ﬂ ushed face.
 2. Physical and behavioral impairment based on blood alcohol 
concentrations differ according to gender, body size, physical 
condition, and level of tolerance. 
 3. The legal deﬁ nition of intoxication in most states in the 
United States is a blood alcohol concentration of 80 or 100 mg 
ethanol per deciliter of blood (mg/dL), which is also measured 
as 0.08 to 0.10 g/dL. 
 4. Nontolerant individuals with blood alcohol concentrations 
greater than 300 mg/dL are at risk for respiratory failure, 
coma, and death (Sadock & Sadock, 2007).
Alcohol Withdrawal
 1. Occurs within 4 to 12 hours of cessation of, or reduction in, 
heavy and prolonged alcohol use.
 2. Symptoms include coarse tremor of hands, tongue, or eye-
lids; nausea or vomiting; malaise or weakness; tachycardia; 
sweating; elevated blood pressure; anxiety; depressed mood 
or irritability; transient hallucinations or illusions; headache; 
seizures; and insomnia.
 3. Without aggressive intervention, the individual may prog-
ress to alcohol withdrawal delirium about the second or third 
day following cessation of, or reduction in, prolonged, heavy 
alcohol use. Symptoms include those described under the 
syndrome of delirium (see Chapter 3).
Amphetamine (or Amphetamine-like) 
Dependence/Abuse
 1. The use of amphetamines is often initiated for their appetite-
suppressant effect in an attempt to lose or control weight.
 2. Amphetamines are also taken for the initial feeling of well-
being and conﬁ dence.
 3. They are typically taken orally, intravenously, or by nasal 
inhalation.
 4. Chronic daily (or almost daily) use usually results in an 
increase in dosage over time to produce the desired effect.
 5. Episodic use often takes the form of binges, followed by 
an intense and unpleasant “crash” in which the individual 
experiences anxiety, irritability, and feelings of fatigue and 
depression.
 6. Continued use appears to be related to a “craving” for the 
substance, rather than to prevention or alleviation of with-
drawal symptoms.
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Amphetamine (or Amphetamine-like) 
Intoxication
 1. Amphetamine intoxication usually begins with a “high” feeling, 
followed by the development of symptoms such as euphoria with 
enhanced vigor, gregariousness, hyperactivity, restlessness, hy-
pervigilance, interpersonal sensitivity, talkativeness, anxiety, 
tension, alertness, grandiosity, stereotypical and repetitive be-
havior, anger, ﬁ ghting, and impaired judgment (APA, 2000).
 2. Physical signs and symptoms that occur with amphetamine 
intoxication include tachycardia or bradycardia, pupillary 
dilation, elevated or lowered blood pressure, perspiration or 
chills, nausea or vomiting, psychomotor retardation or agita-
tion, muscular weakness, respiratory depression, chest pain 
or cardiac arrhythmias, confusion, seizures, dyskinesias, dys-
tonias, or coma (APA, 2000).
Amphetamine (or Amphetamine-like) 
Withdrawal
 1. Amphetamine withdrawal symptoms occur after cessation of 
(or reduction in) amphetamine (or a related substance) use 
that has been heavy and prolonged.
 2. Symptoms of amphetamine withdrawal develop within a few 
hours to several days and include fatigue; vivid, unpleasant 
dreams; insomnia or hypersomnia; increased appetite; and 
psychomotor retardation or agitation.
Cannabis Dependence/Abuse/
 1. Cannabis preparations are almost always smoked but may 
also be taken orally.
 2. It is commonly regarded incorrectly to be a substance with-
out potential for dependence.
 3. Tolerance to the substance may result in increased frequency 
of its use.
 4. Abuse is evidenced by participation in hazardous activities 
while motor coordination is impaired from cannabis use. 
Cannabis Intoxication
 1. Cannabis intoxication is characterized by impaired motor 
coordination, euphoria, anxiety, sensation of slowed time, 
impaired judgment, and social withdrawal that develop dur-
ing or shortly after cannabis use (APA, 2000).
 2. Physical symptoms of cannabis intoxication include conjuncti-
val injection, increased appetite, dry mouth, and tachycardia.
 3. The impairment of motor skills lasts for 8 to 12 hours. 
Cocaine Dependence/Abuse
 1. Various forms are smoked, inhaled, injected, or taken orally.
 2. Chronic daily (or almost daily) use usually results in an 
increase in dosage over time to produce the desired effect.
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 3. Episodic use often takes the form of binges, followed by an in-
tense and unpleasant “crash” in which the individual experiences 
anxiety, irritability, and feelings of fatigue and depression.
 4. The drug user often abuses, or is dependent on, a CNS 
depressant to relieve the residual effects of cocaine.
 5. Cocaine abuse and dependence lead to tolerance of the 
substance and subsequent use of increasing doses.
 6. Continued use appears to be related to a “craving” for the 
substance, rather than to prevention or alleviation of with-
drawal symptoms. 
Cocaine Intoxication
 1. Symptoms of cocaine intoxication develop during, or shortly 
after, use of cocaine.
 2. Symptoms of cocaine intoxication include euphoria or 
affective blunting, changes in sociability, hypervigilance, 
interpersonal sensitivity, anxiety, tension, anger, stereo-
typed behaviors, impaired judgment, and impaired social or 
occupational functioning.
 3. Physical symptoms of cocaine intoxication include tachycar-
dia or bradycardia, pupillary dilation, elevated or lowered 
blood pressure, perspiration or chills, nausea or vomiting, 
psychomotor agitation or retardation, muscular weakness, 
respiratory depression, chest pain, cardiac arrhythmias, con-
fusion, seizures, dyskinesias, dystonias, or coma. 
Cocaine Withdrawal
 1. Symptoms of withdrawal occur after cessation of, or reduc-
tion in, cocaine use that has been heavy and prolonged.
 2. Symptoms of cocaine withdrawal include dysphoric mood; 
fatigue; vivid, unpleasant dreams; insomnia or hypersomnia; 
increased appetite; psychomotor retardation or agitation. 
Hallucinogen Dependence/Abuse
 1. Hallucinogenic substances are taken orally.
 2. The cognitive and perceptual impairment may last for up to 
12 hours, so use is generally episodic, because the individual 
must organize time during the daily schedule for its use.
 3. Frequent use results in tolerance to the effects of the 
substance.
 4. Dependence is rare, and most people are able to resume their 
previous lifestyle, following a period of hallucinogen use, 
without much difﬁ culty.
 5. Flashbacks may occur following cessation of hallucinogen use. 
These episodes consist of visual or auditory misperceptions 
usually lasting only a few seconds but sometimes lasting up to 
several hours.
82 ● ALTERATIONS IN PSYCHOSOCIAL ADAPTATION
2506_Ch04_071-104.indd   Sec1:82 10/1/10   9:33:58 AM
Substance-Related Disorders ● 83
 6. Hallucinogens are highly unpredictable in the effects they 
may induce each time they are used. 
Hallucinogen Intoxication
 1. Symptoms of intoxication develop during or shortly after 
hallucinogen use.
 2. Symptoms include marked anxiety or depression, ideas of 
reference, fear of losing one’s mind, paranoid ideation, and 
impaired judgment.
 3. Other symptoms include subjective intensiﬁ cation of percep-
tions, depersonalization, derealization, illusions, hallucina-
tions, and synesthesias.
 4. Physical symptoms include pupillar dilation, tachycar-
dia, sweating, palpitations, blurring of vision, tremors, and 
incoordination (APA, 2000). 
Inhalant Dependence/Abuse
 1. Effects are induced by inhaling the vapors of volatile sub-
stances through the nose or mouth.
 2. Examples of substances include glue, gasoline, paint, paint 
thinners, various cleaning chemicals, and typewriter correc-
tion ﬂ uid.
 3. Use of inhalants often begins in childhood, and considerable 
family dysfunction is characteristic.
 4. Use may be daily or episodic, and chronic use may continue 
into adulthood.
 5. Tolerance has been reported among individuals with heavy 
use, but a withdrawal syndrome from these substances has 
not been well documented. 
Inhalant Intoxication
 1. Symptoms of intoxication develop during, or shortly after, 
use of, or exposure to, volatile inhalants.
 2. Symptoms of inhalant intoxication include belligerence, 
assaultiveness, apathy, impaired judgment, and impaired 
social or occupational functioning.
 3. Physical symptoms of inhalant intoxication include dizzi-
ness, nystagmus, incoordination, slurred speech, unsteady 
gait, lethargy, depressed reﬂ exes, psychomotor retardation, 
tremor, generalized muscle weakness, blurred vision or dip-
lopia, stupor or coma, and euphoria (APA, 2000). 
Nicotine Dependence
 1. The effects of nicotine are induced through inhaling the 
smoke of cigarettes, cigars, or pipe tobacco and orally through 
the use of snuff or chewing tobacco.
 2. Continued use results in a “craving” for the substance.
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 3. Nicotine is commonly used to relieve or to avoid withdrawal 
symptoms that occur when the individual has been in a situ-
ation where use is restricted.
 4. Continued use despite knowledge of medical problems related 
to smoking is a particularly important health problem. 
Nicotine Withdrawal
 1. Symptoms of withdrawal develop within 24 hours after 
abrupt cessation of (or reduction in) prolonged nicotine use.
 2. Symptoms of nicotine withdrawal include dysphoric or 
depressed mood, insomnia, irritability, frustration, anger, 
anxiety, difﬁ culty concentrating, restlessness, decreased 
heart rate, and increased appetite. 
Opioid Dependence/Abuse
 1. Various forms are taken orally, intravenously, by nasal inha-
lation, and by smoking.
 2. Dependence occurs after recreational use of the substance 
“on the street” or after prescribed use of the substance for 
relief of pain or cough.
 3. Chronic use leads to remarkably high levels of tolerance.
 4. Once abuse or dependence is established, substance procure-
ment often comes to dominate the person’s life.
 5. Cessation or decreased consumption results in a “craving” for 
the substance and produces a speciﬁ c syndrome of withdrawal. 
Opioid Intoxication
 1. Symptoms of intoxication develop during or shortly after 
opioid use.
 2. Symptoms of opioid intoxication include euphoria (initially) 
followed by apathy, dysphoria, psychomotor agitation or 
retardation, impaired judgment, and impaired social or 
occupational functioning.
 3. Physical symptoms of opioid intoxication include pupil-
lary constriction, drowsiness or coma, slurred speech, and 
impairment in attention or memory (APA, 2000). 
Opioid Withdrawal
 1. Symptoms of opioid withdrawal occur after cessation of (or 
reduction in) heavy and prolonged opioid use. Symptoms of 
withdrawal can also occur after administration of an opioid 
antagonist after a period of opioid use.
 2. Symptoms of opioid withdrawal can occur within minutes 
to several days following use (or antagonist), and include 
dysphoric mood, nausea or vomiting, muscle aches, lacrima-
tion or rhinorrhea, pupillary dilation, piloerection, sweating, 
abdominal cramping, diarrhea, yawning, fever, and insomnia. 
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Phencyclidine Dependence/Abuse
 1. Phencyclidine (PCP) is taken orally, intravenously, or by 
smoking or inhaling.
 2. Use can be on a chronic daily basis but more often is taken 
episodically in binges that can last several days.
 3. Physical dependence does not occur with PCP; however, psy-
chological dependence characterized by craving for the drug 
has been reported in chronic users, as has the development of 
tolerance.
 4. Tolerance apparently develops quickly with frequent use. 
Phencyclidine Intoxication
 1. Symptoms of intoxication develop during or shortly after 
PCP use.
 2. Symptoms of PCP intoxication include belligerence, assaul-
tiveness, impulsiveness, unpredictability, psychomotor agita-
tion, and impaired judgment.
 3. Physical symptoms occur within 1 hour of PCP use and 
include vertical or horizontal nystagmus, hypertension or 
tachycardia, numbness or diminished responsiveness to pain, 
ataxia, dysarthria, muscle rigidity, seizures or coma, and 
hyperacusis (APA, 2000). 
Sedative, Hypnotic, or Anxiolytic Dependence/
Abuse
 1. Effects are produced through oral intake of these substances.
 2. Dependence can occur following recreational use of the 
substance “on the street” or after prescribed use of the 
substance for relief of anxiety or insomnia.
 3. Chronic use leads to remarkably high levels of tolerance.
 4. Once dependence develops, there is evidence of strong 
substance-seeking behaviors (obtaining prescriptions from 
several physicians or resorting to illegal sources to maintain 
adequate supplies of the substance).
 5. Abrupt cessation of these substances can result in life-
threatening withdrawal symptoms. 
Sedative, Hypnotic, or Anxiolytic Intoxication
 1. Symptoms of intoxication develop during or shortly after 
intake of sedatives, hypnotics, or anxiolytics.
 2. Symptoms of intoxication include inappropriate sexual or 
aggressive behavior, mood lability, impaired judgment, and 
impaired social or occupational functioning.
 3. Physical symptoms of sedative, hypnotic, or anxiolytic 
intoxication include slurred speech, incoordination, unsteady 
gait, nystagmus, impairment in attention or memory, stupor, 
or coma (APA, 2000). 
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Sedative, Hypnotic, or Anxiolytic Withdrawal
 1. Withdrawal symptoms occur after cessation of (or reduc-
tion in) heavy and prolonged use of sedatives, hypnotics, or 
anxiolytics.
 2. Symptoms of withdrawal occur within several hours to a few 
days after abrupt cessation or reduction in use of the drug.
 3. Symptoms of withdrawal include autonomic hyperactiv-
ity (e.g., sweating or pulse rate greater than 100); increased 
hand tremor; insomnia; nausea or vomiting; transient visual, 
tactile, or auditory hallucinations or illusions; psychomotor 
agitation; anxiety; or grand mal seizures. 
A summary of symptoms associated with the syndromes of 
intoxication and withdrawal is presented in Table 4-2.
Common Nursing Diagnoses 
and Interventions for Clients 
with Substance-Related Disorders
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.) 
●
 RISK FOR INJURY
Deﬁ nition: At risk for injury as a result of [internal or external] 
environmental conditions interacting with the individual’s adaptive 
and defensive resources. 
Related/Risk Factors (“related to”)
[Substance intoxication]
[Substance withdrawal]
[Disorientation]
[Seizures]
[Hallucinations]
[Psychomotor agitation]
[Unstable vital signs]
[Delirium]
[Flashbacks]
[Panic level of anxiety] 
Goals/Objectives
Short-term Goal
Client’s condition will stabilize within 72 hours.
Long-term Goal
Client will not experience physical injury.
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Interventions with Selected Rationales
 1. Assess client’s level of disorientation to determine speciﬁ c 
requirements for safety. Knowledge of client’s level of func-
tioning is necessary to formulate appropriate plan of care.
 2. Obtain a drug history, if possible, to determine the following:
 a. Type of substance(s) used.
 b. Time of last ingestion and amount consumed.
 c. Length and frequency of consumption.
 d. Amount consumed on a daily basis. 
 3. Obtain urine sample for laboratory analysis of substance 
content. Subjective history is often not accurate. Knowledge 
regarding substance ingestion is important for accurate as-
sessment of client condition.
 4. Place client in quiet, private room. Excessive stimuli increase 
client agitation.
 5. Institute necessary safety precautions (CLIENT safety is a 
nursing priority.): 
 a. Observe client behaviors frequently; assign staff on one-
to-one basis if condition is warranted; accompany and 
assist client when ambulating; use wheelchair for trans-
porting long distances.
 b. Be sure that side rails are up when client is in bed.
 c. Pad headboard and side rails of bed with thick towels to 
protect client in case of seizure.
 d. Use mechanical restraints as necessary to protect client if 
excessive hyperactivity accompanies the disorientation.
 6. Ensure that smoking materials and other potentially harmful 
objects are stored away from client’s access. Client may harm 
self or others in disoriented, confused state.
 7. Frequently orient client to reality and surroundings. Disori-
entation may endanger client safety if he or she unknow-
ingly wanders away from safe environment.
 8. Monitor client’s vital signs every 15 minutes initially and less 
frequently as acute symptoms subside. Vital signs provide 
the most reliable information about client condition and 
need for medication during acute detoxifi cation period.
 9. Follow medication regimen, as ordered by physician. Com-
mon medical intervention for detoxiﬁ cation from the follow-
ing substances includes:
 a. Alcohol. Benzodiazepines are the most widely used 
group of drugs for substitution therapy in alcohol with-
drawal. They are administered in decreasing doses until 
withdrawal is complete. Commonly used agents include 
chlordiazepoxide (Librium), oxazepam (Serax), diazepam 
(Valium), and alprazolam (Xanax). In clients with liver 
disease, accumulation of the longer-acting agents, such as 
chlordiazepoxide (Librium), may be problematic, and the 
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use of shorter-acting benzodiazepines, such as oxazepam 
(Serax), is more appropriate. Some physicians may order 
anticonvulsant medication to be used prophylactically; 
however, this is not a universal intervention. Multivitamin 
therapy, in combination with daily thiamine (either orally 
or by injection), is common protocol.
 b. Narcotics. Narcotic antagonists, such as naloxone 
(Narcan), naltrexone (ReVia), or nalmefene (Revex), 
are administered intravenously for narcotic overdose. 
Withdrawal is managed with rest and nutritional ther-
apy. Substitution therapy may be instituted to decrease 
withdrawal symptoms using propoxyphene (Darvon), 
methadone (Dolophine), or buprenorphine (Subutex).
 c. Depressants. Substitution therapy may be instituted 
to decrease withdrawal symptoms using a long-acting 
barbiturate, such as phenobarbital (Luminal). The dos-
age required to suppress withdrawal symptoms is given. 
When stabilization has been achieved, the dose is gradu-
ally decreased by 30 mg/day until withdrawal is complete. 
Long-acting benzodiazepines are commonly used for 
substitution therapy when the abused substance is a non-
barbiturate CNS depressant.
 d. Stimulants. Treatment of stimulant intoxication usually 
begins with minor tranquilizers such as chlordiazepoxide 
(Librium) and progresses to major tranquilizers such as 
haloperidol (Haldol). Antipsychotics should be adminis-
tered with caution because of their propensity to lower 
seizure threshold. Repeated seizures are treated with 
intravenous diazepam. Withdrawal treatment is usually 
aimed at reducing drug craving and managing severe 
depression. The client is placed in a quiet atmosphere 
and allowed to sleep and eat as much as is needed or 
desired. Suicide precautions may need to be instituted. 
Antidepressant therapy may be helpful in treating symp-
toms of depression. Desipramine has been especially 
successful with symptoms of cocaine withdrawal and 
abstinence (Mack, Franklin, & Frances, 2003).
 e. Hallucinogens and Cannabinols. Substitution therapy 
is not required with these drugs. When adverse reactions, 
such as anxiety or panic, occur, benzodiazepines (e.g., 
diazepam or chlordiazepoxide) may be prescribed to pre-
vent harm to the client or others. Psychotic reactions may 
be treated with antipsychotic medications.
Outcome Criteria
 1. Client is no longer exhibiting any signs or symptoms of sub-
stance intoxication or withdrawal.
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 2. Client shows no evidence of physical injury obtained during 
substance intoxication or withdrawal. 
●
 INEFFECTIVE DENIAL
Deﬁ nition: Conscious or unconscious attempt to disavow the 
knowledge or meaning of an event to reduce anxiety/fear, but lead-
ing to the detriment of health. 
Possible Etiologies (“related to”)
[Weak, underdeveloped ego]
[Underlying fears and anxieties]
[Low self-esteem]
[Fixation in early level of development] 
Deﬁ ning Characteristics (“evidenced by”)
[Denies substance abuse or dependence]
[Denies that substance use creates problems in his or her life]
[Continues to use substance, knowing it contributes to impair-
ment in functioning or exacerbation of physical symptoms]
[Uses substance(s) in physically hazardous situations]
[Use of rationalization and projection to explain maladaptive 
behaviors]
Unable to admit impact of disease on life pattern
Goals/Objectives
Short-term Goal
Client will divert attention away from external issues and focus 
on behavioral outcomes associated with substance use.
Long-term Goal
Client will verbalize acceptance of responsibility for own behavior 
and acknowledge association between substance use and personal 
problems.
Interventions with Selected Rationales
 1. Begin by working to develop a trusting nurse-client relation-
ship. Be honest. Keep all promises. Trust is the basis of a 
therapeutic relationship.
 2. Convey an attitude of acceptance to client. Ensure that he 
or she understands, “It is not you but your behavior that is 
unacceptable.” An attitude of acceptance promotes feelings 
of dignity and self-worth.
 3. Provide information to correct misconceptions about sub-
stance abuse. Client may rationalize his or her behavior with 
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statements such as, “I’m not an alcoholic. I can stop drink-
ing any time I want. Besides, I only drink beer.” or “I only 
smoke pot to relax before class. So what? I know lots of 
people who do. Besides, you can’t get hooked on pot.” Many 
myths abound regarding use of specifi c substances. Factual 
information presented in a matter-of-fact, nonjudgmental 
way explaining what behaviors constitute substance-related 
disorders may help client focus on his or her own behaviors 
as an illness that requires help.
 4. Identify recent maladaptive behaviors or situations that have 
occurred in client’s life, and discuss how use of substances 
may have been a contributing factor. The fi rst step in decreas-
ing use of denial is for client to see the relationship between 
substance use and personal problems.
 5. Use confrontation with caring. Do not allow client to fanta-
size about his or her lifestyle. Confrontation interferes with 
client’s ability to use denial; a caring attitude preserves self-
esteem and avoids putting client on the defensive.
CLINICAL PEARL          It is important to speak objectively and nonjudgmentally 
to a person in denial. Examples: “It is my understanding that the last time you drank 
alcohol, you . . .” or “The lab report shows that your blood alcohol level was 
250 when you were involved in that automobile accident.” 
 6. Do not accept the use of rationalization or projection as 
client attempts to make excuses for or blame his or her be-
havior on other people or situations. Rationalization and 
projection prolong the stage of denial that problems exist in 
client’s life because of substance use.
 7. Encourage participation in group activities.  Peer feedback is 
often more accepted than feedback from authority fi gures. 
Peer pressure can be a strong factor as well as the association 
with individuals who are experiencing or who have experi-
enced similar problems.
 8. Offer immediate positive recognition of client’s expres-
sions of insight gained regarding illness and acceptance of 
responsibility for own behavior. Positive reinforcement en-
hances self-esteem and encourages repetition of desirable 
behaviors.
Outcome Criteria
 1. Client verbalizes understanding of the relationship between 
personal problems and the use of substances.
 2. Client verbalizes acceptance of responsibility for own behavior.
 3. Client verbalizes understanding of substance dependence and 
abuse as an illness requiring ongoing support and treatment.
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●
 INEFFECTIVE COPING
Deﬁ nition: Inability to form a valid appraisal of the stressors, in-
adequate choices of practiced responses, and/or inability to use 
available resources. 
Possible Etiologies (“related to”)
[Inadequate support systems]
[Inadequate coping skills]
[Underdeveloped ego]
[Possible hereditary factor]
[Dysfunctional family system]
[Negative role modeling]
[Personal vulnerability] 
Deﬁ ning Characteristics (“evidenced by”)
[Low self-esteem]
[Chronic anxiety]
[Chronic depression]
Inability to meet role expectations
[Alteration in societal participation]
Inability to meet basic needs
[Inappropriate use of defense mechanisms]
Abuse of chemical agents
[Low frustration tolerance]
[Need for immediate gratiﬁ cation]
[Manipulative behavior] 
Goals/Objectives
Short-term Goal
Client will express true feelings associated with use of substances 
as a method of coping with stress.
Long-term Goal
Client will be able to verbalize adaptive coping mechanisms to 
use, instead of substance abuse, in response to stress.
Interventions with Selected Rationales
 1. Establish trusting relationship with client (be honest; keep 
appointments; be available to spend time).  The therapeutic 
nurse-client relationship is built on trust.
 2. Set limits on manipulative behavior. Be sure that client 
knows what is acceptable, what is not, and the consequenc-
es for violating the limits set. Ensure that all staff main-
tain consistency with this intervention. Client is unable to 
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establish own limits, so limits must be set for him or her. Unless 
administration of consequences for violation of limits is 
consistent, manipulative behavior will not be eliminated.
 3. Encourage client to verbalize feelings, fears, and anxiet-
ies. Answer any questions he or she may have regarding 
the disorder. Verbalization of feelings in a nonthreaten-
ing environment may help client come to terms with long-
unresolved issues.
 4. Explain the effects of substance abuse on the body. Empha-
size that prognosis is closely related to abstinence. Many 
clients lack knowledge regarding the deleterious effects of 
substance abuse on the body.
 5. Explore with client the options available to assist with stress-
ful situations rather than resorting to substance abuse (e.g., 
contacting various members of Alcoholics Anonymous or 
Narcotics Anonymous; physical exercise; relaxation tech-
niques; meditation).  Client may have persistently resorted to 
chemical abuse and thus may possess little or no knowledge 
of adaptive responses to stress.
 6. Provide positive reinforcement for evidence of gratiﬁ ca-
tion delayed appropriately. Positive reinforcement enhances 
self-esteem and encourages client to repeat acceptable 
behaviors.
 7. Encourage client to be as independent as possible in 
own self-care. Provide positive feedback for independent 
decision-making and effective use of problem-solving skills.
Outcome Criteria
 1. Client is able to verbalize adaptive coping strategies as alter-
natives to substance use in response to stress.
 2. Client is able to verbalize the names of support people from 
whom he or she may seek help when the desire for substance 
use is intense.
●
 IMBALANCED NUTRITION: LESS 
THAN BODY REQUIREMENTS
Deﬁ nition: Intake of nutrients insuffi cient to meet metabolic 
needs. 
Possible Etiologies (“related to”)
[Drinking alcohol instead of eating nourishing food]
[Eating only “junk food”]
[Eating nothing (or very little) while on a “binge”]
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[No money for food (having spent what is available on substances)]
[Problems with malabsorption caused by chronic alcohol abuse] 
Deﬁ ning Characteristics (“evidenced by”)
Loss of weight
Pale conjunctiva and mucous membranes
Poor muscle tone
[Poor skin turgor]
[Edema of extremities]
[Electrolyte imbalances]
[Cheilosis (cracks at corners of mouth)]
[Scaly dermatitis]
[Weakness]
[Neuropathies]
[Anemias]
[Ascites] 
Goals/Objectives
Short-term Goals
 1. Client will gain 2 lb during next 7 days.
 2. Client’s electrolytes will be restored to normal within 1 week.
Long-term Goal
Client will exhibit no signs or symptoms of malnutrition by dis-
charge. (This is not a realistic goal for a chronic alcoholic in the 
end stages of the disease. For such a client, it is more appropriate 
to establish short-term goals, as realistic step objectives, to use 
in the evaluation of care given.)
Interventions with Selected Rationales
 1. In collaboration with dietitian, determine number of calories 
required to provide adequate nutrition and realistic (accord-
ing to body structure and height) weight gain.
 2. Strict documentation of intake, output, and calorie count. 
This information is necessary to make an accurate nutri-
tional assessment and maintain client safety.
 3. Weigh daily. Weight loss or gain is important assessment 
information.
 4. Determine client’s likes and dislikes and collaborate with di-
etitian to provide favorite foods. Client is more likely to eat 
foods that he or she particularly enjoys.
 5. Ensure that client receives small, frequent feedings, includ-
ing a bedtime snack, rather than three larger meals. Large 
amounts of food may be objectionable, or even intolerable, 
to client.
 6. Administer vitamin and mineral supplements, as ordered by 
physician, to improve nutritional state.
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 7. If appropriate, ask family members or signiﬁ cant others to 
bring in special foods that client particularly enjoys.
 8. Monitor laboratory work, and report signiﬁ cant changes to 
physician.
 9. Explain the importance of adequate nutrition. Client may 
have inadequate or inaccurate knowledge regarding the 
contribution of good nutrition to overall wellness.
Outcome Criteria
 1. Client has achieved and maintained at least 90% of normal 
body weight.
 2. Client’s vital signs, blood pressure, and laboratory serum 
studies are within normal limits.
 3. Client is able to verbalize importance of adequate 
nutrition.
●
 CHRONIC LOW SELF-ESTEEM
Deﬁ nition: Long-standing negative self-evaluating/feelings about 
self or self-capabilities. 
Possible Etiologies (“related to”)
[Retarded ego development]
[Dysfunctional family system]
[Lack of positive feedback]
[Perceived failures] 
Deﬁ ning Characteristics (“evidenced by”)
[Difﬁ culty accepting positive reinforcement]
[Failure to take responsibility for self-care]
[Self-destructive behavior (substance abuse)]
Lack of eye contact
[Withdraws into social isolation]
[Highly critical and judgmental of self and others]
[Sense of worthlessness]
[Fear of failure]
[Unable to recognize own accomplishments]
[Setting self up for failure by establishing unrealistic goals]
[Unsatisfactory interpersonal relationships]
[Negative or pessimistic outlook]
[Denial of problems obvious to others]
[Projection of blame or responsibility for problems]
[Rationalizing personal failures]
[Hypersensitivity to slight criticism]
[Grandiosity] 
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Goals/Objectives
Short-term Goal
Client will accept responsibility for personal failures and verbalize 
the role substances played in those failures.
Long-term Goal
By time of discharge, client will exhibit increased feelings of 
self-worth as evidenced by verbal expression of positive aspects 
about self, past accomplishments, and future prospects.
Interventions with Selected Rationales
 1. Be accepting of client and his or her negativism. An attitude 
of acceptance enhances feelings of self-worth.
 2. Spend time with client to convey acceptance and contribute 
toward feelings of self-worth.
 3. Help client to recognize and focus on strengths and accom-
plishments. Discuss past (real or perceived) failures, but 
minimize amount of attention devoted to them beyond client’s 
need to accept responsibility for them. Client must accept re-
sponsibility for own behavior before change in behavior can 
occur. Minimizing attention to past failures may help to 
eliminate negative ruminations and increase client’s sense of 
self-worth.
 4. Encourage participation in group activities from which cli-
ent may receive positive feedback and support from peers.
 5. Help client identify areas he or she would like to change 
about self and assist with problem solving toward this effort. 
Low self-worth may interfere with client’s perception of own 
problem-solving ability. Assistance may be required.
 6. Ensure that client is not becoming increasingly dependent 
and that he or she is accepting responsibility for own behav-
iors. Client must be able to function independently if he or 
she is to be successful within the less-structured community 
environment.
 7. Ensure that therapy groups offer client simple methods of 
achievement. Offer recognition and positive feedback for 
actual accomplishments. Successes and recognition increase 
self-esteem.
 8. Provide instruction in assertiveness techniques: the ability 
to recognize the difference among passive, assertive, and 
aggressive behaviors and the importance of respecting the 
human rights of others while protecting one’s own basic 
human rights. Self-esteem is enhanced by the ability to in-
teract with others in an assertive manner.
 9. Teach effective communication techniques, such as the use 
of “I” messages and placing emphasis on ways to avoid mak-
ing judgmental statements. 
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Outcome Criteria
 1. Client is able to verbalize positive aspects about self.
 2. Client is able to communicate assertively with others.
 3. Client expresses an optimistic outlook for the future. 
●
 DEFICIENT KNOWLEDGE (Effects 
of Substance Abuse on the Body)
Deﬁ nition: Absence or defi ciency of cognitive information 
related to [the effects of substance abuse on the body and 
its interference with achievement and maintenance of optimal 
wellness]. 
Possible Etiologies (“related to”)
Lack of interest in learning
[Low self-esteem]
[Denial of need for information]
[Denial of risks involved with substance abuse]
Unfamiliarity with information resources 
Deﬁ ning Characteristics (“evidenced by”)
[Abuse of substances]
[Statement of lack of knowledge]
[Statement of misconception]
[Request for information]
Verbalization of the problem
Goals/Objectives
Short-term Goal
Client will be able to verbalize effects of [substance used] on the 
body following implementation of teaching plan.
Long-term Goal
Client will verbalize the importance of abstaining from use of 
[substance] to maintain optimal wellness.
Interventions with Selected Rationales
 1. Assess client’s level of knowledge regarding effects of 
[substance] on body. Baseline assessment of knowledge 
is required to develop appropriate teaching plan for 
client.
 2. Assess client’s level of anxiety and readiness to learn. Learn-
ing does not take place beyond moderate level of anxiety.
 3. Determine method of learning most appropriate for client 
(e.g., discussion, question and answer, use of audio or visual
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  aids, oral or written method). Level of education and devel-
opment are important considerations as to methodology 
selected.
 4. Develop teaching plan, including measurable objectives 
for the learner. Measurable objectives provide criteria on 
which to base evaluation of the teaching experience.
 5. Include signiﬁ cant others, if possible. Lifestyle changes of-
ten affect all family members.
 6. Implement teaching plan at a time that facilitates and in 
a place that is conducive to optimal learning (e.g., in the 
evening when family members visit, in an empty, quiet class-
room or group therapy room). Learning is enhanced by an 
environment with few distractions.
 7. Begin with simple concepts and progress to the more com-
plex. Retention is increased if introductory material pre-
sented is easy to understand.
 8. Include information on physical effects of [substance]: 
substance’s capacity for physiological and psychologi-
cal dependence, its effects on family functioning, its 
effects  on a fetus (and the importance of contraceptive 
use until abstinence has been achieved), and the impor-
tance of regular participation in an appropriate treatment 
program.
 9. Provide activities for client and signiﬁ cant others in which 
to participate actively during the learning exercise. Active 
participation increases retention.
 10. Ask client and signiﬁ cant others to demonstrate knowledge 
gained by verbalizing information presented. Verbalization 
of knowledge gained is a measurable method of evaluating 
the teaching experience.
 11. Provide positive feedback for participation as well as for 
accurate demonstration of knowledge gained. Positive feed-
back enhances self-esteem and encourages repetition of 
acceptable behaviors.
 12. Evaluate teaching plan. Identify strengths and weaknesses, 
as well as any changes that may enhance the effectiveness 
of the plan. 
Outcome Criteria
 1. Client is able to verbalize effects of [substance] on the 
body.
 2. Client verbalizes understanding of risks involved in use of 
[substance].
 3. Client is able to verbalize community resources for ob-
taining knowledge and support with substance-related 
problems. 
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●
 DYSFUNCTIONAL FAMILY 
PROCESSES
Deﬁ nition: Psychosocial, spiritual, and physiological functions 
of the family unit are chronically disorganized, which leads to con-
fl ict, denial of problems, resistance to change, ineffective problem 
solving, and a series of self-perpetuating crises. 
Possible Etiologies (“related to”)
Abuse of alcohol
Genetic predisposition
Lack of problem-solving skills
Inadequate coping skills
Family history of alcoholism, resistance to treatment
Biochemical inﬂ uences
Addictive personality
Deﬁ ning Characteristics (“evidenced by”)
Anxiety, anger/suppressed rage; shame and embarrassment
Emotional isolation/loneliness; vulnerability; repressed emotions
Disturbed family dynamics; closed communication systems, 
ineffective spousal communication, and marital problems
Altered role function/disruption of family roles
Manipulation; dependency; blaming/criticizing; rationalization/ 
denial of problems
Enabling to maintain drinking; refusal to get help/inability to 
accept and receive help appropriately
Goals/Objectives
Short-term Goals
 1. Family members will participate in individual family pro-
grams and support groups.
 2. Family members will identify ineffective coping behaviors 
and consequences.
 3. Family members will initiate and plan for necessary lifestyle 
changes. 
Long-term Goal
Family members will take action to change self-destructive 
behaviors and alter behaviors that contribute to client’s addiction.
Interventions with Selected Rationales
 1. Review family history; explore roles of family members, 
circumstances involving alcohol use, strengths, areas of 
growth. This information determines areas for focus and 
potential for change.
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 2. Explore how family members have coped with the client’s 
addiction (e.g., denial, repression, rationalization, hurt, 
loneliness, projection). Persons who enable also suffer from 
the same feelings as the client and use ineffective methods 
for dealing with the situation, necessitating help in learn-
ing new and effective coping skills.
 3. Determine understanding of current situation and previous 
methods of coping with life’s problems. Provides informa-
tion on which to base present plan of care.
 4. Assess current level of functioning of family members. 
Affects individual’s ability to cope with the situation.
 5. Determine extent of enabling behaviors being evidenced 
by family members; explore with each individual and client. 
Enabling is doing for the client what he or she needs to do 
for self (rescuing). People want to be helpful and do not want 
to feel powerless to help their loved one to stop substance use 
and change the behavior that is so destructive. However, 
the substance abuser often relies on others to cover up own 
inability to cope with daily responsibilities.
 6. Provide information about enabling behavior and addictive 
disease characteristics for both the user and nonuser. Aware-
ness and knowledge of behaviors (e.g., avoiding and shield-
ing, taking over responsibilities, rationalizing, and subserv-
ing) provide opportunity for individuals to begin the process 
of change.
 7. Identify and discuss sabotage behaviors of family members. 
Even though family member(s) may verbalize a desire 
for the individual to become substance-free, the reality of 
interactive dynamics is that they may unconsciously not 
want the individual to recover, as this would affect the 
family members’ own role in the relationship. Addition-
ally, they may receive sympathy or attention from others 
(secondary gain).
 8. Encourage participation in therapeutic writing, e.g., journ-
aling (narrative), guided or focused. Serves as a release for 
feelings (e.g., anger, grief, stress); helps move individual(s) 
forward in treatment process.
 9. Provide factual information to client and family about the 
effects of addictive behaviors on the family and what to ex-
pect after discharge. Many people are unaware of the na-
ture of addiction. If client is using legally obtained drugs, 
he or she may believe this does not constitute abuse.
 10. Encourage family members to be aware of their own feel-
ings, to look at the situation with perspective and objectiv-
ity. They can ask themselves: “Am I being conned? Am I 
acting out of fear, shame, guilt, or anger? Do I have a need 
to control?” When the enabling family members become 
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aware of their own actions that perpetuate the client’s 
problems, they need to decide to change themselves. If they 
change, the client can then face the consequences of own 
actions and may choose to get well.
 11. Provide support for enabling family members. For change 
to occur, families need support as much as the person who 
has the problem with alcohol.
 12. Assist the client’s partner to become aware that client’s 
abstinence and drug use are not the partner’s responsibility. 
Partners need to learn that the client’s use of substances 
may or may not change despite partner’s involvement in 
treatment.
 13. Help a recovering (former user) partner who is enabling to 
distinguish between destructive aspects of own behavior and 
genuine motivation to aid the client. Enabling behavior can 
be a recovering individual’s attempts at personal survival.
 14. Note how the partner relates to the treatment team and staff. 
Determines enabling style. A parallel exists between how 
partner relates to client and to staff, based on the partner’s 
feelings about self and situation.
 15. Explore conﬂ icting feelings the enabling partner may have 
about treatment (e.g., feelings similar to those of the sub-
stance abuser [blend of anger, guilt, fear, exhaustion, em-
barrassment, loneliness, distrust, grief, and possibly relief]). 
This is useful in establishing the need for therapy for the 
partner. This individual’s own identity may have been 
lost—he or she may fear self-disclosure to staff and may 
have diffi culty giving up the dependent relationship.
 16. Involve family members in discharge referral plans. Alcohol 
abuse is a family illness. Because the family has been so in-
volved in dealing with the substance abuse behavior, family 
members need help adjusting to the new behavior of sobriety/
abstinence. Incidence of recovery is almost doubled when 
the family is treated along with the client.
 17. Encourage involvement with self-help associations, such as 
Alcoholics Anonymous, Al-Anon, Alateen, and professional 
family therapy. Puts client and family in direct contact 
with support systems necessary for continued sobriety and 
assists with problem resolution. 
Outcome Criteria
 1. Family members verbalize understanding of dynamics of 
enabling behaviors.
 2. Family members demonstrate patterns of effective commu-
nication.
 3. Family members regularly participate in self-help support 
programs.
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 4. Family members demonstrate behaviors required to change 
destructive patterns of behavior that contribute to and enable 
dysfunctional family process.
 INTERNET REFERENCES
 • Additional information on addictions may be located at the 
following websites:
 a. http://www.samhsa.gov/index.aspx
 b. http://www.ccsa.ca/Pages/Splash.htm
 c. http://www.well.com/user/woa
 d. http://www.apa.org/about/division/div50.html
 • Additional information on self-help organizations may be 
located at the following websites:
 a. http://www.ca.org (Cocaine Anonymous)
 b. http://www.aa.org (Alcoholics Anonymous)
 c. http://www.na.org (Narcotics Anonymous)
 d. http://www.al-anon.org
 • Additional information about medications for treatment of 
alcohol and drug dependence may be located at the following 
websites:
 a. http://www.fadavis.com/townsend
 b. http://www.nlm.nih.gov/medlineplus/
 c. http://www.nimh.nih.gov/publicat/medicate.cfm 
Movie Connections
Afﬂ iction (alcoholism) • Days of Wine and Roses (alcoholism) 
• I’ll Cry Tomorrow (alcoholism) • When a Man Loves a Woman 
(alcoholism) • Clean and Sober (addiction—cocaine) • 28 Days 
(alcoholism) • Lady Sings the Blues (addiction—heroin) • I’m Dancing 
as Fast as I Can (addiction—sedatives) • The Rose (polysubstance addiction)
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C H A P T E R  5
Schizophrenia and 
Other Psychotic 
Disorders
● BACKGROUND ASSESSMENT DATA
The syndrome of symptoms associated with schizophrenia and 
other psychotic disorders reveals alterations in content and orga-
nization of thoughts, perception of sensory input, affect or emo-
tional tone, sense of identity, volition, psychomotor behavior, and 
ability to establish satisfactory interpersonal relationships.
Categories 
Paranoid Schizophrenia
Paranoid schizophrenia is characterized by extreme suspicious-
ness of others and by delusions and hallucinations of a perse-
cutory or grandiose nature. The individual is often tense and 
guarded and may be argumentative, hostile, and aggressive.
Disorganized Schizophrenia
In disorganized schizophrenia, behavior is typically regressive and 
primitive. Affect is inappropriate, with common characteristics 
being silliness, incongruous giggling, facial grimaces, and extreme 
social withdrawal. Communication is consistently incoherent.
Catatonic Schizophrenia
Catatonic schizophrenia manifests itself in the form of stupor 
(marked psychomotor retardation, mutism, waxy ﬂ exibility 
[posturing], negativism, and rigidity) or excitement (extreme psy-
chomotor agitation, leading to exhaustion or the possibility of 
hurting self or others if not curtailed).
Undifferentiated Schizophrenia
Undifferentiated schizophrenia is characterized by disorganized 
behaviors and psychotic symptoms (e.g., delusions, hallucina-
tions, incoherence, and grossly disorganized behavior) that may 
appear in more than one category.
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Residual Schizophrenia
Behavior in residual schizophrenia is eccentric, but psychotic 
symptoms, if present at all, are not prominent. Social withdrawal 
and inappropriate affect are characteristic. The patient has a his-
tory of at least one episode of schizophrenia in which psychotic 
symptoms were prominent.
Schizoaffective Disorder
Schizoaffective disorder refers to behaviors characteristic of 
schizophrenia, in addition to those indicative of disorders of 
mood, such as depression or mania.
Brief Psychotic Disorder
The essential features of brief psychotic disorder include a sud-
den onset of psychotic symptoms that last at least 1 day but less 
than 1 month and in which there is a virtual return to the pre-
morbid level of functioning. The diagnosis is further speciﬁ ed 
by whether it follows a severe identiﬁ able stressor or whether the 
onset occurs within 4 weeks postpartum.
Schizophreniform Disorder
The essential features of schizophreniform disorder are identical 
to those of schizophrenia, with the exception that the duration is 
at least 1 month but less than 6 months. The diagnosis is termed 
“provisional” if a diagnosis must be made prior to recovery.
Delusional Disorder
Delusional disorder is characterized by the presence of one 
or more nonbizarre delusions that last for at least 1 month. 
Hallucinatory activity is not prominent. Apart from the delu-
sions, behavior and functioning are not impaired. The following 
types are based on the predominant delusional theme (American 
Medical Association [AMA], 2000):
 1. Persecutory Type. Delusions that one is being malevolently 
treated in some way.
 2. Jealous Type. Delusions that one’s sexual partner is 
unfaithful.
 3. Erotomanic Type. Delusions that another person of higher 
status is in love with him or her.
 4. Somatic Type. Delusions that the person has some physical 
defect, disorder, or disease.
 5. Grandiose Type. Delusions of inﬂ ated worth, power, knowl-
edge, special identity, or special relationship to a deity or 
famous person.
Shared Psychotic Disorder (Folie à Deux) 
In shared psychotic disorder, a delusional system develops in the 
context of a close relationship with another person who already 
has a psychotic disorder with prominent delusions.
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Psychotic Disorder Due to a General Medical 
Condition
The American Psychiatric Association (APA, 2000) Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition, Text Revision 
(DSM-IV-TR) identiﬁ es the essential features of this disorder as 
prominent hallucinations and delusions that can be directly attrib-
uted to a general medical condition. Examples of general medical 
conditions that may cause psychotic symptoms include neurologic 
conditions (e.g., neoplasms, Huntington’s disease, central nervous 
system [CNS] infections); endocrine conditions (e.g., hyperthy-
roidism, hypothyroidism, hypoadrenocorticism); metabolic condi-
tions (e.g., hypoxia, hypercarbia, hypoglycemia); autoimmune dis-
orders (e.g., systemic lupus erythematosus); and others (e.g., ﬂ uid 
or electrolyte imbalances, hepatic or renal diseases) (APA, 2000).
Substance-Induced Psychotic Disorder 
The essential features of this disorder are the presence of promi-
nent hallucinations and delusions that are judged to be directly 
attributable to the physiological effects of a substance (i.e., a 
drug of abuse, a medication, or toxin exposure) (APA, 2000).
Predisposing Factors
 1. Physiological
 a. Genetics. Studies show that relatives of individuals with 
schizophrenia have a much higher probability of develop-
ing the disease than does the general population. Whereas 
the lifetime risk for developing schizophrenia is about 1% 
in most population studies, the siblings or offspring of 
an identiﬁ ed client have a 5% to 10% risk of developing 
schizophrenia (Andreasen & Black, 2006). Twin and adop-
tion studies add additional evidence for the genetic basis of 
schizophrenia.
 b. Histological Changes. Jonsson and associates (1997) have 
suggested that schizophrenic disorders may in fact be a 
birth defect, occurring in the hippocampus region of the 
brain, and related to an inﬂ uenza virus encountered by 
the mother during the second trimester of pregnancy. 
The studies have shown a “disordering” of the pyramidal 
cells in the brains of individuals with schizophrenia, but 
the cells in the brains of individuals without the disorder 
appeared to be arranged in an orderly fashion. Further 
research is required to determine the possible link between 
this birth defect and the development of schizophrenia.
 c. The Dopamine Hypothesis. This theory suggests that 
schizophrenia (or schizophrenia-like symptoms) may 
be caused by an excess of dopamine-dependent neuronal 
activity in the brain. This excess activity may be related to 
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increased production or release of the substance at nerve 
terminals, increased receptor sensitivity, too many dopa-
mine receptors, or a combination of these mechanisms 
(Sadock & Sadock, 2007).
 d. Anatomical Abnormalities. With the use of neuroimag-
ing technologies, structural brain abnormalities have been 
observed in individuals with schizophrenia. Ventricular 
enlargement is the most consistent ﬁ nding; however, sulci 
enlargement and cerebellar atrophy are also reported.
 2. Environmental
 a. Sociocultural Factors. Many studies have been conducted 
that have attempted to link schizophrenia to social class. 
Indeed, epidemiological statistics have shown that greater 
numbers of individuals from the lower socioeconomic 
classes experience symptoms associated with schizophre-
nia than do those from the higher socioeconomic groups 
(Ho, Black, & Andreasen, 2003). This may occur as a 
result of the conditions associated with living in poverty, 
such as congested housing accommodations, inadequate 
nutrition, absence of prenatal care, few resources for deal-
ing with stressful situations, and feelings of hopelessness 
for changing one’s lifestyle of poverty.
An alternative view is that of the downward drift 
hypothesis. This hypothesis suggests that, because of the 
characteristic symptoms of the disorder, individuals 
with schizophrenia have difﬁ culty maintaining gainful 
employment and “drift down” to a lower socioeconomic 
level (or fail to rise out of a lower socioeconomic group). 
Proponents of this notion view poor social conditions as 
a consequence rather than a cause of schizophrenia.
 b. Stressful Life Events.  Studies have been conducted in an 
effort to determine whether psychotic episodes may be 
precipitated by stressful life events. There is no scientiﬁ c 
evidence to indicate that stress causes schizophrenia. It is 
very probable, however, that stress contributes to the se-
verity and course of the illness. It is known that extreme 
stress can precipitate psychotic episodes. Stress may 
indeed precipitate symptoms in an individual who pos-
sesses a genetic vulnerability to schizophrenia. Stressful 
life events may be associated with exacerbation of schizo-
phrenic symptoms and increased rates of relapse.
Symptomatology (Subjective/Objective Data)
 1. Autism. There is a focus inward. The individual with psy-
chosis may create his or her own world. Words and events 
may take on special meaning of a highly symbolic nature that 
only the individual can understand.
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 2. Emotional Ambivalence. Powerful emotions of love, hate, 
and fear produce much conﬂ ict within the individual. Each 
emotion tends to balance the other until an emotional neu-
tralization occurs, and the individual experiences apathy or 
indifference.
 3. Inappropriate Affect. The affect is blunted or ﬂ at, and 
often inappropriate (e.g., person who laughs when told of 
the death of a parent).
 4. Associative Looseness. This term describes the very 
disorganized thoughts and verbalizations of the psychotic 
person. Ideas shift from one unrelated subject to another. 
When the condition is severe, speech may be incoherent.
 5. Echolalia. The psychotic person often repeats words he or 
she hears.
 6. Echopraxia.  The psychotic person often repeats move-
ments he or she sees in others. (Echolalia and echopraxia 
are products of the person’s very weak ego boundaries.)
 7. Neologisms. Words that are invented by the psychotic per-
son that are meaningless to others but have symbolic mean-
ing to the individual.
 8. Concrete Thinking. The psychotic person has difﬁ culty 
thinking on the abstract level and may use literal transla-
tions concerning aspects of the environment.
 9. Clang Associations. The individual uses rhyming words in 
a nonsensical pattern.
 10. Word Salad. The psychotic person may put together a ran-
dom jumble of words.
 11. Mutism. Psychotic individuals may refuse or be unable to 
speak.
 12. Circumstantiality.  Circumstantiality refers to a psychotic 
person’s delay in reaching the point of a communication 
because of unnecessary and tedious details.
 13. Tangentiality. Tangentiality differs from circumstantiality 
in that the psychotic person never really gets to the point of 
the communication. Unrelated topics are introduced, and 
the original discussion is lost.
 14. Perseveration. The individual with psychosis may persis-
tently repeat the same word or idea in response to different 
questions.
 15. Delusions. These are false ideas or beliefs. Types of delu-
sions include the following:
 a. Grandeur. The psychotic person has an exaggerated feel-
ing of importance or power.
 b. Persecution. The psychotic person feels threatened and 
believes others intend harm or persecution toward him 
or her in some way.
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 c. Reference. All events within the environment are referred 
by the psychotic person to himself or herself.
 d. Control or Infl uence. The psychotic individual believes 
certain objects or people have control over his or her 
behavior.
 16. Hallucinations. Hallucinations are false sensory percep-
tions that may involve any of the ﬁ ve senses. Auditory and 
visual hallucinations are most common, although olfactory, 
tactile, and gustatory hallucinations can occur.
 17. Regression. This is a primary ego defense mechanism 
used in psychoses. Childlike mannerisms and comfort tech-
niques are employed. Socially inappropriate behavior may be 
evident.
 18. Religiosity. The psychotic person becomes preoccupied 
with religious ideas, a defense mechanism thought to be 
used in an attempt to provide stability and structure to dis-
organized thoughts and behaviors.
Common Nursing Diagnoses and 
Interventions for Individuals with 
Schizophrenia and Other Psychotic Disorders
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.) 
●
 RISK FOR SELF-DIRECTED 
OR OTHER-DIRECTED VIOLENCE
Deﬁ nition: At risk for behaviors in which an individual demon-
strates that he or she can be physically, emotionally, and/or sexu-
ally harmful [either to self or to others.]
Related/Risk Factors (“related to”)
[Lack of trust (suspiciousness of others)]
[Panic level of anxiety]
[Catatonic excitement]
[Negative role modeling]
[Rage reactions]
[Command hallucinations]
[Delusional thinking]
Body language—rigid posture, clenching of ﬁ sts and jaw, 
hyperactivity, pacing, breathlessness, and threatening stances.
[History or threats of violence toward self or others or of 
destruction to the property of others]
Impulsivity
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Suicidal ideation, plan, available means
[Perception of the environment as threatening]
[Receiving auditory or visual commands of a threatening na-
ture] 
Goals/Objectives
Short-term Goals
 1. Within [a speciﬁ ed time], client will recognize signs of 
increasing anxiety and agitation and report to staff for assis-
tance with intervention.
 2. Client will not harm self or others 
Long-term Goal
Client will not harm self or others.
Interventions with Selected Rationales
 1. Maintain low level of stimuli in client’s environment (low 
lighting, few people, simple decor, low noise level). Anxi-
ety level rises in a stimulating environment. A suspicious, 
agitated client may perceive individuals as threatening.
 2. Observe client’s behavior frequently (every 15 minutes). 
Do this while carrying out routine activities so as to avoid 
creating suspiciousness in the individual. Close observation 
is necessary so that intervention can occur if required to 
ensure client’s (and others’) safety.
 3. Remove all dangerous objects from client’s environment so 
that in his or her agitated, confused state client may not use 
them to harm self or others.
 4. Try to redirect the violent behavior with physical outlets for 
the client’s anxiety (e.g., punching bag).  Physical exercise is 
a safe and effective way of relieving pent-up tension.
 5. Staff should maintain and convey a calm attitude toward 
client. Anxiety is contagious and can be transmitted from 
staff to client.
 6. Have sufﬁ cient staff available to indicate a show of strength 
to client if it becomes necessary. This shows the client 
evidence of control over the situation and provides some 
physical security for staff.
 7. Administer tranquilizing medications as ordered by physi-
cian. Monitor medication for its effectiveness and for any 
adverse side effects. The avenue of the “least restrictive 
alternative” must be selected when planning interventions 
for a psychiatric client.
 8. If client is not calmed by “talking down” or by medication, use 
of mechanical restraints may be necessary. Restraints should 
be used only as a last resort, after all other interventions have 
been unsuccessful, and the client is clearly at risk of harm 
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to self or others. Be sure to have sufﬁ cient staff available to 
assist. 
     Follow protocol established by the institution. The Joint 
Commission formerly the Joint Commission on Acredita-
tion of Healthcare Organizations [JCAHO]) requires that 
an in-person evaluation (by a physician, clinical psycholo-
gist, or other licensed independent practitioner responsible 
for the care of the patient) be conducted within 1 hour of 
initiating restraint or seclusion (The Joint Commission, 
2010). The physician must physician reissue a new order for 
restraints every 4 hours for adults and every 1 to 2 hours for 
children and adolescents. 
 9. Observe the client in restraints every 15 minutes (or ac-
cording to institutional policy). Ensure that circulation to 
extremities is not compromised (check temperature, color, 
pulses). Assist client with needs related to nutrition, hy-
dration, and elimination. Position client so that comfort is 
facilitated and aspiration can be prevented. Continuous 
one-to-one monitoring may be necessary for the client who 
is highly agitated or for whom there is a high risk of self- or 
accidental injury. Client safety is a nursing priority.
 10. As agitation decreases, assess client’s readiness for restraint 
removal or reduction. Remove one restraint at a time while 
assessing client’s response. This minimizes risk of injury to 
client and staff.
Outcome Criteria
 1. Anxiety is maintained at a level at which client feels no need 
for aggression.
 2. Client demonstrates trust of others in his or her environment.
 3. Client maintains reality orientation.
 4. Client causes no harm to self or others.
●
 SOCIAL ISOLATION
Deﬁ nition: Aloneness experienced by the individual and perceived 
as imposed by others and as a negative or threatening state. 
Possible Etiologies (“related to”)
[Lack of trust]
[Panic level of anxiety]
[Regression to earlier level of development]
[Delusional thinking]
[Past experiences of difﬁ culty in interactions with others]
[Repressed fears]
Unaccepted social behavior
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Deﬁ ning Characteristics (“evidenced by”)
[Staying alone in room]
Uncommunicative, withdrawn, no eye contact [mutism, autism]
Sad, dull affect
[Lying on bed in fetal position with back to door]
[Inappropriate or immature interests and activities for develop-
mental age or stage]
Preoccupation with own thoughts; repetitive, meaningless actions
[Approaching staff for interaction, then refusing to respond to 
staff’s acknowledgment]
Expression of feelings of rejection or of aloneness imposed by 
others
Goals/Objectives
Short-term Goal
Client will willingly attend therapy activities accompanied by 
trusted staff member within 1 week.
Long-term Goal
Client will voluntarily spend time with other clients and staff 
members in group activities.
Interventions with Selected Rationales
 1. Convey an accepting attitude by making brief, frequent con-
tacts. An accepting attitude increases feelings of self-worth 
and facilitates trust.
 2. Show unconditional positive regard. This conveys your belief 
in the client as a worthwhile human being.
 3. Be with the client to offer support during group activities that 
may be frightening or difﬁ cult for him or her. The presence 
of a trusted individual provides emotional security for the 
client.
 4. Be honest and keep all promises. Honesty and dependability 
promote a trusting relationship.
 5. Orient client to time, person, and place, as necessary.
 6. Be cautious with touch. Allow client extra space and an 
avenue for exit if he or she becomes too anxious. A suspicious 
client may perceive touch as a threatening gesture.
 7. Administer tranquilizing medications as ordered by physi-
cian. Monitor for effectiveness and for adverse side effects. 
Antipsychotic medications help to reduce psychotic symp-
toms in some individuals, thereby facilitating interactions 
with others.
 8. Discuss with client the signs of increasing anxiety and 
techniques to interrupt the response (e.g., relaxation 
exercises, thought stopping). Maladaptive behaviors such 
as withdrawal and suspiciousness are manifested during 
times of increased anxiety.
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 9. Give recognition and positive reinforcement for client’s vol-
untary interactions with others. Positive reinforcement en-
hances self-esteem and encourages repetition of acceptable 
behaviors.
Outcome Criteria
 1. Client demonstrates willingness and desire to socialize with 
others.
 2. Client voluntarily attends group activities.
 3. Client approaches others in appropriate manner for one-
to-one interaction.
●
 INEFFECTIVE COPING
Deﬁ nition: Inability to form a valid appraisal of the stressors, 
inadequate choices of practiced responses, and/or inability to use 
available resources.
Possible Etiologies (“related to”)
[Inability to trust]
[Panic level of anxiety]
[Personal vulnerability] 
[Low self-esteem]
[Inadequate support systems]
[Negative role model]
[Repressed fears]
[Possible hereditary factor]
[Dysfunctional family system] 
Deﬁ ning Characteristics (“evidenced by”)
[Suspiciousness of others, resulting in: 
 • Alteration in societal participation
 • Inability to meet basic needs
 • Inappropriate use of defense mechanisms]
Goals/Objectives
Short-term Goal
Client will develop trust in at least one staff member within 
1 week.
Long-term Goal
Client will demonstrate use of more adaptive coping skills as 
evidenced by appropriateness of interactions and willingness to 
participate in the therapeutic community.
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Interventions with Selected Rationales
 1. Encourage same staff to work with client as much as 
possible in order to promote development of trusting 
relationship.
 2. Avoid physical contact. Suspicious clients may perceive touch 
as a threatening gesture.
 3. Avoid laughing, whispering, or talking quietly where client 
can see but not hear what is being said. Suspicious clients 
often believe others are discussing them, and secretive be-
haviors reinforce the paranoid feelings.
 4. Be honest and keep all promises. Honesty and dependability 
promote a trusting relationship.
 5. A creative approach may have to be used to encourage food 
intake (e.g., canned food and own can opener or family-
style meals). Suspicious clients may believe they are being 
poisoned and refuse to eat food from the individually pre-
pared tray.
 6. Mouth checks may be necessary following medication 
administration to verify whether client is swallowing the 
tablets or capsules. Suspicious clients may believe they 
are being poisoned with their medication and attempt to 
discard the pills.
 7. Activities should never include anything competitive. 
Activities that encourage a one-to-one relationship with the 
nurse or therapist are best. Competitive activities are very 
threatening to suspicious clients.
 8. Encourage client to verbalize true feelings. The nurse should 
avoid becoming defensive when angry feelings are directed 
at him or her. Verbalization of feelings in a nonthreaten-
ing environment may help client come to terms with long-
unresolved issues.
 9. An assertive, matter-of-fact, yet genuine approach is least 
threatening and most therapeutic. A suspicious person does 
not have the capacity to relate to an overly friendly, overly 
cheerful attitude.
Outcome Criteria
 1. Client is able to appraise situations realistically and refrain 
from projecting own feelings onto the environment.
 2. Client is able to recognize and clarify possible misinterpreta-
tions of the behaviors and verbalizations of others.
 3. Client eats food from tray and takes medications without 
evidence of mistrust.
 4. Client appropriately interacts and cooperates with staff and 
peers in therapeutic community setting.
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●
 DISTURBED SENSORY PERCEPTION: 
AUDITORY/VISUAL
Deﬁ nition: Change in the amount or patterning of incoming 
stimuli [either internally or externally initiated] accompanied by a 
diminished, exaggerated, distorted, or impaired response to such 
stimuli. 
Possible Etiologies (“related to”)
[Panic level of anxiety]
[Withdrawal into the self]
[Stress sufﬁ ciently severe to threaten an already weak ego] 
Deﬁ ning Characteristics (“evidenced by”)
[Talking and laughing to self]
[Listening pose (tilting head to one side as if listening)]
[Stops talking in middle of sentence to listen]
[Rapid mood swings]
[Disordered thought sequencing]
[Inappropriate responses] 
Disorientation
Poor concentration
Sensory distortions
Goals/Objectives
Short-term Goal
Client will discuss content of hallucinations with nurse or thera-
pist within 1 week.
Long-term Goal
Client will be able to deﬁ ne and test reality, eliminating the 
occurrence of hallucinations. (This goal may not be realistic 
for the individual with chronic illness who has experienced 
auditory hallucinations for many years.) A more realistic goal 
may be:
Client will verbalize understanding that the voices are a re-
sult of his or her illness and demonstrate ways to interrupt the 
hallucination.
Interventions with Selected Rationales
 1. Observe client for signs of hallucinations (listening pose, 
laughing or talking to self, stopping in mid-sentence). Early 
intervention may prevent aggressive responses to command 
hallucinations.
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 2. Avoid touching the client before warning him or her that you 
are about to do so. Client may perceive touch as threatening 
and respond in an aggressive manner.
 3. An attitude of acceptance will encourage the client to share 
the content of the hallucination with you. This is important 
in order to prevent possible injury to the client or others 
from command hallucinations.
 4. Do not reinforce the hallucination. Use words such as “the 
voices” instead of “they” when referring to the hallucination. 
Words like “they” validate that the voices are real.
CLINICAL PEARL  Let the client who is “hearing voices” know that you do not 
share the perception. 
  Say “Even though I realize that the voices are real to you, I do not hear any 
voices speaking.” The nurse must be honest with the client so that he or she may 
realize that the hallucinations are not real.
 5. Try to connect the times of the hallucinations to times of 
increased anxiety. Help the client to understand this con-
nection. If client can learn to interrupt escalating anxiety, 
hallucinations may be prevented.
 6. Try to distract the client away from the hallucination. 
Involvement in interpersonal activities and explanation 
of the actual situation will help bring the client back to 
reality.
 7. For some clients, auditory hallucinations persist after the 
acute psychotic episode has subsided. Listening to the 
radio or watching television helps distract some clients 
from attention to the voices. Others have beneﬁ ted from 
an intervention called voice dismissal. With this technique, 
the client is taught to say loudly, “Go away!” or “Leave me 
alone!”, thereby exerting some conscious control over the 
behavior.
Outcome Criteria
 1. Client is able to recognize that hallucinations occur at times 
of extreme anxiety.
 2. Client is able to recognize signs of increasing anxiety and 
employ techniques to interrupt the response.
●
 DISTURBED THOUGHT PROCESSES
Deﬁ nition: Disruption in cognitive operations and activities.  
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Possible Etiologies (“related to”)
[Inability to trust]
[Panic level of anxiety]
[Repressed fears]
[Stress sufﬁ ciently severe to threaten an already weak ego]
[Possible hereditary factor] 
Deﬁ ning Characteristics (“evidenced by”)
[Delusional thinking (false ideas)]
[Inability to concentrate]
Hypervigilance
[Altered attention span]—distractibility 
Inaccurate interpretation of the environment
[Impaired ability to make decisions, problem-solve, reason, 
abstract or conceptualize, calculate] 
[Inappropriate social behavior (reﬂ ecting inaccurate thinking)]
Inappropriate [non–reality-based] thinking
Goals/Objectives
Short-term Goal
[By speciﬁ ed time deemed appropriate], client will recognize and 
verbalize that false ideas occur at times of increased anxiety. 
Long-term Goal
Depending on chronicity of disease process, choose the most 
realistic long-term goal for the client:
 1. By time of discharge from treatment, client’s speech will re-
ﬂ ect reality-based thinking.
 2. By time of discharge from treatment, client will be able to 
differentiate between delusional thinking and reality.
Interventions with Selected Rationales
 1. Convey your acceptance of client’s need for the false belief, 
while letting him or her know that you do not share the 
belief. It is important to communicate to the client that you 
do not accept the delusion as reality.
 2. Do not argue or deny the belief. Use reasonable doubt as a 
therapeutic technique: “I understand that you believe this 
is true, but I personally ﬁ nd it hard to accept.” Arguing 
with the client or denying the belief serves no useful pur-
pose, because delusional ideas are not eliminated by this 
approach, and the development of a trusting relationship 
may be impeded.
 3. Help client trye to connect the false beliefs to times of in-
creased anxiety. Discuss techniques that could be used to 
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control anxiety (e.g., deep-breathing exercises, other re-
laxation exercises, thought stopping techniques). If the cli-
ent can learn to interrupt escalating anxiety, delusional 
thinking may be prevented.
 4. Reinforce and focus on reality. Discourage long ruminations 
about the irrational thinking. Talk about real events and real 
people. Discussions that focus on the false ideas are pur-
poseless and useless, and may even aggravate the psychosis.
 5. Assist and support client in his or her attempt to verbalize 
feelings of anxiety, fear, or insecurity. Verbalization of feel-
ings in a nonthreatening environment may help client come 
to terms with long-unresolved issues.
Outcome Criteria
 1. Verbalizations reﬂ ect thinking processes oriented in reality.
 2. Client is able to maintain activities of daily living (ADLs) to 
his or her maximal ability.
 3. Client is able to refrain from responding to delusional 
thoughts, should they occur. 
●
 IMPAIRED VERBAL 
COMMUNICATION
Deﬁ nition: Decreased, delayed, or absent ability to receive, 
process, transmit, and use a system of symbols [to communicate]. 
Possible Etiologies (“related to”)
Altered perceptions
[Inability to trust]
[Panic level of anxiety]
[Regression to earlier level of development]
[Withdrawal into the self]
[Disordered, unrealistic thinking] 
Deﬁ ning Characteristics (“evidenced by”)
[Loose association of ideas]
[Use of words that are symbolic to the individual (neologisms)]
[Use of words in a meaningless, disconnected manner (word 
salad)]
[Use of words that rhyme in a nonsensical fashion (clang 
association)]
[Repetition of words that are heard (echolalia)]
[Does not speak (mutism)]
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[Verbalizations reﬂ ect concrete thinking (inability to think in 
abstract terms)]
[Poor eye contact (either no eye contact or continuous staring 
into the other person’s eyes)] 
Goals/Objectives
Short-term Goal
Client will demonstrate ability to remain on one topic, using 
appropriate, intermittent eye contact for 5 minutes with nurse 
or therapist.
Long-term Goal
By time of discharge from treatment, client will demonstrate 
ability to carry on a verbal communication in a socially accept-
able manner with staff and peers.
Interventions with Selected Rationales
 1. Use the techniques of consensual validation and seeking clari-
ﬁ cation to decode communication patterns. (Examples: “Is it 
that you mean...?” or “I don’t understand what you mean by 
that. Would you please explain it to me?”) These techniques 
reveal to the client how he or she is being perceived by others, 
and the responsibility for not understanding is accepted by 
the nurse.
 2. Maintain consistency of staff assignment over time, to facili-
tate trust and the ability to understand client’s actions and 
communication.
 3. In a nonthreatening manner, explain to client how his or her 
behavior and verbalizations are viewed by and may alienate 
others.
 4. If client is unable or unwilling to speak (mutism), use of the 
technique of verbalizing the implied is therapeutic. (Example: 
“That must have been very difﬁ cult for you when....”) This 
may help to convey empathy, develop trust, and eventually 
encourage client to discuss painful issues.
 5. Anticipate and fulﬁ ll client’s needs until satisfactory com-
munication patterns return. Client comfort and safety are 
nursing priorities. 
Outcome Criteria
 1. Client is able to communicate in a manner that is understood 
by others.
 2. Client’s nonverbal messages are congruent with verbalizations.
 3. Client is able to recognize that disorganized thinking and 
impaired verbal communication occur at times of increased 
anxiety and intervene to interrupt the process.
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●
 SELF-CARE DEFICIT (Identify 
Speciﬁ c Area)
Deﬁ nition: Impaired ability to perform or complete [activities of 
daily living (ADLs)]. 
Possible Etiologies (“related to”)
[Withdrawal into the self]
[Regression to an earlier level of development]
[Panic level of anxiety]
Perceptual or cognitive impairment
[Inability to trust] 
Deﬁ ning Characteristics (“evidenced by”)
[Difﬁ culty in bringing or] inability to bring food from 
receptacle to mouth
Inability [or refusal] to wash body or body parts
[Impaired ability or lack of interest in selecting appropri-
ate clothing to wear, dressing, grooming, or maintaining 
appearance at a satisfactory level]
[Inability or unwillingness to carry out toileting procedures 
without assistance] 
Goals/Objectives
Short-term Goal
Client will verbalize a desire to perform ADLs by end of 
1 week.
Long-term Goal
By time of discharge from treatment, client will be able to 
perform ADLs in an independent manner and demonstrate a 
willingness to do so.
Interventions with Selected Rationales
 1. Encourage client to perform normal ADLs to his or her level 
of ability. Successful performance of independent activities 
enhances self-esteem.
 2. Encourage independence, but intervene when client is unable 
to perform. Client comfort and safety are nursing priorities.
 3. Offer recognition and positive reinforcement for independent 
accomplishments. (Example: “Mrs. J., I see you have put on a 
clean dress and combed your hair.”) Positive reinforcement 
enhances self-esteem and encourages repetition of desirable 
behaviors.
 4. Show client, on concrete level, how to perform activities with 
which he or she is having difﬁ culty. (Example: If client is not 
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eating, place spoon in his or her hand, scoop some food into it, 
and say, “Now, eat a bite of mashed potatoes (or other food).” 
Because concrete thinking prevails, explanations must be 
provided at the client’s concrete level of comprehension.
 5. Keep strict records of food and ﬂ uid intake. This information 
is necessary to acquire an accurate nutritional assessment.
 6. Offer nutritious snacks and ﬂ uids between meals. Client may 
be unable to tolerate large amounts of food at mealtimes 
and may therefore require additional nourishment at other 
times during the day to receive adequate nutrition.
 7. If client is not eating because of suspiciousness and fears of 
being poisoned, provide canned foods and allow client to 
open them; or, if possible, suggest that food be served family-
style so that client may see everyone eating from the same 
servings.
 8. If client is soiling self, establish routine schedule for toilet-
ing needs. Assist client to bathroom on hourly or bi-hourly 
schedule, as need is determined, until he or she is able to 
fulﬁ ll this need without assistance.
Outcome Criteria
 1. Client feeds self without assistance.
 2. Client selects appropriate clothing, dresses, and grooms self 
daily without assistance.
 3. Client maintains optimal level of personal hygiene by bathing 
daily and carrying out essential toileting procedures without 
assistance.
●
 INSOMNIA
Deﬁ nition: A disruption in amount and quality of sleep that 
impairs functioning. 
Possible Etiologies (“related to”)
[Panic level of anxiety]
[Repressed fears]
[Hallucinations]
[Delusional thinking] 
Deﬁ ning Characteristics (“evidenced by”)
[Difﬁ culty falling asleep]
[Awakening very early in the morning]
[Pacing; other signs of increasing irritability caused by lack of 
sleep]
[Frequent yawning, nodding off to sleep] 
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Goals/Objectives
Short-term Goal
Within ﬁ rst week of treatment, client will fall asleep within 
30 minutes of retiring and sleep 5 hours without awakening, 
with use of sedative if needed.
Long-term Goal
By time of discharge from treatment, client will be able to fall 
asleep within 30 minutes of retiring and sleep 6 to 8 hours with-
out a sleeping aid.
Interventions with Selected Rationales
 1. Keep strict records of sleeping patterns. Accurate baseline 
data are important in planning care to assist client with this 
problem.
 2. Discourage sleep during the day to promote more restful 
sleep at night.
 3. Administer antipsychotic medication at bedtime so client 
does not become drowsy during the day.
 4. Assist with measures that promote sleep, such as warm, non-
stimulating drinks; light snacks; warm baths; and back rubs.
 5. Performing relaxation exercises to soft music may be helpful 
prior to sleep.
 6. Limit intake of caffeinated drinks such as tea, coffee, and 
colas. Caffeine is a CNS stimulant and may interfere with 
the client’s achievement of rest and sleep.
Outcome Criteria
 1. Client is able to fall asleep within 30 minutes after retiring.
 2. Client sleeps at least 6 consecutive hours without waking.
 3. Client does not require a sedative to fall asleep.
 INTERNET REFERENCES
 • Additional information about schizophrenia may be located 
at the following websites:
 a. http://www.schizophrenia.com
 b. http://www.nimh.nih.gov
 c. http://www.nami.org/schizophrenia
 d. http://mentalhealth.com
 e. http://www.narsad.org
 • Additional information about medications to treat schizo-
phrenia may be located at the following websites:
 a. http://www.medicinenet.com/medications/article.htm
 b. http://www.fadavis.com/townsend
 c. http://www.nlm.nih.gov/medlineplus
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Movie Connections
I Never Promised You a Rose Garden (schizophrenia) • A Beautiful 
Mind (schizophrenia) • The Fisher King (schizophrenia) • Benny & Joon 
(schizophrenia) • Out of Darkness (schizophrenia) • Conspiracy Theory 
(paranoia) • The Fan (delusional disorder)
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C H A P T E R  6
Mood Disorders: 
Depression
● BACKGROUND ASSESSMENT DATA
“Mood” is deﬁ ned as an individual’s sustained emotional tone, 
which signiﬁ cantly inﬂ uences behavior, personality, and per-
ception. A disturbance in mood is the predominant feature of 
the mood disorders (American Psychiatric Association [APA], 
2000). Mood disorders are classiﬁ ed as depressive or bipolar.
Major Depressive Disorder
Major depressive disorder is described as a disturbance of mood 
involving depression or loss of interest or pleasure in the usual 
activities and pastimes. There is evidence of interference in 
social and occupational functioning for at least 2 weeks. There 
is no history of manic behavior and the symptoms cannot be 
attributed to use of substances or a general medical condition. 
The following speciﬁ ers may be used to further describe the 
depressive episode:
 1. Single Episode or Recurrent: This speciﬁ er identiﬁ es 
whether the individual has experienced prior episodes of 
depression.
 2. Mild, Moderate, or Severe: These categories are identiﬁ ed 
by the number and severity of symptoms.
 3. With Psychotic Features: Impairment of reality testing is 
evident. The individual experiences hallucinations and/or 
delusions.
 4. With Catatonic Features: This category identiﬁ es the 
presence of psychomotor disturbances, such as severe psycho-
motor retardation, with or without the presence of waxy ﬂ ex-
ibility or stupor or excessive motor activity. The client also 
may manifest symptoms of negativism, mutism, echolalia, or 
echopraxia.
 5. With Melancholic Features: This is a typically severe 
form of major depressive episode. Symptoms are exagger-
ated. There is a loss of interest in all activities. Depression is 
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regularly worse in the morning. There is a history of major 
depressive episodes that have responded well to somatic anti-
depressant therapy.
 6. Chronic: This classiﬁ cation applies when the current episode 
of depressed mood has been evident continuously for at least 
the past 2 years.
 7. With Seasonal Pattern: This diagnosis indicates the pres-
ence of depressive symptoms during the fall or winter months. 
This diagnosis is made when the number of seasonal depres-
sive episodes substantially outnumbers the non–seasonal 
depressive episodes that have occurred over the individual’s 
lifetime (APA, 2000). This disorder has previously been iden-
tiﬁ ed in the literature as seasonal affective disorder (SAD).
 8. With Postpartum Onset: This speciﬁ er is used when symp-
toms of major depression occur within 4 weeks postpartum.
Dysthymic Disorder
Dysthymic disorder is a mood disturbance with character-
istics similar to, if somewhat milder than, those ascribed to 
major depressive disorder. There is no evidence of psychotic 
symptoms.
Depressive Disorder Due to General Medical 
Condition
This disorder is characterized by a prominent and persistent de-
pressed mood that is judged to be the direct result of the physi-
ological effects of a general medical condition (APA, 2000).
Substance-Induced Depressed Mood Disorder 
The depressed mood associated with this disorder is considered 
to be the direct result of the physiological effects of a substance 
(e.g., use or abuse of a drug or a medication, or toxin exposure).
● PREDISPOSING FACTORS TO DEPRESSION
 1. Physiological
 a. Genetic: Numerous studies have been conducted that sup-
port the involvement of heredity in depressive illness. The 
disorder is 1.5 to 3 times more common among ﬁ rst-degree 
relatives of individuals with the disorder than among the 
general population (APA, 2000).
 b. Biochemical: A biochemical theory implicates the bio
genic amines norepinephrine, dopamine, and serotonin. 
The levels of these chemicals have been found to be deﬁ -
cient in individuals with depressive illness.
 c. Neuroendocrine Disturbances: Elevated levels of serum 
cortisol and decreased levels of thyroid-stimulating 
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hormone have been associated with depressed mood in 
some individuals.
 d. Medication Side Effects: A number of drugs can produce 
a depressive syndrome as a side effect. Common ones in-
clude anxiolytics, antipsychotics, and sedative-hypnotics. 
Antihypertensive medications such as propranolol and re-
serpine have been known to produce depressive symptoms.
 e. Other Physiological Conditions: Depressive symptoms 
may occur in the presence of electrolyte disturbances, 
hormonal disturbances, nutritional deﬁ ciencies, and 
with certain physical disorders, such as cardiovascular 
accident, systemic lupus erythematosus, hepatitis, and 
diabetes mellitus.
 2. Psychosocial
 a. Psychoanalytical: Freud observed that melancholia occurs 
after the loss of a loved object, either actually by death 
or emotionally by rejection, or the loss of some other ab-
straction of value to the individual. Freud indicated that 
in clients with melancholia, the depressed person’s rage is 
internally directed because of identiﬁ cation with the lost 
object (Sadock & Sadock, 2007).
 b. Cognitive: Beck and colleagues (1979) proposed that 
depressive illness occurs as a result of impaired cognition. 
Disturbed thought processes foster a negative evaluation 
of self by the individual. The perceptions are of inade-
quacy and worthlessness. Outlook for the future is one of 
pessimism and hopelessness.
 c. Learning Theory: Learning theory (Seligman, 1973) pro-
poses that depressive illness is predisposed by the individ-
ual’s belief that there is a lack of control over his or her 
life situation. It is thought that this belief arises out of 
experiences that result in failure (either perceived or real). 
Following numerous failures, the individual feels helpless 
to succeed at any endeavor and therefore gives up trying. 
This “learned helplessness” is viewed as a predisposition 
to depressive illness.
 d. Object Loss Theory: The theory of object loss suggests 
that depressive illness occurs as a result of having been 
abandoned by, or otherwise separated from, a signiﬁ cant 
other during the ﬁ rst 6 months of life. Because during this 
period the mother represents the child’s main source of 
security, she is the “object.” The response occurs not only 
with a physical loss. This absence of attachment, which 
may be either physical or emotional, leads to feelings of 
helplessness and despair that contribute to lifelong pat-
terns of depression in response to loss.
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●  SYMPTOMATOLOGY (SUBJECTIVE 
AND OBJECTIVE DATA)
 1. The affect of a depressed person is one of sadness, dejection, 
helplessness, and hopelessness. The outlook is gloomy and 
pessimistic. A feeling of worthlessness prevails.
 2. Thoughts are slowed and concentration is difﬁ cult. Obsessive 
ideas and rumination of negative thoughts are common. In 
severe depression (major depressive disorder or bipolar 
depression), psychotic features such as hallucinations and 
delusions may be evident, reﬂ ecting misinterpretations of 
the environment.
 3. Physically, there is evidence of weakness and fatigue—very 
little energy to carry on activities of daily living (ADLs). 
The individual may express an exaggerated concern over 
bodily functioning, seemingly experiencing heightened 
sensitivity to somatic sensations. 
 4. Some individuals may be inclined toward excessive eating 
and drinking, whereas others may experience anorexia and 
weight loss. In response to a general slowdown of the body, 
digestion is often sluggish, constipation is common, and 
urinary retention is possible. 
 5. Sleep disturbances are common, either insomnia or 
hypersomnia. 
 6. At the less severe level (dysthymic disorder), individuals 
tend to feel their best early in the morning, then continu-
ally feel worse as the day progresses. The opposite is true of 
persons experiencing severe depression. The exact cause of 
this phenomenon is unknown, but it is thought to be related 
to the circadian rhythm of the hormones and their effects 
on the body.
 7. A general slowdown of motor activity commonly accompa-
nies depression (called psychomotor retardation). Energy level 
is depleted, movements are lethargic, and performance of 
daily activities is extremely difﬁ cult. Regression is common, 
evidenced by withdrawal into the self and retreat to the fetal 
position. Severely depressed persons may manifest psycho-
motor activity through symptoms of agitation. These are 
constant, rapid, purposeless movements, out of touch with 
the environment.
 8. Verbalizations are limited. When depressed persons do 
speak, the content may be either ruminations regarding 
their own life regrets or, in psychotic clients, a reﬂ ection of 
their delusional thinking.
 9. Social participation is diminished. The depressed client 
has an inclination toward egocentrism and narcissism—an 
intense focus on the self. This discourages others from 
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pursuing a relationship with the individual, which increases 
his or her feelings of worthlessness and penchant for isolation.
Common Nursing Diagnoses and Interventions 
for Depression
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.) 
●
 RISK FOR SUICIDE
Deﬁ nition: At risk for self-infl icted, life-threatening injury. 
Related/Risk Factors (“related to”)
[Depressed mood]
Grief; hopelessness; social isolation
History of prior suicide attempt
[Has a suicide plan and means to carry it out]
Widowed or divorced
Chronic or terminal illness
Psychiatric illness or substance abuse
States desire to die
Threats of killing self
Goals/Objectives
Short-term Goals
 1. Client will seek out staff when feeling urge to harm self.
 2. Client will make short-term verbal (or written) contract with 
nurse not to harm self.
 3. Client will not harm self.
Long-term Goal
Client will not harm self. 
Interventions with Selected Rationales
 1. Ask client directly: “Have you thought about harming your-
self in any way? If so, what do you plan to do? Do you have the 
means to carry out this plan?” The risk of suicide is greatly 
increased if the client has developed a plan and particularly 
if means exist for the client to execute the plan.
 2. Create a safe environment for the client. Remove all poten-
tially harmful objects from client’s access (sharp objects, 
straps, belts, ties, glass items). Supervise closely during meals 
and medication administration. Perform room searches as 
deemed necessary. Client safety is a nursing priority.
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 3. Formulate a short-term verbal or written contract with the 
client that he or she will not harm self during speciﬁ c time 
period. When that contract expires, make another, and so 
forth. Discussion of suicidal feelings with a trusted indi-
vidual provides some relief to the client. A contract gets 
the subject out in the open and places some of the respon-
sibility for the client’s safety with the client. An attitude 
of acceptance of the client as a worthwhile individual is 
conveyed.
 4. Secure promise from client that he or she will seek out 
a staff member or support person if thoughts of suicide 
emerge. Suicidal clients are often very ambivalent about 
their feelings. Discussion of feelings with a trusted indi-
vidual may provide assistance before the client experiences 
a crisis situation.
 5. Maintain close observation of client. Depending on level of 
suicide precaution, provide one-to-one contact, constant 
visual observation, or every-15-minute checks. Place client 
in room close to nurse’s station; do not assign to private 
room. Accompany client to off-unit activities if attendance 
is indicated. May need to accompany client to bathroom. 
Close observation is necessary to ensure that client does 
not harm self in any way. Being alert for suicidal and 
escape attempts facilitates being able to prevent or inter-
rupt harmful behavior.
 6. Maintain special care in administration of medications. 
Prevents saving up to overdose or discarding and not 
taking.
 7. Make rounds at frequent, irregular intervals (especially at 
night, toward early morning, at change of shift, or other 
predictably busy times for staff). Prevents staff surveillance 
from becoming predictable. To be aware of client’s location 
is important, especially when staff is busy, unavailable, or 
less observable.
 8. Encourage verbalizations of honest feelings. Through 
exploration and discussion, help client to identify symbols of 
hope in his or her life.
 9. Encourage client to express angry feelings within appropriate 
limits. Provide safe method of hostility release. Help client to 
identify true source of anger and to work on adaptive coping 
skills for use outside the treatment setting. Depression and 
suicidal behaviors may be viewed as anger turned inward on 
the self. If this anger can be verbalized in a nonthreatening 
environment, the client may be able to eventually resolve 
these feelings.
 10. Identify community resources that client may use as sup-
port system and from whom he or she may request help 
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if feeling suicidal. Having a concrete plan for seeking 
assistance during a crisis may discourage or prevent self-
destructive behaviors.
 11. Orient client to reality, as required. Point out sensory 
misperceptions or misinterpretations of the environment. 
Take care not to belittle client’s fears or indicate disapproval 
of verbal expressions.
 12. Most important, spend time with client. This provides a 
feeling of safety and security, while also conveying the mes-
sage, “I want to spend time with you because I think you are 
a worthwhile person.”
Outcome Criteria
 1. Client verbalizes no thoughts of suicide.
 2. Client commits no acts of self-harm.
 3. Client is able to verbalize names of resources outside the 
hospital from whom he or she may request help if feeling 
suicidal.
●
 COMPLICATED GRIEVING
Deﬁ nition: A disorder that occurs after the death of a signifi cant 
other [or any other loss of signifi cance to the individual], in which the 
experience of distress accompanying bereavement fails to follow 
normative expectations and manifests in functional impairment.
Possible Etiologies (“related to”)
[Real or perceived loss of any concept of value to the individual]
[Bereavement overload (cumulative grief from multiple unresolved 
losses)]
[Thwarted grieving response to a loss]
[Absence of anticipatory grieving]
[Feelings of guilt generated by ambivalent relationship with lost 
entity] 
Deﬁ ning Characteristics (“evidenced by”)
[Idealization of lost entity]
[Denial of loss]
[Excessive anger, expressed inappropriately]
[Obsessions with past experiences]
[Ruminations of guilt feelings, excessive and exaggerated out of 
proportion to the situation]
[Developmental regression]
[Difﬁ culty in expressing loss]
[Prolonged difﬁ culty coping following a loss]
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[Reliving of past experiences with little or no reduction of 
intensity of the grief]
[Prolonged interference with life functioning, with onset or 
exacerbation of somatic or psychosomatic responses]
[Labile affect]
[Alterations in eating habits, sleep patterns, dream patterns, 
activity level, libido] 
Goals/Objectives
Short-term Goal
Client will express anger toward lost entity.
Long-term Goals
 1. Client will be able to verbalize behaviors associated with the 
normal stages of grief. 
 2. Client will be able to recognize own position in grief process 
as he or she progresses at own pace toward resolution.
Interventions with Selected Rationales
 1. Determine stage of grief in which client is ﬁ xed. Identify 
behaviors associated with this stage. Accurate baseline as-
sessment data are necessary to effectively plan care for the 
grieving client.
 2. Develop trusting relationship with client. Show empathy and 
caring. Be honest and keep all promises. Trust is the basis for 
a therapeutic relationship.
 3. Convey an accepting attitude, and enable the client to express 
feelings openly. An accepting attitude conveys to the client 
that you believe he or she is a worthwhile person. Trust is 
enhanced.
 4. Encourage client to express anger. Do not become defensive 
if initial expression of anger is displaced on nurse or therapist. 
Assist client to explore angry feelings so that they may be di-
rected toward the intended object or person. Verbalization of 
feelings in a nonthreatening environment may help client 
come to terms with unresolved issues.
 5. Assist client to discharge pent-up anger through participation 
in large motor activities (e.g., brisk walks, jogging, physical 
exercises, volleyball, punching bag, exercise bike). Physical 
exercise provides a safe and effective method for discharging 
pent-up tension.
 6. Teach the normal stages of grief and behaviors associated with 
each stage. Help client to understand that feelings such as guilt 
and anger toward the lost entity are appropriate and accept-
able during the grief process. Knowledge of acceptability of the 
feelings associated with normal grieving may help to relieve 
some of the guilt that these responses generate.
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 7. Encourage client to review relationship with the lost entity. 
With support and sensitivity, point out reality of the situa-
tion in areas where misrepresentations are expressed. Client 
must give up an idealized perception and be able to accept 
both positive and negative aspects about the lost entity be-
fore the grief process is complete.
 8. Communicate to client that crying is acceptable. Use of 
touch is therapeutic and appropriate with most clients. 
Knowledge of cultural inﬂ uences speciﬁ c to the client is 
important before using this technique.
 9. Assist client in problem solving as he or she attempts to deter-
mine methods for more adaptive coping with the experienced 
loss. Provide positive feedback for strategies identiﬁ ed and 
decisions made. Positive feedback increases self-esteem and 
encourages repetition of desirable behaviors.
 10. Encourage client to reach out for spiritual support during this 
time in whatever form is desirable to him or her. Assess spiri-
tual needs of client and assist as necessary in the fulﬁ llment of 
those needs.
Outcome Criteria
 1. Client is able to verbalize normal stages of the grief process 
and behaviors associated with each stage.
 2. Client is able to identify own position within the grief pro-
cess and express honest feelings related to the lost entity.
 3. Client is no longer manifesting exaggerated emotions and 
behaviors related to complicated grieving and is able to carry 
out ADLs independently.
●
 LOW SELF-ESTEEM
Deﬁ nition: Negative self-evaluation/feelings about self or self-
capabilities. 
Possible Etiologies (“related to”)
[Lack of positive feedback]
[Feelings of abandonment by signiﬁ cant other]
[Numerous failures (learned helplessness)]
[Underdeveloped ego and punitive superego]
[Impaired cognition fostering negative view of self] 
Deﬁ ning Characteristics (“evidenced by”)
[Difﬁ culty accepting positive reinforcement]
[Withdrawal into social isolation]
[Being highly critical and judgmental of self and others]
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[Expressions of worthlessness]
[Fear of failure]
[Inability to recognize own accomplishments]
[Setting self up for failure by establishing unrealistic goals]
[Unsatisfactory interpersonal relationships]
[Negative, pessimistic outlook]
[Hypersensitive to slight or criticism]
[Grandiosity] 
Goals/Objectives
Short-term Goals
 1. Within reasonable time period, client will discuss fear of 
failure with nurse.
 2. Within reasonable time period, client will verbalize things 
he or she likes about self. 
Long-term Goals
 1. By time of discharge from treatment, client will exhibit 
increased feelings of self-worth as evidenced by verbal 
expression of positive aspects of self, past accomplishments, 
and future prospects.
 2. By time of discharge from treatment, client will exhibit 
increased feelings of self-worth by setting realistic goals and 
trying to reach them, thereby demonstrating a decrease in 
fear of failure. 
Interventions with Selected Rationales
 1. Be accepting of client and his or her negativism. An attitude 
of acceptance enhances feelings of self-worth.
 2. Spend time with client to convey acceptance and contribute 
toward feelings of self-worth.
 3. Help client to recognize and focus on strengths and 
accomplishments. Minimize attention given to past (real or 
perceived) failures. Lack of attention may help to eliminate 
negative ruminations.
 4. Encourage participation in group activities from which client 
may receive positive feedback and support from peers.
 5. Help client identify areas he or she would like to change 
about self, and assist with problem solving toward this 
effort. Low self-worth may interfere with client’s percep-
tion of own problem-solving ability. Assistance may be 
required.
 6. Ensure that client is not becoming increasingly dependent 
and that he or she is accepting responsibility for own behav-
iors. Client must be able to function independently if he or 
she is to be successful within the less-structured community 
environment.
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 7. Ensure that therapy groups offer client simple methods of 
achievement. Offer recognition and positive feedback for 
actual accomplishments. Successes and recognition increase 
self-esteem.
 8. Teach assertiveness techniques: the ability to recognize the 
differences among passive, assertive, and aggressive behaviors, 
and the importance of respecting the human rights of others 
while protecting one’s own basic human rights. Self-esteem is 
enhanced by the ability to interact with others in an assertive 
manner.
 9. Teach effective communication techniques, such as the use 
of “I” messages. “I-statements” can be used to take owner-
ship for one’s feelings rather than saying they are caused by 
the other person. Example: “I feel angry when you criticize 
me in front of other people, and I would prefer that you stop 
doing that.” “You-statements” put the other individual on 
the defensive. Example: “You are a jerk for criticizing me in 
front of other people!”
 10. Assist client in performing aspects of self-care when required. 
Offer positive feedback for tasks performed independently. 
Positive feedback enhances self-esteem and encourages rep-
etition of desirable behaviors.
Outcome Criteria
 1. Client is able to verbalize positive aspects of self.
 2. Client is able to communicate assertively with others.
 3. Client expresses some optimism and hope for the future.
 4. Client sets realistic goals for self and demonstrates willing 
attempt to reach them.
●
 SOCIAL ISOLATION/IMPAIRED 
SOCIAL INTERACTION
Deﬁ nition: Social isolation is the condition of aloneness experi-
enced by the individual and perceived as imposed by others and as a 
negative or threatened state; impaired social interaction is an insuffi -
cient or excessive quantity or ineffective quality of social exchange. 
Possible Etiologies (“related to”)
[Developmental regression]
[Egocentric behaviors (which offend others and discourage 
relationships)]
Disturbed thought processes [delusional thinking]
[Fear of rejection or failure of the interaction]
[Impaired cognition fostering negative view of self]
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[Unresolved grief]
Absence of signiﬁ cant others
Deﬁ ning Characteristics (“evidenced by”)
Sad, dull affect
Being uncommunicative, withdrawn; lacking eye contact
Preoccupation with own thoughts; performance of repetitive, 
meaningless actions
Seeking to be alone
[Assuming fetal position]
Expression of feelings of aloneness or rejection
Discomfort in social situations
Dysfunctional interaction with others
Goals/Objectives
Short-term Goal
Client will develop trusting relationship with nurse or counselor 
within time period to be individually determined.
Long-term Goals
 1. Client will voluntarily spend time with other clients and 
nurse or therapist in group activities by time of discharge 
from treatment.
 2. Client will refrain from using egocentric behaviors that offend 
others and discourage relationships by time of discharge from 
treatment.
Interventions with Selected Rationales
 1. Spend time with client. This may mean just sitting in silence 
for a while. Your presence may help improve client’s percep-
tion of self as a worthwhile person.
 2. Develop a therapeutic nurse-client relationship through 
frequent, brief contacts and an accepting attitude. Show un-
conditional positive regard. Your presence, acceptance, and 
conveyance of positive regard enhance the client’s feelings of 
self-worth.
 3. After client feels comfortable in a one-to-one relationship, 
encourage attendance in group activities. May need to attend 
with client the ﬁ rst few times to offer support. Accept cli-
ent’s decision to remove self from group situation if anxiety 
becomes too great. The presence of a trusted individual 
provides emotional security for the client.
 4. Verbally acknowledge client’s absence from any group 
activities. Knowledge that his or her absence was noticed 
may reinforce the client’s feelings of self-worth.
 5. Teach assertiveness techniques. Interactions with others 
may be discouraged by client’s use of passive or aggressive 
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behaviors. Knowledge of the use of assertive techniques 
could improve client’s relationships with others.
 6. Provide direct feedback about client’s interactions with others. 
Do this in a nonjudgmental manner. Help client learn how to 
respond more appropriately in interactions with others. Teach 
client skills that may be used to approach others in a more 
socially acceptable manner. Practice these skills through role-
play. Client may not realize how he or she is being perceived 
by others. Direct feedback from a trusted individual may 
help to alter these behaviors in a positive manner. Having 
practiced these skills in role-play facilitates their use in real 
situations.
 7. The depressed client must have lots of structure in his or 
her life because of the impairment in decision-making and 
problem-solving ability. Devise a plan of therapeutic ac-
tivities and provide client with a written time schedule. 
Remember: The client who is moderately depressed feels 
best early in the day, whereas later in the day is a better 
time for the severely depressed individual to participate in 
activities. It is important to plan activities at a time when 
the client has more energy and is more likely to gain from 
the experience.
 8. Provide positive reinforcement for client’s voluntary interac-
tions with others. Positive reinforcement enhances self-esteem 
and encourages repetition of desirable behaviors.
Outcome Criteria
 1. Client demonstrates willingness and desire to socialize with 
others.
 2. Client voluntarily attends group activities.
 3. Client approaches others in appropriate manner for one-to-one 
interaction.
●
 POWERLESSNESS
Deﬁ nition: Perception that one’s own action will not signifi cantly 
affect an outcome; a perceived lack of control over a current situa-
tion or immediate happening. 
Possible Etiologies (“related to”)
Lifestyle of helplessness
Healthcare environment
[Complicated grieving process]
[Lack of positive feedback]
[Consistent negative feedback] 
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Deﬁ ning Characteristics (“evidenced by”)
Verbal expressions of having no control (e.g., over self-care, 
situation, outcome)
Nonparticipation in care or decision making when opportunities 
are provided
Expression of doubt regarding role performance
Reluctance to express true feelings
Apathy
Dependence on others that may result in irritability, resentment, 
anger, and guilt
Passivity
Goals/Objectives
Short-term Goal
Client will participate in decision making regarding own care 
within 5 days.
Long-term Goal
Client will be able to effectively problem solve ways to take 
control of his or her life situation by time of discharge from 
treatment, thereby decreasing feelings of powerlessness.
Interventions with Selected Rationales
 1. Encourage client to take as much responsibility as possible 
for own self-care practices. Providing client with choices will 
increase his or her feelings of control.
  Examples:
 a. Include client in setting the goals of care he or she wishes 
to achieve.
 b. Allow client to establish own schedule for self-care 
activities.
 c. Provide client with privacy as need is determined.
 d. Provide positive feedback for decisions made. Respect 
client’s right to make those decisions independently, and 
refrain from attempting to inﬂ uence him or her toward 
those that may seem more logical. 
 2. Help client set realistic goals. Unrealistic goals set the client 
up for failure and reinforce feelings of powerlessness.
 3. Help client identify areas of life situation that he or she can 
control. Client’s emotional condition interferes with his or 
her ability to solve problems. Assistance is required to per-
ceive the benefi ts and consequences of available alternatives 
accurately.
 4. Help client identify areas of life situation that are not within 
his or her ability to control. Encourage verbalization of feel-
ings related to this inability in an effort to deal with unre-
solved issues and accept what cannot be changed.
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 5. Identify ways in which client can achieve. Encourage partici-
pation in these activities, and provide positive reinforcement 
for participation, as well as for achievement. Positive reinforce-
ment enhances self-esteem and encourages repetition of desir-
able behaviors. 
Outcome Criteria
 1. Client verbalizes choices made in a plan to maintain control 
over his or her life situation.
 2. Client verbalizes honest feelings about life situations over 
which he or she has no control.
 3. Client is able to verbalize system for problem solving as 
required for adequate role performance.
●
 DISTURBED THOUGHT PROCESSES
Deﬁ nition: Disruption in cognitive operations and activities. 
Possible Etiologies (“related to”)
[Withdrawal into the self]
[Underdeveloped ego; punitive superego]
[Impaired cognition fostering negative perception of self and 
the environment] 
Deﬁ ning Characteristics (“evidenced by”)
Inaccurate interpretation of environment
[Delusional thinking]
Hypovigilance
[Altered attention span]—distractibility
Egocentricity
[Impaired ability to make decisions, problem solve, reason]
[Negative ruminations] 
Goals/Objectives
Short-term Goal
Client will recognize and verbalize when interpretations of the 
environment are inaccurate within 1 week.
Long-term Goal
By time of discharge from treatment, client’s verbalizations will 
reﬂ ect reality-based thinking with no evidence of delusional or 
distorted ideation.
Interventions with Selected Rationales
 1. Convey your acceptance of client’s need for the false belief, 
while letting him or her know that you do not share the 
delusion. A positive response would convey to the client that 
you accept the delusion as reality.
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 2. Do not argue or deny the belief. Use reasonable doubt as a 
therapeutic technique: “I understand that you believe this is 
true, but I personally ﬁ nd it hard to accept.” Arguing with 
the client or denying the belief serves no useful purpose, as 
delusional ideas are not eliminated by this approach, and the 
development of a trusting relationship may be impeded.
 3. Use the techniques of consensual validation and seeking clari-
ﬁ cation when communication reﬂ ects alteration in thinking. 
(Examples: “Is it that you mean . . . ?” or “I don’t understand 
what you mean by that. Would you please explain?”) These 
techniques reveal to the client how he or she is being perceived 
by others, while the responsibility for not understanding is 
accepted by the nurse.
 4. Reinforce and focus on reality. Talk about real events and real 
people. Use real situations and events to divert client away 
from long, purposeless, repetitive verbalizations of false ideas.
 5. Give positive reinforcement as client is able to differenti-
ate between reality-based and non–reality-based thinking. 
Positive reinforcement enhances self-esteem and encourages 
repetition of desirable behaviors.
 6. Teach client to intervene, using thought-stopping techniques, 
when irrational or negative thoughts prevail. Thought stop-
ping involves using the command “stop!” or a loud noise 
(such as hand clapping) to interrupt unwanted thoughts. This 
noise or command distracts the individual from the unde-
sirable thinking that often precedes undesirable emotions or 
behaviors.
 7. Use touch cautiously, particularly if thoughts reveal ideas of 
persecution. Clients who are suspicious may perceive touch 
as threatening and may respond with aggression.
Outcome Criteria
 1. Client’s thinking processes reﬂ ect accurate interpretation of 
the environment.
 2. Client is able to recognize negative or irrational thoughts and 
intervene to “stop” their progression.
●
 IMBALANCED NUTRITION, LESS 
THAN BODY REQUIREMENTS
Deﬁ nition: Intake of nutrients insuffi cient to meet metabolic needs. 
Possible Etiologies (“related to”)
Inability to ingest food because of:
 [Depressed mood]
 [Loss of appetite]
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 [Energy level too low to meet own nutritional needs]
 [Regression to lower level of development]
 [Ideas of self-destruction] 
Deﬁ ning Characteristics (“evidenced by”)
Loss of weight
Lack of interest in food
Pale mucous membranes
Poor muscle tone
[Amenorrhea]
[Poor skin turgor]
[Edema of extremities]
[Electrolyte imbalances]
[Weakness]
[Constipation]
[Anemias] 
Goals/Objectives
Short-term Goal
Client will gain 2 lb per week for the next 3 weeks.
Long-term Goal
Client will exhibit no signs or symptoms of malnutrition 
by time of discharge from treatment (e.g., electrolytes 
and blood counts will be within normal limits; a steady 
weight gain will be demonstrated; constipation will be cor-
rected; client will exhibit increased energy in participation in 
activities).
Interventions with Selected Rationales
 1. In collaboration with dietitian, determine number of calories 
required to provide adequate nutrition and realistic (accord-
ing to body structure and height) weight gain.
 2. To prevent constipation, ensure that diet includes foods high 
in ﬁ ber content. Encourage client to increase ﬂ uid consump-
tion and physical exercise to promote normal bowel func-
tioning. Depressed clients are particularly vulnerable to 
constipation because of psychomotor retardation. Constipa-
tion is also a common side effect of many antidepressant 
medications.
 3. Keep strict documentation of intake, output, and calorie 
count. This information is necessary to make an accurate 
nutritional assessment and maintain client safety.
 4. Weigh client daily. Weight loss or gain is important assess-
ment information.
 5. Determine client’s likes and dislikes, and collaborate with 
dietitian to provide favorite foods. Client is more likely to 
eat foods that he or she particularly enjoys.
2506_Ch06_125-144.indd   0141 10/1/10   9:34:37 AM
142 ● ALTERATIONS IN PSYCHOSOCIAL ADAPTATION
 6. Ensure that client receives small, frequent feedings, includ-
ing a bedtime snack, rather than three larger meals. Large 
amounts of food may be objectionable, or even intolerable, 
to the client.
 7. Administer vitamin and mineral supplements and stool 
softeners or bulk extenders, as ordered by physician.
 8. If appropriate, ask family members or signiﬁ cant others to 
bring in special foods that client particularly enjoys.
 9. Stay with client during meals to assist as needed and to offer 
support and encouragement.
 10. Monitor laboratory values, and report signiﬁ cant changes to 
physician. Laboratory values provide objective data regard-
ing nutritional status.
 11. Explain the importance of adequate nutrition and ﬂ uid 
intake. Client may have inadequate or inaccurate knowl-
edge regarding the contribution of good nutrition to 
overall wellness.
Outcome Criteria
 1. Client has shown a slow, progressive weight gain during 
hospitalization.
 2. Vital signs, blood pressure, and laboratory serum studies are 
within normal limits.
 3. Client is able to verbalize importance of adequate nutrition 
and ﬂ uid intake.
●
 DISTURBED SLEEP PATTERN 
Deﬁ nition: Time-limited interruptions of sleep amount and quality 
due to [internal] or external factors. 
Possible Etiologies (“related to”)
[Depression]
[Repressed fears]
[Feelings of hopelessness]
[Anxiety]
[Hallucinations]
[Delusional thinking] 
Deﬁ ning Characteristics (“evidenced by”)
[Verbal complaints of difﬁ culty falling asleep]
[Awakening earlier or later than desired]
[Interrupted sleep]
Verbal complaints of not feeling well rested
[Awakening very early in the morning and being unable to go 
back to sleep]
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[Excessive yawning and desire to nap during the day]
[Hypersomnia; using sleep as an escape] 
Goals/Objectives
Short-term Goal
Client will be able to sleep 4 to 6 hours with the aid of a sleeping 
medication within 5 days.
Long-term Goal
Client will be able to fall asleep within 30 minutes of retiring 
and obtain 6 to 8 hours of uninterrupted sleep each night with-
out medication by time of discharge from treatment.
Interventions with Selected Rationales
 1. Keep strict records of sleeping patterns. Accurate baseline 
data are important in planning care to assist client with this 
problem.
 2. Discourage sleep during the day to promote more restful 
sleep at night.
 3. Administer antidepressant medication at bedtime so client 
does not become drowsy during the day.
 4. Assist with measures that may promote sleep, such as warm, 
nonstimulating drinks, light snacks, warm baths, back rubs.
 5. Performing relaxation exercises to soft music may be helpful 
prior to sleep.
 6. Limit intake of caffeinated drinks, such as tea, coffee, and 
colas. Caffeine is a central nervous system (CNS) stimulant 
that may interfere with the client’s achievement of rest and 
sleep.
 7. Administer sedative medications, as ordered, to assist client 
to achieve sleep until normal sleep pattern is restored.
8. Some depressed clients may use excessive sleep as an escape. 
For the client experiencing hypersomnia, set limits on time 
spent in room. Plan stimulating diversionary activities on a 
structured, daily schedule. Explore fears and feelings that 
sleep is helping to suppress.
Outcome Criteria
 1. Client is sleeping 6 to 8 hours per night without medication.
 2. Client is able to fall asleep within 30 minutes of retiring.
 3. Client is dealing with fears and feelings rather than escaping 
from them through excessive sleep.
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 INTERNET REFERENCES
Additional information about depressive disorders, including 
psychosocial and pharmacological treatment of these disorders, 
may be located at the following websites:
 a. http://depression.about.com/
 b. http://www.dbsalliance.org/
 c. http://www.fadavis.com/townsend
 d. http://www.mentalhealth.com/
 e. http://www.mental-health-matters.com/disorders/
 f. http://www.mentalhelp.net
 g. http://www.nlm.nih.gov/medlineplus
 h. http://www.cmellc.com/topics/depress.html
Movie Connections
Prozac Nation (depression) • The Butcher Boy (depression) 
• night, Mother (depression) • The Prince of Tides (depression/suicide)
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Mood Disorders: 
Bipolar Disorders
● BACKGROUND ASSESSMENT DATA
Mood is deﬁ ned as an individual’s sustained emotional tone, 
which signiﬁ cantly inﬂ uences behavior, personality, and percep-
tion. A disturbance in mood is the predominant feature of the 
mood disorders American Psychiatric Association (APA, 2000). 
Mood disorders are classiﬁ ed as depressive or bipolar.
Bipolar Disorders 
Bipolar disorders are characterized by mood swings from pro-
found depression to extreme euphoria (mania), with intervening 
periods of normalcy.
During an episode of mania, the mood is elevated, expansive, 
or irritable. Motor activity is excessive and frenzied. Psychotic 
features may be present. A somewhat milder form is called hypo-
mania. It is usually not severe enough to require hospitalization, 
and it does not include psychotic features.
The diagnostic picture for bipolar depression is identical to that 
described for major depressive disorder, with one exception—the 
client must have a history of one or more manic episodes.
When the symptom presentation includes rapidly alternating 
moods (sadness, irritability, euphoria) accompanied by symp-
toms associated with both depression and mania, the individual 
is given a diagnosis of bipolar disorder, mixed.
Bipolar I Disorder
Bipolar I disorder is the diagnosis given to an individual who is 
experiencing, or has experienced, a full syndrome of manic or 
mixed symptoms. The client may also have experienced episodes 
of depression.
Bipolar II Disorder
Bipolar II disorder is characterized by recurrent bouts of 
major depression with the episodic occurrence of hypomania. 
This individual has never experienced a full syndrome of manic 
or mixed symptoms.
145
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Cyclothymic Disorder
The essential feature is a chronic mood disturbance of at least 
2 years’ duration, involving numerous periods of depression and 
hypomania, but not of sufﬁ cient severity and duration to meet 
the criteria for either bipolar I or II disorder. There is an absence 
of psychotic features.
Bipolar Disorder due to General Medical 
Condition
This disorder is characterized by a prominent and persistent dis-
turbance in mood (bipolar symptomatology) that is judged to be 
the direct result of the physiological effects of a general medical 
condition (APA, 2000).
Substance-Induced Bipolar Disorder 
The bipolar symptoms associated with this disorder are con-
sidered to be the direct result of the physiological effects of a 
substance (e.g., use or abuse of a drug or a medication, or toxin 
exposure).
●  PREDISPOSING FACTORS TO BIPOLAR 
DISORDER
 1. Biological
 a. Genetics. Twin studies have indicated a concordance rate for 
bipolar disorder among monozygotic twins at 60% to 80% 
compared to 10% to 20% in dizygotic twins. Family studies 
have shown that if one parent has bipolar disorder, the risk 
that a child will have the disorder is around 28% (Dubovsky, 
Davies, & Dubovsky, 2003). If both parents have the disor-
der, the risk is two to three times as great. Bipolar disorder 
appears to be equally common in men and women (APA, 
2000). Increasing evidence continues to support the role of 
genetics in the predisposition to bipolar disorder.
 b. Biochemical.  Just as there is an indication of lowered lev-
els of norepinephrine and dopamine during an episode of 
depression, the opposite appears to be true of an individ-
ual experiencing a manic episode. Thus, the behavioral 
responses of elation and euphoria may be caused by an 
excess of these biogenic amines in the brain. It has also 
been suggested that manic individuals have increased 
intracellular sodium and calcium. These electrolyte im-
balances may be related to abnormalities in cellular mem-
brane function in bipolar disorder.
 2. Physiological
 a. Neuroanatomical factors. Right-sided lesions in the 
limbic system, temporobasal areas, basal ganglia, 
and thalamus have been shown to induce secondary 
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mania. Magnetic resonance imaging studies have revealed 
enlarged third ventricles and subcortical white matter and 
periventricular hyperintensities in clients with bipolar 
disorder (Dubovsky, Davies, & Dubovsky, 2003).
 3. Medication Side Effects. Certain medications used to treat 
somatic illnesses have been known to trigger a manic re-
sponse. The most common of these are the steroids fre-
quently used to treat chronic illnesses such as multiple scle-
rosis and systemic lupus erythematosus. Some clients whose 
ﬁ rst episode of mania occurred during steroid therapy have 
reported spontaneous recurrence of manic symptoms years 
later. Amphetamines, antidepressants, and high doses of an-
ticonvulsants and narcotics also have the potential for initiat-
ing a manic episode (Dubovsky, Davies, & Dubovsky, 2003).
●  SYMPTOMATOLOGY (SUBJECTIVE 
AND OBJECTIVE DATA)
(Note: The symptoms and treatment of bipolar depression are compara-
ble to those of major depression, which are addressed in Chapter 6. This 
chapter will focus on the symptoms and treatment of bipolar mania.)
 1. The affect of a manic individual is one of elation and 
euphoria—a continuous “high.” However, the affect is very 
labile and may change quickly to hostility (particularly in re-
sponse to attempts at limit setting), or to sadness, ruminating 
about past failures.
 2. Alterations in thought processes and communication pat-
terns are manifested by the following:
 a. Flight of Ideas. There is a continuous, rapid shift from 
one topic to another.
 b. Loquaciousness. The pressure of the speech is so force-
ful and strong that it is difﬁ cult to interrupt maladaptive 
thought processes.
 c. Delusions of Grandeur. The individual believes he or she 
is all important, all powerful, with feelings of greatness 
and magniﬁ cence.
 d. Delusions of Persecution. The individual believes some-
one or something desires to harm or violate him or her in 
some way.
 3. Motor activity is constant. The individual is literally moving 
at all times.
 4. Dress is often inappropriate: bright colors that do not match, 
clothing inappropriate for age or stature, excessive makeup 
and jewelry.
 5. The individual has a meager appetite, despite excessive activ-
ity level. He or she is unable or unwilling to stop moving in 
order to eat.
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 6. Sleep patterns are disturbed. Client becomes oblivious to 
feelings of fatigue, and rest and sleep are abandoned for days 
or weeks.
 7. Spending sprees are common. Individual spends large 
amounts of money, which is not available, on numerous 
items, which are not needed.
 8. Usual inhibitions are discarded in favor of sexual and behav-
ioral indiscretions.
 9. Manipulative behavior and limit testing are common in the 
attempt to fulﬁ ll personal desires. Verbal or physical hostil-
ity may follow failure in these attempts.
 10. Projection is a major defense mechanism. The individual 
refuses to accept responsibility for the negative consequences 
of personal behavior.
 11. There is an inability to concentrate because of a limited 
attention span. The individual is easily distracted by even 
the slightest stimulus in the environment.
 12. Alterations in sensory perception may occur, and the indi-
vidual may experience hallucinations.
 13. As agitation increases, symptoms intensify. Unless the client 
is placed in a protective environment, death can occur from 
exhaustion or injury.
●  COMMON NURSING DIAGNOSES 
AND INTERVENTIONS FOR MANIA
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.)
● RISK FOR INJURY
Deﬁ nition:  At risk of injury as a result of environmental conditions 
interacting with the individual’s adaptive and defensive resources 
Related/Risk Factors (“related to”)
Biochemical dysfunction
Psychological (affective orientation)
[Extreme hyperactivity]
[Destructive behaviors]
[Anger directed at the environment]
[Hitting head (hand, arm, foot, etc.) against wall when angry]
[Temper tantrums—becomes destructive of inanimate objects]
[Increased agitation and lack of control over purposeless, and 
potentially injurious, movements] 
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Goals/Objectives
Short-term Goal
Client will no longer exhibit potentially injurious movements 
after 24 hours with administration of tranquilizing medication.
Long-term Goal
Client will experience no physical injury.
Interventions with Selected Rationales
 1. Reduce environmental stimuli. Assign a private room, if pos-
sible, with soft lighting, low noise level, and simple room 
decor. In the hyperactive state, the client is extremely 
distractible, and responses to even the slightest stimuli are 
exaggerated.
 2. Assign to a quiet unit, if possible. Milieu unit may be too 
distracting.
 3. Limit group activities. Help client try to establish one or two 
close relationships. Client’s ability to interact with others is 
impaired. He or she feels more secure in a one-to-one rela-
tionship that is consistent over time.
 4. Remove hazardous objects and substances from client’s 
environment (including smoking materials). Client’s rational-
ity is impaired, and he or she may harm self inadvertently. 
Client safety is a nursing priority.
 5. Stay with the client to offer support and provide a feeling of 
security as agitation grows and hyperactivity increases.
 6. Provide structured schedule of activities that includes estab-
lished rest periods throughout the day. A structured schedule 
provides a feeling of security for the client.
 7. Provide physical activities as a substitution for purpose-
less hyperactivity (examples: brisk walks, housekeeping 
chores, dance therapy, aerobics). Physical exercise pro-
vides a safe and effective means of relieving pent-up 
tension.
 8. Administer tranquilizing medication, as ordered by phy-
sician. Antipsychotic drugs are commonly prescribed for 
rapid relief of agitation and hyperactivity. Atypical forms 
commonly used include olanzapine, ziprasidone, and 
aripiprazole. Examples of the typical forms include halo-
peridol and chlorpromazine. Observe for effectiveness and 
evidence of adverse side effects (see Chapter 28).
Outcome Criteria
 1. Client is no longer exhibiting signs of physical agitation.
 2. Client exhibits no evidence of physical injury obtained while 
experiencing hyperactive behavior.
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●
 RISK FOR SELF-DIRECTED 
OR OTHER-DIRECTED VIOLENCE
Deﬁ nition: At risk for behaviors in which an individual demon-
strates that he or she can be physically, emotionally, and/or sexu-
ally harmful [either to self or to others] 
Related/Risk Factors (“related to”)
[Manic excitement]
[Biochemical alterations]
[Threat to self-concept]
[Suspicion of others]
[Paranoid ideation]
[Delusions]
[Hallucinations]
[Rage reactions]
Body language (e.g., rigid posture, clenching of ﬁ sts and jaw, 
hyperactivity, pacing, breathlessness, threatening stances)
[History or threats of violence toward self or others or of 
destruction to the property of others]
Impulsivity
Suicidal ideation, plan, available means
[Repetition of verbalizations (continuous complaints, requests, 
and demands)] 
Goals/Objectives
Short-term Goal
Client’s agitation will be maintained at manageable level with 
the administration of tranquilizing medication during ﬁ rst week 
of treatment (decreasing risk of violence to self or others).
Long-term Goal
Client will not harm self or others.
Interventions with Selected Rationales
 1. Maintain low level of stimuli in client’s environment (low light-
ing, few people, simple decor, low noise level). Anxiety and 
agitation rise in a stimulating environment. Individuals may 
be perceived as threatening by a suspicious, agitated client.
 2. Observe client’s behavior frequently (every 15 minutes). 
Close observation is required so that intervention can occur 
if required to ensure client’s (and others’) safety.
 3. Remove all dangerous objects from client’s environment 
(sharp objects, glass or mirrored items, belts, ties, smoking 
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materials) so that in his or her agitated, hyperactive state, 
client may not use them to harm self or others.
 4. Try to redirect the violent behavior with physical outlets for 
the client’s hostility (e.g., punching bag). Physical exercise is 
a safe and effective way of relieving pent-up tension.
 5. Intervene at the ﬁ rst sign of increased anxiety, agitation, or 
verbal or behavioral aggression. Offer empathetic response 
to client’s feelings:  “You seem anxious (or frustrated, or an-
gry) about this situation. How can I help?” Validation of 
the client’s feelings conveys a caring attitude and offering 
assistance reinforces trust.
 6. Staff should maintain and convey a calm attitude to the 
client. Respond matter-of-factly to verbal hostility. Anxiety 
is contagious and can be transmitted from staff to client.
 7. Have sufﬁ cient staff available to indicate a show of strength 
to client if necessary. This conveys to the client evidence of 
control over the situation and provides some physical secu-
rity for staff.
 8. Administer tranquilizing medications as ordered by physi-
cian. Monitor medication for effectiveness and for adverse 
side effects.
 9. If the client is not calmed by “talking down” or by medi-
cation, use of mechanical restraints may be necessary. The 
avenue of the “least restrictive alternative” must be selected 
when planning interventions for a violent client. Restraints 
should be used only as a last resort, after all other interven-
tions have been unsuccessful, and the client is clearly at risk 
of harm to self or others. 
 10. If restraint is deemed necessary, ensure that sufﬁ cient staff 
is available to assist. Follow protocol established by the 
institution. The Joint Commission formerly, the Joint 
Commission on Accreditation of Healthcare Organiza-
tions [JCAHO]) requires that an in-person evaluation (by a 
physician, clinical psychologist, or other licensed indepen-
dent practitioner responsible for the care of the patient) be 
conducted within 1 hour of initiating restraint or seclusion 
(The Joint Commission, 2010). The physician must reissue 
a new order for restraints every 4 hours for adults and every 
1 to 2 hours for children and adolescents. 
 11. The Joint Commision requires that the client in restraints 
be observed every 15 minutes to ensure that circulation to 
extremities is not compromised (check temperature, color, 
pulses); to assist client with needs related to nutrition, hy-
dration, and elimination; and to position client so that com-
fort is facilitated and aspiration can be prevented. Some 
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institutions may require continuous one-to-one monitoring 
of restrained clients, particularly those who are highly agi-
tated, and for whom there is a high risk of self- or accidental 
injury. Client safety is a nursing priority.
 12. As agitation decreases, assess client’s readiness for restraint 
removal or reduction. Remove one restraint at a time, while 
assessing client’s response. This procedure minimizes the 
risk of injury to client and staff. 
Outcome Criteria
 1. Client is able to verbalize anger in an appropriate manner.
 2. There is no evidence of violent behavior to self or others.
 3. Client is no longer exhibiting hyperactive behaviors. 
●
 IMBALANCED NUTRITION, LESS 
THAN BODY REQUIREMENTS
Deﬁ nition: Intake of nutrients insuffi cient to meet metabolic 
needs 
Possible Etiologies (“related to”)
[Refusal or inability to sit still long enough to eat meals]
[Lack of appetite]
[Excessive physical agitation]
[Physical exertion in excess of energy produced through caloric 
intake]
[Lack of interest in food]
Deﬁ ning Characteristics (“evidenced by”)
Loss of weight
Pale mucous membranes
Poor muscle tone
[Amenorrhea]
[Poor skin turgor]
[Anemias]
[Electrolyte imbalances]
Goals/Objectives
Short-term Goal
Client will consume sufﬁ cient ﬁ nger foods and between-meal 
snacks to meet recommended daily allowances of nutrients.
Long-term Goal
Client will exhibit no signs or symptoms of malnutrition.
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Interventions with Selected Rationales
 1. In collaboration with dietitian, determine the number of calo-
ries required to provide adequate nutrition for maintenance or 
realistic (according to body structure and height) weight gain.
 2. Provide client with high-protein, high-calorie, nutritious 
ﬁ nger foods and drinks that can be consumed “on the run.” 
Because of hyperactive state, client has diffi culty sitting 
still long enough to eat a meal. The likelihood is greater 
that he or she will consume food and drinks that can be 
carried around and eaten with little effort.
 3. Have juice and snacks available on the unit at all times. 
Nutritious intake is required on a regular basis to 
compensate for increased caloric requirements due to
hyperactivity.
 4. Maintain accurate record of intake, output, and calorie 
count. This information is necessary to make an accurate 
nutritional assessment and maintain client’s safety.
 5. Weigh client daily. Weight loss or gain is important nutri-
tional assessment information.
 6. Determine client’s likes and dislikes, and collaborate with 
dietitian to provide favorite foods. Client is more likely to 
eat foods that he or she particularly enjoys.
 7. Administer vitamin and mineral supplements, as ordered by 
physician, to improve nutritional state.
 8. Pace or walk with client as ﬁ nger foods are taken. As agi-
tation subsides, sit with client during meals. Offer support 
and encouragement. Assess and record amount consumed. 
Presence of a trusted individual may provide feeling of 
security and decrease agitation. Encouragement and posi-
tive reinforcement increase self-esteem and foster repeti-
tion of desired behaviors.
 9. Monitor laboratory values, and report signiﬁ cant changes to 
physician. Laboratory values provide objective nutritional 
assessment data.
 10. Explain the importance of adequate nutrition and ﬂ uid in-
take. Client may have inadequate or inaccurate knowledge 
regarding the contribution of good nutrition to overall 
wellness. 
Outcome Criteria
 1. Client has gained (maintained) weight during hospitalization.
 2. Vital signs, blood pressure, and laboratory serum studies are 
within normal limits.
 3. Client is able to verbalize importance of adequate nutrition 
and ﬂ uid intake. 
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●
 DISTURBED THOUGHT PROCESSES
Deﬁ nition: Disruption in cognitive operations and activities 
Possible Etiologies (“related to”)
[Biochemical alterations]
[Electrolyte imbalance]
[Psychotic process]
[Sleep deprivation]
Deﬁ ning Characteristics (“evidenced by”)
Inaccurate interpretation of environment
Hypervigilance
[Altered attention span]—distractibility
Egocentricity
[Decreased ability to grasp ideas]
[Impaired ability to make decisions, problem-solve, reason]
[Delusions of grandeur]
[Delusions of persecution]
[Suspiciousness]
Goals/Objectives
Short-term Goal
Within 1 week, client will be able to recognize and verbalize 
when thinking is non–reality-based.
Long-term Goal
By time of discharge from treatment, client’s verbalizations will 
reﬂ ect reality-based thinking with no evidence of delusional 
ideation.
Interventions with Selected Rationales
 1. Convey your acceptance of client’s need for the false belief, 
while letting him or her know that you do not share the delu-
sion. A positive response would convey to the client that you 
accept the delusion as reality.
 2. Do not argue or deny the belief. Use reasonable doubt as a 
therapeutic technique: “I understand that you believe this is 
true, but I personally ﬁ nd it hard to accept.” Arguing with the 
client or denying the belief serves no useful purpose, because 
delusional ideas are not eliminated by this approach and the 
development of a trusting relationship may be impeded.
 3. Use the techniques of consensual validation and seeking clari-
ﬁ cation when communication reﬂ ects alteration in think-
ing. (Examples: “Is it that you mean...?” or “I don’t under-
stand what you mean by that. Would you please explain?”) 
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These techniques reveal to the client how he or she is being 
perceived by others, and the responsibility for not under-
standing is accepted by the nurse.
 4. Reinforce and focus on reality. Talk about real events and 
real people. Use real situations and events to divert client 
from long, tedious, repetitive verbalizations of false ideas.
 5. Give positive reinforcement as client is able to differenti-
ate between reality-based and non–reality-based thinking. 
Positive reinforcement enhances self-esteem and encourages 
repetition of desirable behaviors.
 6. Teach client to intervene, using thought-stopping tech-
niques, when irrational thoughts prevail. Thought stop-
ping involves using the command “Stop!” or a loud noise 
(such as hand clapping) to interrupt unwanted thoughts. 
This noise or command distracts the individual from the 
undesirable thinking, which often precedes undesirable 
emotions or behaviors.
 7. Use touch cautiously, particularly if thoughts reveal ideas of 
persecution. Clients who are suspicious may perceive touch 
as threatening and may respond with aggression. 
Outcome Criteria
 1. Thought processes reﬂ ect an accurate interpretation of the 
environment.
 2. Client is able to recognize thoughts that are not based in 
reality and intervene to stop their progression. 
●
 DISTURBED SENSORY PERCEPTION
Deﬁ nition: Change in the amount or patterning of incoming 
stimuli [either internally or externally initiated] accompanied by a 
diminished, exaggerated, distorted, or impaired response to such 
stimuli
Possible Etiologies (“related to”)
Biochemical imbalance
Electrolyte imbalance
[Sleep deprivation]
[Psychotic process]
Deﬁ ning Characteristics (“evidenced by”)
Change in usual response to stimuli
Hallucinations
Disorientation
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[Inappropriate responses]
[Rapid mood swings]
[Exaggerated emotional responses]
[Visual and auditory distortions]
[Talking and laughing to self]
[Listening pose (tilting head to one side as if listening)]
[Stops talking in middle of sentence to listen]
Goals/Objectives
Short-term Goal
Client will be able to recognize and verbalize when he or she is 
interpreting the environment inaccurately.
Long-term Goal
Client will be able to deﬁ ne and test reality, eliminating the 
occurrence of sensory misperceptions.
Interventions with Selected Rationales
 1. Observe client for signs of hallucinations (listening pose, 
laughing or talking to self, stopping in midsentence). Early 
intervention may prevent aggressive responses to command 
hallucinations.
 2. Avoid touching the client before warning him or her that you 
are about to do so. Client may perceive touch as threatening 
and respond in an aggressive manner.
 3. An attitude of acceptance will encourage the client to share 
the content of the hallucination with you. This is important 
in order to prevent possible injury to the client or others 
from command hallucinations.
 4. Do not reinforce the hallucination. Use words such as “the 
voices” instead of “they” when referring to the hallucination. 
Words like “they” validate that the voices are real.
 5. Try to connect the times of the misperceptions to times of 
increased anxiety. Help client to understand this connection. 
If client can learn to interrupt the escalating anxiety, real-
ity orientation may be maintained.
 6. Try to distract the client away from the misperception. 
Involvement in interpersonal activities and explana-
tion of the actual situation may bring the client back to
reality. 
CLINICAL PEARL  Let the client who is “hearing voices” know that you do not 
share the perception.  
  Say, “Even though I realize that the voices are real to you, I do not hear any 
voices speaking.”  The nurse must be honest with the client so that he or she may 
realize that the hallucinations are not real.  
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Outcome Criteria
 1. Client is able to differentiate between reality and unrealistic 
events or situations.
 2. Client is able to refrain from responding to false sensory 
perceptions. 
●
 IMPAIRED SOCIAL INTERACTION 
Deﬁ nition: Insuffi cient or excessive quantity or ineffective qual-
ity of social exchange  
Possible Etiologies (“related to”)
Disturbed thought processes
[Delusions of grandeur]
[Delusions of persecution]
Self-concept disturbance
Deﬁ ning Characteristics (“evidenced by”)
Discomfort in social situations
Inability to receive or communicate a satisfying sense of social en-
gagement (e.g., belonging, caring, interest, or shared history)
Use of unsuccessful social interaction behaviors
Dysfunctional interaction with others
[Excessive use of projection—does not accept responsibility for 
own behavior]
[Verbal manipulation]
[Inability to delay gratiﬁ cation]
Goals/Objectives
Short-term Goal
Client will verbalize which of his or her interaction behaviors 
are appropriate and which are inappropriate within 1 week.
Long-term Goal
Client will demonstrate use of appropriate interaction skills as 
evidenced by lack of, or marked decrease in, manipulation of 
others to fulﬁ ll own desires.
Interventions with Selected Rationales
 1. Recognize the purpose these behaviors serve for the client: to 
reduce feelings of insecurity by increasing feelings of power 
and control. Understanding the motivation behind the ma-
nipulation may facilitate acceptance of the individual and his 
or her behavior.
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 2. Set limits on manipulative behaviors. Explain to client 
what you expect and what the consequences are if the limits 
are violated. Limits must be agreed upon by all staff 
who will be working with the client. Client is unable to 
establish own limits, so this must be done for him or her. 
Unless administration of consequences for violation of 
limits is consistent, manipulative behavior will not be 
eliminated.
 3. Do not argue, bargain, or try to reason with the client. 
Merely state the limits and expectations. Be sure to follow 
through with consequences if limits are violated. Consistency 
is essential for success of this intervention. Do not let this 
“charmer” talk you out of it. Ignoring these attempts may 
work to decrease manipulative behaviors.
 4. Provide positive reinforcement for nonmanipulative behaviors. 
Explore feelings, and help the client seek more appropriate 
ways of dealing with them. Positive reinforcement enhances 
self-esteem and promotes repetition of desirable behaviors.
 5. Help client recognize consequences of own behaviors and refrain 
from attributing them to others. Client must accept responsibil-
ity for own behaviors before adaptive change can occur.
 6. Help client identify positive aspects about self, recognize 
accomplishments, and feel good about them. As self-esteem 
is increased, client will feel less need to manipulate others 
for own gratifi cation. 
Outcome Criteria
 1. Client is able to verbalize positive aspects of self.
 2. Client accepts responsibility for own behaviors.
 3. Client does not manipulate others for gratiﬁ cation of own 
needs. 
●
 INSOMNIA
Deﬁ nition: A disruption in amount and quality of sleep that 
impairs functioning 
Possible Etiologies (“related to”)
[Excessive hyperactivity]
[Agitation]
[Biochemical alterations]
Deﬁ ning Characteristics (“evidenced by”)
Difﬁ culty falling asleep
[Pacing in hall during sleeping hours]
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[Sleeping only short periods at a time]
[Numerous periods of wakefulness during the night]
[Awakening and rising extremely early in the morning; exhibit-
ing signs of restlessness]
Goals/Objectives
Short-term Goal
Within 3 days, with the aid of a sleeping medication, client will 
sleep 4 to 6 hours without awakening.
Long-term Goal
By time of discharge from treatment, client will be able to 
acquire 6 to 8 hours of uninterrupted sleep without sleeping 
medication.
Interventions with Selected Rationales
 1. Provide a quiet environment, with a low level of stimulation. 
Hyperactivity increases and ability to achieve sleep and rest 
are hindered in a stimulating environment.
 2. Monitor sleep patterns. Provide structured schedule of activ-
ities that includes established times for naps or rest.  Accurate 
baseline data are important in planning care to help client 
with this problem. A structured schedule, including time 
for naps, will help the hyperactive client achieve much-
needed rest.
 3. Assess client’s activity level. Client may ignore or be un-
aware of feelings of fatigue. Observe for signs such as 
increasing restlessness, ﬁ ne tremors, slurred speech, and 
puffy, dark circles under eyes. Client can collapse from 
exhaustion if hyperactivity is uninterrupted and rest is 
not achieved.
 4. Before bedtime, provide nursing measures that promote 
sleep, such as back rub; warm bath; warm, nonstimulating 
drinks; soft music; and relaxation exercises.
 5. Prohibit intake of caffeinated drinks, such as tea, coffee, and 
colas. Caffeine is a CNS stimulant and may interfere with 
the client’s achievement of rest and sleep.
 6. Administer sedative medications, as ordered, to assist client 
achieve sleep until normal sleep pattern is restored. 
Outcome Criteria
 1. Client is sleeping 6 to 8 hours per night without sleeping 
medication.
 2. Client is able to fall asleep within 30 minutes of retiring.
 3. Client is dealing openly with fears and feelings rather than 
manifesting denial of them through hyperactivity. 
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Movie Connections
Lust for Life (bipolar disorder) • Call Me Anna (bipolar disorder) 
• Blue Sky (bipolar disorder) • A Woman Under the Inﬂ uence (bipolar disorder)
 INTERNET REFERENCES
Additional information about bipolar disorders, including psy-
chosocial and pharmacological treatment of these disorders, 
may be located at the following websites:
 a. http://www.dbsalliance.org/
 b. http://www.fadavis.com/townsend
 c. http://www.mentalhealth.com/
 d. http://www.cmellc.com/topics/bipolar.html
 e. http://www.mental-health-matters.com/disorders/
 f. http://www.mentalhelp.net
 g. http://www.nlm.nih.gov/medlineplus 
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Anxiety Disorders
● BACKGROUND ASSESSMENT DATA
The characteristic features of this group of disorders are symp-
toms of anxiety and avoidance behavior. Anxiety disorders are 
categorized in the following manner:
Panic Disorder (with or without Agoraphobia) 
Panic disorder is characterized by recurrent panic attacks, the 
onset of which are unpredictable, and manifested by intense 
apprehension, fear, or terror, often associated with feelings of 
impending doom, and accompanied by intense physical discom-
fort. The attacks usually last minutes or, more rarely, hours. If 
accompanied by agoraphobia, there is a fear of being in places or 
situations from which escape might be difﬁ cult or in which help 
might not be available in the event of a panic attack (American 
Psychiatric Association [APA], 2000). Common agoraphobic sit-
uations include being outside the home alone; being in a crowd 
or standing in a line; being on a bridge; and traveling in a bus, 
train, or car.
Agoraphobia without History of Panic 
Disorder
The APA (2000) Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition, Text Revision (DSM-IV-TR) identiﬁ es 
the essential feature of this disorder as fear of being in places 
or situations from which escape might be difﬁ cult or in which 
help might not be available in the event of suddenly developing 
a symptom(s) that could be incapacitating or extremely embar-
rassing. Travel is restricted or the individual needs a companion 
when away from home or else endures agoraphobic situations 
despite intense anxiety.
Social Phobia
Social phobia is characterized by a persistent fear of behaving 
or performing in the presence of others in a way that will be 
humiliating or embarrassing to the individual. The individual 
has extreme concerns about being exposed to possible scrutiny 
161
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by others and fears social or performance situations in which 
embarrassment may occur (APA, 2000). Exposure to the pho-
bic situation is avoided, or it is endured with intense anxiety. 
Common social phobias include speaking or writing in front of 
a group of people, eating in the presence of others, and using 
public restrooms.
Speciﬁ c Phobia
Formerly called simple phobia, this disorder is characterized by 
persistent fears of speciﬁ c objects or situations. These phobias 
are fairly widespread among the general population, the most 
common being fear of animals (zoophobia), fear of closed places 
(claustrophobia), and fear of heights (acrophobia). Exposure to 
the phobic stimulus is avoided or endured with intense anxiety.
Obsessive-Compulsive Disorder
This disorder is characterized by involuntary recurring thoughts 
or images that the individual is unable to ignore and by recur-
ring impulse to perform a seemingly purposeless activity. These 
obsessions and compulsions serve to prevent extreme anxiety on 
the part of the individual.
Posttraumatic Stress Disorder
Posttraumatic stress disorder (PTSD) is characterized by the 
development of physiological and behavioral symptoms follow-
ing a psychologically traumatic event that is generally outside 
the range of usual human experience. The stressor, which would 
be considered markedly distressing to almost anyone, has usu-
ally been experienced with intense fear, terror, and helplessness. 
If duration of the symptoms is 3 months or longer, the diagnosis 
is speciﬁ ed as “chronic.” If there is a delay of 6 months or longer 
in the onset of symptoms, the diagnosis is speciﬁ ed as “delayed 
onset.”
Acute Stress Disorder
Acute stress disorder is characterized by the development of 
physiological and behavioral symptoms similar to those of 
PTSD. The major difference in the diagnoses lies in the length 
of time the symptoms exist. With acute stress disorder, the 
symptoms must subside within 4 weeks of occurrence of the 
stressor. If they last longer than 4 weeks, the individual is given 
the diagnosis of PTSD. 
Generalized Anxiety Disorder
This disorder is characterized by chronic, unrealistic, and exces-
sive anxiety and worry. The symptoms must have occurred more 
days than not for at least 6 months and must cause clinically 
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signiﬁ cant distress or impairment in social, occupational, or 
other important areas of functioning (APA, 2000). Symptoms 
include restlessness, feeling “on edge,” becoming easily fatigued, 
difﬁ culty concentrating, and irritability.
Anxiety Disorder Due to a General Medical 
Condition
The symptoms of this disorder are judged to be the direct physi-
ological consequence of a general medical condition. Symptoms 
may include prominent generalized anxiety symptoms, panic 
attacks, or obsessions or compulsions (APA, 2000). Medical 
conditions that have been known to cause anxiety disorders 
include endocrine, cardiovascular, respiratory, metabolic, and 
neurological disorders.
Substance-Induced Anxiety Disorder 
The DSM-IV-TR (APA, 2000) describes the essential features of 
this disorder as prominent anxiety symptoms that are judged to 
be caused by the direct physiological effects of a substance (i.e., 
a drug of abuse, a medication, or toxin exposure). The symptoms 
may occur during substance intoxication or withdrawal and may 
involve intense anxiety, panic attacks, phobias, or obsessions or 
compulsions.
●  PREDISPOSING FACTORS TO ANXIETY 
DISORDERS
 1. Physiological
 a. Biochemical: Increased levels of norepinephrine have 
been noted in panic and generalized anxiety disorders. 
Abnormal elevations of blood lactate have also been 
noted in clients with panic disorder. Decreased levels 
of serotonin have been implicated in the etiology of 
obsessive-compulsive disorder.
 b. Genetic: Studies suggest that anxiety disorders are preva-
lent within the general population. It has been shown that 
they are more common among ﬁ rst-degree biological rel-
atives of people with the disorders than among the general 
population (APA, 2000).
 c. Medical or Substance-Induced: Anxiety disorders may be 
caused by a variety of medical conditions or the ingestion 
of various substances. (Refer to previous section on cat-
egories of anxiety disorders.) 
 2. Psychosocial
 a. Psychodynamic Theory: The psychodynamic view focuses 
on the inability of the ego to intervene when conﬂ ict occurs 
between the id and the superego, producing anxiety. For 
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various reasons (unsatisfactory parent-child relationship; 
conditional love or provisional gratiﬁ cation), ego develop-
ment is delayed. When developmental defects in ego func-
tions compromise the capacity to modulate anxiety, the 
individual resorts to unconscious mechanisms to resolve 
the conﬂ ict. Overuse or ineffective use of ego defense 
mechanisms results in maladaptive responses to anxiety.
 b. Cognitive Theory: The main thesis of the cognitive view 
is that faulty, distorted, or counterproductive thinking 
patterns accompany or precede maladaptive behaviors and 
emotional disorders (Sadock & Sadock, 2007). When there 
is a disturbance in this central mechanism of cognition, 
there is a consequent disturbance in feeling and behavior. 
Because of distorted thinking, anxiety is maintained by 
erroneous or dysfunctional appraisal of a situation. There 
is a loss of ability to reason regarding the problem, wheth-
er it is physical or interpersonal. The individual feels 
vulnerable in a given situation, and the distorted think-
ing results in an irrational appraisal, fostering a negative 
outcome.
●  SYMPTOMATOLOGY (SUBJECTIVE 
AND OBJECTIVE DATA)
An individual may experience a panic attack under any of the 
following conditions:
● As the predominant disturbance, with no apparent precipitant
● When exposed to a phobic stimulus
● When attempts are made to curtail ritualistic behavior
● Following a psychologically traumatic event
Symptoms include the following (APA, 2000):
● Pounding, rapid heart rate
● Feeling of choking or smothering
● Difﬁ culty breathing
● Pain in the chest
● Feeling dizzy or faint
● Increased perspiration
● Feeling of numbness or tingling in the extremities
● Trembling
● Fear that one is dying or going crazy
● Sense of impending doom
● Feelings of unreality (derealization and/or depersonalization)
Other symptoms of anxiety disorders include the following:
 1. Restlessness, feeling “on edge,” excessive worry, being easily 
fatigued, difﬁ culty concentrating, irritability, and sleep dis-
turbances (generalized anxiety disorder).
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 2. Recurrent and intrusive recollections or dreams about the trau-
matic event, feeling of reliving the trauma (ﬂ ashback episodes), 
difﬁ culty feeling emotion (a “numbing” affect), insomnia, and 
irritability or outbursts of anger (PTSD).
 3. Repetitive, obsessive thoughts, common ones being related 
to violence, contamination, and doubt; repetitive, compul-
sive performance of purposeless activity, such as handwash-
ing, counting, checking, and touching (obsessive-compulsive 
disorder).
 4. Marked and persistent fears of speciﬁ c objects or situations 
(speciﬁ c phobia), social or performance situations (social 
phobia), or being in a situation from which one has difﬁ culty 
escaping (agoraphobia).
Common Nursing Diagnoses 
and Interventions
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.) 
● ANXIETY (PANIC)
Deﬁ nition: Vague uneasy feeling of discomfort or dread accom-
panied by an autonomic response (the source often nonspecifi c or 
unknown to the individual); a feeling of apprehension caused by 
anticipation of danger. It is an alerting signal that warns of impend-
ing danger and enables the individual to take measures to deal with 
threat. 
Possible Etiologies (“related to”)
Unconscious conﬂ ict about essential values and goals of life
Situational and maturational crises
[Real or perceived] threat to self-concept
[Real or perceived] threat of death
Unmet needs
[Being exposed to a phobic stimulus]
[Attempts at interference with ritualistic behaviors]
[Traumatic experience] 
Deﬁ ning Characteristics (“evidenced by”)
Increased respiration
Increased pulse
Decreased or increased blood pressure
Nausea
Confusion
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Increased perspiration
Faintness
Trembling or shaking
Restlessness
Insomnia
[Nightmares or visual perceptions of traumatic event]
[Fear of dying, going crazy, or doing something uncontrolled 
during an attack] 
Goals/Objectives
Short-term Goal
Client will verbalize ways to intervene in escalating anxiety 
within 1 week.
Long-term Goal
Client will be able to recognize symptoms of onset of anxiety 
and intervene before reaching panic stage by time of discharge 
from treatment.
Interventions with Selected Rationales
 1. Maintain a calm, nonthreatening manner while working 
with client. Anxiety is contagious and may be transferred 
from staff to client or vice versa. Client develops feeling of 
security in presence of calm staff person.
 2. Reassure client of his or her safety and security. This can be 
conveyed by physical presence of nurse. Do not leave client 
alone at this time. Client may fear for his or her life. Presence 
of a trusted individual provides client with feeling of security 
and assurance of personal safety.
 3. Use simple words and brief messages, spoken calmly and 
clearly, to explain hospital experiences to client. In an intense-
ly anxious situation, client is unable to comprehend anything 
but the most elementary communication.
 4. Keep immediate surroundings low in stimuli (dim lighting, 
few people, simple decor). A stimulating environment may 
increase level of anxiety.
 5. Administer tranquilizing medication, as ordered by physi-
cian. Assess medication for effectiveness and for adverse side 
effects.
 6. When level of anxiety has been reduced, explore with client 
possible reasons for occurrence. Recognition of precipitating
factor(s) is the fi rst step in teaching client to interrupt 
escalation of the anxiety.
 7. Encourage client to talk about traumatic experience un-
der nonthreatening conditions. Help client work through 
feelings of guilt related to the traumatic event. Help client 
understand that this was an event to which most people 
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would have responded in like manner. Support client during 
ﬂ ashbacks of the experience. Verbalization of feelings in a 
nonthreatening environment may help client come to terms 
with unresolved issues.
 8. Teach signs and symptoms of escalating anxiety, and ways to 
interrupt its progression (e.g., relaxation techniques, deep-
breathing exercises, physical exercises, brisk walks, jogging, 
meditation).
Outcome Criteria
 1. Client is able to maintain anxiety at level in which problem 
solving can be accomplished.
 2. Client is able to verbalize signs and symptoms of escalating 
anxiety.
 3. Client is able to demonstrate techniques for interrupting the 
progression of anxiety to the panic level.
●
 FEAR
Deﬁ nition: Response to perceived threat that is consciously 
recognized as a danger. 
Possible Etiologies (“related to”)
Phobic stimulus 
[Being in place or situation from which escape might be 
difﬁ cult]
[Causing embarrassment to self in front of others] 
Deﬁ ning Characteristics (“evidenced by”)
[Refuses to leave own home alone]
[Refuses to eat in public]
[Refuses to speak or perform in public]
[Refuses to expose self to (specify phobic object or situation)]
Identiﬁ es object of fear
[Symptoms of apprehension or sympathetic stimulation in 
presence of phobic object or situation] 
Goals/Objectives
Short-term Goal
Client will discuss phobic object or situation with nurse or 
therapist within 5 days.
Long-term Goal
Client will be able to function in presence of phobic object or 
situation without experiencing panic anxiety by time of dis-
charge from treatment.
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Interventions with Selected Rationales
 1. Reassure client of his or her safety and security. At panic 
level of anxiety, client may fear for own life.
 2. Explore client’s perception of threat to physical integrity 
or threat to self-concept. It is important to understand the 
client’s perception of the phobic object or situation in order 
to assist with the desensitization process.
 3. Discuss reality of the situation with client in order to rec-
ognize aspects that can be changed and those that cannot. 
Client must accept the reality of the situation (aspects that 
cannot change) before the work of reducing the fear can 
progress.
 4. Include client in making decisions related to selection of 
alternative coping strategies. (Example: Client may choose 
either to avoid the phobic stimulus or attempt to eliminate 
the fear associated with it.) Allowing the client choices pro-
vides a measure of control and serves to increase feelings of 
self-worth.
 5. If the client elects to work on elimination of the fear, tech-
niques of desensitization may be employed. This is a sys-
tematic plan of behavior modiﬁ cation, designed to expose 
the individual gradually to the situation or object (either in 
reality or through fantasizing) until the fear is no longer 
experienced. This is also sometimes accomplished through 
implosion therapy, in which the individual is “ﬂ ooded” with 
stimuli related to the phobic situation or object (rather than 
in gradual steps) until anxiety is no longer experienced in 
relation to the object or situation. Fear is decreased as the 
physical and psychological sensations diminish in response 
to repeated exposure to the phobic stimulus under non-
threatening conditions.
 6. Encourage client to explore underlying feelings that may be 
contributing to irrational fears. Help client to understand 
how facing these feelings, rather than suppressing them, 
can result in more adaptive coping abilities. Verbalization of 
feelings in a nonthreatening environment may help client 
come to terms with unresolved issues.
Outcome Criteria
 1. Client does not experience disabling fear when exposed to 
phobic object or situation, or
 2. Client verbalizes ways in which he or she will be able to 
avoid the phobic object or situation with minimal change in 
lifestyle.
 3. Client is able to demonstrate adaptive coping techniques that 
may be used to maintain anxiety at a tolerable level. 
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●
 INEFFECTIVE COPING
Deﬁ nition: Inability to form a valid appraisal of the stressors, 
inadequate choices of practiced responses, and/or inability to use 
available resources. 
Possible Etiologies (“related to”)
[Underdeveloped ego; punitive superego]
[Fear of failure]
Situational crises
Maturational crises
[Personal vulnerability]
[Inadequate support systems]
[Unmet dependency needs] 
Deﬁ ning Characteristics (“evidenced by”)
[Ritualistic behavior]
[Obsessive thoughts]
Inability to meet basic needs
Inability to meet role expectations
Inadequate problem solving
[Alteration in societal participation] 
Goals/Objectives
Short-term Goal
Within 1 week, client will decrease participation in ritualistic 
behavior by half.
Long-term Goal
By time of discharge from treatment, client will demonstrate abil-
ity to cope effectively without resorting to obsessive-compulsive 
behaviors or increased dependency.
Interventions with Selected Rationales
 1. Assess client’s level of anxiety. Try to determine the types of 
situations that increase anxiety and result in ritualistic behav-
iors. Recognition of precipitating factors is the fi rst step in 
teaching the client to interrupt the escalating anxiety.
 2. Initially meet client’s dependency needs as required. Encour-
age independence and give positive reinforcement for inde-
pendent behaviors. Sudden and complete elimination of all 
avenues for dependency would create intense anxiety on the 
part of the client. Positive reinforcement enhances self-esteem 
and encourages repetition of desired behaviors.
 3. In the beginning of treatment allow plenty of time for ritu-
als. Do not be judgmental or verbalize disapproval of the 
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behavior. To deny client this activity may precipitate panic 
level of anxiety.
 4. Support client’s efforts to explore the meaning and purpose 
of the behavior. Client may be unaware of the relationship 
between emotional problems and compulsive behaviors. 
Recognition is important before change can occur.
 5. Provide structured schedule of activities for the client, includ-
ing adequate time for completion of rituals. Structure provides 
a feeling of security for the anxious client.
 6. Gradually begin to limit the amount of time allotted for 
ritualistic behavior as client becomes more involved in unit 
activities. Anxiety is minimized when client is able to replace 
ritualistic behaviors with more adaptive ones.
 7. Give positive reinforcement for nonritualistic behaviors. 
Positive reinforcement enhances self-esteem and encourages 
repetition of desired behaviors.
 8. Encourage recognition of situations that provoke obsessive 
thoughts or ritualistic behaviors. Explain ways of interrupting 
these thoughts and patterns of behavior (e.g., thought-stopping 
techniques, relaxation techniques, physical exercise, or other 
constructive activity with which client feels comfortable).
Outcome Criteria
 1. Client is able to verbalize signs and symptoms of increasing 
anxiety and intervene to maintain anxiety at manageable level.
 2. Client demonstrates ability to interrupt obsessive thoughts 
and refrain from ritualistic behaviors in response to stressful 
situations.
●
 POWERLESSNESS
Deﬁ nition: The perception that one’s own action will not signifi -
cantly affect an outcome; a perceived lack of control over a current 
situation or immediate happening. 
Possible Etiologies (“related to”)
Lifestyle of helplessness
[Fear of disapproval from others]
[Unmet dependency needs]
[Lack of positive feedback]
[Consistent negative feedback] 
Deﬁ ning Characteristics (“evidenced by”)
Verbal expressions of having no control (e.g., over self-care, situ-
ation, outcome)
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Nonparticipation in care or decision making when opportunities 
are provided
Expression of doubt regarding role performance
Reluctance to express true feelings
Apathy
Dependence on others that may result in irritability, resentment, 
anger, and guilt
Passivity
Goals/Objectives
Short-term Goal
Client will participate in decision making regarding own care 
within 5 days.
Long-term Goal
Client will be able to effectively problem-solve ways to take con-
trol of his or her life situation by discharge, thereby decreasing 
feelings of powerlessness.
Interventions with Selected Rationales
 1. Allow client to take as much responsibility as possible for 
own self-care practices. Providing client with choices will 
increase his or her feelings of control.
  Examples are as follows:
 a. Include client in setting the goals of care he or she wishes 
to achieve.
 b. Allow client to establish own schedule for self-care 
activities.
 c. Provide client with privacy as need is determined.
 d. Provide positive feedback for decisions made. Respect 
client’s right to make those decisions independently, and 
refrain from attempting to inﬂ uence him or her toward 
those that may seem more logical.
 2. Help client set realistic goals. Unrealistic goals set the client 
up for failure and reinforce feelings of powerlessness.
 3. Help identify areas of life situation that client can control. 
Client’s emotional condition interferes with his or her 
ability to solve problems. Assistance is required to perceive 
the benefi ts and consequences of available alternatives 
accurately.
 4. Help client identify areas of life situation that are not with-
in his or her ability to control. Encourage verbalization of 
feelings related to this inability in an effort to deal with 
unresolved issues and accept what cannot be changed.
 5. Identify ways in which client can achieve. Encourage par-
ticipation in these activities, and provide positive reinforce-
ment for participation, as well as for achievement. Positive 
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reinforcement enhances self-esteem and encourages repeti-
tion of desirable behaviors.
Outcome Criteria
 1. Client verbalizes choices made in a plan to maintain control 
over his or her life situation.
 2. Client verbalizes honest feelings about life situations over 
which he or she has no control.
 3. Client is able to verbalize system for problem-solving as 
required for adequate role performance.
●
 SOCIAL ISOLATION
Deﬁ nition: Aloneness experienced by the individual and per-
ceived as imposed by others and as a negative or threatening 
state. 
Possible Etiologies (“related to”)
[Panic level of anxiety]
[Past experiences of difﬁ culty in interactions with others]
[Need to engage in ritualistic behavior in order to keep anxiety 
under control]
[Repressed fears] 
Deﬁ ning Characteristics (“evidenced by”)
[Stays alone in room]
Uncommunicative
Withdrawn
No eye contact
Developmentally [or culturally] inappropriate behaviors
Preoccupation with own thoughts; repetitive, meaningless 
actions
Expression of feelings of rejection or of aloneness imposed by 
others
Experiences feelings of differences from others
Insecurity in public
Goals/Objectives
Short-term Goal
Client will willingly attend therapy activities accompanied by 
trusted support person within 1 week.
Long-term Goal
Client will voluntarily spend time with other clients and staff 
members in group activities by time of discharge from treatment.
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Interventions with Selected Rationales
 1. Convey an accepting attitude by making brief, frequent con-
tacts. An accepting attitude increases feelings of self-worth 
and facilitates trust.
 2. Show unconditional positive regard. This conveys your belief 
in the client as a worthwhile human being.
 3. Be with the client to offer support during group activities 
that may be frightening or difﬁ cult for him or her.  The pres-
ence of a trusted individual provides emotional security for 
the client.
 4. Be honest and keep all promises. Honesty and dependability 
promote a trusting relationship.
 5. Be cautious with touch. Allow client extra space and an avenue 
for exit if he or she becomes too anxious. A person in panic 
anxiety may perceive touch as a threatening gesture.
 6. Administer tranquilizing medications as ordered by physi-
cian. Monitor for effectiveness and for adverse side effects. 
Short-term use of antianxiety medications, such as diaze-
pam, chlordiazepoxide, or alprazolam, helps to reduce level of 
anxiety in most individuals, thereby facilitating interactions 
with others.
 7. Discuss with client the signs of increasing anxiety and techniques 
for interrupting the response (e.g., relaxation exercises, thought 
stopping). Maladaptive behaviors, such as withdrawal and sus-
piciousness, are manifested during times of increased anxiety.
 8. Give recognition and positive reinforcement for client’s volun-
tary interactions with others. Positive reinforcement enhances 
self-esteem and encourages repetition of acceptable behaviors.
Outcome Criteria
 1. Client demonstrates willingness or desire to socialize with 
others.
 2. Client voluntarily attends group activities.
 3. Client approaches others in appropriate manner for one-to-one 
interaction.
●
 SELF-CARE DEFICIT (IDENTIFY 
SPECIFIC AREA)
Deﬁ nition: Impaired ability to perform or complete [activities of 
daily living (ADL) independently]. 
Possible Etiologies (“related to”)
[Withdrawal; isolation from others]
[Unmet dependency needs]
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[Excessive ritualistic behavior]
[Disabling anxiety]
[Irrational fears] 
Deﬁ ning Characteristics (“evidenced by”)
[Unwillingness to bathe regularly]
[Uncombed hair; dirty clothes; offensive body and breath odor; 
disheveled appearance]
[Eating only a few bites of food off meal tray]
[Lack of interest in selecting appropriate clothing to wear, 
dressing, grooming, or maintaining appearance at a satisfac-
tory level]
[Incontinence] 
Goals/Objectives
Short-term Goal
Client will verbalize desire to take control of self-care activities 
within 5 days.
Long-term Goal
Client will be able to take care of own ADLs and demonstrate a 
willingness to do so by time of discharge from treatment.
Interventions with Selected Rationales
 1. Urge client to perform normal ADLs to his or her level of 
ability. Successful performance of independent activities 
enhances self-esteem.
 2. Encourage independence, but intervene when client is unable 
to perform. Client comfort and safety are nursing priorities.
 3. Offer recognition and positive reinforcement for independent 
accomplishments. (Example: “Mrs. J., I see you have put on a 
clean dress and combed your hair.”) Positive reinforcement 
enhances self-esteem and encourages repetition of desired 
behaviors.
 4. Show client how to perform activities with which he or she is 
having difﬁ culty. When anxiety is high, client may require 
simple, concrete demonstrations of activities that would be 
performed without diffi culty under normal conditions.
 5. Keep strict records of food and ﬂ uid intake. This information 
is necessary to formulate an accurate nutritional assessment.
 6. Offer nutritious snacks and ﬂ uids between meals. Client may 
be unable to tolerate large amounts of food at mealtimes 
and may therefore require additional nourishment at other 
times during the day to receive adequate nutrition.
 7. If client is incontinent, establish routine schedule for toilet-
ing needs. Assist client to bathroom on hourly or bihourly 
schedule, as need is determined, until he or she is able to 
fulﬁ ll this need without assistance.
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Outcome Criteria
 1. Client feeds self, leaving no more than a few bites of food on 
food tray.
 2. Client selects appropriate clothing and dresses and grooms 
self daily.
 3. Client maintains optimal level of personal hygiene by bathing 
daily and carrying out essential toileting procedures without 
assistance.
 INTERNET REFERENCES 
• Additional information about anxiety disorders and medica-
tions to treat these disorders may be located at the following 
websites:
 a. http://www.adaa.org
 b. http://www.mentalhealth.com
 c. http://www.nimh.nih.gov
 d. http://www.anxietynetwork.com/pdhome.html
 e. http://www.fadavis.com/townsend
 f. http://www.drugs.com/condition/anxiety.html 
Movie Connections
As Good as It Gets (OCD) • The Aviator (OCD) • What About 
Bob? (phobias) • Copycat (agoraphobia) • Analyze This (panic disorder) 
• Vertigo (speciﬁ c phobia) • Born on the Fourth of July (PTSD) • The Deer 
Hunter (PTSD)
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Somatoform Disorders
● BACKGROUND ASSESSMENT DATA
Somatoform disorders are characterized by physical symptoms 
suggesting medical disease but without demonstrable organic 
pathology or a known pathophysiological mechanism to account 
for them. They are classiﬁ ed as mental disorders because patho-
physiological processes are not demonstrable or understandable 
by existing laboratory procedures, and there is either evidence 
or strong presumption that psychological factors are the major 
cause of the symptoms. It is now well documented that a large 
proportion of clients in general medical outpatient clinics and 
private medical ofﬁ ces do not have organic disease requiring 
medical treatment. It is likely that many of these clients have 
somatoform disorders, but they do not perceive themselves 
as having a psychiatric problem and thus do not seek treat-
ment from psychiatrists. The American Psychiatric Association 
(APA, 2000) Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition, Text Revision (DSM-IV-TR) identiﬁ es the follow-
ing categories of somatoform disorders:
● SOMATOFORM DISORDERS
Somatization Disorder
Somatization disorder is a chronic syndrome of multiple somatic 
symptoms that cannot be explained medically and are associated 
with psychosocial distress and long-term seeking of assistance 
from health-care professionals. Symptoms can represent virtu-
ally any organ system but commonly are expressed as neuro-
logical, gastrointestinal, psychosexual, or cardiopulmonary dis-
orders. Onset of the disorder is usually in adolescence or early 
adulthood and is more common in women than in men. The 
disorder usually runs a ﬂ uctuating course, with periods of re-
mission and exacerbation.
Pain Disorder
The essential feature of pain disorder is severe and prolonged 
pain that causes clinically signiﬁ cant distress or impairment in 
176
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social, occupational, or other important areas of functioning 
(APA, 2000). This diagnosis is made when psychological factors 
have been judged to have a major role in the onset, severity, ex-
acerbation, or maintenance of the pain, even when the physical 
examination reveals pathology that is associated with the pain.
Hypochondriasis
Hypochondriasis is an unrealistic preoccupation with the fear 
of having a serious illness. The DSM-IV-TR suggests that this 
fear arises out of an unrealistic interpretation of physical signs 
and symptoms. Occasionally medical disease may be pres-
ent, but in the hypochondriacal individual, the symptoms are 
grossly disproportionate to the degree of pathology. Individu-
als with hypochondriasis often have a long history of “doctor 
shopping” and are convinced that they are not receiving the 
proper care.
Conversion Disorder
Conversion disorder is a loss of or change in body function re-
sulting from a psychological conﬂ ict, the physical symptoms of 
which cannot be explained by any known medical disorder or 
pathophysiological mechanism. The most common conversion 
symptoms are those that suggest neurological disease such as 
paralysis, aphonia, seizures, coordination disturbance, akinesia, 
dyskinesia, blindness, tunnel vision, anosmia, anesthesia, and 
paresthesia.
Body Dysmorphic Disorder
This disorder, formerly called dysmorphophobia, is charac-
terized by the exaggerated belief that the body is deformed or 
defective in some speciﬁ c way. The most common complaints 
involve imagined or slight ﬂ aws of the face or head, such as 
thinning hair, acne, wrinkles, scars, vascular markings, facial 
swelling or asymmetry, or excessive facial hair (APA, 2000).
●  PREDISPOSING FACTORS 
TO SOMATOFORM DISORDERS
 1. Physiological
 a. Genetic. Studies have shown an increased incidence of 
somatization disorder, conversion disorder, and hypo-
chondriasis in ﬁ rst-degree relatives, implying a possible 
inheritable predisposition (Sadock & Sadock, 2007; Soares 
& Grossman, 2007; Yutzy, 2003). 
 b. Biochemical. Decreased levels of serotonin and endor-
phins may play a role in the etiology of pain disorder.
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 2. Psychosocial
 a. Psychodynamic. Some psychodynamicists view hypochon-
driasis as an ego defense mechanism. They hypothesize 
that physical complaints are the expression of low self-
esteem and feelings of worthlessness and that the individual 
believes it is easier to feel something is wrong with the body 
than to feel something is wrong with the self.
    The psychodynamic theory of conversion disorder pro-
poses that emotions associated with a traumatic event that 
the individual cannot express because of moral or ethical 
unacceptability are “converted” into physical symptoms. 
The unacceptable emotions are repressed and converted 
to a somatic hysterical symptom that is symbolic in some 
way of the original emotional trauma.
 b. Family Dynamics. Some families have difﬁ culty expressing 
emotions openly and resolving conﬂ icts verbally. When this 
occurs, the child may become ill, and a shift in focus is made 
from the open conﬂ ict to the child’s illness, leaving unre-
solved the underlying issues that the family cannot confront 
openly. Thus, somatization by the child brings some stabil-
ity to the family, as harmony replaces discord and the child’s 
welfare becomes the common concern. The child in turn 
receives positive reinforcement for the illness.
 c. Sociocultural/Familial Factors. Somatic complaints are 
often reinforced when the sick role relieves the individual 
from the need to deal with a stressful situation, whether it 
be within society or within the family. When the sick per-
son is allowed to avoid stressful obligations and postpone 
unwelcome challenges, is excused from troublesome du-
ties, or becomes the prominent focus of attention because 
of the illness, positive reinforcement virtually guarantees 
repetition of the response.
 d. Past Experience with Physical Illness. Personal experi-
ence, or the experience of close family members, with seri-
ous or life-threatening illness can predispose an individual 
to hypochondriasis. Once an individual has experienced a 
threat to biological integrity, he or she may develop a fear 
of recurrence. The fear of recurring illness generates an 
exaggerated response to minor physical changes, leading 
to hypochondriacal behaviors.
 e. Cultural and Environmental Factors. Some cultures and 
religions carry implicit sanctions against verbalizing or 
directly expressing emotional states, thereby indirectly 
encouraging “more acceptable” somatic behaviors. Cross-
cultural studies have shown that the somatization symp-
toms associated with depression are relatively similar, 
but the “cognitive” or emotional symptoms such as guilt
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  are predominantly seen in Western societies. In Middle 
Eastern and Asian cultures, depression is almost exclusively 
manifested by somatic or vegetative symptoms. 
    Environmental inﬂ uences may be signiﬁ cant in the 
predisposition to somatization disorder. Some studies have 
suggested that a tendency toward somatization appears to be 
more common in individuals who have low socioeconomic, 
occupational, and educational status. 
●  SYMPTOMATOLOGY (SUBJECTIVE 
AND OBJECTIVE DATA)
 1. Any physical symptom for which there is no organic basis 
but for which evidence exists for the implication of psycho-
logical factors.
 2. Depressed mood is common.
 3. Loss or alteration in physical functioning, with no organic 
basis. Examples include the following:
 a. Blindness or tunnel vision
 b. Paralysis
 c. Anosmia (inability to smell)
 d. Aphonia (inability to speak)
 e. Seizures
 f. Coordination disturbances
 g. Pseudocyesis (false pregnancy)
 h. Akinesia or dyskinesia
 i. Anesthesia or paresthesia
  4. “La belle indifference”—a relative lack of concern regard-
ing the severity of the symptoms just described (e.g., a 
person is suddenly blind but shows little anxiety over the 
situation).
 5. “Doctor shopping”
 6. Excessive use of analgesics
 7. Requests for surgery
 8. Assumption of an invalid role
 9. Impairment in social or occupational functioning because 
of preoccupation with physical complaints
 10. Psychosexual dysfunction (impotence, dyspareunia [painful 
coitus], sexual indifference)
 11. Excessive dysmenorrhea
 12. Excessive preoccupation with physical defect that is out of 
proportion to the actual condition
Common Nursing Diagnoses and Interventions
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.) 
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●
 CHRONIC PAIN
Deﬁ nition: Unpleasant sensory and emotional experience aris-
ing from actual or potential tissue damage or described in terms of 
such damage (International Association for the Study of Pain); sud-
den or slow onset of any intensity from mild to severe, constant or 
recurring without an anticipated or predictable end and a duration 
of greater than 6 months. 
Possible Etiologies (“related to”)
[Severe level of anxiety, repressed]
[Low self-esteem]
[Unmet dependency needs]
[Secondary gains from the sick role] 
Deﬁ ning Characteristics (“evidenced by”)
Verbal report of pain [in the absence of pathophysiological 
evidence]
Reduced interaction with people
Facial mask [of pain]
Guarding behavior
[Demanding behaviors]
[Refuses to attend therapeutic activities because of pain]
[History of seeking assistance from numerous health-care 
professionals]
[Excessive use of analgesics, without relief of pain]
Self-focusing
Goals/Objectives
Short-term Goal
Within 2 weeks, client will verbalize understanding of correla-
tion between pain and psychological problems.
Long-term Goal
By time of discharge from treatment, client will verbalize a 
noticeable, if not complete, relief from pain.
Interventions with Selected Rationales
 1. Monitor physician’s ongoing assessments and laboratory re-
ports to ascertain that organic pathology is clearly ruled out.
 2. Recognize and accept that the pain is real to the individual, 
even though no organic cause can be identiﬁ ed. Denying the 
client’s feelings is nontherapeutic and hinders the develop-
ment of a trusting relationship.
  3. Observe and record the duration and intensity of the 
pain. Note factors that precipitate the onset of pain. 
Identification of the precipitating stressor is important
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  for assessment purposes. This information will be used 
to develop a plan for assisting the client to cope more 
adaptively.
 4. Provide pain medication as prescribed by physician. Client 
comfort and safety are nursing priorities.
 5. Assist with comfort measures, such as back rub, warm bath, 
and heating pad. Be careful, however, not to respond in a 
way that reinforces the behavior. Secondary gains from 
physical symptoms may prolong maladaptive behaviors.
 6. Offer your attention at times when client is not focusing on 
pain. Positive reinforcement encourages repetition of adap-
tive behaviors.
 7. Identify activities that serve to distract client from focus on 
self and pain. These distractors serve in a therapeutic man-
ner as a transition from focus on self or physical manifes-
tations to focus on unresolved psychological issues.
 8. Encourage verbalization of feelings. Explore meaning that 
pain holds for client. Help client connect symptoms of pain 
to times of increased anxiety and to identify speciﬁ c situa-
tions that cause anxiety to rise. Verbalization of feelings in 
a nonthreatening environment facilitates expression and 
resolution of disturbing emotional issues.
 9. Encourage client to identify alternative methods of coping 
with stress. These may avert the physical pain as a mal-
adaptive response to stress.
 10. Explore ways to intervene as symptoms begin to intensify, 
so that pain does not become disabling (e.g., visual or audi-
tory distractions, mental imagery, deep-breathing exercises, 
application of hot or cold compresses, relaxation exercises).
 11. Provide positive reinforcement for adaptive behaviors. Posi-
tive reinforcement enhances self-esteem and encourages 
repetition of desired behaviors.
Outcome Criteria
 1. Client verbalizes that pain does not interfere with comple-
tion of daily activities.
 2. Client verbalizes an understanding of the relationship 
between pain and emotional problems.
 3. Client demonstrates ability to intervene as anxiety rises, to 
prevent the onset or increase in severity of pain.
●
 INEFFECTIVE COPING
Deﬁ nition: Inability to form a valid appraisal of the stressors, in-
adequate choices of practiced responses, and/or inability to use 
available resources.
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Possible Etiologies (“related to”)
[Severe level of anxiety, repressed]
[Low self-esteem]
[Unmet dependency needs]
[History of self or loved one having experienced a serious 
illness or disease]
[Regression to, or ﬁ xation in, an earlier level of development]
[Retarded ego development]
[Inadequate coping skills] 
Deﬁ ning Characteristics (“evidenced by”)
[Numerous physical complaints verbalized, in the absence of 
any pathophysiological evidence]
[Total focus on the self and physical symptoms]
[History of doctor shopping]
[Demanding behaviors]
[Refuses to attend therapeutic activities]
[Does not correlate physical symptoms with psychological 
problems]
Inability to meet basic needs
Inability to meet role expectations
Inadequate problem-solving
Sleep disturbance
Goals/Objectives
Short-term Goal
Within 2 weeks, client will verbalize understanding of correla-
tion between physical symptoms and psychological problems.
Long-term Goal
By time of discharge from treatment, client will demonstrate 
ability to cope with stress by means other than preoccupation 
with physical symptoms.
Interventions with Selected Rationales
 1. Monitor physician’s ongoing assessments, laboratory reports, 
and other data to maintain assurance that possibility of organic 
pathology is clearly ruled out. Knowledge of these data is vital 
for the provision of adequate and appropriate client care.
 2. Recognize and accept that the physical complaint is indeed real 
to the individual, even though no organic cause can be identi-
ﬁ ed. Denial of the client’s feelings is nontherapeutic and in-
terferes with establishment of a trusting relationship.
 3. Identify gains that the physical symptom is providing for 
the client: increased dependency, attention, distraction from 
other problems. These are important assessment data to be 
used in assisting the client with problem resolution.  
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  4. Initially, fulﬁ ll client’s most urgent dependency needs. 
Failure to do this may cause client to become extremely 
anxious, with an increase in maladaptive behaviors.
  5. Gradually withdraw attention to physical symptoms. Minimize 
time given in response to physical complaints. Lack of positive 
response will discourage repetition of undesirable behaviors.
  6. Explain to client that any new physical complaints will be 
referred to the physician, and give no further attention to 
them. Be sure to note physician’s assessment of the com-
plaint. The possibility of organic pathology must always be 
taken into consideration. Failure to do so could jeopardize 
client’s safety.
  7. Encourage client to verbalize fears and anxieties. Explain 
that attention will be withdrawn if rumination about physi-
cal complaints begins. Follow through. Without consistency 
of limit setting, change will not occur.
  8. Help client observe that physical symptoms occur because 
of, or are exacerbated by, speciﬁ c stressors. Discuss alterna-
tive coping responses to these stressors.
  9. Give positive reinforcement for adaptive coping strategies. 
Positive reinforcement encourages repetition of desired 
behaviors.
 10. Help client identify ways to achieve recognition from oth-
ers without resorting to physical symptoms. Positive rec-
ognition from others enhances self-esteem and minimizes 
the need for attention through maladaptive behaviors.
 11. Discuss how interpersonal relationships are affected by 
client’s narcissistic behavior. Explain how this behavior 
alienates others. Client may not realize how he or she is 
perceived by others.
 12. Provide instruction in relaxation techniques and assertive-
ness skills. These approaches decrease anxiety and increase 
self-esteem, which facilitate adaptive responses to stressful 
situations.
Outcome Criteria
 1. Client is able to demonstrate techniques that may be used in 
response to stress to prevent the occurrence or exacerbation 
of physical symptoms. 
 2. Client verbalizes an understanding of the relationship 
between emotional problems and physical symptoms.
●
 DISTURBED BODY IMAGE 
Deﬁ nition: Confusion in mental picture of one’s physical self.
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Possible Etiologies (“related to”)
[Severe level of anxiety, repressed]
[Low self-esteem]
[Unmet dependency needs] 
Deﬁ ning Characteristics (“evidenced by”)
[Preoccupation with real or imagined change in bodily 
structure or function]
[Verbalizations about physical appearance that are out of pro-
portion to any actual physical abnormality that may exist]
Fear of reaction by others
Negative feelings about body
Change in social involvement
Goals/Objectives
Short-term Goal
Client will verbalize understanding that changes in bodily 
structure or function are exaggerated out of proportion to the 
change that actually exists. (Time frame for this goal must be 
determined according to individual client’s situation.)
Long-term Goal
Client will verbalize perception of own body that is realistic to 
actual structure or function by time of discharge from treatment.
Interventions with Selected Rationales
 1. Establish trusting relationship with client. Trust enhances 
therapeutic interactions between nurse and client.
 2. If there is actual change in structure or function, encourage 
client to progress through stages of grieving. Assess level of 
knowledge and provide information regarding normal griev-
ing process and associated feelings. Knowledge of acceptable 
feelings facilitates progression through the grieving process.
 3. Identify misperceptions or distortions client has regarding 
body image. Correct inaccurate perceptions in a matter-
of-fact, nonthreatening manner. Withdraw attention when 
preoccupation with distorted image persists. Lack of atten-
tion may encourage elimination of undesirable behaviors.
 4. Help client recognize personal body boundaries. Use of touch 
may help him or her recognize acceptance of the individual 
by others and reduce fear of rejection because of changes in 
bodily structure or function.
 5. Encourage independent self-care activities, providing as-
sistance as required. Self-care activities accomplished inde-
pendently enhance self-esteem and also create the necessity 
for client to confront reality of his or her bodily condition.
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 6. Provide positive reinforcement for client’s expressions of 
realistic bodily perceptions. Positive reinforcement en-
hances self-esteem and encourages repetition of desired 
behaviors.
Outcome Criteria
 1. Client verbalizes realistic perception of bodily condition.
 2. Client demonstrates acceptance of changes in bodily struc-
ture or function, as evidenced by expression of positive feel-
ings about body, ability or willingness to perform self-care 
activities independently, and a focus on personal achievements 
rather than preoccupation with distorted body image.
●
 DISTURBED SENSORY PERCEPTION
Deﬁ nition: Change in the amount or patterning of incoming stimuli 
[either internally or externally initiated] accompanied by a dimin-
ished, exaggerated, distorted, or impaired response to such stimuli. 
Possible Etiologies (“related to”)
[Severe level of anxiety, repressed]
[Low self-esteem]
[Unmet dependency needs]
[Regression to, or ﬁ xation in, an earlier level of development]
[Retarded ego development]
[Inadequate coping skills]
Psychological stress [narrowed perceptual ﬁ elds caused by 
anxiety] 
Deﬁ ning Characteristics (“evidenced by”)
[Loss or alteration in physical functioning suggesting a 
physical disorder (often neurological in nature) but for which 
organic pathology is not evident. Common alterations include 
paralysis, anosmia, aphonia, deafness, blindness]
[La belle indifference] 
Goals/Objectives
Short-term Goal
Client will verbalize understanding of emotional problems as a 
contributing factor to alteration in physical functioning within 
10 days.
Long-term Goal
Client will demonstrate recovery of lost function.
2506_Ch09_176-190.indd   Sec1:185 10/1/10   9:35:19 AM
186 ● ALTERATIONS IN PSYCHOSOCIAL ADAPTATION
Interventions with Selected Rationales
 1. Monitor physician’s ongoing assessments, laboratory reports, 
and other data to maintain assurance that possibility of or-
ganic pathology is clearly ruled out. Failure to do so may 
jeopardize client’s safety.
 2. Identify gains that the physical symptom is providing for 
the client: increased dependency, attention, distraction from 
other problems. These are important assessment data to be 
used in assisting the client with problem resolution.
 3. Fulﬁ ll client’s needs related to activities of daily living (ADLs) 
with which the physical symptom is interfering. Client com-
fort and safety are nursing priorities.
 4. Do not focus on the disability, and allow client to be as inde-
pendent as possible. Intervene only when client requires as-
sistance. Positive reinforcement would encourage continual 
use of the maladaptive response for secondary gains, such as 
dependency.
 5. Encourage client to participate in therapeutic activities to the 
best of his or her ability. Do not allow client to use the disability 
as a manipulative tool. Withdraw attention if client continues 
to focus on physical limitation. Reinforce reality as required, 
but ensure maintenance of a nonthreatening environment.
 6. Encourage client to verbalize fears and anxieties. Help client 
to recognize that the physical symptom appears at a time of 
extreme stress and is a mechanism used for coping. Client 
may be unaware of the relationship between physical symp-
tom and emotional stress.
 7. Help client identify coping mechanisms that he or she could 
use when faced with stressful situations rather than retreat-
ing from reality with a physical disability.
 8. Explain assertiveness techniques and practice use of same 
through role-playing. Use of assertiveness techniques en-
hances self-esteem and minimizes anxiety in interpersonal 
relationships.
 9. Help client identify a satisfactory support system within 
the community from which he or she may seek assistance as 
needed to cope with overwhelming stress.
Outcome Criteria
 1. Client is no longer experiencing symptoms of altered physi-
cal functioning.
 2. Client verbalizes an understanding of the relationship 
between extreme psychological stress and loss of physical 
functioning.
 3. Client is able to verbalize adaptive ways of coping with stress 
and identify community support systems to which he or she 
may go for help.
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●
 SELF-CARE DEFICIT (IDENTIFY 
SPECIFIC AREA)
Deﬁ nition: Impaired ability to perform or complete [activities of 
daily living ADLs independently]
Possible Etiologies (“related to”)
[Paralysis of body part]
[Inability to see]
[Inability to hear]
[Inability to speak]
Pain, discomfort
Deﬁ ning Characteristics (“evidenced by”)
Inability to bring food from a receptacle to the mouth
Inability to wash body or body parts; obtain or get to water 
sources; regulate temperature or ﬂ ow
Impaired ability to put on or take off necessary items of 
clothing; obtain or replace articles of clothing; fasten 
clothing; maintain appearance at a satisfactory level
Inability to get to toilet or commode [impaired mobility]
Inability to manipulate clothing for toileting
Inability to ﬂ ush toilet or commode
Inability to sit on or rise from toilet or commode
Inability to carry out proper toilet hygiene
Goals/Objectives
Short-term Goal
Client will perform self-care needs independently, to the extent 
that physical ability will allow, within 5 days.
Long-term Goal
By discharge from treatment, client will be able to perform 
ADLs independently and demonstrate a willingness to do so.
Interventions with Selected Rationales
 1. Assess client’s level of disability; note areas of strength 
and impairment. This knowledge is required to develop 
adequate plan of care for client.
 2. Encourage client to perform normal ADLs to his or her level 
of ability. Successful performance of independent activities 
enhances self-esteem.
 3. Encourage independence, but intervene when client is unable 
to perform. Client comfort and safety are nursing priorities.
 4. Ensure that nonjudgmental attitude is conveyed as nursing 
assistance with self-care activities is provided. Remember
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  that the physical symptom is real to the client. It is not with-
in the client’s conscious control. A judgmental attitude 
interferes with the nurse’s ability to provide therapeutic 
care for this client.
 5. Feed client, if necessary, and provide assistance with con-
tainers, positioning, and other matters, as required. Client 
comfort and safety are nursing priorities.
 6. Bathe client, or assist with bath, depending on his or her level 
of ability. Client comfort and safety are nursing priorities.
 7. Assist client with dressing, oral hygiene, combing hair, and 
applying makeup, as required. Client comfort and safety are 
nursing priorities.
 8. Provide bedpan, commode, or assistance to bathroom as 
determined by client’s level of ability. Client comfort and 
safety are nursing priorities.
 9. Provide positive reinforcement for ADLs performed inde-
pendently. Positive reinforcement enhances self-esteem and 
encourages repetition of desired behaviors.
 10. Take precautions against fostering dependency by inter-
vening when client is capable of performing independently. 
Allow ample time for client to complete these activities to 
the best of his or her ability without assistance. Allowing 
the client to maintain dependency may provide secondary 
gains and delay recovery from the disability.
 11. Encourage client to discuss feelings regarding the disability 
and the need for dependency it creates. Help client to see 
the purpose this disability is serving for him or her. Self-
disclosure and exploration of feelings with a trusted in-
dividual may help client fulfi ll unmet needs and confront 
unresolved issues.
Outcome Criteria
 1. Client feeds self without assistance.
 2. Client selects appropriate clothing and dresses and grooms 
self daily.
 3. Client maintains optimal level of personal hygiene by bathing 
daily and carrying out essential toileting procedures without 
assistance.
●
 DEFICIENT KNOWLEDGE 
(PSYCHOLOGICAL CAUSES 
FOR PHYSICAL SYMPTOMS)
Deﬁ nition: Absence or defi ciency of cognitive information related 
to a specifi c topic. 
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Possible Etiologies (“related to”)
Lack of interest in learning
[Severe level of anxiety] 
Deﬁ ning Characteristics (“evidenced by”)
[Denial of emotional problems]
[Statements such as, “I don’t know why the doctor put me on the 
psychiatric unit. I have a physical problem.”]
[History of “shopping” for a doctor who will substantiate symp-
toms as pathophysiological]
[Noncompliance with psychiatric treatment plan] 
Goals/Objectives
Short-term Goal
Client will verbalize an understanding that no pathophysiologi-
cal condition exists to substantiate physical symptoms.
Long-term Goal
By time of discharge from treatment, client will be able to ver-
balize psychological cause(s) for physical symptoms.
Interventions with Selected Rationales
 1. Assess client’s level of knowledge regarding effects of psy-
chological problems on the body. An adequate database 
is necessary for the development of an effective teaching 
plan.
 2. Assess client’s level of anxiety and readiness to learn. Learn-
ing does not occur beyond the moderate level of anxiety.
 3. Discuss physical examinations and laboratory tests that have 
been conducted. Explain purpose and results of each.
 4. Explore feelings and fears held by client. Go slowly. These 
feelings may have been suppressed or repressed for a very 
long time and their disclosure will undoubtedly be a pain-
ful experience. Be supportive. Verbalization of feelings in a 
nonthreatening environment may help client come to terms 
with long-unresolved issues.
 5. Have client keep a diary of appearance, duration, and intensity 
of physical symptoms. A separate record of situations that the 
client ﬁ nds especially stressful should also be kept. Compari-
son of these records may provide objective data from which 
to observe the relationship between physical symptoms and 
stress.
 6. Help client identify needs that are being met through the 
sick role. Together, formulate a more adaptive means for 
fulﬁ lling these needs. Practice by role-playing. Change 
cannot occur until the client realizes that physical symp-
toms are used to fulfi ll unmet needs. Anxiety is relieved by 
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role-playing, since the client is able to anticipate responses 
to stressful situations.
 7. Explain assertiveness techniques to the client. Discuss the 
importance of recognizing the differences among passive, 
assertive, and aggressive behaviors, and of respecting the 
human rights of others while protecting one’s own basic 
human rights. Use of these techniques enhances self-esteem 
and facilitates client’s interpersonal relationships.
 8. Discuss adaptive methods of stress management: relaxation 
techniques, physical exercise, meditation, breathing exer-
cises, or mental imagery. These techniques may be employed 
in an attempt to relieve anxiety and discourage the use of 
physical symptoms as a maladaptive response.
Outcome Criteria
 1. Client verbalizes an understanding of the relationship 
between psychological stress and physical symptoms.
 2. Client demonstrates the ability to use therapeutic techniques 
in the management of stress.
 INTERNET REFERENCES
 • Additional information about somatoform disorders may be 
located at the following websites:
 a. http://psyweb.com/Mdisord/jsp/somatd.jsp
 b. http://www.uib.no/med/avd/med_a/gastro/wilhelms/
hypochon.html
 c. http://emedicine.medscape.com/article/805361-overview
 d. http://psychological.com/somatofom_disorders.htm
 e. http://emedicine.medscape.com/article/917864-overview 
 f. http://findarticles.com/p/articles/mi_g2601/is_0012/
ai_2601001276
Movie Connections
Bandits (hypochondriasis) • Hannah and Her Sisters 
(hypochondriasis) • Send Me No Flowers (hypochondriasis)
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C H A P T E R 10
Dissociative Disorders
● BACKGROUND ASSESSMENT DATA
The essential feature of the dissociative disorders is a disruption 
in the usually integrated functions of consciousness, memory, 
identity, or perception (APA, 2000). During periods of intoler-
able stress, the individual blocks off part of his or her life from 
consciousness. The stressful emotion becomes a separate entity, 
as the individual “splits” from it and mentally drifts into a fan-
tasy state. The following categories are deﬁ ned in the Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition, Text 
Revision (DSM-IV-TR) (APA, 2000):
 1. Dissociative Amnesia: An inability to recall important per-
sonal information, usually of a traumatic or stressful nature. 
The extent of the disturbance is too great to be explained by 
ordinary forgetfulness. Types of impairment in recall include 
the following:
 a. Localized Amnesia: Inability to recall all incidents asso-
ciated with a traumatic event for a speciﬁ c time period 
following the event (usually a few hours to a few days).
 b. Selective Amnesia: Inability to recall only certain incidents 
associated with a traumatic event for a speciﬁ c period fol-
lowing the event.
 c. Continuous Amnesia: Inability to recall events subse-
quent to a speciﬁ c time up to and including the present. 
(The memory does not return after a short period, as in 
localized amnesia. The individual is unable to form new 
memories.)
 d. Systematized Amnesia: With this type of amnesia, the 
individual cannot remember events that relate to a speciﬁ c 
category of information, such as one’s family, or to one 
particular person or event.      
 e. Generalized Amnesia: Failure of recall encompassing 
one’s entire life.
 2. Dissociative Fugue. A sudden, unexpected travel away from 
home or customary work locale with assumption of a new 
identity and an inability to recall one’s previous identity. 
Following recovery, there is no recollection of events that 
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took place during the fugue. Course is typically brief—hours 
to days, and rarely, months. Recurrences are rare.
 3. Dissociative Identity Disorder (DID). The existence with-
in the individual of two or more distinct personalities, each of 
which is dominant at a particular time.  The original person-
ality usually is not aware (at least initially) of the existence of 
subpersonalities. When there are more than two subperson-
alities, however, they are usually aware of each other. Transi-
tion from one personality to another is usually sudden and 
often associated with psychosocial stress. The course tends 
to be more chronic than in the other dissociative disorders.
 4. Depersonalization Disorder. Characterized by a temporary 
change in the quality of self-awareness, which often takes the 
form of feelings of unreality, changes in body image, feelings 
of detachment from the environment, or a sense of observing 
oneself from outside the body.
●  PREDISPOSING FACTORS 
TO DISSOCIATIVE DISORDER
 1. Physiological
 a. Genetics. The DSM-IV-TR suggests that DID is more 
common in ﬁ rst-degree relatives of people with the disor-
der than in the general population. The disorder is often 
seen in more than one generation of a family.
 b. Neurobiological. Some clinicians have suggested a possible 
correlation between neurological alterations and dissocia-
tive disorders. Although available information is inadequate, 
it is possible that dissociative amnesia and dissociative fugue 
may be related to alterations in certain areas of the brain 
that have to do with memory.  These include the hippocam-
pus, mammillary bodies, amygdala, fornix, thalamus, and 
frontal cortex.  Some studies have suggested a possible link 
between DID and certain neurological conditions, such 
as temporal lobe epilepsy and severe migraine headaches. 
Electroencephalographic abnormalities have been observed 
in some clients with DID.
 2. Psychosocial
 a. Psychodynamic Theory. Freud (1962) believed that dis-
sociative behaviors occurred when individuals repressed 
distressing mental contents from conscious awareness. 
He believed that the unconscious was a dynamic entity in 
which repressed mental contents were stored and unavail-
able to conscious recall. Current psychodynamic explana-
tions of dissociation are based on Freud’s concepts.
 b. Psychological Trauma. A growing body of evidence 
points to the etiology of DID as a set of traumatic experi-
ences that overwhelms the individual’s capacity to cope 
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by any means other than dissociation. These experiences 
usually take the form of severe physical, sexual, and/or 
psychological abuse by a parent or signiﬁ cant other in the 
child’s life. DID is thought to serve as a survival strategy 
for the child in this traumatic environment, whereby he 
or she creates a new being who is able to experience the 
overwhelming pain of the cruel reality, while the primary 
self can then escape awareness of the pain. It has been sug-
gested that the number of an individual’s alternate per-
sonalities may be related to the number of different types 
of abuse he or she suffered as a child.  Individuals with 
many personalities have usually been severely abused well 
into adolescence.
●  SYMPTOMATOLOGY (SUBJECTIVE 
AND OBJECTIVE DATA)
 1. Impairment in recall. 
 a. Inability to remember speciﬁ c incidents.
 b. Inability to recall any of one’s past life, including one’s 
identity.
 2. Sudden travel away from familiar surroundings; assumption 
of new identity, with inability to recall past.
 3. Assumption of additional identities within the personality; 
behavior involves transition from one identity to another as a 
method of dealing with stressful situations.
 4. Feeling of unreality; detachment from a stressful situation—
may be accompanied by dizziness, depression, obsessive ru-
mination, somatic concerns, anxiety, fear of going insane, and 
a disturbance in the subjective sense of time (APA, 2000).
Common Nursing Diagnoses and Interventions
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.) 
●
 INEFFECTIVE COPING
Deﬁ nition: Inability to form a valid appraisal of the stressors, in-
adequate choices of practiced responses, and/or inability to use 
available resources 
Possible Etiologies (“related to”)
[Severe level of anxiety, repressed]
[Childhood trauma]
[Childhood abuse]
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[Low self-esteem]
[Unmet dependency needs]
[Regression to, or ﬁ xation in, an earlier level of development]
[Inadequate coping skills] 
Deﬁ ning Characteristics (“evidenced by”)
[Dissociating self from painful situation by experiencing:
Memory loss (partial or complete)
Sudden travel away from home with inability to recall 
previous identity
The presence of more than one personality within the 
individual
Detachment from reality]
Inadequate problem-solving
Inability to meet role expectations
[Inappropriate use of defense mechanisms] 
Goals/Objectives
Short-term Goal
 1. Client will verbalize understanding that he or she is employ-
ing dissociative behaviors in times of psychosocial stress.
 2. Client will verbalize more adaptive ways of coping in stress-
ful situations than resorting to dissociation.
Long-term Goal
Client will demonstrate ability to cope with stress (employing 
means other than dissociation).
Interventions with Selected Rationales
 1. Reassure client of safety and security by your presence. 
Dissociative behaviors may be frightening to the client. 
Presence of a trusted individual provides feeling of security 
and assurance of freedom from harm.
 2. Identify stressor that precipitated severe anxiety. This infor-
mation is necessary to the development of an effective plan 
of client care and problem resolution.
 3. Explore feelings that client experienced in response to the 
stressor. Help client understand that the disequilibrium 
felt is acceptable—indeed, even expected—in times of se-
vere stress. Client’s self-esteem is preserved by the knowl-
edge that others may experience these behaviors in similar 
circumstances.
 4. As anxiety level decreases (and memory returns), use explo-
ration and an accepting, nonthreatening environment to 
encourage client to identify repressed traumatic experiences 
that contribute to chronic anxiety.
 5. Have client identify methods of coping with stress in the 
past and determine whether the response was adaptive or 
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maladaptive.  In times of extreme anxiety, client is unable 
to evaluate appropriateness of response. This information 
is necessary for client to develop a plan of action for the 
future.
 6. Help client deﬁ ne more adaptive coping strategies. Make 
suggestions of alternatives that might be tried. Examine 
beneﬁ ts and consequences of each alternative. Assist cli-
ent in the selection of those that are most appropriate for 
him or her. Depending on current level of anxiety, client 
may require assistance with problem-solving and decision-
making.
 7. Provide positive reinforcement for client’s attempts to change. 
Positive reinforcement enhances self-esteem and encourages 
repetition of desired behaviors.
 8. Identify community resources to which the individual may 
go for support if past maladaptive coping patterns return.
Outcome Criteria
 1. Client is able to demonstrate techniques that may be used in 
response to stress to prevent dissociation.
 2. Client verbalizes an understanding of the relationship 
between severe anxiety and the dissociative response.
●
 DISTURBED THOUGHT PROCESSES
Deﬁ nition: Disruption in cognitive operations and activities 
Possible Etiologies (“related to”)
[Severe level of anxiety, repressed]
[Childhood trauma]
[Childhood abuse]
[Threat to physical integrity]
[Threat to self-concept] 
Deﬁ ning Characteristics (“evidenced by”)
[Memory loss—inability to recall selected events related to a 
stressful situation]
[Memory loss—inability to recall events associated with entire 
life]
[Memory loss—inability to recall own identity] 
Goals/Objectives
Short-term Goal
Client will verbalize understanding that loss of memory is related 
to stressful situation and begin discussing stressful situation with 
nurse or therapist.
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Long-term Goal
Client will recover deﬁ cits in memory and develop more adap-
tive coping mechanisms to deal with stressful situations.
Interventions with Selected Rationales
 1. Obtain as much information as possible about client from 
family and signiﬁ cant others (likes, dislikes, important peo-
ple, activities, music, pets).  A baseline assessment is impor-
tant for the development of an effective plan of care.
 2. Do not ﬂ ood client with data regarding his or her past life. 
Individuals who are exposed to painful information from 
which the amnesia is providing protection may decompen-
sate even further into a psychotic state.
 3. Instead, expose client to stimuli that represent pleasant expe-
riences from the past, such as smells associated with enjoyable 
activities, beloved pets, and music known to have been plea-
surable to client. 
 4. As memory begins to return, engage client in activities that 
may provide additional stimulation. Recall may occur during 
activities that simulate life experiences.
 5. Encourage client to discuss situations that have been espe-
cially stressful and to explore the feelings associated with 
those times.  Verbalization of feelings in a nonthreatening 
environment may help client come to terms with unre-
solved issues that may be contributing to the dissociative 
process.
 6. Identify speciﬁ c conﬂ icts that remain unresolved, and assist 
client to identify possible solutions.  Unless these underlying 
confl icts are resolved, any improvement in coping behaviors 
must be viewed as only temporary.
 7. Provide instruction regarding more adaptive ways to re-
spond to anxiety so that dissociative behaviors are no longer 
needed.
Outcome Criteria
 1. Client is able to recall all events of past life.
 2. Client is able to demonstrate adaptive coping strategies that 
may be used in response to severe anxiety to avert amnestic 
behaviors.
●
 DISTURBED PERSONAL IDENTITY 
Deﬁ nition: Inability to maintain an integrated and complete 
perception of self 
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Possible Etiologies (“related to”)
[Severe level of anxiety, repressed]
[Childhood trauma]
[Childhood abuse]
[Threat to physical integrity]
[Threat to self-concept] 
Deﬁ ning Characteristics (“evidenced by”)
[Presence of more than one personality within the individual] 
Goals/Objectives
Short-term Goal
Client will verbalize understanding of the existence of 
multiple personalities within the self and be able to recog-
nize stressful situations that precipitate transition from one to 
another.
Long-term Goal
Client will verbalize understanding of the need for, enter into, 
and cooperate with long-term therapy for this disorder, with 
the ultimate goal being integration into one personality.
Interventions with Selected Rationales
 1. The nurse must develop a trusting relationship with the 
original personality and with each of the subpersonalities.
Trust is the basis of a therapeutic relationship. Each of the 
personalities views itself as a separate entity and must ini-
tially be treated as such.
 2. Help the client understand the existence of the subpersonali-
ties. Client may be unaware of this dissociative response to 
stressful situations.
 3. Help client identify the need each subpersonality serves in 
the personal identity of the individual.  Knowledge of these 
unfulfi lled needs is the fi rst step toward integration of the 
personalities and the client’s ability to face unresolved issues 
without dissociation.
 4. Help the client identify stressful situations that precipitate 
the transition from one personality to another. Carefully 
observe and record these transitions. This knowledge is 
required to assist the client in responding more adap-
tively and to eliminate the need for transition to another 
personality.
 5. Use nursing interventions necessary to deal with maladaptive 
behaviors associated with individual subpersonalities. For ex-
ample, if one personality is suicidal, precautions must be taken 
to guard against client’s self-harm. If another personality has a 
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tendency toward physical hostility, precautions must be taken 
for the protection of others. Safety of the client and others is a 
nursing priority.
CLINICAL PEARL  It may be possible to seek assistance from one 
of the personalities.  For example, a strong-willed personality may 
help to control the behaviors of a “suicidal” personality.
 6. Help subpersonalities to understand that their “being” will 
not be destroyed, but integrated into a uniﬁ ed identity within 
the individual.  Because subpersonalities function as sepa-
rate entities, the idea of total elimination generates fear and 
defensiveness.
 7. Provide support during disclosure of painful experiences 
and reassurance when the client becomes discouraged with 
lengthy treatment.
Outcome Criteria
 1. Client recognizes the existence of more than one personality.
 2. Client is able to verbalize the purpose these personalities serve.
 3. Client verbalizes the intention of seeking long-term outpatient 
psychotherapy.
●
 DISTURBED SENSORY PERCEPTION 
(KINESTHETIC)
Deﬁ nition: Change in the amount or patterning of incoming stimuli 
[either internally or externally initiated] accompanied by a dimin-
ished, exaggerated, distorted, or impaired response to such stimuli. 
Possible Etiologies (“related to”)
[Severe level of anxiety, repressed]
[Childhood trauma]
[Childhood abuse]
[Threat to physical integrity]
[Threat to self-concept] 
Deﬁ ning Characteristics (“evidenced by”)
[Alteration in the perception or experience of the self]
[Loss of one’s own sense of reality]
[Loss of the sense of reality of the external world] 
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Goals/Objectives
Short-term Goal
Client will verbalize adaptive ways of coping with stress.
Long-term Goal
By time of discharge from treatment, client will demonstrate 
the ability to perceive stimuli correctly and maintain a sense of 
reality during stressful situations.
Interventions with Selected Rationales
 1. Provide support and encouragement during times of deper-
sonalization. The client manifesting these symptoms may 
express fear and anxiety at experiencing such behaviors. 
They do not understand the response and may express a 
fear of “going insane.” Support and encouragement from a 
trusted individual provide a feeling of security when fears 
and anxieties are manifested.
 2. Explain the depersonalization behaviors and the pur-
pose they usually serve for the client. This knowledge may 
help to minimize fears and anxieties associated with their 
occurrence.
 3. Explain the relationship between severe anxiety and deper-
sonalization behaviors. The client may be unaware that the 
occurrence of depersonalization behaviors is related to severe 
anxiety.
 4. Help client relate these behaviors to times of severe psy-
chological stress that he or she has experienced personally. 
Knowledge of this relationship is the fi rst step in the process 
of behavioral change.
 5. Explore past experiences and possibly repressed painful 
situations such as trauma or abuse. It is thought that trau-
matic experiences predispose individuals to dissociative 
disorders.
 6. Discuss these painful experiences with the client and en-
courage him or her to deal with the feelings associated 
with these situations. Work to resolve the conﬂ icts these 
repressed feelings have nurtured. These interventions 
serve to decrease the need for the dissociative response to 
anxiety.
 7. Discuss ways the client may more adaptively respond to stress 
and role-play with him or her to practice using these new 
methods. Having practiced through role-play helps to pre-
pare client to face stressful situations by using these new 
behaviors when they occur in real life.
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Outcome Criteria
 1. Client perceives stressful situations correctly and is able to 
maintain a sense of reality.
 2. Client demonstrates use of adaptive strategies for coping 
with stress.
 INTERNET REFERENCES
 • Additional information about Dissociative Disorders may be 
located at the following websites:
 a. http://www.human-nature.com/odmh/dissociative.html
 b. ht t p: //w w w.nam i.org/Content /ContentGroups/
Helpline1/Dissociative_Disorders.htm
 c. http://www.mental-health-matters.com/disorders
 d. http://www.issd.org/
 e. http://www.sidran.org/didbr.html
 f. http://emedicine.medscape.com/article/294508-overview
 g. http://ﬁ ndarticles.com/p/articles/mi_g2601/is_0004/ai_
2601000438
Movie Connections
Dead Again (amnesia) • Mirage (amnesia) • Suddenly Last 
Summer (amnesia) • The Three Lives of Karen (fugue) • Sybil (DID) 
• The Three Faces of Eve (DID) • Identity (DID)
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Sexual and Gender 
Identity Disorders
● BACKGROUND ASSESSMENT DATA
The American Psychiatric Association (APA, 2000) Diagnos-
tic and Statistical Manual of Mental Disorders, Fourth Edition, 
Text Revision (DSM-IV-TR) identiﬁ es two categories of sexual 
disorders: paraphilias and sexual dysfunctions. Paraphilias are 
characterized by recurrent, intense sexual urges, fantasies, or 
behaviors that involve unusual objects, activities, or situations 
(APA, 2000). Sexual dysfunction disorders can be described as an 
impairment or disturbance in any of the phases of the sexual 
response cycle. These include disorders of desire, arousal, and 
orgasm and disorders that relate to the experience of genital 
pain during intercourse. Gender identity disorders are char-
acterized by strong and persistent cross-gender identiﬁ cation 
accompanied by persistent discomfort with one’s assigned sex 
(APA, 2000).
Paraphilias
The term “paraphilia” is used to identify repetitive or preferred 
sexual fantasies or behaviors that involve any of the following:
 1. The preference for use of a nonhuman object.
 2. Repetitive sexual activity with humans involving real or sim-
ulated suffering or humiliation.
 3. Repetitive sexual activity with nonconsenting partners.
Types of paraphilias include the following:
 1. Exhibitionism. The major symptoms include recurrent, in-
tense sexual urges, behaviors, or sexually arousing fantasies, 
of at least 6 months’ duration, involving the exposure of one’s 
genitals to an unsuspecting stranger (APA, 2000). Masturba-
tion may occur during the exhibitionism. Most individuals 
with paraphilias are men, and the behavior is generally estab-
lished in adolescence (Andreasen & Black, 2006).
 2. Fetishism. Fetishism involves recurrent, intense sexual 
urges or behaviors, or sexually arousing fantasies, of at least 
201
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6 months’ duration, involving the use of nonliving objects 
(APA, 2000). Common fetish objects include bras, women’s 
underpants, stockings, shoes, boots, or other wearing apparel. 
The fetish object is generally used during masturbation or in-
corporated into sexual activity with another person to pro-
duce sexual excitation. When the fetish involves cross-dressing, 
the disorder is called transvestic fetishism.
 3. Frotteurism. This disorder is deﬁ ned as the recurrent pre-
occupation with intense sexual urges or fantasies, of at least 
6 months’ duration, involving touching or rubbing against 
a nonconsenting person (APA, 2000). Sexual excitement is 
derived from the actual touching or rubbing, not from the 
coercive nature of the act.
 4. Pedophilia. The DSM-IV-TR describes the essential feature 
of pedophilia as recurrent sexual urges, behaviors, or sexually 
arousing fantasies, of at least 6 months’ duration, involving 
sexual activity with a prepubescent child. The age of the mo-
lester is 16 or older and is at least 5 years older than the child. 
This category of paraphilia is the most common of sexual 
assaults.
 5. Sexual Masochism. The identifying feature of this disor-
der is recurrent, intense sexual urges, behaviors, or sexually 
arousing fantasies, of at least 6 months’ duration, involving 
the act of being humiliated, beaten, bound, or otherwise 
made to suffer (APA, 2000). These masochistic activities may 
be fantasized, solitary, or with a partner. Examples include 
becoming sexually aroused by self-inﬂ icted pain or by being 
restrained, raped, or beaten by a sexual partner.
 6. Sexual Sadism. The essential feature of sexual sadism is 
identiﬁ ed as recurrent, intense, sexual urges, behaviors, or 
sexually arousing fantasies, of at least 6 months’ duration, 
involving acts in which the psychological or physical suffer-
ing (including humiliation) of the victim is sexually exciting 
(APA, 2000). The sadistic activities may be fantasized or 
acted on with a consenting or nonconsenting partner. In all 
instances, sexual excitation occurs in response to the suffer-
ing of the victim. Examples include rape, beating, torture, or 
even killing.
 7. Voyeurism. This disorder is identiﬁ ed by recurrent, intense 
sexual urges, behaviors, or sexually arousing fantasies, 
of at least 6 months’ duration, involving the act of observ-
ing an unsuspecting person who is naked, in the process 
of disrobing, or engaging in sexual activity (APA, 2000). 
Sexual excitement is achieved through the act of looking, 
and no contact with the person is attempted. Masturba-
tion usually accompanies the “window peeping” but may 
2506_Ch11_201-217.indd   0202 10/1/10   9:35:43 AM
Sexual and Gender Identity Disorders ● 203
occur later as the individual fantasizes about the voyeuris-
tic act. 
Predisposing Factors to Paraphilias
 1. Physiological
 a. Biological Factors: Various studies have implicated sev-
eral organic factors in the etiology of paraphilias. De-
struction of parts of the limbic system in animals has 
been shown to cause hypersexual behavior (Becker & 
Johnson, 2008). Temporal lobe diseases, such as psy-
chomotor seizures or temporal lobe tumors, have been 
implicated in some individuals with paraphilias. Abnor-
mal levels of androgens also may contribute to inappro-
priate sexual arousal. The majority of studies involved 
violent sex offenders, and the results cannot accurately 
be generalized. 
 2. Psychosocial
 a. Psychoanalytical Theory: The psychoanalytic approach 
deﬁ nes a paraphiliac as one who has failed the normal 
developmental process toward heterosexual adjustment 
(Sadock & Sadock, 2007). This occurs when the indi-
vidual fails to resolve the Oedipal crisis and identiﬁ es 
with the parent of the opposite gender. This creates in-
tense anxiety, which leads the individual to seek sexual 
gratiﬁ cation in ways that provide a “safe substitution” for 
the parent (Becker & Johnson, 2008).
Symptomatology (Subjective and Objective Data)
 1. Exposure of one’s genitals to a stranger.
 2. Sexual arousal in the presence of nonliving objects.
 3. Touching and rubbing one’s genitals against an unconsent-
ing person.
 4. Sexual attraction to, or activity with, a prepubescent 
child.
 5. Sexual arousal from being humiliated, beaten, bound, or 
otherwise made to suffer (through fantasy, self-inﬂ iction, or 
by a sexual partner).
 6. Sexual arousal by inﬂ icting psychological or physical 
suffering on another individual (either consenting or 
nonconsenting).
 7. Sexual arousal from dressing in the clothes of the opposite 
gender.
 8. Sexual arousal from observing unsuspecting people either 
naked or engaged in sexual activity.
 9. Masturbation often accompanies the activities described 
when they are performed solitarily.
 10. The individual is markedly distressed by these activities.
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Sexual Dysfunctions
Sexual dysfunctions may occur in any phase of the sexual response 
cycle. Types of sexual dysfunctions include the following:
 1. Sexual Desire Disorders
 a. Hypoactive Sexual Desire Disorder: This disorder is 
deﬁ ned by the DSM-IV-TR (APA, 2000) as a persistent 
or recurrent deﬁ ciency or absence of sexual fantasies and 
desire for sexual activity. The complaint appears to be 
more common among women than men.
 b. Sexual Aversion Disorder: This disorder is character-
ized by a persistent or recurrent extreme aversion to, and 
avoidance of, all (or almost all) genital sexual contact with 
a sexual partner (APA, 2000).
 2. Sexual Arousal Disorders
 a. Female Sexual Arousal Disorder: This disorder is iden-
tiﬁ ed in the DSM-IV-TR (APA, 2000) as a persistent or 
recurrent inability to attain, or to maintain until com-
pletion of the sexual activity, an adequate lubrication or 
swelling response of sexual excitement.
 b. Male Erectile Disorder: This disorder is characterized by 
a persistent or recurrent inability to attain, or to maintain 
until completion of the sexual activity, an adequate erec-
tion (APA, 2000).
 3. Orgasmic Disorders
 a. Female Orgasmic Disorder (Anorgasmia): This disorder 
is deﬁ ned by the DSM-IV-TR as a persistent or recurrent 
delay in, or absence of, orgasm following a normal sexual 
excitement phase.
 b. Male Orgasmic Disorder (Retarded Ejaculation): With 
this disorder, the man is unable to ejaculate, even though 
he has a ﬁ rm erection and has had more than adequate 
stimulation. The severity of the problem may range 
from only occasional problems ejaculating to a history 
of never having experienced an orgasm.
 c. Premature Ejaculation: The DSM-IV-TR describes this 
disorder as persistent or recurrent ejaculation with mini-
mal sexual stimulation before, on, or shortly after pen-
etration and before the person wishes it.
 4. Sexual Pain Disorders
 a. Dyspareunia: Dyspareunia is deﬁ ned as recurrent or per-
sistent genital pain associated with sexual intercourse, in 
either a man or a woman, that is not caused by vaginismus, 
lack of lubrication, another general medical condition, or 
the physiological effects of substance use (APA, 2000).
 b. Vaginismus: Vaginismus is characterized by an involun-
tary constriction of the outer third of the vagina, which 
prevents penile insertion and intercourse.
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Predisposing Factors to Sexual Dysfunctions
 1. Physiological Factors
 a. Sexual Desire Disorders: In men, these disorders have 
been linked to low levels of serum testosterone and to 
elevated levels of serum prolactin. Evidence also exists 
that suggests a relationship between serum testosterone 
and increased female libido. Various medications, such as 
antihypertensives, antipsychotics, antidepressants, anxio-
lytics, and anticonvulsants, as well as chronic use of drugs 
such as alcohol and cocaine, have also been implicated in 
sexual desire disorders.
 b. Sexual Arousal Disorders: These may occur in response 
to decreased estrogen levels in postmenopausal women. 
Medications such as antihistamines and cholinergic 
blockers may produce similar results. Erectile dysfunc-
tions in men may be attributed to arteriosclerosis, dia-
betes, temporal lobe epilepsy, multiple sclerosis, some 
medications (antihypertensives, antidepressants, tran-
quilizers), spinal cord injury, pelvic surgery, and chronic 
use of alcohol.
 c. Orgasmic Disorders: In women these may be attributed 
to some medical conditions (hypothyroidism, diabetes, 
and depression) and certain medications (antihyperten-
sives, antidepressants). Medical conditions that may in-
terfere with male orgasm include genitourinary surgery 
(e.g., prostatectomy), Parkinson’s disease, and diabetes. 
Various medications have also been implicated, including 
antihypertensives, antidepressants, and antipsychotics. 
Transient cases of the disorder may occur with excessive 
alcohol intake.
 d. Sexual Pain Disorders: In women these can be caused 
by disorders of the vaginal entrance, irritation or damage 
to the clitoris, vaginal or pelvic infections, endometrio-
sis, tumors, or cysts. Painful intercourse in men may be 
attributed to penile infections, phimosis, urinary tract 
infections, or prostate problems.
 2. Psychosocial Factors
 a. Sexual Desire Disorders: Phillips (2000) has identiﬁ ed 
a number of individual and relationship factors that may 
contribute to hypoactive sexual desire disorder. Individual 
causes include religious orthodoxy; sexual identity con-
ﬂ icts; past sexual abuse; ﬁ nancial, family, or job problems; 
depression; and aging-related concerns (e.g., changes in 
physical appearance). Among the relationship causes are 
interpersonal conﬂ icts; current physical, verbal, or sexual 
abuse; extramarital affairs; and desire or practices differ-
ent from partner.
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 b. Sexual Arousal Disorders: In the female these may be 
attributed to doubts, fears, guilt, anxiety, shame, con-
ﬂ ict, embarrassment, tension, disgust, resentment, grief, 
anger toward the partner, and puritanical or moralistic 
upbringing. A history of sexual abuse may also be an im-
portant etiologic factor (Leiblum, 1999). The etiology of 
male erectile disorder may be related to chronic stress, 
anxiety, or depression. Early developmental factors that 
promote feelings of inadequacy and a sense of being un-
loving or unlovable may also result in impotence. Dif-
ﬁ culties in the relationship may also be a contributing 
factor.
 c. Orgasmic Disorders: A number of factors have been im-
plicated in the etiology of female orgasm disorders. They 
include fear of becoming pregnant, hostility toward men, 
negative cultural conditioning, childhood exposure to 
rigid religious orthodoxy, and traumatic sexual experi-
ences during childhood or adolescence. Orgasm disorders 
in men may be related to a rigid, puritanical background 
where sex was perceived as sinful and the genitals as dirty; 
or interpersonal difﬁ culties, such as ambivalence about 
commitment, fear of pregnancy, or unexpressed hostility, 
may be implicated.
 d. Sexual Pain Disorders: Vaginismus may occur after hav-
ing experienced painful intercourse for any organic rea-
son, after which involuntary constriction of the vagina 
occurs in anticipation and fear of recurring pain. Other 
psychosocial factors that have been implicated in the 
etiology of vaginismus include negative childhood con-
ditioning of sex as dirty, sinful, and shameful; early child-
hood sexual trauma; homosexual orientation; traumatic 
experience with an early pelvic examination; pregnancy 
phobia; sexually transmitted disease phobia; or cancer
phobia (Phillips, 2000; King, 2005; Leiblum, 1999; Sadock 
& Sadock, 2007).
Symptomatology (Subjective and Objective Data)
 1. Absence of sexual fantasies and desire for sexual activity.
 2. Discrepancy between partners’ levels of desire for sexual 
activity.
 3. Feelings of disgust, anxiety, or panic responses to genital 
contact.
 4. Inability to produce adequate lubrication for sexual 
activity.
 5. Absence of a subjective sense of sexual excitement during 
sexual activity.
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 6. Failure to attain or maintain penile erection until comple-
tion of sexual activity.
 7. Inability to achieve orgasm (in men, to ejaculate) following a 
period of sexual excitement judged adequate in intensity and 
duration to produce such a response.
 8. Ejaculation occurs with minimal sexual stimulation or 
before, on, or shortly after penetration and before the indi-
vidual wishes it.
 9. Genital pain occurring before, during, or after sexual 
intercourse.
 10. Constriction of the outer third of the vagina prevents penile 
penetration.
Common Nursing Diagnoses and Interventions 
for Paraphilias and Sexual Dysfunctions
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.)
●
 SEXUAL DYSFUNCTION
Deﬁ nition: The state in which an individual experiences a change 
in sexual function during the sexual response phases of desire, 
excitation, and/or orgasm, which is viewed as unsatisfying, unre-
warding, or inadequate.
Possible Etiologies (“related to”)
Ineffectual or absent role models
Physical [or sexual] abuse
Psychosocial abuse
Values conﬂ ict
Lack of privacy
Lack of signiﬁ cant other
Altered body structure or function (pregnancy, recent childbirth, 
drugs, surgery, anomalies, disease process, trauma, radiation)
Misinformation or deﬁ cient knowledge
[Depression]
[Pregnancy phobia]
[Sexually transmitted disease phobia]
[Cancer phobia]
[Previous painful experience]
[Severe anxiety]
[Relationship difﬁ culties] 
2506_Ch11_201-217.indd   0207 10/1/10   9:35:45 AM
208 ● ALTERATIONS IN PSYCHOSOCIAL ADAPTATION
Deﬁ ning Characteristics (“evidenced by”)
Verbalization of problem:
 • [Absence of desire for sexual activity
 • Feelings of disgust, anxiety, or panic responses to genital 
contact
 • Absence of lubrication or subjective sense of sexual excite-
ment during sexual activity
 • Failure to attain or maintain penile erection during sexual 
activity
 • Inability to achieve orgasm or ejaculation
 • Premature ejaculation
 • Genital pain during intercourse
 • Constriction of the vagina that prevents penile penetration]
Inability to achieve desired satisfaction
Goals/Objectives
Short-term Goals
 1. Client will identify stressors that may contribute to loss of 
sexual function within 1 week or
 2. Client will discuss pathophysiology of disease process that 
contributes to sexual dysfunction within 1 week.
For client with permanent dysfunction due to disease process:
 3. Client will verbalize willingness to seek professional assis-
tance from a sex therapist in order to learn alternative ways 
of achieving sexual satisfaction with partner by (time is indi-
vidually determined).
Long-term Goal
Client will resume sexual activity at level satisfactory to self and 
partner by (time is individually determined).
Interventions with Selected Rationales
 1. Assess client’s sexual history and previous level of satisfac-
tion in sexual relationship. This establishes a database from 
which to work and provides a foundation for goal setting.
 2. Assess client’s perception of the problem. Client’s idea of 
what constitutes a problem may differ from the nurse’s. It 
is the client’s perception on which the goals of care must be 
established.
 3. Help client determine time dimension associated with the 
onset of the problem and discuss what was happening in his 
or her life situation at that time. Stress in any areas of life 
can affect sexual functioning. Client may be unaware of 
correlation between stress and sexual dysfunction.
 4. Assess client’s mood and level of energy. Depression and 
fatigue decrease desire and enthusiasm for participation in 
sexual activity.
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 5. Review medication regimen; observe for side effects. Many 
medications can affect sexual functioning. Evaluation of 
drug and individual response is important to ascertain 
whether drug may be contributing to the problem.
 6. Encourage client to discuss disease process that may be con-
tributing to sexual dysfunction. Ensure that client is aware 
that alternative methods of achieving sexual satisfaction exist 
and can be learned through sex counseling if he or she and 
partner desire to do so. Client may be unaware that satis-
factory changes can be made in his or her sex life. He or she 
may also be unaware of the availability of sex counseling.
 7. Encourage client to ask questions regarding sexuality and 
sexual functioning that may be troubling him or her. In-
creasing knowledge and correcting misconceptions can 
decrease feelings of powerlessness and anxiety and facilitate 
problem resolution.
 8. Make referral to sex therapist, if necessary. Client may even 
request that an initial appointment be made for him or her. 
Complex problems are likely to require assistance from an in-
dividual who is specially trained to treat problems related to 
sexuality. Client and partner may be somewhat embarrassed 
to seek this kind of assistance. Support from a trusted nurse 
can provide the impetus for them to pursue the help they need.
Outcome Criteria
 1. Client is able to correlate physical or psychosocial factors 
that interfere with sexual functioning.
 2. Client is able to communicate with partner about their sexual 
relationship without discomfort.
 3. Client and partner verbalize willingness and desire to seek 
assistance from professional sex therapist or
 4. Client verbalizes resumption of sexual activity at level satis-
factory to self and partner.
●
 INEFFECTIVE SEXUALITY PATTERN
Deﬁ nition:  Expressions of concern regarding own sexuality.
Possible Etiologies (“related to”)
Lack of signiﬁ cant other
Ineffective or absent role models
[Illness-related alterations in usual sexuality patterns]
Conﬂ icts with sexual orientation or variant preferences
[Unresolved Oedipal conﬂ ict]
[Delayed sexual adjustment]
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Deﬁ ning Characteristics (“evidenced by”)
Reported difﬁ culties, limitations, or changes in sexual behaviors 
or activities
[Expressed dissatisfaction with sexual behaviors]
[Reports that sexual arousal can only be achieved through 
variant practices, such as pedophilia, fetishism, masochism, 
sadism, frotteurism, exhibitionism, voyeurism]
[Desires to experience satisfying sexual relationship with an-
other individual without need for arousal through variant 
practices]
Goals/Objectives
(Time elements to be determined by individual situation.)
Short-term Goals
 1. Client will verbalize aspects about sexuality that he or she 
would like to change.
 2. Client and partner will communicate with each other 
ways in which each believes their sexual relationship could 
be improved.
Long-term Goals
 1. Client will express satisfaction with own sexuality pattern.
 2. Client and partner will express satisfaction with sexual 
relationship.
Interventions with Selected Rationales
 1. Take sexual history, noting client’s expression of areas of dis-
satisfaction with sexual pattern. Knowledge of what client 
perceives as the problem is essential for providing the type of 
assistance he or she may need.
 2. Assess areas of stress in client’s life and examine relationship 
with sexual partner. Variant sexual behaviors are often as-
sociated with added stress in the client’s life. Relationship 
with partner may deteriorate as individual eventually gains 
sexual satisfaction only from variant practices.
 3. Note cultural, social, ethnic, racial, and religious factors that 
may contribute to conﬂ icts regarding variant sexual prac-
tices. Client may be unaware of the infl uence these factors 
exert in creating feelings of discomfort, shame, and guilt 
regarding sexual attitudes and behavior.
 4. Be accepting and nonjudgmental. Sexuality is a very per-
sonal and sensitive subject. The client is more likely to share 
this information if he or she does not fear being judged by 
the nurse.
 5. Assist therapist in plan of behavior modiﬁ cation to help cli-
ent who desires to decrease variant sexual behaviors. Indi-
viduals with paraphilias are treated by specialists who have 
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experience in modifying variant sexual behaviors. Nurses 
can intervene by providing assistance with implementation 
of the plan for behavior modifi cation.
 6. If altered sexuality patterns are related to illness or medi-
cal treatment, provide information to client and partner re-
garding the correlation between the illness and the sexual 
alteration. Explain possible modiﬁ cations in usual sexual 
patterns that client and partner may try in an effort to 
achieve a satisfying sexual experience in spite of the limi-
tation. Client and partner may be unaware of alternate 
possibilities for achieving sexual satisfaction, or anxiety 
associated with the limitation may interfere with rational 
problem solving.
 7. Explain to client that sexuality is a normal human response 
and does not relate exclusively to the sex organs or sexual be-
havior. Sexuality involves complex interrelationships among 
one’s self-concept, body image, personal history, and family 
and cultural inﬂ uences; and all interactions with others. If client 
feels “abnormal” or very unlike everyone else, the self-concept 
is likely to be very low—he or she may even feel worthless. To 
increase the client’s feelings of self-worth and desire to change 
behavior, help him or her to see that even though the behavior 
is variant, feelings and motivations are common.
Outcome Criteria
 1. Client is able to verbalize fears about abnormality and inap-
propriateness of sexual behaviors.
 2. Client expresses desire to change variant sexual behavior and 
cooperates with plan of behavior modiﬁ cation.
 3. Client and partner verbalize modiﬁ cations in sexual activi-
ties in response to limitations imposed by illness or medical 
treatment.
 4. Client expresses satisfaction with own sexuality pattern or a 
satisfying sexual relationship with another.
Gender Identity Disorders
Gender identity is the sense of knowing to which gender one 
belongs—that is, the awareness of one’s masculinity or femininity. 
Gender identity disorders occur when there is incongruity be-
tween anatomic sex and gender identity. An individual with gen-
der identity disorder has an intense desire to be, or insists that he 
or she is of, the other gender. The DSM-IV-TR (APA, 2000) iden-
tiﬁ es two categories of the disorder: gender identity disorder in 
children and gender identity disorder in adolescents and adults.
Intervention with adolescents and adults with gender identity 
disorder is difﬁ cult. Adolescents commonly act out and rarely 
have the motivation required to alter their cross-gender roles. 
2506_Ch11_201-217.indd   0211 10/1/10   9:35:46 AM
212 ● ALTERATIONS IN PSYCHOSOCIAL ADAPTATION
Adults generally seek therapy to learn how to cope with their 
altered sexual identity, not to correct it.
Treatment of children with the disorder is aimed at helping 
them to become more comfortable with their assigned gender 
and to avoid the possible development of gender dissatisfaction 
in adulthood.
Predisposing Factors to Gender Identity Disorder
 1. Physiological
 a. Studies of genetics and physiological alterations have 
been conducted in an attempt to determine whether or 
not a biological predisposition to gender identity disorder 
exists. To date, no clear evidence has been demonstrated. 
 2. Psychosocial
 a. Family Dynamics: It appears that family dynamics plays 
the most inﬂ uential role in the etiology of gender disor-
ders. Sadock and Sadock (2007) state, “Children develop 
a gender identity consonant with their sex of rearing (also 
known as assigned sex).” Gender roles are culturally de-
termined, and parents encourage masculine or feminine 
behaviors in their children. Although “temperament” may 
play a role with certain behavioral characteristics being 
present at birth, mothers usually foster a child’s pride in 
their gender. Sadock and Sadock (2007) state:
   The father’s role is also important in the early years, 
and his presence normally helps the separation-
individuation process. Without a father, mother and 
child may remain overly close. For a girl, the father 
is normally the prototype of future love objects; for 
a boy, the father is a model for male identiﬁ cation” 
(p. 719).
 b. Psychoanalytical Theory. This theory suggests that gen-
der identity problems begin during the struggle of the 
Oedipal/Electra conﬂ ict. Problems may reﬂ ect both real 
family events and those created in the child’s imagination. 
These conﬂ icts, whether real or imagined, interfere with 
the child’s loving of the opposite-gender parent and iden-
tifying with the same-gender parent, and ultimately with 
normal gender identity.
Symptomatology (Subjective and Objective Data)
In children or adolescents:
 1. Repeatedly stating intense desire to be of the opposite gender.
 2. Insistence that one is of the opposite gender.
 3. Preference in males for cross-dressing or simulating female 
attire.
 4. Insistence by females on wearing only stereotypical mascu-
line clothing.
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 5. Fantasies of being of the opposite gender.
 6. Strong desire to participate only in the stereotypical games 
and pastimes of the opposite gender.
 7. Strong preference for playmates (peers) of the opposite gender.
In adults: 
 1. A stated desire to be of the opposite gender.
 2. Frequently passing as the opposite gender.
 3. Desire to live or be treated as the opposite gender.
 4. Stated conviction that one has the typical feelings and reac-
tions of the opposite gender.
 5. Persistent discomfort with or sense of inappropriateness in 
the assigned gender role.
 6. Request for opposite gender hormones or surgery to alter 
sexual characteristics.
Common Nursing Diagnoses and Interventions 
for Gender Identity Disorder
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.)
NOTE: Because adults and adolescents rarely have the desire or 
motivation to modify their gender identity, nursing interventions 
in this section are focused on working with gender-disordered 
children. Becker and Johnson (2008) state, “It is important to note 
that not all children with gender identity disorder become adults 
with gender identity disorder.” (p. 733).
● DISTURBED PERSONAL IDENTITY 
Deﬁ nition: Inability to maintain an integrated and complete per-
ception of self.
Possible Etiologies (“related to”)
[Parenting patterns that encourage culturally unacceptable 
behaviors for assigned gender]
[Unresolved Oedipal/Electra conﬂ ict]
Deﬁ ning Characteristics (“evidenced by”)
[Statements of desire to be opposite gender]
[Statements that one is the opposite gender]
[Cross-dressing, or passing as the opposite gender]
[Strong preference for playmates (peers) of the opposite gender]
[Stated desire to be treated as the opposite gender]
[Statements of having feelings and reactions of the opposite 
gender]
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Goals/Objectives
Short-term Goals
 1. Client will verbalize knowledge of behaviors that are appro-
priate and culturally acceptable for assigned gender.
 2. Client will verbalize desire for congruence between personal 
feelings and behavior and assigned gender.
Long-term Goals
 1. Client will demonstrate behaviors that are appropriate and 
culturally acceptable for assigned gender.
 2. Client will express personal satisfaction and feelings of being 
comfortable in assigned gender.
Interventions with Selected Rationales
  1. Spend time with client and show positive regard. Trust and 
unconditional acceptance are essential to the establishment 
of a therapeutic nurse-client relationship.
 2. Be aware of own feelings and attitudes toward this client 
and his or her behavior. Attitudes infl uence behavior. The 
nurse must not allow negative attitudes to interfere with the 
effectiveness of interventions.
 3. Allow client to describe his or her perception of the problem. 
It is important to know how the client perceives the problem 
before attempting to correct misperceptions.
 4. Discuss with the client the types of behaviors that are more 
culturally acceptable. Practice these behaviors through role-
playing or with play therapy strategies (e.g., male and female 
dolls). Positive reinforcement or social attention may be given 
for use of appropriate behaviors. No response is given for ste-
reotypical opposite-gender behaviors. The goal is to enhance 
culturally appropriate same-gender behaviors, but not neces-
sarily to extinguish all coexisting opposite-gender behaviors.
Outcome Criteria
 1. Client demonstrates behaviors that are culturally appropriate 
for assigned gender.
 2. Client verbalizes and demonstrates self-satisfaction with 
assigned gender role.
 3. Client demonstrates development of a close relationship with 
the parent of the same gender. 
●
 IMPAIRED SOCIAL INTERACTION
Deﬁ nition: Insuffi cient or excessive quantity or ineffective qual-
ity of social exchange.
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Possible Etiologies (“related to”)
[Socially and culturally unacceptable behavior]
[Negative role modeling]
[Low self-esteem]
Deﬁ ning Characteristics (“evidenced by”)
Discomfort in social situations
Inability to receive or communicate a satisfying sense of belong-
ing, caring, interest, or shared history
Use of unsuccessful social interaction behaviors
Dysfunctional interaction with others
Goals/Objectives
Short-term Goal
Client will verbalize possible reasons for ineffective interactions 
with others.
Long-term Goal
Client will interact with others using culturally acceptable 
behaviors.
Interventions with Selected Rationales
 1. Once client feels comfortable with the new behaviors in role 
playing or one-to-one nurse-client interactions, the new be-
haviors may be tried in group situations. If possible, remain 
with the client during initial interactions with others. Pres-
ence of a trusted individual provides security for the client 
in a new situation. It also provides the potential for feedback 
to the client about his or her behavior.
 2. Observe client behaviors and the responses he or she 
elicits from others. Give social attention (e.g., smile, nod) 
to desired behaviors. Follow up these “practice” sessions 
with one-to-one processing of the interaction. Give posi-
tive reinforcement for efforts. Positive reinforcement en-
courages repetition of desirable behaviors. One-to-one 
processing provides time for discussing the appropriate-
ness of specifi c behaviors and why they should or should 
not be repeated.
 3. Offer support if client is feeling hurt from peer ridicule. 
Matter-of-factly discuss the behaviors that elicited the rid-
icule. Offer no personal reaction to the behavior. Personal 
reaction from the nurse would be considered judgmental. 
Validation of client’s feelings is important, yet it is also 
important that client understand why his or her behav-
ior was the subject of ridicule and how to avoid it in the 
future.
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Outcome Criteria
 1. Client interacts appropriately with others demonstrating
 culturally acceptable behaviors.
 2. Client verbalizes and demonstrates comfort in assigned 
gender role in interactions with others.
●
 LOW SELF-ESTEEM 
Deﬁ nition: Negative self-evaluating/feelings about self or self-
capabilities.
Possible Etiologies (“related to”)
[Rejection by peers]
Lack of approval and/or affection
Repeated negative reinforcement
[Lack of personal satisfaction with assigned gender]
Deﬁ ning Characteristics (“evidenced by”)
[Inability to form close, personal relationships]
[Negative view of self]
[Expressions of worthlessness]
[Social isolation]
[Hypersensitivity to slight or criticism]
Expressions of shame or guilt
Self-negating verbalizations
Lack of eye contact
Goals/Objectives
Short-term Goal
Client will verbalize positive statements about self, including 
past accomplishments and future prospects.
Long-term Goal
Client will verbalize and demonstrate behaviors that indicate 
self-satisfaction with assigned gender, ability to interact with 
others, and a sense of self as a worthwhile person.
Interventions with Selected Rationales
 1. To enhance the child’s self-esteem:
 a. Encourage the child to engage in activities in which he or 
she is likely to achieve success.
 b. Help the child to focus on aspects of his or her life for 
which positive feelings exist. Discourage rumination 
about situations that are perceived as failures or over 
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which the client has no control. Give positive feedback for 
these behaviors.
 2. Help the client identify behaviors or aspects of life he or she 
would like to change. If realistic, assist the child in problem 
solving ways to bring about the change. Having some control 
over his or her life may decrease feelings of powerlessness 
and increase feelings of self-worth.
 3. Offer to be available for support to the child when he or she is 
feeling rejected by peers. Having an available support per-
son who does not judge the child’s behavior and who provides 
unconditional acceptance assists the child to progress toward 
acceptance of self as a worthwhile person.
Outcome Criteria
 1. Client verbalizes positive perception of self.
 2. Client verbalizes self-satisfaction about accomplishments 
and demonstrates behaviors that reﬂ ect self-worth.
 INTERNET REFERENCES 
• Additional information about sexual disorders may be located 
at the following websites:
 a. http://www.sexualhealth.com/
 b. http://www.cmellc.com/topics/sexual.html
 c. http://www.priory.com/sex.htm
 d. http://web4health.info/en/answers/sex-menu.htm
 e. http://allpsych.com/disorders/sexual/index.html
• Additional information about gender identity disorders may be 
located at the following websites:
 a. http://www.avitale.com/
 b. http://www.leaderu.com/jhs/rekers.html
 c. http://emedicine.medscape.com/article/293890-overview
 d. http://psyweb.com/Mdisord/jsp/sexd.jsp
Movie Connections
Mystic River (pedophilia) • Blue Velvet (sexual masochism) 
• Looking for Mr. Goodbar (sadism/masochism) • Normal (transvestitism) 
• Transamerica (transvestitism)
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Eating Disorders
● BACKGROUND ASSESSMENT DATA
The American Psychiatric Association (APA, 2000) Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition, Text 
Revision (DSM-IV-TR) identiﬁ es eating disorders as those char-
acterized by severe disturbances in eating behavior. Two such 
disorders are described in the DSM-IV-TR: anorexia nervosa 
and bulimia nervosa. Obesity is not classiﬁ ed as a psychiatric 
disorder per se; however, because of the strong emotional fac-
tors associated with it, the DSM-IV-TR suggests that obesity 
may be considered within the category of Psychological Factors 
Affecting Medical Condition. A third category of eating disorder, 
binge eating disorder, is also being considered by the American 
Psychiatric Association.
Anorexia Nervosa
Deﬁ ned
Anorexia nervosa is a clinical syndrome in which the person has a 
morbid fear of obesity. It is characterized by the individual’s gross 
distortion of body image, preoccupation with food, and refusal to 
eat. The disorder occurs predominantly in females 12 to 30 years 
of age. Without intervention, death from starvation can occur.
Symptomatology (Subjective and Objective Data) 
 1. Morbid fear of obesity. Preoccupied with body size. Reports 
“feeling fat” even when in an emaciated condition.
 2. Refusal to eat. Reports “not being hungry,” although it is 
thought that the actual feelings of hunger do not cease until 
late in the disorder.
 3. Preoccupation with food. Thinks and talks about food at 
great length. Prepares enormous amounts of food for friends 
and family members but refuses to eat any of it.
 4. Amenorrhea is common, often appearing even before notice-
able weight loss has occurred.
 5. Delayed psychosexual development.
 6. Compulsive behavior, such as excessive hand washing, may 
be present.
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 7. Extensive exercising is common.
 8. Feelings of depression and anxiety often accompany this 
disorder.
 9. May engage in the binge-and-purge syndrome from time to 
time (see following section on bulimia nervosa).
Bulimia Nervosa
Deﬁ ned
Bulimia nervosa is an eating disorder (commonly called “the 
binge-and-purge syndrome”) characterized by extreme over-
eating, followed by self-induced vomiting and abuse of laxatives 
and diuretics. The disorder occurs predominantly in females 
and begins in adolescence or early adult life.
Symptomatology (Subjective and Objective Data) 
 1. Binges are usually solitary and secret, and the individual may 
consume thousands of calories in one episode.
 2. After the binge has begun, there is often a feeling of loss of 
control or inability to stop eating.
 3. Following the binge, the individual engages in inappropriate 
compensatory measures to avoid gaining weight (e.g., self-
induced vomiting; excessive use of laxatives, diuretics, or en-
emas; fasting; and extreme exercising).
 4. Eating binges may be viewed as pleasurable but are followed 
by intense self-criticism and depressed mood.
 5. Individuals with bulimia are usually within normal weight 
range, some a few pounds underweight, some a few pounds 
overweight.
 6. Obsession with body image and appearance is a predominant 
feature of this disorder. Individuals with bulimia display 
undue concern with sexual attractiveness and how they will 
appear to others.
 7. Binges usually alternate with periods of normal eating and 
fasting.
 8. Excessive vomiting may lead to problems with dehydration 
and electrolyte imbalance. 
 9. Gastric acid in the vomitus may contribute to the erosion of 
tooth enamel.
Predisposing Factors to Anorexia Nervosa 
and Bulimia Nervosa
 1. Physiological Factors
 a. Genetics: A hereditary predisposition to eating disorders 
has been hypothesized on the basis of family histories and 
an apparent association with other disorders for which the 
likelihood of genetic inﬂ uences exist. Anorexia nervosa is 
more common among sisters and mothers of those with 
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the disorder than among the general population. Several 
studies have reported a higher than expected frequency of 
mood disorders among ﬁ rst-degree biological relatives of 
people with anorexia nervosa and bulimia nervosa and 
of substance abuse and dependence in relatives of indi-
viduals with bulimia nervosa (APA, 2000). 
 b. Neuroendocrine Abnormalities: Some speculation has 
occurred regarding a primary hypothalamic dysfunction 
in anorexia nervosa. Studies consistent with this theory 
have revealed elevated cerebrospinal ﬂ uid cortisol levels 
and a possible impairment of dopaminergic regulation in 
individuals with anorexia (Halmi, 2008).
 c.  Neurochemical Infl uences: Neurochemical inﬂ uences in 
bulimia may be associated with the neurotransmitters 
serotonin and norepinephrine. This hypothesis has been 
supported by the positive response these individuals 
have shown to therapy with the selective serotonin reup-
take inhibitors (SSRIs). Some studies have found high 
levels of endogenous opioids in the spinal ﬂ uid of cli-
ents with anorexia, promoting the speculation that these 
chemicals may contribute to denial of hunger (Sadock 
& Sadock, 2007). Some of these individuals have been 
shown to gain weight when given naloxone, an opioid 
antagonist.
 2. Psychosocial Factors
 a. Psychodynamic Theory: The psychodynamic theory sug-
gests that behaviors associated with eating disorders reﬂ ect 
a developmental arrest in the very early years of childhood 
caused by disturbances in mother-infant interactions. The 
tasks of trust, autonomy, and separation-individuation 
go unfulﬁ lled, and the individual remains in the depen-
dent position. Ego development is retarded. The problem 
is compounded when the mother responds to the child’s 
physical and emotional needs with food. Manifestations 
include a disturbance in body identity and a distortion in 
body image. When events occur that threaten the vulner-
able ego, feelings emerge of lack of control over one’s body 
(self). Behaviors associated with food and eating provide 
feelings of control over one’s life.
 b. Family Dynamics: This theory proposes that the issue of 
control becomes the overriding factor in the family of the 
individual with an eating disorder. These families often 
consist of a passive father, a domineering mother, and an 
overly dependent child. A high value is placed on perfec-
tionism in this family, and the child feels he or she must 
satisfy these standards. Parental criticism promotes an 
increase in obsessive and perfectionistic behavior on the 
2506_Ch12_218-235.indd   Sec1:220 10/1/10   9:35:59 AM
Eating Disorders  ● 221
part of the child, who continues to seek love, approval, and 
recognition. The child eventually begins to feel helpless 
and ambivalent toward the parents. In adolescence, these 
distorted eating patterns may represent a rebellion against 
the parents, viewed by the child as a means of gaining and 
remaining in control. The symptoms are often triggered 
by a stressor that the adolescent perceives as a loss of con-
trol in some aspect of his or her life.
Obesity
Deﬁ ned
The following formula is used to determine the degree of 
obesity in an individual:
 weight (kg)
 Body mass index (BMI) = 
 height (m)
2
The BMI range for normal weight is 20 to 24.9. Studies by the 
National Center for Health Statistics indicate that overweight is 
deﬁ ned as a BMI of 25.0 to 29.9 (based on U.S. Dietary Guide-
lines for Americans). Based on criteria of the World Health 
Organization, obesity is deﬁ ned as a BMI of 30.0 or greater. 
These guidelines, which were released by the National Heart, 
Lung, and Blood Institute in July 1998, markedly increased the 
number of Americans considered to be overweight. The average 
American woman has a BMI of 26, and fashion models typically 
have BMIs of 18 (Priesnitz, 2005). 
Obesity is known to contribute to a number of health prob-
lems, including hyperlipidemia, diabetes mellitus, osteoarthritis, 
and increased workload on the heart and lungs.
Predisposing Factors to Obesity
 1. Physiological Factors
 a. Genetics: Genetics have been implicated in the develop-
ment of obesity in that 80% of offspring of two obese 
parents are obese (Halmi, 2008). This hypothesis has also 
been supported by studies of twins reared by normal and 
overweight parents.
 b. Physical Factors: Overeating and/or obesity has also been 
associated with lesions in the appetite and satiety centers 
of the hypothalamus, hypothyroidism, decreased insulin 
production in diabetes mellitus, and increased cortisone 
production in Cushing’s disease.
 c. Lifestyle Factors: On a more basic level, obesity can be 
viewed as the ingestion of a greater number of calories 
than are expended. Weight gain occurs when caloric in-
take exceeds caloric output in terms of basal metabolism 
and physical activity. Many overweight individuals lead 
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sedentary lifestyles, making it very difﬁ cult to burn off 
calories.
 2. Psychosocial Factors
 a. Psychoanalytical Theory: This theory suggests that obe-
sity is the result of unresolved dependency needs, with 
the individual being ﬁ xed in the oral stage of psychosex-
ual development. The symptoms of obesity are viewed as 
depressive equivalents, attempts to regain “lost” or frus-
trated nurturance and care.
Common Nursing Diagnoses and Interventions 
for Anorexia and Bulimia
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.)
●
 IMBALANCED NUTRITION: LESS 
THAN BODY REQUIREMENTS
Deﬁ nition: Intake of nutrients insuffi cient to meet metabolic 
needs.
Possible Etiologies (“related to”)
[Refusal to eat]
[Ingestion of large amounts of food, followed by self-induced 
vomiting]
[Abuse of laxatives, diuretics, and/or diet pills]
[Physical exertion in excess of energy produced through caloric 
intake]
Deﬁ ning Characteristics (“evidenced by”)
[Loss of 15% of expected body weight (anorexia nervosa)]
Pale mucous membranes
Poor muscle tone
Excessive loss of hair [or increased growth of hair on body 
(lanugo)]
[Amenorrhea]
[Poor skin turgor]
[Electrolyte imbalances]
[Hypothermia]
[Bradycardia]
[Hypotension]
[Cardiac irregularities]
[Edema]
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Goals/Objectives
Short-term Goal
Client will gain            lbs per week (amount to be established by 
client, nurse, and dietitian).
Long-term Goal
By discharge from treatment, client will exhibit no signs or 
symptoms of malnutrition.
Interventions with Selected Rationales
 1. If client is unable or unwilling to maintain adequate oral in-
take, physician may order a liquid diet to be administered via 
nasogastric tube. Nursing care of the individual receiving 
tube feedings should be administered according to established 
hospital procedures. The client’s physical safety is a nursing 
priority, and without adequate nutrition, a life-threatening 
situation exists.
For oral diet:
 2. In collaboration with dietitian, determine number of cal-
ories required to provide adequate nutrition and realistic 
(according to body structure and height) weight gain. Ad-
equate calories are required to affect a weight gain of 2 to 
3 lbs per week.
 3. Explain to client details of behavior modiﬁ cation program 
as outlined by physician. Explain beneﬁ ts of compliance 
with prandial routine and consequences for noncompliance. 
Behavior modifi cation bases privileges granted or restricted 
directly on weight gain and loss. Focus is placed on emo-
tional issues, rather than food and eating specifi cally.
 4. Sit with client during mealtimes for support and to observe 
amount ingested. A limit (usually 30 minutes) should be 
imposed on time allotted for meals. Without a time limit, 
meals can become lengthy, drawn-out sessions, providing 
client with attention based on food and eating.
 5. Client should be observed for at least 1 hour following meals. 
This time may be used by client to discard food stashed from 
tray or to engage in self-induced vomiting.
 6. Client may need to be accompanied to bathroom if self-
induced vomiting is suspected.
 7. Strict documentation of intake and output. This information 
is required to promote client safety and plan nursing care.
 8. Weigh client daily immediately on arising and following 
ﬁ rst voiding. Always use same scale, if possible. Client care, 
privileges, and restrictions will be based on accurate daily 
weights.
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 9. Do not discuss food or eating with client, once protocol has 
been established. Do, however, offer support and positive 
reinforcement for obvious improvements in eating behav-
iors. Discussing food with client provides positive feedback 
for maladaptive behaviors.
 10. Client must understand that if, because of poor oral intake, 
nutritional status does not improve, tube feedings will be ini-
tiated to ensure client’s safety. Staff must be consistent and 
ﬁ rm with this action, using a matter-of-fact, nonpunitive ap-
proach regarding the tube insertion and subsequent feedings.
 11. As nutritional status improves and eating habits are estab-
lished, begin to explore with client the feelings associated 
with his or her extreme fear of gaining weight. Emotional 
issues must be resolved if maladaptive responses are to be 
eliminated.
Outcome Criteria
 1. Client has achieved and maintained at least 85% of expected 
body weight.
 2. Vital signs, blood pressure, and laboratory serum studies are 
within normal limits.
 3. Client verbalizes importance of adequate nutrition.
●
 DEFICIENT FLUID VOLUME 
Deﬁ nition: Decreased intravascular, interstitial, and/or intracel-
lular fl uid. This refers to dehydration, water loss alone without 
change in sodium.
Possible Etiologies (“related to”)
[Decreased ﬂ uid intake]
[Abnormal ﬂ uid loss caused by self-induced vomiting]
[Excessive use of laxatives or enemas]
[Excessive use of diuretics]
[Electrolyte or acid-base imbalance brought about by malnour-
ished condition or self-induced vomiting]
Deﬁ ning Characteristics (“evidenced by”)
Decreased urine output
[Output greater than intake]
Increased urine concentration
Elevated hematocrit
Decreased blood pressure
Increased pulse rate
Increased body temperature
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Dry skin
Decreased skin turgor
Weakness
Change in mental state
Dry mucous membranes
Goals/Objectives
Short-term Goal
Client will drink 125 mL of ﬂ uid each hour during waking 
hours.
Long-term Goal
By discharge from treatment, client will exhibit no signs or 
symptoms of dehydration (as evidenced by quantity of urinary 
output sufﬁ cient to individual client; normal speciﬁ c gravity; 
vital signs within normal limits; moist, pink mucous membranes; 
good skin turgor; and immediate capillary reﬁ ll).
Interventions with Selected Rationales
 1. Keep strict record of intake and output. Teach client 
importance of daily ﬂ uid intake of 2000 to 3000 mL. This 
information is required to promote client safety and plan 
nursing care.
 2. Weigh client daily immediately on arising and following ﬁ rst 
voiding. Always use same scale, if possible. An accurate daily 
weight is needed to plan nursing care for the client.
 3. Assess and document condition of skin turgor and any chang-
es in skin integrity. Condition of skin provides valuable data 
regarding client hydration.
 4. Discourage client from bathing every day if skin is very dry. 
Hot water and soap are drying to the skin.
 5. Monitor laboratory serum values, and notify physician of 
signiﬁ cant alterations. Laboratory data provide an objective 
measure for evaluating adequate hydration.
 6. Client should be observed for at least 1 hour following meals 
and may need to be accompanied to the bathroom if self-
induced vomiting is suspected. Vomiting causes active loss of 
body fl uids and can precipitate fl uid volume defi cit.
 7. Assess and document moistness and color of oral mucous 
membranes. Dry, pale mucous membranes may be indica-
tive of malnutrition or dehydration.
 8. Encourage frequent oral care to moisten mucous membranes, 
reducing discomfort from dry mouth, and to decrease bacte-
rial count, minimizing risk of tissue infection.
 9. Help client identify true feelings and fears that contribute 
to maladaptive eating behaviors. Emotional issues must be 
resolved if maladaptive behaviors are to be eliminated.
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Outcome Criteria
 1. Client’s vital signs, blood pressure, and laboratory serum 
studies are within normal limits.
 2. No abnormalities of skin turgor and dryness of skin and oral 
mucous membranes are evident.
 3. Client verbalizes knowledge regarding consequences of ﬂ uid 
loss due to self-induced vomiting and importance of adequate 
ﬂ uid intake.
●
 INEFFECTIVE COPING
Deﬁ nition: Inability to form a valid appraisal of the stressors, in-
adequate choices of practiced responses, and/or inability to use 
available resources.
Possible Etiologies (“related to”)
[Retarded ego development]
[Unfulﬁ lled tasks of trust and autonomy]
[Dysfunctional family system]
[Unmet dependency needs]
[Feelings of helplessness and lack of control in life situation]
[Possible chemical imbalance caused by malfunction of 
hypothalamus]
[Unrealistic perceptions]
Deﬁ ning Characteristics (“evidenced by”)
[Preoccupation with extreme fear of obesity, and distortion of 
own body image]
[Refusal to eat]
[Obsessed with talking about food]
[Compulsive behavior (e.g., excessive hand washing)]
[Excessive overeating, followed by self-induced vomiting and/or 
abuse of laxatives and diuretics]
[Poor self-esteem]
[Chronic fatigue]
[Chronic anxiety]
[Chronic depression]
Inadequate problem solving
Inability to meet role expectations
Destructive behavior toward self
Goals/Objectives
Short-term Goal
Within 7 days, client will eat regular meals and attend activities 
without discussing food or physical appearance.
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Long-term Goal
Client will be able to verbalize adaptive coping mechanisms that 
can be realistically incorporated into his or her lifestyle, thereby 
eliminating the need for maladaptive eating behaviors.
Interventions with Selected Rationales
 1. Establish a trusting relationship with client by being honest, 
accepting, and available and by keeping all promises. The ther-
apeutic nurse-client relationship is built on trust.
 2. Acknowledge client’s anger at feelings of loss of con-
trol brought about by established eating regimen (refer to 
INTERVENTIONS for Imbalanced Nutrition).
 3. When nutritional status has improved, begin to explore with 
client the feelings associated with his or her extreme fear 
of gaining weight. Emotional issues must be resolved if mal-
adaptive behaviors are to be eliminated.
 4. Explore family dynamics. Help client to identify his or her 
role contributions and their appropriateness within the family 
system. Assist client to identify speciﬁ c concerns within the 
family structure and ways to help relieve those concerns. Also, 
discuss importance of client’s separation of self as individu-
al within the family system, and of identifying independent 
emotions and accepting them as his or her own. Client must 
recognize how maladaptive eating behaviors are related to 
emotional problems—often issues of control within the fam-
ily structure.
 5. Initially, allow client to maintain dependent role. To deprive 
the individual of this role at this time could cause his or her 
anxiety to rise to an unmanageable level. As trust is developed 
and physical condition improves, encourage client to be as in-
dependent as possible in self-care activities. Offer positive rein-
forcement for independent behaviors and problem-solving and 
decision-making. Client must learn to function indepen-
dently. Positive reinforcement increases self-esteem and en-
courages the client to use behaviors that are more acceptable.
 6. Explore with client ways in which he or she may feel in con-
trol within the environment without resorting to maladap-
tive eating behaviors. When client feels control over major 
life issues, the need to gain control through maladaptive 
eating behaviors will diminish.
Outcome Criteria
 1. Client is able to assess maladaptive coping behaviors 
accurately.
 2. Client is able to verbalize adaptive coping strategies that can 
be used in the home environment.
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●
 ANXIETY (Moderate to Severe)
Deﬁ nition: Vague uneasy feeling of discomfort or dread accom-
panied by an autonomic response (the source often nonspecifi c or 
unknown to the individual); a feeling of apprehension caused by 
anticipation of danger. It is an alerting signal that warns of impend-
ing danger and enables the individual to take measures to deal with 
threat.
Possible Etiologies (“related to”)
Situational and maturational crises
[Unmet dependency needs]
[Low self-esteem]
[Dysfunctional family system]
[Feelings of helplessness and lack of control in life situation]
[Unfulﬁ lled tasks of trust and autonomy]
Deﬁ ning Characteristics (“evidenced by”)
Increased tension
Increased helplessness
Overexcited
Apprehensive; fearful
Restlessness
Poor eye contact
[Increased difﬁ culty taking oral nourishment]
[Inability to learn]
Goals/Objectives
Short-term Goal
Client will demonstrate use of relaxation techniques to maintain 
anxiety at manageable level within 7 days.
Long-term Goal
By time of discharge from treatment, client will be able to rec-
ognize events that precipitate anxiety and intervene to prevent 
disabling behaviors.
Interventions with Selected Rationales
 1. Be available to stay with client. Remain calm and provide re-
assurance of safety. Client safety and security is a nursing 
priority.
 2. Help client identify the situation that precipitated onset of 
anxiety symptoms. Client may be unaware that emotional 
issues are related to symptoms of anxiety. Recognition may 
be the fi rst step in elimination of this maladaptive response.
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 3. Review client’s methods of coping with similar situations 
in the past. In seeking to create change, it is helpful for 
client to identify past responses and determine whether 
they were successful and whether they could be employed 
again. Client strengths should be identifi ed and used to his 
or her advantage.
 4. Provide quiet environment. Reduce stimuli: low lighting, few 
people. Anxiety level may be decreased in calm atmosphere 
with few stimuli.
 5. Administer antianxiety medications, as ordered by physician. 
Monitor for effectiveness of medication as well as for adverse 
side effects. Short-term use of antianxiety medications (e.g., 
lorazepam, chlordiazepoxide, alprazolam) provides relief 
from the immobilizing effects of anxiety, and facilitates 
client’s cooperation with therapy.
 6. Teach client to recognize signs of increasing anxiety 
and ways to intervene for maintaining the anxiety at a 
manageable level (e.g., exercise, walking, jogging, relax-
ation techniques). Anxiety and tension can be reduced 
safely and with benefi t to the client through physical 
activities.
Outcome Criteria
 1. Client is able to verbalize events that precipitate anxiety and 
demonstrate techniques for its reduction.
 2. Client is able to verbalize ways in which he or she may gain 
more control of the environment and thereby reduce feelings 
of helplessness. 
●
 DISTURBED BODY IMAGE/LOW 
SELF-ESTEEM
Deﬁ nition: Confusion in mental picture of one’s physical self. 
Negative self-evaluating/feelings about self or self-capabilities.
Possible Etiologies (“related to”)
[Lack of positive feedback]
[Perceived failures]
[Unrealistic expectations (on the part of self and others)]
[Retarded ego development]
[Unmet dependency needs]
[Threat to security caused by dysfunctional family dynamics]
[Morbid fear of obesity]
[Perceived loss of control in some aspect of life]
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Deﬁ ning Characteristics (“evidenced by”)
[Distorted body image, views self as fat, even in the presence of 
normal body weight or severe emaciation]
[Denial that problem with low body weight exists]
[Difﬁ culty accepting positive reinforcement]
[Not taking responsibility for self-care (self-neglect)]
[Nonparticipation in therapy]
[Self-destructive behavior (self-induced vomiting; abuse of laxa-
tives or diuretics; refusal to eat)]
Lack of eye contact
[Depressed mood and self-deprecating thoughts following epi-
sode of binging and purging]
[Preoccupation with appearance and how others perceive them]
Goals/Objectives
Short-term Goal
Client will verbally acknowledge misperception of body image 
as “fat” within speciﬁ ed time (depending on severity and chro-
nicity of condition).
Long-term Goal
Client will demonstrate an increase in self-esteem as manifested 
by verbalizing positive aspects of self and exhibiting less preoc-
cupation with own appearance as a more realistic body image is 
developed by time of discharge from therapy.
Interventions with Selected Rationales
 1. Help client reexamine negative perceptions of self and recog-
nize positive attributes. Client’s own identifi cation of strengths 
and positive attributes can increase sense of self-worth.
 2. Offer positive reinforcement for independently made deci-
sions inﬂ uencing client’s life. Positive reinforcement en-
hances self-esteem and may encourage client to continue 
functioning more independently.
 3. Offer positive reinforcement when honest feelings related to 
autonomy and dependence issues remain separated from mal-
adaptive eating behaviors.
 4. Help client develop a realistic perception of body image and 
relationship with food. Client needs to recognize that his or 
her perception of body image is unhealthy and that main-
taining control through maladaptive eating behaviors is 
dangerous—even life-threatening.
 5. Promote feelings of control within the environment through 
participation and independent decision making. Through 
positive feedback, help client learn to accept self as is, in-
cluding weaknesses as well as strengths. Client must come 
to understand that he or she is a capable, autonomous 
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individual who can perform outside the family unit and 
who is not expected to be perfect. Control of his or her 
life must be achieved in other ways besides dieting and 
weight loss.
 6. Help client realize that perfection is unrealistic, and explore 
this need with him or her. As client begins to feel better about 
self and identifi es positive self-attributes, and develops the 
ability to accept certain personal inadequacies, the need for 
unrealistic achievements should diminish.
 7. Help client claim ownership of angry feelings and recognize 
that expressing them is acceptable if done so in an appropri-
ate manner. Be an effective role model. Unexpressed anger is 
often turned inward on the self, resulting in depreciation of 
self-esteem. 
Outcome Criteria
 1. Client is able to verbalize positive aspects about self.
 2. Client expresses interest in welfare of others and less preoc-
cupation with own appearance.
 3. Client verbalizes that image of body as “fat” was misper-
ception and demonstrates ability to take control of own life 
without resorting to maladaptive eating behaviors. 
Common Nursing Diagnoses and Interventions 
for Obesity
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.)
●
 IMBALANCED NUTRITION: MORE 
THAN BODY REQUIREMENTS
Deﬁ nition: Intake of nutrients that exceeds metabolic needs.
Possible Etiologies (“related to”)
[Compulsive eating]
Excessive intake in relation to metabolic needs
[Sedentary lifestyle]
[Genetics]
[Unmet dependency needs—ﬁ xation in oral developmental 
stage]
Deﬁ ning Characteristics (“evidenced by”)
Weight 20% over ideal for height and frame
[Body mass index of 30 or more]
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Goals/Objectives
Short-term Goal
Client will verbalize understanding of what must be done to lose 
weight.
Long-term Goal
Client will demonstrate change in eating patterns resulting in a 
steady weight loss.
Interventions with Selected Rationales
 1. Encourage the client to keep a diary of food intake. A food 
diary provides the opportunity for the client to gain a realis-
tic picture of the amount of food ingested and provides data 
on which to base the dietary program.
 2. Discuss feelings and emotions associated with eating. This 
helps to identify when client is eating to satisfy an emotional 
need rather than a physiological one.
 3. With input from the client, formulate an eating plan that in-
cludes food from the basic food pyramid with emphasis on 
low-fat intake. It is helpful to keep the plan as similar to the 
client’s usual eating pattern as possible. Diet must eliminate 
calories while maintaining adequate nutrition. Client is 
more likely to stay on the eating plan if he or she is able to 
participate in its creation and it deviates as little as possible 
from usual types of foods.
 4. Identify realistic increment goals for weekly weight loss. 
Reasonable weight loss (1 to 2 lb/wk) results in more lasting 
effects. Excessive, rapid weight loss may result in fatigue 
and irritability and may ultimately lead to failure in meet-
ing goals for weight loss. Motivation is more easily sustained 
by meeting “stair-step” goals.
 5. Plan progressive exercise program tailored to individual goals 
and choice. Exercise may enhance weight loss by burning 
calories and reducing appetite, increasing energy, toning 
muscles, and enhancing sense of well-being and accom-
plishment. Walking is an excellent choice for overweight 
individuals.
 6. Discuss the probability of reaching plateaus when weight 
remains stable for extended periods. Client should know 
that this is likely to happen as changes in metabolism occur. 
Plateaus cause frustration, and client may need additional 
support during these times to remain on the weight loss 
program.
 7. Provide instruction about medications to assist with weight 
loss if ordered by the physician. Appetite-suppressant drugs 
(e.g., sibutramine) and others that have weight loss as a 
side effect (e.g., fl uoxetine; topiramate) may be helpful to 
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someone who is severely overweight. Drugs should be used 
for this purpose for only a short period while the individual 
attempts to adjust to the new pattern of eating.
Outcome Criteria
 1. Client has established a healthy pattern of eating for weight 
control with weight loss progressing toward a desired goal.
 2. Client verbalizes plans for future maintenance of weight 
control.
●
 DISTURBED BODY IMAGE/LOW 
SELF-ESTEEM
Deﬁ nition: Confusion in mental picture of one’s physical self. 
Negative self-evaluating/feelings about self or self-capabilities.
Possible Etiologies (“related to”)
[Dissatisfaction with appearance]
[Unmet dependency needs]
[Lack of adequate nurturing by maternal ﬁ gure]
Deﬁ ning Characteristics (“evidenced by”)
Negative feelings about body (e.g., feelings of helplessness, 
hopelessness, or powerlessness)
[Verbalization of desire to lose weight]
[Failure to take responsibility for self-care (self-neglect)]
Lack of eye contact
[Expressions of low self-worth]
Goals/Objectives
Short-term Goal
Client will begin to accept self based on self-attributes rather 
than on appearance.
Long-term Goal
Client will pursue loss of weight as desired.
Interventions with Selected Rationales
 1. Assess client’s feelings and attitudes about being obese. Obe-
sity and compulsive eating behaviors may have deep-rooted 
psychological implications, such as compensation for lack of 
love and nurturing or a defense against intimacy.
 2. Ensure that the client has privacy during self-care activi-
ties. The obese individual may be sensitive or self-conscious 
about his or her body.
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 3. Have client recall coping patterns related to food in family of 
origin, and explore how these may affect current situation. 
Parents are role models for their children. Maladaptive 
eating behaviors are learned within the family system and 
are supported through positive reinforcement. Food may be 
substituted by the parent for affection and love, and eat-
ing is associated with a feeling of satisfaction, becoming the 
primary defense.
 4. Determine client’s motivation for weight loss and set goals. 
The individual may harbor repressed feelings of hostility, 
which may be expressed inward on the self. Because of a poor 
self-concept, the person often has diffi culty with relation-
ships. When the motivation is to lose weight for someone 
else, successful weight loss is less likely to occur.
 5. Help client identify positive self-attributes. Focus on strengths 
and past accomplishments unrelated to physical appearance. 
It is important that self-esteem not be tied solely to size of the 
body. Client needs to recognize that obesity need not interfere 
with positive feelings regarding self-concept and self-worth.
 6. Refer client to support or therapy group. Support groups can 
provide companionship, increase motivation, decrease lone-
liness and social ostracism, and give practical solutions to 
common problems. Group therapy can be helpful in dealing 
with underlying psychological concerns.
Outcome Criteria
 1. Client has established a healthy pattern of eating for weight 
control with weight loss progressing toward a desired goal.
 2. Client verbalizes plans for future maintenance of weight 
control.
 INTERNET REFERENCES
 • Additional information about anorexia nervosa and bulimia 
nervosa may be located at the following websites:
 a. http://www.aabainc.org
 b. http://healthyminds.org/multimedia/eatingdisorders.pdf
 c. http://www.mentalhealth.com/dis/p20-et01.html
 d. http://www.anred.com/
 e. http://www.mentalhealth.com/dis/p20-et02.html
 f. http://www.nimh.nih.gov/publicat/eatingdisorders.cfm
 g. http://medlineplus.nlm.nih.gov/medlineplus/eatingdisorders 
.html
 • Additional information about obesity may be located at the 
following websites:
 a. http://www.shapeup.org/
 b. http://www.obesity.org/
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 c. http://medlineplus.nlm.nih.gov/medlineplus/obesity
.html
 d. http://www.asbp.org/
 e. http://win.niddk.nih.gov/publications/binge.htm
Movie Connections
The Best Little Girl in the World (anorexia nervosa) • Kate’s Secret 
(bulimia nnervosa) • For the Love of Nancy (anorexia nervosa) • Super Size 
Me (obesity) 
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Adjustment Disorder
● BACKGROUND ASSESSMENT DATA
The essential feature of adjustment disorder is a maladaptive re-
action to an identiﬁ able psychosocial stressor that occurs within 
3 months after the onset of the stressor and has persisted for no 
longer than 6 months (American Psychiatric Association [APA], 
2000). The response is considered maladaptive either because 
there is impairment in social or occupational functioning or be-
cause the behaviors are exaggerated beyond the usual, expected 
response to such a stressor. The impairment is corrected with 
the disappearance of, or adaptation to, the stressor. The follow-
ing categories are deﬁ ned:
 1. Adjustment Disorder with Depressed Mood. This cat-
egory is the most commonly diagnosed adjustment disorder. 
The major symptoms include depressed mood, tearfulness, 
and hopelessness. A differential diagnosis with the affective 
disorders must be considered.
 2. Adjustment Disorder with Anxiety. The major symptom of 
this adjustment disorder is anxiety. Primary manifestations 
include nervousness, worry, and restlessness. A differential 
diagnosis with the anxiety disorders must be considered.
 3. Adjustment Disorder with Mixed Anxiety and Depressed 
Mood. This type of adjustment disorder is identiﬁ ed by a com-
bination of depression and anxiety. A differential diagnosis 
must be made considering the affective and anxiety disorders.
 4. Adjustment Disorder with Disturbance of Conduct. The 
major response involves conduct in which there is violation 
of the rights of others or of major age-appropriate societal 
norms and rules. A differential diagnosis with conduct disor-
der or antisocial personality disorder must be considered.
 5. Adjustment Disorder with Mixed Disturbance of Emo-
tions and Conduct. The behavioral manifestations include 
both emotional symptoms (e.g., depression, anxiety) and dis-
turbances in conduct.
 6. Adjustment Disorder Unspecifi ed. This diagnosis is used 
when the maladaptive reaction is not consistent with any of 
236
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the other categories of adjustment disorder. Manifestations 
may include physical complaints, social withdrawal, and 
occupational or academic inhibition, without signiﬁ cant 
depressed or anxious mood.
Predisposing Factors
 1. Physiological
 a. Developmental Impairment. Chronic conditions, such 
as organic mental disorder or mental retardation, are 
thought to impair the ability of an individual to adapt 
to stress, causing increased vulnerability to adjustment 
disorder. Sadock and Sadock (2007) suggest that genetic 
factors also may inﬂ uence individual risks for maladaptive 
response to stress.
 2. Psychosocial Theories
 a. Psychoanalytical Theory. Some proponents of psychoana-
lytical theory view adjustment disorder as a maladaptive 
response to stress that is caused by early childhood trau-
ma, increased dependency, and retarded ego development. 
Other psychoanalysts put considerable weight on the con-
stitutional factor, or birth characteristics that contribute to 
the manner in which individuals respond to stress. In many 
instances, adjustment disorder is precipitated by a speciﬁ c 
meaningful stressor having found a point of vulnerability 
in an individual of otherwise adequate ego strength.
 b. Developmental Model. Some studies relate a predispo-
sition to adjustment disorder to factors such as develop-
mental stage, timing of the stressor, and available support 
systems. When a stressor occurs, and the individual does 
not have the developmental maturity, available support 
systems, or adequate coping strategies to adapt, normal 
functioning is disrupted, resulting in psychological or 
somatic symptoms. The disorder also may be related to 
a dysfunctional grieving process. The individual may 
remain in the denial or anger stage, with inadequate de-
fense mechanisms to complete the grieving process.
 c. Stress-Adaptation Model. This model considers the type 
of stressor the individual experiences, the situational con-
text in which it occurs, and intrapersonal factors in the 
predisposition to adjustment disorder. It has been found 
that continuous stressors (those to which an individual is 
exposed over an extended period of time) are more com-
monly cited than sudden-shock stressors (those that occur 
without warning) as precipitants to maladaptive function-
ing. The situational context in which the stressor occurs 
may include factors such as personal and general economic 
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conditions; occupational and recreational opportunities; 
the availability of social supports, such as family, friends, 
and neighbors; and the availability of cultural or religious 
support groups. Intrapersonal factors that have been 
implicated in the predisposition to adjustment disorder 
include birth temperament, learned social skills and cop-
ing strategies, the presence of psychiatric illness, degree 
of ﬂ exibility, and level of intelligence.
Symptomatology (Subjective and Objective Data)
 1. Depressed mood
 2. Tearfulness
 3. Hopelessness
 4. Nervousness
 5. Worry
 6. Restlessness
 7. Ambivalence
 8. Anger, expressed inappropriately
 9. Increased dependency
 10. Violation of the rights of others
 11. Violation of societal norms and rules, such as truancy, van-
dalism, reckless driving, ﬁ ghting
 12. Inability to function occupationally or academically
 13. Manipulative behavior
 14. Social isolation
 15. Physical complaints, such as headache, backache, other 
aches and pains, fatigue
Common Nursing Diagnoses 
and Interventions
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.)
●
 RISK FOR SELF-DIRECTED 
OR OTHER-DIRECTED VIOLENCE
Deﬁ nition: At risk for behaviors in which an individual demon-
strates that he or she can be physically, emotionally, and/or sexu-
ally harmful either to self or to others.
Related/Risk Factors (“related to”)
[Fixation in earlier level of development]
[Negative role modeling]
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[Dysfunctional family system]
[Low self-esteem]
[Unresolved grief]
[Psychic overload]
[Extended exposure to stressful situation]
[Lack of support systems]
[Biological factors, such as organic changes in the brain]
Body language (e.g., rigid posture, clenching of ﬁ sts and jaw, 
hyperactivity, pacing, breathlessness, threatening stances)
[History or threats of violence toward self or others or of 
destruction to the property of others]
Impulsivity
Suicidal ideation, plan, available means
[Anger; rage]
[Increasing anxiety level]
[Depressed mood]
Goals/Objectives
Short-term Goals
 1. Client will seek out staff member when hostile or suicidal 
feelings occur.
 2. Client will verbalize adaptive coping strategies for use when 
hostile or suicidal feelings occur. 
Long-term Goals
 1. Client will demonstrate adaptive coping strategies for use 
when hostile or suicidal feelings occur.
 2. Client will not harm self or others. 
Interventions with Selected Rationales
 1. Observe client’s behavior frequently. Do this through rou-
tine activities and interactions; avoid appearing watchful and 
suspicious. Close observation is required so that intervention 
can occur if required to ensure client’s (and others’) safety.
 2. Observe for suicidal behaviors: verbal statements, such as 
“I’m going to kill myself” and “Very soon my mother won’t 
have to worry herself about me any longer,” and nonverbal 
behaviors, such as giving away cherished items and mood 
swings. Clients who are contemplating suicide often give 
clues regarding their potential behavior. The clues may be 
very subtle and require keen assessment skills by the nurse.
 3. Determine suicidal intent and available means. Ask direct 
questions, such as “Do you plan to kill yourself?” and “How 
do you plan to do it?” The risk of suicide is greatly increased 
if the client has developed a plan and particularly if means 
exist for the client to execute the plan.
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 4. Obtain verbal or written contract from client agreeing not 
to harm self and to seek out staff in the event that suicidal 
ideation occurs. Discussion of suicidal feelings with a trusted 
individual provides some relief to the client. A contract gets 
the subject out in the open and places some of the responsibil-
ity for his or her safety with the client. An attitude  of accep-
tance of the client as a worthwhile individual is conveyed.
 5. Help client recognize when anger occurs and to accept 
those feelings as his or her own. Have client keep an “anger 
notebook,” in which feelings of anger experienced during a 
24-hour period are recorded. Information regarding source 
of anger, behavioral response, and client’s perception of the 
situation should also be noted. Discuss entries with client 
and suggest alternative behavioral responses for those iden-
tiﬁ ed as maladaptive.
 6. Act as a role model for appropriate expression of angry feel-
ings and give positive reinforcement to client for attempting 
to conform. It is vital that the client express angry feelings, 
because suicide and other self-destructive behaviors are often 
viewed as the result of anger turned inward on the self.
 7. Remove all dangerous objects from client’s environment 
(e.g., sharp items, belts, ties, straps, breakable items, smok-
ing materials). Client safety is a nursing priority.
 8. Try to redirect violent behavior by means of physical outlets 
for the client’s anxiety (e.g., punching bag, jogging). Physi-
cal exercise is a safe and effective way of relieving pent-up 
tension.
 9. Be available to stay with client as anxiety level and tensions 
begin to rise. Presence of a trusted individual provides a 
feeling of security and may help to prevent rapid escalation 
of anxiety.
 10. Staff should maintain and convey a calm attitude to client. 
Anxiety is contagious and can be transmitted from staff 
members to client.
 11. Have sufﬁ cient staff available to indicate a show of strength 
to client if necessary. This conveys to the client evidence of 
control over the situation and provides some physical secu-
rity for staff.
 12. Administer tranquilizing medications as ordered by physi-
cian or obtain an order if necessary. Monitor client response 
for effectiveness of the medication and for adverse side ef-
fects. Short-term use of tranquilizing medications such as 
anxiolytics or antipsychotics can induce a calming effect on 
the client and may prevent aggressive behaviors.
 13. Use of mechanical restraints or isolation room may be re-
quired if less restrictive interventions are unsuccessful. 
Follow policy and procedure prescribed by the institu-
tion in executing this intervention. The Joint Commission 
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(formerly the Joint Commission on Accreditation of Health-
care Organizations [JCAHO]) requires that an in-person 
evaluation (by a physician, clinical psychologist, or other 
licensed independent practitioner responsible for the care 
of the patient) be conducted within 1 hour of initiating 
restraint or seclusion (The Joint Commission, 2010). The 
physician must reevaluate and issue a new order for re-
straints every 4 hours for adults and every 1 to 2 hours for 
children and adolescents.
 14. Observe the client in restraints every 15 minutes (or ac-
cording to institutional policy). Ensure that circulation to 
extremities is not compromised (check temperature, color, 
pulses). Assist client with needs related to nutrition, hy-
dration, and elimination. Position client so that comfort is 
facilitated and aspiration can be prevented. Client safety is 
a nursing priority.
 15. As agitation decreases, assess client’s readiness for restraint 
removal or reduction. Remove one restraint at a time, while 
assessing client’s response. This minimizes risk of injury to 
the client and staff. 
Outcome Criteria
 1. Anxiety is maintained at a level at which client feels no need 
for aggression.
 2. Client denies any ideas of self-destruction.
 3. Client demonstrates use of adaptive coping strategies when 
feelings of hostility or suicide occur.
 4. Client verbalizes community support systems from which as-
sistance may be requested when personal coping strategies 
are not successful. 
●
 ANXIETY (MODERATE TO SEVERE)
Deﬁ nition: Vague uneasy feeling of discomfort or dread accom-
panied by an autonomic response (the source often nonspecifi c or 
unknown to the individual); a feeling of apprehension caused by antic-
ipation of danger. It is an alerting signal that warns of impending dan-
ger and enables the individual to take measures to deal with threat.
Possible Etiologies (“related to”)
Situational and maturational crises
[Low self-esteem]
[Dysfunctional family system]
[Feelings of powerlessness and lack of control in life situation]
[Retarded ego development]
[Fixation in earlier level of development]
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Deﬁ ning Characteristics (“evidenced by”)
Increased tension
[Increased helplessness]
Overexcited
Apprehensive; fearful
Restlessness
Poor eye contact
Feelings of inadequacy
Insomnia
Focus on the self
Increased cardiac and respiratory rates
Diminished ability to problem solve and learn
Goals/Objectives
Short-term Goal
Client will demonstrate use of relaxation techniques to maintain 
anxiety at manageable level within 7 days.
Long-term Goal
By time of discharge from treatment, client will be able to rec-
ognize events that precipitate anxiety and intervene to prevent 
disabling behaviors.
Interventions with Selected Rationales
 1. Be available to stay with client. Remain calm and provide 
assurance of safety. Client safety and security is a nursing 
priority.
 2. Help client identify situation that precipitated onset of anxi-
ety symptoms. Client may be unaware that emotional issues 
are related to symptoms of anxiety. Recognition may be the 
fi rst step in elimination of this maladaptive response.
 3. Review client’s methods of coping with similar situations in 
the past. Discuss ways in which client may assume control 
over these situations. In seeking to create change, it would be 
helpful for client to identify past responses and to determine 
whether they were successful and if they could be employed 
again. A measure of control reduces feelings of powerlessness 
in a situation, ultimately decreasing anxiety. Client strengths 
should be identifi ed and used to his or her advantage.
 4. Provide quiet environment. Reduce stimuli: low lighting, few 
people. Anxiety level may be decreased in calm atmosphere 
with few stimuli.
 5. Administer antianxiety medications as ordered by physician, 
or obtain order if necessary. Monitor client’s response for 
effectiveness of the medication as well as for adverse side 
effects. Short-term use of antianxiety medications (e.g., 
lorazepam, chlordiazepoxide, alprazolam) provides relief 
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from the immobilizing effects of anxiety and facilitates 
client’s cooperation with therapy.
 6. Discuss with client signs of increasing anxiety and ways of in-
tervening to maintain the anxiety at a manageable level (e.g., 
exercise, walking, jogging, relaxation techniques). Anxiety 
and tension can be reduced safely and with benefi t to the 
client through physical activities. 
Outcome Criteria
 1. Client is able to verbalize events that precipitate anxiety and 
to demonstrate techniques for its reduction.
 2. Client is able to verbalize ways in which he or she may gain 
more control of the environment and thereby reduce feelings 
of powerlessness. 
●
 INEFFECTIVE COPING
Deﬁ nition: Inability to form a valid appraisal of the stressors, in-
adequate choices of practiced responses, and/or inability to use 
available resources.
Possible Etiologies (“related to”)
Situational crises
Maturational crises
[Inadequate support systems]
[Negative role modeling]
[Retarded ego development]
[Fixation in earlier level of development]
[Dysfunctional family system]
[Low self-esteem]
[Unresolved grief]
Deﬁ ning Characteristics (“evidenced by”)
Inability to meet role expectations
[Alteration in societal participation]
Inadequate problem solving
[Increased dependency]
[Manipulation of others in the environment for purposes of ful-
ﬁ lling own desires]
[Refusal to follow rules] 
Goals/Objectives
Short-term Goal
By the end of 1 week, client will comply with rules of therapy 
and refrain from manipulating others to fulﬁ ll own desires.
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Long-term Goal
By time of discharge from treatment, client will identify, de-
velop, and use socially acceptable coping skills.
Interventions with Selected Rationales
 1. Discuss with client the rules of therapy and consequences of 
noncompliance. Carry out the consequences matter-of-factly 
if rules are broken. Negative consequences may work to de-
crease manipulative behaviors.
 2. Do not debate, argue, rationalize, or bargain with the client 
regarding limit-setting on manipulative behaviors. Ignoring 
these attempts may work to decrease manipulative behav-
iors. Consistency among all staff members is vital if this 
intervention is to be successful.
 3. Encourage discussion of angry feelings. Help client identify 
the true object of the hostility. Provide physical outlets for 
healthy release of the hostile feelings (e.g., punching bags, 
pounding boards). Verbalization of feelings with a trusted 
individual may help client work through unresolved issues. 
Physical exercise provides a safe and effective means of re-
leasing pent-up tension.
 4. Take care not to reinforce dependent behaviors. Encourage 
client to perform as independently as possible, and provide 
positive feedback. Independent accomplishment and positive 
reinforcement enhance self-esteem and encourage repetition 
of desirable behaviors.
 5. Help client recognize some aspects of his or her life over which 
a measure of control is maintained. Recognition of personal 
control, however minimal, diminishes the feeling of power-
lessness and decreases the need for manipulation of others.
 6. Identify the stressor that precipitated the maladaptive cop-
ing. If a major life change has occurred, encourage client to 
express fears and feelings associated with the change. Assist 
client through the problem-solving process: 
 a. Identify possible alternatives that indicate positive 
adaptation.
 b. Discuss beneﬁ ts and consequences of each alternative.
 c. Select the most appropriate alternative.
 d. Implement the alternative.
 e. Evaluate the effectiveness of the alternative.
 f. Recognize areas of limitation, and make modiﬁ cations. 
Request assistance with this process, if needed. 
 7. Provide positive reinforcement for application of adaptive 
coping skills and evidence of successful adjustment. Positive 
reinforcement enhances self-esteem and encourages repeti-
tion of desirable behaviors. 
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Outcome Criteria
 1. Client is able to verbalize alternative, socially acceptable, and 
lifestyle-appropriate coping skills he or she plans to use in 
response to stress.
 2. Client is able to solve problems and fulﬁ ll activities of daily 
living independently.
 3. Client does not manipulate others for own gratiﬁ cation. 
●
 RISK-PRONE HEALTH BEHAVIOR*
Deﬁ nition: Impaired ability to modify lifestyle/behaviors in a man-
ner that improves health status.
Possible Etiologies (“related to”)
[Low self-esteem]
[Intense emotional state]
[Negative attitudes toward health behavior]
[Absence of intent to change behavior]
Multiple stressors
[Absence of social support for changed beliefs and practices]
[Disability or health status change requiring change in lifestyle]
[Lack of motivation to change behaviors]
Deﬁ ning Characteristics (“evidenced by”)
Minimizes health status change
Failure to achieve optimal sense of control
Failure to take action that prevents health problems
Demonstrates nonacceptance of health status change
Goals/Objectives
Short-term Goals
 1. Client will discuss with primary nurse the kinds of lifestyle 
changes that will occur because of the change in health 
status.
 2. With the help of primary nurse, client will formulate a plan 
of action for incorporating those changes into his or her life-
style.
 3. Client will demonstrate movement toward independence, 
considering change in health status. 
*  According to the NANDA International deﬁ nition, this diagnosis is 
appropriate for the person with adjustment disorder only if the pre-
cipitating stressor is a change in health status.
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Long-term Goal
Client will demonstrate competence to function independently 
to his or her optimal ability, considering change in health status, 
by time of discharge from treatment.
Interventions with Selected Rationales
 1. Encourage client to talk about lifestyle prior to the change 
in health status. Discuss coping mechanisms that were used 
at stressful times in the past. It is important to identify the 
client’s strengths so that they may be used to facilitate adap-
tation to the change or loss that has occurred.
 2. Encourage client to discuss the change or loss and particularly 
to express anger associated with it. Some individuals may not 
realize that anger is a normal stage in the grieving process. If 
it is not released in an appropriate manner, it may be turned 
inward on the self, leading to pathological depression.
 3. Encourage client to express fears associated with the change 
or loss, or alteration in lifestyle that the change or loss has 
created. Change often creates a feeling of disequilibrium 
and the individual may respond with fears that are irra-
tional or unfounded. He or she may benefi t from feedback 
that corrects misperceptions about how life will be with the 
change in health status.
 4. Provide assistance with activities of daily living (ADLs) as 
required, but encourage independence to the limit that cli-
ent’s ability will allow. Give positive feedback for activities 
accomplished independently. Independent accomplishments 
and positive feedback enhance self-esteem and encourage 
repetition of desired behaviors. Successes also provide hope 
that adaptive functioning is possible and decrease feelings 
of powerlessness.
 5. Help client with decision making regarding incorporation 
of change or loss into lifestyle. Identify problems that the 
change or loss is likely to create. Discuss alternative solu-
tions, weighing potential beneﬁ ts and consequences of each 
alternative. Support client’s decision in the selection of an 
alternative. The great amount of anxiety that usually ac-
companies a major lifestyle change often interferes with an 
individual’s ability to solve problems and to make appropri-
ate decisions. Client may need assistance with this process in 
an effort to progress toward successful adaptation.
 6. Use role-playing to decrease anxiety as client anticipates 
stressful situations that might occur in relation to the health 
status change. Role-playing decreases anxiety and provides 
a feeling of security by providing client with a plan of action 
for responding in an appropriate manner when a stressful 
situation occurs.
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 7. Ensure that client and family are fully knowledgeable re-
garding the physiology of the change in health status and its 
necessity for optimal wellness. Encourage them to ask ques-
tions, and provide printed material explaining the change to 
which they may refer following discharge. Increased knowl-
edge enhances successful adaptation.
 8. Help client identify resources within the community from 
which he or she may seek assistance in adapting to the change 
in health status. Examples include self-help or support groups 
and public health nurse, counselor, or social worker. Encour-
age client to keep follow-up appointments with physician, or 
to call physician’s ofﬁ ce prior to follow-up date if problems or 
concerns arise. 
Outcome Criteria
 1. Client is able to perform ADLs independently.
 2. Client is able to make independent decisions regarding life-
style considering change in health status.
 3. Client is able to express hope for the future with consider-
ation of change in health status. 
●
 COMPLICATED GRIEVING
Deﬁ nition: A disorder that occurs after the death of a signifi -
cant other [or any other loss of signifi cance to the individual], in 
which the experience of distress accompanying bereavement 
fails to follow normative expectations and manifests in functional 
impairment.
Possible Etiologies (“related to”)
[Real or perceived loss of any entity of value to the individual]
[Bereavement overload (cumulative grief from multiple unre-
solved losses)]
[Thwarted grieving response to a loss]
[Absence of anticipatory grieving]
[Feelings of guilt generated by ambivalent relationship with lost 
entity]
Deﬁ ning Characteristics (“evidenced by”)
[Verbal expression of distress at loss]
[Idealization of lost entity]
[Denial of loss]
[Excessive anger, expressed inappropriately]
[Developmental regression]
[Altered activities of daily living]
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[Diminished sense of control]
[Persistent anxiety]
Depression
Goals/Objectives
Short-term Goal
By end of 1 week, client will express anger toward lost entity.
Long-term Goal
Client will be able to verbalize behaviors associated with the 
normal stages of grief and identify own position in grief process, 
while progressing at own pace toward resolution.
Interventions with Selected Rationales
 1. Determine stage of grief in which client is ﬁ xed. Identify 
behaviors associated with this stage. Accurate baseline as-
sessment data are necessary to plan effective care for the 
grieving client.
 2. Develop trusting relationship with client. Show empathy and 
caring. Be honest and keep all promises. Trust is the basis for 
a therapeutic relationship.
 3. Convey an accepting attitude so that the client is not afraid 
to express feelings openly. An accepting attitude conveys to 
the client that you believe he or she is a worthwhile person. 
Trust is enhanced.
 4. Allow client to express anger. Do not become defensive if 
initial expression of anger is displaced on nurse or therapist. 
Help client explore angry feelings so that they may be di-
rected toward the intended object or person. Verbalization 
of feelings in a nonthreatening environment may help client 
come to terms with unresolved issues.
 5. Help client discharge pent-up anger through participation 
in large motor activities (e.g., brisk walks, jogging, physical 
exercises, volleyball, punching bag, exercise bike). Physical 
exercise provides a safe and effective method for discharging 
pent-up tension.
 6. Explain to client the normal stages of grief and the behaviors 
associated with each stage. Help client to understand that 
feelings such as guilt and anger toward the lost entity are 
appropriate and acceptable during the grief process. Knowl-
edge of the acceptability of the feelings associated with nor-
mal grieving may help to relieve some of the guilt that these 
responses generate.
 7. Encourage client to review personal perception of the loss or 
change. With support and sensitivity, point out reality of the 
situation in areas where misrepresentations are expressed. 
Client must give up an idealized perception and be able to
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  accept both positive and negative aspects about the painful 
life change before the grief process is complete.
 8. Communicate to client that crying is acceptable. Use of 
touch is therapeutic and appropriate with most clients. 
Knowledge of cultural inﬂ uences speciﬁ c to the client is im-
portant before employing this technique. Touch is consid-
ered inappropriate in some cultures.
 9. Help client solve problems as he or she attempts to determine 
methods for more adaptive coping with the experienced loss. 
Provide positive feedback for strategies identiﬁ ed and deci-
sions made. Positive reinforcement enhances self-esteem 
and encourages repetition of desirable behaviors.
 10. Encourage client to reach out for spiritual support during 
this time in whatever form is desirable to him or her. As-
sess spiritual needs of client, and assist as necessary in the 
fulﬁ llment of those needs. Spiritual support can enhance 
successful adaptation to painful life experiences for some 
individuals. 
Outcome Criteria
 1. Client is able to verbalize normal stages of grief process and 
behaviors associated with each stage.
 2. Client is able to identify own position within the grief pro-
cess and express honest feelings related to the lost entity.
 3. Client is no longer manifesting exaggerated emotions and 
behaviors related to complicated grieving and is able to carry 
out ADLs independently. 
●
 LOW SELF-ESTEEM 
Deﬁ nition: Negative self-evaluating/feelings about self or self-
capabilities.
Possible Etiologies (“related to”)
Repeated negative reinforcement
[Unmet dependency needs]
[Retarded ego development]
Repeated failures
[Personal or situational factors such as dysfunctional family sys-
tem or absence of social support]
Deﬁ ning Characteristics (“evidenced by”)
Rejects positive feedback about self
Exaggerates negative feedback about self
[Nonparticipation in therapy]
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Self-negating verbalizations
Evaluation of self as unable to deal with events or situations
Hesitant to try new things or situations [because of fear of 
failure]
[Projection of blame or responsibility for problems]
[Rationalization of personal failures]
[Hypersensitivity to slight or criticism]
[Grandiosity]
Lack of eye contact
[Manipulation of one staff member against another in an 
attempt to gain special privileges]
[Inability to form close, personal relationships]
[Degradation of others in an attempt to increase own feelings 
of self-worth]
Goals/Objectives
Short-term Goals
 1. Client will discuss fear of failure with nurse within (realistic 
time period).
 2. Client will verbalize things he or she likes about self within 
(realistic time period). 
Long-term Goals
 1. Client will exhibit increased feelings of self-worth as evi-
denced by verbal expression of positive aspects about self, 
past accomplishments, and future prospects.
 2. Client will exhibit increased feelings of self-worth by setting 
realistic goals and trying to reach them, thereby demonstrat-
ing a decrease in fear of failure. 
Interventions with Selected Rationales
 1. Ensure that goals are realistic. It is important for client to 
achieve something, so plan for activities in which success is 
likely. Success enhances self-esteem.
 2. Convey unconditional positive regard for the client. Promote 
understanding of your acceptance for him or her as a worthwhile 
human being. Unconditional positive regard and acceptance 
promote trust and increase client’s feelings of self-worth.
 3. Spend time with the client, both on a one-to-one basis and in 
group activities. This conveys to client that you feel he or she 
is worth your time.
 4. Help client identify positive aspects of self and to develop 
plans for changing the characteristics he or she views as neg-
ative. Individuals with low self-esteem often have diffi culty 
recognizing their positive attributes. They may also lack 
problem-solving ability and require assistance to formulate 
a plan for implementing the desired changes.
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 5. Encourage and support client in confronting the fear of 
failure by attending therapy activities and undertaking new 
tasks. Offer recognition of successful endeavors and positive 
reinforcement for attempts made. Recognition and positive 
reinforcement enhance self-esteem.
 6. Do not allow client to ruminate about past failures. With-
draw attention if he or she persists. Lack of attention to 
these behaviors may discourage their repetition. Client 
must focus on positive attributes if self-esteem is to be 
enhanced.
 7. Minimize negative feedback to client. Enforce limit-setting 
in matter-of-fact manner, imposing previously established 
consequences for violations. Negative feedback can be ex-
tremely threatening to a person with low self-esteem, pos-
sibly aggravating the problem. Consequences should convey 
unacceptability of the behavior, but not the person.
 8. Encourage independence in the performance of personal re-
sponsibilities, as well as in decision-making related to own 
self-care. Offer recognition and praise for accomplishments. 
The ability to perform self-care activities independently 
enhances self-esteem. Positive reinforcement encourages 
repetition of the desirable behavior.
 9. Help client increase level of self-awareness through criti-
cal examination of feelings, attitudes, and behaviors. Help 
him or her to understand that it is perfectly acceptable for 
one’s attitudes and behaviors to differ from those of others as 
long as they do not become intrusive. As the client achieves 
self-awareness and self-acceptance, the need for judging the 
behavior of others will diminish. 
Outcome Criteria
 1. Client verbalizes positive perception of self.
 2. Client demonstrates ability to manage own self-care, make 
independent decisions, and use problem-solving skills.
 3. Client sets goals that are realistic and works to achieve those 
goals without evidence of fear of failure. 
●
 IMPAIRED SOCIAL INTERACTION
Deﬁ nition: Insuffi cient or excessive quantity or ineffective qual-
ity of social exchange.
Possible Etiologies (“related to”)
[Retarded ego development]
[Fixation in an earlier level of development]
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[Negative role modeling]
Self-concept disturbance
Deﬁ ning Characteristics (“evidenced by”)
Discomfort in social situations
Inability to receive or communicate a satisfying sense of so-
cial engagement (e.g., belonging, caring, interest, shared 
history)
Use of unsuccessful social interaction behaviors
Dysfunctional interaction with others
[Exhibiting behaviors unacceptable for age, as deﬁ ned by domi-
nant cultural group]
Goals/Objectives
Short-term Goal
Client will develop trusting relationship with staff member 
within (realistic time period), seeking that staff member out for 
one-to-one interaction.
Long-term Goals
 1. Client will be able to interact with others on a one-to-one 
basis with no indication of discomfort.
 2. Client will voluntarily spend time with others in group ac-
tivities demonstrating acceptable, age-appropriate behavior. 
Interventions with Selected Rationales
 1. Develop trusting relationship with client. Be honest; keep all 
promises; convey acceptance of person, separate from unac-
ceptable behaviors (“It is not you, but your behavior, that is 
unacceptable.”) Unconditional acceptance of the client in-
creases his or her feelings of self-worth.
 2. Offer to remain with client during initial interactions with 
others on the unit. Presence of a trusted individual provides 
a feeling of security.
 3. Provide constructive criticism and positive reinforcement 
for efforts. Positive reinforcement enhances self-esteem and 
encourages repetition of desirable behaviors.
 4. Confront client and withdraw attention when interactions 
with others are manipulative or exploitative. Attention to the 
unacceptable behavior may reinforce it.
 5. Act as role model for client through appropriate interactions 
with him or her, other clients, and staff members. Role mod-
eling is one of the strongest forms of learning.
 6. Provide group situations for client. It is through these 
group interactions, with positive and negative feedback 
from his or her peers, that client will learn socially accept-
able behavior. 
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Outcome Criteria
 1. Client seeks out staff member for social as well as therapeutic 
interaction.
 2. Client has formed and satisfactorily maintained one inter-
personal relationship with another client.
 3. Client willingly and appropriately participates in group 
activities.
 4. Client verbalizes reasons for inability to form close interper-
sonal relationships with others in the past. 
●
 RELOCATION STRESS SYNDROME*
Deﬁ nition: Physiological and/or psychosocial disturbance fol-
lowing transfer from one environment to another.
Possible Etiologies (“related to”)
Move from one environment to another
[Losses involved with decision to move]
Feelings of powerlessness
Lack of adequate support system
[Little or no preparation for the impending move]
Impaired psychosocial health [status]
Decreased [physical] health status
Deﬁ ning Characteristics (“evidenced by”)
Anxiety
Depression
Loneliness
Verbalizes unwillingness to move
Sleep disturbance
Increased physical symptoms
Dependency
Insecurity 
Withdrawal
Anger; fear
Goals/Objectives
Short-term Goal
Client will verbalize at least one positive aspect regarding re-
location to new environment within (realistic time period).
*  This diagnosis would be appropriate for the individual with adjustment 
disorder if the precipitating stressor was relocation to a new environment.
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Long-term Goal
Client will demonstrate positive adaptation to new environment, 
as evidenced by involvement in activities, expression of satis-
faction with new acquaintances, and elimination of previously 
evident physical and psychological symptoms associated with 
the relocation (time dimension to be determined individually).
Interventions with Selected Rationales
 1. Encourage individual to discuss feelings (concerns, fears, 
anger) regarding relocation. Exploration of feelings with 
a trusted individual may help the individual perceive 
the situation more realistically and come to terms with the 
inevitable change.
 2. Encourage individual to discuss how the change will af-
fect his or her life. Ensure that the individual is involved in 
decision-making and problem-solving regarding the move. 
Taking responsibility for making choices regarding the relo-
cation will increase feelings of control and decrease feelings 
of powerlessness.
 3. Help the individual identify positive aspects about the move. 
Anxiety associated with the opposed relocation may inter-
fere with the individual’s ability to recognize anything posi-
tive about it. Assistance may be required.
 4. Help the individual identify resources within the new com-
munity from which assistance with various types of services 
may be obtained. Because of anxiety and depression, the in-
dividual may not be able to identify these resources alone. 
Assistance with problem-solving may be required.
 5. Identify groups within the community that specialize in 
helping individuals adapt to relocation. Examples include 
Newcomers’ Club, Welcome Wagon International, senior 
citizens’ groups, and school and church organizations. These 
groups offer support from individuals who may have en-
countered similar experiences. Adaptation may be enhanced 
by the reassurance, encouragement, and support of peers 
who exhibit positive adaptation to relocation stress.
 6. Refer individual or family for professional counseling if 
deemed necessary. An individual who is experiencing com-
plicated grieving over loss of previous residence may require 
therapy to achieve resolution of the problem. It may be that 
other unresolved issues are interfering with successful ad-
aptation to the relocation. 
Outcome Criteria
 1. The individual no longer exhibits signs of anxiety, depres-
sion, or somatic symptoms.
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 2. The individual verbalizes satisfaction with new environment.
 3. The individual willingly participates in social and vocational 
activities within his or her new environment. 
 INTERNET REFERENCES
 • Additional information about adjustment disorder may be 
located at the following websites:
 a. http://www.mentalhealth.com/rx/p23-aj01.html
 b. http://psyweb.com/Mdisord/jsp/adjd.jsp
 c. http://emedicine.medscape.com/article/292759-overview
 d. http://www.athealth.com/Consumer/disorders/Adjustment
.html
 e. http://www.nlm.nih.gov/medlineplus/ency/article/000932
.htm
 f. http://www.mayoclinic.com/health/adjustment-disorders/ 
DS00584
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Impulse Control 
Disorders
● BACKGROUND ASSESSMENT DATA
Impulse control disorders are characterized by a need or 
desire that must be satisﬁ ed immediately, regardless of the con-
sequences. Many of the behaviors have adverse or even destruc-
tive consequences for the individuals affected, and seldom do 
these individuals know why they do what they do or why it is 
pleasurable.
The American Psychiatric Association (APA, 2000) Diag-
nostic and Statistical Manual of Mental Disorders, Fourth Edition, 
Text Revision (DSM-IV-TR) describes the essential features of 
impulse control disorders as follows:
 1. The individual is unable to resist an impulse, drive, or 
temptation to act in a way that is harmful to the person or 
others.
 2. The individual experiences an increasing sense of tension or 
arousal before committing the act and pleasure, gratiﬁ cation, 
or relief at the time of committing the act. 
 3. Afterward, he or she may experience regret, remorse, or 
embarrassment.
The DSM-IV-TR (APA, 2000) describes the following 
categories of impulse control disorders:
Intermittent Explosive Disorder
This disorder is characterized by episodes of loss of aggres-
sion control resulting in serious assaultive acts or destruc-
tion of property (APA, 2000). Some clients report changes in 
sensorium, such as confusion during an episode or amnesia 
for events that occurred during an episode. Symptoms usu-
ally appear suddenly without apparent provocation and ter-
minate abruptly, lasting only minutes to a few hours, followed 
by feelings of genuine remorse and self-reproach about the 
behavior.
256
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Kleptomania
“Kleptomania” is described by the DSM-IV-TR as “the recurrent 
failure to resist impulses to steal items not needed for personal 
use or for their monetary value” (APA, 2000, p. 667). Often the 
stolen items (for which the individual usually has enough money 
to pay) are given away, discarded, returned, or kept and hidden. 
The individual with kleptomania steals purely for the sake of 
stealing and for the sense of relief and gratiﬁ cation that follows 
an episode.
Pathological Gambling
The DSM-IV-TR deﬁ nes “pathological gambling” as “persistent 
and recurrent maladaptive gambling behavior that disrupts per-
sonal, family, or vocational pursuits” (APA, 2000, p. 671). The 
preoccupation with gambling, and the impulse to gamble, in-
tensiﬁ es when the individual is under stress. Many pathological 
gamblers exhibit characteristics associated with narcissism and 
grandiosity and often have difﬁ culties with intimacy, empathy, 
and trust.
Pyromania
Pyromania is the inability to resist the impulse to set ﬁ res. The 
act itself is preceded by tension or affective arousal, and the indi-
vidual experiences intense pleasure, gratiﬁ cation, or relief when 
setting the ﬁ res, witnessing their effects, or participating in 
their aftermath (APA, 2000). Motivation for the behavior is self-
gratiﬁ cation, and even though some individuals with pyromania 
may take precautions to avoid apprehension, many are totally 
indifferent to the consequences of their behavior.
Trichotillomania
This disorder is deﬁ ned by the DSM-IV-TR as “the recurrent 
pulling out of one’s own hair that results in noticeable hair loss” 
(APA, 2000, p. 674). The impulse is preceded by an increasing 
sense of tension, and the individual experiences a sense of release 
or gratiﬁ cation from pulling out the hair.
Predisposing Factors to Impulse Control 
Disorders 
 1. Physiological
 a. Genetics. A familial tendency appears to be a factor in 
some cases of intermittent explosive disorder and patho-
logical gambling.
 b. Physical Factors. Brain trauma or dysfunction and mental 
retardation have also been implicated in the predisposi-
tion to impulse control disorders.
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 2. Psychosocial
 a. Family Dynamics. Various dysfunctional family patterns 
have been suggested as contributors in the predisposition 
to impulse control disorders. These include the following:
 • Child abuse or neglect
 • Parental rejection or abandonment
 • Harsh or inconsistent discipline
 • Emotional deprivation
 • Parental substance abuse
 • Parental unpredictability
Symptomatology (Subjective and Objective 
Data)
 1. Sudden inability to control violent, aggressive impulses
 2. Aggressive behavior accompanied by confusion or amnesia
 3. Feelings of remorse following aggressive behavior
 4. Inability to resist impulses to steal
 5. Increasing tension before committing the theft, followed by 
pleasure or relief during and following the act
 6. Sometimes discards, returns, or hides stolen items
 7. Inability to resist impulses to gamble
 8. Preoccupation with ways to obtain money with which to 
gamble
 9. Increasing tension that is relieved only by placing a bet
 10. The need to gamble or loss of money interferes with social 
and occupational functioning
 11. Inability to resist the impulse to set ﬁ res
 12. Increasing tension that is relieved only by starting a ﬁ re
 13. Inability to resist impulses to pull out one’s own hair
 14. Increasing tension followed by a sense of release or gratiﬁ ca-
tion from pulling out the hair
 15. Hair-pulling may be accompanied by other types of self-
mutilation (e.g., head-banging, biting, scratching)
Common Nursing Diagnoses 
and Interventions
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.)
●
 RISK FOR OTHER-DIRECTED 
VIOLENCE
Deﬁ nition: At risk for behaviors in which an individual demon-
strates that he or she can be physically, emotionally, and/or sexu-
ally harmful to others.
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Related/Risk Factors (“related to”)
[Possible familial tendency]
[Dysfunctional family system, resulting in behaviors such as the 
following:
Child abuse or neglect
Parental rejection or abandonment
Harsh or inconsistent discipline
Emotional deprivation
Parental substance abuse
Parental unpredictability]
Body language (e.g., rigid posture, clenching of ﬁ sts and 
jaw, hyperactivity, pacing, breathlessness, threatening 
stances)
History of threats of violence [toward others or of destruc-
tion to the property of others]
Impulsivity
Neurological impairment
Cognitive impairment
Goals/Objectives
Short-term Goal
Client will recognize signs of increasing tension, anxiety, and 
agitation, and report to staff (or others) for assistance with inter-
vention (time dimension to be individually determined).
Long-term Goal
Client will not harm others or the property of others (time 
dimension to be individually determined).
Interventions with Selected Rationales
 1. Convey an accepting attitude toward the client. Feelings of 
rejection are undoubtedly familiar to him or her. Work on the 
development of trust. Be honest, keep all promises, and con-
vey the message that it is not the person but the behavior that is 
unacceptable. An attitude of acceptance promotes feelings of 
self-worth. Trust is the basis of a therapeutic relationship.
 2. Maintain low level of stimuli in client’s environment (low 
lighting, few people, simple decor, low noise level). A stimu-
lating environment may increase agitation and promote 
aggressive behavior. Make the client’s environment as safe 
as possible by removing all potentially dangerous objects.
 3. Help client identify the true object of his or her hostility. 
Because of weak ego development, client may be unable to 
use ego defense mechanisms correctly. Helping him or her 
recognize this in a nonthreatening manner may help reveal 
unresolved issues so that they may be confronted.
 4. Staff should maintain and convey a calm attitude. Anxiety 
is contagious and can be transferred from staff to client. A 
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calm attitude provides the client with a feeling of safety and 
security.
 5. Help client recognize the signs that tension is increasing 
and ways in which violence can be averted. Activities that 
require physical exertion are helpful in relieving pent-up 
tension.
 6. Explain to the client that should explosive behavior occur, 
staff will intervene in whatever way is required (e.g., tran-
quilizing medication, restraints, isolation) to protect client 
and others. This conveys to the client evidence of control 
over the situation and provides a feeling of safety and 
security. 
Outcome Criteria
 1. Anxiety is maintained at a level at which client feels no need 
for aggression.
 2. The client is able to verbalize the symptoms of increasing 
tension and adaptive ways of coping with it.
 3. The client is able to inhibit the impulse for violence and 
aggression. 
●
 RISK FOR SELF-MUTILATION
Deﬁ nition: At risk for deliberate self-injurious behavior causing 
tissue damage with the intent of causing nonfatal injury to attain 
relief of tension.
Related/Risk Factors (“related to”)
[Central nervous system trauma]
[Mental retardation]
[Early emotional deprivation]
[Parental rejection or abandonment]
[Child abuse or neglect]
[History of self-mutilative behaviors in response to increasing 
anxiety: hair-pulling, biting, head-banging, scratching]
Goals/Objectives
Short-term Goals
 1. Client will cooperate with plan of behavior modiﬁ cation in 
an effort to respond more adaptively to stress (time dimen-
sion ongoing).
 2. Client will not harm self. 
Long-term Goal
Client will not harm self.
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Interventions with Selected Rationales
 1. Intervene to protect client when self-mutilative behaviors, 
such as head-banging or hair-pulling, become evident. The 
nurse is responsible for ensuring client safety.
 2. A helmet may be used to protect against head-banging, hand 
mitts to prevent hair-pulling, and appropriate padding to pro-
tect extremities from injury during hysterical movements.
 3. Try to determine if self-mutilative behaviors occur in re-
sponse to increasing anxiety, and if so, to what the anxiety 
may be attributed. Self-mutilative behaviors may be averted 
if the cause can be determined.
 4. Work on one-to-one basis with client to establish trust.
 5. Assist with plan for behavior modiﬁ cation in an effort to 
teach the client more adaptive ways of responding to stress.
 6. Encourage client to discuss feelings, particularly anger, in an 
effort to confront unresolved issues and expose internalized 
rage that may be triggering self-mutilative behaviors.
 7. Offer self to client during times of increasing anxiety, to pro-
vide feelings of security and decrease need for self-mutilative 
behaviors. 
Outcome Criteria
 1. Anxiety is maintained at a level at which client feels no need 
for self-mutilation.
 2. Client demonstrates ability to use adaptive coping strategies 
in the face of stressful situations. 
● INEFFECTIVE COPING
Deﬁ nition: Inability to form a valid appraisal of the stressors, in-
adequate choices of practiced responses, and/or inability to use 
available resources.
Possible Etiologies (“related to”)
[Possible hereditary factors]
[Brain trauma or dysfunction]
[Mental retardation]
[Dysfunctional family system, resulting in behaviors such as the 
following:
Child abuse or neglect
Parental rejection or abandonment
Harsh or inconsistent discipline
Emotional deprivation
Parental substance abuse
Parental unpredictability]
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Deﬁ ning Characteristics (“evidenced by”)
[Inability to control impulse of violence or aggression]
[Inability to control impulse to steal]
[Inability to control impulse to gamble]
[Inability to control impulse to set ﬁ res]
[Inability to control impulse to pull out own hair]
[Feeling of intense anxiety and tension that precedes, and is 
relieved by, engaging in these impulsive behaviors]
Goals/Objectives
Short-term Goal
Client will verbalize adaptive ways to cope with stress by means 
other than impulsive behaviors (time dimension to be individu-
ally determined).
Long-term Goal
Client will be able to delay gratiﬁ cation and use adaptive coping 
strategies in response to stress (time dimension to be individu-
ally determined).
Interventions with Selected Rationales
 1. Help client gain insight into his or her behaviors. Often these 
individuals rationalize to such an extent that they deny that 
what they have done is wrong. Client must come to under-
stand that certain behaviors will not be tolerated within the 
society and that severe consequences will be imposed on those 
individuals who refuse to comply. Client must WANT to 
become a productive member of society before he or she can 
be helped.
 2. Talk about past behaviors with client. Discuss behaviors that 
are acceptable by societal norms and those that are not. Help 
client identify ways in which he or she has exploited others. 
Encourage client to explore how he or she would feel if the 
circumstances were reversed. An attempt may be made to 
enlighten the client to the sensitivity of others by promoting 
self-awareness in an effort to assist the client gain insight 
into his or her own behavior.
 3. Throughout relationship with client, maintain attitude of “It 
is not you, but your behavior, that is unacceptable.” An attitude 
of acceptance promotes feelings of dignity and self-worth.
 4. Work with client to increase the ability to delay gratiﬁ cation. 
Reward desirable behaviors, and provide immediate positive 
feedback. Rewards and positive feedback enhance self-esteem 
and encourage repetition of desirable behaviors.
 5. Help client identify and practice more adaptive strategies for 
coping with stressful life situations. The impulse to perform 
the maladaptive behavior may be so great that the client is 
unable to see any other alternatives to relieve stress. 
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Outcome Criteria
 1. Client is able to demonstrate techniques that may be used in 
response to stress to prevent resorting to maladaptive impul-
sive behaviors.
 2. Client verbalizes understanding that behavior is unaccept-
able and accepts responsibility for own behavior. 
 INTERNET REFERENCES 
 • Additional information about impulse control disorders may 
be located at the following websites:
 a. http://www.ncpgambling.org/
 b. http://www.gamblersanonymous.org/ 
 c. http://www.crescentlife.com/disorders/pyromania.htm
 d. http://www.biopsychiatry.com/klepto.htm
 e. http://www.enotes.com/medicine-encyclopedia/impulse-
control-disorders
 f. http://emedicine.medscape.com/article/915057-overview
 g. http://emedicine.medscape.com/article/294626-overview
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Psychological Factors 
Affecting Medical 
Condition
● BACKGROUND ASSESSMENT DATA
The American Psychiatric Association (APA, 2000, p. 731) Di-
agnostic and Statistical Manual of Mental Disorders, Fourth Edition, 
Text Revision (DSM-IV-TR) identiﬁ es “psychological factors 
affecting medical condition” as “the presence of one or more 
speciﬁ c psychological or behavioral factors that adversely affect 
a general medical condition.” These factors can adversely affect 
the medical condition in several ways:
 1. By inﬂ uencing the course of the medical condition (i.e., con-
tributing to the development or exacerbation of, or delayed 
recovery from, the medical condition).
 2. By interfering with treatment of the medical condition.
 3. By constituting an additional health risk for the individual 
(e.g., the individual who has peptic ulcers who continues to 
drink and smoke).
Several types of psychological factors are implicated by the 
DSM-IV-TR as those that can affect the general medical condi-
tion. They include:
 1. Mental disorders (e.g., Axis I disorders, such as major 
depression).
 2. Psychological symptoms (e.g., depressed mood or anxiety).
 3. Personality traits or coping style (e.g., denial of the need for 
medical care).
 4. Maladaptive health behaviors (e.g., smoking or overeating).
 5. Stress-related physiological responses (e.g., tension head-
aches).
 6. Other or unspeciﬁ ed psychological factors (e.g., interpersonal 
or cultural factors).
264
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Deﬁ ned
This diagnosis is indicated when there is evidence of a physi-
cal symptom(s) or a physical disorder that is adversely affected 
by psychological factors. The DSM-IV-TR (APA, 2000) 
states,
Psychological and behavioral factors may affect the course of 
almost every major category of disease, including cardiovascular 
conditions, dermatological conditions, endocrinological condi-
tions, gastrointestinal conditions, neoplastic conditions, neuro-
logical conditions, pulmonary conditions, renal conditions, and 
rheumatological conditions (p. 732).
This category differs from somatoform disorders and 
conversion disorders in that there is evidence of either de-
monstrable organic pathology (e.g., the inﬂ ammation as-
sociated with rheumatoid arthritis) or a known pathophysi-
ological process (e.g., the cerebral vasodilation of migraine 
headaches).
Predisposing Factors
 1. Physiological
 a. Physical Factors. Selye (1956) believed that psychophysi-
ological disorders can occur when the body is exposed to 
prolonged stress, producing a number of physiological 
effects under direct control of the pituitary-adrenal axis. 
He also suggests that genetic predisposition inﬂ uences 
which organ system will be affected and determines the 
type of psychophysiological disorder the individual will 
develop.
 2. Psychosocial
 a. Emotional Response Pattern. It has been hypothesized 
that individuals exhibit speciﬁ c physiological responses to 
certain emotions. For example, in response to the emo-
tion of anger, one person may experience peripheral va-
soconstriction, resulting in an increase in blood pressure. 
The same emotion, in another individual, may evoke the 
response of cerebral vasodilation, manifesting a migraine 
headache.
 b. Personality Traits. Various studies have suggested that 
individuals with speciﬁ c personality traits are predisposed 
to certain disease processes. Although personality cannot 
account totally for the development of psychophysiologi-
cal disorders, the literature has alluded to the following 
possible relationships:
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Asthma  Dependent personality characteristics
Ulcers, hypertension Repressed anger
Cancer  Depressive personality
Rheumatoid arthritis, ulcerative colitis Self-sacrifi cing; suppressed anger
Migraine headaches  Compulsive and perfectionistic
Coronary heart disease Aggressive and competitive
 c. Learning Theory. A third psychosocial theory considers 
the role of learning in the psychophysiological response 
to stress. If a child grows up observing the attention, 
increased dependency, or other secondary gain an indi-
vidual receives because of the illness, such behaviors may 
be viewed as desirable responses and subsequently imi-
tated by the child.
 d. Theory of Family Dynamics. This theory relates to the 
predisposition of those individuals who are members of 
dysfunctional family systems to use psychophysiological 
problems to cover up interpersonal conﬂ icts. The anxi-
ety in a dysfunctional family situation is shifted from 
the conﬂ ict to the ailing individual. Anxiety decreases, 
the conﬂ ict is avoided, and the person receives positive 
reinforcement for his or her symptoms. The situation 
appears more comfortable, but the real problem remains 
unresolved.
Symptomatology (Subjective and Objective 
Data)
 1. Complaints of physical illness that can be substantiated by 
objective evidence of physical pathology or known patho-
physiological process
 2. Moderate to severe level of anxiety
 3. Denial of emotional problems; client is unable to see a 
relationship between physical problems and response to 
stress
 4. Use of physical illness as excuse for noncompliance with 
psychiatric treatment plan
 5. Repressed anger or anger expressed inappropriately
 6. Verbal hostility
 7. Depressed mood
 8. Low self-esteem
 9. Dependent behaviors
 10. Attention-seeking behaviors
 11. Report (or other evidence) of numerous stressors occurring 
in person’s life
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Common Nursing Diagnoses 
and Interventions*
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.)
● INEFFECTIVE COPING
Deﬁ nition: Inability to form a valid appraisal of the stressors, 
inadequate choices of practiced responses, and/or inability to use 
available resources.
Possible Etiologies (“related to”)
[Repressed anxiety]
[Inadequate support systems]
[Inadequate coping methods]
[Low self-esteem]
[Unmet dependency needs]
[Negative role modeling]
[Dysfunctional family system]
Deﬁ ning Characteristics (“evidenced by”)
[Initiation or exacerbation of physical illness (specify)]
[Denial of relationship between physical symptoms and emo-
tional problems]
[Use of sick role for secondary gains]
Inability to meet role expectations
Inadequate problem-solving
Goals/Objectives
Short-term Goals
 1. Within 1 week, client will verbalize understanding of 
correlation between emotional problems and physical 
symptoms.
 2. Within 1 week, client will verbalize adaptive ways of coping 
with stressful situations. 
*  A number of nursing diagnoses common to speciﬁ c physical disorders 
or symptoms could be used (e.g., pain, activity intolerance, impaired 
tissue integrity, diarrhea). For purposes of this chapter, only nursing 
diagnoses common to the general category are presented.
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Long-term Goal
Client will achieve physical wellness and demonstrate the ability 
to prevent exacerbation of physical symptoms as a coping mech-
anism in response to stress.
Interventions with Selected Rationales
 1. Perform thorough physical assessment in order to deter-
mine specifi c care required for client’s physical condition. 
Monitor laboratory values, vital signs, intake and output, 
and other assessments necessary to maintain an accurate, 
ongoing appraisal.
 2. Together with the client, identify goals of care and ways in 
which client believes he or she can best achieve those goals. 
Client may need assistance with problem-solving. Personal 
involvement in his or her care provides a feeling of control 
and increases chances for positive outcomes.
 3. Encourage client to discuss current life situations that he 
or she perceives as stressful and the feelings associated with 
each. Verbalization of true feelings in a nonthreatening en-
vironment may help client come to terms with unresolved 
issues.
 4. During client’s discussion, note times during which a sense 
of powerlessness or loss of control over life situations emerges. 
Focus on these times and discuss ways in which the client may 
maintain a feeling of control. A sense of self-worth develops 
and is maintained when an individual feels power over his 
or her own life situations.
 5. As client becomes able to discuss feelings more openly, as-
sist him or her, in a nonthreatening manner, to relate certain 
feelings to the appearance of physical symptoms. Client may 
be unaware of the relationship between physical symptoms 
and emotional problems.
 6. Discuss stressful times when physical symptoms did not 
appear and the adaptive coping strategies that were used dur-
ing those situations. Therapy is facilitated by considering 
areas of strength and using them to the client’s benefi t.
 7. Provide positive reinforcement for adaptive coping mecha-
nisms identiﬁ ed or used. Suggest alternative coping strategies 
but allow client to determine which can most appropriately be 
incorporated into his or her lifestyle. Positive reinforcement 
enhances self-esteem and encourages repetition of desirable 
behaviors. Client may require assistance with problem-solving
but must be allowed and encouraged to make decisions 
independently.
 8. Help client to identify a resource within the community 
(friend, signiﬁ cant other, group) to use as a support system 
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for the expression of feelings. A positive support system 
may help to prevent maladaptive coping through physical 
illness.
Outcome Criteria
 1. Client is able to demonstrate techniques that may be used in 
response to stress to prevent the occurrence or exacerbation 
of physical symptoms.
 2. Client verbalizes an understanding of the relationship 
between emotional problems and physical symptoms.
●
 LOW SELF-ESTEEM
Deﬁ nition: Negative self-evaluating/feelings about self or self-
capabilities.
Possible Etiologies (“related to”)
Repeated negative reinforcement
[Unmet dependency needs]
[Retarded ego development]
[Dysfunctional family system]
Deﬁ ning Characteristics (“evidenced by”)
Rejects positive feedback about self
[Nonparticipation in therapy]
Self-negating verbalizations
Evaluation of self as unable to deal with events
Hesitant to try new things or situations [because of fear of 
failure]
[Hypersensitive to slight or criticism]
Lack of eye contact
[Inability to form close, personal relationships]
[Degradation of others in an attempt to increase own feelings 
of self-worth]
Goals/Objectives
Short-term Goals
 1. Client will discuss fear of failure with nurse within 3 days.
 2. Client will verbalize aspects he or she likes about self within 
5 days. 
Long-term Goals
 1. Client will exhibit increased feelings of self-worth as evi-
denced by verbal expression of positive aspects about self, 
past accomplishments, and future prospects.
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 2. Client will exhibit increased feelings of self-worth by setting 
realistic goals and trying to reach them, thereby demonstrat-
ing a decrease in fear of failure.
Interventions with Selected Rationales
 1. Ensure that goals are realistic. It is important for client to 
achieve something, so plan activities in which success is likely. 
Success increases self-esteem.
 2. Minimize amount of attention given to physical symptoms. 
Client must perceive self as a worthwhile person, separate 
and apart from the role of client. Lack of attention may 
discourage use of undesirable behaviors.
 3. Promote your acceptance of client as a worthwhile person 
by spending time with him or her. Develop trust through 
one-to-one interactions, then encourage client to participate 
in group activities. Support group attendance with your pres-
ence until client feels comfortable attending alone. The feel-
ing of acceptance by others increases self-esteem.
 4. Ask client to make a written list of positive and negative as-
pects about self. Discuss each item on the list with client. 
Develop plans of change for the characteristics viewed as 
negative. Assist client in implementing the plans. Provide 
positive feedback for successful change. Individuals with low 
self-esteem often have diffi culty recognizing their positive 
attributes. They may also lack problem-solving skills and 
require assistance to formulate a plan for implementing the 
desired changes. Positive feedback enhances self-esteem and 
encourages repetition of desired behaviors.
 5. Avoid fostering dependence by “doing for” the client. Allow 
client to perform as independently as physical condition will 
permit. Offer recognition and praise for accomplishments. The 
ability to perform self-care activities independently provides 
a feeling of self-control and enhances self-esteem. Positive re-
inforcement encourages repetition of the desirable behavior.
 6. Allow client to be an active participant in his or her therapy. 
Promote feelings of control or power by encouraging input 
into the decision-making regarding treatment and for plan-
ning discharge from treatment. Provide positive feedback for 
adaptive responses. Control over own life experiences pro-
motes feelings of self-worth.
Outcome Criteria
 1. Client verbalizes positive perception of self.
 2. Client demonstrates ability to manage own self-care, make 
independent decisions, and use problem-solving skills.
 3. Client sets goals that are realistic and works to achieve those 
goals without evidence of fear of failure.
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●
 INEFFECTIVE ROLE PERFORMANCE
Deﬁ nition: Patterns of behavior and self-expression that do not 
match the environmental context, norms, and expectations.
Possible Etiologies (“related to”)
[Physical illness accompanied by real or perceived disabling 
symptoms]
[Unmet dependency needs]
[Dysfunctional family system]
Deﬁ ning Characteristics (“evidenced by”)
Change in self-perception of role
Change in [physical] capacity to resume role
[Assumption of dependent role]
Change in usual patterns of responsibility [because of conﬂ ict 
within dysfunctional family system]
Goals/Objectives
Short-term Goal
Client will verbalize understanding that physical symptoms in-
terfere with role performance in order to ﬁ ll an unmet need.
Long-term Goal
Client will be able to assume role-related responsibilities by time 
of discharge from treatment.
Interventions with Selected Rationales
 1. Determine client’s usual role within the family system. Iden-
tify roles of other family members. An accurate database is 
required in order to formulate appropriate plan of care for 
the client.
 2. Assess speciﬁ c disabilities related to role expectations. 
Assess relationship of disability to physical condition. 
It is important to determine the realism of client’s role 
expectations.
 3. Encourage client to discuss conﬂ icts evident within the fam-
ily system. Identify ways in which client and other family 
members have responded to these conﬂ icts. It is necessary to 
identify specifi c stressors, as well as adaptive and maladap-
tive responses within the system, before assistance can be 
provided in an effort to create change.
 4. Help client identify feelings associated with family conﬂ ict, 
the subsequent exacerbation of physical symptoms, and the 
accompanying disabilities. Client may be unaware of the 
relationship between physical symptoms and emotional 
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problems. An awareness of the correlation is the fi rst step 
toward creating change.
 5. Help client identify changes he or she would like to occur 
within the family system. Encourage family participation in 
the development of plans to effect positive change, and work 
to resolve the conﬂ ict for which the client’s sick role provides 
relief. Input from the individuals who will be directly in-
volved in the change will increase the likelihood of a positive 
outcome.
 6. Allow all family members input into the plan for change: 
knowledge of beneﬁ ts and consequences for each alternative, 
selection of appropriate alternatives, methods for implemen-
tation of alternatives, and an alternate plan in the event ini-
tial change is unsuccessful. Family may require assistance 
with this problem-solving process.
 7. Ensure that client has accurate perception of role expecta-
tions within the family system. Use role-playing to practice 
areas associated with his or her role that client perceives as 
painful. Repetition through practice may help to desensitize 
client to the anticipated distress.
 8. As client is able to see the relationship between exacerba-
tion of physical symptoms and existing conﬂ ict, discuss more 
adaptive coping strategies that may be used to prevent inter-
ference with role performance during times of stress.
CLINICAL PEARL  Coping strategies are very individual, and only the client 
knows what will work for him or her. The nurse may make suggestions and help 
the client practice through role-play, but the client alone must decide what will be 
adaptive in his or her personal situation. The nurse must be careful not to impose 
on the client ideas that the nurse thinks are more appropriate but which may not be 
adaptive for the client.
Outcome Criteria
 1. Client is able to verbalize realistic perception of role 
expectations.
 2. Client is physically able to assume role-related responsibilities.
 3. Client and family are able to verbalize plan for attempt at 
conﬂ ict resolution.
●
 DEFICIENT KNOWLEDGE 
(PSYCHOLOGICAL FACTORS 
AFFECTING MEDICAL CONDITION)
Deﬁ nition: Absence or defi ciency of cognitive information related 
to a specifi c topic.
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Possible Etiologies (“related to”)
Lack of interest in learning
[Severe level of anxiety]
[Low self-esteem]
[Regression to earlier level of development]
Deﬁ ning Characteristics (“evidenced by”)
[Denial of emotional problems]
[Statements such as, “I don’t know why the doctor put me on the 
psychiatric unit. I have a physical problem.”]
[History of numerous exacerbations of physical illness]
[Noncompliance with psychiatric treatment]
Inappropriate or exaggerated behaviors (e.g., hysterical, hostile, 
agitated, apathetic)
Goals/Objectives
Short-term Goal
Client will cooperate with plan for teaching provided by pri-
mary nurse.
Long-term Goal
By time of discharge from treatment, client will be able to verbal-
ize psychological factors affecting his or her medical condition.
Interventions with Selected Rationales
 1. Assess client’s level of knowledge regarding effects of psy-
chological problems on the body. An adequate database is 
necessary for the development of an effective teaching plan.
 2. Assess client’s level of anxiety and readiness to learn. Learn-
ing does not occur beyond the moderate level of anxiety.
 3. Discuss physical examinations and laboratory tests that have 
been conducted. Explain purpose and results of each. Fear 
of the unknown may contribute to elevated level of anxiety. 
The client has the right to know about and accept or refuse 
any medical treatment.
 4. Explore client’s feelings and fears. Go slowly. These feelings 
may have been suppressed or repressed for so long that their 
disclosure may be very painful. Be supportive. Verbalization 
of feelings in a nonthreatening environment and with a 
trusting individual may help the client come to terms with 
unresolved issues.
 5. Have client keep a diary of appearance, duration, and intensi-
ty of physical symptoms. A separate record of situations that 
the client ﬁ nds especially stressful should also be kept. Com-
parison of these records may provide objective data from 
which to observe the relationship between physical symptoms 
and stress.
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 6. Help client identify needs that are being met through the 
sick role. Together, formulate more adaptive means for 
fulﬁ lling these needs. Practice by role-playing. Repetition 
through practice serves to reduce discomfort in the actual 
situation.
 7. Provide instruction in assertiveness techniques, especial-
ly the ability to recognize the differences among passive, 
assertive, and aggressive behaviors and the importance of
respecting the human rights of others while protecting one’s 
own basic human rights. These skills will preserve client’s 
self-esteem while also improving his or her ability to form 
satisfactory interpersonal relationships.
 8. Discuss adaptive methods of stress management such as 
relaxation techniques, physical exercise, meditation, breath-
ing exercises, and autogenics. Use of these adaptive tech-
niques may decrease appearance of physical symptoms in 
response to stress.
Outcome Criteria
 1. Client verbalizes an understanding of the relationship 
between psychological stress and exacerbation of physical 
illness.
 2. Client demonstrates the ability to use adaptive coping strate-
gies in the management of stress.
 INTERNET REFERENCES 
 • Additional information about psychophysiological disorders 
discussed in this chapter may be located at the following 
websites:
 a. http://www.cancer.gov/
 b. http://www.cancer.org
 c. http://www.heart.org/HEARTORG/
 d. http://www.headaches.org/
 e. http://www.pslgroup.com/ASTHMA.HTM
 f. http://www.gastro.org/
 g. http://www.pslgroup.com/HYPERTENSION.HTM
 h. http://www.arthritis.org
 i. http://digestive.niddk.nih.gov/ddiseases/pubs/colitis/
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Personality Disorders
● BACKGROUND ASSESSMENT DATA
The American Psychiatric Association (APA, 2000, p. 686) Di-
agnostic and Statistical Manual of Mental Disorders, Fourth Edition, 
Text Revision (DSM-IV-TR) describes personality traits as “en-
during patterns of perceiving, relating to, and thinking about 
the environment and oneself that are exhibited in a wide range 
of social and personal contexts.” A personality disorder is said to 
exist only when these traits become inﬂ exible and maladaptive 
and cause either signiﬁ cant functional impairment or subjective 
distress.
The DSM-IV-TR groups the personality disorders into three 
clusters. They are coded on Axis II in the DMS-IV-TR Classi-
ﬁ cation. These clusters, and the disorders classiﬁ ed under each, 
are described as follows:
 1. Cluster A: Behaviors described as odd or eccentric
 a. Paranoid personality disorder
 b. Schizoid personality disorder
 c. Schizotypal personality disorder
 2. Cluster B: Behaviors described as dramatic, emotional, or 
erratic
 a. Antisocial personality disorder
 b. Borderline personality disorder
 c. Histrionic personality disorder
 d. Narcissistic personality disorder
 3. Cluster C: Behaviors described as anxious or fearful
 a. Avoidant personality disorder
 b. Dependent personality disorder
 c. Obsessive-compulsive personality disorder
 d. Passive-aggressive personality disorder
Note: The third edition of the DSM included passive-aggressive 
personality disorder in Cluster C. In the DSM-IV-TR, this dis-
order is included in the section on Criteria Provided for Further 
Study. For purposes of this text, passive-aggressive personality 
disorder is described with the cluster C disorders.
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Categories of personality disorders described by the DSM-IV-TR 
include the following:
 1. Cluster A
 a. Paranoid Personality Disorder. The essential feature is 
a pervasive and unwarranted suspiciousness and mistrust 
of people. There is a general expectation of being exploit-
ed or harmed by others in some way. Symptoms include 
guardedness in relationships with others, pathological 
jealousy, hypersensitivity, inability to relax, unemotional-
ity, and lack of a sense of humor. These individuals are 
very critical of others but have much difﬁ culty accepting 
criticism themselves.
 b. Schizoid Personality Disorder. This disorder is character-
ized by an inability to form close, personal relationships. 
Symptoms include social isolation; absence of warm, ten-
der feelings for others; indifference to praise, criticism, 
or the feelings of others; and ﬂ at, dull affect (appears cold 
and aloof).
 c. Schizotypal Personality Disorder. This disorder is char-
acterized by peculiarities of ideation, appearance, and be-
havior, and deﬁ cits in interpersonal relatedness that are 
not severe enough to meet the criteria for schizophrenia. 
Symptoms include magical thinking; ideas of reference; 
social isolation; illusions; odd speech patterns; aloof, cold, 
suspicious behavior; and undue social anxiety.
 2. Cluster B
 a. Antisocial Personality Disorder. This disorder is charac-
terized by a pattern of socially irresponsible, exploitative, 
and guiltless behavior, as evidenced by the tendency to 
fail to conform to the law, to sustain consistent employ-
ment, to exploit and manipulate others for personal gain, 
to deceive, and to fail to develop stable relationships. The 
individual must be at least 18 years of age and have a his-
tory of conduct disorder before the age of 15. (Symptoms 
of this disorder are identiﬁ ed later in this chapter, along 
with predisposing factors and nursing care.)
 b. Borderline Personality Disorder. The features of this dis-
order are described as marked instability in interpersonal 
relationships, mood, and self-image. The instability is sig-
niﬁ cant to the extent that the individual seems to hover on 
the border between neurosis and psychosis. (Symptoms of 
this disorder are identiﬁ ed later in this chapter, along with 
predisposing factors and nursing care.)
 c. Histrionic Personality Disorder. The essential feature of 
this disorder is described by the DSM-IV-TR as a “perva-
sive pattern of excessive emotionality and attention-seeking 
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behavior” (APA, 2000, p. 711). Symptoms include exagger-
ated expression of emotions, incessant drawing of atten-
tion to oneself, overreaction to minor events, constantly 
seeking approval from others, egocentricity, vain and de-
manding behavior, extreme concern with physical appear-
ance, and inappropriately sexually seductive appearance or 
behavior.
 d. Narcissistic Personality Disorder. This disorder is char-
acterized by a grandiose sense of self-importance; pre-
occupation with fantasies of success, power, brilliance, 
beauty, or ideal love; a constant need for admiration 
and attention; exploitation of others for fulﬁ llment of own 
desires; lack of empathy; response to criticism or failure 
with indifference or humiliation and rage; and preoccupa-
tion with feelings of envy.
 3. Cluster C
 a. Avoidant Personality Disorder. This disorder is charac-
terized by social withdrawal brought about by extreme 
sensitivity to rejection. Symptoms include unwillingness 
to enter into relationships unless given unusually strong 
guarantees of uncritical acceptance; low self-esteem; and 
social withdrawal despite a desire for affection and accep-
tance. Depression and anxiety are common. Social phobia 
may be a complication of this disorder.
 b. Dependent Personality Disorder. Individuals with this 
disorder passively allow others to assume responsibility 
for major areas of life because of their inability to func-
tion independently. They lack self-conﬁ dence, are unable 
to make decisions, perceive themselves as helpless and stu-
pid, possess fear of being alone or abandoned, and seek 
constant reassurance and approval from others.
 c. Obsessive-Compulsive Personality Disorder. This dis-
order is characterized by a pervasive pattern of perfec-
tionism and inﬂ exibility. Interpersonal relationships have 
a formal and serious quality, and others often perceive 
these individuals as stilted or “stiff.” Other symptoms in-
clude difﬁ culty expressing tender feelings, insistence that 
others submit to his or her way of doing things, exces-
sive devotion to work and productivity to the exclusion 
of pleasure, indecisiveness, perfectionism, preoccupation 
with details, depressed mood, and being judgmental of 
self and others.
 d. Passive-Aggressive Personality Disorder. Characteristic 
of this disorder is a passive resistance to demands for ad-
equate performance in both occupational and social func-
tioning (APA, 2000). Symptoms include obstructionism, 
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procrastination, stubbornness, intentional inefﬁ ciency, 
dawdling, “forgetfulness,” criticism of persons in author-
ity, dependency, and low self-esteem. Oppositional deﬁ ant 
disorder in childhood or adolescence is a predisposing 
factor.
Many of the behaviors associated with the various personal-
ity disorders may be manifested by clients with virtually every 
psychiatric diagnosis, as well as by those individuals described as 
“healthy.” It is only when personality traits or styles repetitively 
interfere with an individual’s ability to function within age-
appropriate cultural and developmental expectations, disrupt 
interpersonal relationships, and distort a person’s pattern of per-
ception and thinking about the environment that a diagnosis of 
personality disorder is assigned.
Individuals with personality disorders may be encountered 
in all types of treatment settings. They are not often treated in 
acute care settings, but because of the instability of the borderline 
client, hospitalization is necessary from time to time. The indi-
vidual with antisocial personality disorder also may be hospital-
ized as an alternative to imprisonment when a legal determination 
is made that psychiatric intervention may be helpful. Because of 
these reasons, suggestions for inpatient care of individuals with 
these disorders are included in this chapter; however, these inter-
ventions may be used in other types of treatment settings as well. 
Undoubtedly, these clients represent the ultimate challenge for 
the psychiatric nurse.
● BORDERLINE PERSONALITY DISORDER
Deﬁ ned
This personality disorder is characterized by instability of 
affect, behavior, object relationships, and self-image. The term 
“borderline” came into being because these clients’ emotionally 
unstable behavior seems to fall on the border between neurotic 
and psychotic. Transient psychotic symptoms appear during 
periods of extreme stress. The disorder is more commonly diag-
nosed in women than in men.
Predisposing Factors to Borderline 
Personality Disorder
 1. Physiological
 a. Biochemical. Cummings and Mega (2003) have suggested 
a possible serotonergic defect in clients with borderline 
personality disorder. In positron emission tomography 
using α-[11C]methyl-l-tryptophan (α-[11C]MTrp), which 
reﬂ ects serotonergic synthesis capability, clients with bor-
derline personality demonstrated signiﬁ cantly decreased 
α-[11C]MTrp in medial frontal, superior temporal, and 
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striatal regions of the brain. Cummings and Mega (2003) 
stated:
These functional imaging studies support a medial and 
orbitofrontal abnormality that may promote the impulsive 
aggression demonstrated by patients with the borderline 
personality disorder (p. 230). 
 b. Genetic. The decrease in serotonin may also have genetic 
implications for borderline personality disorder. Sadock 
and Sadock (2007) report that depression is common in 
the family backgrounds of clients with borderline person-
ality disorder. They stated:
These patients have more relatives with mood disorders than 
do control groups, and persons with borderline personality 
disorder often have mood disorder as well (p. 791). 
 2. Psychosocial
 a. Childhood Trauma. Studies have shown that many indi-
viduals with borderline personality disorder were reared 
in families with chaotic environments. Lubit and Finley-
Belgrad (2008) stated, “Risk factors [for borderline per-
sonality disorder] include family environments character-
ized by trauma, neglect, and/or separation; exposure to 
sexual and physical abuse; and serious parental psychopa-
thology such as substance abuse and antisocial personality 
disorder.” From 40% to 71% of borderline personality dis-
order clients report having been sexually abused, usually 
by a noncaregiver (National Institute of Mental Health 
[NIMH], 2009). In some instances, this disorder has 
been likened to posttraumatic stress disorder in response 
to childhood trauma and abuse. Oldham and associates 
(2006) stated:
Even when full criteria for comorbid PTSD are not present, 
patients with borderline personality disorder may experi-
ence PTSD-like symptoms. For example, symptoms such as 
intrusion, avoidance, and hyperarousal may emerge during 
psychotherapy. Awareness of the trauma-related nature of 
these symptoms can facilitate both psychotherapeutic and 
pharmacological efforts in symptom relief (p. 1267).
 b. Theory of Object Relations. This theory suggests that 
the basis for borderline personality lies in the ways the 
child relates to the mother and does not separate from her. 
Mahler and associates (1975) deﬁ ne this process in a series 
of phases described as follows: 
  •  Phase 1 (Birth to 1 month), Autistic Phase. Most of 
the infant’s time is spent in a half-waking, half-sleeping 
state. The main goal is fulﬁ llment of needs for survival 
and comfort.
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 •  Phase 2 (1 to 5 months), Symbiotic Phase. A type of 
psychic fusion of mother and child. The child views the 
self as an extension of the parenting ﬁ gure, although 
there is a developing awareness of external sources of 
need fulﬁ llment.
 •  Phase 3 (5 to 10 months), Differentiation Phase. 
The child is beginning to recognize that there is separ-
ateness between the self and the parenting ﬁ gure.
 •  Phase 4 (10 to 16 months), Practicing Phase. This 
phase is characterized by increased locomotor function-
ing and the ability to explore the environment indepen-
dently. A sense of separateness of the self is increased.
 •  Phase 5 (16 to 24 months), Rapprochement Phase. 
Awareness of separateness of the self becomes acute. 
This is frightening to the child, who wants to regain 
some lost closeness but not return to symbiosis. The 
child wants the mother there as needed for “emotional 
refueling” and to maintain feelings of security.
 •  Phase 6 (24 to 36 months), On the Way to Object 
Constancy Phase. In this phase, the child completes the 
individuation process and learns to relate to objects in 
an effective, constant manner. A sense of separateness 
is established, and the child is able to internalize a sus-
tained image of the loved object or person when out of 
sight. Separation anxiety is resolved.
The theory of object relations suggests that the individual 
with borderline personality is ﬁ xed in the rapprochement phase 
of development. This ﬁ xation occurs when the mother begins to 
feel threatened by the increasing autonomy of her child and so 
withdraws her emotional support during those times or she may 
instead reward clinging, dependent behaviors. In this way, the 
child comes to believe that
“To grow up and be independent = a ‘bad’ child.”
“To stay immature and dependent = a ‘good’ child.”
“Mom withholds nurturing from ‘bad’ child.”
Consequently, the child develops a deep fear of abandon-
ment that persists into adulthood. In addition, because object 
constancy is never achieved, the child continues to view objects 
(people) as parts—either good or bad. This is called splitting, 
a primary defense mechanism of borderline personality.
Symptomatology (Subjective and Objective 
Data)
Individuals with borderline personality always seem to be in 
a state of crisis. Their affect is one of extreme intensity and 
their behavior reﬂ ects frequent changeability. These changes 
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can occur within days, hours, or even minutes. Often these 
individuals exhibit a single, dominant affective tone, such as 
depression, which may give way periodically to anxious agitation 
or inappropriate outbursts of anger.
Common symptoms include the following:
 1. Chronic depression. Depression is so common in clients 
with this disorder that before the inclusion of borderline 
personality disorder in the DSM, many of these clients were 
diagnosed as depressed. Depression occurs in response to 
feelings of abandonment by the mother in early childhood 
(see “Predisposing Factors”). Underlying the depression is a 
sense of rage that is sporadically turned inward on the self 
and externally on the environment. Seldom is the individual 
aware of the true source of these feelings until well into long-
term therapy.
 2. Inability to be alone. Because of this chronic fear of aban-
donment, clients with borderline personality disorder have 
little tolerance for being alone. They prefer a frantic search 
for companionship, no matter how unsatisfactory, to sitting 
with feelings of loneliness, emptiness, and boredom (Sadock 
& Sadock, 2007).
 3. Clinging and distancing. The client with borderline person-
ality disorder commonly exhibits a pattern of interaction with 
others that is characterized by clinging and distancing behav-
iors. When clients are clinging to another individual, they 
may exhibit helpless, dependent, or even childlike behaviors. 
They overidealize a single individual with whom they want 
to spend all their time, with whom they express a frequent 
need to talk, or from whom they seek constant reassurance. 
Acting-out behaviors, even self-mutilation, may result when 
they cannot be with this chosen individual. Distancing be-
haviors are characterized by hostility, anger, and devaluation 
of others, arising from a feeling of discomfort with closeness. 
Distancing behaviors also occur in response to separations, 
confrontations, or attempts to limit certain behaviors. Deval-
uation of others is manifested by discrediting or undermining 
their strengths and personal signiﬁ cance.
 4. Splitting. Splitting is a primitive ego defense mechanism that 
is common in people with borderline personality disorder. It 
arises from their lack of achievement of object constancy and 
is manifested by an inability to integrate and accept both posi-
tive and negative feelings. In their view, people—including 
themselves—and life situations are either all good or all bad. 
 5. Manipulation. In their efforts to prevent the separation 
they so desperately fear, clients with this disorder become 
masters of manipulation. Virtually any behavior becomes an 
acceptable means of achieving the desired result: relief from 
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separation anxiety. Playing one individual against another is 
a common ploy to allay these fears of abandonment.
 6. Self-destructive behaviors. Repetitive, self-mutilative be-
haviors, such as cutting, scratching, and burning, are classic 
manifestations of borderline personality disorder. Although 
these acts can be fatal, most commonly they are manipulative 
gestures designed to elicit a rescue response from signiﬁ cant 
others. Suicide attempts are not uncommon and often result 
from feelings of abandonment following separation from a 
signiﬁ cant other.
 7. Impulsivity. Individuals with borderline personality dis-
order have poor impulse control based on primary process 
functioning. Impulsive behaviors associated with borderline 
personality disorder include substance abuse, gambling, pro-
miscuity, reckless driving, and binging and purging (APA, 
2000). Many times these acting-out behaviors occur in 
response to real or perceived feelings of abandonment.
 8. Feelings of unreality. Transient episodes of extreme stress 
can precipitate periods of dissociation in the individual with 
borderline personality disorder.
 9. Rage reactions. Difﬁ culty controlling anger. 
Common Nursing Diagnoses 
and Interventions 
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.) 
●
 RISK FOR SELF-MUTILATION/
RISK FOR SELF-DIRECTED OR 
OTHER-DIRECTED VIOLENCE 
Deﬁ nition: At risk for deliberate self-injurious behavior causing 
tissue damage with the intent of causing nonfatal injury to attain 
relief of tension. At risk for behaviors in which an individual demon-
strates that he or she can be physically, emotionally, and/or sexu-
ally harmful either to self or to others.
Related/Risk Factors (“related to”)
[Extreme fears of abandonment]
[Feelings of unreality]
[Depressed mood]
[Use of suicidal gestures for manipulation of others]
[Unmet dependency needs]
Low self-esteem
[Unresolved grief]
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[Rage reactions]
[Physically self-damaging acts (cutting, burning, drug overdose, 
etc.)]
Body language (e.g., rigid posture, clenching of ﬁ sts and jaw, 
hyperactivity, pacing, breathlessness, threatening stances)
History or threats of violence toward self or others or of 
destruction to the property of others
Impulsivity
Suicidal ideation, plan, available means
History of suicide attempts
Goals/Objectives
Short-term Goals
 1. Client will seek out staff member if feelings of harming self 
or others emerge.
 2. Client will not harm self or others.
Long-term Goal
Client will not harm self or others.
Interventions with Selected Rationales 
 1. Observe client’s behavior frequently. Do this through rou-
tine activities and interactions; avoid appearing watchful and 
suspicious. Close observation is required so that intervention 
can occur if required to ensure client’s (and others’) safety.
 2. Secure a verbal contract from client that he or she will seek 
out a staff member when the urge for self-mutilation is expe-
rienced. Discussing feelings of self-harm with a trusted indi-
vidual provides some relief to the client. A contract gets the 
subject out in the open and places some of the responsibility 
for his or her safety with the client. An attitude of acceptance 
of the client as a worthwhile individual is conveyed.
 3. If self-mutilation occurs, care for the client’s wounds in a 
matter-of-fact manner. Do not give positive reinforcement 
to this behavior by offering sympathy or additional attention. 
Lack of attention to the maladaptive behavior may decrease 
repetition of its use.
 4. Encourage client to talk about feelings he or she was having just 
prior to this behavior. To problem-solve the situation with the 
client, knowledge of the precipitating factors is important.
 5. Act as a role model for appropriate expression of angry feel-
ings and give positive reinforcement to the client when at-
tempts to conform are made. It is vital that the client express 
angry feelings, because suicide and other self-destructive 
behaviors are often viewed as a result of anger turned 
inward on the self.
 6. Remove all dangerous objects from the client’s environment. 
Client safety is a nursing priority.
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 7. Try to redirect violent behavior with physical outlets for the 
client’s anxiety (e.g., punching bag, jogging). Physical exer-
cise is a safe and effective way of relieving pent-up tension.
 8. Have sufﬁ cient staff available to indicate a show of strength 
to the client if necessary. This conveys to the client evidence 
of control over the situation and provides some physical 
security for staff.
 9. Administer tranquilizing medications as ordered by physi-
cian or obtain an order if necessary. Monitor the client for 
effectiveness of the medication and for the appearance of 
adverse side effects. Tranquilizing medications such as 
anxiolytics or antipsychotics may have a calming effect on 
the client and may prevent aggressive behaviors.
 10. Use of mechanical restraints or isolation room may be 
required if less restrictive interventions are unsuccessful. 
Follow policy and procedure prescribed by the institu-
tion in executing this intervention. The Joint Commis-
sion (formerly the Joint Commission on Accreditation of 
Healthcare Organizations [ JCAHO]) requires that an in-
person evaluation (by a physician, clinical psychologist, or 
other licensed independent practitioner responsible for the 
care of the patient) be conducted within 1 hour of initiat-
ing restraint or seclusion (The Joint Commission, 2010). 
The physician must reevaluate and issue a new order for 
restraints every 4 hours for adults and every 1 to 2 hours 
for children and adolescents. 
 11. Observe the client in restraints every 15 minutes (or 
according to institutional policy). Ensure that circulation to 
extremities is not compromised (check temperature, color, 
pulses). Assist the client with needs related to nutrition, 
hydration, and elimination. Position the client so that com-
fort is facilitated and aspiration can be prevented. Client 
safety is a nursing priority.
 12. May need to assign staff on a one-to-one basis if warranted 
by acuity of the situation. Clients with borderline personal-
ity disorder have extreme fear of abandonment; leaving 
them alone at such a time may cause an acute rise in level 
of anxiety and agitation.
Outcome Criteria
 1. Client has not harmed self or others.
 2. Anxiety is maintained at a level in which client feels no need 
for aggression.
 3. Client denies any ideas of self-harm.
 4. Client verbalizes community support systems from which as-
sistance may be requested when personal coping strategies 
are unsuccessful.
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●
 ANXIETY (SEVERE TO PANIC)
Deﬁ nition: Vague uneasy feeling of discomfort or dread accom-
panied by an autonomic response (the source often nonspecifi c or 
unknown to the individual); a feeling of apprehension caused by an-
ticipation of danger. It is an alerting signal that warns of impending 
danger and enables the individual to take measures to deal with 
threat.
Possible Etiologies (“related to”)
Threat to self-concept
Unmet needs
[Extreme fear of abandonment]
Unconscious conﬂ icts [associated with ﬁ xation in earlier level of 
development]
Deﬁ ning Characteristics (“evidenced by”)
[Transient psychotic symptoms in response to severe stress, 
manifested by disorganized thinking, confusion, altered com-
munication patterns, disorientation, misinterpretation of the 
environment]
[Excessive use of projection (attributing own thoughts and feel-
ings to others)]
[Depersonalization (feelings of unreality)]
[Derealization (a feeling that the environment is unreal)]
[Acts of self-mutilation in an effort to ﬁ nd relief from feelings 
of unreality]
Goals/Objectives
Short-term Goal
Client will demonstrate use of relaxation techniques to maintain 
anxiety at manageable level.
Long-term Goal
Client will be able to recognize events that precipitate anxiety 
and intervene to prevent disabling behaviors.
Interventions with Selected Rationales
 1. Symptoms of depersonalization often occur at the panic level 
of anxiety. Clients with borderline personality disorder often 
resort to cutting or other self-mutilating acts in an effort to 
relieve the anxiety. Being able to feel pain or see blood is a 
reassurance of existence to the person. If injury occurs, care 
for the wounds in a matter-of-fact manner without providing 
reinforcement for this behavior. Lack of reinforcement may 
discourage repetition of the maladaptive behavior.
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 2. During periods of panic anxiety, stay with the client and provide 
reassurance of safety and security. Orient client to the reality of 
the situation. Client comfort and safety are nursing priorities.
 3. Administer tranquilizing medications as ordered by physi-
cian, or obtain order if necessary. Monitor client for effec-
tiveness of the medication as well as for adverse side effects. 
Antianxiety medications (e.g., lorazepam, chlordiazepoxide, 
alprazolam) provide relief from the immobilizing effects of 
anxiety and facilitate client’s cooperation with therapy.
 4. Correct misinterpretations of the environment as expressed by 
client. Confronting misinterpretations honestly, with a car-
ing and accepting attitude, provides a therapeutic orienta-
tion to reality and preserves the client’s feelings of dignity 
and self-worth.
 5. Encourage the client to talk about true feelings. Help him or 
her recognize ownership of these feelings rather than pro-
jecting them onto others in the environment. Exploration of 
feelings with a trusted individual may help the client per-
ceive the situation more realistically and come to terms with 
unresolved issues.
 6. Help client work toward achievement of object constancy. 
Client may feel totally abandoned when nurse or therapist 
leaves at shift change or at end of therapy session. There may 
even be feelings that the therapist ceases to exist. Leaving 
a signed note or card with the client for reassurance may 
help. It is extremely important for more than one nurse to 
develop a therapeutic relationship with the borderline client. 
It is also necessary that staff maintain open communication 
and consistency in the provision of care for these individu-
als. Individuals with borderline personality disorder have a 
tendency to cling to one staff member, if allowed, transfer-
ring their maladaptive dependency to that individual. This 
dependency can be avoided if the client is able to establish 
therapeutic relationships with two or more staff members 
who encourage independent self-care activities.
Outcome Criteria
 1. Client is able to verbalize events that precipitate anxiety and 
demonstrate techniques for its reduction.
 2. Client manifests no symptoms of depersonalization.
 3. Client interprets the environment realistically. 
●
 COMPLICATED GRIEVING
Deﬁ nition: A disorder that occurs after the death of a signifi cant 
other [or any other loss of signifi cance to the individual], in which 
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the experience of distress accompanying bereavement fails to fol-
low normative expectations and manifests in functional impairment.
Possible Etiologies (“related to”)
[Maternal deprivation during rapprochement phase of develop-
ment (internalized as a loss, with ﬁ xation in the anger stage of 
the grieving process)]
Deﬁ ning Characteristics (“evidenced by”)
Persistent emotional distress
[Anger]
[Internalized rage]
Depression
[Labile affect]
[Extreme fear of being alone (fear of abandonment)]
[Acting-out behaviors, such as sexual promiscuity, suicidal 
gestures, temper tantrums, substance abuse]
[Difﬁ culty expressing feelings]
[Altered activities of daily living]
[Reliving of past experiences with little or no reduction of 
intensity of the grief]
[Feelings of inadequacy; dependency]
Goals/Objectives
Short-term Goal
Client will discuss with nurse or therapist maladaptive patterns 
of expressing anger.
Long-term Goal
Client will be able to identify the true source of angry feelings, 
accept ownership of these feelings, and express them in a so-
cially acceptable manner, in an effort to satisfactorily progress 
through the grieving process.
Interventions with Selected Rationales
 1. Convey an accepting attitude—one that creates a nonthreat-
ening environment for the client to express feelings. Be hon-
est and keep all promises. An accepting attitude conveys to 
the client that you believe he or she is a worthwhile person. 
Trust is enhanced.
 2. Identify the function that anger, frustration, and rage serve 
for the client. Allow the client to express these feelings within 
reason. Verbalization of feelings in a nonthreatening envi-
ronment may help the client come to terms with unresolved 
issues.
 3. Encourage client to discharge pent-up anger through par-
ticipation in large motor activities (e.g., brisk walks, jogging, 
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physical exercises, volleyball, punching bag, exercise bike). 
Physical exercise provides a safe and effective method for 
discharging pent-up tension.
 4. Explore with client the true source of the anger. This is pain-
ful therapy that often leads to regression as the client deals 
with the feelings of early abandonment. It seems that some-
times the client must “get worse before he or she can get bet-
ter.” Reconciliation of the feelings associated with this stage 
is necessary before progression through the grieving process 
can continue.
 5. As anger is displaced onto the nurse or therapist, caution 
must be taken to guard against the negative effects of coun-
tertransference. These are very diffi cult clients who have 
the capacity for eliciting a whole array of negative feel-
ings from the therapist. The existence of negative feel-
ings by the nurse or therapist must be acknowledged, but 
they must not be allowed to interfere with the therapeutic 
process.
 6. Explain the behaviors associated with the normal grieving 
process. Help the client to recognize his or her position in 
this process. Knowledge of the acceptability of the feelings 
associated with normal grieving may help to relieve some of 
the guilt that these responses generate.
 7. Help client understand appropriate ways of expressing anger. 
Give positive reinforcement for behaviors used to express 
anger appropriately. Act as a role model. Positive rein-
forcement enhances self-esteem and encourages repetition 
of desirable behaviors. It is appropriate to let the client 
know when he or she has done something that has gener-
ated angry feelings in you. Role-modeling ways to express 
anger in an appropriate manner is a powerful learning 
tool.
 8. Set limits on acting-out behaviors and explain consequences 
of violation of those limits. Be supportive, yet consistent and 
ﬁ rm, in caring for this client. Client lacks suffi cient self-
control to limit maladaptive behaviors, so assistance is re-
quired from staff. Without consistency on the part of all 
staff members working with this client, a positive outcome 
will not be achieved. 
Outcome Criteria
 1. Client is able to verbalize how anger and acting-out behav-
iors are associated with maladaptive grieving.
 2. Client is able to discuss the original source of the anger 
and demonstrates socially acceptable ways of expressing the 
emotion. 
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●
 IMPAIRED SOCIAL INTERACTION
Deﬁ nition: Insuffi cient or excessive quantity or ineffective qual-
ity of social exchange.
Possible Etiologies (“related to”)
[Fixation in rapprochement phase of development]
[Extreme fears of abandonment and engulfment]
[Lack of personal identity]
Deﬁ ning Characteristics (“evidenced by”)
[Alternating clinging and distancing behaviors]
[Inability to form satisfactory intimate relationship with an-
other person]
Use of unsuccessful social interaction behaviors
[Use of primitive dissociation (splitting) in their relationships 
(viewing others as all good or all bad)]
Goals/Objectives
Short-term Goal
Client will discuss with nurse or therapist behaviors that impede 
the development of satisfactory interpersonal relationships.
Long-term Goals
 1. Client will interact with others in the therapy setting in both 
social and therapeutic activities without difﬁ culty by time of 
discharge from treatment.
 2. Client will display no evidence of splitting or clinging and 
distancing behaviors in relationships by time of discharge 
from treatment. 
Interventions with Selected Rationales
 1. Encourage client to examine these behaviors (to recognize 
that they are occurring). Client may be unaware of splitting 
or of clinging and distancing pattern of interaction with 
others.
 2. Help client realize that you will be available, without rein-
forcing dependent behaviors. Knowledge of your availability 
may provide needed security for the client.
 3. Give positive reinforcement for independent behaviors. Posi-
tive reinforcement enhances self-esteem and encourages 
repetition of desirable behaviors.
 4. Rotate staff who work with the client in order to avoid client’s 
developing dependence on particular staff members. Client 
must learn to relate to more than one staff member in an 
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effort to decrease use of splitting and to diminish fears of 
abandonment. 
CLINICAL PEARL  Recognize when the client is playing one staff member against 
another. Remember that splitting is a primary defense mechanism of these individuals, 
and the impressions they have of others as either “good” or “bad” are a manifestation 
of this defense. Do not listen as the client tries to degrade other staff members. 
Suggest that the client discuss the problem directly with the staff person involved.
 5. Explore with client feelings that relate to fears of abandon-
ment and engulfment. Help client understand that cling-
ing and distancing behaviors are engendered by these fears. 
Exploration of feelings with a trusted individual may help 
client come to terms with unresolved issues.
 6. Help client understand how these behaviors interfere with 
satisfactory relationships. Client may be unaware of others’ 
perception of him or her and why these behaviors are not 
acceptable to others.
 7. Assist the client to work toward achievement of object con-
stancy. Be available, without promoting dependency. This 
may help client resolve fears of abandonment and develop 
the ability to establish satisfactory intimate relationships. 
Outcome Criteria
 1. Client is able to interact with others in both social and thera-
peutic activities in a socially acceptable manner.
 2. Client does not use splitting or clinging and distancing be-
haviors in relationships and is able to relate the use of these 
behaviors to failure of past relationships. 
●
 DISTURBED PERSONAL IDENTITY 
Deﬁ nition: Inability to maintain an integrated and complete per-
ception of self.
Possible Etiologies (“related to”)
[Failure to complete tasks of separation/individuation stage of 
development]
[Underdeveloped ego]
[Unmet dependency needs]
[Absence of, or rejection by, parental sex-role model]
Deﬁ ning Characteristics (“evidenced by”)
[Excessive use of projection]
[Vague self-image]
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[Unable to tolerate being alone]
[Feelings of depersonalization and derealization]
[Self-mutilation (cutting, burning) to validate existence of self]
Gender confusion
Feelings of emptiness
Uncertainties about goals and values
Goals/Objectives
Short-term Goal
Client will describe characteristics that make him or her a 
unique individual.
Long-term Goal
Client will be able to distinguish own thoughts, feelings, behav-
iors, and image from those of others, as the initial step in the 
development of a healthy personal identity.
Interventions with Selected Rationales
 1. Help client recognize the reality of his or her separateness. 
Do not attempt to translate client’s thoughts and feelings into 
words. Because of the blurred ego boundaries, client may 
believe you can read his or her mind. For this reason, caution 
should be taken in the use of empathetic understanding. For 
example, avoid statements such as, “I know how you must feel 
about that.”
 2. Help client recognize separateness from nurse by clarifying 
which behaviors and feelings belong to whom. If deemed 
appropriate, allow client to touch your hand or arm. Touch 
and physical presence provide reality for the client and serve 
to strengthen weak ego boundaries.
 3. Encourage client to discuss thoughts and feelings. Help 
client recognize ownership of these feelings rather than pro-
jecting them onto others in the environment. Verbalization 
of feelings in a nonthreatening environment may help client 
come to terms with unresolved issues.
 4. Confront statements that project client’s feelings onto others. 
Ask client to validate that others possess those feelings. The 
expression of reasonable doubt as a therapeutic technique may 
be helpful (“I ﬁ nd that hard to believe”).
 5. If the problem is with gender identity, ask the client to 
describe his or her perception of appropriate male and 
female behaviors. Provide information about role behav-
iors and sex education, if necessary. Convey acceptance 
of the person regardless of preferred identity. Client may 
require clarifi cation of distorted ideas or misinformation. 
An attitude of acceptance reinforces client’s feelings of 
self-worth.
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 6. Always call client by his or her name. If client experiences 
feelings of depersonalization or derealization, orientation to 
the environment and correction of misperceptions may be 
helpful. These interventions help to preserve client’s feel-
ings of dignity and self-worth.
 7. Help client understand that there are more adaptive ways of 
validating his or her existence than self-mutilation. Contract 
with the client to seek out staff member when these feel-
ings occur. A contract gets the subject out in the open and 
places some of the responsibility for his or her safety with the 
client. Client safety is a nursing priority.
 8. Work with client to clarify values. Discuss beliefs, attitudes, 
and feelings underlying his or her behaviors. Help client 
to identify those values that have been (or are intended to 
be) incorporated as his or her own. Care must be taken 
by the nurse to avoid imposing his or her own value sys-
tem on the client. Because of underdeveloped ego and fi x-
ation in early developmental level, client may not have 
established own value system. In order to accomplish this, 
ownership of beliefs and attitudes must be identifi ed and 
clarifi ed.
 9. Use of photographs of the client may help to establish or 
clarify ego boundaries. Photographs may help to increase 
client’s awareness of self as separate from others.
 10. Alleviate anxiety by providing assurance to client that 
he or she will not be left alone. Early childhood traumas 
may predispose borderline clients to extreme fears of 
abandonment.
 11. Use of touch is sometimes therapeutic in identity conﬁ rma-
tion. Before this technique is used, however, assess cultural 
inﬂ uences and degree of trust. Touch and physical presence 
provide reality for the client and serve to strengthen weak 
ego boundaries. 
Outcome Criteria
 1. Client is able to distinguish between own thoughts and feel-
ings and those of others.
 2. Client claims ownership of those thoughts and feelings and 
does not use projection in relationships with others.
 3. Client has clariﬁ ed own feelings regarding sexual identity. 
●
 LOW SELF-ESTEEM
Deﬁ nition: Negative self-evaluating/feelings about self or self-
capabilities.
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Possible Etiologies (“related to”)
[Lack of positive feedback]
[Unmet dependency needs]
[Retarded ego development]
[Repeated negative feedback, resulting in diminished self-
worth]
[Dysfunctional family system]
[Fixation in earlier level of development]
Deﬁ ning Characteristics (“evidenced by”)
[Difﬁ culty accepting positive reinforcement]
[Self-destructive behavior]
[Frequent use of derogatory and critical remarks against the 
self]
Lack of eye contact
[Manipulation of one staff member against another in an 
attempt to gain special privileges]
[Inability to form close, personal relationships]
[Inability to tolerate being alone]
[Degradation of others in an attempt to increase own feelings 
of self-worth]
Hesitancy to try new things or situations [because of fear of 
failure]
Goals/Objectives
Short-term Goals
 1. Client will discuss fear of failure with nurse or therapist.
 2. Client will verbalize things he or she likes about self. 
Long-term Goals
 1. Client will exhibit increased feelings of self-worth as evi-
denced by verbal expression of positive aspects about self, 
past accomplishments, and future prospects.
 2. Client will exhibit increased feelings of self-worth by setting 
realistic goals and trying to reach them, thereby demonstrat-
ing a decrease in fear of failure. 
Interventions with Selected Rationales
 1. Ensure that goals are realistic. It is important for client to 
achieve something, so plan for activities in which success is 
likely. Success increases self-esteem.
 2. Convey unconditional positive regard for client. Promote 
understanding of your acceptance for him or her as a worth-
while human being. Acceptance by others increases feelings 
of self-worth.
 3. Set limits on manipulative behavior. Identify the consequences 
for violation of those limits. Minimize negative feedback to 
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the client. Enforce the limits and impose the consequences 
for violations in a matter-of-fact manner. Consistency among 
all staff members is essential. Negative feedback can be ex-
tremely threatening to a person with low self-esteem and 
possibly aggravate the problem. Consequences should convey 
unacceptability of the behavior but not the person.
 4. Encourage independence in the performance of personal re-
sponsibilities, as well as in decision-making related to client’s 
self-care. Offer recognition and praise for accomplishments. 
Positive reinforcement enhances self-esteem and encourages 
repetition of desirable behaviors.
 5. Help client increase level of self-awareness through criti-
cal examination of feelings, attitudes, and behaviors. Self-
exploration in the presence of a trusted individual may help 
the client come to terms with unresolved issues.
 6. Help client identify positive self-attributes as well as those 
aspects of the self he or she ﬁ nds undesirable. Discuss ways 
to effect change in these areas. Individuals with low self-
esteem often have diffi culty recognizing their positive at-
tributes. They may also lack problem-solving ability and 
require assistance to formulate a plan for implementing the 
desired changes.
 7. Discuss client’s future. Assist client in the establishment of 
short-term and long-term goals. What are his or her strengths? 
How can he or she best use those strengths to achieve those 
goals? Encourage client to perform at a level realistic to his or 
her ability. Offer positive reinforcement for decisions made. 
Outcome Criteria
 1. Client verbalizes positive aspects about self.
 2. Client demonstrates ability to make independent decisions 
regarding management of own self-care.
 3. Client expresses some optimism and hope for the future.
 4. Client sets realistic goals for self and demonstrates willing-
ness to reach them. 
● ANTISOCIAL PERSONALITY DISORDER
Deﬁ ned
Antisocial personality disorder is characterized by a pattern of 
antisocial behavior that began before the age of 15. These behav-
iors violate the rights of others, and individuals with this disorder 
display no evidence of guilt feelings at having done so. There is 
often a long history of involvement with law-enforcement agen-
cies. Substance abuse is not uncommon. The disorder is more 
frequently diagnosed in men than in women. Individuals with 
antisocial personalities are often labeled sociopathic or psychopathic 
in the lay literature.
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Predisposing Factors to Antisocial 
Personality Disorder
 1. Physiological
 a. Genetics. The DSM-IV-TR reports that antisocial per-
sonality is more common among ﬁ rst-degree biological 
relatives of those with the disorder than among the gen-
eral population (APA, 2000). Twin and adoptive studies 
have implicated the role of genetics in antisocial personal-
ity disorder (Skodol & Gunderson, 2008). These studies 
of families of individuals with antisocial personality show 
higher numbers of relatives with antisocial personality or 
alcoholism than are found in the general population. Ad-
ditional studies have shown that children of parents with 
antisocial behavior are more likely to be diagnosed as an-
tisocial personality, even when they are separated at birth 
from their biological parents and reared by individuals 
without the disorder.
 b. Temperament. Characteristics associated with tempera-
ment in the newborn may be signiﬁ cant in the predispo-
sition to antisocial personality. Parents who bring their 
children with behavior disorders to clinics often report 
that the child displayed temper tantrums from infancy 
and would become furious when awaiting a bottle or a 
diaper change. As these children mature, they commonly 
develop a bullying attitude toward other children. Parents 
report that they are undaunted by punishment and gener-
ally quite unmanageable. They are daring and foolhardy 
in their willingness to chance physical harm, and they 
seem unaffected by pain.
 2. Psychosocial
 a. Theories of Family Dynamics. Antisocial personality dis-
order frequently arises from a chaotic home environment. 
Parental deprivation during the ﬁ rst 5 years of life appears 
to be a critical predisposing factor in the development of 
antisocial personality disorder. Separation due to parental 
delinquency appears to be more highly correlated with the 
disorder than is parental loss from other causes. The pres-
ence or intermittent appearance of inconsistent impulsive 
parents, not the loss of a consistent parent, is environmen-
tally most damaging.
   Studies have shown that individuals with antisocial per-
sonality disorder often have been severely physically abused 
in childhood. The abuse contributes to the development of 
antisocial behavior in several ways. First, it provides a model 
for behavior. Second, it may result in injury to the child’s 
central nervous system, thereby impairing the child’s ability 
to function appropriately. Finally, it engenders rage in the 
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victimized child, which is then displaced onto others in the 
environment.
   Disordered family functioning has been implicated as an 
important factor in determining whether an individual devel-
ops antisocial personality (Hill, 2003; Skodol & Gunderson, 
2008; Ramsland, 2009). The following circumstances may be 
infl uential in the predisposition to the disorder:
  • Absence of parental discipline
  • Extreme poverty
  • Removal from the home
  • Growing up without parental ﬁ gures of both genders
  • Erratic and inconsistent methods of discipline
  •  Being “rescued” each time they are in trouble (never hav-
ing to suffer the consequences of their own behavior)
  • Maternal deprivation
Symptomatology (Subjective and Objective 
Data)
 1. Extremely low-self esteem (abuses other people in an at-
tempt to validate his or her own superiority)
 2. Inability to sustain satisfactory job performance
 3. Inability to function as a responsible parent
 4. Failure to follow social and legal norms; repeated perfor-
mance of antisocial acts that are grounds for arrest (whether 
arrested or not)
 5. Inability to develop satisfactory, enduring, intimate rela-
tionship with a sexual partner
 6. Aggressive behaviors; repeated physical ﬁ ghts; spouse or 
child abuse
 7. Extreme impulsivity
 8. Repeated lying for personal beneﬁ t
 9. Reckless driving; driving while intoxicated
 10. Inability to learn from punishment
 11. Lack of guilt or remorse felt in response to exploitation of 
others
 12. Difﬁ culty with interpersonal relationships
 13. Social extroversion; stimulation through interaction with 
and abuse of others
 14. Repeated failure to honor ﬁ nancial obligations
●  COMMON NURSING DIAGNOSES 
AND INTERVENTIONS
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.)
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● RISK FOR OTHER-DIRECTED 
VIOLENCE
Deﬁ nition: At risk for behaviors in which an individual demon-
strates that he or she can be physically, emotionally, and/or sexu-
ally harmful to others.
Related/Risk Factors (“related to”) 
[Rage reactions]
History of witnessing family violence
Neurological impairment (e.g., positive electroencephalogram)
[Suspiciousness of others]
[Interruption of client’s attempt to fulﬁ ll own desires]
[Inability to tolerate frustration]
[Learned behavior within client’s subculture]
[Vulnerable self-esteem]
Body language (e.g., rigid posture, clenching of ﬁ sts and jaw, 
hyperactivity, pacing, breathlessness, threatening stances)
[History or threats of violence toward self or others or of 
destruction to the property of others]
Impulsivity
Availability of weapon(s)
[Substance abuse or withdrawal]
[Provocative behavior: Argumentative, dissatisﬁ ed, overreac-
tive, hypersensitive]
History of childhood abuse
Goals/Objectives
Short-term Goals
 1. Client will discuss angry feelings and situations that precipi-
tate hostility.
 2. Client will not harm others.
Long-term Goal
Client will not harm others.
Interventions with Selected Rationales
 1. Convey an accepting attitude toward this client. Feelings 
of rejection are undoubtedly familiar to him or her. Work 
on development of trust. Be honest, keep all promises, and 
convey the message to the client that it is not him or her, but 
the behavior that is unacceptable. An attitude of acceptance 
promotes feelings of self-worth. Trust is the basis of a thera-
peutic relationship.
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 2. Maintain low level of stimuli in client’s environment (low 
lighting, few people, simple decor, low noise level). A stimu-
lating environment may increase agitation and promote 
aggressive behavior.
 3. Observe client’s behavior frequently. Do this through rou-
tine activities and interactions; avoid appearing watchful and 
suspicious. Close observation is required so that intervention 
can occur if needed to ensure client’s (and others’) safety.
 4. Remove all dangerous objects from client’s environment. 
Client safety is a nursing priority.
 5. Help client identify the true object of his or her hostility 
(e.g., “You seem to be upset with...”). Because of weak ego 
development, client may be misusing the defense mecha-
nism of displacement. Helping him or her recognize this 
in a nonthreatening manner may help reveal unresolved 
issues so that they may be confronted.
 6. Encourage client to gradually verbalize hostile feelings. 
Verbalization of feelings in a nonthreatening environment 
may help client come to terms with unresolved issues.
 7. Explore with client alternative ways of handling frustration 
(e.g., large motor skills that channel hostile energy into so-
cially acceptable behavior). Physically demanding activities 
help to relieve pent-up tension.
 8. Staff should maintain and convey a calm attitude toward 
client. Anxiety is contagious and can be transferred from 
staff to client. A calm attitude provides client with a feeling 
of safety and security.
 9. Have sufﬁ cient staff available to present a show of strength 
to client if necessary. This conveys to the client evidence of 
control over the situation and provides some physical secu-
rity for staff.
 10. Administer tranquilizing medications as ordered by physi-
cian or obtain an order if necessary. Monitor client for ef-
fectiveness of the medication as well as for appearance of 
adverse side effects. Antianxiety agents (e.g., lorazepam, 
chlordiazepoxide, oxazepam) produce a calming effect and 
may help to allay hostile behaviors. (NOTE: Medications 
are often not prescribed for clients with antisocial personal-
ity disorder because of these individuals’ strong susceptibil-
ity to addictions.)
 11. If client is not calmed by “talking down” or by medica-
tion, use of mechanical restraints may be necessary. Be sure 
to have sufﬁ cient staff available to assist. Follow protocol 
established by the institution in executing this intervention. 
The Joint Commission requires that and in-person evalu-
ation by a licensed independent practitioner be conducted 
within 1 hour of initiating restraint or seclusion. The physi-
cian must reevaluate and issue a new order for restraints 
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every 4 hours for adults age 18 and older. Never use restraints 
as a punitive measure but rather as a protective measure for 
a client who is out of control.
 12. Observe client in restraints every 15 minutes (or according 
to institutional policy). Ensure that circulation to extremi-
ties is not compromised (check temperature, color, pulses). 
Assist client with needs related to nutrition, hydration, and 
elimination. Position client so that comfort is facilitated 
and aspiration can be prevented. Client safety is a nursing 
priority.
Outcome Criteria
 1. Client is able to rechannel hostility into socially acceptable 
behaviors.
 2. Client is able to discuss angry feelings and verbalize ways to 
tolerate frustration appropriately.
●
 INEFFECTIVE COPING
Deﬁ nition: Inability to form a valid appraisal of the stressors, in-
adequate choices of practiced responses, and/or inability to use 
available resources.
Possible Etiologies (“related to”)
[Inadequate support systems]
[Inadequate coping method]
[Underdeveloped ego]
[Underdeveloped superego]
[Dysfunctional family system]
[Negative role modeling]
[Absent, erratic, or inconsistent methods of discipline]
[Extreme poverty]
Deﬁ ning Characteristics (“evidenced by”)
[Disregard for societal norms and laws]
[Absence of guilt feelings]
[Inability to delay gratiﬁ cation]
[Extreme impulsivity]
[Inability to learn from punishment]
Goals/Objectives
Short-term Goal
Within 24 hours after admission, client will verbalize under-
standing of the rules and regulations of the treatment setting 
and the consequences for violation of them.
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Long-term Goal
Client will be able to cope more adaptively by delaying gratiﬁ ca-
tion of own desires and following rules and regulations of the 
treatment setting by time of discharge.
Interventions with Selected Rationales
 1. From the onset, client should be made aware of which be-
haviors will not be accepted in the treatment setting. Explain 
consequences of violation of the limits. Consequences must 
involve something of value to the client. All staff must be 
consistent in enforcing these limits. Consequences should be 
administered in a matter-of-fact manner immediately after 
the infraction. Because client cannot (or will not) impose own 
limits on maladaptive behaviors, these behaviors must be 
delineated and enforced by staff. Undesirable consequences 
may help to decrease repetition of these behaviors.
 2. Do not attempt to coax or convince client to do the “right 
thing.” Do not use the words “You should (or shouldn’t)...”; 
instead, use “You will be expected to... .” The ideal would be 
for this client to eventually internalize societal norms, begin-
ning with this step-by-step, “either/or” approach on the unit 
(either you do [don’t do] this, or this will occur). Explanations 
must be concise, concrete, and clear, with little or no capac-
ity for misinterpretation.
 3. Provide positive feedback or reward for acceptable behaviors. 
Positive reinforcement enhances self-esteem and encourages 
repetition of desirable behaviors.
 4. In an attempt to assist client to delay gratifi cation, begin to 
increase the length of time requirement for acceptable be-
havior in order to achieve the reward. For example, 2 hours 
of acceptable behavior may be exchanged for a telephone 
call; 4 hours of acceptable behavior for 2 hours of television; 
1 day of acceptable behavior for a recreational therapy bowl-
ing activity; 5 days of acceptable behavior for a weekend pass.
 5. A milieu unit provides an appropriate environment for the 
client with antisocial personality. The democratic approach, 
with specifi c rules and regulations, community meetings, 
and group therapy sessions, emulates the type of societal 
situation in which the client must learn to live. Feedback 
from peers is often more effective than confrontation from 
an authority fi gure. The client learns to follow the rules of 
the group as a positive step in the progression toward inter-
nalizing the rules of society.
 6. Help client gain insight into own behavior. Often, these indi-
viduals rationalize to such an extent that they deny that their 
behavior is inappropriate. (For example, “The owner of this 
store has so much money, he’ll never miss the little bit I take. 
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He has everything, and I have nothing. It’s not fair! I deserve 
to have some of what he has.”) Client must come to under-
stand that certain behaviors will not be tolerated within the 
society and that severe consequences will be imposed on those 
individuals who refuse to comply. Client must want to be-
come a productive member of society before he or she can be 
helped.
 7. Talk about past behaviors with client. Discuss which behav-
iors are acceptable by societal norms and which are not. Help 
client identify ways in which he or she has exploited others. 
Encourage client to explore how he or she would feel if the 
circumstances were reversed. An attempt may be made to 
enlighten the client to the sensitivity of others by promoting 
self-awareness in an effort to help the client gain insight 
into his or her own behavior.
 8. Throughout relationship with client, maintain attitude of “It 
is not you, but your behavior, that is unacceptable.” An attitude 
of acceptance promotes feelings of dignity and self-worth.
Outcome Criteria
 1. Client follows rules and regulations of the milieu environ-
ment.
 2. Client is able to verbalize which of his or her behaviors are 
not acceptable.
 3. Client shows regard for the rights of others by delaying grati-
ﬁ cation of own desires when appropriate.
●
 DEFENSIVE COPING
Deﬁ nition: Repeated projection of falsely positive self-evaluation 
based on a self-protective pattern that defends against underlying 
perceived threats to positive self-regard.
Possible Etiologies (“related to”)
[Low self-esteem]
[Retarded ego development]
[Underdeveloped superego]
[Negative role models]
[Lack of positive feedback]
[Absent, erratic, or inconsistent methods of discipline]
[Dysfunctional family system]
Deﬁ ning Characteristics (“evidenced by”)
Denial of obvious problems or weaknesses
Projection of blame or responsibility
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Rationalization of failures
Hypersensitivity to criticism
Grandiosity
Superior attitude toward others
Difﬁ culty establishing or maintaining relationships
Hostile laughter or ridicule of others
Difﬁ culty in perception of reality testing
Lack of follow-through or participation in treatment or 
therapy
Goals/Objectives
Short-term Goal
Client will verbalize personal responsibility for difﬁ culties ex-
perienced in interpersonal relationships within (time period 
reasonable for client).
Long-term Goal
Client will demonstrate ability to interact with others with-
out becoming defensive, rationalizing behaviors, or expressing 
grandiose ideas.
Interventions with Selected Rationales
 1. Recognize and support basic ego strengths. Focusing on 
positive aspects of the personality may help to improve self-
concept.
 2. Encourage client to recognize and verbalize feelings of inad-
equacy and need for acceptance from others, and how these 
feelings provoke defensive behaviors, such as blaming others 
for own behaviors. Recognition of the problem is the fi rst 
step in the change process toward resolution.
 3. Provide immediate, matter-of-fact, nonthreatening feed-
back for unacceptable behaviors. Client may lack knowledge 
about how he or she is being perceived by others. Providing 
this information in a nonthreatening manner may help to 
eliminate these undesirable behaviors.
 4. Help client identify situations that provoke defensiveness and 
practice through role-playing more appropriate responses. 
Role-playing provides confi dence to deal with diffi cult situ-
ations when they actually occur.
 5. Provide immediate positive feedback for acceptable behav-
iors. Positive feedback enhances self-esteem and encourages 
repetition of desirable behaviors.
 6. Help client set realistic, concrete goals and determine 
appropriate actions to meet those goals. Success increases 
self-esteem.
 7. Evaluate with client the effectiveness of the new behaviors 
and discuss any modiﬁ cations for improvement. Because of 
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limited problem-solving ability, assistance may be required 
to reassess and develop new strategies in the event that 
certain of the new coping methods prove ineffective.
Outcome Criteria
 1. Client verbalizes and accepts responsibility for own behavior.
 2. Client verbalizes correlation between feelings of inadequacy 
and the need to defend the ego through rationalization and 
grandiosity.
 3. Client does not ridicule or criticize others.
 4. Client interacts with others in group situations without tak-
ing a defensive stance.
●
 LOW SELF-ESTEEM 
Deﬁ nition: Negative self-evaluating/feelings about self or self-
capabilities.
Possible Etiologies (“related to”)
[Lack of positive feedback]
[Unmet dependency needs]
[Retarded ego development]
[Repeated negative feedback, resulting in diminished self-
worth]
[Dysfunctional family system]
[Absent, erratic, or inconsistent parental discipline]
[Extreme poverty]
[History of childhood abuse]
Deﬁ ning Characteristics (“evidenced by”)
[Denial of problems obvious to others]
[Projection of blame or responsibility for problems]
[Grandiosity]
[Aggressive behavior]
[Frequent use of derogatory and critical remarks against 
others]
[Manipulation of one staff member against another in an at-
tempt to gain special privileges]
[Inability to form close, personal relationships]
Goals/Objectives
Short-term Goal
Client will verbalize an understanding that derogatory and criti-
cal remarks against others reﬂ ects feelings of self-contempt.
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Long-term Goal
Client will experience an increase in self-esteem, as evidenced 
by verbalizations of positive aspects of self and the lack of ma-
nipulative behaviors toward others.
Interventions with Selected Rationales
 1. Ensure that goals are realistic. It is important for client to 
achieve something, so plan for activities in which success is 
likely. Success increases self-esteem.
 2. Identify ways in which client is manipulating others. Set 
limits on manipulative behavior. Because client is unable (or 
unwilling) to limit own maladaptive behaviors, assistance 
is required from staff.
 3. Explain consequences of manipulative behavior. All staff 
must be consistent and follow through with consequences 
in a matter-of-fact manner. From the onset, client must be 
aware of the outcomes his or her maladaptive behaviors will 
effect. Without consistency of follow-through from all staff, 
a positive outcome cannot be achieved.
 4. Encourage client to talk about his or her behavior, the limits, 
and consequences for violation of those limits. Discussion of 
feelings regarding these circumstances may help the client 
achieve some insight into his or her situation.
 5. Discuss how manipulative behavior interferes with forma-
tion of close, personal relationships. Client may be unaware 
of others’ perception of him or her and of why these behav-
iors are not acceptable to others.
 6. Help client identify more adaptive interpersonal strategies. 
Provide positive feedback for nonmanipulative behaviors. 
Client may require assistance with solving problems. Posi-
tive reinforcement enhances self-esteem and encourages 
repetition of desirable behaviors.
 7. Encourage client to confront the fear of failure by attending 
therapy activities and undertaking new tasks. Offer recogni-
tion of successful endeavors.
 8. Help client identify positive aspects of the self and develop 
ways to change the characteristics that are socially unaccept-
able. Individuals with low self-esteem often have diffi culty 
recognizing their positive attributes. They may also lack 
problem-solving ability and require assistance to formulate 
a plan for implementing the desired changes.
 9. Minimize negative feedback to client. Enforce limit-setting 
in a matter-of-fact manner, imposing previously established 
consequences for violations. Negative feedback can be ex-
tremely threatening to a person with low self-esteem, pos-
sibly aggravating the problem. Consequences should convey 
unacceptability of the behavior but not the person.
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 10. Encourage independence in the performance of personal 
responsibilities and in decision-making related to own self-
care. Offer recognition and praise for accomplishments. 
Positive reinforcement enhances self-esteem and encour-
ages repetition of desirable behaviors.
 11. Help client increase level of self-awareness through critical 
examination of feelings, attitudes, and behaviors. Help cli-
ent understand that it is perfectly acceptable for attitudes 
and behaviors to differ from those of others, as long as they 
do not become intrusive. As the client becomes more aware 
and accepting of himself or herself, the need for judging the 
behavior of others will diminish.
 12. Teach client assertiveness techniques, especially the ability 
to recognize the differences among passive, assertive, and 
aggressive behaviors and the importance of respecting the 
human rights of others while protecting one’s own basic 
human rights. These techniques increase self-esteem while 
enhancing the ability to form satisfactory interpersonal 
relationships.
Outcome Criteria
 1. Client verbalizes positive aspects about self.
 2. Client does not manipulate others in an attempt to increase 
feelings of self-worth.
 3. Client considers the rights of others in interpersonal 
interactions.
●
 IMPAIRED SOCIAL INTERACTION
Deﬁ nition: Insuffi cient or excessive quantity or ineffective qual-
ity of social exchange.
Possible Etiologies (“related to”)
Self-concept disturbance
[Unmet dependency needs]
[Retarded ego development]
[Retarded superego development]
[Negative role-modeling]
Knowledge deﬁ cit about ways to enhance mutuality
Deﬁ ning Characteristics (“evidenced by”)
Discomfort in social situations
Inability to receive or communicate a satisfying sense of social 
engagement (e.g., belonging, caring, interest, shared history)
Use of unsuccessful social interaction behaviors
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Dysfunctional interaction with others
[Exploitation of others for the fulﬁ llment of own desires]
[Inability to develop satisfactory, enduring, intimate relation-
ship with a sexual partner]
[Physical and verbal hostility toward others when fulﬁ llment of 
own desires is thwarted]
Goals/Objectives
Short-term Goal
Client will develop satisfactory relationship (no evidence 
of manipulation or exploitation) with nurse or therapist within 
1 week.
Long-term Goal
Client will interact appropriately with others, demonstrating 
concern for the needs of others as well as for his or her own 
needs, by time of discharge from treatment.
Interventions with Selected Rationales
 1. Develop therapeutic rapport with client. Establish trust by 
always being honest; keep all promises; convey acceptance of 
person, separate from unacceptable behaviors (“It is not you, 
but your behavior, that is unacceptable.”) An attitude of ac-
ceptance promotes feelings of self-worth. Trust is the basis of 
a therapeutic relationship.
 2. Offer to remain with client during initial interactions with 
others. Presence of a trusted individual increases feelings of 
security during uncomfortable situations.
 3. Provide constructive criticism and positive reinforcement for 
efforts. Positive feedback enhances self-esteem and encour-
ages repetition of desirable behaviors.
 4. Confront client as soon as possible when interactions with 
others are manipulative or exploitative. Establish con-
sequences for unacceptable behavior, and always follow 
through. Because of the strong id infl uence on client’s be-
havior, he or she should receive immediate feedback when 
behavior is unacceptable. Consistency in enforcing the con-
sequences is essential if positive outcomes are to be achieved. 
Inconsistency creates confusion and encourages testing of 
limits.
 5. Act as a role model for client through appropriate interac-
tions with him or her and with others. Role-modeling is a 
powerful and effective form of learning.
 6. Provide group situations for client. It is through these 
group interactions with positive and negative feedback 
from his or her peers that client will learn socially accept-
able behavior.
2506_Ch16_275-309.indd   0306 10/1/10   9:37:04 AM
Personality Disorders ● 307
Outcome Criteria
 1. Client willingly and appropriately participates in group 
activities.
 2. Client has satisfactorily established and maintained one 
interpersonal relationship with nurse or therapist, without 
evidence of manipulation or exploitation.
 3. Client demonstrates ability to interact appropriately with 
others, showing respect for self and others.
 4. Client is able to verbalize reasons for inability to form close 
interpersonal relationships with others in the past.
●
 DEFICIENT KNOWLEDGE (SELF-CARE 
ACTIVITIES TO ACHIEVE AND 
MAINTAIN OPTIMAL WELLNESS)
Deﬁ nition: Absence or defi ciency of cognitive information related 
to a specifi c topic.
Possible Etiologies (“related to”)
Lack of interest in learning
[Low self-esteem]
[Denial of need for information]
[Denial of risks involved with maladaptive lifestyle]
Unfamiliarity with information sources
Deﬁ ning Characteristics (“evidenced by”)
[History of substance abuse]
[Statement of lack of knowledge]
[Statement of misconception]
[Request for information]
[Demonstrated lack of knowledge regarding basic health 
practices]
[Reported or observed inability to take the responsibility 
for meeting basic health practices in any or all functional pat-
tern areas]
[History of lack of health-seeking behavior]
Inappropriate or exaggerated behaviors (e.g., hysterical, hostile, 
agitated, apathetic)
Goals/Objectives
Short-term Goal
Client will verbalize understanding of knowledge required 
to fulﬁ ll basic health needs following implementation of teach-
ing plan.
2506_Ch16_275-309.indd   0307 10/1/10   9:37:05 AM
308 ● ALTERATIONS IN PSYCHOSOCIAL ADAPTATION
Long-term Goal
Client will be able to demonstrate skills learned for fulﬁ llment 
of basic health needs by time of discharge from therapy.
Interventions with Selected Rationales
 1. Assess client’s level of knowledge regarding positive self-
care practices. An adequate database is necessary for the 
development of an effective teaching plan.
 2. Assess client’s level of anxiety and readiness to learn. Learn-
ing does not occur beyond the moderate level of anxiety.
 3. Determine method of learning most appropriate for client 
(e.g., discussion, question and answer, use of audio or visual 
aids, oral, written). Be sure to consider level of education 
and development. Teaching will be ineffective if presented 
at a level or by a method inappropriate to the client’s ability 
to learn.
 4. Develop teaching plan, including measurable objectives for 
the learner. Provide information regarding healthful strate-
gies for activities of daily living as well as about harmful 
effects of substance abuse on the body. Include suggestions 
for community resources to assist client when adaptability is 
impaired. Client needs this information to promote effec-
tive health maintenance.
 5. Include signiﬁ cant others in the learning activity, if pos-
sible. Input from individuals who are directly involved in 
the potential change increases the likelihood of a positive 
outcome.
 6. Implement teaching plan at a time that facilitates, and in a 
place that is conducive to, optimal learning (e.g., in the eve-
ning when family members visit; in an empty, quiet class-
room or group therapy room). Learning is enhanced by an 
environment with few distractions.
 7. Begin with simple concepts and progress to the more com-
plex. Retention is increased if introductory material is easy 
to understand.
 8. Provide activities for client and signiﬁ cant others in which 
to actively participate during the learning exercise. Active 
participation increases retention.
 9. Ask client and signiﬁ cant others to demonstrate knowledge 
gained by verbalizing information regarding positive self-
care practices. Verbalization of knowledge gained is a mea-
surable method of evaluating the teaching experience.
 10. Provide positive feedback for participation, as well as for 
accurate demonstration of knowledge gained. Positive feed-
back enhances self-esteem and encourages repetition of 
desirable behaviors.
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Outcome Criteria
 1. Client is able to verbalize information regarding positive 
self-care practices.
 2. Client is able to verbalize available community resources for 
obtaining knowledge about and help with deﬁ cits related to 
health care.
 INTERNET REFERENCES
 • Additional information about personality disorders may be 
located at the following websites:
 a. http://www.mentalhealth.com/dis/p20-pe04.html
 b. http://www.mentalhealth.com/dis/p20-pe08.html
 c. http://www.mentalhealth.com/dis/p20-pe05.html
 d. http://www.mentalhealth.com/dis/p20-pe09.html
 e. http://www.mentalhealth.com/dis/p20-pe06.html
 f. http://www.mentalhealth.com/dis/p20-pe07.html
 g. http://www.mentalhealth.com/dis/p20-pe10.html
 h. http://www.mentalhealth.com/dis/p20-pe01.html
 i. http://www.mentalhealth.com/dis/p20-pe02.html
 j. http://www.mentalhealth.com/dis/p20-pe03.html
 k. http://www.mentalhealth.com/p13.html#Per
Movie Connections
Taxi Driver (schizoid personality) • One Flew Over the Cuckoo’s 
Nest (antisocial) •The Boston Strangler (antisocial) • Just Cause (antisocial) 
• The Dream Team (antisocial) • Goodfellas (antisocial) • Fatal Attraction 
(borderline) • Play Misty for Me (borderline) • Girl, Interrupted (borderline) 
• Gone With the Wind (histrionic) • Wall Street (narcissistic) • The Odd 
Couple (obsessive-compulsive) • As Good As It Gets (obsessive-compulsive)
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● BACKGROUND ASSESSMENT DATA
Categories of Abuse and Neglect
Physical Abuse of a Child
Physical abuse of a child includes “any nonaccidental physical in-
jury (ranging from minor bruises to severe fractures or death) 
as a result of punching, beating, kicking, biting, burning, shak-
ing, throwing, stabbing, choking, hitting (with a hand, stick, 
strap, or other object), burning, or otherwise harming a child, 
that is inﬂ icted by a parent, caregiver, or other person who 
has responsibility for the child” (Child Welfare Information 
Gateway [CWIG], 2008). The most obvious way to detect it is 
by outward physical signs. However, behavioral indicators may 
also be evident.
Sexual Abuse of a Child
This category is deﬁ ned as “employment, use, persuasion, in-
ducement, enticement, or coercion of any child to engage in, or 
assist any other person to engage in, any sexually explicit con-
duct or any simulation of such conduct for the purpose of pro-
ducing any visual depiction of such conduct; or the rape, and in 
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cases of caretaker or inter-familial relationships, statutory rape, 
molestation, prostitution, or other form of sexual exploitation of 
children, or incest with children” (CWIG, 2008). Incest is the 
occurrence of sexual contacts or interaction between, or sexual 
exploitation of, close relatives, or between participants who are 
related to each other by a kinship bond that is regarded as a pro-
hibition to sexual relations (e.g., caretakers, stepparents, stepsib-
lings) (Sadock & Sadock, 2007).
Neglect of a Child
Physical neglect of a child includes refusal of or delay in seeking 
health care, abandonment, expulsion from the home or refusal 
to allow a runaway to return home, and inadequate supervision. 
Emotional neglect refers to a chronic failure by the parent or care-
taker to provide the child with the hope, love, and support nec-
essary for the development of a sound, healthy personality.
Physical Abuse of an Adult
Physical abuse of an adult may be deﬁ ned as behavior used 
with the intent to cause harm and to establish power and con-
trol over another person. It may include slaps, punches, biting, 
hair-pulling, choking, kicking, stabbing or shooting, or forcible 
restraint.
Sexual Abuse of an Adult
Sexual abuse of an adult may be deﬁ ned as the expression of 
power and dominance by means of sexual violence, most com-
monly by men over women, although men may also be victims of 
sexual assault. Sexual assault is identiﬁ ed by the use of force and 
executed against the person’s will.
Predisposing Factors (that Contribute 
to Patterns of Abuse) 
 1. Physiological
 a. Neurophysiological Infl uences. Various components of 
the neurological system in both humans and animals have 
been implicated in both the facilitation and inhibition of 
aggressive impulses. Areas of the brain that may be in-
volved include the temporal lobe, the limbic system, and 
the amygdaloid nucleus (Tardiff, 2003).
 b. Biochemical Infl uences. Studies show that various 
neurotransmitters—in particular norepinephrine, dopa-
mine, and serotonin—may play a role in the facilitation 
and inhibition of aggressive impulses (Hollander, Berlin, 
& Stein, 2008). 
 c. Genetic Infl uences. Some studies have implicated heredity 
as a component in the predisposition to aggressive behav-
ior. Both direct genetic links and the genetic karyotype 
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XYY have been investigated as possibilities. Evidence 
remains inconclusive.
 d. Disorders of the Brain. Various disorders of the brain 
including tumors, trauma, and certain diseases (e.g., 
encephalitis and epilepsy) have been implicated in the pre-
disposition to aggressive behavior.
 2. Psychosocial
 a. Psychodynamic Theory. The psychodynamic theorists 
imply that unmet needs for satisfaction and security re-
sult in an underdeveloped ego and a weak superego. It is 
thought that when frustration occurs, aggression and vio-
lence supply this individual with a dose of power and pres-
tige that boosts the self-image and validates a signiﬁ cance 
to his or her life that is lacking. The immature ego cannot 
prevent dominant id behaviors from occurring, and the 
weak superego is unable to produce feelings of guilt. 
 b. Learning Theory. This theory postulates that aggressive 
and violent behaviors are learned from prestigious and 
inﬂ uential role models. Individuals who were abused as 
children or whose parents disciplined with physical pun-
ishment are more likely to behave in a violent manner as 
adults (Tardiff, 2003).
 c. Societal Infl uences. Social scientists believe that aggres-
sive behavior is primarily a product of one’s culture and 
social structure. Societal inﬂ uences may contribute to 
violence when individuals believe that their needs and 
desires cannot be met through conventional means, and 
they resort to delinquent behaviors in an effort to obtain 
desired ends.
Symptomatology (Subjective and Objective 
Data) 
 1. Signs of physical abuse may include the following:
 a. Bruises over various areas of the body. They may present 
with different colors of bluish-purple to yellowish-green 
(indicating various stages of healing).
 b. Bite marks, skin welts, burns.
 c. Fractures, scars, serious internal injuries, brain damage.
 d. Lacerations, abrasions, or unusual bleeding.
 e. Bald spots indicative of severe hair pulling.
 f. In a child, regressive behaviors (such as thumb sucking 
and enuresis) are common.
 g. Extreme anxiety and mistrust of others.
 2. Signs of neglect of a child may include the following:
 a. Soiled clothing that does not ﬁ t and may be inappropriate 
for the weather.
 b. Poor hygiene.
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 c. Always hungry, with possible signs of malnutrition (e.g., 
emaciated with swollen belly).
 d. Listless and tired much of the time.
 e. Unattended medical problems.
 f. Social isolation; unsatisfactory peer relationships.
 g. Poor school performance and attendance record.
 3. Signs of sexual abuse of a child include the following:
 a. Frequent urinary infections.
 b. Difﬁ culty or pain in walking or sitting.
 c. Rashes or itching in the genital area; scratching the area a 
great deal or ﬁ dgeting when seated.
 d. Frequent vomiting.
 e. Seductive behavior; compulsive masturbation; precocious 
sex play.
 f. Excessive anxiety and mistrust of others.
 g. Sexually abusing another child.
 4. Signs of sexual abuse of an adult include the following 
(Burgess, 2009):
 a. Contusions and abrasions about various parts of the body.
 b. Headaches, fatigue, sleep-pattern disturbances.
 c. Stomach pains, nausea, and vomiting.
 d. Vaginal discharge and itching, burning on urination, rec-
tal bleeding and pain.
 e. Rage, humiliation, embarrassment, desire for revenge, 
self-blame.
 f. Fear of physical violence and death.
Common Nursing Diagnoses 
and Interventions
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.)
●
 RAPE-TRAUMA SYNDROME
Deﬁ nition: Sustained maladaptive response to a forced, violent 
sexual penetration against the victim’s will and consent.
Possible Etiologies (“related to”)
[Having been the victim of sexual violence executed with the 
use of force and against one’s personal will and consent] 
Deﬁ ning Characteristics (“evidenced by”)
Disorganization
Change in relationships
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Confusion
Physical trauma (e.g., bruising, tissue irritation)
Suicide attempts
Denial; guilt
Paranoia; humiliation, embarrassment
Aggression; muscle tension and/or spasms
Mood swings
Dependence
Powerlessness; helplessness
Nightmares and sleep disturbances
Sexual dysfunction
Revenge; phobias
Loss of self-esteem
Impaired decision-making
Substance abuse; depression
Anger; anxiety; agitation
Shame; shock; fear
Goals/Objectives
Short-term Goal
The client’s physical wounds will heal without complication.
Long-term Goal
The client will begin a healthy grief resolution, initiating the 
process of physical and psychological healing (time to be indi-
vidually determined).
Interventions with Selected Rationales
 1. It is important to communicate the following to the victim of 
sexual assault: 
 a. You are safe here.
 b. I’m sorry that it happened.
 c. I’m glad that you survived.
 d. It’s not your fault. No one deserves to be treated this 
way.
 e. You did the best that you could. 
 The woman who has been sexually assaulted fears for her 
life and must be reassured of her safety. She may also be 
overwhelmed with self-doubt and self-blame, and these 
statements instill trust and validate self-worth. 
 2. Explain every assessment procedure that will be conducted 
and why. Ensure that data collection is conducted in a car-
ing, nonjudgmental manner to decrease fear and anxiety and 
increase trust.
 3. Ensure that the client has adequate privacy for all immediate 
post-crisis interventions. Try to have as few people as pos-
sible providing the immediate care or collecting immediate 
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evidence. The post-trauma client is extremely vulnerable. 
Additional people in the environment increase this feeling 
of vulnerability and may escalate anxiety.
 4. Encourage the client to give an account of the assault. Lis-
ten, but do not probe. Nonjudgmental listening provides an 
avenue for catharsis that the client needs to begin healing. 
A detailed account may be required for legal follow-up, and 
a caring nurse, as client advocate, may help to lessen the 
trauma of evidence collection.
 5. Discuss with the client whom to call for support or assistance. 
Provide information about referrals for aftercare. Because of 
severe anxiety and fear, client may need assistance from oth-
ers during this immediate postcrisis period. Provide referral 
information in writing for later reference (e.g., psychothera-
pist, mental health clinic, community advocacy group). 
Outcome Criteria
 1. Client is no longer experiencing panic anxiety.
 2. Client demonstrates a degree of trust in the primary nurse.
 3. Client has received immediate attention to physical injuries.
 4. Client has initiated behaviors consistent with the grief 
response. 
●
 POWERLESSNESS
Deﬁ nition: Perception that one’s own action will not signifi cantly 
affect an outcome; a perceived lack of control over a current situa-
tion or immediate happening.
Possible Etiologies (“related to”)
Lifestyle of helplessness
[Low self-esteem]
[Living with, or in a long-term relationship with, an individ-
ual who victimizes by inﬂ icting physical pain or injury with 
the intent to cause harm, and continues to do so over a long 
period of time]
[Lack of support network of caring others]
[Lack of ﬁ nancial independence] 
Deﬁ ning Characteristics (“evidenced by”)
Verbal expressions of having no control [or inﬂ uence] over situ-
ation or outcome
Reluctance to express true feelings
Passivity
[Verbalizations of abuse]
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[Lacerations over areas of body]
[Fear for personal and children’s safety]
[Verbalizations of no way to get out of relationship] 
Goals/Objectives
Short-term Goal
Client will recognize and verbalize choices that are available, 
thereby perceiving some control over life situation (time dimen-
sion to be individually determined).
Long-term Goal
Client will exhibit control over life situation by making deci-
sion about what to do regarding living with cycle of abuse (time 
dimension to be individually determined).
Interventions with Selected Rationales
 1. In collaboration with physician, ensure that all physical 
wounds, fractures, and burns receive immediate attention. 
Take photographs if the victim will permit. Client safety is a 
nursing priority. Photographs may be called in as evidence 
if charges are fi led.
 2. Take the client to a private area to do the interview. If the cli-
ent is accompanied by the person who did the battering, she 
or he is not likely to be truthful about the injuries.
 3. If she has come alone or with her children, assure her of her 
safety. (Author’s note: Female gender is used here because most 
intimate partner violence [IPV] is directed by men toward women— 
although it is understood that men are also victims of IPV.) En-
courage her to discuss the battering incident. Ask questions 
about whether this has happened before, whether the abuser 
takes drugs, whether the woman has a safe place to go, and 
whether she is interested in pressing charges. Some women 
will attempt to keep secret how their injuries occurred in an 
effort to protect the partner or because they are fearful that 
the partner will kill them if they tell.
 4. Ensure that “rescue” efforts are not attempted by the nurse. 
Offer support, but remember that the ﬁ nal decision must be 
made by the client. Making her own decision will give the 
client a sense of control over her life situation. Imposing 
judgments and giving advice are nontherapeutic.
 5. Stress to the victim the importance of safety. She must be 
made aware of the variety of resources that are available to 
her. These may include crisis hotlines, community groups for 
women who have been abused, shelters, counseling services, 
and information regarding the victim’s rights in the civil 
and criminal justice system. Following a discussion of these 
available resources, the woman may choose for herself. If her 
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decision is to return to the marriage and home, this choice 
also must be respected. Knowledge of available choices can 
serve to decrease the victim’s sense of powerlessness, but 
true empowerment comes only when she chooses to use that 
knowledge for her own benefi t. 
Outcome Criteria
 1. Client has received immediate attention to physical injuries.
 2. Client verbalizes assurance of her immediate safety.
 3. Client discusses life situation with primary nurse.
 4. Client is able to verbalize choices available to her from which 
she may receive assistance. 
●
 RISK FOR DELAYED DEVELOPMENT
Deﬁ nition: At risk for delay of 25% or more in one or more of the 
areas of social or self-regulatory behavior, or in cognitive, lan-
guage, gross or fi ne motor skills.
Related/Risk Factors (“related to”)
[The inﬂ iction by caretakers of physical or sexual abuse, usually 
occurring over an extended period of time]
[Ignoring the child’s basic physiological needs]
[Indifference to the child]
[Ignoring the child’s presence]
[Ignoring the child’s social, educational, recreational, and devel-
opmental needs] 
Goals/Objectives
Short-term Goal
Client will develop trusting relationship with nurse and report 
how evident injuries were sustained (time dimension to be indi-
vidually determined).
Long-term Goal
Client will demonstrate behaviors consistent with age-appropriate 
growth and development.
Interventions with Selected Rationales
 1. Perform complete physical assessment of the child. Take par-
ticular note of bruises (in various stages of healing), lacera-
tions, and client complaints of pain in speciﬁ c areas. Do not 
overlook or discount the possibility of sexual abuse. Assess for 
nonverbal signs of abuse: aggressive conduct, excessive fears, 
extreme hyperactivity, apathy, withdrawal, age-inappropriate 
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behaviors. An accurate and thorough physical assessment is 
required in order to provide appropriate care for the client.
 2. Conduct an in-depth interview with the parent or adult who 
accompanies the child. Consider: If the injury is being reported 
as an accident, is the explanation reasonable? Is the injury 
consistent with the explanation? Is the injury consistent with 
the child’s developmental capabilities? Fear of imprisonment 
or loss of child custody may place the abusive parent on the 
defensive. Discrepancies may be evident in the description of 
the incident, and lying to cover up involvement is a common 
defense that may be detectable in an in-depth interview.
 3. Use games or play therapy to gain child’s trust. Use these 
techniques to assist in describing his or her side of the story. 
Establishing a trusting relationship with an abused child 
is extremely diffi cult. The child may not even want to be 
touched. These types of play activities can provide a non-
threatening environment that may enhance the child’s at-
tempt to discuss these painful issues.
 4. Determine whether the nature of the injuries warrants re-
porting to authorities. Speciﬁ c state statutes must enter into 
the decision of whether to report suspected child abuse. 
Individual state statues regarding what constitutes child 
abuse and neglect may be found at http://www.childwelfare.
gov/systemwide/laws_policies/state/. A report is commonly 
made if there is reason to suspect that a child has been in-
jured as a result of physical, mental, emotional, or sexual 
abuse. “Reason to suspect” exists when there is evidence 
of a discrepancy or inconsistency in explaining a child’s 
injury. Most states require that the following individuals 
report cases of suspected child abuse: all health-care work-
ers, all mental health therapists, teachers, child-care pro-
viders, fi refi ghters, emergency medical services personnel, 
and law enforcement personnel. Reports are made to the 
Department of Health and Human Services or a law en-
forcement agency. 
Outcome Criteria
 1. Client has received immediate attention to physical injuries.
 2. Client demonstrates trust in primary nurse by discussing 
abuse through the use of play therapy.
 3. Client is demonstrating a decrease in regressive behaviors. 
 INTERNET REFERENCES
 • Additional information related to child abuse may be located 
at the following websites:
 a. http://www.childwelfare.gov
 b. http://endabuse.org/
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 c. http://www.child-abuse.com
 d. http://www.nlm.nih.gov/medlineplus/childabuse.html
 • Additional information related to sexual assault may be 
located at the following websites:
 a. http://www.vaw.umn.edu/
 b. http://www.nlm.nih.gov/medlineplus/rape.html
 • Additional information related to intimate partner violence 
may be located at the following websites:
 a. http://www.ndvh.org/
 b. http://home.cybergrrl.com/dv/book/toc.html
 c. http://www.crisis-support.org/
 d. http://www.ama-assn.org/ama/no-index/about-ama/ 
13577.shtml
 e. http://www.nursingworld.org/MainMenuCategories/ 
A NA Marketplace/A NA Periodicals/OJIN/Tableof
Contents/Volume72002/No1Jan2002.aspx
Movie Connections
The Burning Bed (domestic violence) • Life With Billy (domestic 
violence) • Two Story House (child abuse) • The Prince of Tides (domestic 
violence) • Radio Flyer (child abuse) • Flowers in the Attic (child abuse) 
• A Case of Rape (sexual assault)
2506_Ch17_310-319.indd   Sec1:319 10/1/10   9:37:18 AM
C H A P T E R  18
Premenstrual 
Dysphoric Disorder
● BACKGROUND ASSESSMENT DATA
Deﬁ ned
Premenstrual dysphoric disorder (PMDD) is identiﬁ ed by a 
variety of physical and emotional symptoms that occur during 
the last week of the luteal phase of the menstrual cycle and that 
remit within a few days after the onset of the follicular phase. 
In most women, these symptoms occur in the week before, and 
remit within a few days after, the onset of menses. The disorder 
has also been reported in nonmenstruating women who have 
had a hysterectomy but retain ovarian function. The diagnosis 
is given only when the symptoms are sufﬁ ciently severe to cause 
marked impairment in social or occupational functioning and 
have occurred during a majority of menstrual cycles in the past 
year (American Psychiatric Association [APA], 2000).
Predisposing Factors to PMDD
 1. Physiological
 a. Biochemical. An imbalance of the hormones estrogen and 
progesterone has been implicated in the predisposition 
to PMDD. It is postulated that excess estrogen or a high 
estrogen-to-progesterone ratio during the luteal phase 
causes water retention and that this hormonal imbalance 
has other effects as well, resulting in the symptoms asso-
ciated with premenstrual syndrome.
 b. Nutritional. A number of nutritional alterations have 
been implicated in the etiology of PMDD, although 
the exact role is unsubstantiated. Deﬁ ciencies in the B 
vitamins, calcium, magnesium, manganese, vitamin E, 
and linolenic acid have been suggested. Glucose toler-
ance ﬂ uctuations, abnormal fatty acid metabolism, and 
sensitivity to caffeine and alcohol may also play a role 
in contributing to the symptoms associated with this 
disorder.
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Symptomatology (Subjective and Objective 
Data)
The following symptoms have been associated with PMDD 
(APA, 2000; Sadock & Sadock, 2007):
 1. Feelings of depression and hopelessness
 2. Increased anxiety and restlessness
 3. Mood swings
 4. Anger and irritability
 5. Decreased interest in usual activities 
 6. Difﬁ culty concentrating
 7. Anergia; increased fatigability
 8. Appetite changes (e.g., food cravings)
 9. Changes in sleep patterns (e.g., hypersomnia or insomnia)
 10. Somatic complaints (e.g., breast tenderness, headaches, 
edema) 
Other subjective symptoms that have been reported include:
 11. Cramps
 12. Alcohol intolerance
 13. Acne
 14. Cystitis
 15. Oliguria
 16. Altered sexual drive
 17. Forgetfulness
 18. Suicidal ideations or attempts 
Common Nursing Diagnoses 
and Interventions
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.)
●
 ACUTE PAIN
Deﬁ nition: Sudden or slow onset of any intensity from mild to 
severe with an anticipated or predictable end and a duration of less 
than 6 months.
Possible Etiologies (“related to”)
[Imbalance in estrogen and progesterone levels]
[Possible nutritional alterations, including the following:
Vitamin B deﬁ ciencies
Glucose tolerance ﬂ uctuations
Abnormal fatty acid metabolism, which may contribute to 
alterations in prostaglandin synthesis
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Magnesium deﬁ ciency
Vitamin E deﬁ ciency
Caffeine sensitivity 
Alcohol intolerance]
[Fluid retention]
Deﬁ ning Characteristics (“evidenced by”)
[Subjective communication of:
Headache
Backache
Joint or muscle pain
A sensation of “bloating”
Abdominal cramping
Breast tenderness and swelling]
Facial mask [of pain]
Sleep disturbance
Self-focus
Changes in appetite [and eating]
Goals/Objectives
Short-term Goal
Client cooperates with efforts to manage symptoms of PMDD 
and minimize feelings of discomfort.
Long-term Goal
Client verbalizes relief from discomfort associated with symp-
toms of PMDD.
Interventions with Selected Rationales
 1. Assess and record location, duration, and intensity of pain. 
Background assessment data are necessary to formulate an 
accurate plan of care for the client.
 2. Provide nursing comfort measures with a matter-of-fact ap-
proach that does not give positive reinforcement to the pain 
behavior (e.g., backrub, warm bath, heating pad). Give addi-
tional attention at times when client is not focusing on physi-
cal symptoms. These measures may serve to provide some 
temporary relief from pain. Absence of secondary gains in 
the form of positive reinforcement may discourage client’s 
use of the pain as attention-seeking behavior.
 3. Encourage the client to get adequate rest and sleep and avoid 
stressful activity during the premenstrual period. Fatigue 
exaggerates symptoms associated with PMDD. Stress elicits 
heightened symptoms of anxiety, which may contribute to 
exacerbation of symptoms and altered perception of pain.
 4. Assist client with activities that distract from focus on self 
and pain. Demonstrate techniques such as visual or auditory 
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distractions, guided imagery, breathing exercises, massage, 
application of heat or cold, and relaxation techniques that 
may provide symptomatic relief. These techniques may help 
to maintain anxiety at a manageable level and prevent the 
discomfort from becoming disabling.
 5. In an effort to correct the possible nutritional alterations 
that may be contributing to PMDD, the following guide-
lines may be suggested:
 a. Reduce intake of fats in the diet, particularly saturated 
fats.
 b. Limit intake of dairy products to two servings a day (exces-
sive dairy products block the absorption of magnesium).
 c. Increase intake of complex carbohydrates (vegetables, 
legumes, cereals, and whole grains) and cis-linoleic acid–
containing foods (e.g., safﬂ ower oil).
 d. Decrease reﬁ ned and simple sugars. (Excess sugar is thought 
to cause nervous tension, palpitations, headache, dizziness, 
drowsiness, and excretion of magnesium in the urine.)
 e. Decrease salt intake to 3 g per day but not less than 0.5 g 
per day. (Salt restriction prevents edema; too little salt 
stimulates norepinephrine and causes sleep disturbances.)
 f. Limit intake of caffeine (coffee, tea, colas, and chocolate) 
and alcohol (one or two drinks a week). Caffeine increases 
breast tenderness and pain. Alcohol can cause reactive 
hypoglycemia and ﬂ uid retention.
 g. Because some women crave junk food during the pre-
menstrual period, it is important that they take a multiple 
vitamin or mineral tablet daily to ensure that adequate 
nutrients are consumed.
 6. Administer medications as prescribed. Monitor client re-
sponse for effectiveness of the medication, as well as for ap-
pearance of adverse side effects. When other measures are 
insuffi cient to bring about relief, physician may prescribe 
symptomatic drug therapy. Provide client with information 
about the medication to be administered. Client has the 
right to know about the treatment she is receiving. Some 
medications commonly used for symptomatic treatment 
of PMDD are presented in Table 18-1. Some women have 
experienced relief from the symptoms of PMDD through 
the use of herbal medications; some of these are listed in 
Table 18-2.
Outcome Criteria
 1. Client demonstrates ability to manage premenstrual symp-
toms with minimal discomfort.
 2. Client verbalizes relief of painful symptoms.
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TABLE 18 –1  Medications for Symptomatic Relief of PMDD
Medication Indication
Fluoxetine (Sarafem), sertraline 
(Zoloft), paroxetine (Paxil)
These medications have been 
approved by the FDA for 
treatment of PMDD.
Hydrochlorothiazide (Ezide, 
HydroDiuril), furosemide 
(Lasix)
Diuretics may provide relief from 
edema when diet and sodium 
restriction are not sufﬁ cient.
Ibuprofen (Advil, Motrin), 
naproxen (Naprosyn, 
 Aleve)
Nonsteroidal anti-inﬂ ammatory 
agents may provide relief 
from joint, muscle, and lower 
abdominal pain related to 
increased prostaglandins.
Propranolol (Inderal), verapamil 
(Isoptin)
β-Blockers and calcium channel 
blockers are often given for pro-
phylactic treatment of migraine 
headaches.
Sumatriptan (Imitrex), naratriptan 
(Amerge), rizatriptan (Maxalt), 
zolmitriptan (Zomig), frovatrip-
tan (Frova), almotriptan (Axert), 
eletriptan (Relpax)
These serotonin 5-HT1 receptor 
agonists are highly effective in 
the treatment of acute migraine 
attack.
Bromocriptine (Parlodel) This drug may be prescribed to 
relieve breast pain and other 
symptoms of PMDD that may be 
caused by elevated prolactin. 
TABLE 18 –2  Herbals Used for Symptoms of Premenstrual 
Syndrome
Herbal
Precautions/Adverse 
Effects Contraindications
Black cohosh
(Cimicifuga 
racemosa)
May potentiate the effects 
of antihypertensive 
medications. Some indi-
viduals may experience 
nausea or headache.
Pregnancy 
Bugleweed
(Lycopus 
virginicus)
No side effects known. 
Should not be taken 
concomitantly with
thyroid preparations.
Thyroid disease
Chaste tree
(Vitex agnus-
castus)
Occasional rashes may 
occur. Should not be 
taken concomitantly 
with dopamine-receptor 
antagonists.
Pregnancy and 
lactation
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●
 INEFFECTIVE COPING
Deﬁ nition: Inability to form a valid appraisal of the stressors, in-
adequate choices of practiced responses, and/or inability to use 
available resources.
Possible Etiologies (“related to”)
[Imbalance in estrogen and progesterone levels]
[Possible nutritional alterations, including the following:
Vitamin B deﬁ ciencies
Glucose tolerance ﬂ uctuations
Abnormal fatty acid metabolism, which may contribute to 
alterations in prostaglandin synthesis
Magnesium deﬁ ciency
Vitamin E deﬁ ciency
Caffeine sensitivity
Alcohol intolerance]
TABLE 18 –2  Herbals Used for Symptoms of Premenstrual 
Syndrome—cont’d
Herbal
Precautions/Adverse 
Effects Contraindications
Evening primrose
(Oenothera 
biennis)
May lower the seizure 
threshold. Should not be 
taken concomitantly with 
other drugs that lower the 
seizure threshold. 
Potentilla
(Potentilla 
anserine)
May cause stomach 
irritation.
Shepherd’s purse
(Capsella bursa-
pastoris)
No side effects known. Pregnancy
Valerian
(Valeriana 
ofﬁ cinalis)
With long-term use: 
headache, restless states, 
sleeplessness, mydriasis, 
disorders of cardiac 
function. Should not 
be taken concomitantly 
with CNS depressants.
Pregnancy and 
lactation
Sources: PDR for Herbal Medicines (4th ed.). (2007). Montvale, NJ: Thomson 
Healthcare Inc.; and Presser, A.M. (2000). Pharmacist’s guide to medicinal herbs. 
Petaluma, CA: Smart Publications. 
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Deﬁ ning Characteristics (“evidenced by”)
[Mood swings]
[Marked anger or irritability]
[Increased anxiety and restlessness]
[Feelings of depression and hopelessness]
[Decreased interest in usual activities]
[Anergia; easy fatigability]
[Difﬁ culty concentrating; forgetfulness]
[Changes in appetite]
[Hypersomnia or insomnia]
[Altered sexual drive]
[Suicidal ideations or attempts]
Inadequate problem-solving
Inability to meet role expectations 
Goals/Objectives
Short-term Goals
 1. Client will seek out support person if thoughts of suicide 
emerge.
 2. Client will verbalize ways to express anger in an appropriate 
manner and maintain anxiety at a manageable level.
Long-term Goals
 1. Client will not harm self while experiencing symptoms as-
sociated with PMDD.
 2. Client will demonstrate adaptive coping strategies to use in 
an effort to minimize disabling behaviors during the pre-
menstrual and perimenstrual periods.
Interventions with Selected Rationales
 1. Assess client’s potential for suicide. Has she expressed feel-
ings of not wanting to live? Does she have a plan? A means? 
Depression is the most prevalent disorder that precedes sui-
cide. The risk of suicide is greatly increased if the client has 
developed a plan and particularly if means exist for the cli-
ent to execute the plan.
 2. Formulate a short-term verbal contract with the client that 
she will not harm herself during a speciﬁ c period of time. 
When that contract expires, make another, and so forth. 
Discussion of suicidal feelings with a trusted individual 
provides a degree of relief to the client. A contract gets the 
subject out in the open and places some of the responsibility 
for the client’s safety with the client. An attitude of accep-
tance of the client as a worthwhile individual is conveyed.
 3. Secure a promise from client that she will seek out a staff 
member if thoughts of suicide emerge. Suicidal clients are 
often very ambivalent about their feelings. Discussion of
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   feelings with a trusted individual may provide assistance 
before the client experiences a crisis situation.
 4. Encourage client to express angry feelings within appropri-
ate limits. Provide safe method of hostility release. Help cli-
ent to identify source of anger, if possible. Work on adaptive 
coping skills for use outside the health-care system. Depres-
sion and suicidal behaviors are sometimes viewed as anger 
turned inward on the self. If this anger can be verbalized 
in a nonthreatening environment, the client may be able to 
resolve these feelings, regardless of the discomfort involved.
 5. Encourage client to discharge pent-up anger through par-
ticipation in large motor activities (e.g., brisk walks, jog-
ging, physical exercises, volleyball, punching bag, exercise 
bike). Physical exercise provides a safe and effective method 
for discharging pent-up tension.
 6. Help client identify stressors that precipitate anxiety and 
irritability and develop new methods of coping with these 
situations (e.g., stress reduction techniques, relaxation, and 
visualization skills). Knowing stress factors and ways of 
handling them reduces anxiety and allows client to feel a 
greater measure of control over the situation.
 7. Identify extent of feelings and situations when loss of control 
occurs. Assist with problem-solving to identify behaviors 
for protection of self and others (e.g., call support person, 
remove self from situation). Recognition of potential for 
harm to self or others and development of a plan enables 
client to take effective actions to meet safety needs.
 8. Encourage client to reduce or shift workload and social 
activities during the premenstrual period as part of a total 
stress management program. Stress may play a role in the 
exacerbation of symptoms.
 9. At each visit, evaluate symptoms. Discuss those that may be 
most troublesome and continue to persist well after initiation 
of therapy. If traditional measures are inadequate, phar-
macological intervention may be required to enhance cop-
ing abilities. For example, antidepressants may be admin-
istered for depression that remains unresolved after other 
symptoms have been relieved.
 10. Encourage participation in support group, psychotherapy, 
marital counseling, or other type of therapy as deemed nec-
essary. Professional assistance may be required to help the 
client and family members learn effective coping strategies 
and support lifestyle changes that may be needed.
Outcome Criteria
 1. Client participates willingly in treatment regimen and initi-
ates necessary lifestyle changes.
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 2. Client demonstrates adaptive coping strategies to deal with 
episodes of depression and anxiety.
 3. Client verbalizes that she has no suicidal thoughts or 
intentions.
 INTERNET REFERENCES 
 a. http://www.aafp.org/afp/980700ap/daughert.html
 b. http://www.drdonnica.com/display.asp?article=1086
 c. ht tp://www.obg yn.net /women/women.asp?page=/
women/articles/coffee_talk/ct007
 d. http://www.usdoctor.com/pms.htm
 e. ht t p: //w w w.hea lt hy place.com /depress ion /main /
premenstrual-dysphoric-disorder-pmdd/menu-id-68/
 f. http://familydoctor.org/752.xml
 g. http://www.obgyn.net/pmspmdd/pmspmdd.asp
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HIV Disease
● BACKGROUND ASSESSMENT DATA
The Immune Response to HIV
The cells responsible for nonspeciﬁ c immune reactions include 
neutrophils, monocytes, and macrophages. In the normal im-
mune response, they work to destroy an invasive organism and 
initiate and facilitate repair to damaged tissue. If these cells are 
not effective in accomplishing a satisfactory healing response, 
speciﬁ c immune mechanisms take over.
The elements of the cellular response include the T4 lym-
phocytes. T4 cells are also called CD4 cells. When the body is 
invaded by a foreign antigen, these T4 cells divide many times, 
producing antigen-speciﬁ c T4 cells with other functions. One 
of these is the T4 killer cell, which serves to help destroy the 
antigen.
The most conspicuous immunologic abnormality associ-
ated with human immunodeﬁ ciency virus (HIV) infection is a 
striking depletion of T4 lymphocytes. The HIV infects the T4 
lymphocyte, thereby destroying the very cell the body needs to 
direct an attack on the virus. An individual with a healthy im-
mune system may present with a T4 count between 600/mm3 and 
1200/mm3. The individual with HIV infection may experience 
a drop at the time of acute infection, with a subsequent increase 
when the acute stage subsides. Typically, the T-cell count is 
about 500 to 600 when the individual begins to develop chronic 
persistent generalized lymphadenopathy (PGL). Opportun-
istic infections are common when the T-cell count reaches 200. 
T4 cell counts in individuals with advanced HIV disease drop 
dramatically, in some cases down to zero (New Mexico AIDS 
Education and Training Center, 2009).
Stages and Symptoms of HIV Disease
 1. Early Stage (Category 1) HIV Disease (≥500 T4 cells/
mm3)
 a. Acute (Primary) HIV Infection. Although some people 
are asymptomatic at this stage, the acute HIV infection is 
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often identiﬁ ed by a characteristic syndrome of symptoms 
that occurs from 6 days to 6 weeks after exposure to the 
virus. The symptoms have an abrupt onset, are somewhat 
vague, and are similar to those sometimes seen in mono-
nucleosis. Symptoms of acute HIV infection include fever, 
myalgia, malaise, lymphadenopathy, sore throat, anorexia, 
nausea and vomiting, headaches, skin rash, and diarrhea 
(Hare, 2006). Most symptoms resolve in 1 to 3 weeks, 
with the exception of fever, myalgia, lymphadenopathy, 
and malaise, which may continue for several months. 
 b. Seroconversion. Seroconversion, the detectability of HIV 
antibodies in the blood, most often is detected between 
6 and 12 weeks. Most people show positive for HIV by 
3 months after infection. In some individuals it may take 
up to 6 months. The time between infection and serocon-
version is called the window period.
 c. Asymptomatic Infection. The acute infection progresses 
to an asymptomatic stage. Probably the largest number of 
HIV-infected individuals fall within this group. Individu-
als may remain in this asymptomatic stage for 10 years or 
longer. The progression of the illness is faster in infants 
and children than it is in adults.
 2. Middle Stage (Category 2) Chronic HIV Disease (499 to 
200 T4 cells/mm3)
 a. Persistent Generalized Lymphadenopathy. Clients with 
HIV infection may develop a generalized lymphadenopa-
thy, in which lymph nodes in at least two different loca-
tions in the body (usually the neck, armpit, and groin) 
swell and remain swollen for months, with no other signs 
of a related infectious disease.
 b. Systemic Complaints. Fever, night sweats, chronic diar-
rhea, fatigue, minor oral infections, headaches.
 3. Late Stage (Category 3) Clinical AIDS (<200 T4 cell/
mm3)
 a. HIV Wasting Syndrome. Severe weight loss, large-
volume diarrhea, fever, and weakness. Involuntary weight 
loss of more than 10% of baseline body weight is common.
 b. Opportunistic Infections. Opportunistic infections are 
those that occur because of the altered immune state of 
the host. These infections, which include protozoan, 
fungal, viral, and bacterial infections, have long been a 
deﬁ ning characteristic of AIDS. The most common, life-
threatening opportunistic infection seen in clients with 
AIDS is pneumocystis pneumonia (PCP).
 c. AIDS-Related Malignancies. HIV-positive individuals 
are at risk for developing certain types of malignancies. 
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These include Kaposi’s sarcoma, non-Hodgkin’s lympho-
ma, Hodgkin’s disease, squamous-cell carcinomas, malig-
nant melanoma, testicular cancers, and primary hepato-
cellular carcinoma.
 d. Altered Mental States. 
 (1) The most common alterations in mental states observed 
in AIDS clients include delirium (fl uctuating conscious-
ness, abnormal vital signs, and psychotic phenomena) 
and dementia (called HIV-associated dementia [HAD]). 
Symptoms of HAD include cognitive, motor, and behav-
ioral changes similar to those seen in individuals with 
other cognitive disorders [see Chapter 3]). 
 (2) Depression is the most common psychiatric disorder ob-
served among HIV-positive clients (Sagrestano, Rogers, 
& Service, 2008). It can occur during any stage of the 
disease process. Anticipatory or actual grief is an impor-
tant cause of depressive symptoms in clients with HIV 
disease. Transient suicidal ideation on learning of HIV 
positivity is quite common, although the incidence of 
serious suicidal behavior is low. Depression in AIDS cli-
ents may be related to receiving a new diagnosis of HIV 
positivity or AIDS, perceiving rejection by loved ones, 
experiencing multiple losses of friends to the disease, 
having an inadequate social and fi nancial support sys-
tem, and the presence of an early cognitive disorder. 
Predisposing Factors to HIV Disease
 1. Sexual Transmission
 a. Heterosexual Transmission. Because the virus is found in 
greater concentration in semen than in vaginal secretions, it 
is more readily transmitted from men to women than from 
women to men. However, female-to-male transmission is 
possible, as HIV has been isolated in vaginal secretions.
 b. Homosexual Transmission. The most signiﬁ cant risk 
factors for homosexual transmission of HIV are receptive 
anal intercourse and the number of male sexual partners. 
The lining of the anal canal is delicate and prone to tear-
ing and bleeding, making anal intercourse an easy way for 
infections to be passed from one person to another.
 2. Bloodborne Transmission
 a. Transfusion with Blood Products. Although laboratory 
tests are more than 99% sensitive, screening problems 
may occur when donations are received from individuals 
recently infected with HIV who have not yet developed 
antibodies or from persistently antibody-negative donors 
who are infected with HIV. 
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 b. Transmission by Needles Infected with HIV. The highest 
number of cases occurring via this route is among IV drug 
users who share needles and other equipment contami-
nated with HIV-infected blood. Other bloodborne modes 
of transmission of HIV are by health-care workers who 
experience accidental needle sticks with contaminated 
needles and who may become infected from other con-
taminated equipment used for therapeutic purposes.
 3. Perinatal Transmission
 a. Modes of transmission include transplacental, through 
exposure to maternal blood and vaginal secretions dur-
ing delivery, and through breast milk. The risk of perina-
tal transmission has been signiﬁ cantly reduced in recent 
years with the advent of free or low-cost prenatal care, 
provision of access to anti-HIV medication during preg-
nancy, and education about the dangers of breastfeeding.
 4. Other Possible Modes of Transmission
 a. To date, HIV has been isolated from blood, semen, vaginal 
secretions, saliva, tears, breast milk, cerebrospinal ﬂ uid, 
and amniotic ﬂ uid. However, only blood, semen, vaginal 
secretions, and breast milk have been epidemiologically 
linked to transmission of the virus.
Common Nursing Diagnoses 
and Interventions*
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community outpatient clinic, 
home health, and private practice.)
●
 INEFFECTIVE PROTECTION
Deﬁ nition: Decrease in the ability to guard self from internal or 
external threats such as illness or injury.
Possible Etiologies (“related to”)
[Compromised immune status secondary to diagnosis of HIV 
disease]
Deﬁ ning Characteristics (“evidenced by”)
[Laboratory values indicating decreased numbers of T4 cells]
[Presence of opportunistic infections]
*  The interventions for this care plan have been adapted from “Nursing 
Care Plan for the AIDS Patient,” written by the nursing staff of Hospice, 
Inc., Wichita, KS.
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[Manifestations of
Fever, night sweats, diarrhea
Anorexia, weight loss
Fatigue, malaise
Swollen lymph glands
Cough, dyspnea
Rash, skin lesions, white patches in mouth
Headache
Ataxia
Bleeding, bruising
Neurological defects]
Goals/Objectives
Short-term Goal
Client will exhibit no new signs or symptoms of infection.
Long-term Goal
Client safety and comfort will be maximized.
Interventions with Selected Rationales
 1. To prevent infection in an immunocompromised individual:
 a. Implement Universal Precautions.
 b. Wash hands with antibacterial soap before entering and 
on leaving client’s room.
 c. Monitor vital signs at regular intervals.
 d. Monitor complete blood counts (CBCs) for leukopenia/
neutropenia.
 e. Monitor for signs and symptoms of speciﬁ c opportunistic 
infections.
 f. Protect client from individuals with infections.
 g. Maintain meticulous sterile technique for dressing changes 
and any invasive procedure.
 h. Administer antibiotics as ordered.
 2. To restore nutritional status and decrease nausea, vomit-
ing, and diarrhea:
 a. Provide low-residue, high-protein, high-calorie, soft, 
bland diet. Maintain hydration with adequate ﬂ uid 
intake.
 b. Obtain daily weight and record intake and output.
 c. Monitor serum electrolytes and CBCs.
 d. If client is unable to eat, provide isotonic tube feedings as 
tolerated. Check for gastric residual frequently.
 e. If client is unable to tolerate oral intake or tube feedings, 
consult physician regarding possibility of parenteral hy-
peralimentation. Observe hyperalimentation administra-
tion site for signs of infection. 
 f. Administer antidiarrheals and antiemetics as ordered.
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 g. Perform frequent oral care. Promote prevention and heal-
ing of lesions in the mouth.
 h. Have the client eat small, frequent meals with high-calorie 
snacks rather than three large meals per day.
 3. To promote improvement of skin and mucous membrane 
integrity:
 a. Monitor skin condition for signs of redness and break-
down.
 b. Reposition client every 1 to 2 hours.
 c. Encourage ambulation and chair activity as tolerated.
 d. Use “egg crate” mattress or air mattress on bed.
 e. Wash skin daily with soap and rinse well with water.
 f. Apply lotion to skin to maintain skin softness.
 g. Provide wound care as ordered for existing pressure sores 
or lesions.
 h. Cleanse skin exposed to diarrhea thoroughly and protect 
rectal area with ointment.
 i. Apply artiﬁ cial tears to eyes as appropriate.
 j. Perform frequent oral care; apply ointment to lips.
 4. To maximize oxygen consumption and minimize respira-
tory distress:
 a. Assess respiratory status frequently:
 (1) Monitor depth, rate, and rhythm of respirations.
 (2) Auscultate lung fi elds every 2 hours and as needed.
 (3) Monitor arterial blood gases.
 (4) Check color of skin, nail beds, and sclerae.
 (5) Assess sputum for color, odor, and viscosity.
 b. Encourage coughing and deep-breathing exercises.
 c. Provide humidiﬁ ed oxygen as ordered.
 d. Suction as needed using sterile technique.
 e. Space nursing care to allow client adequate rest periods 
between procedures.
 f. Administer analgesics or sedatives judiciously to prevent 
respiratory depression.
 g. Administer bronchodilators and antibiotics as ordered.
 5. To minimize the potential for easy bleeding caused by 
HIV-induced thrombocytopenia:
 a. Follow protocol for maintenance of skin integrity.
 b. Provide safe environment to minimize falling or bumping 
into objects.
 c. Provide soft toothbrush or “toothette” swabs for cleaning 
teeth and gums.
 d. Ensure that client does not take aspirin or other medica-
tions that increase the potential for bleeding.
 e. Clean up areas contaminated by client’s blood with house-
hold bleach diluted 1:10 with water.
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 6. To maintain near-normal body temperature:
 a. Provide frequent tepid water sponge baths.
 b. Provide antipyretic as ordered by physician (avoid aspirin).
 c. Place client in cool room, with minimal clothing and bed 
covers.
 d. Encourage intake of cool liquids (if not contraindicated).
Outcome Criteria
 1. Client does not experience respiratory distress.
 2. Client maintains optimal nutrition and hydration.
 3. Client has experienced no further weight loss.
 4. Client maintains integrity of skin and mucous membranes.
 5. Client shows no new signs or symptoms of infection.
●
 INTERRUPTED FAMILY PROCESSES
Deﬁ nition: Change in family relationships and/or functioning.
Possible Etiologies (“related to”)
[Crisis associated with having a family member diagnosed with 
HIV disease]
Deﬁ ning Characteristics (“evidenced by”)
Changes in availability for affective responsiveness and intimacy
Changes in participation in problem-solving and decision-making
Changes in communication patterns
Changes in availability for emotional support
Changes in satisfaction with family
Changes in expressions of conﬂ ict within family
Goals/Objectives
Short-term Goal
Family members will express feelings regarding loved one’s 
diagnosis and prognosis.
Long-term Goal
Family will verbalize areas of dysfunction and demonstrate 
ability to cope more effectively.
Interventions with Selected Rationales
 1. Create an environment that is comfortable, supportive, and 
private and promotes trust. Basic needs of the family must be 
met before crisis resolution can be attempted.
 2. Encourage each individual member to express feelings re-
garding loved one’s diagnosis and prognosis. Each individual 
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is unique and must feel that his or her private needs can be 
met within the family constellation.
 3. If the client is homosexual, and this is the family’s ﬁ rst 
awareness, help them deal with guilt and shame they may 
experience. Help parents to understand they are not re-
sponsible and their child is still the same individual they 
have always loved. Resolving guilt and shame enables fam-
ily members to respond adaptively to the crisis. Their re-
sponse can affect the client’s remaining future as well as 
the family’s future.
 4. Serve as facilitator between client’s family and homosexual 
partner. The family may have difﬁ culty accepting the part-
ner as a person who is as signiﬁ cant as a spouse. Clarify 
roles and responsibilities of family and partner. Do this by 
bringing both parties together to deﬁ ne and distribute the 
tasks involved in the client’s care. By minimizing the lack of 
legally defi ned roles and by focusing on the need for making 
realistic decisions about the client’s care, communication 
and resolution of confl ict are enhanced.
 5. Encourage use of stress management techniques (e.g., relax-
ation exercises, guided imagery, attendance at support group 
meetings for signiﬁ cant others of clients with HIV disease). 
Reduction of stress and support from others who share simi-
lar experiences enable individuals to begin to think more 
clearly and develop new behaviors to cope with this situ-
ational crisis.
 6. Provide educational information about HIV disease and 
opportunity to ask questions and express concerns. Many 
misconceptions about the disease abound within the public 
domain. Clarifi cation may calm some of the family’s fears 
and facilitate interaction with the client.
 7. Make family referrals to community organizations that 
provide supportive help or ﬁ nancial assistance to clients 
with HIV disease. Extended care can place a fi nancial bur-
den on client and family members. Respite care may pro-
vide family members with occasional much-needed relief 
away from the stress of physical and emotional caregiving 
responsibilities.
Outcome Criteria
 1. Family members are able to discuss feelings regarding client’s 
diagnosis and prognosis.
 2. Family members are able to make rational decisions re-
garding care of their loved one and the effect on family 
functioning.
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●
 DEFICIENT KNOWLEDGE 
(PREVENTION OF TRANSMISSION 
AND PROTECTION OF THE CLIENT)
Deﬁ nition: Absence or defi ciency of cognitive information related 
to a specifi c topic.
Possible Etiologies (“related to”)
Cognitive limitation
Information misinterpretation
Lack of exposure [to accurate information]
Deﬁ ning Characteristics (“evidenced by”)
Verbalization of the problem
Inappropriate or exaggerated behaviors
Inaccurate follow-through of instruction
[Inaccurate statements by client and family]
Goals/Objectives
Short-term Goal
Client and family verbalize understanding about disease pro-
cess, modes of transmission, and prevention of infection.
Long-term Goals
 1. Client and family demonstrate ability to execute precautions for 
preventing transmission of HIV and infection of the client.
 2. Transmission of HIV and infection of the client are 
prevented.
Interventions with Selected Rationales
 1. Present the following information in an effort to clarify 
misconceptions, calm fears, and support an environment of 
appropriate interventions for care of the client with HIV 
disease. Teach that HIV cannot be contracted from:
 a. Casual or household contact with an individual with HIV 
infection.
 b. Shaking hands, hugging, social (dry) kissing, holding 
hands, or other nonsexual physical contact.
 c. Touching unsoiled linens or clothing, money, furniture, 
or other inanimate objects.
 d. Being near someone who has HIV disease at work, school, 
restaurants, or in elevators.
 e. Toilet seats, bathtubs, towels, showers, or swimming 
pools.
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 f. Dishes, silverware, or food handled by a person with HIV 
disease.
 g. Animals (pets may transmit opportunistic organisms).
 h. (Very unlikely spread by) coughing, sneezing, spitting, 
kissing, tears, or saliva.
 2. HIV dies quickly outside the body because it requires living 
tissue to survive. It is readily killed by soap, cleansers, hot 
water, and disinfectants.
 3. Teach client to protect self from infections by taking the 
following precautions:
 a. Avoid unpasteurized milk or milk products.
 b. Cook all raw vegetables and fruits before eating. Raw or 
improperly washed foods may transmit microbes.
 c. Cook all meals well before eating.
 d. Avoid direct contact with persons with known contagious 
illnesses.
 e. Consult physician before getting a pet. Pets require extra 
infection control precautions because of the opportunistic 
organisms carried by animals.
 f. Avoid touching animal feces, urine, emesis, litter boxes, 
aquariums, or bird cages. Always wear mask and gloves 
when cleaning up after a pet.
 g. Avoid traveling in countries with poor sanitation.
 h. Avoid vaccines or vaccinations that contain live organ-
isms. Vaccination with live organisms may be fatal to 
severely immunosuppressed persons.
 i. Exercise regularly.
 j. Control stress factors. A counselor or support group may 
be helpful.
 k. Stop smoking. Smoking predisposes to respiratory 
infections.
 l. Maintain good personal hygiene.
 4. Teach client/signiﬁ cant others about prevention of 
transmission:
 a. Do not donate blood, plasma, body organs, tissues, or 
semen.
 b. Inform physician, dentist, and anyone providing care that 
you have HIV disease.
 c. Do not share needles or syringes.
 d. Do not share personal items, such as toothbrushes, razors, 
or other implements that may be contaminated with blood 
or body ﬂ uids.
 e. Do not eat or drink from the same dinnerware and 
utensils without washing them between uses.
 f. Avoid becoming pregnant if at risk for HIV infection.
 g. Engage in only “safer” sexual practices (those not involv-
ing exchange of body ﬂ uids).
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 h. Avoid sexual practices medically classiﬁ ed as “unsafe,” 
such as anal or vaginal intercourse and oral sex. 
 i. Avoid the use of recreational drugs because of their 
immunosuppressive effects.
 5. Teach the home caregiver(s) to protect self from HIV infec-
tion by taking the following precautions:
 a. Wash hands thoroughly with liquid antibiotic soap 
before and after each client contact. Use moisturizing lotion 
afterward to prevent dry, cracking skin.
 b. Wear gloves when in contact with blood or body ﬂ uids 
(e.g., open wounds, suctioning, feces). Gown or aprons 
may be worn if soiling is likely.
 c. Wear a mask:
 (1) When client has a productive cough and tuberculosis has 
not been ruled out.
 (2) To protect client if caregiver has a cold.
 (3) During suctioning.
 d. Bag disposable gloves and masks with client’s trash.
 e. Dispose of the following in the toilet:
 (1) Organic material on clothes or linen before laundering.
 (2) Blood or body fl uids.
 (3) Soiled tissue or toilet paper.
 (4) Cleaners or disinfectants used to clean contaminated 
articles.
 (5) Solutions contaminated with blood or body fl uids.
 f. Double-bag client’s trash and soiled dressings in an im-
penetrable, plastic bag. Tie the bag shut and discard with 
household trash.
 g. Do not recap needles, syringes, and other sharp items. 
Use puncture-proof covered containers for disposal (e.g., 
coffee cans and jars are appropriate for home use).
 h. Place soiled linen and clothing in a plastic bag and tie shut 
until washed. Launder these separately from other laun-
dry. Use bleach or other disinfectant in hot water.
 i. When house cleaning, all equipment used in care of the 
client, as well as bathroom and kitchen surfaces, should be 
cleaned with a 1:10 dilute bleach solution.
 j. Mops, sponges, and other items used for cleaning should 
be reserved speciﬁ cally for that purpose.
Outcome Criteria
 1. Client, family, and signiﬁ cant other(s) are able to verbalize in-
formation presented regarding ways in which HIV can and can-
not be transmitted, ways to protect the client from infections, 
and ways to prevent transmission to caregivers and others.
 2. Transmission to others and infection of the client have been 
avoided.
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 INTERNET REFERENCES
 • Additional information about HIV/AIDS may be located at 
the following websites:
 a. http://www.avert.org/
 b. http://www.aegis.com/main/
 c. http://www.HIVpositive.com/index.html
 d. http://research.med.umkc.edu/teams/cml/AIDS.html
 e. http://www.cdc.gov/hiv
 f. http://hivinsite.ucsf.edu/InSite?page=KB
 g. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5212a1 
.htm
Movie Connections
Philadelphia • Longtime Companion • A Mother’s Prayer 
• Breaking the Surface – The Greg Louganis Story • And the Band 
Played On
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Homelessness
● BACKGROUND ASSESSMENT DATA
It is difﬁ cult to determine how many individuals are homeless 
in the United States. Estimates have been made at somewhere 
between 250,000 and 4 million. 
Who are the Homeless?
 1. Age. Studies have produced a variety of statistics related to 
age of the homeless: 39% are younger than 18 years; indi-
viduals between the ages of 25 and 34 comprise 25%; and 6% 
are ages 55 to 64.
 2. Gender. More men than women are homeless. The National 
Coalition for the Homeless (NCH, 2007) reports that single 
men comprise 51% of the homeless population and single 
women comprise 17%.
 3. Families. Families with children are among the fastest grow-
ing segments of the homeless population. Families comprise 
33% of the urban homeless population, but research indicates 
that this number is higher in rural areas, where families, 
single mothers, and children make up the largest group of 
homeless people.
 4. Ethnicity. The homeless population is estimated to be 
42% African American, 39% white, 13% Hispanic, 4% 
Native American, and 2% Asian (U.S. Conference of Mayors 
[USCM], 2006). The ethnic makeup of homeless populations 
varies according to geographic location.
Mental Illness and Homelessness
The USCM (2008) survey revealed that approximately 26% 
of the homeless population has some form of mental illness. 
Schizophrenia is frequently described as the most common 
diagnosis. Other prevalent disorders include bipolar affective 
disorder, substance abuse and dependence, depression, person-
ality disorders, and organic mental disorders.
341
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Predisposing Factors to Homelessness 
Among the Mentally Ill
 1. Deinstitutionalization. Deinstitutionalization is frequently 
implicated as a contributing factor to homelessness among 
persons with mental illness. Deinstitutionalization began out 
of expressed concern by mental health professionals and oth-
ers who described the “deplorable conditions” under which 
mentally ill individuals were housed. Some individuals be-
lieved that institutionalization deprived the mentally ill of 
their civil rights. Not the least of the motivating factors for 
deinstitutionalization was the ﬁ nancial burden that these cli-
ents placed on state governments.
 2. Poverty. Cuts in various government entitlement programs 
have depleted the allotments available for individuals with 
severe and persistent mental illness living in the community. 
The job market is prohibitive for individuals whose behavior 
is incomprehensible or even frightening to many. The stigma 
and discrimination associated with mental illness may be di-
minishing slowly, but it is highly visible to those who suffer 
from its effects.
 3. A Scarcity of Affordable Housing. The NCH (2008b) 
stated:
A lack of affordable housing and the limited scale of housing 
assistance programs have contributed to the current housing 
crisis and to homelessness. The gap between the number of 
affordable housing units and the number of people needing 
them has created a housing crisis for poor people. Between 
1970 and 1995, the gap between the number of low-income 
renters and the amount of affordable housing units sky-
rocketed from a nonexistent gap to a shortage of 4.4 million 
affordable housing units—the largest shortfall on record.
  In addition, the number of single-room-occupancy (SRO) 
hotels has diminished drastically. These SRO hotels provid-
ed a means of relatively inexpensive housing, and although 
some people believe that these facilities nurtured isola-
tion, they provided adequate shelter from the elements for 
their occupants. So many individuals currently frequent the 
shelters of our cities that there is concern that the shelters 
are becoming mini-institutions for people with serious men-
tal illness. 
 4. Lack of Affordable Health Care. For families barely able to 
scrape together enough money to pay for day-to-day living, a 
catastrophic illness can create the level of poverty that starts 
the downward spiral to homelessness.
 5. Domestic Violence. The NCH (2008b) reports that approx-
imately half of all women and children experiencing home-
lessness are ﬂ eeing domestic violence. Battered women are 
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often forced to choose between an abusive relationship and 
homelessness.
 5. Addiction Disorders. For individuals with alcohol or drug ad-
dictions, in the absence of appropriate treatment, the chances 
increase for being forced into life on the street. The following 
have been cited as obstacles to addiction treatment for home-
less persons: lack of health insurance, lack of documentation, 
waiting lists, scheduling difﬁ culties, daily contact require-
ments, lack of transportation, ineffective treatment methods, 
lack of supportive services, and cultural insensitivity.
Symptomatology (Commonly Associated with 
Homelessness)
 1. Mobility and migration (the penchant for frequent move-
ment to various geographic locations)
 2. Substance abuse
 3. Nutritional deﬁ ciencies
 4. Difﬁ culty with thermoregulation
 5. Increased incidence of tuberculosis
 6. Increased incidence of sexually transmitted diseases
 7. Increased incidence of gastrointestinal (GI) and respiratory 
disorders
 8. Among homeless children (compared with control samples), 
increased incidence of:
 a. Ear infections
 b. GI and respiratory disorders
 c. Infestational ailments
 d. Developmental delays
 e. Psychological problems
Common Nursing Diagnoses 
and Interventions
(Interventions are applicable to various health-care settings, such as 
inpatient and partial hospitalization, community health clinic, “street 
clinic,” and homeless shelters.)
●
 INEFFECTIVE HEALTH 
MAINTENANCE
Deﬁ nition: Inability to identify, manage, and/or seek out help to 
maintain health.
Possible Etiologies (“related to”)
Perceptual/cognitive impairment
Deﬁ cient communication skills
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Unachieved developmental tasks
Insufﬁ cient resources (e.g., equipment, ﬁ nances)
Inability to make appropriate judgments
Ineffective individual coping
Deﬁ ning Characteristics (“evidenced by”)
History of lack of health-seeking behavior
Impairment of personal support systems
Demonstrated lack of knowledge about basic health practices
Demonstrated lack of adaptive behaviors to environmental 
changes
Inability to take responsibility for meeting basic health practices
Goals/Objectives
Short-term Goal
Client will seek and receive assistance with current health matters.
Long-term Goals
 1. Client will assume responsibility for own health-care needs 
within level of ability.
 2. Client will adopt lifestyle changes that support individual 
health-care needs.
Interventions with Selected Rationales
 1. The triage nurse in the emergency department, street clinic, 
or shelter will begin the biopsychosocial assessment of the 
homeless client. An adequate assessment is required to en-
sure appropriate nursing care is provided.
 2. Assess developmental level of functioning and ability to com-
municate. Use language that the client can comprehend. This 
information is essential to ensure that client achieves an ac-
curate understanding of information presented and that the 
nurse correctly interprets what the client is attempting to 
convey.
 3. Assess client’s use of substances, including use of tobacco. 
Discuss eating and sleeping habits. These actions may be 
contributing to current health problems.
 4. Assess sexual practices, to determine level of personal risk.
 5. Assess oral hygiene practices, to determine specifi c self-care 
needs.
 6. Assess client’s ability to make decisions. Client may need as-
sistance in determining the type of care that is required, 
how to determine the most appropriate time to seek that 
care, and where to go to receive it.
 7. It is important to ask the following basic questions of the 
homeless client:
 a. Do you understand what your problem is?
 b. How will you get your prescriptions ﬁ lled?
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 c. Where are you going when you leave here, or where will 
you sleep tonight?
  Answers to these questions at admission will initiate dis-
charge planning for the client.
 8. Teach client the basics of self-care (e.g., proper hygiene; 
facts about nutrition). The client must have this type of 
knowledge if he or she is to become more self-suffi cient.
 9. Teach client about safe sex practices in an effort to avoid 
sexually transmitted diseases.
 10. Identify immediate problems and assist with crisis inter-
vention. Emergency departments, “storefront” clinics, 
or shelters may be the homeless client’s only resource in a 
crisis situation.
 11. Tend to physical needs immediately. Ensure that client has thor-
ough physical examination. The client cannot deal with psycho-
social issues until physical problems have been addressed.
 12. Assess mental health status. Many homeless individuals 
have some form of mental illness. Ensure that appropriate 
psychiatric care is provided. If possible, inquire about pos-
sible long-acting medication injections for client. The client 
may be less likely to discontinue the medication if he or she 
does not have to take pills every day. 
 13. Refer client to others who can provide assistance (e.g., case 
manager; social worker). If the client is to be discharged 
to a shelter, a case manager or social worker may be the 
best link between the client and the health-care system to 
ensure that he or she obtains appropriate follow-up care.
Outcome Criteria
 1. Client verbalizes understanding of information presented 
regarding optimal health maintenance. 
 2. Client is able to verbalize signs and symptoms that should be 
reported to a health-care professional. 
 3. Client verbalizes knowledge of available resources from 
which he or she may seek assistance as required.
●
 POWERLESSNESS
Deﬁ nition: Perception that one’s own action will not signifi cantly 
affect an outcome; a perceived lack of control over a current situa-
tion or immediate happening.
Possible Etiologies (“related to”)
Lifestyle of helplessness
[Homelessness]
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Deﬁ ning Characteristics (“evidenced by”)
Verbal expressions of having no control (e.g., over self-care, situ-
ation, outcome)
Apathy
Inadequate coping patterns
Goals/Objectives
Short-term Goal
Client will identify areas over which he or she has control.
Long-term Goal
Client will make decisions that reﬂ ect control over present situ-
ation and future outcome.
Interventions with Selected Rationales
 1. Provide opportunities for the client to make choices about 
his or her present situation. Providing client with choices will 
increase his or her feeling of control.
 2. Avoid arguing or using logic with the client who feels power-
less. Client will not believe it can make a difference.
 3. Accept expressions of feelings, including anger and hopeless-
ness. An attitude of acceptance enhances feelings of trust 
and self-worth.
 4. Help client identify personal strengths and establish realistic 
life goals. Unrealistic goals set the client up for failure and 
reinforce feelings of powerlessness.
 5. Help client identify areas of life situation that he or she can 
control. Client’s emotional condition interferes with his or 
her ability to solve problems. Assistance is required to ac-
curately perceive the benefi ts and consequences of available 
alternatives.
 6. Help client identify areas of life situation that are not within 
his or her ability to control. Encourage verbalization of feel-
ings related to this inability in an effort to deal with unre-
solved issues and accept what cannot be changed.
 7. Encourage client to seek out support group or shelter re-
sources. Social isolation promotes feelings of powerlessness 
and hopelessness.
Outcome Criteria
 1. Client verbalizes choices made in a plan to maintain control 
over his or her life situation.
 2. Client verbalizes honest feelings about life situations over 
which he or she has no control.
 3. Client is able to verbalize system for problem-solving as re-
quired to maintain hope for the future.
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 INTERNET REFERENCES
 a. http://www.nationalhomeless.org/
 b. http://www.endhomelessness.org/
 c. http://portal.hud.gov/portal/page/portal/HUD/topics/
homelessness
 d. http://www.hhs.gov/homeless/
 e. http://www.nrchmi.samhsa.gov/Default.aspx
 f. http://www.abanet.org/homeless/
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Psychiatric Home 
Nursing Care
● BACKGROUND ASSESSMENT DATA
Dramatic changes in the health care delivery system and sky-
rocketing costs have created a need to ﬁ nd a way to provide 
quality, cost-effective care to psychiatric clients. Home care 
has become one of the fastest growing areas in the healthcare 
system and is now recognized by many reimbursement agencies 
as a preferred method of community-based service. Just what 
is home health care? The American Nurses Association (ANA, 
2008) contributed the following deﬁ nition:
Home health nursing is nursing practice applied to patients of all 
ages in the patients’ residences, which may include private homes, 
assisted living, or personal care facilities. Patients and their families 
and other caregivers are the focus of home health nursing practice. 
The goal of care is to maintain or improve the quality of life for 
patients and the families and other caregivers, or to support patients 
in their transition to end of life (p. 3). 
The psychiatric home care nurse must have knowledge and 
skills to meet both the physical and the psychosocial needs of 
the homebound client. Serving health care consumers in their 
home environment charges the nurse with the responsibility of 
providing holistic care.
Predisposing Factors
An increase in psychiatric home care may be associated with the 
following factors:
 1. Earlier hospital discharges
 2. Increased demand for home care as an alternative to institu-
tional care
 3. Broader third-party payment coverage
 4. Greater physician acceptance of home care 
 5. The increasing need to contain health-care costs and the 
growth of managed care 
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Psychiatric home nursing care is provided through private 
home health agencies; private hospitals; public hospitals; gov-
ernment institutions, such as the Veterans Administration; 
and community mental health centers. Most often, home care 
is viewed as follow-up care to inpatient, partial, or outpatient 
hospitalization.
The majority of home healthcare is paid for by Medicare. 
Other sources include Medicaid, private insurance, self-pay, and 
others. Medicare requires that the following criteria be met to 
qualify for psychiatric home care (Jensen & Miller, 2004):
 1. The client is conﬁ ned to the home.
 2. The client must receive services under a plan of care estab-
lished and periodically reviewed by a physician. 
 3. The client must be in need of skilled nursing care on an 
intermittent basis.
 4. Services must be reasonable and necessary for treating the 
client’s psychiatric diagnosis and/or symptoms.
 5. Home health psychiatric care must be provided by a skilled 
psychiatric nurse.
Jensen and Miller (2004) reported:
Care can be provided in one’s own home or residence, assisted liv-
ing, adult family homes, or retirement homes, but not in hospitals 
or skilled nursing facilities. A home health psychiatric care patient 
is unable to leave the home without considerable difﬁ culty or the as-
sistance of another person. The patient can leave home infrequently 
or for a short duration, for example, going to church on Sunday. The 
patient can also go out for medical treatment, partial hospitalization, 
adult day care, or chemotherapy. A patient can also be homebound 
for psychiatric reasons, such as depression, agoraphobia, paranoia, 
or panic disorder (p. 3).
Although Medicare and Medicaid are the largest reimburse-
ment providers, a growing number of health maintenance or-
ganizations (HMOs) and preferred provider organizations 
(PPOs) are recognizing the cost-effectiveness of psychiatric 
home nursing care and are including it as part of their beneﬁ t 
packages. Most managed care agencies require that treatment, 
or even a speciﬁ c number of visits, be preauthorized for psychi-
atric home nursing care. The plan of treatment and subsequent 
charting must explain why the client’s psychiatric disorder keeps 
him or her at home and justify the need for services.
Symptomatology (Subjective and Objective 
Data)
Homebound psychiatric clients most often have diagnoses of de-
pression, dementia, anxiety disorders, bipolar affective disorder, 
and schizophrenia. Psychiatric nurses also provide consultation 
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for clients with primary medical disorders. Many elderly clients 
are homebound because of medical conditions that impair mo-
bility and necessitate home care. Psychiatric nurses may provide 
the following types of home nursing care:
 • To clients with primary Axis I psychiatric diagnoses, 
the symptoms of which are immobilizing, and the client 
and family require assistance with management of the 
symptoms
 • To clients who are homebound for medical conditions but 
have a psychiatric condition for which they have been 
receiving (and continue to need ongoing) treatment
 • To clients who are homebound with medical conditions 
and who may develop serious psychiatric symptoms in 
response to their medical illness 
Table 21-1 identiﬁ es some of the conditions for which a psy-
chiatric nursing home care consultation may be sought.
The following components should be included in the com-
prehensive assessment of the homebound client: 
 1. The client’s perception of the problem and need for assistance
 2. Information regarding the client’s strengths and personal 
habits
 3. Health history, review of systems, and vital signs
 4. Any recent changes (physical, psychosocial, and environmental)
 5. Availability of support systems
 6. Current medication regimen (including the client’s under-
standing about the medications and reason for taking)
 7. Nutritional and elimination assessment
 8. Activities of daily living (ADLs) assessment
 9. Substance use assessment
 10. Neurological assessment
TABLE 21 – 1  Conditions that Warrant Psychiatric Nursing 
Consultation
●
 When a client has a new psychiatric diagnosis
●
 When a new psychotropic medication has been added to the regimen 
●
 When the client’s mental status exacerbates or causes deterioration in 
his or her medical condition 
●
 When the client is suspected of abusing alcohol or drugs
●
 When a client is expressing suicidal ideation
●
 When a client is noncompliant with psychotropic medication
●
 When a client develops a fundamental change in mood or a thought 
disorder
●
 When a client is immobilized by severe depression or anxiety
SOURCE: Adapted from Schroeder, 2009.
2506_Ch21_348-357.indd   Sec1:350 10/1/10   9:38:02 AM
Psychiatric Home Nursing Care ● 351
 11. Mental status examination (see Appendix M)
 12. Global Assessment of Functioning (GAF) scale rating (see 
Appendix K) 
Other important assessments include information about 
acute or chronic medical conditions, patterns of sleep and rest, 
solitude and social interaction, use of leisure time, education 
and work history, issues related to religion or spirituality, and 
adequacy of the home environment.
Common Nursing Diagnoses and Interventions 
for Psychiatric Homebound Clients
●
 INEFFECTIVE SELF-HEALTH 
MANAGEMENT
Deﬁ nition: Pattern of regulating and integrating into daily living a 
therapeutic regime for treatment of illness and its sequelae that is 
unsatisfactory for meeting specifi c health goals.
Possible Etiologies (“related to”) 
Perceived barriers
Social support deﬁ cits
Powerlessness
Perceived beneﬁ ts
[Mistrust of regimen and/or health care personnel]
Knowledge deﬁ cit
Complexity of therapeutic regimen
Deﬁ ning Characteristics (“evidenced by”) 
Makes choices in daily living ineffective for meeting health goals
Failure to include treatment regimens in daily living
Failure to take action to reduce risk factors
Verbalizes difﬁ culty with prescribed regimens
Verbalizes desire to manage the illness
Goals/Objectives
Short-term Goals
 1. Client will verbalize understanding of barriers to self-health 
management.
 2. Client will participate in problem-solving efforts toward 
adequate self-health management.
Long-term Goal
Client will incorporate changes in lifestyle necessary to main-
tain effective self-health management.
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Interventions with Selected Rationales
 1. Assess client’s knowledge of condition and treatment needs. 
Client may lack full comprehension of need for treatment 
regimen.
 2. Identify client’s perception of treatment regimen. Client 
may be mistrustful of treatment regimen or of health care 
system in general.
 3. Promote a trusting relationship with the client by being 
honest, encouraging client to participate in decision-making, 
and conveying genuine positive regard. 
 4. Assist client in recognizing strengths and past successes. 
Recognition of strengths and past successes increases self-
esteem and indicates to client that he or she can be successful 
in managing therapeutic regimen.
 5. Provide positive reinforcement for efforts. Positive rein-
forcement increases self-esteem and encourages repetition 
of desirable behaviors.
 6. Emphasize importance of need for treatment and/or medica-
tion. Client must understand that the consequence of lack of 
follow-through is possible decompensation.
 7. In an effort to incorporate lifestyle changes and promote 
wellness, help client develop plans for managing therapeutic 
regimen, such as support groups, social and family systems, 
and ﬁ nancial assistance. 
Outcome Criteria
 1. Client verbalizes understanding of information presented 
 regarding management of therapeutic regimen.
 2. Client demonstrates desire and ability to perform strategies 
necessary to maintain adequate management of therapeutic 
regimen.
 3. Client verbalizes knowledge of available resources from 
which he or she may seek assistance as required.
●
 RISK-PRONE HEALTH BEHAVIOR
Deﬁ nition: Impaired ability to modify lifestyle/behaviors in a man-
ner that improves health status.
Possible Etiologies (“related to”) 
Inadequate comprehension
Inadequate social support
Low self-efﬁ cacy
Low socioeconomic status
Multiple stressors
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Negative attitude toward healthcare
[Intense emotional state]
Deﬁ ning Characteristics (“evidenced by”) 
Demonstrates nonacceptance of health status change
Failure to achieve optimal sense of control
Failure to take actions that prevent health problems
Minimizes health status change
Goals/Objectives
Short-term Goals
 1. Client will discuss with home health nurse the kinds of life-
style changes that will occur because of the change in health 
status.
 2. With the help of home health nurse, client will formulate a 
plan of action for incorporating those changes into his or her 
lifestyle.
 3. Client will demonstrate movement toward independence, 
considering change in health status.
Long-term Goal
Client will demonstrate competence to function independently 
to his or her optimal ability, considering change in health status, 
by time of discharge from home health care.
Interventions with Selected Rationales
 1. Encourage client to talk about lifestyle prior to the change 
in health status. Discuss coping mechanisms that were used 
at stressful times in the past. It is important to identify the 
client’s strengths so that they may be used to facilitate adap-
tation to the change or loss that has occurred.
 2. Encourage client to discuss the change or loss and particu-
larly to express anger associated with it. Some individuals 
may not realize that anger is a normal stage in the grieving 
process. If it is not released in an appropriate manner, it 
may be turned inward on the self, leading to pathological 
depression.
 3. Encourage client to express fears associated with the change 
or loss or alteration in lifestyle that the change or loss has 
created. Change often creates a feeling of disequilibrium 
and the individual may respond with fears that are irra-
tional or unfounded. He or she may benefi t from feedback 
that corrects misperceptions about how life will be with the 
change in health status.
 4. Provide assistance with ADLs as required, but encourage in-
dependence to the limit that client’s ability will allow. Give 
positive feedback for activities accomplished independently. 
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Independent accomplishments and positive feedback enhance 
self-esteem and encourage repetition of desired behaviors. 
Successes also provide hope that adaptive functioning is 
possible and decrease feelings of powerlessness.
 5. Help client with decision-making regarding incorporation 
of change or loss into lifestyle. Identify problems that the 
change or loss is likely to create. Discuss alternative solu-
tions, weighing potential beneﬁ ts and consequences of each 
alternative. Support client’s decision in the selection of 
an alternative. The great amount of anxiety that usually 
accompanies a major lifestyle change often interferes 
with an individual’s ability to solve problems and to make 
appropriate decisions. Client may need assistance with 
this process in an effort to progress toward successful 
adaptation.
 6. Use role-playing to decrease anxiety as client anticipates 
stressful situations that might occur in relation to the health 
status change. Role-playing decreases anxiety and provides 
a feeling of security by arming the client with a plan of 
action with which to respond in an appropriate manner 
when a stressful situation occurs.
 7. Ensure that client and family are fully knowledgeable re-
garding the physiology of the change in health status and its 
necessity for optimal wellness. Encourage them to ask ques-
tions, and provide printed material explaining the change to 
which they may refer following discharge.
 8. Help client identify resources within the community from 
which he or she may seek assistance in adapting to the 
change in health status. Examples include self-help or sup-
port groups, counselor, or social worker. Encourage client to 
keep follow-up appointments with physician or to call phy-
sician’s ofﬁ ce prior to follow-up date if problems or concerns 
arise.
Outcome Criteria
 1. Client is able to perform ADLs independently.
 2. Client is able to make independent decisions regarding life-
style considering change in health status.
 3. Client is able to express hope for the future with consider-
ation of change in health status.
●
 SOCIAL ISOLATION
Deﬁ nition: Aloneness experienced by the individual and perceived 
as imposed by others and as a negative or threatening state.
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Possible Etiologies (“related to”) 
Alterations in mental status
Inability to engage in satisfying personal relationships
Unaccepted social values
Unaccepted social behavior
Inadequate personal resources
Immature interests
Alterations in physical appearance
Altered state of wellness
Deﬁ ning Characteristics (“evidenced by”) 
Expresses feelings of aloneness imposed by others
Expresses feelings of rejection
Developmentally inappropriate interests 
Inability to meet expectations of others
Insecurity in public
Absence of supportive signiﬁ cant other(s)
Projects hostility 
Withdrawn; uncommunicative
Seeks to be alone
Preoccupation with own thoughts
Sad, dull affect 
Goals/Objectives
Short-term Goal
Client will verbalize willingness to be involved with others.
Long-term Goal
Client will participate in interactions with others at level of abil-
ity or desire.
Interventions with Selected Rationales
 1. Convey an accepting attitude by making regular visits. An 
accepting attitude increases feelings of self-worth and facili-
tates trust.
 2. Show unconditional positive regard. This conveys your belief 
in the client as a worthwhile human being.
 3. Be honest and keep all promises. Honesty and dependability 
promote a trusting relationship.
 4. Be cautious with touch until trust has been established. A sus-
picious client may perceive touch as a threatening gesture.
 5. Be with the client to offer support during activities that may 
be frightening or difﬁ cult for him or her. The presence of a 
trusted individual provides emotional security for the client.
 6. Take walks with the client. Help him or her perform simple 
tasks around the house. Increased activity enhances both 
physical and mental status.
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 7. Assess lifelong patterns of relationships. Basic personal-
ity characteristics will not change. Most individuals keep 
the same style of relationship development that they had in 
the past.
 8. Help the client identify present relationships that are satisfying 
and activities that he or she considers interesting. Only the cli-
ent knows what he or she truly likes, and these personal pref-
erences will facilitate success in reversing social isolation.
 9. Consider the feasibility of a pet. There are many documented 
studies of the benefi ts of companion animals.
Outcome Criteria
 1. Client demonstrates willingness and desire to socialize with 
others.
 2. Client independently pursues social activities with others.
●
 RISK FOR CAREGIVER ROLE STRAIN
Deﬁ nition: Caregiver is vulnerable for felt diffi culty in performing 
the family caregiver role.
Risk Factors 
Caregiver not developmentally ready for caregiver role
Inadequate physical environment for providing care
Unpredictable illness course or instability in the care receiver’s 
health
Psychological or cognitive problems in care receiver
Presence of abuse or violence
Past history of poor relationship between caregiver and care 
receiver
Marginal caregiver’s coping patterns
Lack of respite and recreation for caregiver
Addiction or codependency
Caregiver’s competing role commitments
Illness severity of the care receiver
Duration of caregiving required
Family/caregiver isolation 
Goals/Objectives
Short-term Goal
Caregivers will verbalize understanding of ways to facilitate the 
caregiver role.
Long-term Goal
Caregivers will demonstrate effective problem-solving skills and 
develop adaptive coping mechanisms to regain equilibrium.
2506_Ch21_348-357.indd   Sec1:356 10/1/10   9:38:05 AM
Psychiatric Home Nursing Care ● 357
Interventions with Selected Rationales
 1. Assess caregivers’ ability to anticipate and fulﬁ ll client’s un-
met needs. Provide information to assist caregivers with this 
responsibility. Ensure that caregivers encourage client to be 
as independent as possible. Caregivers may be unaware of 
what the client can realistically accomplish. They may be 
unaware of the nature of the illness.
 2. Ensure that caregivers are aware of available community sup-
port systems from which they can seek assistance when re-
quired. Examples include respite care services, day treatment 
centers, and adult day-care centers. Caregivers require relief 
from the pressures and strain of providing 24-hour care for 
their loved one. Studies have shown that abuse arises out of 
caregiving situations that place overwhelming stress on the 
caregivers.
 3. Encourage caregivers to express feelings, particularly anger. 
Release of these emotions can serve to prevent psychopathol-
ogy, such as depression or psychophysiological disorders, 
from occurring.
 4. Encourage participation in support groups composed of 
members with similar life situations. Provide information 
about support groups that may be helpful: 
 a. National Alliance for the Mentally Ill—(800) 950-NAMI
 b. American Association on Intellectual and Developmental 
Disabilities—(800) 424-3688
 c. Alzheimer’s Association—(800) 272-3900
Hearing others who are experiencing the same problems 
discuss ways in which they have coped may help the caregiver 
adopt more adaptive strategies. Individuals who are experi-
encing similar life situations provide empathy and support for 
each other.
Outcome Criteria
 1. Caregivers are able to problem-solve effectively regarding 
care of the client.
 2. Caregivers demonstrate adaptive coping strategies for deal-
ing with stress of caregiver role.
 3. Caregivers openly express feelings.
 4. Caregivers express desire to join support group of other 
caregivers.
 INTERNET REFERENCES
 a. http://www.cms.hhs.gov/
 b. http://www.nahc.org/
 c. http://www.aahomecare.org/ 
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Forensic Nursing
● BACKGROUND ASSESSMENT DATA
The International Association of Forensic Nurses (IAFN) 
(2009) has deﬁ ned forensic nursing as:
The practice of nursing globally when health and legal systems 
intersect (p. 3).
Bellﬁ eld and Catalano (2009) have stated: 
Forensic nursing is an emerging ﬁ eld that forms an alliance between 
nursing, law enforcement, and the forensic sciences. The term 
forensic means anything belonging to, or pertaining to, the law. 
Forensic nurses provide a continuum of care to victims and their 
families beginning in the emergency room or crime scene and lead-
ing to participation in the criminal investigation and the courts of 
law (p. 446).
Areas of forensic nursing include:
 1. Clinical forensic nursing
 2. The sexual assault nurse examiner (SANE)
 3. Forensic psychiatric nursing specialty
 4. Correctional/institutional nursing specialty
 5. Nurses in general practice 
Clinical Forensic Nursing in Trauma Care
Assessment
Lynch, Roach, and Sadler (2006) have stated, “Forensic nurse 
specialists are speciﬁ cally trained to deal with cases of sexual 
assault, child abuse, acute psychiatric emergencies, and death 
investigation” (p. 603). All traumatic injuries in which liability 
is suspected are considered within the scope of forensic nurs-
ing. Reports to legal agencies are required to ensure follow-up 
investigation; however, the protection of clients’ rights remains 
a nursing priority.
Several areas of assessment in which the clinical forensic 
nurse specialist in trauma care may become involved include:
 1. Preservation of Evidence. Evidence from both crime-
related and self-inﬂ icted traumas must be safeguarded in a 
358
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manner consistent with the investigation. Evidence such as 
clothing, bullets, bloodstains, hairs, ﬁ bers, and small pieces 
of material such as fragments of metal, glass, paint, and wood 
should be saved and documented in all medical accident in-
stances that have legal implications.
 2. Investigation of Wound Characteristics. Wounds that the 
nurse must be able to identify include: 
 a. Sharp-Force Injuries: Sharp-force injuries including stab 
wounds and other wounds resulting from penetration 
with a sharp object.
 b. Blunt-Force Injuries: Includes cuts and bruises resulting 
from the impact of a blunt object against the body.
 c. Dicing Injuries: Multiple, minute cuts and abrasions 
caused by contact with shattered glass (e.g., often occur in 
motor vehicle accidents).
 d. Patterned Injuries: Speciﬁ c injuries that reﬂ ect the 
pattern of the weapon used to inﬂ ict the injury.
 e. Bite-Mark Injuries: A type of patterned injury inﬂ icted 
by a human or an animal.
 f. Defense Wounds: Injuries that reﬂ ect the victim’s attempt 
to defend himself or herself from attack.
 g. Hesitation Wounds: Usually superﬁ cial, sharp-force 
wounds; often found perpendicular to the lower part of 
the body and may reﬂ ect self-inﬂ icted wounds.
 h. Fast-Force Injuries: Usually gunshot wounds; may reﬂ ect 
various patterns of injury.
 3. Deaths in the Emergency Department. When deaths oc-
cur in the emergency department as a result of abuse or acci-
dent, evidence must be retained, the death must be reported 
to legal authorities, and an investigation is conducted. It is 
therefore essential that the nurse carefully document the 
appearance, condition, and behavior of the victim upon ar-
rival at the hospital. The information gathered from the cli-
ent and family (or others accompanying the client) may serve 
to facilitate the postmortem investigation and may be used 
during criminal justice proceedings.
  The critical factor is to be able to determine if the cause 
of death is natural or unnatural. A death is deemed natural if 
it occurs because of a congenital anomaly or a disease process 
that interferes with vital organ functioning (Lynch, 2006). In 
the emergency department, most deaths are sudden and un-
expected. Those that are considered natural most commonly 
involve the cardiovascular, respiratory, and central nervous sys-
tems. Deaths that are considered unnatural include those from 
trauma, from self-infl icted acts, or from injuries infl icted by an-
other. Legal authorities must be notifi ed of all deaths related to 
unnatural circumstances. 
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Common Nursing Diagnoses and Interventions 
for Forensic Nursing in Trauma Care
●
 POST-TRAUMA SYNDROME
Deﬁ nition: Sustained maladaptive response to a traumatic, over-
whelming event.
Possible Etiologies (“related to”) 
Physical and/or psychosocial abuse
Tragic occurrence involving multiple deaths
Sudden destruction of one’s home or community
Epidemics
Disasters
Rape
Serious accidents (e.g., industrial, motor vehicle)
Witnessing mutilation, violent death, [or other horrors]
Serious threat or injury to self or loved ones
Deﬁ ning Characteristics (“evidenced by”) 
[Physical injuries related to trauma]
Avoidance
Repression
Difﬁ culty concentrating
Grieving; guilt
Intrusive thoughts 
Neurosensory irritability
Palpitations
Anger and/or rage; aggression
Intrusive dreams; nightmares; ﬂ ashbacks
Panic attacks; fear
Gastric irritability
Psychogenic amnesia
Substance abuse
Goals/Objectives
Short-term Goals
 1. The client’s physical wounds will heal without complication.
 2. The client will begin a healthy grief resolution, initiating the 
process of psychological healing.
Long-term Goal
The client will demonstrate ability to deal with emotional reac-
tions in an individually appropriate manner.
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Interventions with Selected Rationales
 1. It is important to communicate the following to the victim of 
sexual assault:
 a. “You are safe here.”
 b. “I’m sorry that it happened.”
 c. “I am very glad you survived.”
 d. “It is not your fault. No one deserves to be treated this 
way.”
 e. “You did the best that you could.”
The woman who has been sexually assaulted fears for her life 
and must be reassured of her safety. She may also be over-
whelmed with self-doubt and self-blame, and these state-
ments instill trust and validate self-worth.
 2. Explain every assessment procedure that will be conducted 
and why it is being conducted. Ensure that data collection 
is conducted in a caring, nonjudgmental manner to decrease 
fear and anxiety and increase trust.
 3. Ledray (2001) suggested the following ﬁ ve essential compo-
nents of a forensic examination of the sexual assault survivor 
in the emergency department:
 a. Treatment and documentation of injuries. Samples of blood, se-
men, hair, and ﬁ ngernail scrapings should be sealed in paper, 
not plastic, bags, to prevent the possible growth of mildew 
from accumulation of moisture inside the plastic container, 
and the subsequent contamination of the evidence. 
 b. Maintaining the proper chain of evidence. Samples must be 
properly labeled, sealed, and refrigerated when necessary 
and kept under observation or properly locked until ren-
dered to the proper legal authority in order to ensure the 
proper chain of evidence and freshness of the samples.
 c. Treatment and evaluation of sexually transmitted diseases 
(STDs). If conducted within 72 hours of the attack, sev-
eral tests and interventions are available for prophylactic 
treatment of certain STDs.
 d. Pregnancy risk evaluation and prevention. Prophylactic regi-
mens are 97% to 98% effective if started within 24 hours 
of the sexual attack and are generally only recommended 
within 72 hours (Ledray, 2001).
 e. Crisis intervention and arrangements for follow-up counseling. 
Because a survivor is often too ashamed or fearful to seek 
follow-up counseling, it may be important for the nurse to 
obtain the individual’s permission to allow a counselor to 
call her to make a follow-up appointment.
 4. In the case of other types of trauma (e.g., gunshot victims; 
automobile/pedestrian hit-and-run victims), ensure that any 
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possible evidence is not lost. Clothing that is removed from a 
victim should not be shaken, and each separate item of cloth-
ing should be placed carefully in a paper bag, which should be 
sealed, dated, timed, and signed.
 5. Ensure that the client has adequate privacy for all immediate 
postcrisis interventions. Try to have as few people as possible 
providing the immediate care or collecting immediate evi-
dence. The post-trauma client is extremely vulnerable. Ad-
ditional people in the environment may increase this feeling 
of vulnerability and escalate anxiety.
 6. Encourage the client to give an account of the trauma/
assault. Listen, but do not probe. Nonjudgmental listening 
provides an opportunity for catharsis that the client needs to 
begin healing. A detailed account may be required for legal 
follow-up, and a caring nurse, as client advocate, may help 
to lessen the trauma of evidence collection.
 7. Discuss with the client whom to call for support or assistance. 
Provide information about referrals for aftercare. Because of 
severe anxiety and fear, client may need assistance from oth-
ers during this immediate postcrisis period. Provide referral 
information in writing for later reference (e.g., psychothera-
pist, mental health clinic, community advocacy group).
 8. In the event of a sudden and unexpected death in the trauma 
care setting, the clinical forensic nurse may be called upon to 
present information associated with an anatomical donation 
request to the survivors. The clinical forensic nurse specialist 
is an expert in legal issues and has the knowledge and sensi-
tivity to provide coordination between the medical examiner 
and families who are grieving the loss of loved ones.
Outcome Criteria
 1. The client is no longer experiencing panic anxiety.
 2. The client demonstrates a degree of trust in the primary 
nurse.
 3. The client has received immediate attention to physical injuries.
 4. The client has initiated behaviors consistent with the grief 
response.
 5. Necessary evidence has been collected and preserved in 
order to proceed appropriately within the legal system. 
Forensic Psychiatric Nursing in Correctional 
Facilities
Assessment
It was believed that deinstitutionalization increased the freedom 
of mentally ill individuals in accordance with the principle of 
“least restrictive alternative.” However, because of inadequate 
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community-based services, many of these individuals drift 
into poverty and homelessness, increasing their vulnerability 
to criminalization. Because the bizarre behavior of mentally ill 
individuals living on the street is sometimes offensive to com-
munity standards, law enforcement ofﬁ cials have the authority 
to protect the welfare of the public, as well as the safety of the 
individual, by initiating emergency hospitalization. However, 
legal criteria for commitment are so stringent in most cases, 
that arrest becomes an easier way of getting the mentally ill 
person off the street if a criminal statute has been violated. 
According to the Bureau of Justice, more than half of all pris-
on and jail inmates have some form of mental health problem 
(James & Glaze, 2006). Some of these individuals are incarcer-
ated as a result of the increasingly popular “guilty but mentally 
ill” verdict. With this verdict, individuals are deemed mentally 
ill, yet are held criminally responsible for their actions. The 
individual is incarcerated and receives special treatment, if 
needed, but it is no different from that available for and needed 
by any prisoner.
Psychiatric diagnoses commonly identiﬁ ed at the time of 
incarceration include schizophrenia, bipolar disorder, major 
depression, personality disorders, and substance disorders, and 
many have dual diagnoses (Yurkovich & Smyer, 2000). Com-
mon psychiatric behaviors include hallucinations, suspicious-
ness, thought disorders, anger/agitation, and impulsivity. De-
nial of problems is a common behavior among this population. 
Use of substances and medication noncompliance are common 
obstacles to rehabilitation. Substance abuse has been shown 
to have a strong correlation with recidivism among the prison 
population. Many individuals report that they were under the 
inﬂ uence of substances at the time of their criminal actions, 
and dual diagnoses are common. Detoxiﬁ cation frequency oc-
curs in jails and prisons, and some inmates have died from the 
withdrawal syndrome because of inadequate treatment during 
this process. 
Common Nursing Diagnoses and Interventions 
for Forensic Nursing in Correctional Facilities
●
 DEFENSIVE COPING
Deﬁ nition: Repeated projection of falsely positive self-evaluation 
based on a self-protective pattern that defends against underlying 
perceived threats to positive self-regard.
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Possible Etiologies (“related to”) 
[Low self-esteem]
[Retarded ego development]
[Underdeveloped superego]
[Negative role models]
[Lack of positive feedback]
[Absent, erratic, or inconsistent methods of discipline]
[Dysfunctional family system] 
Deﬁ ning Characteristics (“evidenced by”) 
Denial of obvious problems or weaknesses
Projection of blame or responsibility
Rationalization of failures
Hypersensitivity to criticism
Grandiosity
Superior attitude toward others
Difﬁ culty establishing or maintaining relationships
Hostile laughter or ridicule of others
Difﬁ culty in perception of reality testing
Lack of follow-through or participation in treatment or therapy
Goals/Objectives
Short-term Goal
Client will verbalize personal responsibility for own actions, 
successes, and failures.
Long-term Goal
Client will demonstrate ability to interact with others and adapt 
to lifestyle goals without becoming defensive, rationalizing 
behaviors, or expressing grandiose ideas.
Interventions with Selected Rationales
 1. Recognize and support basic ego strengths. Focusing on 
positive aspects of the personality may help to improve self-
concept.
 2. Encourage client to recognize and verbalize feelings of inad-
equacy and need for acceptance from others, and how these 
feelings provoke defensive behaviors, such as blaming others 
for own behaviors. Recognition of the problem is the fi rst 
step in the change process toward resolution.
 3. Provide immediate, matter-of-fact, nonthreatening feed-
back for unacceptable behaviors. Client may lack knowledge 
about how he or she is being perceived by others. Direct the 
behavior in a nonthreatening manner to a more acceptable 
behavior.
 4. Help client identify situations that provoke defensiveness and 
practice more appropriate responses through role-playing. 
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Role-playing provides confi dence to deal with diffi cult situa-
tions when they actually occur.
 5. Provide immediate positive feedback for acceptable behav-
iors. Positive feedback enhances self-esteem and encourages 
repetition of desirable behaviors.
 6. Help client set realistic, concrete goals and determine appropri-
ate actions to meet those goals. Success increases self-esteem.
 7. Evaluate with client the effectiveness of the new behaviors 
and discuss any modiﬁ cations for improvement. Because of 
limited problem-solving ability, assistance may be required 
to reassess and develop new strategies, in the event that cer-
tain of the new coping methods prove ineffective.
 8. Use confrontation judiciously to help client begin to iden-
tify defense mechanisms (e.g., denial and projection) that 
are hindering development of satisfying relationships and 
adaptive behaviors.
Outcome Criteria
 1. Client verbalizes and accepts responsibility for own behavior.
 2. Client verbalizes correlation between feelings of inadequacy 
and the need to defend the ego through rationalization and 
grandiosity.
 3. Client does not ridicule or criticize others.
 4. Client interacts with others in group situations without tak-
ing a defensive stance. 
●
 COMPLICATED GRIEVING
Deﬁ nition: A disorder that occurs after the death of a signifi cant 
other [or any other loss of signifi cance to the individual], in which the 
experience of distress accompanying bereavement fails to follow 
normative expectations and manifests in functional impairment.
Possible Etiologies (“related to”) 
[Loss of freedom] 
Deﬁ ning Characteristics (“evidenced by”) 
[Anger]
[Internalized rage]
Depression
[Labile affect]
[Suicidal ideation]
[Difﬁ culty expressing feelings]
[Altered activities of daily living]
[Prolonged difﬁ culty coping] 
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Goals/Objectives
Short-term Goal
Client will verbalize feelings of grief related to loss of freedom.
Long-term Goal
Client will progress satisfactorily through the grieving process.
Interventions with Selected Rationales
 1. Convey an accepting attitude—one that creates a nonthreat-
ening environment for the client to express feelings. Be hon-
est and keep all promises. An accepting attitude conveys to 
the client that you believe he or she is a worthwhile person. 
Trust is enhanced.
 2. Identify the function that anger, frustration, and rage serve 
for the client. Allow the client to express these feelings within 
reason. Verbalization of feelings in a nonthreatening envi-
ronment may help the client come to terms with unresolved 
grief.
 3. Encourage the client to discharge pent-up anger through 
participation in large motor activities (e.g., physical exercises, 
volleyball, punching bag). Physical exercise provides a safe 
and effective method for discharging pent-up tension.
 4. Anger may be displaced onto the nurse or therapist, and cau-
tion must be taken to guard against the negative effects of 
countertransference. These are very difﬁ cult clients who have 
the capacity for eliciting a whole array of negative feelings 
from the therapist. These feelings must be acknowledged but 
not allowed to interfere with the therapeutic process.
 5. Explain the behaviors associated with the normal grieving 
process. Help the client to recognize his or her position in this 
process. This knowledge about normal grieving may help fa-
cilitate the client’s progression toward resolution of grief.
 6. Help the client understand appropriate ways to express anger. 
Give positive reinforcement for behaviors used to express an-
ger appropriately. Act as a role model. Positive reinforcement 
enhances self-esteem and encourages repetition of desirable 
behaviors. It is appropriate to let the client know when he or 
she has done something that has generated angry feelings in 
you. Role-modeling ways to express anger in an appropriate 
manner is a powerful learning tool.
 7. Set limits on acting-out behaviors and explain consequences 
of violation of those limits. Be supportive, yet consistent and 
ﬁ rm in working with this client. Client lacks suffi cient self-
control to limit maladaptive behaviors; therefore, assistance 
is required from staff. Without consistency on the part of all 
staff members working with the client, a positive outcome 
will not be achieved.
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 8. Provide a safe and protective environment for the client 
against risk of self-directed violence. Depression is the emo-
tion that most commonly precedes suicidal attempts.
Outcome Criteria
 1. Client is able to verbalize ways in which anger and acting-out 
behaviors are associated with maladaptive grieving.
 2. Client is expresses anger and hostility outwardly in a safe and 
acceptable manner.
 3. Client has not harmed self or others.
●
 RISK FOR INJURY
Deﬁ nition: At risk of injury as a result of [internal or external] en-
vironmental conditions interacting with the individual’s adaptive 
and defensive resources.
Related/Risk Factors (“related to”) 
[Substance use/detoxiﬁ cation at time of incarceration, exhibit-
ing any of the following:
Substance intoxication
Substance withdrawal
Disorientation
Seizures
Hallucinations
Psychomotor agitation
Unstable vital signs
Delirium
Flashbacks
Panic level of anxiety] 
Goals/Objectives
Short-term Goal
Client’s condition will stabilize within 72 hours.
Long-term Goal
Client will not experience physical injury.
Interventions with Selected Rationales
 1. Assess client’s level of disorientation to determine spe-
ciﬁ c requirements for safety. Knowledge of client’s level 
of functioning is necessary to formulate appropriate plan 
of care.
 2. Obtain a drug history, if possible, to determine 
 a. Type of substance(s) used.
 b. Time of last ingestion and amount consumed.
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 c. Duration and frequency of consumption.
 d. Amount consumed on a daily basis. 
 3. Obtain urine sample for laboratory analysis of substance 
content. Subjective history often is not accurate. Knowledge 
regarding substance ingestion is important for accurate as-
sessment of client condition.
 4. Place client in quiet room, if possible. Excessive stimuli in-
crease client agitation.
 5. Institute necessary safety precautions. Client safety is a 
nursing priority. 
 a. Observe client behaviors frequently; assign staff on one-
to-one basis if condition warrants it; accompany and assist 
client when ambulating; use wheelchair for transporting 
long distances.
 b. Be sure that side rails are up when client is in bed.
 c. Pad headboard and side rails of bed with thick towels to 
protect client in case of seizure.
 d. Use mechanical restraints as necessary to protect client if 
excessive hyperactivity accompanies the disorientation. 
 6. Ensure that smoking materials and other potentially harmful 
objects are stored outside client’s access. Client may harm 
self or others in disoriented, confused state.
 7. Monitor vital signs every 15 minutes initially and less fre-
quently as acute symptoms subside. Vital signs provide the 
most reliable information regarding client condition and 
need for medication during acute detoxifi cation period.
 8. Follow medication regimen, as ordered by physician. Com-
mon medical interventions for detoxiﬁ cation from the fol-
lowing substances include:
 a. Alcohol. Benzodiazepines are the most widely used group 
of drugs for substitution therapy in alcohol withdrawal. 
The approach to treatment is to start with relatively high 
doses and reduce the dosage by 20% to 25% each day until 
withdrawal is complete. In clients with liver disease, ac-
cumulation of the longer-acting agents, such as chlordi-
azepoxide (Librium), may be problematic, and the use of 
the shorter-acting benzodiazepine, oxazepam (Serax), is 
more appropriate. Some physicians may order anticonvul-
sant medication to be used prophylactically; however, this 
is not a universal intervention. Multivitamin therapy, in 
combination with daily thiamine (either orally or by injec-
tion), is common protocol.
 b. Narcotics. Narcotic antagonists, such as naloxone (Narcan), 
naltrexone (ReVia), or nalmefene (Revex), are admin-
istered for opioid intoxication. Withdrawal is managed 
with rest and nutritional therapy. Substitution therapy 
may be instituted to decrease withdrawal symptoms using 
propoxyphene (Darvon) for weaker effects or methadone
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(Dolophine) for longer effects. In October 2002, the 
U.S. Food and Drug Administration approved two forms 
of the drug buprenorphine for treating opiate dependence. 
Buprenorphine is less powerful than methadone but is 
considered to be somewhat safer and causes fewer side 
effects, making it especially attractive for clients who are 
mildly or moderately addicted.
 c. Depressants. Substitution therapy may be instituted to 
decrease withdrawal symptoms using a long-acting barbi-
turate, such as phenobarbital (Luminal). Some physicians 
prescribe oxazepam (Serax) as needed for objective symp-
toms, gradually decreasing the dosage until the drug is dis-
continued. Long-acting benzodiazepines are commonly 
used for substitution therapy when the abused substance is 
a nonbarbiturate central nervous system depressant.
 d. Stimulants. Treatment of stimulant intoxication is geared 
toward stabilization of vital signs. Intravenous antihyper-
tensives may be used, along with intravenous diazepam 
(Valium) to control seizures. Minor tranquilizers, such as 
chlordiazepoxide, may be administered orally for the ﬁ rst 
few days while the client is “crashing.” Treatment is aimed 
at reducing drug craving and managing severe depression. 
Suicide precautions may be required. Therapy with anti-
depressant medication is not uncommon.
 e. Hallucinogens and Cannabinols. Medications are nor-
mally not prescribed for withdrawal from these substances. 
However, in the event of overdose or the occurrence of 
adverse reactions (e.g., anxiety or panic), benzodiazepines 
(e.g., diazepam or chlordiazepoxide) may be given as 
needed to decrease agitation. Should psychotic reactions 
occur, they may be treated with antipsychotics. 
Outcome Criteria
 1. Client is no longer exhibiting any signs or symptoms of sub-
stance intoxication or withdrawal.
 2. Client shows no evidence of physical injury obtained during 
substance intoxication or withdrawal. 
 INTERNET REFERENCES
Additional information related to forensic nursing may be found 
at the following websites:
 a. http://www.forensiceducation.com/
 b. http://www.iafn.org/
 c. http://www.amrn.com/
 d. http://nursing.advanceweb.com/common/Editorial/
Editorial.aspx?CC=40302
 e. http://www.forensicnursemag.com
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C H A P T E R  23
Complementary 
Therapies
● INTRODUCTION
The connection between mind and body, and the inﬂ uence of 
each on the other, is well recognized by all clinicians, and par-
ticularly by psychiatrists. Traditional medicine as it is currently 
practiced in the United States is based on scientiﬁ c methodol-
ogy. Traditional medicine is also known as allopathic medicine 
and is the type historically taught in U.S. medical schools.
The term alternative medicine has come to be recognized as 
practices that differ from the usual traditional practices in the 
treatment of disease. “Alternative” refers to an intervention that 
is used instead of conventional treatment. “Complementary ther-
apy” is an intervention that is different from, but used in conjunc-
tion with, traditional or conventional medical treatment. In the 
United States, approximately 38% of adults and 12% of children 
use some form of complementary or alternative therapy (National 
Institutes of Health [NIH], 2008). When prayer speciﬁ cally for 
health reasons is included in the deﬁ nition of alternative medi-
cine, the numbers are even higher. More than $27 billion a year 
is spent on alternative medical therapies in the United States.
In 1991, an Ofﬁ ce of Alternative Medicine (OAM) was estab-
lished by the NIH to study nontraditional therapies and to eval-
uate their usefulness and their effectiveness. Since that time, the 
name has been changed to the National Center for Complemen-
tary Medicine and Alternative Medicine (NCCAM or CAM). 
The mission statement of the CAM states (NIH, 2008): 
NCCAM’s mission is to explore complementary and alternative 
healing practices in the context of rigorous science, train CAM 
researchers, and disseminate authoritative information to the public 
and professionals.
Some health insurance companies and health maintenance 
organizations (HMOs) appear to be bowing to public pressure 
by including alternative providers in their networks of providers 
370
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for treatments such as acupuncture and massage therapy. Chi-
ropractic care has been covered by some third-party payers for 
many years. Individuals who seek alternative therapy, however, 
are often reimbursed at lower rates than are those who choose 
traditional practitioners.
Client education is an important part of complementary care. 
Positive lifestyle changes are encouraged, and practitioners serve 
as educators as well as treatment specialists. Complementary 
medicine is viewed as holistic health-care, which deals with not 
only the physical perspective but also the emotional and spir-
itual components of the individual. Dr. Tom Coniglione, former 
professor of medicine at the University of Oklahoma Health 
Sciences Center, has stated,
We must look at treating the “total person” in order to be more 
efﬁ cient and balanced within the medical community. Even ﬁ nd-
ing doctors who are well-rounded and balanced has become a cri-
terion in the admitting process for medical students. Medicine has 
changed from just looking at the “scientist perspective of organ and 
disease” to the total perspective of lifestyle and real impact/results 
to the patient. This evolution is a progressive and very positive shift 
in the right direction (Coniglione, 1998, p. 2). 
Terms such as harmony and balance are often associated with 
complementary care. In fact, restoring harmony and balance 
between body and mind is often the goal of complementary 
health-care approaches.
● TYPES OF COMPLEMENTARY THERAPIES
Herbal Medicine
The use of plants to heal is probably as old as humankind. Virtually 
every culture in the world has relied on herbs and plants to treat 
illness. Clay tablets from about 4000 b.c. reveal that the Sumerians 
had apothecaries for dispensing medicinal herbs. At the root of 
Chinese medicine is the Pen Tsao, a Chinese text written around 
3000 b.c. that contained hundreds of herbal remedies. When the 
Pilgrims came to America in the 1600s, they brought with them a 
variety of herbs to be established and used for medicinal purposes. 
The new settlers soon discovered that the Native Americans had 
their own varieties of plants that they used for healing.
Many people are seeking a return to herbal remedies, because 
they perceive these remedies as being less potent than prescrip-
tion drugs and as being free of adverse side effects. However, 
because the U.S. Food and Drug Administration (FDA) clas-
siﬁ es herbal remedies as dietary supplements or food additives, 
their labels cannot indicate medicinal uses. They are not subject 
to FDA approval, and they lack uniform standards of quality 
control. 
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Common Name 
(Botanical Name)
Medicinal Uses/
Possible Action
Safety 
Profi le
Black cohosh
(Cimicifuga 
racemosa)
May provide relief of 
menstrual cramps; 
improved mood; 
calming effect. 
Extracts from the 
roots are thought to 
have action similar 
to estrogen.
Generally considered safe in 
low doses. Occasionally 
causes GI discomfort. 
Toxic in large doses, 
causing dizziness, nausea, 
headaches, stiffness, and 
trembling. Should not 
take with heart problems, 
concurrently with anti-
hypertensives, or during 
pregnancy.
Cascara sagrada
(Rhamnus 
purshiana)
Relief of constipation Generally recognized 
as safe; sold as 
over-the-counter 
drug in the U.S. Should 
not be used during 
pregnancy. 
Contraindicated in 
bowel obstruction or 
inﬂ ammation.
Several organizations have been established to attempt reg-
ulation and control of the herbal industry. They include the 
Council for Responsible Nutrition, the American Herbal Asso-
ciation, and the American Botanical Council. The Commission 
E of the German Federal Health Agency is the group respon-
sible for researching and regulating the safety and efﬁ cacy of 
herbs and plant medicines in Germany. All of the Commission 
E monographs of herbal medicines have been translated into 
English and compiled into one text (Blumenthal, 1998). 
Until more extensive testing has been completed on hu-
mans and animals, the use of herbal medicines must be 
approached with caution and responsibility. The notion that some-
thing being “natural” means it is therefore completely safe is a myth. 
In fact, some of the plants from which prescription drugs are de-
rived are highly toxic in their natural state. Also, because of lack 
of regulation and standardization, ingredients may be adulter-
ated. Their method of manufacture also may alter potency. For 
example, dried herbs lose potency rapidly because of exposure to 
air. In addition, it is often safer to use preparations that contain 
only one herb. There is a greater likelihood of unwanted side 
effects with combined herbal preparations. 
Table 23-1 lists information about common herbal remedies, 
with possible implications for psychiatric/mental health nursing. 
Botanical names, medicinal uses, and safety proﬁ les are included.
TABLE 23 – 1  Herbal Remedies
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Common Name 
(Botanical Name)
Medicinal Uses/
Possible Action
Safety 
Profi le
Chamomile
(Matricaria 
chamomilla)
As a tea, is effective as 
a mild sedative in 
the relief of insom-
nia. May also aid 
digestion, relieve 
menstrual cramps, 
and settle upset 
stomach.
Generally recognized as 
safe when consumed in 
reasonable amounts.
Echinacea
(Echinacea 
angustifolia and 
Echinacea pur-
purea)
Stimulates the immune 
system; may have 
value in ﬁ ghting 
infections and eas-
ing the symptoms of 
colds and ﬂ u.
Considered safe in reason-
able doses. 
Observe for side effects or 
allergic reaction.
Fennel
(Foeniculum 
vulgare or 
Foeniculum 
ofﬁ cinale)
Used to ease stomach- 
aches and to aid 
digestion. Taken in 
a tea or in extracts 
to stimulate the 
appetites of people 
with anorexia 
(1-2 tsp. seeds 
steeped in boiling 
water for making 
tea)
Generally recognized as 
safe when consumed in 
reasonable amounts.
Feverfew
(Tanacetum 
parthenium)
Prophylaxis and treat-
ment of migraine 
headaches. Effective 
in either the fresh 
leaf or freeze-dried 
forms (2-3 fresh 
leaves [or equivalent] 
per day) 
A small percentage of 
individuals may experi-
ence the adverse effect 
of temporary mouth 
ulcers. Considered safe in 
reasonable doses.
Ginger
(Zingiber 
ofﬁ cinale)
Ginger tea to ease 
stomachaches and to 
aid digestion. Two 
powdered ginger-
root capsules have 
been shown to be 
effective in prevent-
ing motion sickness.
Generally recognized 
as safe in designated 
therapeutic doses.
TABLE 23 – 1  Herbal Remedies—cont’d
Continued
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Common Name 
(Botanical Name)
Medicinal Uses/
Possible Action
Safety 
Profi le
Ginkgo
(Ginkgo
biloba)
Used to treat senility, 
short-term memory 
loss, and peripheral 
insufﬁ ciency. Has 
been shown to dilate 
blood vessels. 
Usual dosage is 
120-240 mg/day.
Safety has been established 
with recommended 
dosages. Possible side 
effects include head-
ache, GI problems, and 
dizziness. Contraindi-
cated in pregnancy and 
lactation and in patients 
with bleeding disorder. 
Possible compound effect 
with concomitant use of 
aspirin or anticoagulants.
Ginseng
(Panax 
ginseng)
The ancient Chinese 
saw this herb as 
one that increased 
wisdom and longev-
ity. Current studies 
support a possible 
positive effect on 
the cardiovascular 
system. Action not 
known.
Generally considered safe. 
Side effects may include 
headache, insomnia, anxi-
ety, skin rashes, diarrhea. 
Avoid concomitant use 
with anticoagulants.
Hops
(Humulus 
lupulus)
Used in cases of ner-
vousness, mild anxi-
ety, and insomnia. 
Also may relieve the 
cramping associated 
with diarrhea. May 
be taken as a tea, in 
extracts, or capsules.
Generally recognized as 
safe when consumed in 
recommended dosages.
Kava-Kava
(Piper 
methylsticum)
Used to reduce anxiety 
while promoting 
mental acuity. 
Dosage: 150-300 mg 
BID.
Scaly skin rash may occur 
when taken at high 
dosage for long periods. 
Motor reﬂ exes and judg-
ment when driving may 
be reduced while taking 
the herb. 
Concurrent use with CNS 
depressants may produce 
additive tranquilizing 
effects.
Reports of potential for 
liver damage. Investiga-
tions continue.
Should not be taken for 
longer than 3 months 
without a physician’s 
supervision.
TABLE 23 – 1  Herbal Remedies—cont’d
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Common Name 
(Botanical Name)
Medicinal Uses/
Possible Action
Safety 
Profi le
Passion ﬂ ower
(Passiﬂ ora 
incarnata)
Used in tea, capsules, 
or extracts to treat 
nervousness and 
insomnia. Depresses 
the central nervous 
system to produce a 
mild sedative effect.
Generally recognized as 
safe in recommended 
doses.
Peppermint
(Mentha 
piperita)
Used as a tea to relieve 
upset stomachs and 
headaches and as a 
mild sedative. Pour 
boiling water over 
1 tbsp. dried leaves 
and steep to make 
a tea. Oil of pep-
permint is also used 
for inﬂ ammation of 
the mouth, pharynx, 
and bronchus.
Considered to be safe when 
consumed in designated 
therapeutic dosages.
Psyllium
(Plantago 
ovata)
Psyllium seeds are a 
popular bulk laxative 
commonly used for 
chronic constipa-
tion. Also found 
to be useful in the 
treatment of hyper-
cholesterolemia.
Approved as an 
over-the-counter 
drug in the U.S.
Scullcap
(Scutellaria 
lateriﬂ ora)
Used as a sedative for 
mild anxiety and 
nervousness.
Considered safe in reason-
able amounts.
St. John’s Wort
(Hypericum 
perforatum)
Used in the treatment 
of mild to moderate 
depression. May 
block reuptake 
of serotonin/ 
norepinephrine 
and have a mild 
monoamine 
oxide-inhibiting 
effect. Effective 
dose: 900 mg/day.
May also have 
antiviral, anti-
bacterial, and 
anti-inﬂ ammatory 
properties.
Generally recognized as 
safe when taken at recom-
mended dosages. Side 
effects include mild GI 
irritation that is lessened 
with food; photosensitiv-
ity when taken in high 
dosages over long peri-
ods. Should not be taken 
with other psychoactive 
medications.
TABLE 23 – 1  Herbal Remedies—cont’d
Continued
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Acupressure and Acupuncture
Acupressure and acupuncture are healing techniques based on 
the ancient philosophies of traditional Chinese medicine dating 
back to 3000 b.c. The main concept behind Chinese medicine 
is that healing energy (qi) ﬂ ows through the body along speciﬁ c 
pathways called meridians. It is believed that these meridians 
of qi connect various parts of the body in a way similar to the 
way in which lines on a road map link various locations. The 
pathways link a conglomerate of points, called acupoints. There-
fore, it is possible to treat a part of the body distant to another 
because they are linked by a meridian. Trivieri and Anderson 
(2002) have stated, “The proper ﬂ ow of qi along energy channels 
(meridians) within the body is crucial to a person’s health and 
vitality.” 
In acupressure, the ﬁ ngers, thumbs, palms, or elbows are 
used to apply pressure to the acupoints. This pressure is thought 
to dissolve any obstructions in the ﬂ ow of healing energy and 
to restore the body to a healthier functioning. In acupuncture, 
hair-thin, sterile, disposable, stainless-steel needles are inserted 
into acupoints to dissolve the obstructions along the meridians. 
The needles may be left in place for a speciﬁ ed length of time, 
they may be rotated, or a mild electric current may be applied. 
An occasional tingling or numbness is experienced, but little to 
no pain is associated with the treatment (NCCAM, 2007).
Common Name 
(Botanical Name)
Medicinal Uses/
Possible Action
Safety 
Profi le
Valerian
(Valeriana 
ofﬁ cinals)
Used to treat nervous-
ness and insomnia. 
Produces restful 
sleep without morn-
ing “hangover.” The 
root may be used 
to make a tea, or 
capsules are avail-
able in a variety of 
dosages. Mechanism 
of action is similar 
to benzodiazepines, 
but without addict-
ing properties. Daily 
dosage range: 
100-1000 mg.
Generally recognized as 
safe when taken at recom-
mended dosages. Side 
effects may include mild 
headache or upset stom-
ach. Taking doses higher 
than recommended may 
result in severe headache, 
nausea, morning grog-
giness, blurry vision. 
Should not be taken 
concurrently with CNS 
depressants. 
Sources: Sadock and Sadock (2007), Trivieri and Anderson (2002), Holt and 
Kouzi (2002), PDR for Herbal Medicines (2007), and Pranthikanti (2007).
TABLE 23 – 1  Herbal Remedies—cont’d
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The Western medical philosophy regarding acupressure and 
acupuncture is that they stimulate the body’s own painkilling 
chemicals—the morphine-like substances known as endorphins. 
The treatment has been found to be effective in the treatment 
of asthma, dysmenorrhea, cervical pain, insomnia, anxiety, 
depression, substance abuse, stroke rehabilitation, nausea of 
pregnancy, postoperative and chemotherapy-induced nausea 
and vomiting, tennis elbow, ﬁ bromyalgia, low back pain, car-
pal tunnel syndrome, and many other conditions (Council of 
Acupuncture and Oriental Medicine Associations [CAOMA], 
2009; NCCAM, 2007; Sadock & Sadock, 2007). Recent studies 
suggest that acupuncture may aid in the treatment of cocaine 
dependence and chronic daily headaches (Avants et al., 2000; 
Coeytaux et al., 2005).
Acupuncture is gaining wide acceptance is the United States 
by both patients and physicians. This treatment can be admin-
istered at the same time other techniques are being used, such 
as conventional Western techniques, although it is essential that 
all health-care providers have knowledge of all treatments being 
received. Acupuncture should be administered by a physician 
or an acupuncturist who is licensed by the state in which the 
service is provided. Typical training for licensed acupuncturists, 
doctors of oriental medicine, and acupuncture physicians is a 
3- or 4-year program of 2500 to 3500 hours.
Diet and Nutrition
The value of nutrition in the healing process has long been un-
derrated. Lutz and Przytulski (2006) stated:
Today many diseases are linked to lifestyle behaviors such as smok-
ing, lack of adequate physical activity, and poor nutritional habits. 
The World Health Organization (WHO) reports that nearly one-
third of early death and disability stems from nutritional or dietary 
causes. Healthcare providers emphasize the relationship between 
lifestyle and the risk of disease. Many people, at least in industrial-
ized countries, are increasingly managing their health problems and 
making personal commitments to lead healthier lives. Nutrition is, 
in part, a preventive science. Given sufﬁ cient resources, how and 
what one eats is a lifestyle choice (p. 4). 
Individuals select the foods they eat based on a number of fac-
tors, not the least of which is enjoyment. Eating must serve social 
and cultural, as well as nutritional, needs. The U.S. Department 
of Agriculture (USDA) and Department of Health and Human 
Services (USDHHS) have collaborated on a set of guidelines to 
help individuals understand what types of foods to eat and the 
healthy lifestyle they need to pursue in order to promote health 
and prevent disease. Following is a list of key recommendations 
from these guidelines (USDA/USDHHS, 2005).
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 1. Adequate Nutrients within Calorie Needs
 a. Consume a variety of nutrient-dense foods and beverages 
within and among the basic food groups while choosing 
foods that limit the intakes of fat, cholesterol, added sug-
ars, salt, and alcohol.
 b. Meet recommended intakes within energy needs by 
adopting a balanced eating pattern, such as the guidelines 
in Table 23-2. Table 23-3 provides a summary of informa-
tion about essential vitamins and minerals.
TABLE 23 – 2  Sample USDA Food Guide at the 2000-Calorie 
Level
Food Groups and 
Subgroups
USDA Food Guide
Daily Amount
Examples/
Equivalent Amounts
Fruit group
Vegetable group
Grain group
Meat and beans 
group
2 cups (4 servings)
2.5 cups (5 servings)
●
 Dark green vegetables: 
3 cups/week
●
 Orange vegetables: 
2 cups/week
●
 Legumes (dry beans/
peas): 3 cups/week
●
 Starchy vegetables: 
3 cups/week
●
 Other vegetables: 
6.5 cups/week
6 ounce-equivalents
●
 Whole grains: 
3 ounce-equivalents
●
 Other grains: 3 
ounce-equivalents
5.5 ounce-equivalents
1⁄2 cup equivalent is:
●
 
1⁄2 cup fresh, frozen, 
or canned fruit
●
 1 medium fruit
●
 
1⁄4 cup dried fruit
●
 
1⁄2 cup fruit juice
1⁄2 cup equivalent is:
●
 
1⁄2 cup cut-up raw or 
cooked vegetable
●
 1 cup raw leafy 
vegetable
●
 
1⁄2 cup vegetable juice
1 ounce-equivalent is:
●
 1 slice bread
●
 1 cup dry cereal
●
 
1⁄2 cup cooked rice, 
pasta, cereal
1 ounce-equivalent is:
●
 1 oz. cooked lean 
meat, poultry, or ﬁ sh
●
 1 egg
●
 
1⁄4 cup cooked dry 
beans or tofu
●
 1 tbsp. peanut butter
●
 
1⁄2 oz. nuts or seeds
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TABLE 23 – 2  Sample USDA Food Guide at the 2000-Calorie 
Level—cont’d
Food Groups and 
Subgroups
USDA Food Guide
Daily Amount
Examples/
Equivalent Amounts
Milk group
Oils
Discretionary 
calorie allowance
3 cups
24 grams (6 tsp.)
267 calories
Example of distribution:
●
 Solid fats 18 grams 
(e.g., saturated & trans 
fats)
●
 Added sugars 
32 grams (8 tsp.) (e.g., 
sweetened cereals)
1 cup equivalent is:
●
 1 cup low fat/fat-free 
milk
●
 1 cup low fat/fat-free 
yogurt
●
 11⁄2 oz low-fat or fat-
free natural cheese
●
 2 oz. low-fat or fat-
free processed cheese
1 tsp. equivalent is:
●
 1 tbsp. low-fat mayo
●
 2 tbsp. light salad 
dressing
●
 1 tsp. vegetable oil
●
 1 tsp. soft margarine 
with zero trans-fat
1 tbsp. added sugar 
equivalent is:
●
 
1⁄2 oz. jelly beans
●
 8 oz. lemonade
Examples of solid fats:
●
 Fat in whole milk/ice 
cream
●
 Fatty meats
Essential oils (above) 
are not considered 
part of the discre-
tionary calories 
Source: Dietary Guidelines for Americans 2005. Washington, D.C.: USDA/USDHHS, 
2005.
 2. Weight Management
 a. Maintain body weight in a healthy range; balance calories 
from foods and beverages with calories expended.
 b. To prevent gradual weight gain over time, make small de-
creases in food and beverage calories and increase physi-
cal activity. 
 3. Physical Activity
 a. Engage in regular physical activity and reduce sedentary 
activities to promote health, psychological well-being, 
and a healthy body weight.
 b. To reduce the risk of chronic disease in adulthood, en-
gage in at least 30 minutes of moderate-intensity physical 
activity, above usual activity, at work or home on most 
days of the week.
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 c. To help manage body weight and prevent gradual, unhealthy 
body weight gain in adulthood, engage in approximately 
60 minutes of moderate- to vigorous-intensity activity on 
most days of the week while not exceeding caloric intake 
requirements.
 d. To sustain weight loss in adulthood, participate in at least 
60 to 90 minutes of daily moderate-intensity physical 
activity while not exceeding caloric intake requirements.
 e. Achieve physical ﬁ tness by including cardiovascular con-
ditioning, stretching exercises for ﬂ exibility, and resis-
tance exercises or calisthenics for muscle strength and 
endurance. 
 4. Food Groups to Encourage
 a. Fruits and Vegetables. Choose a variety of fruits and 
vegetables each day. In particular, select from all ﬁ ve veg-
etable subgroups several times a week.
 b. Whole Grains. Half the daily servings of grains should 
come from whole grains.
 c. Milk and Milk Products. Daily choices of fat-free or 
low-fat milk or milk products are important. To help meet 
calcium needs, non-dairy calcium-containing alterna-
tives may be selected by individuals with lactose intoler-
ance or those who choose to avoid all milk products (e.g., 
vegans). 
 5. Food Groups to Moderate
 a. Fats. Keep total fat intake between 20% and 35% of calo-
ries, with most fats coming from sources of polyunsatu-
rated and monounsaturated fatty acids, such as ﬁ sh, nuts, 
and vegetable oils. Consume less than 10% of calories 
from saturated fatty acids and less than 300 mg/day of 
cholesterol, and keep trans–fatty acid consumption as low 
as possible.
 b. Carbohydrates. Carbohydrate intake should comprise 
45% to 64% of total calories, with the majority coming 
from ﬁ ber-rich foods. Important sources of nutrients from 
carbohydrates include fruits, vegetables, whole grains, 
and milk. Added sugars, caloric sweeteners, and reﬁ ned 
starches should be used prudently.
 c. Sodium Chloride. Consume less than 2300 mg (approxi-
mately 1 teaspoon of salt) of sodium per day. Choose and 
prepare foods with little salt. At the same time, consume 
potassium-rich foods, such as fruits and vegetables.
 d. Alcoholic Beverages. Individuals who choose to drink al-
coholic beverages should do so sensibly and in moderation— 
deﬁ ned as the consumption of up to one drink per day for 
women and up to two drinks per day for men. One drink 
should count as:
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 • 12 ounces of regular beer (150 calories)
 • 5 ounces of wine (100 calories)
 • 1.5 ounces of 80-proof distilled spirits (100 calories)
Alcohol should be avoided by individuals who are unable to 
restrict their intake; women who are pregnant, may become 
pregnant, or are breastfeeding and individuals who are taking 
medications that may interact with alcohol or who have speciﬁ c 
medical conditions.
Chiropractic Medicine
Chiropractic medicine is probably the most widely used form 
of alternative healing in the United States. It was developed in 
the late 1800s by a self-taught healer named David Palmer. It 
was later reorganized and expanded by his son Joshua, a trained 
practitioner. Palmer’s objective was to ﬁ nd a cure for disease and 
illness that did not use drugs but instead relied on more natu-
ral methods of healing (Trivieri & Anderson, 2002). Palmer’s 
theory of chiropractic medicine was that energy ﬂ ows from the 
brain to all parts of the body through the spinal cord and spinal 
nerves. When vertebrae of the spinal column become displaced, 
they may press on a nerve and interfere with the normal nerve 
transmission. Palmer named the displacement of these verte-
brae subluxation, and he alleged that the way to restore normal 
function was to manipulate the vertebrae back into their normal 
positions. These manipulations are called adjustments.
Adjustments are usually performed by hand, although some 
chiropractors have special treatment tables equipped to facilitate 
these manipulations. Other processes used to facilitate the out-
come of the spinal adjustment by providing muscle relaxation in-
clude massage tables, application of heat or cold, and ultrasound 
treatments.
The chiropractor takes a medical history and performs a clini-
cal examination, which usually includes x-ray ﬁ lms of the spine. 
Today’s chiropractors may practice “straight” therapy—that is, the 
only therapy provided is that of subluxation adjustments. Mixer is 
a term applied to a chiropractor who combines adjustments with 
adjunct therapies, such as exercise, heat treatments, or massage. 
Individuals seek treatment from chiropractors for many types 
of ailments and illnesses; the most common is back pain. In ad-
dition, chiropractors treat clients with headaches, neck injuries, 
scoliosis, carpal tunnel syndrome, respiratory and gastrointes-
tinal disorders, menstrual difﬁ culties, allergies, sinusitis, and 
certain sports injuries (Trivieri & Anderson, 2002). Some chi-
ropractors are employed by professional sports teams as their 
team physicians.
Chiropractors are licensed to practice in all 50 states and 
treatment costs are covered by government and most private 
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insurance plans. They treat more than 20 million people in the 
United States annually (Sadock & Sadock, 2007). 
Therapeutic Touch and Massage
Therapeutic Touch
The technique of therapeutic touch was developed in the 1970s by 
Dolores Krieger, a nurse associated with the New York University 
School of Nursing. This therapy is based on the philosophy that the 
human body projects a ﬁ eld of energy around it. When this ﬁ eld 
of energy becomes blocked, pain or illness occurs. Practitioners 
of therapeutic touch use this technique to correct the blockages, 
thereby relieving the discomfort and improving health.
Based on the premise that the energy ﬁ eld extends beyond 
the surface of the body, the practitioner need not actually touch 
the client’s skin. The therapist’s hands are passed over the 
client’s body, remaining 2 to 4 inches from the skin. The goal 
is to repattern the energy ﬁ eld by performing slow, rhythmic, 
sweeping hand motions over the entire body. Heat should be felt 
where the energy is blocked. The therapist “massages” the en-
ergy ﬁ eld in that area, smoothing it out, and thus correcting the 
obstruction. Therapeutic touch is thought to reduce pain and 
anxiety and promote relaxation and health maintenance. It has 
been useful in the treatment of chronic health conditions.
Massage
Massage is the technique of manipulating the muscles and soft 
tissues of the body. Chinese physicians prescribed massage for 
the treatment of disease more than 5000 years ago. The East-
ern style focuses on balancing the body’s vital energy (qi) as it 
ﬂ ows through pathways (meridians), as described earlier in the 
discussion of acupressure and acupuncture. The Western style 
of massage affects muscles, connective tissues (e.g., tendons and 
ligaments), and the cardiovascular system. Swedish massage, 
which is probably the best-known Western style, uses a variety 
of gliding and kneading strokes along with deep circular move-
ments and vibrations to relax the muscles, improve circulation, 
and increase mobility (Trivieri & Anderson, 2002).
Massage has been shown to be beneﬁ cial in the following 
conditions: anxiety, chronic back and neck pain, arthritis, sciat-
ica, migraine headaches, muscle spasms, insomnia, pain of labor 
and delivery, stress-related disorders, and whiplash. Massage is 
contraindicated in certain conditions, such as high blood pres-
sure, acute infection, osteoporosis, phlebitis, skin conditions, 
and varicose veins. It also should not be performed over the site 
of a recent injury, bruise, or burn.
Massage therapists require specialized training in a program 
accredited by the American Massage Therapy Association and 
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must pass the National Certiﬁ cation Examination for Thera-
peutic Massage and Bodywork.
Yoga
Yoga is thought to have developed in India some 5000 years 
ago and is attributed to an Indian physician and Sanskrit scholar 
named Patanjali. The objective of yoga is to integrate the phys-
ical, mental, and spiritual energies that enhance health and 
well-being (Trivieri & Anderson, 2002). Yoga has been found 
to be especially helpful in relieving stress and in improving 
overall physical and psychological wellness. Proper breathing is 
a major component of yoga. It is believed that yoga breathing—a 
deep, diaphramatic breathing—increases oxygen to the brain 
and body tissues, thereby easing stress and fatigue and boosting 
energy.
Another component of yoga is meditation. Individuals who 
practice the meditation and deep breathing associated with yoga 
ﬁ nd that they are able to achieve a profound feeling of relaxation.
The most familiar type of yoga practiced in Western coun-
tries is hatha yoga. Hatha yoga uses body postures, along with 
the meditation and breathing exercises, to achieve a balanced, 
disciplined workout that releases muscle tension, tones the 
internal organs, and energizes the mind, body, and spirit, to 
allow natural healing to occur. The complete routine of poses 
is designed to work all parts of the body—stretching and ton-
ing muscles and keeping joints ﬂ exible. Studies have shown that 
yoga has provided beneﬁ cial effects to some individuals with 
back pain, stress, migraine, insomnia, high blood pressure, 
rapid heart rates, and limited mobility (Sadock & Sadock, 2007; 
Steinberg, 2002; Trivieri & Anderson, 2002).
Pet Therapy
The therapeutic value of pets is no longer just theory. Evidence 
has shown that animals can directly inﬂ uence a person’s mental 
and physical well-being. Many pet-therapy programs have been 
established across the country and the numbers are increasing 
regularly.
Several studies have provided information about the positive 
results of human interaction with pets. Some of these include 
the following:
 1. Petting a dog or cat has been shown to lower blood pressure. 
In one study, volunteers experienced a 7.1 mm Hg drop in 
systolic and an 8.1 mm Hg decrease in diastolic blood pres-
sure when they talked to and petted their dogs, as opposed to 
reading aloud or resting quietly (Whitaker, 2000).
 2. Bringing a pet into a nursing home or other institution for 
the elderly has been shown to enhance a client’s mood and 
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social interaction (Godenne, 2001). Another study revealed 
that animal-assisted therapy with nursing home residents 
signiﬁ cantly reduced loneliness for those in the study group 
(Banks & Banks, 2002).
 3. One study of 96 patients who had been admitted to a cor-
onary care unit for heart attack or angina revealed that in 
the year following hospitalization, the mortality rate among 
those who did not own pets was 22% higher than that among 
pet owners (Whitaker, 2000).
 4. Individuals with AIDS who have pets are less likely to suffer 
from depression than people with AIDS who do not own pets 
(Siegel et al., 1999). 
Some researchers believe that animals may actually retard 
the aging process among those who live alone. Loneliness often 
results in premature death, and having a pet mitigates the ef-
fects of loneliness and isolation.
 Whitaker (2000) has suggested:
Though owning a pet doesn’t make you immune to illness, pet own-
ers are, on the whole, healthier than those who don’t own pets. Study 
after study shows that people with pets have fewer minor health 
problems, require fewer visits to the doctor and less medication, and 
have fewer risk factors for heart disease, such as high blood pressure 
or cholesterol levels (p. 7). 
It may never be known precisely why animals affect humans 
they way they do, but for those who have pets to love, the thera-
peutic beneﬁ ts come as no surprise. Pets provide unconditional, 
nonjudgmental love and affection, which can be the perfect an-
tidote for a depressed mood or a stressful situation. The role of 
animals in the human healing process requires more research, 
but its validity is now widely accepted in both the medical and 
lay communities.
● SUMMARY
Complementary therapies help the practitioner view the client 
in a holistic manner. Most complementary therapies consider 
the mind and body connection and strive to enhance the body’s 
own natural healing powers. The OAM of the NIH has estab-
lished a list of alternative therapies to be used in practice and for 
investigative purposes. More than $27 billion a year is spent on 
alternative medical therapies in the United States.
This chapter examined herbal medicine, acupressure, acu-
puncture, diet and nutrition, chiropractic medicine, therapeutic 
touch, massage, yoga, and pet therapy. Nurses must be familiar 
with these therapies, as more and more clients seek out the heal-
ing properties of these complementary care strategies.
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Loss and Bereavement
● BACKGROUND ASSESSMENT DATA
Loss is the experience of separation from something of personal 
importance. Loss is anything that is perceived as such by the 
individual. The separation from loved ones or the giving up of 
treasured possessions, for whatever reason; the experience of 
failure, either real or perceived; or life events that create change 
in a familiar pattern of existence—all can be experienced as loss, 
and all can trigger behaviors associated with the grieving pro-
cess. Loss and bereavement are universal events encountered by 
all beings who experience emotions. Following are examples of 
some notable forms of loss:
 1. A signiﬁ cant other (person or pet) through death, divorce, or 
separation for any reason.
 2. Illness or debilitating conditions. Examples include (but are 
not limited to) diabetes, stroke, cancer, rheumatoid arthritis, 
multiple sclerosis, Alzheimer’s disease, hearing or vision loss, 
and spinal cord or head injuries. Some of these conditions 
not only incur a loss of physical and/or emotional wellness 
but may also result in the loss of personal independence.
 3. Developmental/maturational changes or situations, such as 
menopause, andropause, infertility, “empty nest” syndrome, 
aging, impotence, or hysterectomy.
 4. A decrease in self-esteem, if one is unable to meet 
self-expectations or the expectations of others (even if 
these expectations are only perceived by the individual 
as unfulﬁ lled). This includes a loss of potential hopes and 
dreams.
 5. Personal possessions that symbolize familiarity and security 
in a person’s life. Separation from these familiar and per-
sonally valued external objects represents a loss of material 
extensions of the self.
Some texts differentiate the terms mourning and grief by 
describing mourning as the psychological process (or stages) 
through which the individual passes on the way to successful 
adaptation to the loss of a valued object. Grief may be viewed 
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as the subjective states that accompany mourning, or the emo-
tional work involved in the mourning process. For purposes of 
this text, grief work and the process of mourning are collectively 
referred to as the grief response.
Theoretical Perspectives on Loss 
and Bereavement (Symptomatology)
Stages of Grief
Behavior patterns associated with the grief response include 
many individual variations. However, sufﬁ cient similarities have 
been observed to warrant characterization of grief as a syndrome 
that has a predictable course with an expected resolution. Early 
theorists, including Kübler-Ross (1969), Bowlby (1961), and 
Engel (1964), described behavioral stages through which indi-
viduals advance in their progression toward resolution. A num-
ber of variables inﬂ uence one’s progression through the grief 
process. Some individuals may reach acceptance, only to revert 
to an earlier stage; some may never complete the sequence; and 
some may never progress beyond the initial stage. 
A more contemporary grief specialist, J. William Worden 
(2009), offers a set of tasks that must be processed to complete 
the grief response. He suggests that it is possible for a person to 
accomplish some of these tasks and not others, resulting in an 
incomplete bereavement and thus impairing further growth and 
development.
ELISABETH KÜBLER-ROSS
These well-known stages of the grief process were identiﬁ ed by 
Kübler-Ross in her extensive work with dying patients. Behaviors 
associated with each of these stages can be observed in individuals 
experiencing the loss of any concept of personal value.
Stage I: Denial. The individual does not acknowledge that 
the loss has occurred. He or she may say, “No, it can’t be 
true!” or “It’s just not possible.” This stage may protect the 
individual against the psychological pain of reality.
Stage II: Anger. This is the stage when reality sets in. 
Feelings associated with this stage include sadness, guilt, 
shame, helplessness, and hopelessness. Self-blame or blam-
ing of others may lead to feelings of anger toward the self 
and others. The anxiety level may be elevated, and the in-
dividual may experience confusion and a decreased ability 
to function independently. He or she may be preoccupied 
with an idealized image of what has been lost. Numerous 
somatic complaints are common.
Stage III: Bargaining. The individual attempts to strike a 
bargain with God for a second chance or for more time. 
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The person acknowledges the loss, or impending loss, but 
holds out hope for additional alternatives, as evidenced by 
such statements as, “If only I could...” or “If only I had... .”
Stage IV: Depression. The individual mourns for that which 
has been or will be lost. This is a very painful stage, dur-
ing which the individual must confront feelings associated 
with having lost someone or something of value (called 
reactive depression). An example might be the individual 
who is mourning a change in body image. Feelings associ-
ated with an impending loss (called preparatory depression) 
are also confronted. Examples include permanent life-
style changes related to the altered body image or even an 
impending loss of life itself. Regression, withdrawal, and 
social isolation may be observed behaviors with this stage. 
Therapeutic intervention should be available, but not 
imposed, and with guidelines for implementation based on 
client readiness.
Stage V: Acceptance. The individual has worked through 
the behaviors associated with the other stages and either 
accepts or is resigned to the loss. Anxiety decreases, and 
methods for coping with the loss have been established. 
The client is less preoccupied with what has been lost and 
increasingly interested in other aspects of the environ-
ment. If this is an impending death of self, the individual is 
ready to die. The person may become very quiet and with-
drawn, seemingly devoid of feelings. These behaviors are 
an attempt to facilitate the passage by slowly disengaging 
from the environment.
JOHN BOWLBY
John Bowlby hypothesized four stages in the grief process. He 
implied that these behaviors can be observed in all individu-
als who have experienced the loss of something or someone of 
value, even in infants as young as 6 months.
Stage I: Numbness or Protest. This stage is characterized 
by a feeling of shock and disbelief that the loss has occurred. 
Reality of the loss is not acknowledged.
Stage II: Disequilibrium. During this stage, the individual 
has a profound urge to recover what has been lost. Behaviors 
associated with this stage include a preoccupation with the 
loss, intense weeping and expressions of anger toward the 
self and others, and feelings of ambivalence and guilt associ-
ated with the loss.
Stage III: Disorganization and Despair. Feelings of 
despair occur in response to the realization that the loss 
has occurred. Activities of daily living become increasingly 
disorganized, and behavior is characterized by restlessness 
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and aimlessness. Efforts to regain productive patterns of 
behavior are ineffective and the individual experiences fear, 
helplessness, and hopelessness. Somatic complaints are com-
mon. Perceptions of visualizing or being in the presence of 
that which has been lost may occur. Social isolation is com-
mon, and the individual may feel a great deal of loneliness.
Stage IV: Reorganization. The individual accepts or becomes 
resigned to the loss. New goals and patterns of organization 
are established. The individual begins a reinvestment in new 
relationships and indicates a readiness to move forward with-
in the environment. Grief subsides and recedes into valued 
remembrances.
GEORGE ENGEL
Stage I: Shock and Disbelief. The initial reaction to a loss 
is a stunned, numb feeling and refusal by the individual 
to acknowledge the reality of the loss. Engel states that 
this stage is an attempt by the individual to protect the self 
“against the effects of the overwhelming stress by raising 
the threshold against its recognition or against the painful 
feelings evoked thereby.”
Stage II: Developing Awareness. This stage begins within 
minutes to hours of the loss. Behaviors associated with this 
stage include excessive crying and regression to a state of 
helplessness and a childlike manner. Awareness of the loss 
creates feelings of emptiness, frustration, anguish, and de-
spair. Anger may be directed toward the self or toward others 
in the environment who are held accountable for the loss.
Stage III: Restitution. The various rituals associated with 
loss within a culture are performed. Examples include 
funerals, wakes, special attire, a gathering of friends and 
family, and religious practices customary to the spiritual 
beliefs of the bereaved. Participation in these rituals is 
thought to assist the individual to accept the reality of the 
loss and to facilitate the recovery process.
Stage IV: Resolution of the Loss. This stage is characterized 
by a preoccupation with the loss. The concept of the loss 
is idealized, and the individual may even imitate admired 
qualities of a person who has been lost. Preoccupation with 
the loss gradually decreases over a year or more, and the 
individual eventually begins to reinvest feelings in others.
Stage V: Recovery. Obsession with the loss has ended, and 
the individual is able to go on with his or her life.
J. WILLIAM WORDEN
Worden views the bereaved as active and self-determining rather 
than passive participants in the grief process. He proposes that 
bereavement includes a set of tasks that must be reconciled in 
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order to complete the grief process. Worden’s four tasks of 
mourning include the following:
Task I: Accepting the Reality of the Loss. When some-
thing of value is lost, it is common for individuals to refuse 
to believe that the loss has occurred. Behaviors include 
misidentifying individuals in the environment for their 
lost loved one, retaining possessions of the lost loved one 
as though he or she has not died, and removing all remind-
ers of the lost loved one so as not to have to face the reality 
of the loss. Worden (2009) stated:
Coming to an acceptance of the reality of the loss takes time since 
it involves not only an intellectual acceptance but also an emotional 
one. The bereaved person may be intellectually aware of the ﬁ nal-
ity of the loss long before the emotions allow full acceptance of the 
information as true (p. 42). 
Belief and denial are intermittent while grappling with 
this task. It is thought that traditional rituals such as the 
funeral help some individuals move toward acceptance of 
the loss. 
Task II: Processing the Pain of Grief. Pain associated 
with a loss includes both physical pain and emotional pain. 
This pain must be acknowledged and worked through. 
To avoid or suppress it serves only to delay or prolong the 
grieving process. People accomplish this by refusing to 
allow themselves to think painful thoughts, by idealizing 
or avoiding reminders of what has been lost, and by using 
alcohol or drugs. The intensity of the pain and the manner 
in which it is experienced are different for all individuals. 
But the commonality is that it must be experienced. Failure 
to do so generally results in some form of depression that 
commonly requires therapy, which then focuses on work-
ing through the pain of grief that the individual failed to 
work through at the time of the loss. In this very difﬁ -
cult Task II, individuals must “allow themselves to process 
the pain—to feel it and to know that one day it will pass” 
(Worden, 2009, p. 45).
Task III: Adjusting to a World without the Lost Entity. 
It usually takes a number of months for a bereaved person 
to realize what his or her world will be like without the lost 
entity. In the case of a lost loved one, how the environment 
changes will depend on the types of roles that person ful-
ﬁ lled in life. In the case of a changed lifestyle, the individual 
will be required to make adaptations to his or her environ-
ment in terms of the changes as they are presented in daily 
life. In addition, those individuals who had deﬁ ned their 
identity through the lost entity will require an adjustment 
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to their own sense of self. Worden (2009) stated, “The cop-
ing strategy of redeﬁ ning the loss in such a way that it can 
redound to the beneﬁ t of the survivor is often part of the 
successful completion of Task III” (p. 47). 
If the bereaved person experiences failures in his or her 
attempt to adjust in an environment without the lost entity, 
feelings of low self-esteem may result. Regressed behav-
iors and feelings of helplessness and inadequacy are not 
uncommon. Worden (2009) stated: 
[Another] area of adjustment may be to one’s sense of the world. 
Loss through death can challenge one’s fundamental life values 
and philosophical beliefs—beliefs that are inﬂ uenced by our fami-
lies, peers, education, and religion as well as life experiences. The 
bereaved person searches for meaning in the loss and its attendant 
life changes in order to make sense of it and to regain some control 
of his or her life (pp. 48–49).
To be successful in Task III, bereaved individuals must devel-
op new skills to cope and adapt to their new environment 
without the lost entity. Successful achievement of this task 
determines the outcome of the mourning process—that of 
continued growth or a state of arrested development.
Task IV: Finding an Enduring Connection with the Lost 
Entity in the Midst of Embarking on a New Life. This 
task allows for the bereaved person to identify a special 
place for the lost entity. Individuals need not purge from 
their history or ﬁ nd a replacement for that which has been 
lost. Instead, there is a kind of continued presence of the 
lost entity that only becomes relocated in the life of the 
bereaved. Successful completion of Task IV involves letting 
go of past attachments and forming new ones. However, 
there is also the recognition that although the relationship 
between the bereaved and what has been lost is changed, it 
is nonetheless still a relationship. Worden (2009) suggests 
that one never loses memories of a signiﬁ cant relationship. 
He stated: 
For many people Task IV is the most difﬁ cult one to accomplish. 
They get stuck at this point in their grieving and later realize that 
their life in some way stopped at the point the loss occurred (p. 52). 
Worden (2009) relates the story of a teenaged girl who had 
a difﬁ cult time adjusting to the death of her father. After 
2 years, when she began to ﬁ nally fulﬁ ll some of the tasks 
associated with successful grieving, she wrote these words 
that express rather clearly what bereaved people in Task IV 
are struggling with: “There are other people to be loved, 
and it doesn’t mean that I love Dad any less” (p. 52). 
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Length of the Grief Process
Stages of grief allow bereaved persons an orderly approach to the 
resolution of mourning. Each stage presents tasks that must be 
overcome through a painful experiential process. Engel (1964) 
stated that successful resolution of the grief response is thought 
to have occurred when a bereaved individual is able “to remem-
ber comfortably and realistically both the pleasures and disap-
pointments of [what has been lost].” The duration of the grief 
process depends on the individual and can last for a number of 
years without being maladaptive. The acute phase of normal 
grieving usually lasts 6 to 8 weeks—longer in older adults—but 
complete resolution of the grief response may take much longer. 
Sadock and Sadock (2007) stated:
Ample evidence suggests that the bereavement process does not end 
within a prescribed interval; certain aspects persist indeﬁ nitely for 
many otherwise high-functioning, normal individuals. Common 
manifestations of protracted grief occur intermittently. Most grief 
does not fully resolve or permanently disappear; rather grief be-
comes circumscribed and submerged only to reemerge in response 
to certain triggers (p. 64). 
A number of factors inﬂ uence the eventual outcome of the 
grief response. The grief response can be more difﬁ cult if:
 • The bereaved person was strongly dependent on or per-
ceived the lost entity as an important means of physical 
and/or emotional support.
 • The relationship with the lost entity was highly ambiva-
lent. A love-hate relationship may instill feelings of guilt 
that can interfere with the grief work.
 • The individual has experienced a number of recent losses. 
Grief tends to be cumulative, and if previous losses have 
not been resolved, each succeeding grief response becomes 
more difﬁ cult.
 • The loss is that of a young person. Grief over loss of a child 
is often more intense than it is over the loss of an elderly 
person.
 • The state of the person’s physical or psychological health is 
unstable at the time of the loss.
 • The bereaved person perceives (whether real or imagined) 
some responsibility for the loss. 
The grief response may be facilitated if: 
 • The individual has the support of signiﬁ cant others to 
assist him or her through the mourning process.
 • The individual has the opportunity to prepare for the 
loss. Grief work is more intense when the loss is sudden 
and unexpected. The experience of anticipatory grieving is 
thought to facilitate the grief response that occurs at the 
time of the actual loss. 
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Worden (2009) stated:
There is a sense in which mourning can be ﬁ nished, when people 
regain an interest in life, feel more hopeful, experience gratiﬁ cation 
again, and adapt to new roles. There is also a sense in which mourn-
ing is never ﬁ nished. [People must understand] that mourning is a 
long-term process, and the culmination [very likely] will not be to a 
pre-grief state (p. 77). 
Anticipatory Grief
Anticipatory grieving is the experiencing of the feelings and 
emotions associated with the normal grief response before the 
loss actually occurs. One dissimilar aspect relates to the fact that 
conventional grief tends to diminish in intensity with the pas-
sage of time. Anticipatory grief can become more intense as the 
expected loss becomes imminent.
Although anticipatory grief is thought to facilitate the actual 
mourning process following the loss, there may be some problems. 
In the case of a dying person, difﬁ culties can arise when the family 
members complete the process of anticipatory grief, and detach-
ment from the dying person occurs prematurely. The person who 
is dying experiences feelings of loneliness and isolation as the psy-
chological pain of imminent death is faced without family support. 
Another example of difﬁ culty associated with premature comple-
tion of the grief response is one that can occur on the return of 
persons long absent and presumed dead (e.g., soldiers missing in 
action or prisoners of war). In this instance, resumption of the pre-
vious relationship may be difﬁ cult for the bereaved person.
Anticipatory grieving may serve as a defense for some indi-
viduals to ease the burden of loss when it actually occurs. It may 
prove to be less functional for others who, because of interper-
sonal, psychological, or sociocultural variables, are unable in 
advance of the actual loss to express the intense feelings that 
accompany the grief response.
Maladaptive Responses to Loss
When, then, is the grieving response considered to be mal-
adaptive? Three types of pathological grief reactions have 
been described. These include delayed or inhibited grief, an 
exaggerated or distorted grief response, and chronic or pro-
longed grief.
Delayed or Inhibited Grief 
Delayed or inhibited grief refers to the absence of evidence of 
grief when it ordinarily would be expected. Many times, cultural 
inﬂ uences, such as the expectation to keep a “stiff upper lip,” 
cause the delayed response.
Delayed or inhibited grief is potentially pathological because 
the person is simply not dealing with the reality of the loss. 
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He or she remains ﬁ xed in the denial stage of the grief proc-
ess, sometimes for many years. When this occurs, the grief re-
sponse may be triggered, sometimes many years later, when the 
individual experiences a subsequent loss. Sometimes the grief 
process is triggered spontaneously or in response to a seemingly 
insigniﬁ cant event. Overreaction to another person’s loss may 
be one manifestation of delayed grief.
The recognition of delayed grief is critical because, depend-
ing on the profoundness of the loss, the failure of the mourning 
process may prevent assimilation of the loss and thereby delay 
a return to satisfying living. Delayed grieving most commonly 
occurs because of ambivalent feelings toward the lost entity, 
outside pressure to resume normal function, or perceived lack of 
internal and external resources to cope with a profound loss.
Distorted (Exaggerated) Grief Response
In the distorted grief reaction, all of the symptoms associated 
with normal grieving are exaggerated. Feelings of sadness, help-
lessness, hopelessness, powerlessness, anger, and guilt, as well 
as numerous somatic complaints, render the individual dysfunc-
tional in terms of management of daily living. Murray, Zentner, 
and Yakimo (2009) described an exaggerated grief reaction in 
the following way:
An intensiﬁ cation of grief to the point that the person is over-
whelmed, demonstrates prolonged maladaptive behavior, manifests 
excessive symptoms and extensive interruptions in healing, and does 
not progress to integration of the loss, ﬁ nding meaning in the loss, 
and resolution of the mourning process (p. 706). 
When the exaggerated reaction occurs, the individual remains 
ﬁ xed in the anger stage of the grief response. This anger may 
be directed toward others in the environment to whom the in-
dividual may be attributing the loss. However, many times the 
anger is turned inward on the self. When this occurs, depression 
is the result. Depressive mood disorder is a type of exaggerated 
grief reaction.
Chronic or Prolonged Grieving
Some authors have discussed a chronic or prolonged grief 
response as a type of maladaptive grief response. Care must be 
taken in making this determination because, as was stated previ-
ously, length of the grief response depends on the individual. An 
adaptive response may take years for some people. A prolonged 
process may be considered maladaptive when certain behaviors 
are exhibited. Prolonged grief may be a problem when behav-
iors such as maintaining personal possessions aimed at keeping a 
lost loved one alive (as though he or she will eventually reenter 
the life of the bereaved) or disabling behaviors that prevent the 
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bereaved from adaptively performing activities of daily living 
are in evidence. Another example is of a widow who refused to 
participate in family gatherings following the death of her hus-
band. For many years until her own death, she took a sandwich 
to the cemetery on holidays, sat on the tombstone, and ate her 
“holiday meal” with her husband. Other bereaved individuals 
have been known to set a place at the table for the deceased loved 
one long after the completed mourning process would have been 
expected.
Normal versus Maladaptive Grieving
Several authors have identiﬁ ed one crucial difference between 
normal and maladaptive grieving: the loss of self-esteem. 
Marked feelings of worthlessness are indicative of depression 
rather than uncomplicated bereavement. Corr, Nabe, and Corr 
(2008) have stated, “Normal grief reactions do not include the 
loss of self-esteem commonly found in most clinical depression” 
(p. 215).
Cheong, Herkov, and Goodman (2009) afﬁ rmed:
Although both conditions may have depressed mood, loss of appetite, 
sleep disturbance, and decreased energy, people with depression usu-
ally experience a sense of worthlessness, guilt and/or low self-esteem 
that is not common in normal grief reactions. 
It is thought that this major difference between normal 
grieving and maladaptive grieving (the feeling of worthlessness 
or low self-esteem) ultimately precipitates depression.
Concepts of Death—Developmental Issues
Children
Birth to Age 2. Infants are unable to recognize and under-
stand death, but they can experience the feelings of loss and 
separation. Infants who are separated from their mothers 
may become quiet, lose weight, and sleep less. Children at 
this age will likely sense changes in the atmosphere of the 
home where a death has occurred. They often react to the 
emotions of adults by becoming more irritable and crying 
more.
Ages 3 to 5. Preschoolers and kindergartners have some 
understanding about death but often have difﬁ culty distin-
guishing between fantasy and reality. They believe death 
is reversible, and their thoughts about death may include 
magical thinking. For example, they may believe that their 
thoughts or behaviors caused a person to become sick or 
to die.
Children of this age are capable of understanding at least 
some of what they see and hear from adult conversations or 
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media reports. They become frightened if they feel a threat 
to themselves or to their loved ones. They are concerned 
with safety issues and require a great deal of personal reas-
surance that they will be protected. Regressive behaviors, 
such as loss of bladder or bowel control, thumb sucking, 
and temper tantrums, are not uncommon. Changes in eat-
ing and sleeping patterns may also occur.
Ages 6 to 9. Children at this age begin to understand the 
ﬁ nality of death. They are able to understand a more de-
tailed explanation of why or how the person died, although 
the concept of death is often associated with old age or with 
accidents. They may believe that death is contagious and 
avoid association with individuals who have experienced a 
loss by death. Death is often personiﬁ ed in the form of 
a “bogey man” or a monster—someone who takes people 
away or someone whom they can avoid if they try hard 
enough. It is difﬁ cult for them to perceive their own death. 
Normal grief reactions at this age include regressive and 
aggressive behaviors, withdrawal, school phobias, somatic 
symptoms, and clinging behaviors.
Ages 10 to 12. Preadolescent children are able to understand 
that death is ﬁ nal and eventually affects everyone, includ-
ing themselves. They are interested in the physical aspects 
of dying and the ﬁ nal disposition of the body. They may 
ask questions about how the death will affect them per-
sonally. Feelings of anger, guilt, and depression are com-
mon. Peer relationships and school performance may be 
disrupted. There may be a preoccupation with the loss and 
a withdrawal into the self. They will require reassurance of 
their own safety and self-worth.
Adolescents
Adolescents are usually able to view death on an adult level. 
They understand death to be universal and inevitable; however, 
they have difﬁ culty tolerating the intense feelings associated 
with the death of a loved one. They may or may not cry. They 
may withdraw into themselves or attempt to go about usual 
activities in an effort to avoid dealing with the pain of the loss. 
Some teens exhibit acting-out behaviors, such as aggression 
and deﬁ ance. It is often easier for adolescents to discuss their 
feelings with peers than with their parents or other adults. 
Some adolescents may show regressive behaviors whereas oth-
ers react by trying to take care of their loved ones who are 
also grieving. In general, individuals of this age group have an 
attitude of immortality. Although they understand that their 
own death is inevitable, the concept is so far-reaching as to be 
imperceptible.
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Adults
The adult’s concept of death is inﬂ uenced by cultural and reli-
gious backgrounds (Murray, Zentner, & Yakimo, 2009). Behaviors 
associated with grieving in the adult were discussed in the section 
on “Theoretical Perspectives on Loss and Bereavement.”
Elderly Persons
Bateman (1999) has stated:
For the older adult, the later years have been described by philoso-
phers and poets as the “season of loss.” Loss of one’s occupational 
role upon retirement, loss of control and competence, loss in some 
life experiences, loss of material possessions, and loss of dreams, 
loved ones, and friends must be understood and accepted if the older 
adult is to adapt effectively (p. 144). 
By the time individuals reach their 60s and 70s, they have 
experienced numerous losses, and mourning has become a life-
long process. Those who are most successful at adapting to 
losses earlier in life will similarly cope better with the losses 
and grief inherent in aging. Unfortunately, with the aging proc-
ess comes a convergence of losses, the timing of which makes it 
impossible for the aging individual to complete the grief process 
in response to one loss before another occurs. Because grief is 
cumulative, this can result in bereavement overload; the person 
is less able to adapt and reintegrate, and mental and physical 
health is jeopardized (Halstead, 2005). Bereavement overload 
has been implicated as a predisposing factor in the development 
of depressive disorder in the elderly person.
Depression is a common symptom in the grief response to 
signiﬁ cant losses. It is important to understand the difference 
between the depression of normal grieving and the disorder of 
clinical depression. Some of these differences are presented in 
Table 24-1.
Common Nursing Diagnoses and 
Interventions for the Individual 
Who Is Grieving
●
 RISK FOR COMPLICATED GRIEVING
Deﬁ nition: At risk for a disorder that occurs after the death of a 
signifi cant other [or any other loss of signifi cance to the individual], 
in which the experience of distress accompanying bereavement 
fails to follow normative expectations and manifests in functional 
impairment.
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Risk Factors (“related to”)
[Actual or perceived object loss (e.g., people, pets, possessions, 
job, status, home, ideals, parts and process of the body)]
[Denial of loss]
[Interference with life functioning]
[Reliving of past experiences with little or no reduction 
(diminishment) of intensity of the grief]
Lack of social support
Emotional instability
Goals/Objectives
Short-term Goals
 1. Client will acknowledge awareness of the loss.
 2. Client will express feelings about the loss.
 3. Client will verbalize own position in the grief process.
Long-term Goal
Client will progress through the grief process in a healthful 
manner toward resolution.
Interventions with Selected Rationales
 1. Assess client’s stage in the grief process. Accurate baseline 
data are required to provide appropriate assistance.
TABLE 2 4 – 1  Normal Grief Reactions versus Symptoms 
of Clinical Depression
Normal Grief Clinical Depression
Self-esteem intact Self-esteem disturbed
May openly express anger Usually does not directly express anger
Experiences a mixture of “good 
and bad days”
Persistent state of dysphoria
Able to experience moments of 
pleasure
Anhedonia prevalent
Accepts comfort and support 
from others
Does not respond to social interaction 
and support from others
Maintains feeling of hope Feelings of hopelessness prevail
May express guilt feelings over 
some aspect of the loss
Has generalized feelings of guilt
Relates feelings of depression to 
speciﬁ c loss experienced
Does not relate feelings to a particular 
experience
May experience transient 
physical symptoms
Expresses chronic physical complaints
Sources: Cheong, Herkov, and Goodman (2009); Corr, Nabe, and Corr (2008); 
and Sadock and Sadock (2007). 
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 2. Develop trust. Show empathy, concern, and unconditional 
positive regard. Developing trust provides the basis for a 
therapeutic relationship.
 3. Help the client actualize the loss by talking about it. “When 
did it happen? How did it happen?” and so forth. Reviewing 
the events of the loss can help the client come to full aware-
ness of the loss.
 4. Help the client identify and express feelings. Until client can 
recognize and accept personal feelings regarding the loss, 
grief work cannot progress. Some of the more problematic 
feelings include:
 a. Anger. The anger may be directed at the deceased, at God, 
displaced on others, or retroﬂ ected inward on the self. 
Encourage the client to examine this anger and validate 
the appropriateness of this feeling. Many people will not 
admit to angry feelings, believing it is inappropriate and 
unjustifi ed. Expression of this emotion is necessary to 
prevent fi xation in this stage of grief.
 b. Guilt. The client may feel that he or she did not do enough 
to prevent the loss. Help the client by reviewing the cir-
cumstances of the loss and the reality that it could not 
be prevented. Feelings of guilt prolong resolution of the 
grief process.
 c. Anxiety and helplessness. Help the client to recognize the way 
that life was managed before the loss. Help the client to put 
the feelings of helplessness into perspective by pointing out 
ways that he or she managed situations effectively without 
help from others. Role-play life events and assist with deci-
sion-making situations. The client may have fears that he 
or she may not be able to carry on alone.
 5. Interpret normal behaviors associated with grieving and 
provide client with adequate time to grieve. Understanding 
of the grief process will help prevent feelings of guilt gen-
erated by these responses. Individuals need adequate time 
to accommodate to the loss and all its ramifi cations. This 
involves getting past birthdays and anniversaries of which 
the deceased was a part.
 6. Provide continuing support. If this is not possible by the 
nurse, then offer referrals to support groups. Support groups 
of individuals going through the same experiences can be 
very helpful for the grieving individual. The availability of 
emotional support systems facilitates the grief process.
 7. Identify pathological defenses that the client may be using 
(e.g., drug/alcohol use, somatic complaints, social isolation). 
Assist the client in understanding why these are not healthy 
defenses and how they delay the process of grieving. The 
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bereavement process is impaired by behaviors that mask the 
pain of the loss.
 8. Encourage the client to make an honest review of the rela-
tionship with what has been lost. Journal keeping is a facilita-
tive tool with this intervention. Only when the client is able 
to see both positive and negative aspects related to the loss 
will the grieving process be complete.
Outcome Criteria
 1. Client is able to express feelings about the loss.
 2. Client verbalizes stages of the grief process and behaviors 
associated with each stage.
 3. Client acknowledges own position in the grief process and 
recognizes the appropriateness of the associated feelings and 
behaviors.
●
 RISK FOR SPIRITUAL DISTRESS
Deﬁ nition: At risk for an impaired ability to experience and inte-
grate meaning and purpose in life through a person’s connected-
ness with self, others, art, music, literature, nature, and/or a power 
greater than oneself.
Risk Factors (“related to”)
Loss [of any concept of value to the individual] 
Low self-esteem
Natural disasters
Physical illness
Depression; anxiety; stress
Separated from support systems
Life change
Goals/Objectives
Short-term Goal
Client will identify meaning and purpose in life, moving forward 
with hope for the future.
Long-term Goal
Client will express achievement of support and personal satisfac-
tion from spiritual practices.
Interventions with Selected Rationales
 1. Be accepting and nonjudgmental when client expresses an-
ger and bitterness toward God. Stay with client. The nurse’s 
presence and nonjudgmental attitude increase the client’s 
feelings of self-worth and promote trust in the relationship. 
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 2. Encourage client to ventilate feelings related to meaning of 
own existence in the face of current loss. Client may be-
lieve he or she cannot go on living without the lost entity. 
Catharsis can provide relief and put life back into realistic 
perspective.
 3. Encourage client as part of grief work to reach out to previ-
ously used religious practices for support. Encourage client 
to discuss these practices and how they provided support in 
the past. Client may fi nd comfort in religious rituals with 
which he or she is familiar.
 4. Ensure client that he or she is not alone when feeling inad-
equate in the search for life’s answers. Validation of client’s 
feelings and assurance that they are shared by others offer 
reassurance and an affi rmation of acceptability.
 5. Contact spiritual leader of client’s choice, if he or she requests. 
These individuals serve to provide relief from spiritual 
distress and often can do so when other support persons 
cannot.
Outcome Criteria
 1. Client verbalizes increased sense of self-concept and hope for 
the future.
 2. Client verbalizes meaning and purpose in life that reinforces 
hope, peace, and contentment.
 3. Client expresses personal satisfaction and support from 
spiritual practices.
 INTERNET REFERENCES
● Additional references related to bereavement may be located 
at the following websites:
a. http://www.journeyofhearts.org
b. http://www.nhpco.org
c. http://www.aarp.org/family/lifeafterloss/
d. http://www.hospicefoundation.org
e. http://www.bereavement.org
f. http://www.caringinfo.org/
g. http://www.aahpm.org/
h. http://www.hpna.org/
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● CHEMICAL CLASS: ANTIHISTAMINES
Examples
Generic 
Name Trade Name
Half-life 
(hr)
Pregnancy 
Category
Available Forms 
(mg) 
Hydroxyzine Vistaril 3 C Caps: 10, 25, 50, 100
Oral susp: 25/5 mL
Syrup: 10/5 mL
Inj: 25/mL, 50/mL
Indications
● Anxiety disorders
● Temporary relief of anxiety symptoms
● Allergic reactions producing pruritic conditions
● Antiemetic
● Reduction of narcotic requirement, alleviation of anxiety, and 
control of emesis in preoperative/postoperative clients (paren-
teral only) 
Action
● Exerts central nervous system (CNS)-depressant activity at 
the subcortical level of the CNS
● Has anticholinergic, antihistaminic, and antiemetic properties
U N I T  F O U R
PSYCHOTROPIC 
MEDICATIONS
C H A P T E R  25
Antianxiety Agents
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Contraindications and Precautions: 
Contraindicated in: • Hypersensitivity • Pregnancy and 
lactation
Use Cautiously in: • Elderly or debilitated patients (dos-
age reduction recommended) • Hepatic or renal dysfunction 
• Concomitant use of other CNS depressants
Adverse Reactions and Side Effects
● Dry mouth
● Drowsiness
● Pain at intramuscular site
Interactions
● Additive CNS depression with other CNS depressants (e.g., 
alcohol, other anxiolytics, opioid analgesics, and sedative/
hypnotics) and with herbal depressants (e.g., kava, valerian)
● Additive anticholinergic effects with other drugs possessing 
anticholinergic properties (e.g., antihistamines, antidepres-
sants, atropine, haloperidol, phenothiazines) and herbal 
products such as angel’s trumpet, jimson weed, and scopolia
● Can antagonize the vasopressor effects of epinephrine
Route and Dosage 
INTRAMUSCULAR
Anxiety 
Adults: 50 to 100 mg 4 times a day
Pruritis 
Adults: 25 mg 3 or 4 times a day
Preoperative and Postoperative Sedative 
Adults: 50 to 100 mg
Children: 0.6 mg/kg
Antiemetic/Adjunctive Therapy to Analgesia 
Adults: 25 to 100 mg every 4 to 6 hours as needed
Children: 0.5 to 1 mg/kg every 4 to 6 hours as needed
ORAL
Anxiety 
Adults: 50 to 100 mg 4 times a day
Children (>6 years): 50 to 100 mg/day in divided doses
Children (<6 years): 50 mg/day in divided doses
Pruritus 
Adults: 25 mg 3 or 4 times a day
Children (>6 years): 50 to 100 mg/day in divided doses
Children (<6 years): 50 mg/day in divided doses
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Preoperative and Postoperative Sedative 
Adults: 50 to 100 mg
Children: 0.6 mg/kg
● CHEMICAL CLASS: BENZODIAZEPINES
Examples
Generic 
(Trade) 
Name
Controlled/ 
Pregnancy 
Categories
Half-life 
(hr) Indications
Available Forms 
(mg)
Alprazolam 
(Xanax)
C-IV/D 6.3–26.9 ● Anxiety disorders
● Anxiety symptoms
● Anxiety associated 
with depression
● Panic disorder
Tabs: 0.25, 0.5, 1.0, 
2.0
Tabs ER: 0.5, 1.0, 
2.0, 3.0
Tabs (orally 
disintegrating): 
0.25, 0.5, 1.0, 2.0
Oral solu: 1/mL
Chlordiazepoxide 
(Librium)
C-IV/D 5–30 ● Anxiety disorders
● Anxiety symptoms
● Acute alcohol 
withdrawal
● Preoperative 
sedation
Caps: 5, 10, 25
Clonazepam 
(Klonopin)
C-IV/C 18–50 ●  Petit mal, akinetic, 
and myoclonic 
seizures
● Panic disorder
Unlabeled uses:
● Acute manic 
episodes
● Neuralgias
● Restless leg 
syndrome
● Adjunct therapy in 
schizophrenia
Tabs: 0.5, 1.0, 2.0
Tabs (orally 
disintegrating): 
0.125, 0.25, 0.5, 
1.0, 2.0
Clorazepate 
(Tranxene)
C-IV/UK 40–50 ●  Anxiety disorders
● Anxiety symptoms
● Acute alcohol 
withdrawal
● Partial seizures
Tabs: 3.75, 7.5, 15
Tabs (extended 
release): 11.25, 
22.5
Diazepam
(Valium) 
C-IV/D 20–80 ●  Anxiety disorders
●  Anxiety symptoms
● Skeletal muscle 
relaxant
● Acute alcohol 
withdrawal
● Adjunct therapy in 
convulsive disorders
● Status epilepticus
● Preoperative 
sedation
Tabs: 2, 5, 10
Oral solu: 5/5 mL, 
5/mL
Inj: 5/mL
Rectal gel: 2.5, 10, 20
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Action
● Benzodiazepines are thought to potentiate the effects of 
gamma-aminobutyric acid (GABA), a powerful inhibitory 
neurotransmitter, thereby producing a calmative effect. The 
activity may involve the spinal cord, brain stem, cerebellum, 
limbic system, and cortical areas. 
Contraindications and Precautions: 
Contraindicated in: • Hypersensitivity • Psychoses • Acute 
narrow-angle glaucoma • Preexisting CNS depression • Preg-
nancy and lactation • Shock • Coma
Use Cautiously in: • Elderly or debilitated patients (reduced 
dosage recommended) • Patients with hepatic/renal/pulmonary 
impairment • History of drug abuse/dependence • Depressed/
suicidal patients • Children
Adverse Reactions and Side Effects
● Drowsiness; dizziness, lethargy
● Nausea and vomiting
● Ataxia
● Dry mouth
● Blurred vision
● Rash
● Hypotension
● Tolerance
● Physical and psychological dependence
● Paradoxical excitation
Lorazepam 
(Ativan)
C-IV/D 10–20 ● Anxiety disorders
● Anxiety symptoms
● Status epilepticus
● Preoperative 
sedation
Unlabeled uses:
● Insomnia
● Chemotherapy-
induced nausea 
and vomiting
Tabs: 0.5, 1.0, 2.0
Oral solu: 2/mL
Inj: 2/mL, 4/mL
Oxazepam C-IV/D 5–20 ● Anxiety disorders
● Anxiety symptoms
● Acute alcohol 
withdrawal
Unlabeled uses:
●  Management of 
irritable bowel 
syndrome
Caps: 10, 15, 30
Generic 
(Trade) 
Name
Controlled/ 
Pregnancy 
Categories
Half-life 
(hr) Indications
Available Forms 
(mg)
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Interactions
● Additive CNS depression with other CNS depressants 
(e.g., alcohol, other anxiolytics, opioid analgesics, and 
sedative/hypnotics) and with herbal depressants (e.g., kava, 
valerian)
● Cimetidine, oral contraceptives, disulfi ram, fl uoxetine, iso-
niazid, ketoconazole, metoprolol, propoxyphene, propran-
olol, or valproic acid may enhance effects of benzodiazepines
● Benzodiazepines may decrease the efﬁ cacy of levodopa.
● Sedative effects of benzodiazepines may be decreased by 
theophylline.
● Rifampin may decrease the efﬁ cacy of benzodiazepines.
● Serum concentration of digoxin may be increased (and sub-
sequent toxicity can occur) with concurrent benzodiazepine 
therapy.
Route and Dosage 
ALPRAZOLAM  (Xanax) 
Anxiety Disorders and Anxiety Symptoms: PO: 0.25 to 
0.5 mg 3 times a day. Maximum daily dose 4 mg in divided 
doses. 
In elderly or debilitated patients: 0.25 mg 2 or 3 times a day. 
Gradually increase if needed and tolerated. 
Panic Disorder: PO: Initial dose: 0.5 mg 3 times a day. Increase 
dose at intervals of 3 to 4 days in increments of no more than 
1 mg/day. 
CHLORDIAZEPOXIDE  (Librium) 
Mild to Moderate Anxiety: PO: 5 or 10 mg 3 or 4 times 
a day. 
Severe Anxiety: PO: 20 or 25 mg 3 or 4 times a day. 
Elderly or Debilitated Patients: PO: 5 mg 2 to 4 times 
a day.
Preoperative Sedation: PO: 5 to 10 mg 3 or 4 times a day. 
Acute Alcohol Withdrawal: PO: 50 to 100 mg; repeat as 
needed up to 300 mg/day. 
CLONAZEPAM  (Klonopin) 
Seizures: Adults: PO: 0.5 mg three times a day. May increase 
by 0.5 to 1 mg every 3 days. Total daily maintenance dose not 
to exceed 20 mg.
Children (10 years or 30 kg): PO: Initial daily dose 0.01 to 
0.03 mg/kg/day (not to exceed 0.05 mg/kg/day) given in 
2 or 3 equally divided doses; increase by no more than 0.25 
to 0.5 mg every third day until a daily maintenance dose of 
0.1 to 0.2 mg/kg has been reached. Therapeutic serum con-
centrations of clonazepam are 20 to 80 ng/ml. 
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Panic Disorder: PO: Initial dose: 0.25 mg 2 times a day. 
Increase after 3 days toward target dose of 1 mg/day. Some 
patients may require up to 4 mg/day, in which case the dose 
may be increased in increments of 0.125 to 0.25 mg twice daily 
every 3 days until symptoms are controlled. 
Acute Manic Episode: PO: 1 to 6 mg/day. 
Neuralgia: PO: 1.5 to 4 mg/day. 
Restless Leg Syndrome: PO: 0.5 to 2 mg 30 minutes before 
bedtime. 
Adjunct Therapy in Schizophrenia: PO: 0.5 to 2 mg/day. 
CLORAZEPATE  (Tranxene) 
Anxiety Disorders/Anxiety Symptoms: Adults: PO: 7.5 to 
15 mg 2 to 4 times a day. Adjust gradually to dose within range 
of 15 to 60 mg/day. May also be given in a single daily dose 
at bedtime. The recommended initial dose is 15 mg. Adjust 
subsequent dosages according to patient response.
Geriatric or debilitated patients: PO: 7.5 to 15 mg/day. 
Acute Alcohol Withdrawal: PO: Day 1: 30 mg initially, 
followed by 15 mg 2 to 4 times a day.
Day 2: 45 to 90 mg in divided doses.
Day 3: 22.5 to 45 mg in divided doses.
Day 4: 15 to 30 mg in divided doses.
Thereafter, gradually reduce the daily dose to 7.5 to 15 mg. 
Discontinue drug as soon as patient’s condition is stable. 
Partial Seizures: Adults: PO: 7.5 mg 3 times a day. Can 
increase by no more than 7.5 mg/day at weekly intervals (daily 
dose not to exceed 90 mg). 
Children (9 to 12 years): PO: 7.5 mg 2 times a day initially; may 
increase by 7.5 mg/week (not to exceed 60 mg/day). 
DIAZEPAM  (Valium) 
Antianxiety/Adjunct Anticonvulsant: Adults: PO: 2 to 10 mg 
2 to 4 times a day.
Children (6 months): PO: 1 to 2.5 mg 3 to 4 times a day. 
Moderate to severe anxiety: Adults: IM or IV: 2 to 10 mg. 
Repeat in 3 to 4 hours if necessary. 
Skeletal Muscle Relaxant: Adults: PO: 2 to 10 mg 3 or 
4 times a day.
Children (6 months): PO: 0.12 to 0.8 mg/kg/day divided into 3 
or 4 equal doses. 
Geriatric or debilitated patients: PO: 2 to 2.5 mg 1 to 2 times daily 
initially. Increase gradually as needed and tolerated. 
Acute Alcohol Withdrawal: PO: 10 mg 3 to 4 times a day in ﬁ rst 
24 hours; decrease to 5 mg 3 or 4 times a day as needed. IM or 
IV: 10 mg initially, then 5 to 10 mg in 3 to 4 hours, if necessary. 
2506_Ch25_406-416.indd   Sec2:411 10/1/10   9:39:03 AM
412 ● PSYCHOTROPIC MEDICATIONS
Status Epilepticus/Acute Seizure Activity: Adults: IV (IM 
route may be used if IV is unavailable): 5 to 10 mg; may repeat 
every 10 to 15 minutes to a total of 30 mg; may repeat regimen 
again in 2 to 4 hours.
Children (5 years): IM or IV: 1 mg every 2 to 5 minutes to a 
maximum of 10 mg. May repeat in 2 to 4 hours if necessary.
Children (1 month to 5 years): IM or IV: 0.2 to 0.5 mg every 2 to 
5 minutes to maximum of 5 mg.  
Preoperative Sedation: Adults: IM: 10 mg. 
LORAZEPAM  (Ativan) 
Anxiety Disorders/Anxiety Symptoms: PO: 2 to 6 mg/day 
(varies from 1 to 10 mg/day) given in divided doses; take the 
largest dose before bedtime. 
Geriatric or debilitated patients: PO: 1 to 2 mg/day in divided 
doses; adjust as needed and tolerated. 
Insomnia: PO: 2 to 4 mg at bedtime. 
Geriatric or debilitated patients: PO: 0.25 to 1 mg at bedtime. 
Preoperative Sedation: IM: 0.05 mg/kg (maximum 4 mg) 
2 hours before surgery.
IV: Initial dose is 2 mg or 0.044 mg/kg, whichever is smaller, 
given 15 to 20 minutes before the procedure. 
Status Epilepticus: IV: 4 mg given slowly (2 mg/min). May 
be repeated after 10 to 15 minutes if seizures continue or 
recur. 
Antiemetic: IV: 2 mg 30 minutes prior to chemotherapy; may 
be repeated every 4 hours as needed. 
OXAZEPAM 
Mild to Moderate Anxiety: PO: 10 to 15 mg 3 or 4 times 
a day. 
Severe Anxiety States: PO: 15 to 30 mg 3 or 4 times a day. 
Geriatric patients: PO: Initial dosage: 10 mg 3 times a day. If 
necessary, increase cautiously to 15 mg 3 or 4 times a day. 
Acute alcohol withdrawal: PO: 15 to 30 mg 3 or 4 times 
a day. 
●  CHEMICAL CLASS: CARBAMATE 
DERIVATIVE
Examples
Generic 
Name
Controlled/
Pregnancy 
Categories
Half-life 
(hr)
Available Forms
(mg)
Meprobamate C-IV/D 6–17 Tabs: 200, 400
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Indications
● Anxiety disorders
● Temporary relief of anxiety symptoms
Action
● Depresses multiple sites in the CNS, including the thala-
mus and limbic system. May act by blocking the reuptake of 
adenosine. 
Contraindications and Precautions: 
Contraindicated in: • Hypersensitivity to the drug • Com-
bination with other CNS depressants • Children under age 6 
• Pregnancy and lactation • Acute intermittent porphyria
Use Cautiously in: • Elderly or debilitated clients • Patients 
with hepatic or renal dysfunction • Individuals with a history of 
drug abuse/addiction • Clients with a history of seizure disor-
ders • Depressed/suicidal clients
Adverse Reactions and Side Effects
● Palpitations, tachycardia
● Drowsiness, dizziness, ataxia
● Nausea, vomiting, diarrhea
● Tolerance
● Physical and psychological dependence
Interactions
● Additive CNS depression with other CNS depressants (e.g., 
alcohol, other anxiolytics, opioid analgesics, and sedative-
hypnotics) and with herbal depressants (e.g., kava, valerian). 
Route and Dosage 
Anxiety Disorders/Anxiety Symptoms: Adults and children: 
>12 years: PO: 1200 to 1600 mg/day in 3 to 4 divided doses. 
Maximum daily dose: 2400 mg. 
Children (6 to 12 years): PO: 100 to 200 mg 2 or 3 times a day. 
●  CHEMICAL CLASS: 
AZASPIRODECANEDIONES
Examples
Generic
Name
Trade
Name
Pregnancy
Category 
Half-life
(hr)
Available 
Forms (mg)
Buspirone HCl BuSpar B 2–3 Tabs: 5, 7.5, 10, 
15, 30
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INDICATIONS
● Generalized anxiety states
Unlabeled use:
● Symptomatic management of premenstrual syndrome
Actions
● Unknown
● May produce desired effects through interactions with sero-
tonin, dopamine, and other neurotransmitter receptors
● Delayed onset (a lag time of 7 to 10 days between onset of 
therapy and subsiding of anxiety symptoms)
● Cannot be used on a PRN basis 
Contraindications and Precautions: 
Contraindicated in: • Hypersensitivity to the drug • Severe 
hepatic or renal impairment • Concurrent use with monoamine 
oxidase (MAO) inhibitors
Use Cautiously in: • Elderly or debilitated clients • Pregnancy 
and lactation • Children • Clients with a history of chronic ben-
zodiazepine or other sedative/hypnotic use. Buspirone will not 
block the withdrawal syndrome in these clients and they should 
be withdrawn gradually from these medications before begin-
ning therapy with buspirone. 
Adverse Reactions and Side Effects
● Drowsiness, dizziness
● Excitement, nervousness
● Fatigue, headache
● Nausea, dry mouth
● Incoordination, numbness
● Palpitations, tachycardia
Interactions
● Increased effects of buspirone with cimetidine, erythromycin, 
itraconazole, nefazodone, ketoconazole, clarithromycin, 
diltiazem, verapamil, fl uvoxamine, and ritonavir
● Decreased effects of buspirone with rifampin, rifabutin, 
phenytoin, phenobarbital, carbamazepine, fl uoxetine, and 
dexamethasone
● Increased serum concentrations of haloperidol when used 
concomitantly with buspirone
● Use of buspirone with an MAO inhibitor may result in 
elevated blood pressure.
● Increased risk of hepatic effects when used concomitantly with 
trazodone
● Additive effects when used with certain herbal products (e.g., 
kava, valerian) 
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Route and Dosage 
Anxiety: Adults: PO: Initial dosage 7.5 mg 2 times a day. 
Increase by 5 mg/day every 2 to 3 days as needed. Maximum 
daily dosage: 60 mg.
●  NURSING DIAGNOSES RELATED 
TO ALL ANTIANXIETY AGENTS
 1. Risk for injury related to seizures, panic anxiety, acute 
agitation from alcohol withdrawal (indications); abrupt 
withdrawal from the medication after long-term use; effects 
of medication intoxication or overdose
 2. Anxiety (specify) related to threat to physical integrity or 
self-concept
 3. Risk for activity intolerance related to medication side effects 
of sedation, confusion, lethargy
 4. Disturbed sleep pattern related to situational crises, physical 
condition, severe level of anxiety
 5. Deﬁ cient knowledge related to medication regimen
 6. Risk for acute confusion related to action of the medication 
on the CNS
●  NURSING IMPLICATIONS 
FOR ANTIANXIETY AGENTS
 1. Instruct client not to drive or operate dangerous machinery 
while taking the medication.
 2. Advise client receiving long-term therapy not to quit 
taking the drug abruptly. Abrupt withdrawal can be life-
threatening (with the exception of buspirone). Symptoms 
include depression, insomnia, increased anxiety, abdomi-
nal and muscle cramps, tremors, vomiting, sweating, con-
vulsions, and delirium.
 3. Instruct client not to drink alcohol or take other medica-
tions that depress the CNS while taking this medication.
 4. Assess mood daily. May aggravate symptoms in depressed 
persons. Take necessary precautions for potential suicide.
 5. Monitor lying and standing blood pressure and pulse every 
shift. Instruct client to arise slowly from a lying or sitting 
position.
 6. Withhold drug and notify the physician should paradoxical 
excitement occur.
 7. Have client take frequent sips of water or ice chips, suck on 
hard candy, or chew sugarless gum to relieve dry mouth.
 8. Have client take drug with food or milk to prevent nausea 
and vomiting.
 9. Symptoms of sore throat, fever, malaise, easy bruising, 
or unusual bleeding should be reported to the physician 
immediately. They may be indications of blood dyscrasias.
Antianxiety Agents ● 415
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 10. Ensure that client taking buspirone (BuSpar) understands 
there is a lag time of 7 to 10 days between onset of therapy 
and subsiding of anxiety symptoms. Client should con-
tinue to take the medication during this time. (Note: This 
medication is not recommended for PRN administration 
because of this delayed therapeutic onset. There is no 
evidence that buspirone creates tolerance or physical 
dependence as do the CNS-depressant anxiolytics.) 
●  CLIENT/FAMILY EDUCATION RELATED 
TO ALL ANTIANXIETY AGENTS
● Do not drive or operate dangerous machinery. Drowsiness 
and dizziness can occur.
● Do not stop taking the drug abruptly. This can produce 
serious withdrawal symptoms, such as depression, insomnia, 
anxiety, abdominal and muscle cramps, tremors, vomiting, 
sweating, convulsions, and delirium.
● (With buspirone only): Be aware of lag time between start 
of therapy and subsiding of symptoms. Relief is usually evi-
dent within 7 to 10 days. Take the medication regularly, as 
ordered, so that it has sufﬁ cient time to take effect.
● Do not consume other CNS depressants (including alcohol).
● Do not take nonprescription medication without approval 
from physician.
● Rise slowly from the sitting or lying position to prevent a sud-
den drop in blood pressure.
● Report to physician immediately symptoms of sore throat, 
fever, malaise, easy bruising, unusual bleeding, or motor rest-
lessness.
● Be aware of risks of taking these drugs during pregnancy. 
(Congenital malformations have been associated with use dur-
ing the ﬁ rst trimester.) If pregnancy is suspected or planned, 
the client should notify the physician of the desirability to 
discontinue the drug.
● Be aware of possible side effects. Refer to written materi-
als furnished by health-care providers regarding the correct 
method of self-administration.
● Carry a card or piece of paper at all times stating the names of 
medications being taken.
 INTERNET REFERENCES
 a. http://www.mentalhealth.com/
 b. http://www.nimh.nih.gov/health/publications/mental-
health-medications/complete-index.shtml
 c. http://www.fadavis.com/townsend
 d. http://www.nlm.nih.gov/medlineplus/druginformation
.html 
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Antidepressants
417
Generic 
(Trade) 
Name
Pregnancy 
Categories/
Half-life (hr) Indications
Therapeutic 
Plasma Level 
Range (ng/ml)
Available 
Forms (mg) 
TRICYCLICS
Amitriptyline D/31–46
 
● Depression 
Unlabeled uses:
● Migraine prevention
● Fibromyalgia
● Postherpetic neuralgia
110–250 
(including 
metabolite)
Tabs: 10, 25, 
50, 75, 100, 
150
Clomipramine  
(Anafranil)
C/19–37 ● Obsessive-compulsive 
disorder (OCD) 
Unlabeled uses:
● Premenstrual 
symptoms
● Panic disorder
80–100 Caps: 25, 
50, 75
Desipramine   
(Norpramin)
C/12–24 Depression 
Unlabeled uses:
● Alcoholism
● Attention-defi cit/
hyperactivity disorder 
(ADHD)
● Bulimia nervosa
● Diabetic neuropathy
● Postherpetic neuralgia
125–300 Tabs: 10, 25, 
50, 75, 100, 
150
●  CHEMICAL CLASS: TRICYCLICS AND 
RELATED (Nonselective Reuptake Inhibitors)
Examples
Continued
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Generic 
(Trade) 
Name
Pregnancy 
Categories/
Half-life (hr) Indications
Therapeutic 
Plasma Level 
Range (ng/ml)
Available 
Forms (mg) 
Doxepin  
(Sinequan)
C/8–24 ● Depression or anxiety
● Depression or anxiety 
associated with 
alcoholism
● Depression or anxiety 
associated with organic 
disease
● Psychotic depressive 
disorders with anxiety
Unlabeled uses:
● Migraine prevention 
100–200 
(including 
metabolite)
Caps: 10, 25, 
50, 75, 100, 
150
Oral conc: 
10/mL
Imipramine 
(Tofranil)
D/11–25 ● Depression
● Childhood enuresis 
Unlabeled uses:
● Alcoholism
● ADHD
● Bulimia nervosa
● Migraine prevention
● Urinary incontinence
200–350 
(including 
metabolite)
HCl tabs: 10, 
25, 50 
Pamoate 
caps: 75, 
100, 125, 
150
Nortriptyline 
(Aventyl; 
Pamelor)
D/18–44 ● Depression 
Unlabeled uses:
● ADHD
● Postherpetic neuralgia
50–150 Caps: 10, 25, 
50, 75
Oral Solution: 
10/5 mL
Protriptyline 
(Vivactil)
C/67–89 ● Depression 
Unlabeled uses:
● Migraine prevention
100–200 Tabs: 5, 10
Trimipramine 
(Surmontil)
C/7–30 ● Depression 180 (includes 
active 
metabolite)
Caps: 25, 50, 
100
DIBENZOXAZEPINE
Amoxapine C/8 ● Depression
● Depression with anxiety
200–500 Tabs: 25, 50, 
100, 150
TETRACYCLIC 
Maprotiline B/21–25 ● Depression
● Depression with anxiety 
Unlabeled uses:
● Postherpetic neuralgia
200–300 
(including 
metabolite)
Tabs: 25, 
50, 75 
Action
 • Inhibit reuptake of norepinephrine or serotonin at the pre-
synaptic neuron
Contraindications and Precautions: 
Contraindicated in: • Hypersensitivity to any tricyclic 
or related drug • Concomitant use with monoamine oxidase 
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inhibitors (MAOIs) • Acute recovery period following myo-
cardial infarction • Narrow angle glaucoma • Pregnancy and 
lactation (safety not established) • Known or suspected sei-
zure disorder (maprotiline) 
Use Cautiously in: • Patients with history of seizures 
(maprotiline contraindicated) • Patients with tendency to have 
urinary retention • Benign prostatic hypertrophy • Cardio-
vascular disorders • Hepatic or renal insufﬁ ciency • Psychotic 
patients • Elderly or debilitated patients
Adverse Reactions and Side Effects
● Drowsiness; fatigue 
● Dry mouth
● Blurred vision 
● Orthostatic hypotension 
● Tachycardia; arrhythmias
● Constipation
● Urinary retention 
● Blood dyscrasias 
● Nausea and vomiting 
● Photosensitivity
● Increased risk of suicidality in children and adolescents (black 
box warning) 
Interactions
● Increased effects of tricyclic antidepressants with bupropion, 
cimetidine, haloperidol, selective serotonin reuptake in-
hibitors (SSRIs), and valproic acid
● Decreased effects of tricyclic antidepressants with carbam-
azepine, barbiturates, and rifamycins
● Hyperpyretic crisis, convulsions, and death can occur with 
MAOIs.
● Coadministration with clonidine may produce hypertensive 
crisis.
● Decreased effects of levodopa and guanethidine with tricyclic 
antidepressants
● Potentiation of pressor response with direct-acting sympa-
thomimetics
● Increased anticoagulation effects with dicumarol
● Increased serum levels of carbamazepine occur with 
concomitant use of tricyclics.
● Increased risk of seizures with concomitant use of maprotiline 
and phenothiazines
● Potential for cardiovascular toxicity of maprotiline when 
given concomitantly with thyroid hormones (e.g., levothy-
roxine) 
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Route and Dosage
AMITRIPTYLINE
Depression: PO: 75 mg/day in divided doses. May gradually 
increase to 150 mg/day. 
Alternative dosing: May initiate at 50 to 100 mg at bedtime; in-
crease by 25 to 50 mg as necessary, to a total of 150 mg/day.
Hospitalized patients: may require up to 300 mg/day. 
Adolescent and elderly patients: 10 mg 3 times a day and 20 mg at 
bedtime. 
Migraine Prevention: PO: Common dosage: 50 to 100 mg/
day in divided doses. Range: 10 to 300 mg/day.
Fibromyalgia: PO: 10 to 50 mg at bedtime
Postherpetic Neuralgia: PO: 65 to 100 mg/day for at least 
3 weeks. 
CLOMIPRAMINE (Anafranil) 
Obsessive-Compulsive Disorder: PO: Adults: 25 mg/day. 
Gradually increase to 100 mg/day during ﬁ rst 2 weeks, given 
in divided doses. May increase gradually over several weeks to 
maximum of 250 mg/day. 
Children and adolescents: 25 mg/day. Gradually increase during 
ﬁ rst 2 weeks to daily dose of 3 mg/kg or 100 mg, whichever is 
smaller. Maximum daily dose: 3 mg/kg or 200 mg, whichever 
is smaller. 
Premenstrual Symptoms: PO: 25 to 75 mg/day for irritability 
and dysphoria
Panic Disorder: PO: Initial dose: 10 mg. Increase to a 
maximum dose of 150 mg given as multiple daily doses. 
DESIPRAMINE  (Norpramin) 
Depression: PO: 100 to 200 mg/day in divided doses or as a single 
daily dose. May increase to maximum dose of 300 mg/day. 
Elderly and adolescents: 25 to 100 mg/day in divided doses or as a 
single daily dose. Maximum dose: 150 mg/day. 
Alcoholism: PO: 200 to 275 mg/day. 
Attention-deﬁ cit/Hyperactivity Disorder (ADHD): PO: 
100 to 200 mg/day
Bulimia Nervosa: PO: Initial dose: 25 mg 3 times a day. Titrate 
dosage up to 200 to 300 mg/day, depending on response and 
adverse effects. 
Diabetic Neuropathy: PO: 50 to 250 mg/day. 
Postherpetic Neuralgia: PO: 94 to 167 mg/day for at least 
6 weeks. 
DOXEPIN (Sinequan) 
Depression and/or Anxiety: PO: (Mild to moderate illness): 
75 mg/day. May increase to maximum dose of 150 mg/day.
2506_Ch26_417-446.indd   1420 10/1/10   9:39:18 AM
Antidepressants ● 421
(Mild symptoms associated with organic illness): 25 to 50 mg/day.
(Severe symptoms): 50 mg 3 times a day; may gradually increase 
to 300 mg/day. 
Migraine Prevention: PO: 75 to 150 mg/day. Occasionally 
dosages up to 300 mg/day may be required. 
IMIPRAMINE  (Tofranil) 
Depression: PO: 75 mg/day. May increase to maximum of 
200 mg/day. Hospitalized patients may require up to 300 mg/
day. 
Adolescent and geriatric patients: 30 to 40 mg/day. May 
increase to maximum of 100 mg/day.
Childhood Enuresis (children ≥6 years of age): PO: 
25 mg/day 1 hour before bedtime. May increase after 1 week to 
50 mg/night if <12 years of age; up to 75 mg/night if > 12 years 
of age. Maximum dose 2.5 mg/kg/day
Alcoholism: PO: 50 mg/day titrated by 50 mg every 3 to 5 days 
to a maximum daily dose of 300 mg. 
ADHD: PO: 1 mg/kg/day titrated to a maximum dose of 4 mg/
kg/day or 200 mg/day, whichever is smaller. 
Bulimia Nervosa: PO: 50 mg/day titrated to 100 mg 2 times 
a day.
Migraine Prevention: PO: 10 to 25 mg 3 times a day. 
Urinary Incontinence: PO: 25 mg 2 to 3 times a day. 
NORTRIPTYLINE  (Aventyl; Pamelor) 
Depression: PO: 25 mg 3 or 4 times a day. The total daily dose 
may be given at bedtime.
Elderly and adolescent patients: 30 to 50 mg daily in divided doses 
or total daily dose may be given once a day. 
ADHD: PO: Adults: 25 mg 3 to 4 times a day. Children and 
adolescents: 0.5 mg/kg/day, titrated to a maximum dose of
2 mg/kg/day or 100 mg, whichever is less. 
Postherpetic Neuralgia: PO: Dosage range: 58 to 89 mg/day 
for at least 5 weeks. 
PROTRIPTYLINE  (Vivactil) 
Depression: PO: 15 to 40 mg/day divided into 3 or 4 doses.
Maximum daily dose: 60 mg.
Adolescent and elderly patients: 5 mg 3 times a day. 
TRIMIPRAMINE  (Surmontil) 
Depression: PO: 75 mg/day. Increase gradually to 150 to 
200 mg/day. Adult hospitalized patients may require up to 
300 mg/day. 
Adolescent and elderly patients: Initially, 50 mg/day, with gradual 
increments up to 100 mg/day. 
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AMOXAPINE
Depression and Depression with Anxiety: PO: 50 mg 2 or 
3 times a day. May increase to 100 mg 2 or 3 times a day by 
end of ﬁ rst week. 
Elderly patients: 25 mg 2 or 3 times a day. May increase to 50 mg 
2 or 3 times a day by end of ﬁ rst week. 
MAPROTILINE 
Depression/Depression with Anxiety: PO: Adults—Initial 
dose: 75 mg/day. After 2 weeks, may increase gradually in 
25 mg increments. Maximum daily dose: 150 to 225 mg. 
Elderly patients: Initiate dosage at 25 mg/day. 50 to 75 mg/day 
may be sufﬁ cient for maintenance therapy in elderly patients. 
Postherpetic Neuralgia: PO: 100 mg/day for 5 weeks. 
●  CHEMICAL CLASS: SELECTIVE SEROTONIN 
REUPTAKE INHIBITORS (SSRIs)
Examples
Generic
(Trade) 
Name
Pregnancy 
Categories/
Half-life Indications
Therapeutic 
Plasma Level 
Ranges
Available 
Forms (mg) 
Citalopram 
(Celexa)
C/~35 ● Treatment of 
depression 
Unlabeled uses:
● Generalized 
anxiety 
disorder (GAD)
● Obsessive-
compulsive 
disorder (OCD)
● Panic disorder
● Premenstrual 
dysphoric disorder 
(PMDD)
● Posttraumatic 
stress disorder 
(PTSD)
Not well 
established
Tabs: 10, 20, 40 
Oral Solution: 
10/5 mL
Escitalopram 
(Lexapro)
C/27–32 hr ● Major depressive 
disorder
● GAD 
Unlabeled uses:
● Post traumatic 
stress disorder
Not well 
established
Tabs: 5, 10, 20
Oral Solution: 
1/mL
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Generic
(Trade) 
Name
Pregnancy 
Categories/
Half-life Indications
Therapeutic 
Plasma Level 
Ranges
Available 
Forms (mg) 
Fluoxetine 
(Prozac; 
Sarafem)
C/1 to 16 days 
(including
metabolite)
● Depression
● OCD
● Bulimia nervosa
● Panic disorder
● PMDD
Unlabeled uses:
● Alcoholism
● Borderline person-
ality disorder
● Fibromyalgia
● Hot fl ashes
● PTSD
● Migraine 
prevention
● Raynaud 
phenomenon
Not well 
established
Tabs: 10, 15, 20
Caps: 10, 20, 40
Caps, delayed-
release: 90
Oral solution: 
20/5 mL
Fluvoxamine 
(Luvox)
C/13.6–15.6 hr ● OCD
● Social anxiety 
disorder 
Unlabeled uses:
● Panic disorder
● PTSD
● Migraine 
prevention
Not well 
established
Tabs: 25, 50, 
100
Caps (ER): 100, 
150
Paroxetine 
(Paxil)
C/21 hr
(CR: 15–20 hr)
● Major depressive 
disorder
● Panic disorder
● OCD
● Social anxiety 
disorder
● GAD
● PTSD
● PMDD 
Unlabeled uses:
● Hot fl ashes
● Diabetic 
neuropathy
Not well 
established
Tabs: 10, 20, 
30, 40
Oral Suspen-
sion: 10/5 mL 
Tabs (CR): 12.5, 
25, 37.5
Sertraline 
(Zoloft)
C/26–104 hr 
(including
metabolite)
● Major depressive 
disorder
● OCD
● Panic disorder
● PTSD
● PMDD
● Social anxiety 
disorder
Not well 
established
Tabs: 25, 50, 
100 
Oral concen-
trate: 20/mL
2506_Ch26_417-446.indd   1423 10/1/10   9:39:19 AM
424 ● PSYCHOTROPIC MEDICATIONS
Action
● Selectively inhibit the central nervous system neuronal uptake 
of serotonin (5-HT) 
Contraindications and Precautions
Contraindicated in: • Hypersensitivity to SSRIs • Concomi-
tant use with, or within 14 days’ use of, MAOIs • Fluoxetine: 
concomitant use with thioridazine (or within 5 weeks after dis-
continuation of ﬂ uoxetine) • Fluvoxamine: concomitant use 
with cisapride, thioridazine, or pimozide • Paroxetine: con-
comitant use with thioridazine • Sertraline: concomitant use 
with pimozide • Sertraline: coadministration of oral concen-
trate with disulﬁ ram
Use Cautiously in: • Patients with history of seizures • Un-
derweight or anorexic patients • Patients with hepatic or renal 
insufﬁ ciency • Elderly or debilitated patients • Suicidal patients 
• Pregnancy and lactation
Adverse Reactions and Side Effects
● Headache 
● Insomnia 
● Nausea 
● Anorexia
● Diarrhea
● Constipation
● Sexual dysfunction 
● Somnolence 
● Dry mouth
● Increased risk of suicidality in children and adolescents (black 
box warning)
● Serotonin syndrome. Can occur if taken concurrently with 
other medications that increase levels of serotonin (e.g., 
MAOIs, tryptophan, amphetamines, other antidepressants, 
buspirone, lithium, dopamine agonists, or serotonin 5-HT1 
receptor agonists [agents for migraine]). Symptoms of sero-
tonin syndrome include diarrhea, cramping, tachycardia, 
labile blood pressure, diaphoresis, fever, tremor, shivering, 
restlessness, confusion, disorientation, mania, myoclonus, hy-
perreﬂ exia, ataxia, seizures, cardiovascular shock, and death. 
Interactions
● Toxic, sometimes fatal, reactions have occurred with concom-
itant use of MAOIs. 
● Increased effects of SSRIs with cimetidine, L-tryptophan, 
lithium, linezolid, and St. John’s wort.
● Serotonin syndrome may occur with concomitant use of SSRIs 
and metoclopramide, sibutramine, tramadol, serotonin 
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5-HT1 receptor agonists (agents for migraine), or any drug 
that increases levels of serotonin.
● Concomitant use of SSRIs may increase effects of hydanto-
ins, tricyclic antidepressants, cyclosporine, benzodiaze-
pines, beta blockers, methadone, carbamazepine, clozap-
ine, olanzapine, pimozide, haloperidol, phenothiazines, 
St. John’s wort, sumatriptan, sympathomimetics, tacrine, 
theophylline, and warfarin. 
● Concomitant use of SSRIs may decrease effects of buspirone 
and digoxin.
● Lithium levels may be increased or decreased by concomitant 
use of SSRIs.
● Decreased effects of SSRIs with concomitant use of carbam-
azepine or cyproheptadine
Route and Dosage
CITALOPRAM  (Celexa) 
Depression: PO: Initial dosage: 20 mg/day as a single 
daily dose. May increase in increments of 20 mg at intervals 
of no less than 1 week. Recommended maximum dose: 
40 mg/day. 
Elderly clients: 20 mg/day. 
OCD: PO: Initial dosage: 20 mg/day. Titrate to a target dosage 
of 40 to 60 mg/day. Maximum dosage: 80 mg. 
ESCITALOPRAM  (Lexapro) 
Depression and GAD: PO: Initial dosage: 10 mg/day as a 
single daily dose. May increase to 20 mg/day after 1 week. 
Elderly clients: PO: 10 mg/day. 
PTSD: PO: Initial dose: 10 mg/day. Increase to 20 mg/day after 
4 weeks. 
FLUOXETINE  (Prozac; Sarafem) 
Depression and OCD: PO: Adults: Initial dosage: 20 mg/day 
in the morning. May increase dosage after several weeks if 
clinical improvement is not observed. Maximum dose: 80 mg/
day. Children and adolescents: 10 to 20 mg/day. 
Bulimia Nervosa: PO: 60 mg/day administered in the morning. 
May need to titrate up to this target dose in some clients. 
Panic Disorder: PO: Initial dose: 10 mg/day. After 1 week, 
increase dose to 20 mg/day. If no improvement is seen 
after several weeks, may consider dose increases up to 
60 mg/day. 
PMDD (Sarafem): PO: Initial dose: 20 mg/day. Maximum: 
80 mg/day. May be given continuously throughout the cycle 
or intermittently (only during the 14 days prior to anticipated 
onset of menses). 
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Alcoholism: PO: Initial dosage: 20 mg/day. Titrate to 40 mg/
day after 2 weeks, if needed. 
Borderline Personality Disorder: PO: 20 to 80 mg/day.
Fibromyalgia: PO: 20 mg/day (in the morning) for up to 
6 weeks. 
Hot Flashes: PO: 20 mg/day.
PTSD: PO: Adults: 10 to 80 mg/day. Children: 10 to 20 mg/day.
Migraine Prevention: PO: 10 to 40 mg/day.
Raynaud Phenomenon: PO: 20 to 60 mg/day.
FLUVOXAMINE  (Luvox) 
OCD: PO: Adults: Initial dose: 50 mg at bedtime. May increase 
dose in 50 mg increments every 4 to 7 days. Maximum dose: 
300 mg. Administer daily doses >100 mg in 2 divided doses. If 
unequal, give larger dose at bedtime. 
Children 8 to 17 years: Initial dose: 25 mg single dose at bedtime. 
May increase the dose in 25 mg increments every 4 to 7 days 
to a maximum dose of 200 mg/day for children up to 11 years 
of age. Maximum dose for adolescents: 300 mg/day. Divide 
daily doses >50 mg into 2 doses. If unequal, give larger dose 
at bedtime. 
Social Anxiety Disorder: PO (extended release capsules): Initial 
dose: 100 mg/day as a single daily dose at bedtime. Increase 
in 50 mg increments every week, as tolerated, until maximum 
therapeutic beneﬁ t is achieved. Maximum dose: 300 mg/day. 
Panic Disorder: PO: Initial dosage: 50 mg/day. Gradually 
increase after several days to 150 mg/day. For clients who fail 
to respond after several weeks of treatment, further increases 
up to 300 mg/day may be considered. 
PTSD: PO: Adults: Initial dosage: 50 mg/day. Increase gradually 
to target dose of 100 to 250 mg/day in adults, and 100 mg/day 
in older adults. Maximum recommended dosage: 300 mg/day. 
Children and adolescents: Target dose: 50 mg/day. 
Migraine Prevention: PO: 50 mg at bedtime for 12 weeks. 
PAROXETINE  (Paxil) 
Depression: PO: Immediate release: Initial dose: 20 mg/day 
in the morning. May increase dose in 10 mg increments at 
intervals of at least 1 week to a maximum of 50 mg/day.
Controlled release: Initial dose: 25 mg/day in the morning. May 
increase dose in 12.5 mg increments at intervals of at least 
1 week to a maximum of 62.5 mg/day.
Panic Disorder: PO: Immediate release: Initial dose: 10 mg/
day in the morning. May increase dose in 10 mg increments 
at intervals of at least 1 week to a target dose of 40 mg/
day. Maximum dose: 60 mg/day. Controlled release: Initial 
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dose: 12.5 mg/day. May increase dose in 12.5 mg/day 
increments at intervals of at least 1 week to a maximum 
dose of 75 mg/day. 
OCD: PO: Immediate release: 20 mg/day. May increase dose 
in 10 mg/day increments at intervals of at least 1 week. 
Recommended dose: 40 mg/day. Maximum dose: 60 mg/day. 
Social Anxiety Disorder: PO: Immediate release: 20 mg/day. 
Usual range is 20 to 60 mg/day. 
Controlled release: 12.5 mg/day. May increase dosage at intervals 
of at least 1 week, in increments of 12.5 mg/day to a maximum 
of 37.5 mg/day. 
GAD and PTSD: PO: Immediate release: 20 mg/day. Usual 
range is 20 to 50 mg/day. Change doses in increments of 
10 mg/day at intervals of at least 1 week. 
PMDD: PO: Controlled release: Initial dose: 12.5 mg/day. Usual 
range: 12.5 to 25 mg/day. Change doses at intervals of at least 
1 week. May be administered daily throughout the menstrual 
cycle or limited to luteal phase of menstrual cycle. 
Hot Flashes: PO: Immediate release: 20 mg/day. 
Controlled release: 12.5 to 25 mg/day
Diabetic Neuropathy: PO: Initial dose: 10 mg/day. Titrate to 
20 to 60 mg/day. 
Elderly or Debilitated Patients: PO: Immediate release: Initial 
dose: 10 mg/day. Maximum dose: 40 mg/day. 
Controlled release: Initial dose: 12.5 mg/day. Maximum dose: 
50 mg/day. 
SERTRALINE  (Zoloft) 
Depression and OCD: PO: 50 mg/day (either morning 
or evening). May increase dosage at 1 week intervals to a 
maximum of 200 mg/day. 
Panic Disorder and PTSD: PO: Initial dose: 25 mg/day. 
After 1 week, increase dose to 50 mg/day. For patients not 
responding, may increase dosage at 1 week intervals to a 
maximum of 200 mg/day. 
PMDD: PO: 50 mg/day given on each day of the menstrual cycle 
or only during each day of the luteal phase of the menstrual 
cycle. For patients not responding, may increase dosage in 
50 mg increments per menstrual cycle up to 150 mg/day when 
dosing throughout the cycle or 100 mg/day when dosing only 
during the luteal phase. If 100 mg/day has been established 
with luteal phase dosing, titrate at 50 mg/day for ﬁ rst 3 days of 
each luteal phase dosing period. 
Social Anxiety Disorder: PO: Initial dose: 25 mg/day. After 
1 week, increase dose to 50 mg/day. May increase gradually to 
maximum dose of 200 mg/day. 
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Generic 
(Trade) 
Name
Pregnancy 
Categories/
Half-life (hr) Indications
Therapeutic 
Plasma Level 
Range 
Available 
Forms (mg) 
Bupropion 
(Wellbutrin; 
Zyban)
C/8–24 ● Depression 
(Wellbutrin)
● Seasonal 
affective disorder 
(Wellbutrin XL)
● Smoking
cessation 
(Zyban) 
Unlabeled uses:
● ADHD 
(Wellbutrin)
Not well 
established
Tabs: 75, 100 
Tabs (SR): 100, 
150, 200 
Tabs (XL): 150, 
300
SR = 12-hour tablets; XL = 24-hour tablets. 
●  CHEMICAL CLASS: NOREPINEPHRINE-
DOPAMINE REUPTAKE INHIBITORS 
(NDRIs)
Examples
Action
● Action is unclear. Thought to inhibit the reuptake of norepi-
nephrine and dopamine into presynaptic neurons. 
Contraindications and Precautions
Contraindicated in: • Hypersensitivity to the drug • Con-
comitant use with, or within 2 weeks use of, MAOIs • Known or 
suspected seizure disorder • Alcohol or benzodiazepine (or other 
sedatives) withdrawal • Current or prior diagnosis of bulimia or 
anorexia nervosa • Concomitant use of Wellbutrin (for depres-
sion or ADHD) and Zyban (for smoking cessation) • Lactation
Use Cautiously in: • Patients with urinary retention 
• Patients with hepatic or renal function impairment • Patients 
with suicidal ideation • Patients with recent history of myocar-
dial infarction or unstable heart disease • Pregnancy (safety not 
established) • Elderly and debilitated patients
Adverse Reactions and Side Effects
● Dry mouth 
● Blurred vision
● Agitation
● Insomnia
● Tremor
● Sedation; dizziness 
● Tachycardia 
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● Excessive sweating
● Headache 
● Nausea/vomiting 
● Anorexia; weight loss
● Seizures 
● Constipation
● Increased risk of suicidality in children and adolescents (black 
box warning) 
Interactions
● Increased effects of bupropion with amantadine, levodopa, 
clopidogrel, CYP2B6 inhibitors (e.g., cimetidine), guanfa-
cine, linezolid, and ticlopidine 
● Increased risk of acute toxicity with MAOIs. Coadministra-
tion is contraindicated.
● Coadministration with a nicotine replacement agent may 
cause hypertension.
● Concomitant use with alcohol may produce adverse neuro-
psychiatric events (alcohol tolerance is reduced).
● Decreased effects of bupropion with carbamazepine and 
rifampin
● Increased anticoagulant effect of warfarin with bupropion
● Increased effects of drugs metabolized by CYP2D6 isoenzyme 
(e.g., nortriptyline, imipramine, desipramine, paroxetine, 
fl uoxetine, sertraline, haloperidol, risperidone, thiorida-
zine, metoprolol, propafenone, and fl ecainide) 
Route and Dosage
BUPROPION  (Wellbutrin; Zyban) 
Depression (Wellbutrin): PO: Adults (immediate release tabs): 
100 mg 2 times a day. May increase after 3 days to 100 mg given 
3 times a day. For patients who do not show improvement after 
several weeks of dosing at 300 mg/day, an increase in dosage up 
to 450 mg/day may be considered. No single dose of bupropion 
should exceed 150 mg. To prevent the risk of seizures, administer 
with an interval of 4 to 6 hours between doses. 
Sustained release tabs: Give as a single 150 mg dose in the morn-
ing. May increase to twice a day (total 300 mg), with 8 hours 
between doses.
Extended release tabs: Begin dosing at 150 mg/day, given as a
 single daily dose in the morning. May increase after 3 days to 
300 mg/day, given as a single daily dose in the morning. 
Seasonal Affective Disorder (Wellbutrin XL): PO: 150 mg 
administered each morning beginning in the autumn prior to 
the onset of depressive symptoms. Dose may be uptitrated to 
the target dose of 300 mg/day after 1 week. Therapy should 
2506_Ch26_417-446.indd   1429 10/1/10   9:39:22 AM
430 ● PSYCHOTROPIC MEDICATIONS
continue through the winter season before being tapered to 
150 mg/day for 2 weeks prior to discontinuation in early spring. 
Smoking Cessation (Zyban): PO: Begin dosing at 150 mg 
given once a day in the morning for 3 days. If tolerated 
well, increase to target dose of 300 mg/day given in doses of 
150 mg 2 times a day with an interval of 8 hours between 
doses. Continue treatment for 7 to 12 weeks. Some patients 
may need treatment for as long as 6 months. 
ADHD: PO: Children: 3 mg/kg/day. Adults: 150 to 450 mg/day. 
No single dose of bupropion should exceed 150 mg. To prevent 
the risk of seizures, administer with an interval of 4 to 6 hours 
between doses. 
●  CHEMICAL CLASS: SEROTONIN-
NOREPINEPHRINE REUPTAKE 
INHIBITORS (SNRIs)
Examples
Generic 
(Trade) 
Name
Pregnancy 
Category/
Half-life (hr) Indications
Therapeutic 
Plasma Level 
Ranges 
Available 
Forms (mg) 
Desvenlafaxine 
(Pristiq)
C/11 ● Depression Not well 
established
Tabs ER: 50, 
100
Duloxetine 
(Cymbalta)
C/8–17 ● Depression
● Diabetic 
peripheral neuro-
pathic pain
● Fibromyalgia
● Generalized 
anxiety disorder 
(GAD) 
Unlabeled uses:
● Stress urinary 
incontinence
Not well 
established
Caps: 20, 
30, 60
Venlafaxine 
(Effexor)
C/5–11 (incl. 
metabolite)
● Depression
● GAD (extended 
release [ER] only)
● Social anxiety 
disorder (ER)
● Panic disorder 
(ER) 
Unlabeled uses:
● Hot fl ashes
● PMDD
● PTSD
Not well 
established
Tabs: 25, 37.5, 
50, 75, 100 
Caps XR: 37.5, 
75, 150
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Action
● SNRIs are potent inhibitors of neuronal serotonin and nor-
epinephrine reuptake; weak inhibitors of dopamine reuptake. 
Contraindications and Precautions
Contraindicated in: • Hypersensitivity to the drug 
• Children (safety not established) • Concomitant (or within 
14 days) use with MAOIs • Severe renal or hepatic impairment 
• Pregnancy and lactation (safety not established) • Uncon-
trolled narrow-angle glaucoma
Use Cautiously in: • Patients with hepatic and renal insuf-
ﬁ ciency • Elderly and debilitated patients • Patients with his-
tory of drug abuse • Patients with suicidal ideation • Patients 
with history of or existing cardiovascular disease • Patients with 
history of mania • Patients with history of seizures • Children 
Adverse Reactions and Side Effects 
● Headache 
● Dry mouth 
● Nausea 
● Somnolence 
● Dizziness 
● Insomnia 
● Asthenia
● Constipation
● Diarrhea
● Mydriasis (venlafaxine)
● Increased risk of suicidality in children and adolescents (black 
box warning)
● Discontinuation syndrome. Abrupt withdrawal may result in 
symptoms such as nausea, vomiting, nervousness, dizziness, 
headache, insomnia, nightmares, paresthesias, and a return of 
symptoms for which the medication was prescribed. A gradual 
reduction in dosage is recommended. 
Interactions
● Concomitant use with MAOIs results in serious, sometimes 
fatal, effects resembling neuroleptic malignant syndrome. 
Coadministration is contraindicated.
● Serotonin syndrome may occur when SNRIs are used con-
comitantly with St. John’s wort, sumatriptan, sibutramine, 
trazodone, or other drugs that increase levels of serotonin.
● Increased effects of haloperidol, clozapine, and desipra-
mine when used concomitantly with venlafaxine
● Increased effects of venlafaxine with cimetidine and azole 
antifungals
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● Decreased effects of venlafaxine with cyproheptadine
● Decreased effects of indinavir and metoprolol with venlafaxine
● Increased effects of warfarin with SNRIs
● Increased effects of duloxetine with CYP1A2 inhibitors (e.g., 
ﬂ uvoxamine, quinolone antibiotics) and CYP2D6 inhibitors 
(e.g., ﬂ uoxetine, quinidine, paroxetine)
● Increased risk of liver injury with concomitant use of alcohol 
and duloxteine
● Increased risk of toxicity or adverse effects from drugs exten-
sively metabolized by CYP2D6 (e.g., fl ecainide, phenothi-
azines, propafenone, tricyclic antidepressants, thiorida-
zine) when used concomitantly with duloxetine
● Increased effects of desipramine with desvenlafaxine
● Decreased effects of midazolam with desvenlafaxine
Route and Dosage
DESVENLAFAXINE  (Pristiq) 
Depression: PO: 50 mg once daily, with or without food. 
(In clinical studies, doses of 50 to 400 mg/day were 
shown to be effective, although no additional beneﬁ t was 
demonstrated at doses greater than 50 mg/day and adverse 
events and discontinuations were more frequent at higher 
doses.) 
DULOXETINE  (Cymbalta) 
Depression: PO: 40 mg/day (given as 20 mg twice a day) to 
60 mg/day (given either once a day or as 30 mg 2 times a day) 
without regard to meals. 
Diabetic Peripheral Neuropathic Pain: PO: 60 mg/day 
given once daily without regard to meals. 
Fibromyalgia: PO: 30 mg once daily for 1 week and then 
increase to 60 mg once daily, if needed. 
GAD: PO: 60 mg once daily. For some patients, it may be 
desirable to start at 30 mg once daily for 1 week to allow the 
patient to adjust to the medication before increasing to 60 mg 
once daily. 
VENLAFAXINE  (Effexor) 
Depression: PO: Immediate-release tabs: Initial dosage: 75 mg/
day in 2 or 3 divided doses, taken with food. May increase 
in increments up to 75 mg/day at intervals of at least 4 days. 
Maximum dosage: 225 mg/day. 
Depression, GAD, and Social Anxiety Disorder: PO: 
Extended-release caps: Initial dosage: 75 mg/day, administered 
in a single dose. May increase dose in increments of up to
75 mg/day at intervals of at least 4 days to a maximum of 
225 mg/day. 
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Panic Disorder: PO: Extended-release caps: Initial dosage: 
37.5 mg/day for 7 days. After 7 days, increase dosage to 
75 mg/day. May increase dose in increments of up to 75 mg/day 
at intervals of at least 7 days to a maximum of 225 mg/day. 
●  CHEMICAL CLASS: SEROTONIN-2 
ANTAGONISTS/REUPTAKE INHIBITORS 
(SARIs)
Examples
Generic 
Name
Pregnancy 
Categories/
Half-life (hr) Indications
Therapeutic-
Plasma Level 
Ranges (ng/ml)
Available 
Forms (mg) 
Nefazodone* C/2–4 ● Depression Not well 
established
Tabs: 50, 100, 
150, 200, 250
Trazodone C/4–9 ● Depression 
Unlabeled uses:
● Aggressive 
behavior
● Panic disorder 
and agorapho-
bia with panic 
attacks
● Insomnia
● Migraine 
prevention
800–1600 Tabs: 50, 100, 
150, 300 
Action
● Trazodone inhibits neuronal reuptake of serotonin; nefazo-
done inhibits neuronal reuptake of serotonin and norepineph-
rine and acts as an antagonist at central 5-HT2 receptors.
Contraindications and Precautions
Contraindicated in: • Hypersensitivity • Coadministration 
with terfenadine, astemizole, cisapride, pimozide, carbamazepine, 
or triazolam (nefazodone) • Patients who were withdrawn because 
of liver injury (nefazodone) • Concomitant use with, or within 
2 weeks of use of, MAOIs • Acute phase of myocardial infarction
Use Cautiously in: • Pregnancy and lactation (safety not 
established) • Children (safety not established) • Patients with 
suicidal ideation • Patients with hepatic, renal, or cardiovascular 
disease • Elderly and debilitated patients
* Bristol-Myers Squibb voluntarily removed their brand of nefazodone (Serzone) 
from the market in 2004. The generic equivalent is currently available through 
various other manufacturers.
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Adverse Reactions and Side Effects
● Drowsiness; dizziness
● Fatigue
● Orthostatic hypotension
● Headache
● Nervousness; insomnia
● Dry mouth
● Nausea
● Somnolence
● Constipation
● Priapism
● Increased risk of suicidality in children and adolescents (black 
box warning)
● Risk of hepatic failure (nefazodone) (black box warning) 
Interactions
● Increased effects of CNS depressants, carbamazepine, 
digoxin, and phenytoin with trazodone
● Increased effects of trazodone with phenothiazines, azole 
antifungals, and protease inhibitors
● Risk of serotonin syndrome with concomitant use of trazo-
done and SSRIs or SNRIs
● Decreased effects of trazodone with carbamazepine
● Increases or decreases in prothrombin time with concurrent 
use of trazodone and warfarin
● Symptoms of serotonin syndrome and those resembling 
neuroleptic malignant syndrome may occur with concomitant 
use of MAOIs and SARIs.
● Risk of serotonin syndrome with concomitant use of nefazo-
done and sibutramine or sumatriptan
● Increased effects of both drugs with concomitant use of 
buspirone and nefazodone
● Increased effects of benzodiazepines, carbamazepine, 
cisapride, cyclosporine, digoxin, and St. John’s Wort with 
nefazodone
● Decreased effects of nefazodone with carbamazepine
● Risk of rhabdomyolysis with concomitant use of nefazodone 
and HMG-CoA reductase inhibitors (e.g., simvastatin, 
atorvastatin, lovastatin) 
Route and Dosage
NEFAZODONE
Depression: PO: Adults: Initial dosage: 200 mg/day, in 
2 divided doses. Dose may be increased in increments of 
100 to 200 mg/day (on a 2 times a day schedule) at intervals of 
at least 1 week. Maximum dose: 600 mg/day.
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Elderly and debilitated patients: PO: 100 mg/day, in 2 divided doses. 
Increases should be titrated slowly and based on careful as-
sessment of the patient’s clinical response. 
TRAZODONE
Depression: PO: Adults: Initial dosage: 150 mg/day in divided 
doses. May be increased by 50 mg/day every 3 to 4 days to 
maximum dose of 400 mg/day. Inpatients or severely depressed 
patients may be given up to a maximum of 600 mg/day. 
Drowsiness may require that largest dose of the medication 
be taken at bedtime. 
Aggressive Behavior: PO: 50 mg 2 times a day (along with 
tryptophan 500 mg 2 times a day). 
Panic Disorder or Agoraphobia with Panic Attacks: PO: 
300 mg/day. 
Insomnia: PO: 50 to 100 mg at bedtime.
Migraine Prevention: PO: 100 mg/day.
●  CHEMICAL CLASS: ALPHA-2 RECEPTOR 
ANTAGONIST
Examples
Generic 
(Trade) 
Name
Pregnancy 
Category/
Half-life (hr) Indications
Therapeutic 
Plasma Level 
Range
Available 
Forms (mg) 
Mirtazapine 
(Remeron)
C/20–40 ● Depression Not well 
established
Tabs: 7.5, 15, 30, 45 
Tabs (orally 
disintegrating): 
15, 30, 45
Action
● Potent antagonist of 5-HT2 and 5-HT3 receptors. Acts as 
antagonist at central presynaptic α2-adrenergic inhibitory 
autoreceptors and heteroreceptors, resulting in an increase 
in central noradrenergic and serotonergic activity. It is also a 
potent antagonist of histamine (H1) receptors.
Contraindications and Precautions
Contraindicated in: • Patients with hypersensitivity to the 
drug • Patients with suicidal ideation • Concurrent use with, or 
within 14 days of therapy with, MAOIs
Use Cautiously in: • History of seizures • History of mania 
or hypomania • Elderly or debilitated patients • Patients with he-
patic, renal, or cardiovascular disease • Pregnancy and lactation 
(safety not established) • Children (safety not established) 
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Adverse Reactions and Side Effects
● Somnolence
● Dizziness
● Dry mouth
● Constipation
● Increased appetite
● Weight gain
● Agranulocytosis 
● Increases in cholesterol and triglyceride levels
Interactions
● Additive impairment in cognitive and motor skills with CNS 
depressants (e.g., benzodiazepines, alcohol)
● Life-threatening symptoms similar to neuroleptic malignant 
syndrome with concurrent use, or within 14 days of use of, 
MAOIs
● Possible interaction with drugs that are metabolized by or 
inhibit cytochrome P450 enzymes CYP2D6, CYP1A2, and 
CYP3A4
● Increased effects of mirtazapine with concomitant use of 
SSRIs (e.g., fl uoxetine, fl uvoxamine) 
Route and Dosage
MIRTAZAPINE  (Remeron) 
Depression: PO: Initial dosage: 15 mg/day, administered in a 
single dose, preferably at bedtime. Dose may be increased at 
intervals of 1 to 2 weeks, up to a maximum dose of 45 mg/day.
When switching to or from an MAOI: At least 14 days should 
elapse between discontinuation of an MAOI and initiation of 
therapy with mirtazapine. In addition, allow at least 14 days 
after stopping mirtazapine before starting an MAOI.
●  CHEMICAL CLASS: MONOAMINE OXIDASE 
INHIBITORS
Examples
Generic 
(Trade) 
Name
Pregnancy 
Category/
Half-life (hr) Indications
Therapeutic 
Plasma Level 
Range 
Available 
Forms (mg) 
Isocarboxazid 
(Marplan)
C/Not 
Established
● Depression Not well 
established
Tabs: 10
Phenelzine 
(Nardil)
C/2–3 ● Depression
Unlabeled uses:
● PTSD
● Migraine 
prevention
Not well 
established
Tabs: 15
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Generic 
(Trade) 
Name
Pregnancy 
Category/
Half-life (hr) Indications
Therapeutic 
Plasma Level 
Range 
Available 
Forms (mg) 
Tranylcypromine
(Parnate)
C/2.4–2.8 ● Depression 
Unlabeled uses:
● Migraine 
prevention
● Social anxiety 
disorder
● Panic disorder
Not well 
established
Tabs: 10
Selegiline 
transdermal 
system 
(Emsam)
C/18–25 
(including 
metabolites)
● Depression Not well 
established
Transdermal 
patches: 6, 
9, 12 
Action
● Inhibition of the enzyme monoamine oxidase, which is respon-
sible for the decomposition of the biogenic amines, epineph-
rine, norepinephrine, dopamine, and serotonin. This action 
results in an increase in the concentration of these endogenous 
amines. 
Contraindications and Precautions
Contraindicated in: • Hypersensitivity • Pheochromo-
cytoma • Hepatic or renal insufﬁ ciency • History of or exist-
ing cardiovascular disease • Hypertension • History of severe 
or frequent headaches • Concomitant use with other MAOIs, 
tricyclic antidepressants, carbamazepine, cyclobenzaprine, 
bupropion, SSRIs, SARIs, buspirone, sympathomimetics, me-
peridine, dextromethorphan, anesthetic agents, CNS depres-
sants, antihypertensives, caffeine, and food with high tyramine 
content • Children younger than 16 years • Pregnancy and 
lactation (safety not established) 
Use Cautiously in: • Patients with a history of seizures 
• Patients with diabetes mellitus • Patients with suicidal ide-
ation • Agitated or hypomanic patients • Patients with a history 
of angina pectoris or hyperthyroidism
Adverse Reactions and Side Effects
● Dizziness 
● Headache 
● Orthostatic hypotension 
● Constipation 
● Nausea 
● Disturbances in cardiac rate and rhythm
● Blurred vision
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● Dry mouth
● Weight gain
● Hypomania
● Site reactions (itching, irritation) (with selegiline transdermal 
system)
● Increased risk of suicidality in children and adolescents (black 
box warning) 
Interactions
● Serious, potentially fatal adverse reactions may occur with 
concurrent use of other antidepressants, carbamazepine, 
cyclobenzaprine, bupropion, SSRIs, SARIs, buspirone, 
sympathomimetics, tryptophan, dextromethorphan, an-
esthetic agents, CNS depressants, and amphetamines. 
Avoid using within 2 weeks of each other (5 weeks after therapy 
with fl uoxetine).
● Hypertensive crisis may occur with amphetamines, methyl-
dopa, levodopa, dopamine, epinephrine, norepinephrine, 
guanethidine, methylphenidate, guanadrel, reserpine, or 
vasoconstrictors.
● Hypertension or hypotension, coma, convulsions, and death 
may occur with opioids (avoid use of meperidine within 14 to 
21 days of MAOI therapy).
● Additive hypotension may occur with antihypertensives, 
thiazide diuretics, or spinal anesthesia.
● Additive hypoglycemia may occur with insulins or oral 
hypoglycemic agents.
● Doxapram may increase pressor response.
● Serotonin syndrome may occur with concomitant use of 
St. John’s wort.
● Hypertensive crisis may occur with ingestion of foods or 
other products containing high concentrations of tyramine 
(see Nursing Implications).
● Consumption of foods or beverages with high caffeine con-
tent increases the risk of hypertension and arrhythmias.
● Bradycardia may occur with concurrent use of MAOIs and 
beta blockers. 
Route and Dosage
ISOCARBOXAZID  (Marplan) 
Depression: PO: Initial dose: 10 mg 2 times a day. May 
increase dosage by 10 mg every 2 to 4 days to 40 mg by end 
of ﬁ rst week. If needed, may continue to increase dosage by 
increments of up to 20 mg/week. Maximum dosage: 60 mg/
day divided into 2 to 4 doses. Gradually reduce to smallest 
effective dose. 
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PHENELZINE  (Nardil) 
Depression: PO: Initial dose: 15 mg 3 times a day. Increase to 
60 to 90 mg/day in divided doses until therapeutic response 
is achieved. Then gradually reduce to smallest effective dose 
(15 mg/day or every other day). 
TRANYLCYPROMINE  (Parnate) 
Depression: PO: 30 mg/day in divided doses. After 2 weeks, 
may increase by 10 mg/day, at 1- to 3-week intervals, up to 
60 mg/day. 
SELEGILINE TRANSDERMAL SYSTEM  (Emsam) 
Depression: Transdermal patch: Initial dose: 6 mg/24 hr. If 
necessary, dosage may be increased in increments of 3 mg/24 hr 
at intervals of no less than 2 weeks up to a maximum dose of 
12 mg/24 hr. 
Elderly clients: The recommended dosage is 6 mg/24 hr. 
● PSYCHOTHERAPEUTIC COMBINATIONS
Examples
Generic (Trade) 
Name Indications Available Forms (mg) 
Olanzapine/fl uoxetine 
(Symbyax)
● For the acute treatment 
of depressive episodes 
associated with bipolar 
I disorder in adults
● For the acute treatment 
of treatment-resistant 
depression
Caps: olanzapine 3/fl uoxetine 25; 
olanzapine 6/fl uoxetine 25; 
olanzapine 6/fl uoxetine 50; 
olanzapine 12/fl uoxetine 25; 
olanzapine 12/fl uoxetine 50
Chlordiazepoxide/
amitriptyline 
(Limbitrol)
● For the treatment of mod-
erate to severe depression 
associated with moderate 
to severe anxiety
Tabs: chlordiazepoxide 5/ 
amitriptyline 12.5; 
chlordiazepoxide 10/
amitriptyline 25
Perphenazine/
amitriptyline 
HCl (Etrafon)
● For the treatment of 
moderate to severe anxiety 
or agitation and depressed 
mood
● For the treatment of 
patients with schizophre-
nia who have associated 
symptoms of depression
Tabs: perphenazine 2/amitriptyline 10; 
perphenazine 2/amitriptyline 25; 
perphenazine 4/amitriptyline 10; 
perphenazine 4/amitriptyline 25; 
perphenazine 4/amitriptyline 50
* These medications are presented for general information only. For detailed 
information, the reader is directed to the chapters that deal with each of the 
speciﬁ c drugs that make up these combinations. 
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Route and Dosage
OLANZAPINE/FLUOXETINE  (Symbyax) 
Depression Associated with Bipolar I Disorder and 
Treatment-resistant Depression: PO: Initial dosage: 
olanzapine 6 mg/ﬂ uoxetine 25 mg once daily in the evening. 
Dosage adjustments, if indicated, can be made according to 
efﬁ cacy and tolerability. 
CHLORDIAZEPOXIDE/AMITRIPTYLINE  (Limbitrol) 
Moderate to Severe Depression Associated with Moderate 
to Severe Anxiety: PO: Initial dose: chlordiazepoxide 10/
amitriptyline 25 given 3 or 4 times a day in divided doses. May 
increase to 6 times a day, as required. Some patients respond 
to smaller doses and can be maintained on 2 tablets daily. 
PERPHENAZINE/AMITRIPTYLINE HCL  (Etrafon) 
Anxiety/Agitation/Depression: PO: Initial dose: perphe-
nazine 2 to 4 mg/amitriptyline 10 to 50 mg, 3 or 4 times/day. 
Once a satisfactory response is achieved, reduce to smallest 
amount necessary to obtain relief. 
●  NURSING DIAGNOSES RELATED 
TO ALL ANTIDEPRESSANTS
 1. Risk for suicide related to depressed mood.
 2. Risk for injury related to side effects of sedation, lowered 
seizure threshold, orthostatic hypotension, priapism, photo-
sensitivity, arrhythmias, and hypertensive crisis.
 3. Social isolation related to depressed mood.
 4. Risk for constipation related to side effects of the medication.
●  NURSING IMPLICATIONS 
FOR ANTIDEPRESSANTS
The plan of care should include monitoring for the following 
side effects from antidepressant medications. Nursing implica-
tions are designated by an asterisk (*).
 1. May occur with all chemical classes: 
 a. Dry mouth
 *  Offer the client sugarless candy, ice, frequent sips of 
water
 *  Strict oral hygiene is very important. 
 b. Sedation
 * Request an order from the physician for the drug to be 
given at bedtime.
 *  Request that the physician decrease the dosage or per-
haps order a less sedating drug.
 *  Instruct the client not to drive or use dangerous equip-
ment while experiencing sedation. 
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 c. Nausea
 * Medication may be taken with food to minimize GI 
distress. 
 d. Discontinuation syndrome
 * All classes of antidepressants have varying potentials to 
cause discontinuation syndromes. Abrupt withdrawal 
following long-term therapy with SSRIs and SNRIs 
may result in dizziness, lethargy, headache, and nausea. 
Fluoxetine is less likely to result in withdrawal symptoms 
because of its long half-life. Abrupt withdrawal from 
tricyclics may produce hypomania, akathisia, cardiac 
arrhythmias, and panic attacks. The discontinuation 
syndrome associated with MAOIs includes confusion, 
hypomania, and worsening of depressive symptoms. All 
antidepressant medication should be tapered gradually 
to prevent withdrawal symptoms. 
 2. Most commonly occur with tricyclics and others, such as 
the SARIs, bupropion, maprotiline, and mirtazapine: 
 a. Blurred vision
 * Offer reassurance that this symptom should subside 
after a few weeks
 * Instruct the client not to drive until vision is clear.
 * Clear small items from routine pathway to prevent 
falls.
 b. Constipation
 * Order foods high in ﬁ ber; increase ﬂ uid intake if not 
contraindicated; and encourage the client to increase 
physical exercise, if possible. 
 c. Urinary retention
 * Instruct the client to report hesitancy or inability to 
urinate.
 * Monitor intake and output.
 * Try various methods to stimulate urination, such as 
running water in the bathroom or pouring water over 
the perineal area. 
 d. Orthostatic hypotension
 * Instruct the client to rise slowly from a lying or sitting 
position.
 * Monitor blood pressure (lying and standing) frequently, 
and document and report signiﬁ cant changes.
 * Instruct the client to avoid long hot showers or tub baths. 
 e. Reduction of seizure threshold
 *  Observe clients with history of seizures closely.
 *  Institute seizure precautions as speciﬁ ed in hospital pro-
cedure manual.
 * Bupropion (Wellbutrin) should be administered in 
doses of no more than 150 mg and should be given at 
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least 4 hours apart. Bupropion has been associated with 
a relatively high incidence of seizure activity in anorexic 
and cachectic clients. 
 f. Tachycardia; arrhythmias
 * Carefully monitor blood pressure and pulse rate 
and rhythm, and report any signiﬁ cant change to the 
physician. 
 g. Photosensitivity 
 * Ensure that client wears sunblock lotion, protective 
clothing, and sunglasses while outdoors. 
 h. Weight gain
 * Provide instructions for reduced-calorie diet.
 * Encourage increased level of activity, if appropriate. 
 3. Most commonly occur with SSRIs: 
 a. Insomnia; agitation
 * Administer or instruct client to take dose early in 
the day.
 * Instruct client to avoid caffeinated food and drinks.
 * Teach relaxation techniques to use before bedtime. 
 b. Headache
 * Administer analgesics, as prescribed.
 * If relief is not achieved, physician may order another 
antidepressant.
 c. Weight loss (may occur early in therapy) 
 * Ensure that client is provided with caloric intake 
sufﬁ cient to maintain desired weight.
 * Caution should be taken in prescribing these drugs for 
anorexic clients.
 * Weigh client daily or every other day, at the same time 
and on the same scale if possible. 
 * After prolonged use, some clients may gain weight on 
SSRIs.
 d. Sexual dysfunction
 * Men may report abnormal ejaculation or impotence.
 * Women may experience delay or loss of orgasm.
 * If side effect becomes intolerable, a switch to another 
antidepressant may be necessary. 
 e. Serotonin syndrome (may occur when two drugs 
that potentiate serotonergic neurotransmission are used 
concurrently [see “Interactions”]). 
 * Most frequent symptoms include changes in mental 
status, restlessness, myoclonus, hyperreﬂ exia, tachycar-
dia, labile blood pressure, diaphoresis, shivering, and 
tremors.
 * Discontinue offending agent immediately. 
 * The physician will prescribe medications to block 
serotonin receptors, relieve hyperthermia and muscle 
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rigidity, and prevent seizures. In severe cases, artiﬁ cial 
ventilation may be required. The histamine-1 receptor 
antagonist cyproheptadine is commonly used to treat 
the symptoms of serotonin syndrome.
 * Supportive nursing measures include monitoring vital 
signs, providing safety measures to prevent injury when 
muscle rigidity and changes in mental status are present, 
cooling blankets and tepid baths to assist with tem-
perature regulation, and monitoring intake and output 
(Prator, 2006).
 * The condition will usually resolve on its own once the 
offending medication has been discontinued. However, 
if the medication is not discontinued, the condition 
may progress to life-threatening complications such as 
seizures, coma, hypotension, ventricular arrhythmias, 
disseminated intravascular coagulation, rhabdomyoly-
sis, metabolic acidosis, and renal failure (Prator, 2006). 
 4. Most commonly occur with MAOIs: 
 a. Hypertensive crisis
 * Hypertensive crisis occurs if the individual consumes 
foods or other substances containing tyramine while
 receiving MAOI therapy. Foods that should be avoided 
include aged cheeses, raisins, fava beans, red wines, 
smoked and processed meats, caviar, pickled herring, 
soy sauce, monosodium glutamate (MSG), beer, choco-
late, yogurt, and bananas. Drugs that should be avoided 
include other antidepressants, sympathomimetics (in-
cluding over-the-counter cough and cold preparations), 
stimulants (including over-the-counter diet drugs), an-
tihypertensives, meperidine and other opioid narcotics, 
and antiparkinsonian agents, such as levodopa.
 * Symptoms of hypertensive crisis include severe occipi-
tal headache, palpitations, nausea and vomiting, nuchal 
rigidity, fever, sweating, marked increase in blood pres-
sure, chest pain, and coma.
 * Treatment of hypertensive crisis: Discontinue drug im-
mediately; monitor vital signs; administer short-acting 
antihypertensive medication, as ordered by physician; 
use external cooling measures to control hyperpyrexia.
 b. Application site reactions (with selegiline transdermal 
system [Emsam]) 
 * The most common reactions include rash, itching, ery-
thema, redness, irritation, swelling, or urticarial lesions. 
Most reactions resolve spontaneously, requiring no 
treatment. However, if reaction becomes problematic, 
it should be reported to the physician. Topical corticos-
teroids have been used in treatment.
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 5. Miscellaneous side effects: 
 a. Priapism (with trazodone) 
 * Priapism is a rare side effect, but it has occurred in some 
men taking trazodone.
 * If the client complains of prolonged or inappropriate 
penile erection, withhold medication dosage and notify 
the physician immediately.
 * Priapism can become very problematic, requiring sur-
gical intervention, and, if not treated successfully, can 
result in impotence.
 b. Hepatic failure (with nefazodone) 
 * Cases of life-threatening hepatic failure have been 
reported in clients treated with nefazodone.
 * Advise clients to be alert for signs or symptoms sug-
gestive of liver dysfunction (e.g., jaundice, anorexia, GI 
complaints, or malaise) and to report them to physician 
immediately.
●  CLIENT/FAMILY EDUCATION RELATED 
TO ALL ANTIDEPRESSANTS
● Continue to take the medication even though the symptoms 
have not subsided. The therapeutic effect may not be seen for 
as long as 4 weeks. If after this length of time no improvement 
is noted, the physician may prescribe a different medication.
● Use caution when driving or operating dangerous machin-
ery. Drowsiness and dizziness can occur. If these side effects 
become persistent or interfere with activities of daily living, 
the client should report them to the physician. Dosage adjust-
ment may be necessary.
● Do not stop taking the drug abruptly. To do so might pro-
duce withdrawal symptoms, such as nausea, vertigo, insomnia, 
headache, malaise, nightmares, and a return of the symptoms 
for which the medication was prescribed. 
● Use sunblock lotion and wear protective clothing when spend-
ing time outdoors. The skin may be sensitive to sunburn.
● Report occurrence of any of the following symptoms to the 
physician immediately: sore throat, fever, malaise, yellowish 
skin, unusual bleeding, easy bruising, persistent nausea and 
vomiting, severe headache, rapid heart rate, difﬁ culty urinat-
ing, anorexia or weight loss, seizure activity, stiff or sore neck, 
and chest pain.
● Rise slowly from a sitting or lying position to prevent a sudden 
drop in blood pressure.
● Take frequent sips of water, chew sugarless gum, or suck 
on hard candy if dry mouth is a problem. Good oral care 
(frequent brushing, ﬂ ossing) is very important.
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● Do not consume the following foods or medications while 
taking MAOIs: aged cheese, wine (especially Chianti), beer, 
chocolate, colas, coffee, tea, sour cream, smoked and pro-
cessed meats, chicken or beef liver, soy sauce, pickled herring, 
yogurt, raisins, caviar, broad beans, cold remedies, or diet 
pills. To do so could cause a life-threatening hypertensive 
crisis.
● Follow the correct procedure for applying the selegiline trans-
dermal patch:
● Apply to dry, intact skin on upper torso, upper thigh, or 
outer surface of upper arm.
● Apply approximately same time each day to new spot on 
skin, after removing and discarding old patch.
● Wash hands thoroughly after applying the patch.
● Avoid exposing application site to direct heat (e.g., heating 
pads, electric blankets, heat lamps, hot tub, or prolonged 
direct sunlight).
● If patch falls off, apply new patch to a new site and resume 
previous schedule.
● Avoid smoking while receiving tricyclic therapy. Smoking 
increases the metabolism of tricyclics, requiring an adjust-
ment in dosage to achieve the therapeutic effect.
● Do not drink alcohol while taking antidepressant therapy. 
These drugs potentiate the effects of each other.
● Do not consume other medications (including over-
the-counter medications) without the physician’s approval 
while receiving antidepressant therapy. Many medications 
contain substances that, in combination with antidepressant 
medication, could precipitate a life-threatening hyperten-
sive crisis.
● Notify physician immediately if inappropriate or prolonged 
penile erections occur while taking trazodone. If the erection 
persists longer than 1 hour, seek emergency department treat-
ment. This condition is rare but has occurred in some men 
who have taken trazodone. If measures are not instituted im-
mediately, impotence can result.
● Do not “double up” on medication if a dose of bupropion 
(Wellbutrin) is missed, unless advised to do so by the physi-
cian. Taking bupropion in divided doses will decrease the risk 
of seizures and other adverse effects.
● Be aware of possible risks of taking antidepressants during 
pregnancy. Safe use during pregnancy and lactation has not 
been fully established. These drugs are believed to readily 
cross the placental barrier; if so, the fetus could experience 
adverse effects of the drug. Inform the physician immediately 
if pregnancy occurs, is suspected, or is planned.
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● Be aware of the side effects of antidepressants. Refer to 
written materials furnished by health care providers for safe 
self-administration.
● Carry a card or other identiﬁ cation at all times describing the 
medications being taken.
 INTERNET REFERENCES 
 a. http://www.mentalhealth.com/
 b. http://www.nimh.nih.gov/publicat/medicate.cfm
 c. http://www.fadavis.com/townsend 
 d. http://www.nlm.nih.gov/medlineplus/druginformation
.html 
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Generic 
(Trade) 
Name
Pregnancy 
Category/
Half-life 
(hrs) Indications
Therapeutic 
Plasma Level 
Range mEq/L
Available 
Forms (mg) 
Lithium 
carbonate 
(Eskalith; 
Lithobid)
Lithium citrate
D/20–27 ● Manic episodes 
associated with 
bipolar disorder
● Maintenance therapy 
to prevent or diminish 
intensity of subse-
quent manic episodes
Unlabeled uses:
● Borderline personality 
disorder
● Neutropenia
● Cluster headaches 
(prophylaxis)
● Alcohol dependence
● Bulimia
● Postpartum affective 
psychosis
● Corticosteroid-
induced psychosis
Acute mania: 
1.0–1.5 
Maintenance: 
0.6–1.2  
Caps: 150, 300, 
600 
Tabs: 300 
Tabs (ER): 300, 
450 
Syrup: 8 mEq 
(as citrate 
equivalent 
to 300 mg 
lithium 
carbonate)/
5 mL
● CHEMICAL CLASS: ANTIMANIC
Examples
Action
● Not fully understood, but lithium may have an inﬂ uence 
on the reuptake of norepinephrine and serotonin. Effects on 
other neurotransmitters have also been noted. Lithium also 
alters sodium transport in nerve and muscle cells.
Contraindications and Precautions: 
Contraindicated in: • Hypersensitivity • Severe cardio-
vascular or renal disease • Dehydrated or debilitated patients 
• Sodium depletion • Pregnancy and lactation
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Use Cautiously in: • Elderly patients • Any degree of cardiac, 
renal, or thyroid disease • Diabetes mellitus • Urinary retention 
• Children younger than 12 years (safety not established) 
Adverse Reactions and Side Effects
● Drowsiness, dizziness, headache 
● Seizures 
● Dry mouth, thirst 
● Indigestion, nausea, anorexia 
● Fine hand tremors
● Hypotension, arrhythmias, electrocardiogram (ECG) changes 
● Polyuria, glycosuria
● Weight gain
● Hypothyroidism
● Dehydration
● Leukocytosis
Interactions
● The effects of lithium (and potential for toxicity) are increased 
with concurrent use of carbamazepine, fl uoxetine, halo-
peridol, loop diuretics, methyldopa, nonsteroidal anti-
infl ammatory drugs (NSAIDs), and thiazide diuretics.
● The effects of lithium are decreased with concurrent use of 
acetazolamide, osmotic diuretics, theophylline, and uri-
nary alkalinizers.
● Increased effects of neuromuscular blocking agents and 
tricyclic antidepressants are seen with concurrent use of 
lithium.
● Decreased pressor sensitivity of sympathomimetics with 
lithium
● Neurotoxicity may occur with concurrent use of lithium and 
high-potency antipsychotics or calcium channel blockers. 
Route and Dosage 
Acute Mania: PO: 600 mg three times a day or 900 mg twice 
daily for the slow release form. Serum levels should be taken 
twice weekly at the initiation of therapy and until therapeutic 
level has been achieved.
Long-Term (Maintenance) Use: PO: 300 mg three to four 
times a day. Serum levels should be monitored in uncomplicated 
cases during maintenance therapy every 1 to 2 months. 
Borderline Personality Disorder: PO: 900 to 2400 mg/day 
in 3 to 4 divided doses (or 900 to 1800 mg/day [ER tabs] in 
2 divided doses). Titrate dosage to maintain serum levels of 
0.8 to 1 mEq/L. 
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Action
● Action in the treatment of bipolar disorder is unclear. 
Contraindications and Precautions 
Carbamazepine
● Contraindicated in hypersensitivity, with monoamine oxidase 
inhibitors (MAOIs), lactation, history of previous bone mar-
row depression.
● Use cautiously in elderly, liver/renal/cardiac disease, pregnancy. 
Clonazepam
● Contraindicated in hypersensitivity, acute narrow-angle 
glaucoma, liver disease, lactation.
● Use cautiously in elderly, liver/renal disease, pregnancy. 
Valproic Acid
● Contraindicated in hypersensitivity, liver disease.
● Use cautiously in elderly, renal/cardiac diseases, pregnancy, 
lactation. 
Lamotrigine
● Contraindicated in hypersensitivity.
● Use cautiously in renal/hepatic/cardiac insufﬁ ciency, preg-
nancy, lactation. 
Gabapentin
● Contraindicated in hypersensitivity, children <3 years of age.
● Use cautiously in renal insufﬁ ciency, pregnancy, lactation, 
children, elderly. 
Topiramate
● Contraindicated in hypersensitivity.
● Use cautiously in renal and hepatic impairment, pregnancy, 
lactation, children, elderly. 
Oxcarbazepine
● Contraindicated in hypersensitivity (cross-sensitivity with 
carbamazepine may occur), lactation.
● Use cautiously in renal impairment, pregnancy, children 
<4 years old. 
Adverse Reactions and Side Effects
Carbamazepine
● Drowsiness, ataxia
● Nausea, vomiting
● Blood dyscrasias
Clonazepam
● Drowsiness, ataxia
● Dependence, tolerance
● Blood dyscrasias
2506_Ch27_447-471.indd   0451 10/1/10   9:39:41 AM
452 ● PSYCHOTROPIC MEDICATIONS 
Valproic Acid
● Drowsiness, dizziness
● Nausea, vomiting
● Prolonged bleeding time
● Tremor
Gabapentin
● Drowsiness, dizziness, ataxia
● Nystagmus
● Tremor
Lamotrigine
● Ataxia, dizziness, headache
● Nausea, vomiting
● Risk of severe rash
● Photosensitivity
Topiramate
● Drowsiness, dizziness, fatigue, ataxia
● Impaired concentration, nervousness
● Vision changes
● Nausea, weight loss
● Decreased efﬁ cacy with oral contraceptives
Oxcarbazepine
 ● Dizziness, drowsiness
● Headache
● Nausea and vomiting
● Abnormal vision, diplopia, nystagmus
● Ataxia
● Tremor
Interactions
The effects 
of:
Are increased 
by:
Are decreased 
by:
Concurrent use may 
result in:
Carbamazepine Verapamil, 
diltiazem, 
propoxyphene, 
erythromycin, 
clarithromycin, 
SSRIs, tricyclic 
antidepressants, 
cimetidine, 
isoniazid, danazol, 
lamotrigine, 
niacin, 
acetazolamide, 
dalfopristin, 
valproate, 
nefazodone
Cisplatin, 
doxorubicin, 
felbamate, 
rifampin, 
barbiturates, 
hydantoins, 
primidone, 
theophylline
Decreased levels of 
corticosteroids, 
doxycycline, felbamate, 
quinidine, warfarin, 
estrogen-containing 
contraceptives, cyclo-
sporine, benzodiazepines, 
theophylline, lamotrigine, 
valproic acid, bupropion, 
haloperidol, olanzapine, 
tiagabine, topiramate, 
voriconazole, ziprasidone. 
felbamate, levothyroxine, 
antidepressants Increased 
levels of lithium Life-
threatening hypertensive 
reaction with MAOIs
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The effects 
of:
Are increased 
by:
Are decreased 
by:
Concurrent use may 
result in:
Clonazepam CNS depressants, 
cimetidine, hormonal 
contraceptives, 
disulfi ram, fl uoxetine, 
isoniazid, ketocon-
azole, metoprolol, 
propoxyphene, 
propranol, valproic 
acid, probenecid
Rifampin, 
theophylline 
(↓ sedative 
effects), 
phenytoin
Increased phenytoin 
levels; decreased effi cacy 
of levodopa
Valproic acid Chlorpromazine, 
cimetidine, 
erythromycin, 
felbamate, 
salicylates
Rifampin, 
carbamazepine, 
cholestyramine, 
lamotrigine, 
phenobarbital, 
ethosuximide, 
hydantoins
Increased effects of 
tricyclic antidepres-
sants, carbamazepine, 
CNS depressants, 
ethosuximide, 
lamotrigine, 
phenobarbital, 
hydantoins, warfarin, 
zidovudine, hydantoins
Gabapentin Cimetidine, 
hydrocodone, 
morphine, naproxin
Antacids Decreased effects of 
hydrocodone
Lamotrigine Valproic acid Primidone, 
phenobarbital, 
phenytoin, 
rifamycin, suc-
cinimides, oral 
contraceptives, 
oxcarbazepine, 
carbamazepine, 
acetaminophen
Decreased levels of 
valproic acid; 
Increased levels of 
carbamazepine and 
topiramate
Topiramate Metformin; 
hydrochlorothiazide
Phenytoin, 
carbamazepine, 
valproic acid, 
lamotrigine
Increased risk of CNS 
depression with 
alcohol or other CNS 
depressants.Increased 
risk of kidney stones with 
carbonic anhydrase 
inhibitors. Increased 
effects of phenytoin, 
metformin, amitripty-
line. Decreased effects 
of oral contraceptives, 
digoxin, lithium, 
riseridone, and 
valproic acid.
Oxcarbazepine Carbamazepine, 
phenobarbital, 
phenytoin, 
valproic acid, 
verapamil
Increased concentrations 
of phenobarbital and 
phenytoin; decreased 
effects of oral 
contraceptives, 
felodipine, and 
lamotrigine
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Route and Dosage 
CARBAMAZEPINE  (Tegretol) 
Seizure Disorders: Adults and children > 12 years: PO: Initial 
dosage: Either 200 mg 2 times a day for tablets and extended-
release (ER) tablets/capsules, or 5 mL (100 mg) 4 times a day 
for suspension. Increase by 200 mg/day every 7 days until 
therapeutic levels are achieved. Maximum dose: 1000 mg/day 
in children 12 to 15 years; 1200 mg/day in patients >15 years. 
Children 6 to 12 years: PO: 100 mg 2 times a day (50 mg 4 times 
a day of suspension). Increase by 100 mg weekly until thera-
peutic levels are obtained. (Usual range: 400 to 800 mg/day.) 
Maximum daily dose: 1000 mg.
Children <6 years: PO: 10 to 20 mg/kg/day in 2 to 3 divided doses. 
May increase weekly to achieve optimal clinical response admin-
istered 3 or 4 times a day. Maximum daily dose: 35 mg/kg/day. 
Trigeminal Neuralgia: PO: Initial dose 100 mg 2 times a day. 
May increase by up to 200 mg/day using 100 mg increments 
every 12 hours. Maximum daily dose: 1200 mg. 
Bipolar Disorder, Mania: (Equetro only) PO: Initial dose: 
200 mg 2 times a day. Dosage may be adjusted in 200 mg daily 
increments to achieve optimal clinical response. Doses higher 
than 1600 mg/day have not been studied. 
Borderline Personality Disorder: PO: 400 mg/day in 
2 divided doses. May increase dose in increments of 200 mg/day 
depending on response, tolerability, and plasma concentrations. 
Maximum dosage: 1600 mg/day. 
Management of Alcohol Withdrawal: PO: Dosage on day 
1: 600 to 1200 mg. Dosage is then tapered over 5 to 10 days 
to 0 mg. 
Restless Leg Syndrome: PO: 100 to 600 mg daily for up to 
5 weeks. 
Postherpetic Neuralgia: PO: 100 to 200 mg/day, slowly 
increased to a maximum of 1200 mg/day. 
CLONAZEPAM  (Klonopin) 
Seizures: Adults: PO: 0.5 mg 3 times a day; may increase by 
0.5 to 1 mg every third day. Maximum daily dose 20 mg. 
Children <10 years or 30 kg: PO: Initial daily dose 0.01 to 
0.03 mg/kg/day (not to exceed 0.05 mg/kg/day) given in 2 to 
3 divided doses; increase by no more than 0.25 to 0.5 mg every 
third day until a daily maintenance dose of 0.1 to 0.2 mg/kg 
has been reached, unless seizures are controlled or side effects 
preclude further increase. 
Panic Disorder: PO: Initial dose: 0.25 mg 2 times a day. 
Increase after 3 days toward target dose of 1 mg/day. Some 
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patients may require up to 4 mg/day, in which case the dose 
may be increased in increments of 0.125 to 0.25 mg twice daily 
every 3 days until symptoms are controlled. 
Bipolar Disorder, Mania: PO: 1 to 6 mg/day. 
Restless Leg Syndrome: PO: 0.5 to 2 mg/night. 
Neuralgias: PO: 1.5 to 4 mg/day. 
VALPROIC ACID  (Depakene; Depakote) 
Epilepsy: PO: Adults and children ≥10 years old: Initial dose: 
5 to 15 mg/kg/day. Increase by 5 to 10 mg/kg/week until 
therapeutic levels are reached. Maximum recommended 
dosage: 60 mg/kg/day. When daily dosage exceeds 250 mg, 
give in 2 divided doses. 
Manic Episodes: PO (Stavzor only): Initial dose: 750 mg/day 
in divided doses. Titrate rapidly to desired clinical effect 
or trough plasma levels of 50 to 125 mcg/mL. Maximum 
recommended dose: 60/mg/kg/day. 
Migraine Prophylaxis: PO (Stavzor only): 250 mg twice daily. 
Some patients may require up to 1000 mg/day. No evidence 
that higher doses lead to greater efﬁ cacy. 
Borderline Personality Disorder: PO: 750 mg/day in divided 
doses. Titrate to maintain a therapeutic plasma level of 50 to 
100 mcg/mL. 
LAMOTRIGINE  (Lamictal) 
Epilepsy Adults and children >12 years: Adjunctive therapy 
with carbamazepine, phenobarbital, phenytoin, or primidone: 
PO: 50 mg as a single daily dose for 2 weeks, then 50 mg 
twice daily for next 2 weeks; then increase by 100 mg/day 
on a weekly basis to maintenance dose of 300 to 500 mg/day 
in 2 doses. If valproic acid is also being taken, the initial dose 
should be 25 mg every other day for 2 weeks, then 25 mg 
once daily for next 2 weeks; then increase by 25 to 50 mg/day 
every 1 to 2 weeks to maintenance dose of 50 to 200 mg twice 
a day. 
Children 2 to 12 years: Refer to manufacturer’s dosing recom-
mendations. 
Bipolar Disorder: Escalation regimen: For patients not taking 
carbamazepine, valproic acid, or other enzyme-inducing drugs: 
PO: Weeks 1 and 2: 25 mg/day; weeks 3 and 4: 50 mg/day; 
week 5: 100 mg/day; then 200 mg/day. 
For patients taking valproic acid: PO: Weeks 1 and 2: 25 mg every 
other day; weeks 3 and 4: 25 mg/day; week 5: 50 mg/day; then 
100 mg/day. 
For patients taking carbamazepine or other enzyme-inducing drugs, 
but not valproic acid: PO: Weeks 1 and 2: 50 mg/day; weeks 3 
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and 4: 100 mg/day in divided doses; week 5: 200 mg/day in 
divided doses; week 6: 300 mg/day in divided doses; then up 
to 400 mg/day in divided doses. 
GABAPENTIN  (Neurontin) 
Epilepsy: Adults and children >12 years: PO: Initial dose: 300 mg 
3 times a day. Titration may be continued until desired results 
have been achieved (range is 900 to 1800 mg/day in 3 divided 
doses). Doses should not be more than 12 hours apart. Doses 
of 2400 to 3600 mg have been well tolerated.
Children 5 to 12 years: PO: Initial dose: 10 to 15 mg/kg/day in 
3 divided doses. Titrate dosage over a period of 3 days to 
25 to 35 mg/kg/day in 3 divided doses. Dosage interval should 
not exceed 12 hours. Dosages up to 50 mg/kg/day have been 
used.
Children 3 to 4 years: PO: Initial dose: 10 to 15 mg/kg/day in 
3 divided doses. Titrate dosage over a period of 3 days to 
40 mg/kg/day in 3 divided doses. Dosage interval should 
not exceed 12 hours. Dosages up to 50 mg/kg/day have been 
used. 
Bipolar Disorder: PO: 900 to 2400 mg/day in 2 or 3 divided 
doses. 
Postherpetic Neuralgia: PO: Adults: 300 mg once daily on 
ﬁ rst day; 300 mg twice daily on second day; then 300 mg three 
times a day on day 3. May then be titrated upward as needed 
up to 600 mg three times a day. 
Migraine Prophylaxis: PO: Adults: 1200 to 2400 mg/day. 
Tremors in Multiple Sclerosis: PO: 1200 to 1800 mg/day. 
TOPIRAMATE  (Topamax) 
Epilepsy: Adults and children ≥17 years (adjunctive therapy): 
PO: Initial dose: 25 to 50 mg/day. Gradually increase by 25 to 
50 mg weekly up to 200 to 400 mg/day in 2 divided doses 
(200 to 400 mg/day in 2 divided doses for partial seizures and 
400 mg/day in 2 divided doses for primary generalized tonic/
clonic seizures). 
Children 2 to 17 years (adjunctive therapy): PO: 5 to 9 mg/kg/day 
in 2 divided doses; initiate with 25 mg (or less, based on 1 to 
3 mg/kg) nightly for 7 days, then increase at 1- to 2-week 
intervals in increments of 1 to 3 mg/kg/day in 2 divided doses. 
Titration should be based on clinical outcome. 
Adults and children ≥10 years (monotherapy): PO: 50 mg/day ini-
tially in 2 divided doses. Gradually increase over 6 weeks to 
400 mg/day in 2 divided doses. 
Migraine Prophylaxis: PO: Target dose of 100 mg/day in 
2 divided doses, titrated weekly according to the following 
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schedule: Week 1: 25 mg in the evening; Week 2: 25 mg in 
the morning and 25 mg in the evening; Week 3: 25 mg in 
the morning and 50 mg in the evening; Week 4: 50 mg in the 
morning and 50 mg in the evening. 
Bipolar Disorder: PO: Initial dose: 25 to 50 mg/day. Increase to 
target range of 100 to 200 mg/day in divided doses. Maximum 
dosage: 400 mg/day. 
OXCARBAZEPINE  (Trileptal) 
Epilepsy: PO: Adults: (adjunctive therapy): 300 mg twice daily, 
may be increased by up to 600 mg/day at weekly intervals 
up to 1200 mg/day (up to 2400 mg/day may be needed). 
Conversion to monotherapy: 300 mg twice daily; may be 
increased by 600 mg/day at weekly intervals, whereas other 
antiepileptic drugs are tapered over 3 to 6 weeks; dose of 
oxcarbazepine should be increased up to 2400 mg/day over 
a period of 2 to 4 weeks. Initiation of monotherapy: 300 mg 
twice daily, increase by 300 mg/day every third day, up 
to 1200 mg/day. Maximum maintenance dose should be 
achieved over 2 to 4 weeks. 
Children 2 to 16 years: (adjunctive therapy): 4 to 5 mg/kg twice 
daily (up to 600 mg/day), increased over 2 weeks to achieve 
900 mg/day in patients 20 to 29 kg, 1200 mg/day in patients 
29.1 to 39 kg, and 1800 mg/day in patients >39 kg (range 
6 to 51 mg/kg/day). In patients <20 kg, initial dose of 16 to 
20 mg/kg/day may be used, not to exceed 60 mg/kg/day. 
Conversion to monotherapy: 8 to 10 mg/kg/day given twice 
daily; may be increased by 10 mg/kg/day at weekly inter-
vals, whereas other antiepileptic drugs are tapered over 
3 to 6 weeks; dose of oxcarbazepine should be increased up 
to 600 to 900 mg/day in patient ≤20 kg, 900 to 1200 mg/
day in patients 25 to 30 kg, 900 to 1500 mg/day in patients 
35 to 40 kg, 1200 to 1500 mg/day in patients 45 kg, 1200 to 
1800 mg/day in patients 50 to 55 kg, 1200 to 2100 mg/day 
in patients 60 to 65 kg, and 1500 to 2100 mg/day in patients 
70 kg. Maximum maintenance dose should be achieved over 
2 to 4 weeks. 
Alcohol Withdrawal: PO: 600 to 1800 mg in divided doses 
for 6 weeks to 6 months. 
Bipolar Disorder: PO: Adults: Initial dose: 300 mg/day. Titrate 
to a maximum dose of 900 to 2400 mg/day. 
Diabetic Neuropathy: PO: Initial dose: 150 to 300 mg/
day. Titrate to recommended dose of 900 to 1200 mg/day. 
Maximum dose: 1800 mg/day. 
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●  CHEMICAL CLASS: CALCIUM CHANNEL 
BLOCKERS
Examples
Generic 
(Trade) 
Name
Pregnancy 
Categories/
Half-life (hr) Indications
Therapeutic 
Plasma Level 
Range 
Available 
Forms (mg) 
Verapamil 
(Calan; 
Isoptin)
C/3–7 (initially) 
4.5–12 
(repeated 
dosing) 
~12 (SR) 
2–5 (IV)
● Angina
● Arrhythmias
● Hypertension
Unlabeled uses:
● Bipolar mania
● Migraine headache 
prophylaxis
80–300 ng/ml Tabs: 40, 80, 120
Tabs (XR; SR): 
120, 180, 240
Caps XR: 100, 
120, 180, 200, 
240, 300, 360
Injection: 2.5/mL
Action
● Action in the treatment of bipolar disorder is unclear. 
Contraindications and Precautions 
Contraindicated in: • Hypersensitivity • Severe left ventric-
ular dysfunction • Heart block • Hypotension • Cardiogenic 
shock • Congestive heart failure • Patients with atrial ﬂ utter or 
atrial ﬁ brillation and an accessory bypass tract
Use Cautiously in: • Liver or renal disease • Cardiomyopa-
thy • Intracranial pressure • Elderly patients • Pregnancy and 
lactation (safety not established) 
Adverse Reactions and Side Effects
● Drowsiness 
● Dizziness
● Headache 
● Hypotension 
● Bradycardia 
● Nausea 
● Constipation
Interactions
● Effects of verapamil are increased with concomitant use of 
amiodarone, beta-blockers, cimetidine, ranitidine, and 
grapefruit juice. 
● Effects of verapamil are decreased with concomitant use of 
barbiturates, calcium salts, hydantoins, rifampin, and 
antineoplastics.
● Effects of the following drugs are increased with concomi-
tant use of verapamil: beta-blockers, disopyramide, fl e-
cainide, doxorubicin, benzodiazepines, buspirone, car-
bamazepine, digoxin, dofetilide, ethanol, imipramine, 
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nondepolarizing muscle relaxants, prazosin, quinidine, siro-
limus, tacrolimus, theophylline, and HMG-CoA reductase 
inhibitors.
● Serum lithium levels may be altered when administered 
concurrently with verapamil. 
Route and Dosage 
Angina: PO: 80 to 120 mg 3 times a day. 
Arrhythmias: PO: 240 to 320 mg/day in 3 or 4 divided doses
Hypertension: PO: 40 to 80 mg 3 times a day. Maximum 
recommended daily dose: 360 mg. 
Bipolar Mania: PO: 80 to 320 mg/day in divided doses. 
Migraine Prophylaxis: PO: 160 to 320 mg/day in 3 to
4 divided doses. 
● CHEMICAL CLASS: ANTIPSYCHOTICS
Examples
Continued
Generic
(Trade) 
Name
Pregnancy 
Categories/
Half-life (hr) Indications
Available 
Forms (mg)
Olanzapine 
(Zyprexa)
C/21–54 ● Schizophrenia
● Bipolar disorder
● Agitation associated 
with schizophrenia 
and mania (IM)
Tabs: 2.5, 5, 7.5, 10, 15, 20
Tabs (Orally disintegrating): 
5, 10, 15, 20
Powder for injection: 
10 mg/vial
Olanzapine and 
fl uoxetine 
(Symbyax)1
● For the treatment of 
depressive episodes 
associated with 
bipolar disorder
● Treatment-
resistant depression
Caps: 3 olanzapine/25 fl uoxetine; 
6 olanzapine/25 fl uoxetine; 
6 olanzapine/50 fl uoxetine;
12 olanzapine/25 fl uoxetine;
12 olanzapine/50 fl uoxetine
Aripiprazole 
(Abilify)
C/75–94 
(including 
metabolite)
● Bipolar mania
● Schizophrenia
● Major depressive 
disorder (adjunctive 
treatment)
Tabs: 2, 5, 10, 15, 20, 30
Tabs (orally disintegrating): 
10, 15
Oral solution: 1/mL
Injection: 7.5/mL 
Chlorpromazine C/24 ● Bipolar mania
● Schizophrenia
● Emesis/hiccoughs
● Acute intermittent 
porphyria
● Hyperexcitable, 
combative behavior in 
children
● Preoperative 
apprehension
Unlabeled uses:
● Migraine headaches
Tabs: 10, 25, 50, 100, 200
Injection: 25/mL
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Action
● Efﬁ cacy in schizophrenia is achieved through a combination 
of dopamine and serotonin type 2 (5-HT2) antagonism.
● Mechanism of action in the treatment of acute manic episodes 
is unknown. 
Contraindications and Precautions 
Olanzapine 
● Contraindicated in hypersensitivity; lactation. Orally disin-
tegrating tablets only: Phenylketonuria (orally disintegrating 
tablets contain aspartame).
● Use cautiously in hepatic insufﬁ ciency, elderly clients (reduce 
dosage), pregnancy and children (safety not established), car-
diovascular or cerebrovascular disease, history of glaucoma, 
history of seizures, history of attempted suicide, prostatic hy-
pertrophy, diabetes or risk factors for diabetes, narrow-angle 
glaucoma, history of paralytic ileus; patients with preexisting 
low white blood cell count and/or history of drug-induced leu-
kopenia/neutropenia; elderly patients with dementia-related 
psychosis (black box warning). 
Generic
(Trade) 
Name
Pregnancy 
Categories/
Half-life (hr) Indications
Available 
Forms (mg)
Quetiapine 
(Seroquel
C/6 ● Schizophrenia
● Acute manic 
episodes
Tabs: 25, 50, 100, 200, 300, 400 
Tabs (XR): 200, 300, 400
Risperidone 
(Risperdal)
C/3–21 
(including 
metabolite)
● Bipolar mania
● Schizophrenia
● Behavioral problems 
associated with 
autism 
Unlabeled uses:
● Severe behavioral 
problems in children
● Obsessive-compulsive 
disorder
Tabs: 0.25, 0.5, 1, 2, 3, 4 
Tabs (orally disintegrating): 
0.5, 1, 2, 3, 4 
Oral solution: 1/mL 
Powder for injection: 
12.5/vial, 25/vial, 37.5/vial, 
50/vial
Ziprasidone 
(Geodon)
C/7 (oral); 
2–5 (IM)
● Bipolar mania
● Schizophrenia
● Acute agitation in 
schizophrenia (IM)
Caps: 20, 40, 60, 80 
Powder for injection: 20/vial
Asenapine 
(Saphris)
C/24 ● Schizophrenia 
● Bipolar disorder
Tabs (Sublingual): 5, 10
1 For information related to action, contraindications/precautions, adverse reac-
tions and side effects, and interactions, refer to the monographs for olanzapine 
(see Chapters 27 and 28) and ﬂ uoxetine (see Chapter 26).
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Aripiprazole 
● Contraindicated in hypersensitivity; lactation.
● Use cautiously in cardiovascular or cerebrovascular dis-
ease; conditions that cause hypotension (dehydration, treat-
ment with antihypertensives or diuretics); elderly patients; 
pregnancy, children, and adolescents (safety not established); 
elderly patients with dementia-related psychosis (black box 
warning). 
Chlorpromazine 
● Contraindicated in hypersensitivity (cross-sensitivity with 
other phenothiazines may occur); narrow-angle glaucoma; 
bone marrow depression; severe liver or cardiovascular dis-
ease; concurrent pimozide use.
● Use cautiously in elderly and debilitated patients; children 
with acute illnesses, infections, gastroenteritis, or dehydration 
(increased risk of extrapyramidal reactions); diabetes; respi-
ratory disease; prostatic hypertrophy; central nervous system 
(CNS) tumors; epilepsy; intestinal obstruction; pregnancy or 
lactation (safety not established); elderly patients with dementia-
related psychosis (black box warning). 
Quetiapine 
● Contraindicated in hypersensitivity; lactation.
● Use cautiously in cardiovascular or cerebrovascular disease; 
dehydration or hypovolemia (increased risk of hypotension); 
elderly patients; hepatic impairment; hypothyroidism; his-
tory of suicide attempt; pregnancy or children (safety not estab-
lished); elderly patients with dementia-related psychosis (black 
box warning). 
Risperidone 
● Contraindicated in hypersensitivity; lactation.
● Use cautiously in elderly or debilitated patients; renal or 
hepatic impairment; cardiovascular disease; history of sei-
zures; history of suicide attempt or drug abuse; diabetes or 
risk factors for diabetes; pregnancy or children (safety not 
established); elderly patients with dementia-related psychosis 
(black box warning). 
Ziprasidone 
● Contraindicated in hypersensitivity; history of QT prolon-
gation, arrhythmias, recent myocardial infarction (MI), or 
uncompensated heart failure; concurrent use of other drugs 
known to prolong QT interval; hypokalemia or hypomagne-
semia; lactation.
● Use cautiously in concurrent diuretic therapy or diarrhea 
(may increase the risk of hypotension, hypokalemia, or hypo-
magnesemia); hepatic impairment; cardiovascular or cerebro-
vascular disease; hypotension, concurrent antihypertensive 
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therapy, dehydration, or hypovolemia (may increase risk of 
orthostatic hypotension); elderly patients; patients at risk for 
aspiration pneumonia; history of suicide attempt; pregnancy 
and children (safety not established); patients with preexisting 
low white blood cell count and/or history of drug-induced 
leukopenia/neutropenia; elderly patients with dementia-
related psychosis (black box warning). 
Asenapine
● Contraindicated in hypersensitivity; lactation; history of QT 
prolongation or arrhythmias; concurrent use of other drugs 
known to prolong QT interval.  
● Use cautiously in patients with hepatic, renal, or cardio-
vascular insufﬁ ciency; diabetes or risk factors for diabetes; 
patients with preexisting low white blood cell count and/or 
history of drug-induced leukopenia/neutropenia; history of 
seizures; history of suicide attempt; patients at risk for aspi-
ration pneumonia; elderly patients; pregnancy and children 
(safety not established); elderly patients with dementia-related 
psychosis (black box warning). 
Adverse Reactions and Side Effects
Olanzapine
● Drowsiness, dizziness, weakness
● Dry mouth, constipation, increased appetite
● Nausea
● Weight gain or loss
● Orthostatic hypotension, tachycardia
● Restlessness
● Rhinitis
● Tremor
● Headache
Aripiprazole
● Drowsiness, lightheadedness
● Headache
● Insomnia, restlessness
● Constipation
● Nausea
● Weight gain
Chlorpromazine
● Sedation
● Blurred vision
● Hypotension
● Constipation
● Dry mouth
● Photosensitivity
● Extrapyramidal symptoms
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● Weight gain
● Urinary retention
Quetiapine
● Drowsiness, dizziness
● Hypotension, tachycardia
● Headache
● Constipation
● Dry mouth
● Nausea
● Weight gain
Risperidone
● Agitation, anxiety
● Drowsiness, dizziness
● Extrapyramidal symptoms
● Headache
● Insomnia
● Constipation
● Nausea/vomiting
● Weight gain
● Rhinitis
● Sexual dysfunction
● Diarrhea
● Dry mouth
Ziprasidone
● Drowsiness, dizziness
● Restlessness
● Headache
● Constipation
● Diarrhea
● Dry mouth
● Nausea
● Weight gain
● Prolonged QT interval
Asenapine
● Constipation
● Dry mouth
● Nausea and vomiting
● Weight gain
● Restlessness
● Extrapyramidal symptoms
● Drowsiness, dizziness
● Insomnia
● Headache 
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The effects of: Are increased by: Are decreased by:
Concurrent use may 
result in: 
Olanzapine Fluvoxamine and other 
CYP-1A2 inhibitors, 
fl uoxetine
Carbamazepine and 
other CYP-1A2 
inducers, 
omeprazole, 
rifampin
Decreased effects of 
levodopa and dopamine 
agonists. Increased 
hypotension with 
antihypertensives. 
Increased CNS depression 
with alcohol or other CNS 
depressants.
Aripiprazole Ketoconazole and 
other CYP-3A4 
inhibitors; quinidine, 
fl uoxetine, par-
oxetine, or other 
potential CYP-2D6 
inhibitors
Carbamazepine, 
famotidine, 
valproate
Increased CNS depression 
with alcohol or other CNS 
depressants. Increased 
hypotension with 
antihypertensives. 
Chlorproma-
zine
Beta-blockers, 
paroxetine
Centrally acting 
anticholinergics
Increased effects of 
beta-blockers; excessive 
sedation and hypoten-
sion with meperidine; 
decreased hypotensive 
effect of guanethidine; 
decreased effect of 
oral anticoagulants; 
decreased or increased 
phenytoin levels; 
increased orthostatic 
hypotension with thiazide 
diuretics; Increased CNS 
depression with alcohol 
or other CNS depressants. 
Increased hypotension 
with antihypertensives. 
Increased anticholinergic 
effects with anticholiner-
gic agents.
Quetiapine Cimetidine; keto-
conazole, itracon-
azole, fl uconazole, 
erythromycin, or 
other CYP-3A4 
inhibitors
Phenytoin, 
thioridazine 
Decreased effects of 
levodopa and dopamine 
agonists. Increased 
CNS depression with 
alcohol or other CNS 
depressants. Increased 
hypotension with 
antihypertensives.
Risperidone Clozapine, fl uoxetine, 
paroxetine, or 
ritonavir
Carbamazepine Decreased effects of 
levodopa and dopamine 
agonists. Increased 
effects of clozapine and 
valproate. Increased CNS 
depression with alcohol 
or other CNS depressants. 
Increased hypotension 
with antihypertensives. 
Interactions
2506_Ch27_447-471.indd   0464 10/1/10   9:39:47 AM
Mood-Stabilizing Drugs ● 465
Route and Dosage 
OLANZAPINE  (Zyprexa) 
Bipolar Disorder: Adults: PO: 10 to 15 mg/day initially; 
may increase every 24 hours by 5 mg/day (not to exceed 
20 mg/day). 
Schizophrenia: Adults: PO: 5 to 10 mg/day initially; may increase 
at weekly intervals by 5 mg/day (not to exceed 20 mg/day). 
Agitation Associated with Schizophrenia or Mania: Adults: 
IM: 2.5 to 10 mg, administered slowly, deep into muscle mass. 
May repeat in 2 hours and again 4 hours later, if needed. 
The effects of: Are increased by: Are decreased by:
Concurrent use may 
result in: 
Ziprasidone Ketoconazole and 
other CYP-3A4 
inhibitors
Carbamazepine Life-threatening prolonga-
tion of QT interval with 
quinidine, dofetilide, 
other class Ia and III 
antiarrhythmics, pimozide, 
sotalol, thioridazine, 
chlorpromazine, fl oquine, 
pentamidine, arsenic 
trioxide, mefl oquine, 
dolasetron, tacrolimus, 
droperidol, gatifl oxacin, 
or moxifl oxacin. De-
creased effects of 
levodopa and dopamine 
agonists. Increased 
CNS depression with 
alcohol or other CNS 
depressants. Increased 
hypotension with 
antihypertensives. 
Asenapine Fluvoxamine, imipra-
mine, valproate
Carbamazepine, 
cimetidine, 
paroxetine
Increased effects of 
paroxetine and dextro-
methorphan; Increased 
CNS depression with 
alcohol or other CNS 
depressants. Increased 
hypotension with antihy-
pertensives; Additive 
effects on QT interval 
prolongation with 
quinidine, dofetilide, 
other Class Ia and III 
antiarrhythmics, pimo-
zide, sotalol, thioridazine, 
chlorpromazine, fl oquine, 
pentamadine, arsenic 
trioxide, mefl oquine, 
dolasetron, tacrolimus, 
droperidol, gatifl oxacin, 
or moxifl oxacin.
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OLANZAPINE AND FLUOXETINE  (Symbyax) 
Depressive Episodes Associated with Bipolar Disorder: 
Adults: PO: Initial dosage: 6/25 given once daily in the 
evening. Adjust dosage according to efﬁ cacy and tolerability 
to within a range of 6 to 12 olanzapine/25 to 50 ﬂ uoxetine. 
ARIPIPRAZOLE  (Abilify) 
Bipolar Mania: Adults: PO: Usual starting dose: 15 mg/day. 
Dosage may be increased to 30 mg/day based on clinical 
response. The safety of dosages higher than 30 mg have not 
been evaluated. 
Major Depressive Disorder (adjunctive treatment): Adults: 
PO: Initial dosage: 2 to 5 mg/day for patients already taking 
another antidepressant. May increase dosage by up to 5 mg/
day at intervals of at least a week. Maintenance dosage range: 
2 to 15 mg/day. 
Schizophrenia: Adults: PO: Initial dosage: 10 or 15 mg/day 
as a single dose. Doses up to 30 mg have been used. Dosage 
increases should not be made before 2 weeks, the time required 
to achieve steady state. 
CHLORPROMAZINE  (Thorazine) 
Psychotic Disorders: Adults: PO: 10 mg 3 or 4 times a day or 
25 mg 2 or 3 times a day. Increase by 20 to 50 mg every 3 to 
4 days until effective dose is reached, usually 200 to 400 mg/
day. IM: Initial dose: 25 mg. May give additional 25 to 50 mg 
in 1 hour. Increase gradually over several days (up to 400 mg 
every 4 to 6 hours in severe cases). 
Pediatric Behavioral Disorders: Children >6 months: 
PO: 0.5 mg/kg every 4 to 6 hours as needed. IM: 0.5 mg/
kg every 6 to 8 hours (not to exceed 40 mg/day in children 
6 months to 5 years or 75 mg/day in children 6 to 12 years). 
Nausea and Vomiting: Adults: PO: 10 to 25 mg every 4 to 
6 hours. IM: 25 mg initially, may repeat 25-50 mg every 3 to 
4 hours. 
Children >6 months: PO: 0.55 mg/kg every 4 to 6 hours. 
IM: 0.55 mg/kg every 6 to 8 hours (not to exceed 40 mg/day in 
children up to 5 years or 75 mg/day in children 5 to 12 years). 
Intractable Hiccoughs: Adults: PO: 25 to 50 mg 3 or 4 times 
daily. If symptoms persist for 2 or 3 days, give 25 to 50 mg IM. 
Preoperative Sedation: Adults: PO: 25 to 50 mg 2 or 3 hours 
before surgery, or IM: 12.5 to 25 mg 1 to 2 hours before 
surgery.
Children: PO: 0.5 mg/kg 2 or 3 hours before surgery, or IM: 
0.5 mg/kg 1 to 2 hours before surgery. 
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Acute Intermittent Porphyria: Adults: PO: 25 to 50 mg 3 or 
4 times a day, or IM: 25 mg 3 or 4 times a day until patient 
can take PO. 
QUETIAPINE  (Seroquel) 
Schizophrenia: Adults: PO: 25 mg twice daily initially, 
increased by 25 to 50 mg 2 or 3 times daily over 3 days, up to 
300 to 400 mg/day in 2 or 3 divided doses by the fourth day 
(not to exceed 800 mg/day). 
Bipolar Mania: Adults: PO: 100 mg/day in 2 divided doses 
on day 1; increase dose by 100 mg/day up to 400 mg/day 
by day 4 given in twice daily divided doses. May increase in 
200 mg/day increments up to 800 mg/day by day 6 if 
required. 
RISPERIDONE  (Risperdal) 
Bipolar mania: Adults: PO: 2 or 3 mg/day as a single daily 
dose; dose may be increased at 24-hour intervals by 1 mg 
(range 1 to 6 mg/day). 
Schizophrenia: Adults: PO: Initial dosage: 2 mg/day 
administered as a single dose or in two divided doses. May 
increase dose at 24-hour intervals in increments of 1 to 2 mg/day 
to a recommended dose of 4 to 8 mg/day. 
IM: Adults: 25 mg every 2 weeks; some patients may require 
larger dose of 37.5 or 50 mg every 2 weeks.  
Adolescents (13 to 17 years): PO: 0.5 mg once daily, increased by 
0.5 to 1.0 mg no more frequently than every 24 hours to 3 mg 
daily. May administer half the daily dose twice daily if drowsi-
ness persists. 
Behavioral Problems Associated with Autistic Disorder: 
Children and adolescents 5 to 16 years weighing <20 kg: 
PO: 0.25 mg/day initially. After at least 4 days of therapy, 
may increase to 0.5 mg/day. Dose increases in increments of 
0.25 mg/day may be considered at 2-week or longer intervals. 
May be given as a single dose or in divided doses. 
Children and adolescents 5 to 16 years weighing >20 kg: PO: 0.5 mg/
day initially. After at least 4 days of therapy, may increase to 
1.0 mg/day. Dose increases in increments of 0.5 mg/day may 
be considered at 2-week or longer intervals. May be given as a 
single dose or in divided doses. 
ZIPRASIDONE  (Geodon) 
Bipolar Mania: Adults: PO: 40 mg twice daily with food. 
Increase dose to 60 or 80 mg twice/day on the second day of 
treatment. Adjust dose on the basis of toleration and efﬁ cacy 
within the range of 40 to 80 mg twice/day. 
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Schizophrenia: Adults: PO: Initial dose: 20 mg twice daily 
with food. Dose increments may be made at 2-day intervals 
up to 80 mg twice daily. 
Acute Agitation in Schizophrenia: Adults: IM: 10 to 20 mg 
as needed up to 40 mg/day. May be given as 10 mg every 
2 hours or 20 mg every 4 hours. Maximum dosage: 40 mg/day. 
ASENAPINE  (Saphris) 
Schizophrenia: Adults: PO: Usual starting and target dose: 
5 mg twice daily. The safety of doses above 10 mg twice daily 
has not been evaluated in clinical trials. 
Bipolar Disorder: Adults: PO: Recommended initial dose: 
10 mg twice daily. The dose can be decreased to 5 mg twice 
daily if there are adverse effects. The safety of doses above 
10 mg twice daily has not been evaluated in clinical trials.
●  NURSING DIAGNOSES RELATED 
TO ALL MOOD-STABILIZING DRUGS
 1. Risk for injury related to manic hyperactivity.
 2. Risk for self-directed or other-directed violence related to 
unresolved anger turned inward on the self or outward on the 
environment.
 3. Risk for injury related to lithium toxicity.
 4. Risk for injury related to adverse effects of mood-stabilizing 
drugs.
 5. Risk for activity intolerance related to side effects of 
drowsiness and dizziness.
●  NURSING IMPLICATIONS FOR 
MOOD-STABILIZING DRUGS
The plan of care should include monitoring for the following 
side effects from mood-stabilizing drugs. Nursing implications 
are designated by an asterisk (*).
 1. May occur with lithium:
 a. Drowsiness, dizziness, headache
 *  Ensure that client does not participate in activities that 
require alertness, or operate dangerous machinery. 
 b. Dry mouth; thirst
 *  Provide sugarless candy, ice, frequent sips of water. 
Ensure that strict oral hygiene is maintained. 
 c. GI upset; nausea/vomiting
 * Administer medications with meals to minimize GI 
upset. 
 d. Fine hand tremors
 *  Report to physician, who may decrease dosage. Some 
physicians prescribe a small dose of beta-blocker pro-
pranolol to counteract this effect. 
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 e. Hypotension; arrhythmias; pulse irregularities
 *  Monitor vital signs two or three times a day. Physician 
may decrease dose of medication. 
 f. Polyuria; dehydration
 * May subside after initial week or two. Monitor daily 
intake and output and weight. Monitor skin turgor 
daily. 
 g. Weight gain
 *  Provide instructions for reduced calorie diet. Emphasize 
importance of maintaining adequate intake of sodium. 
 2. May occur with anticonvulsants: 
 a. Nausea/vomiting
 * May give with food or milk to minimize GI upset. 
 b. Drowsiness; dizziness
 *  Ensure that client does not operate dangerous machin-
ery or participate in activities that require alertness. 
 c. Blood dyscrasias
 * Ensure that client understands the importance of 
regular blood tests while receiving anticonvulsant 
therapy. 
 d. Prolonged bleeding time (with valproic acid) 
 *  Ensure that platelet counts and bleed time are deter-
mined before initiation of therapy with valproic acid. 
Monitor for spontaneous bleeding or bruising. 
 e. Risk of severe rash (with lamotrigine) 
 *  Ensure that client is informed that he or she must report 
evidence of skin rash to physician immediately. 
 f. Decreased effi cacy of oral contraceptives (with 
topiramate) 
 *  Ensure that client is aware of decreased efﬁ cacy of oral 
contraceptives with concomitant use. 
 g. Risk of suicide with all antiepileptic drugs (warning by 
FDA, December 2008) 
 *  Monitor for worsening of depression, suicidal thoughts or 
behavior, or any unusual changes in mood or behavior. 
 3. May occur with calcium channel blockers: 
 a. Drowsiness; dizziness
 *  Ensure that client does not operate dangerous machin-
ery or participate in activities that require alertness. 
 b. Hypotension; bradycardia
 *  Take vital signs just before initiation of therapy and 
before daily administration of the medication. Physician 
will provide acceptable parameters for administration. 
Report marked changes immediately. 
 c. Nausea
 * May give with food to minimize GI upset. 
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 d. Constipation
 *  Encourage increased ﬂ uid (if not contraindicated) and 
ﬁ ber in the diet. 
 4. May occur with antipsychotics: 
 a. Drowsiness; dizziness
 * Ensure that client does not operate dangerous machin-
ery or participate in activities that require alertness. 
 b. Dry mouth; constipation
 * Provide sugarless candy or gum, ice, and frequent sips 
of water. Provide foods high in ﬁ ber; encourage physical 
activity and ﬂ uid if not contraindicated. 
 c. Increased appetite; weight gain
 * Provide calorie-controlled diet. Provide opportunity for 
physical exercise. Provide diet and exercise instruction. 
 d. ECG changes
 * Monitor vital signs. Observe for symptoms of dizziness, 
palpitations, syncope, or weakness. 
 e. Extrapyramidal symptoms
 * Monitor for symptoms. Administer prn medication at 
ﬁ rst sign.
 f. Hyperglycemia and diabetes
 * Monitor blood glucose regularly. Observe for the appear-
ance of symptoms of polydipsia, polyuria, polyphagia, 
and weakness at any time during therapy.
●  CLIENT/FAMILY EDUCATION RELATED 
TO MOOD-STABILIZING DRUGS
● Do not drive or operate dangerous machinery. Drowsiness or 
dizziness can occur.
● Do not stop taking the drug abruptly. Can produce serious 
withdrawal symptoms. The physician will administer orders 
for tapering the drug when therapy is to be discontinued.
● Report the following symptoms to the physician immediately: 
● Client taking anticonvulsant: unusual bleeding, sponta-
neous bruising, sore throat, fever, malaise, skin rash, dark 
urine, and yellow skin or eyes. 
● Client taking calcium channel blocker: irregular heart-
beat, shortness of breath, swelling of the hands and feet, 
pronounced dizziness, chest pain, profound mood swings, 
severe and persistent headache. 
● Client taking lithium: ataxia, blurred vision, severe diar-
rhea, persistent nausea and vomiting, tinnitus, excessive 
urine output, increasing tremors, or mental confusion.  
● Client taking antipsychotic: sore throat, fever, malaise, un-
usual bleeding, easy bruising, persistent nausea and vomit-
ing, severe headache, rapid heart rate, difﬁ culty urinating, 
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muscle twitching, tremors, dark urine, excessive urination, 
excessive thirst, excessive hunger, weakness, pale stools, 
yellow skin or eyes, muscular incoordination, or skin 
rash.
● For the client on lithium: ensure that the diet contains ad-
equate sodium. Drink 6 to 8 glasses of water each day. Avoid 
drinks that contain caffeine (that have a diuretic effect). Have 
serum lithium level checked every 1 to 2 months, or as advised 
by physician.
● For the client on asenapine: Place the tablet under the tongue 
and allow to dissolve completely. Do not chew or swallow 
tablet. Do not eat or drink for 10 minutes.
● Avoid consuming alcoholic beverages and nonprescription 
medications without approval from physician.
● Carry card at all times identifying the name of medications 
being taken.
 INTERNET REFERENCES
 a. http://www.rxlist.com
 b. http://www.nimh.nih.gov/publicat/medicate.cfm
 c. http://www.fadavis.com/townsend
 d. http://www.mentalhealth.com/
 e. http://www.nlm.nih.gov/medlineplus/druginformation
.html
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● CHEMICAL CLASS: PHENOTHIAZINES
Examples
Generic 
(Trade)
Name 
Pregnancy
Categories/ 
Half-life Indications
Available 
Forms (mg)
Chlorpromazine C/24 hr ● Bipolar mania
● Schizophrenia
● Emesis/hiccoughs
● Acute intermittent 
porphyria
● Hyperexcitable, combat-
ive behavior in children
● Preoperative 
apprehension 
Unlabeled uses:
● Migraine headaches
Tabs: 10, 25, 50, 
100, 200 
Injection: 25/mL
Fluphenazine C/HCl: 18 hr 
Decanoate: 
6.8–9.6 days
● Psychotic 
disorders
Tabs: 1, 2.5, 5, 10
Elixir: 2.5/5 mL 
Conc: 5/mL 
Inj: 2.5/mL
Inj (Decanoate): 25/mL
Perphenazine C/9–12 hr ● Psychotic disorders
● Nausea and vomiting
Tabs: 2, 4, 8, 16 
Conc: 16/5 mL
Prochlorperazine C/3–5 hr (oral) 
6.9 hr (IV)
● Schizophrenia
● Nonpsychotic anxiety
● Nausea and vomiting 
Unlabeled uses:
● Migraine headache
Tabs: 5, 10
Supp: 25 
Inj: 5/mL
Thioridazine C/24 hr ● Management of schizo-
phrenia in patients who 
do not have an accept-
able response to other 
antipsychotic therapy
Tabs: 10, 15, 25, 50, 
100, 150, 200
Trifl uoperazine C/18 hr ● Schizophrenia
● Nonpsychotic anxiety
Tabs: 1, 2, 5, 10
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Action
● These drugs are thought to work by blocking postsynaptic 
dopamine receptors in the basal ganglia, hypothalamus, 
limbic system, brainstem, and medulla.
● They also demonstrate varying afﬁ nity for cholinergic, 
alpha1-adrenergic, and histaminic receptors. 
● Antipsychotic effects may also be related to inhibition of 
dopamine-mediated transmission of neural impulses at the 
synapses.
Contraindications and Precautions 
Contraindicated in: • Hypersensitivity (cross-sensitivity 
may exist among phenothiazines) • In comatose or severely cen-
tral nervous system (CNS)-depressed clients • Poorly controlled 
seizure disorders • Clients with blood dyscrasias • Narrow 
angle glaucoma • Clients with liver, renal, or cardiac insufﬁ ciency 
• Bone marrow depression • Concurrent pemozide use • Co-
administration with other drugs that prolong QT interval, or in 
patients with long-QT syndrome or history of cardiac arrhyth-
mias 
Use Cautiously in: • Elderly and debilitated patients • Children 
with acute illnesses, infections, gastroenteritis, or dehydration 
(increased risk of extrapyramidal reactions) • Diabetes • Respira-
tory disease • Prostatic hypertrophy • CNS tumors • Epilepsy 
• Intestinal obstruction • Pregnancy or lactation (safety not estab-
lished) • Elderly patients with dementia-related psychosis (black 
box warning)
Adverse Reactions and Side Effects
● Dry mouth 
● Blurred vision 
● Constipation 
● Urinary retention 
● Nausea 
● Skin rash 
● Sedation 
● Orthostatic hypotension 
● Photosensitivity 
● Decreased libido 
● Amenorrhea 
● Retrograde ejaculation 
● Gynecomastia 
● Weight gain 
● Reduction of seizure threshold 
● Agranulocytosis 
● Extrapyramidal symptoms 
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● Tardive dyskinesia 
● Neuroleptic malignant syndrome
● Prolongation of QT interval (thioridazine) 
Interactions
● Coadministration of phenothiazines and beta-blockers may 
increase effects from either or both drugs.
● Increased effects of phenothiazines with paroxetine
● Concurrent administration with meperidine may produce 
excessive sedation and hypotension.
● Therapeutic effects of phenothiazines may be decreased by 
centrally acting anticholinergics. Anticholinergic effects 
are increased.
● Concurrent use may result in decreased hypotensive effect of 
guanethidine.
● Phenothiazines may reduce effectiveness of oral anticoag-
ulants.
● Concurrent use with phenothiazines may increase or decrease 
phenytoin levels.
● Increased orthostatic hypotension with thiazide diuretics
● Increased CNS depression with alcohol or other CNS 
depressants
● Increased hypotension with antihypertensives
● Concurrent use with epinephrine or dopamine may result in 
severe hypotension.
Route and Dosage 
CHLORPROMAZINE
Psychotic Disorders: Adults: PO: 10 mg 3 or 4 times a day or 
25 mg 2 or 3 times a day. Increase by 20 to 50 mg every 3 to 
4 days until effective dose is reached, usually 200 to 400 mg/
day. IM: Initial dose: 25 mg. May give additional 25 to 50 mg 
in 1 hour. Increase gradually over several days (up to 400 mg 
every 4 to 6 hours in severe cases). 
Pediatric Behavioral Disorders: Children >6 months: 
PO: 0.5 mg/kg every 4 to 6 hours as needed.
  IM: 0.5 mg/kg every 6 to 8 hours (not to exceed 40 mg/day 
in children 6 months to 5 years or 75 mg/day in children 6 to 
12 years). 
Nausea and Vomiting: Adults: PO: 10 to 25 mg every 4 to 
6 hours. IM: 25 mg initially, may repeat 25 to 50 mg every 
3 to 4 hours. 
Children >6 months: PO: 0.55 mg/kg every 4 to 6 hours. 
IM: 0.55 mg/kg every 6 to 8 hours (not to exceed 40 mg/day in 
children up to 5 years or 75 mg/day in children 5 to 12 years). 
Intractable Hiccoughs: Adults: PO: 25 to 50 mg 3 or 4 times 
daily. If symptoms persist for 2 to 3 days, give 25 to 50 mg IM. 
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Preoperative Sedation: Adults: PO: 25 to 50 mg 2 to 3 hours 
before surgery, or IM: 12.5 to 25 mg 1 to 2 hours before 
surgery. 
Children: PO: 0.5 mg/kg 2 to 3 hours before surgery or 
IM: 0.5 mg/kg 1 to 2 hours before surgery. 
Acute Intermittent Porphyria: Adults: PO: 25 to 50 mg 3 or 
4 times a day or IM: 25 mg 3 or 4 times a day until patient 
can take PO. 
FLUPHENAZINE
Psychotic Disorders: Adults: PO: Initial dose: 2.5 to 10 mg/day 
in divided doses every 6 to 8 hours. Maintenance dose: 1 to 
5 mg/day. IM: 1.25 to 2.5 mg every 6 to 8 hours.
Elderly or debilitated patients: PO: 1 to 2.5 mg/day initially. Adjust 
dosage according to response. 
Decanoate Formulation: Adults: IM, SC: Initial dose: 12.5 
to 25 mg. May be repeated every 3 to 4 weeks. Dosage may 
be slowly increased in 12.5 mg increments as needed (not to 
exceed 100 mg/dose). 
PERPHENAZINE
Psychotic Disorders: Adults: PO: Outpatients: 4 to 8 mg 
3 times a day initially. Reduce as soon as possible to minimum 
effective dose. 
Hospitalized patients with schizophrenia: 8 to 16 mg 2 to 4 times a 
day, not to exceed 64 mg/day. 
Nausea and Vomiting: Adults: PO: 8 to 16 mg daily in divided 
doses, up to 24 mg, if necessary. 
PROCHLORPERAZINE
Schizophrenia: Adults (mild conditions): PO: 5 to 10 mg 3 or 
4 times a day. (Moderate conditions): 10 mg 3 or 4 times a day. 
Gradually increase dosage by small increments over 2 or 
3 days to 50 to 75 mg/day. (Severe conditions): 100 to 150 mg/
day. IM: 10 to 20 mg every 2 to 4 hours for up to 4 doses, then 
10 to 20 mg every 4 to 6 hours, if needed. When control is 
achieved, switch to oral dosage. 
Children ≥12 years: PO: 5 to 10 mg 3 to 4 times a day. 
Children 2 to 12 years: PO: 2.5 mg 2 to 3 times a day. 
Nonpsychotic Anxiety: Adults: PO: 5 mg 3 to 4 times a day, 
not to exceed 20 mg/day or longer than 12 weeks. 
Nausea and Vomiting: Adults: PO: 5 to 10 mg 3 or 4 times a 
day. SR caps: 15 mg once daily or 10 mg 2 times a day. Rectal: 
25 mg 2 times a day. IM: 5 to 10 mg. May repeat every 3 or 
4 hours, not to exceed 40 mg/day.
Children 20 to 29 lb: PO/Rectal: 2.5 mg 1 or 2 times a day, not 
to exceed 7.5 mg/day.
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Children 30 to 39 lb: PO/Rectal: 2.5 mg 2 or 3 times a day, not 
to exceed 10 mg/day.
Children 40 to 85 lb: PO/Rectal: 2.5 mg 3 times a day or 5 mg 
2 times a day, not to exceed 15 mg/day. 
Children >20 lb or 2 years of age: IM: 0.132 mg/kg. Usually only 
1 dose is required. 
THIORIDAZINE 
Schizophrenia (Intractable to Other Antipsychotics): 
Adults: PO: Initial dose: 50 to 100 mg 3 times a day. May 
increase gradually to maximum dosage of 800 mg/day. Once 
effective response has been achieved, may reduce gradually 
to determine the minimum maintenance dose. Usual daily 
dosage range: 200 to 800 mg, divided into 2 to 4 doses.
Children: PO: Initial dose: 0.5 mg/kg/day given in divided doses. 
Increase gradually until therapeutic effect has been achieved 
or maximum dose of 3 mg/kg/day has been reached. 
TRIFLUOPERAZINE
Schizophrenia: Adults: PO: 2 to 5 mg 2 times a day. Usual 
optimum dosage range: 15 to 20 mg/day, although a few may 
require 40 mg/day or more. 
Children 6 to 12 years: PO: Initial dose: 1 mg once or 2 times a day. 
May increase dose gradually to a maximum of 15 mg/day. 
Nonpsychotic Anxiety: Adults: PO: 1 or 2 mg 2 times a day. 
Do not administer more than 6 mg/day or for longer than 
12 weeks. 
● CHEMICAL CLASS: THIOXANTHENES
Examples 
Generic (Trade) 
Name 
Pregnancy 
Categories/
Half-life (hr) Indications
Available 
Forms (mg)
Thiothixene 
(Navane)
C/34 ● Schizophrenia Caps: 1, 2, 5, 10, 20 
Action
● Blocks postsynaptic dopamine receptors in the basal ganglia, 
hypothalamus, limbic system, brainstem, and medulla
● Demonstrates varying afﬁ nity for cholinergic, alpha1-adrenergic, 
and histaminic receptors
Contraindications and Precautions 
Contraindicated in: • Hypersensitivity • Comatose or 
severely CNS-depressed patients • Bone marrow depression or 
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blood dyscrasias • Parkinson’s disease • Severe hypotension or 
hypertension • Circulatory collapse • Children <12 years old 
● Pregnancy and lactation (safety not established) 
Use Cautiously in: • Patients with history of seizures 
• Respiratory, renal, hepatic, thyroid, or cardiovascular dis-
orders • Elderly or debilitated patients • Patients exposed to 
extreme environmental heat • Patients taking atropine or 
atropine-like drugs • Elderly patients with dementia-related 
psychosis (black box warning) 
Adverse Reactions and Side Effects
● Refer to this section under Phenothiazines. 
Interactions
● Additive CNS depression with alcohol and other CNS 
depressants
● Additive anticholinergic effects with other drugs that have 
anticholinergic properties
● Possible additive hypotension with antihypertensive agents
● Concurrent use with epinephrine or dopamine may result in 
severe hypotension.
Route and Dosage 
Schizophrenia: Adults and children ≥12 years: PO: (Mild 
conditions): Initial dosage: 2 mg three times a day. May increase 
to 15 mg/day. (Severe conditions): Initial dosage: 5 mg 2 times a 
day. Optimal dose is 20 to 30 mg/day. If needed, may increase 
gradually, not to exceed 60 mg/day. 
●  CHEMICAL CLASS: 
PHENYLBUTYLPIPERADINES
Examples 
Generic 
(Trade) 
Name 
Pregnancy 
Categories/
Half-life Indications Available Forms (mg)
Haloperidol 
(Haldol) 
C/~18 hr (oral); ~3 wk 
(IM decanoate)
● Psychotic disorders
● Tourette’s disorder
● Pediatric behavior 
problems and 
hyperactivity 
Unlabeled uses:
● Intractable 
hiccoughs
● Nausea and 
vomiting
Tabs: 0.5, 1, 2, 5, 10, 20 
Conc: 2/mL
Inj (lactate): 5/mL 
Inj (decanoate): 50/mL; 
100/mL 
Continued
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Action
● Blocks postsynaptic dopamine receptors in the hypothalamus, 
limbic system, and reticular formation 
● Demonstrates varying afﬁ nity for cholinergic, alpha1-adrenergic, 
and histaminic receptors
Contraindications and Precautions 
Contraindicated in: • Hypersensitivity to the drug 
• Coadministration with other drugs that prolong the QT inter-
val • Coadministration with drugs that inhibit CYP3A enzymes 
(pimozide) • Treatment of tics other than those associated with 
Tourette’s disorder (pimozide) • Coadministration with other 
drugs that may cause tics (e.g., pemoline, methylphenidate, 
amphetamines) until it has been determined whether the tics 
are caused by the medications or Tourette’s disorder (pimozide) 
• Parkinson disease (haloperidol) • In comatose or severely 
CNS-depressed clients • Clients with blood dyscrasias or bone 
marrow depression • Narrow-angle glaucoma • Clients with 
liver, renal, or cardiac insufﬁ ciency • Pregnancy and lactation 
(safety not established) 
Use Cautiously in: • Elderly and debilitated clients • Diabetic 
clients • Depressed clients • Clients with history of seizures 
• Clients with respiratory insufﬁ ciency • Prostatic hypertrophy 
• Children • Elderly patients with dementia-related psychosis 
(black box warning) 
Adverse Reactions and Side Effects
● Dry mouth 
● Blurred vision 
● Constipation 
● Urinary retention 
● Nausea 
● Skin rash 
● Sedation 
● Orthostatic hypotension 
● Photosensitivity 
● Decreased libido 
● Amenorrhea 
● Retrograde ejaculation 
Generic 
(Trade) 
Name 
Pregnancy 
Categories/
Half-life Indications Available Forms (mg)
Pimozide
(Orap)
C/~55 hr ● Tourette’s disorder 
Unlabeled uses:
● Schizophrenia
Tabs: 1, 2 
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● Gynecomastia 
● Weight gain 
● Reduction of seizure threshold 
● Agranulocytosis 
● Extrapyramidal symptoms 
● Tardive dyskinesia 
● Neuroleptic malignant syndrome
● Prolongation of QT interval
Interactions
● Decreased serum concentrations of haloperidol, worsening 
schizophrenic symptoms, and tardive dyskinesia with con-
comitant use of anticholinergic agents
● Increased plasma concentrations when administered with 
drugs that inhibit CYP3A enzymes (azole antifungal agents; 
macrolide antibiotics) and CYP1A2 enzymes (fl uoxetine; 
fl uvoxamine)
● Decreased therapeutic effects of haloperidol with carbam-
azepine; increased effects of carbamazepine
● Additive hypotension with antihypertensives
● Additive CNS depression with alcohol or other CNS 
depressants
● Coadministration of haloperidol and lithium may result in 
alterations in consciousness, encephalopathy, extrapyramidal 
effects, fever, leukocytosis, and increased serum enzymes.
● Decreased therapeutic effects of haloperidol with rifamycins
● Concurrent use with epinephrine or dopamine may result in 
severe hypotension.
● Additive effects with other drugs that prolong QT interval 
(e.g., phenothiazines, tricyclic antidepressants, antiar-
rhythmic agents) 
Route and Dosage 
HALOPERIDOL (Haldol) 
Psychotic Disorders: Adults: PO: (Moderate symptoms or 
geriatric or debilitated patients): 0.5 to 2 mg 2 or 3 times a day. 
(Severe symptoms or chronic or resistant patients): 3 to 5 mg 
2 or 3 times a day. Some patients may require dosages up to 
100 mg/day. 
Children (3 to 12 years; weight range 15 to 40 kg): Initial dose: 
0.5 mg/day (25 to 50 mcg/kg/day). May increase in 0.5 mg incre-
ments at 5- to 7-day intervals up to 0.15 mg/kg/day or until ther-
apeutic effect is obtained. Administer in 2 or 3 divided doses. 
Control of Acutely Agitated Schizophrenic Patient: Adults: 
IM (lactate): 2 to 5 mg. May be repeated every 1 to 8 hours, 
not to exceed 100 mg/day. 
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Chronic Psychosis Requiring Prolonged Antipsychotic 
Therapy: Adults: IM (decanoate): 10 to 15 times the 
previous daily oral dose, not to exceed 100 mg initially. 
Repeat every 4 weeks, or adjust interval to patient response. 
For maintenance, titrate dosage upward or downward based 
on therapeutic response. 
Tourette’s Disorder: Adults: PO: Initial dosage: 0.5 to 1.5 mg 
3 times a day. Increase dose gradually as determined by patient 
response. Up to 10 mg/day may be required.
Children (3 to 12 years; 15 to 40 kg): PO: 0.05 to 0.075 mg/
kg/day. 
Behavioral Disorders/Hyperactivity: Children (3 to 12 years; 
15 to 40 kg): PO: 0.05 to 0.075 mg/kg/day. 
PIMOZIDE (Orap) 
Tourette’s Disorder: Adults: PO: Initial dose: 1 to 2 mg/day 
in divided doses. Thereafter, increase dose every other day. 
Maintenance dose: Less than 0.2 mg/kg/day or 10 mg/day, 
whichever is less. Doses greater than 0.2 mg/kg/day or 10 mg/
day are not recommended. 
Children (12 years and older): Initial dose: 0.05 mg/kg, preferably 
taken once at bedtime. The dose may be increased every third 
day to a maximum of 0.2 mg/kg, not to exceed 10 mg/day. 
● CHEMICAL CLASS: DIHYDROINDOLONES
Examples
Generic (Trade) 
Name 
Pregnancy 
Categories/
Half-life (hr) Indications
Available 
Forms (mg)
Molindone
(Moban)
C/12 ● Schizophrenia Caps: 5, 10, 25, 50 
Action
● The exact mechanism of action is not fully understood. 
● It is thought that molindone exerts its effect on the ascending 
reticular activating system. 
Contraindications and Precautions 
● Contraindicated in hypersensitivity, comatose or severely 
CNS-depressed patients, children under 12 (safety not estab-
lished), lactation
● Use cautiously in patients with history of seizures; respiratory, 
renal, hepatic, thyroid, or cardiovascular disorders; elderly or 
debilitated patients, pregnancy. 
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Adverse Reactions and Side Effects
● Drowsiness
● Depression
● Hyperactivity/euphoria
● Extrapyramidal symptoms
● Blurred vision
● Tachycardia
● Nausea
● Dry mouth
● Salivation
● Urinary retention
● Constipation
Interactions
● Additive hypotension with antihypertensive agents
● Additive CNS effects with CNS depressants
● Additive anticholinergic effects with drugs that have anticho-
linergic properties
Route and Dosage 
MOLINDONE (Moban) 
Schizophremna: Adults: PO: Initial dosage: 50 to 75 mg/day. 
May increase to 100 mg in 3 or 4 days, up to 225 mg/day if 
required. 
Maintenance Therapy: Adults (mild symptoms): PO: 5 to 15 mg 
3 or 4 times a day. (Moderate symptoms): PO: 10 to 25 mg 3 or 
4 times a day. (Severe symptoms): PO: Up to 225 mg/day may be 
required. 
● CHEMICAL CLASS: DIBENZEPINES
Examples 
Generic 
(Trade) 
Name
Pregnancy 
Categories/ 
Half-life (hr) Indications
Available 
Forms (mg)
Loxapine 
(Loxitane)
C/8 ● Schizophrenia Caps: 5, 10, 25, 50
Clozapine
(Clozaril)
B/8 (single dose); 
12 (at steady
 state)
● Treatment-resistant 
schizophrenia
● Recurrent suicidal behavior
Unlabeled uses:
● Acute manic episodes 
associated with bipolar 
disorder
Tabs: 12.5, 25, 50, 
100, 200 
Tabs (orally 
disintegrating): 
12.5, 25, 50, 100
Continued
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Action
Loxapine
● Mechanism of action has not been fully established.
● Exerts strong antagonistic effects on dopamine D2 and D4 and 
serotonin 5-HT2 receptors
Clozapine
● Exerts an antagonistic effect on dopamine receptors, with a 
particularly high afﬁ nity for the D4 receptor 
● It appears to be more active at limbic than at striatal dopamine 
receptors. 
● Also acts as an antagonist at adrenergic, cholinergic, hista-
minergic, and serotonergic receptors
Olanzapine
● Efﬁ cacy in schizophrenia is mediated through a combination 
of dopamine and 5-HT2 antagonism.
● Also shows antagonism for muscarinic, histaminic, and adren-
ergic receptors
● The mechanism of action of olanzapine in the treatment of 
bipolar mania is unknown. 
Quetiapine
● Antipsychotic activity is thought to be mediated through 
a combination of dopamine type 2 (D2) and serotonin type 
2 (5-HT2) antagonism. Other effects may be due to an-
tagonism of histamine H1 receptors and alpha1-adrenergic 
receptors. 
Generic 
(Trade) 
Name
Pregnancy 
Categories/ 
Half-life (hr) Indications
Available 
Forms (mg)
Olanzapine 
(Zyprexa)
C/21–54 ● Schizophrenia
● Bipolar mania
● Acute agitation in schizo-
phrenia (IM)
● Acute agitation associated 
with bipolar mania (IM) 
Unlabeled uses:
● Obsessive-compulsive dis-
order (refractory to SSRIs)
Tabs: 2.5, 5, 7.5, 10, 
15, 20 
Tabs (orally 
disintegrating): 5, 
10, 15, 20 
Inj: 10/vial
Quetiapine 
(Seroquel)
C/~6 ● Schizophrenia
● Bipolar mania
Tabs: 25, 50, 100, 
200, 300, 400 
Tabs (XR): 200, 300, 
400
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Contraindications and Precautions: 
Loxapine
● Contraindicated in: hypersensitivity; comatose or severe 
drug-induced depressed states; clients with blood dyscrasias; 
hepatic, renal, or cardiac insufﬁ ciency; severe hypotension or 
hypertension; children, pregnancy, and lactation (safety not 
established)
● Use cautiously in: patients with epilepsy or history of sei-
zures; glaucoma; urinary retention; respiratory insufﬁ ciency; 
prostatic hypertrophy; elderly patients with dementia-related 
psychosis (black box warning). 
Clozapine
● Contraindicated in: hypersensitivity; myeloproliferative dis-
orders; history of clozapine-induced agranulocytosis or severe 
granulocytopenia; concomitant use with other drugs that have 
the potential to suppress bone marrow function; severe CNS 
depression or comatose states; uncontrolled epilepsy; lacta-
tion; children (safety not established) 
● Use cautiously in: patients with hepatic, renal, respiratory, or 
cardiac insufﬁ ciency; diabetes mellitus or risk factors for dia-
betes; prostatic enlargement; narrow-angle glaucoma; preg-
nancy; elderly patients with dementia-related psychosis (black 
box warning). 
Olanzapine
● Contraindicated in: hypersensitivity; lactation. Orally dis-
integrating tablets only: Phenylketonuria (orally disintegrating 
tablets contain aspartame)
● Use cautiously in: hepatic insufﬁ ciency, elderly clients (reduce 
dosage), pregnancy and children (safety not established), car-
diovascular or cerebrovascular disease, history of glaucoma, 
history of seizures, history of attempted suicide, prostatic 
hypertrophy, diabetes or risk factors for diabetes, narrow an-
gle glaucoma, history of paralytic ileus; elderly patients with 
dementia-related psychosis (black box warning). 
Quetiapine
● Contraindicated in: hypersensitivity; lactation
● Use cautiously in: cardiovascular or cerebrovascular dis-
ease; dehydration or hypovolemia (increased risk of hypoten-
sion); hepatic impairment; hypothyroidism; history of suicide 
attempt; pregnancy or children (safety not established); 
patients with diabetes or risk factors for diabetes; elderly pa-
tients with dementia-related psychosis (black box warning). 
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Adverse Reactions and Side Effects
Loxapine
● Drowsiness, dizziness
● Anticholinergic effects (dry mouth, blurred vision, urinary 
retention, constipation, paralytic ileus)
● Nausea and vomiting
● Extrapyramidal symptoms
● Seizures
● Hypotension; hypertension; tachycardia
● Blood dyscrasias
● Neuroleptic malignant syndrome
Clozapine
● Drowsiness, dizziness, sedation
● Nausea and vomiting
● Dry mouth; blurred vision
● Agranulocytosis 
● Seizures (appear to be dose-related) 
● Salivation 
● Myocarditis; cardiomyopathy 
● Tachycardia 
● Constipation
● Fever 
● Weight gain 
● Orthostatic hypotension 
● Neuroleptic malignant syndrome
● Hyperglycemia
Olanzapine
● Drowsiness, dizziness, weakness
● Dry mouth, constipation, increased appetite
● Nausea; weight gain
● Orthostatic hypotension, tachycardia
● Restlessness; insomnia
● Rhinitis
● Tremor
● Headache
● Hyperglycemia
Quetiapine
● Drowsiness, dizziness
● Hypotension, tachycardia
● Headache
● Nausea, dry mouth, constipation
● Weight gain
● Hyperglycemia
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The effects 
of:
Are increased
by:
Are decreased 
by:
Concurrent use may 
result in:
Loxapine Additive CNS depression with 
alcohol or other CNS depres-
sants. Increased hypotension 
with antihypertensive agents. 
Additive anticholinergic 
effects with anticholinergic 
agents. Concomitant use 
with lorazepam (and possibly 
other benzodiazepines) may 
result in respiratory depres-
sion, stupor, hypotension, 
and/or respiratory or cardiac 
arrest.
Clozapine Caffeine, 
citalopram, 
cimetidine, 
fl uoxetine, 
fl uvoxamine, 
sertraline, 
CYP3A4-
inhibiting 
drugs (e.g., 
ketoconazole), 
risperidone, 
ritonavir
CYP1A2 inducers 
(e.g., carbamaze-
pine, omeprazole, 
rifampin), 
phenobarbital, 
phenytoin, 
nicotine
Additive CNS depression with 
alcohol or other CNS depres-
sants. Increased hypotension 
with antihypertensive agents. 
Additive anticholinergic 
effects with anticholinergic 
agents. Concomitant use 
with benzodiazepines may 
result in respiratory depres-
sion, stupor, hypotension, 
and/or respiratory or cardiac 
arrest. Increased effects 
of risperidone with chronic 
coadministration.
Olanzapine Fluvoxamine, 
fl uoxetine
Carbamazepine, 
omeprazole, 
rifampin
Decreased effects of levodopa 
and dopamine agonists. 
Increased hypotension with 
antihypertensives. Increased 
CNS depression with alcohol 
or other CNS depressants. 
Increased anticholinergic 
effects with anticholinergic 
agents.
Quetiapine Cimetidine; 
ketoconazole, 
itraconazole, 
fl uconazole, 
erythromycin, or 
other CYP3A4 
inhibitors
Phenytoin, 
thioridazine
Decreased effects of levodopa 
and dopamine agonists. In-
creased CNS depression with 
alcohol or other CNS depres-
sants. Increased hypotension 
with antihypertensives. 
Additive anticholinergic 
effects with anticholinergic 
agents. 
Interactions
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Route and Dosage 
LOXAPINE (Loxitane) 
Schizophrenia: Adults: PO: Initial dosage: 10 mg 2 times a 
day, although some severely disturbed patients may require up 
to 50 mg/day. Increase dosage fairly rapidly over the ﬁ rst 7 to 
10 days until symptoms are controlled. The usual therapeutic 
and maintenance dosage range is 60 mg to 100 mg/day. Doses 
higher than 250 mg/day are not recommended. Dosage should 
be maintained at the lowest level effective for controlling 
symptoms. 
CLOZAPINE (Clozaril) 
Schizophrenia and Recurrent Suicidal Behavior: Adults: 
PO: Initial dose: 12.5 mg once or 2 times a day. May 
increase dosage by 25 to 50 mg/day over a period of 2 weeks 
to a target dose of 300 to 450 mg/day. If required, make 
additional increases in increments of 100 mg not more than 
once or twice weekly to a maximum dosage of 900 mg/day in 
3 divided doses. The mean and median doses are approximately 
600 mg/day for schizophrenia and 300 mg/day for reducing 
recurrent suicidal behavior. Titrate dosage slowly to observe 
for possible seizures and agranulocytosis. 
 NOTE: A baseline white blood cell (WBC) count and ab-
solute neutrophil count (ANC) must be taken before ini-
tiation of treatment with clozapine and weekly for the ﬁ rst 
6 months of treatment. Because of the risk of agranulocytosis, 
clozapine  is available only in a 1-week supply through the 
Clozaril Patient Management System, which combines WBC 
testing, patient monitoring, and controlled distribution 
through participating pharmacies. If the counts remain with-
in the acceptable levels (i.e., WBC at least 3,500/mm3 and the 
AMC at least 2,000/mm3) during the 6-month period, blood 
counts may be monitored biweekly, and a 2-week supply of 
medication may then be dispensed. If for a 6-month period 
the counts remain within the acceptable level for the biweekly 
period, counts may then be monitored every 4 weeks there-
after. When the medication is discontinued, weekly WBC 
counts are continued for an additional 4 weeks. 
OLANZAPINE (Zyprexa) 
Schizophrenia: Adults: PO: 5 to 10 mg/day initially; may increase 
at weekly intervals by 5 mg/day (not to exceed 20 mg/day). 
Bipolar Disorder: Adults: PO: 10 to 15 mg/day initially; may 
increase every 24 hours by 5 mg/day (not to exceed 20 mg/day). 
Agitation Associated with Schizophrenia or Mania: Adults: 
IM: 2.5 to 10 mg, administered slowly, deep into muscle mass. 
May repeat in 2 hours and again 4 hours later, if needed. 
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QUETIAPINE (Seroquel) 
Schizophrenia: Adults: PO: 25 mg 2 times a day initially, 
increased by 25 to 50 mg 2 to 3 times daily over 3 days, up to 
300 to 400 mg/day in 2 to 3 divided doses by the fourth day 
(not to exceed 800 mg/day). 
Bipolar Mania: Adults: PO: 100 mg/day in 2 divided doses 
on day 1; increase dose by 100 mg/day up to 400 mg/day by 
day 4 given in 2 divided doses. May increase in 200 mg/day 
increments up to 800 mg/day on day 6 if required. 
● CHEMICAL CLASS: BENZISOXAZOLE
Examples
Generic 
(Trade) 
Name 
Pregnancy 
Categories/
Half-life (hr) Indications
Available 
Forms (mg)
Risperidone 
(Risperdal) 
C/~3–20 ● Schizophrenia
● Bipolar mania
● Irritability associ-
ated with autistic 
disorder in children
Unlabeled uses:
● Obsessive-
compulsive 
disorder
(refractory to SSRIs)
Tabs: 0.25, 0.5, 1, 2, 3, 4
Tabs (orally disintegrating): 
0.5, 1, 2, 3, 4
Oral Solu: 1/mL
Powder for injection: 
12.5/vial, 25/vial, 37.5/vial, 
50/vial
Paliperidone 
(Invega)
C/23 ● Schizophrenia Tabs (ER): 3, 6, 9
Inj (ER): 39/0.25 mL, 
78/0.5 mL, 117/0.75 mL, 
156/mL, 234/1.5 mL
Iloperidone 
(Fanapt)
C/18–33 ● Schizophrenia Tabs: 1, 2, 4, 6, 8, 10, 12
Ziprasidone 
(Geodon)
C/~7 (oral) 
2–5 (IM)
● Schizophrenia
● Bipolar mania
● Acute agitation in 
schizophrenia (IM)
Caps: 20, 40, 60, 80
Powder for injection: 20/vial 
Action
● Exerts antagonistic effects on dopamine type 2 (D2), serotonin 
type 2 (5-HT2), alpha1- and alpha2-adrenergic, and H1 hista-
minergic receptors
Contraindications and Precautions: 
Contraindicated in: • Known hypersensitivity • Comatose 
or severely depressed patients • Bradycardia, recent myocardial 
infarction (MI), or uncompensated heart failure • Lactation 
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• Patients with history of QT prolongation or cardiac arrhythmias 
• Concurrent use with drugs known to cause QT prolongation
Use Cautiously in: • Clients with hepatic or renal impair-
ment • Clients with history of seizures • Clients with diabe-
tes or risk factors for diabetes • Clients exposed to temperature 
extremes • Elderly or debilitated clients • Clients with history 
of suicide attempt • Pregnancy and children (safety not estab-
lished) • Elderly patients with dementia-related psychosis (black 
box warning) • Conditions that increase risk of hypotension 
(e.g., dehydration [including from diuretic therapy or diarrhea], 
hypovolemia, concurrent antihypertensive therapy). 
Adverse Reactions and Side Effects
● Anxiety 
● Agitation
● Dry mouth
● Weight gain
● Orthostatic hypotension
● Insomnia
● Sedation 
● Extrapyramidal symptoms 
● Dizziness
● Headache 
● Constipation 
● Diarrhea 
● Nausea 
● Rhinitis 
● Rash 
● Tachycardia
● Hyperglycemia
● Prolonged QT interval
Interactions
● Increased effects of risperidone with clozapine, fl uoxetine, 
paroxetine, or ritonavir
● Decreased effects of levodopa and other dopamine agonists 
with risperidone, paliperidone, and ziprasidone
● Decreased effectiveness of risperidone with carbamazepine
● Additive CNS depression with CNS depressants, such as 
alcohol, antihistamines, sedative/hypnotics, or opioid 
analgesics 
● Increased effects of clozapine and valproate with risperidone 
● Additive hypotension with antihypertensive agents 
● Additive orthostatic hypotension with coadministration of 
other drugs that result in this adverse reaction
● Additive anticholinergic effects with anticholinergic agents
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● Serious life-threatening arrhythmias with drugs known to 
prolong QT interval (e.g., antiarrhythmics [e.g., quinidine, 
procainamide, amiodarone, sotalol], chlorpromazine, 
thiroidazine, gatifl oxacin, moxifl oxacin, pentamidine,
levomethadyl) 
Route and Dosage 
RISPERIDONE (Risperdal) 
Bipolar Mania: Adults: PO: 2 to 3 mg/day as a single daily dose; 
dose may be increased at 24-hour intervals by 1 mg (range 
1 to 6 mg/day). 
Children: Initial dose: 0.5 mg once daily as a single daily dose. 
May increase at 24-hour intervals by 0.5 or 1 mg/day, to a 
recommended dose of 2.5 mg/day. 
Schizophrenia: Adults: PO: Initial dose: 2 mg/day administered 
in a single dose or in 2 divided doses. May increase in 
increments of 1 to 2 mg/day at intervals of 24 hours to a 
recommended dose of 4 to 8 mg/day.
Adolescents (13 to 17 years): Initial dose: 0.5 mg once daily as a 
single dose. May increase in increments of 0.5 or 1 mg/day 
at intervals of 24 hours to a recommended dose of 3 mg/day. 
IM: 25 mg every 2 weeks; some patients may require larger 
dose of 37.5 or 50 mg every 2 weeks. 
Irritability Associated with Autistic Disorder: PO: Children 
and adolescents (5 to 16 years weighing <20 kg): 0.25 mg/day 
initially. After at least 4 days of therapy, may increase to 
0.5 mg/day. Dose increases in increments of 0.25 mg/day may 
be considered at 2 week or longer intervals. May be as a single 
or divided dose. 
Children and adolescents (5 to 16 years weighing >20 kg): 0.5 mg/day
initially. After at least 4 days of therapy, may increase to 
1.0 mg/day. Dose increases in increments of 0.5 mg/day may 
be considered at 2-week or longer intervals. May be as a single 
or divided dose. 
PALIPERIDONE (Invega) 
Schizophrenia: Adults: PO: 6 mg as a single daily dose. After 
clinical assessment, dose increases may be made at intervals 
of more than 5 days. When dose increases are indicated, 
small increments of 3 mg/day are recommended. Maximum 
recommended dose: 12 mg/day. 
ILOPERIDONE (Fanapt) 
Schizophrenia: Adults: PO: Initiate treatment with 1 mg 2 times 
a day on the ﬁ rst day, then 2 mg 2 times a day the second day, 
then increase by 2 mg/day every day until a target dose of 12 to 
24 mg/day given in two divided doses is reached. 
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ZIPRASIDONE (Geodon) 
Schizophrenia: Adults: PO: Initial dosage: 20 mg 2 times a day 
with food. May increase dosage by intervals of at least 2 days 
up to a dosage of 80 mg 2 times a day. 
Bipolar Mania: Adults: PO: Initial dosage: 40 mg 2 times a day 
with food. On the second day of treatment, increase dose to 
60 or 80 mg 2 times a day. Adjust dosage on the basis of toleration 
and efﬁ cacy within the range of 40 to 80 mg 2 times a day. 
Acute Agitation in Schizophrenia: Adults: IM: 10 to 20 mg 
as needed up to a maximum of 40 mg/day. May be given as 
10 mg every 2 hours or 20 mg every 4 hours. 
● CHEMICAL CLASS: QUINOLINONES
Example
Generic 
(Trade) 
Name 
Pregnancy 
Categories/
Half-life (hr) Indications
Available 
Forms (mg)
Aripiprazole
(Abilify)
C/75 (aripiprazole);
94 (metabolite)
● Schizophrenia
● Bipolar mania
● Major depression, 
adjunctive therapy
● Agitation associated 
with schizophrenia 
or bipolar mania (IM)
Tabs: 2, 5, 10, 15, 20, 30
Tabs (orally disintegrating): 
10, 15
Oral solution: 1/mL
Inj: 7.5 mL 
Action
● The efﬁ cacy of aripiprazole is thought to occur through a 
combination of partial agonist activity at D2 and 5-HT1A recep-
tors and antagonist activity at 5-HT2A receptors.
● Also exhibits antagonist activity at adrenergic α1 receptors. 
Contraindications and Precautions 
Contraindicated in: • Hypersensitivity • Lactation
Use Cautiously in: • History of seizures • Hepatic or renal 
impairment • Known cardiovascular or cerebrovascular disease 
• Conditions that cause hypotension (dehydration, hypovole-
mia, treatment with antihypertensive medication) • Conditions 
that increase the core body temperature (excessive exercise, ex-
posure to extreme heat, dehydration) • Patients with diabetes 
or risk factors for diabetes • Pregnancy (weigh beneﬁ ts of the 
drug to potential risk to fetus) • Children and adolescents (safety 
and effectiveness not established) • Elderly patients with dementia-
related psychosis (black box warning) 
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Adverse Reactions and Side Effects
● Headache
● Nausea and vomiting
● Constipation
● Anxiety, restlessness
● Insomnia
● Lightheadedness
● Drowsiness, sedation, somnolence
● Weight gain
● Blurred vision
● Increased salivation
● Extrapyramidal symptoms
● Hyperglycemia
● Disruption in the body’s ability to reduce core body 
temperature
Interactions
● Decreased plasma levels of aripiprazole with carbamazepine 
and other CYP3A4 inducers
● Increased plasma levels and potential for aripiprazole toxicity 
with CYP2D6 inhibitors, such as quinidine, fl uoxetine, and 
paroxetine
● Decreased metabolism and increased effects of aripiprazole 
with ketoconazole or other CYP3A4 inhibitors
● Additive hypotensive effects with antihypertensive drugs
● Additive CNS effects with alcohol and other CNS depressants
Route and Dosage 
Bipolar Mania: Adults: PO: Initial dose: 15 mg once daily. May 
increase to 30 mg/day based on clinical response. Maximum 
dosage: 30 mg/day. 
Children (10 to 17 years): PO: Initial dose: 2 mg/day. May in-
crease to 5 mg after 2 days and to 10 mg after 2 more days. If 
required, additional dose increases may be made in 5 mg/day 
increments. Maintenance dosage: 10 to 30 mg/day (maintain 
at lowest effective dose for symptom remission). 
Schizophrenia: Adults: PO: Initial dose: 10 or 15 mg/day as 
a single dose. Doses up to 30 mg have been used. Dosage 
increases should not be made before 2 weeks, the time required 
to achieve steady state. 
Children (13 to 17 years): PO: Initial dose: 2 mg/day. May in-
crease to 5 mg after 2 days and to 10 mg after 2 more days. If 
required, additional dose increases may be made in 5 mg/day 
increments. Maintenance dosage: 10 to 30 mg/day (maintain 
at lowest effective dose for symptom remission). 
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Major Depression, Adjunctive Therapy: Adults: PO: Initial 
dose: 2 to 5 mg as adjunctive treatment for patients already 
taking an antidepressant. May increase dosage in increments 
of 5 mg/day at intervals of at least 1 week. Maintenance dosage: 
2 to 15 mg/day. 
Agitation Associated with Schizophrenia or Bipolar 
Mania: Adults: IM: Usual dose: 9.75 mg. May use a dose of 
5.25 mg, based on clinical situation. May give additional doses 
up to a maximum of 30 mg/day if needed for agitation. 
●  CHEMICAL CLASS: DIBENZO-OXEPINO 
PYRROLE
Example 
Generic 
(Trade) 
Name 
Pregnancy 
Categories/
Half-life (hr) Indications
Available 
Forms (mg)
Asenapine
(Saphris)
C/24 ● Schizophrenia
● Bipolar mania
Tabs (Sublingual): 5,10
Action
● Efﬁ cacy in schizophrenia is achieved through a combination 
of dopamine and serotonin type 2 (5-HT2) antagonism.
● Mechanism of action in the treatment of acute manic episodes 
is unknown. 
Contraindications and Precautions: 
Contraindicated in: • Hypersensitivity • Lactation • History 
of QT prolongation or arrhythmias • Concurrent use of other 
drugs known to prolong QT interval
Use Cautiously in: • Patients with hepatic, renal, or car-
diovascular insufﬁ ciency • Diabetes or risk factors for diabe-
tes • Patients with preexisting low WBC count and/or history 
of drug-induced leukopenia/neutropenia • History of seizures 
• History of suicide attempt • Patients at risk for aspiration pneu-
monia • Pregnancy and children (safety not established) • Elderly 
patients with dementia-related psychosis (black box warning)
Adverse Reactions and Side Effects
● Constipation
● Dry mouth
● Nausea and vomiting
● Weight gain
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● Restlessness
● Extrapyramidal symptoms
● Drowsiness, dizziness
● Insomnia
● Headache 
Interactions
● Increased effects of asenapine with fl uvoxamine, imipra-
mine, or valproate
● Decreased effects of asenapine with carbamazepine, cimeti-
dine, or paroxetine
● Increased effects of paroxetine or dextromethorphan with 
asenapine
● Increased CNS depression with alcohol or other CNS 
depressants 
● Increased hypotension with antihypertensives
● Additive effects on QT interval prolongation with quinidine, 
dofetilide, other Class Ia and III antiarrhythmics, pimozide, 
sotalol, thioridazine, chlorpromazine, fl oquine, pentama-
dine, arsenic trioxide, mefl oquine, dolasetron, tacrolimus, 
droperidol, gatifl oxacin, or moxifl oxacin
Route and Dosage 
ASENAPINE (Saphris)
Schizophrenia: Adults: PO: Usual starting and target dose: 
5 mg 2 times a day. The safety of doses above 10 mg 2 times a 
day has not been evaluated in clinical trials. 
Bipolar Disorder: Adults: PO: Recommended initial dose: 
10 mg 2 times a day. The dose can be decreased to 5 mg 
2 times a day if there are adverse effects. The safety of doses 
above 10 mg 2 times a day has not been evaluated in clinical 
trials. 
●  NURSING DIAGNOSES RELATED 
TO ALL ANTIPSYCHOTIC AGENTS
 1. Risk for other-directed violence related to panic anxiety and 
mistrust of others.
 2. Risk for injury related to medication side effects of sedation, 
photosensitivity, reduction of seizure threshold, agranulocy-
tosis, extrapyramidal symptoms, tardive dyskinesia, neuro-
leptic malignant syndrome, and/or QT prolongation.
 3. Risk for activity intolerance related to medication side effects 
of sedation, blurred vision, and/or weakness.
 4. Noncompliance with medication regimen related to suspi-
ciousness and mistrust of others.
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●  NURSING IMPLICATIONS 
FOR ANTIPSYCHOTIC AGENTS
The plan of care should include monitoring for the following 
side effects from antipsychotic medications. Nursing implica-
tions related to each side effect are designated by an asterisk (*). 
A proﬁ le of side effects comparing various antipsychotic medi-
cations is presented in Table 28-1.
 1. Anticholinergic effects (see Table 28-1 for differences 
between typicals and atypicals) 
 a. Dry mouth
 * Provide the client with sugarless candy or gum, ice, and 
frequent sips of water.
 * Ensure that client practices strict oral hygiene.
 b. Blurred vision
 * Explain that this symptom will most likely subside after 
a few weeks.
 * Advise client not to drive a car until vision clears.
 * Clear small items from pathway to prevent falls.
 c. Constipation
 * Order foods high in ﬁ ber; encourage increase in physi-
cal activity and ﬂ uid intake if not contraindicated.
 d. Urinary retention
 * Instruct client to report any difﬁ culty urinating; moni-
tor intake and output.
 2. Nausea; gastrointestinal (GI) upset (may occur with all 
classiﬁ cations) 
 * Tablets or capsules may be administered with food to mini-
mize GI upset.
 * Concentrates may be diluted and administered with fruit 
juice or other liquid; they should be mixed immediately 
before administration.
 3. Skin rash (may occur with all classiﬁ cations)
 * Report appearance of any rash on skin to physician.
 * Avoid spilling any of the liquid concentrate on skin; contact 
dermatitis can occur.
 4. Sedation (see Table 28-1 for differences between typicals 
and atypicals)
 * Discuss with physician possibility of administering drug at 
bedtime.
 * Discuss with physician possible decrease in dosage or order 
for less sedating drug.
 * Instruct client not to drive or operate dangerous equipment 
while experiencing sedation.
 5. Orthostatic hypotension (see Table 28-1 for differences 
between typicals and atypicals) 
 * Instruct client to rise slowly from a lying or sitting position
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 * Monitor blood pressure (lying and standing) each shift; 
document and report signiﬁ cant changes.
 6. Photosensitivity (may occur with all classiﬁ cations) 
 * Ensure that client wears protective sunblock lotion, cloth-
ing, and sunglasses while spending time outdoors.
 7. Hormonal effects (may occur with all classiﬁ cations, but 
more common with typicals) 
 a. Decreased libido, retrograde ejaculation, gynecomastia 
(men) 
 * Provide explanation of the effects and reassurance of re-
versibility. If necessary, discuss with physician possibil-
ity of ordering alternate medication.
 b. Amenorrhea (women) 
 * Offer reassurance of reversibility; instruct client to con-
tinue use of contraception, because amenorrhea does 
not indicate cessation of ovulation.
 c. Weight gain (may occur with all classiﬁ cations; has been 
problematic with the atypicals) 
 * Weigh client every other day; order calorie-controlled 
diet; provide opportunity for physical exercise; provide 
diet and exercise instruction.
 8. ECG Changes. ECG changes, including prolongation of 
the QT interval, are possible with most of the antipsychot-
ics. This is particularly true with ziprasidone, thioridazine, 
pimozide, haloperidol, paliperidone, iloperidone, asenapine, 
and clozapine. Caution is advised in prescribing these medica-
tions to individuals with history of arrhythmias. Conditions 
that produce hypokalemia and/or hypomagnesemia, such as 
diuretic therapy or diarrhea, should be taken into consider-
ation when prescribing. Routine ECG should be taken before 
initiation of therapy and periodically during therapy. Clozap-
ine has also been associated with other cardiac events, such 
as ischemic changes, arrhythmias, congestive heart failure, 
myocarditis, and cardiomyopathy.
 * Monitor vital signs every shift.
 * Observe for symptoms of dizziness, palpitations, syncope, 
weakness, dyspnea, and peripheral edema.
 9. Reduction of seizure threshold (more common with typi-
cals than the atypicals, with the exception of clozapine) 
 * Closely observe clients with history of seizures.
 * NOTE: This is particularly important with clients tak-
ing clozapine (Clozaril), with which seizures have been 
frequently associated. Dose appears to be an important 
predictor, with a greater likelihood of seizures occurring 
at higher doses. Extreme caution is advised in prescribing 
clozapine for clients with history of seizures.
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 10. Agranulocytosis (more common with typicals than the 
atypicals, with the exception of clozapine) 
 * It usually occurs within the ﬁ rst 3 months of treatment. 
Observe for symptoms of sore throat, fever, malaise. 
A complete blood count should be monitored if these 
symptoms appear.
 * EXCEPTION: There is a signiﬁ cant risk of agranulo-
cytosis with clozapine (Clozaril). Agranulocytosis is a 
potentially fatal blood disorder in which the client’s 
white blood cell (WBC) count can drop to extremely low 
levels. A baseline WBC count and absolute neutrophil 
count (ANC) must be taken before initiation of treatment 
with clozapine and weekly for the ﬁ rst 6 months of treat-
ment. Only a 1-week’s supply of medication is dispensed 
at a time. If the counts remain within the acceptable
levels (i.e., WBC at least 3,500/mm3 and the ANC at least 
2,000/mm3) during the 6-month period, blood counts 
may be monitored biweekly, and a 2-week supply of medi-
cation may then be dispensed. If for a 6-month period the 
counts remain within the acceptable level for the biweekly 
period, counts may then be monitored every 4 weeks 
thereafter. When the medication is discontinued, weekly 
WBC counts are continued for an additional 4 weeks.
 11. Hypersalivation (most common with clozapine) 
 * A signiﬁ cant number of clients receiving clozapine 
(Clozaril) therapy experience extreme salivation. Offer 
support to the client, as this may be an embarrassing 
situation. It may even be a safety issue (e.g., risk of as-
piration), if the problem is very severe. Management has 
included the use of sugar-free gum to increase the swal-
lowing rate, as well as the prescription of medications 
such as an anticholinergic (e.g., scopolamine patch) or 
alpha2-adrenoceptor agonist (e.g., clonidine).
 12. Extrapyramidal symptoms (EPS) (see Table 28-1 for dif-
ferences between typicals and atypicals) 
 * Observe for symptoms and report; administer an-
tiparkinsonian drugs, as ordered (see Chapter 29)
 a. Pseudoparkinsonism (tremor, shufﬂ ing gait, drooling, 
rigidity)
 * Symptoms may appear 1 to 5 days following initia-
tion of antipsychotic medication; occurs most often in 
women, the elderly, and dehydrated clients. 
 b. Akinesia (muscular weakness) 
 * Same as pseudoparkinsonism. 
 c. Akathisia (continuous restlessness and ﬁ dgeting) 
 * This occurs most frequently in women; symptoms may 
occur 50 to 60 days following initiation of therapy. 
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 d. Dystonia (involuntary muscular movements [spasms] of 
face, arms, legs, and neck) 
 * This occurs most often in men and in people younger 
than 25 years. 
 e. Oculogyric crisis (uncontrolled rolling back of the eyes) 
 * This may appear as part of the syndrome described 
as dystonia. It may be mistaken for seizure activity. 
Dystonia and oculogyric crisis should be treated as 
an emergency situation. The physician should be 
contacted, and intravenous benztropine mesylate 
(Cogentin) is commonly administered. Stay with 
the client and offer reassurance and support during 
this frightening time. 
 13. Tardive dyskinesia (bizarre facial and tongue movements, 
stiff neck, and difﬁ culty swallowing) (may occur with all clas-
siﬁ cations, but more common with typical antipsychotics) 
 * All clients receiving long-term (months or years) antipsy-
chotic therapy are at risk.
 * Symptoms are potentially irreversible.
 * Drug should be withdrawn at ﬁ rst sign, which is usually 
vermiform movements of the tongue; prompt action may 
prevent irreversibility. 
 14. Neuroleptic malignant syndrome (NMS) (more common 
with the typicals than the atypicals) 
 * This is a relatively rare, but potentially fatal, complication 
of treatment with neuroleptic drugs. Routine assessments 
should include temperature and observation for parkinso-
nian symptoms.
 *  Onset can occur within hours or even years after drug 
initiation, and progression is rapid over the following 24 
to 72 hours.
 * Symptoms include severe parkinsonian muscle rigidity, 
very high fever, tachycardia, tachypnea, ﬂ uctuations in 
blood pressure, diaphoresis, and rapid deterioration of 
mental status to stupor and coma.
 * Discontinue neuroleptic medication immediately.
 * Monitor vital signs, degree of muscle rigidity, intake and 
output, level of consciousness.
 * The physician may order bromocriptine (Parlodel) or 
dantrolene (Dantrium) to counteract the effects of NMS. 
 15. Hyperglycemia and diabetes (more common with atypicals)
 * studies have suggested an increased risk of treatment-
emergent hyperglycemia-related adverse events in clients 
using atypical antipsychotics (e.g., risperidone, clozap-
ine, olanzapine, quetiapine, ziprasidone, asenapine, and 
aripiprazole). The FDA recommends that clients with dia-
betes starting on atypical antipsychotic drugs be monitored 
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regularly for worsening of glucose control. Clients with risk 
factors for diabetes should undergo fasting blood glucose 
testing at the beginning of treatment and periodically there-
after. All clients taking these medications should be moni-
tored for symptoms of hyperglycemia (polydipsia, polyuria, 
polyphagia, and weakness). If these symptoms appear during 
treatment, the client should undergo fasting blood glucose 
testing.
 16. Increased risk of mortality in elderly patients with 
dementia-related psychosis. 
 * Recent studies have indicated that elderly patients with 
dementia-related psychosis who are treated with antipsy-
chotic drugs are at increased risk of death, compared with 
placebo. Causes of death are most commonly related to 
infections or cardiovascular problems. All antipsychotic 
drugs now carry black box warnings to this effect. They 
are not approved for treatment of elderly patients with 
dementia-related psychosis. 
●  CLIENT/FAMILY EDUCATION RELATED 
TO ALL ANTIPSYCHOTICS
● Use caution when driving or operating dangerous machinery. 
Drowsiness and dizziness can occur.
● Do not stop taking the drug abruptly after long-term use. To 
do so might produce withdrawal symptoms, such as nausea, 
vomiting, dizziness, gastritis, headache, tachycardia, insom-
nia, and tremulousness.
● Use sunblock lotion and wear protective clothing when spend-
ing time outdoors. Skin is more susceptible to sunburn, which 
can occur in as little as 30 minutes.
● Report weekly (if receiving clozapine therapy) to have blood 
levels drawn and to obtain a weekly supply of the drug.
● Report occurrence of any of the following symptoms to the 
physician immediately: sore throat, fever, malaise, unusual 
bleeding, easy bruising, persistent nausea and vomiting, se-
vere headache, rapid heart rate, fainting, difﬁ culty urinating, 
muscle twitching, tremors, darkly colored urine, excessive 
urination, excessive thirst, excessive hunger, weakness, pale 
stools, yellow skin or eyes, muscular incoordination, or skin 
rash.
● Rise slowly from a sitting or lying position to prevent a sudden 
drop in blood pressure.
● Take frequent sips of water, chew sugarless gum, or suck on 
hard candy, if experiencing a problem with dry mouth. Good 
oral care (frequent brushing, ﬂ ossing) is very important.
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● Consult the physician regarding smoking while taking this 
medication. Smoking increases the metabolism of some anti-
psychotics, possibly requiring adjustment in dosage to achieve 
therapeutic effect.
● Dress warmly in cold weather and avoid extended exposure to 
very high or low temperatures. Body temperature is harder to 
maintain with this medication.
● Do not drink alcohol while on antipsychotic therapy. These 
drugs potentiate each other’s effects.
● Do not consume other medications (including over-the-counter 
products) without physician’s approval. Many medications con-
tain substances that interact with antipsychotics in a way that 
may be harmful.
● Be aware of possible risks of taking antipsychotic medication 
during pregnancy. Safe use during pregnancy and lactation 
has not been established. Antipsychotics are thought to read-
ily cross the placental barrier; if so, a fetus could experience 
adverse effects of the drug. Inform the physician immediately 
if pregnancy occurs, is suspected, or is planned.
● Be aware of side effects of antipsychotic drugs. Refer to writ-
ten materials furnished by health care providers for safe self-
administration.
● Continue to take medication, even if feeling well and as 
though it is not needed. Symptoms may return if medication 
is discontinued.
● Carry card or other identiﬁ cation at all times describing medi-
cations being taken.
 INTERNET REFERENCES
 a. http://www.rxlist.com
 b. http://www.nimh.nih.gov/publicat/medicate.cfm
 c. http://www.fadavis.com/townsend
 d. http://www.mentalhealth.com/
 e. http://www.nlm.nih.gov/medlineplus/druginformation
.html
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● CHEMICAL CLASS: ANTICHOLINERGICS
Examples
Generic (Trade) 
Name
Pregnancy 
Categories/
Half-life (hours) Indications
Available 
Forms (mg) 
Benztropine 
(Cogentin)
C/Unknown ● Parkinsonism
● Drug-induced 
extrapyramidal 
symptoms
Tabs: 0.5, 1, 2
Inj: 1/mL
Biperiden 
(Akineton)
C/18.4–24.3 ● Parkinsonism
● Drug-induced 
extrapyramidal 
symptoms
Tabs: 2
Trihexyphenidyl C/5.6–10.2 ● Parkinsonism
● Drug-induced 
extrapyramidal 
symptoms
Tabs: 2, 5
Elixir: 2/5 mL
Diphenhydramine 
(Benadryl)
B/4–15 ● Parkinsonism
● Drug-induced 
extrapyramidal 
symptoms
● Motion sickness
● Allergy reactions
● Nighttime sleep 
aid
● Cough suppressant 
Tabs and Caps: 25, 50
Tabs (orally 
disintegrating): 
12.5
Tabs, chewable: 
12.5, 25
Strips (orally disinte- 
grating): 12.5, 25
Elixir/syrup/oral solu: 
12.5/5 mL
Inj: 50/mL
* This chapter includes only those antiparkinsonian agents indicated 
for the treatment of antipsychotic-induced extrapyramidal symptoms 
or neuroleptic malignant syndrome (bromocriptine). 
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Action
● Blocks acetylcholine receptors to diminish excess cholinergic 
effects. May also inhibit the reuptake and storage of dopamine 
at central dopamine receptors, thereby prolonging the action 
of dopamine.
● Diphenhydramine also blocks histamine release by compet-
ing with histamine for H1-receptor sites. Decreased allergic 
response and somnolence are effected by diminished hista-
mine activity. 
Contraindications and Precautions
Contraindicated in: • Hypersensitivity • Angle-closure glau-
coma • Pyloric or duodenal obstruction • Peptic ulcers • Pros-
tatic hypertrophy • Bladder neck obstructions • Megaesophagus 
• Megacolon • Myasthenia gravis • Lactation • Children (except 
diphenhydramine) 
Use Cautiously in: • Tachycardia • Cardiac arrhythmias 
• Hypertension • Hypotension • Tendency toward urinary 
retention • Clients exposed to high environmental temperatures 
• Pregnancy
Adverse Reactions and Side Effects
● Dry mouth 
● Blurred vision 
● Constipation 
● Paralytic ileus 
● Urinary retention 
● Tachycardia
● Agitation, nervousness 
● Decreased sweating 
● Elevated temperature 
● Nausea/vomiting
● Sedation 
● Dizziness 
● Exacerbation of psychoses 
● Orthostatic hypotension
Interactions
● (Diphenhydramine): Additive sedative effects with central 
nervous system (CNS) depressants
● Increased effects of beta-blockers with diphenhydramine
● Additive anticholinergic effects with other drugs that have 
anticholinergic properties
● Anticholinergic drugs counteract the cholinergic effects of 
bethanechol.
● Possible increased digoxin levels with anticholinergics
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● Concomitant use of anticholinergics with haloperidol may 
result in worsening of psychotic symptoms, decreased halo-
peridol serum levels, and development of tardive dyskinesia.
● Possible decreased efﬁ cacy of phenothiazines and in-
creased incidence of anticholinergic side effects with con-
comitant use 
● Decreased effects of levodopa with concomitant use
Route and Dosage 
BENZTROPINE  (Cogentin)
Parkinsonism: Adults: PO: 1 to 2 mg/day in 1 to 2 divided 
doses (range 0.5 to 6 mg/day). 
Drug-induced Extrapyramidal Symptoms: Adults: PO: 1 to 
4 mg given 1 or 2 times a day. 
Acute Dystonic Reactions: Adults: IM, IV: 1 to 2 mg, then 1 
to 2 mg PO 2 times a day. 
BIPERIDEN (Akineton) 
Parkinsonism: Adults: PO: 2 mg 3 or 4 times a day, not to 
exceed 16 mg/24 hours. 
Drug-induced Extrapyramidal Symptoms: Adults: PO: 2 mg 
1 to 3 times a day. 
TRIHEXYPHENIDYL 
Parkinsonism: Adults: PO: Initial dose: 1 mg on day 1; increase 
by 2 mg increments at 3- to 5-day intervals, up to a daily dose 
of 6 to 10 mg in 3 divided doses taken at mealtimes. 
Drug-induced Extrapyramidal Symptoms: Adults: PO: 
Initial dosage: 1 mg. Repeat dosage every few hours until 
symptoms are controlled. Maintenance or prophylactic use: 
5 to 15 mg/day. 
DIPHENHYDRAMINE  (Benadryl) 
Parkinsonism and Drug-induced Extrapyramidal 
Symptoms/Motion Sickness/Allergy Reactions: Adults 
and children ≥12 years: PO: 25 to 50 mg every 4 to 6 hours. 
Maximum dosage: 300 mg/day. IM/IV: Adults: 10 to 50 mg 
IV or 100 mg IM. Maximum daily dose: 400 mg.
Children 6 to 12 years: PO: 12.5 to 25 mg every 4 to 6 hours, not 
to exceed 150 mg/day. 
Nighttime Sleep Aid: Adults and children ≥12 years: 50 mg at 
bedtime. 
Cough Suppressant: Adults and children ≥12 years: PO 
Liquid: 25 to 50 mg every 4 hours, not to exceed 300 mg/day. 
PO Syrup: 25 mg every 4 hours, not to exceed 150 mg/day.
Children 6 to 12 years: PO Liquid: 12.5 to 25 mg every 4 hours, 
not to exceed 150 mg/day.
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PO Syrup: 12.5 mg every 4 hours, not to exceed 75 mg/day.
Children 2 to 6 years: PO Syrup: 6.25 mg every 4 hours, not to 
exceed 25 mg/day. 
●  CHEMICAL CLASS: DOPAMINERGIC 
AGONISTS
Examples
Action
● Amantadine increases dopamine at the receptor either by re-
leasing intact striatal dopamine stores or by blocking neuronal 
dopamine reuptake. It also inhibits the replication of inﬂ uenza 
A virus isolates from each of the subtypes.
● Bromocriptine increases dopamine by direct stimulation of 
dopamine receptors. 
Contraindications and Precautions 
Contraindicated in: 
Amantadine 
● Hypersensitivity to the drug 
● Pregnancy, lactation, and in children under 1 year (safety not 
established) 
● Angle closure glaucoma
Bromocriptine 
● Hypersensitivity to this drug, other ergot alkaloids, or sulﬁ tes 
(contained in some preparations)
● Uncontrolled hypertension
● Pregnancy and lactation; children younger than 15 years 
(safety not established) 
Use Cautiously in: • Hepatic or renal impairment • Un-
controlled psychiatric disturbances • History of congestive 
Generic (Trade) 
Name
Pregnancy 
Categories/
Half-life (hr) Indications
Available 
Forms (mg) 
Amantadine 
(Symmetrel)
C/10–25 ● Parkinsonism
● Drug-induced extrapyramidal 
symptoms
● Prophylaxis and treatment of 
Infl uenza A viral infection
Tabs, Caps: 100
Syrup: 50/5 mL
Bromocriptine 
(Parlodel)
B/8–20 ● Parkinsonism
● Hyperprolactinemia-
associated dysfunctions
● Acromegaly
● Neuroleptic malignant 
syndrome
Tabs: 2.5
Caps: 5
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heart failure, myocardial infarction, or ventricular arrhythmia 
• Elderly or debilitated clients • Orthostatic hypotension
Amantadine 
● Clients with a history of seizures
● Concurrent use of CNS stimulants 
Bromocriptine 
● Clients with history of peptic ulcer or gastrointestinal 
bleeding
Adverse Reactions and Side Effects
Amantadine
● Nausea
● Dizziness
● Insomnia; somnolence
● Depression; anxiety
● Hallucinations
● Arrhythmia; tachycardia
● Dry mouth
● Blurred vision
Bromocriptine
● Nausea and vomiting
● Headache; dizziness; drowsiness
● Orthostatic hypotension
● Confusion
● Constipation; diarrhea
● Skin mottling
● Exacerbation of Raynaud syndrome
● Ataxia
Interactions
The effects of: Are increased by: Are decreased by:
Concurrent use may 
result in: 
Amantadine Quinidine, quinine, 
triamterene, 
thiazine diuretics, 
trimethoprim/
sulfamethoxazole, 
thioridazine
Potentiation of 
anticholinergic 
side effects with 
anticholinergic 
agents; increased 
effects of CNS 
stimulants with 
concurrent use.
Bromocriptine Erythromycin, 
sympathomimetics, 
isometheptene, 
phenylpropanolamine
Phenothiazines 
(and other 
antipsychotics), 
metoclopramide
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Route and Dosage 
AMANTADINE  (Symmetrel) 
Parkinsonism: Adults: PO: 100 mg 1 to 2 times/day (up to 
400 mg/day). 
Drug-induced Extrapyramidal Symptoms: Adults: PO: 
100 mg 2 times a day (up to 300 mg/day in divided doses). 
Inﬂ uenza A Viral Infection: Adults and children >12 years: PO: 
200 mg/day as a single dose or 100 mg 2 times a day.
Children 9 to 12 years: PO: 200 mg as a single dose or 100 mg 
2 times a day.
Children 1 to 9 years: PO: 4.4 to 8.8 mg/kg/day given once daily 
or divided 2 times a day, not to exceed 150 mg/day. 
BROMOCRIPTINE  (Parlodel) 
Parkinsonism: Adults: PO: Initial dose: 1.25 mg 2 times a 
day with meals. May increase dosage every 2 to 4 weeks by 
2.5 mg/day with meals. Usual range is 10 to 40 mg/day. If 
adverse reactions necessitate reduction in dosage, reduce dose 
gradually in 2.5 mg increments. 
Hyperprolactinemia-associated Dysfunctions: Adults: PO: 
Initial dose: 1.25 to 2.5 mg/day with meals. May increase by 
2.5 mg every 2 to 7 days. Usual therapeutic dosage range: 2.5 
to 15 mg/day. 
Acromegaly: Adults: PO: Initial dose: 1.25 to 2.5 mg for 
3 days (with food) at bedtime. May increase by 1.25 to 2.5 mg/
day every 3 to 7 days. Usual therapeutic dosage range: 20 to 
30 mg/day. Maximum dosage: 100 mg/day. 
Neuroleptic Malignant Syndrome: Adult: PO: 5 mg every 
4 hours. 
●  NURSING DIAGNOSES RELATED 
TO ANTIPARKINSONIAN AGENTS
 1. Risk for injury related to symptoms of Parkinson’s disease or 
drug-induced EPS.
 2. Hyperthermia related to anticholinergic effect of decreased 
sweating.
 3. Activity intolerance related to side effects of drowsiness, diz-
ziness, ataxia, weakness, confusion.
 4. Deﬁ cient knowledge related to medication regimen. 
●  NURSING IMPLICATIONS FOR 
ANTIPARKINSONIAN AGENTS
The plan of care should include monitoring for the follow-
ing side effects from antiparkinsonian medications. Nursing 
implications related to each side effect are designated by an 
asterisk (*). 
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 1. Anticholinergic Effects. These side effects are identical to 
those produced by antipsychotic drugs. Taking both medica-
tions compounds these effects. For this reason, the physician 
may elect to prescribe an antiparkinsonian agent only at the 
onset of EPS, rather than as routine adjunctive therapy.
 a.  Dry Mouth
 * Offer sugarless candy or gum, ice, frequent sips of 
water.
 * Ensure that client practices strict oral hygiene.
 b. Blurred Vision
 * Explain that symptom will most likely subside after a 
few weeks.
 * Offer to assist with tasks requiring visual acuity. 
 c. Constipation
 * Order foods high in ﬁ ber; encourage increase in physi-
cal activity and ﬂ uid intake, if not contraindicated. 
 d. Paralytic Ileus
 * A rare, but potentially very serious side effect of anti-
cholinergic drugs. Monitor for abdominal distension, 
absent bowel sounds, nausea, vomiting, epigastric pain.
 * Report any of these symptoms to physician immediately.
 e. Urinary Retention
 * Instruct client to report any difﬁ culty urinating; moni-
tor intake and output. 
 f. Tachycardia, Decreased Sweating, Elevated Tem-
perature
 * Assess vital signs each shift; document and report 
signiﬁ cant changes to physician.
 * Ensure that client remains in cool environment, be-
cause the body is unable to cool itself naturally with 
this medication. 
 2. Nausea, Gastrointestinal (GI) Upset
* May administer tablets or capsules with food to minimize 
GI upset. 
 3. Sedation, Drowsiness, Dizziness
* Discuss with physician possibility of administering drug at 
bedtime.
* Discuss with physician possible decrease in dosage or 
order for less sedating drug.
* Instruct client not to drive or use dangerous equipment 
while experiencing sedation or dizziness. 
 4. Exacerbation of Psychoses
* Assess for signs of loss of contact with reality.
* Intervene during a hallucination; talk about real people 
and real events; reorient client to reality.
* Stay with client during period of agitation and delirium; 
remain calm and reassure client of his or her safety.
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* Discuss with physician possible decrease in dosage or 
change in medication. 
 5. Orthostatic Hypotension
* Instruct client to rise slowly from a lying or sitting 
position; monitor blood pressure (lying and standing) each 
shift; document and report signiﬁ cant changes.
●  CLIENT/FAMILY EDUCATION RELATED 
TO ALL ANTIPARKINSONIAN AGENTS
● Take the medication with food if GI upset occurs.
● Use caution when driving or operating dangerous machinery. 
Drowsiness and dizziness can occur.
● Do not stop taking the drug abruptly. To do so might produce 
unpleasant withdrawal symptoms.
● Report occurrence of any of the following symptoms to the 
physician immediately: pain or tenderness in area in front of 
ear; extreme dryness of mouth; difﬁ culty urinating; abdomi-
nal pain; constipation; fast, pounding heart beat; rash; visual 
disturbances; mental changes.
● Rise slowly from a sitting or lying position to prevent a sudden 
drop in blood pressure.
● Stay inside in air-conditioned room when weather is very 
hot. Perspiration is decreased with antiparkinsonian agents, 
and the body cannot cool itself as well. There is greater sus-
ceptibility to heat stroke. Inform physician if air-conditioned 
housing is not available.
● Take frequent sips of water, chew sugarless gum, or suck 
on hard candy if dry mouth is a problem. Good oral care 
(frequent brushing, ﬂ ossing) is very important.
● Do not drink alcohol while on antiparkinsonian therapy.
● Do not consume other medications (including over-the-
counter products) without physician’s approval. Many medica-
tions contain substances that interact with antiparkinsonian 
agents in a way that may be harmful.
● Be aware of possible risks of taking antiparkinsonian agents 
during pregnancy. Safe use during pregnancy and lactation 
has not been fully established. It is thought that antiparkin-
sonian agents readily cross the placental barrier; if so, fetus 
could experience adverse effects of the drug. Inform phy-
sician immediately if pregnancy occurs, is suspected, or is 
planned.
● Be aware of side effects of antiparkinsonian agents. Refer to 
written materials furnished by health-care providers for safe 
self-administration.
● Continue to take medication, even if feeling well and as 
though it is not needed. Symptoms may return if medication is 
discontinued.
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● Carry card or other identiﬁ cation at all times describing 
medications being taken.
 INTERNET REFERENCES
 a. http://www.rxlist.com
 b. http://www.nimh.nih.gov/publicat/medicate.cfm
 c. http://www.fadavis.com/townsend
 d. http://www.mentalhealth.com
 e. http://www.nlm.nih.gov/medlineplus/druginformation
.html 
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Sedative-Hypnotics
511
● CHEMICAL CLASS: BENZODIAZEPINES
Examples
Generic 
(Trade) 
Name
Controlled/
Pregnancy 
Categories
Half-life 
(hr) Indications
Available 
Forms (mg)
Estazolam CIV/X 8–28 ● Insomnia Tabs: 1, 2
Flurazepam 
(Dalmane)
CIV/(Contraindicated 
in pregnancy)
2–3 (active 
metabolite, 
47–100)
● Insomnia Caps: 15, 30
Quazepam 
(Doral)
CIV/X 41 (active 
metabolite, 
47–100)
● Insomnia Tabs: 7.5, 15
Temazepam 
(Restoril)
CIV/X 9–15 ● Insomnia Caps: 7.5, 15, 
22.5, 30
Triazolam 
(Halcion)
CIV/X 1.5–5.5 ● Insomnia Tabs: 0.125, 0.25
Action
● Potentiate gamma-aminobutyric acid (GABA) neuronal 
inhibition 
● The sedative effects involve GABA receptors in the limbic, 
neocortical, and mesencephalic reticular systems. 
Contraindications and Precautions: 
Contraindicated in: • Hypersensitivity to these or other ben-
zodiazepines • Pregnancy and lactation • Respiratory depression 
and sleep apnea • (Triazolam): concurrent use with ketoconazole, 
itraconazole, or nefazodone, medications that impair the metabo-
lism of triazolam by cytochrome P450 3A (CYP3A) • (Flurazepam): 
Children younger than age 15 • (Estazolam, quazepam, temazepam, 
triazolam): Children younger than age 18 
Use Cautiously in: • Elderly and debilitated patients • Hepatic 
or renal dysfunction • Patients with history of drug abuse and 
dependence • Depressed or suicidal patients 
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Adverse Reactions and Side Effects
● Drowsiness 
● Headache 
● Confusion 
● Lethargy 
● Tolerance 
● Physical and psychological dependence 
● Potentiates the effects of other central nervous system (CNS) 
depressants 
● May aggravate symptoms in depressed persons 
● Palpitations; tachycardia; hypotension 
● Paradoxical excitement 
● Dry mouth 
● Nausea and vomiting 
● Blood dyscrasias 
Interactions
● Additive CNS depression with alcohol and other CNS 
depressants
● Decreased clearance and increased effects of benzodiazepines 
with cimetidine, oral contraceptives, disulfi ram, and 
isoniazid
● More rapid onset or more prolonged benzodiazepine effect 
with probenecid
● Increased clearance and decreased half-life of benzodiazepines 
with rifampin
● Increased benzodiazepine clearance with cigarette smoking
● Decreased pharmacological effects of benzodiazepines with 
theophylline
● Increased bioavailability of triazolam with macrolides
● Benzodiazepines may increase serum levels of digoxin and 
phenytoin and increase risk of toxicity
Route and Dosage 
ESTAZOLAM
Insomnia: Adults: PO: 1 to 2 mg at bedtime. 
Healthy elderly: PO: 1 mg at bedtime. Increase with caution.
Debilitated or small elderly patients: PO: 0.5 mg at bedtime. 
FLURAZEPAM  (Dalmane) 
Insomnia: Adults: PO: 15 to 30 mg at bedtime.
Elderly or debilitated: PO: 15 mg at bedtime. 
QUAZEPAM  (Doral) 
Insomnia: Adults: PO: 7.5 to 15 mg at bedtime.
Elderly or debilitated: PO: Initial dose: 7.5 mg at bedtime. If not 
effective after 1 or 2 nights, may increase to 15 mg. 
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TEMAZEPAM  (Restoril) 
Insomnia: Adults: PO: 15 to 30 mg at bedtime. 7.5 mg may be 
sufﬁ cient for some patients.
Elderly or debilitated: PO: 7.5 mg at bedtime. 
TRIAZOLAM  (Halcion) 
Insomnia: Adults: PO: 0.125 to 0.5 mg at bedtime.
Elderly or debilitated: PO: 0.125 to 0.25 mg at bedtime. 
● CHEMICAL CLASS: BARBITURATES
Examples
Generic 
(Trade) 
Name 
Controlled/
Pregnancy 
Categories
Half-life 
(hr) Indications
Available 
Forms (mg)
Amobarbital CII/D 16–40 ● Sedation
● Insomnia
Injection: powder, 
500/vial
Butabarbital 
(Butisol)
CIII/D 66–140 ● Sedation
● Insomnia
Tabs: 15, 30, 50
Elixir: 30/5 mL
Mephobarbital 
(Mebaral)
CIV/D 11–67 ● Sedation
● Epilepsy
Tabs: 32, 50, 100
Pentobarbital 
(Nembutal)
CII/D 15–50 ● Sedation
● Insomnia
● Preanesthetic 
● Acute convulsive 
episodes
Inj: 50/mL
Phenobarbital 
(Solfoton; 
Luminal)
CIV/D 53–118 ● Sedation
● Epilepsy
Tabs: 15, 16, 30, 60, 
90, 100
Caps: 16
Elixir: 15/5 mL; 
20/5 mL
Inj (mg/mL): 30, 60, 
65, 130
Secobarbital 
(Seconal)
CII/D 15–40 ● Preoperative 
sedation
● Insomnia
Caps: 100 
Action
● Depress the sensory cortex, decrease motor activity, and alter 
cerebellar function
● All levels of CNS depression can occur, from mild sedation to 
hypnosis to coma to death
● Can induce anesthesia in sufﬁ ciently high therapeutic doses
Contraindications and Precautions 
Contraindicated in: • Hypersensitivity to barbiturates • Severe 
hepatic, renal, cardiac, or respiratory disease • Individuals with
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history of drug abuse or dependence • Porphyria • Uncontrolled 
severe pain • Intra-arterial or subcutaneous administration 
• Lactation
Use Cautiously in: • Elderly and debilitated patients • Patients 
with hepatic, renal, cardiac, or respiratory impairment • Depressed 
or suicidal patients • Pregnancy • Children
Adverse Reactions and Side Effects
● Bradycardia
● Hypotension
● Somnolence
● Agitation
● Confusion
● Nausea, vomiting
● Constipation
● Skin rashes
● Respiratory depression
● Physical and psychological dependence
Interactions
● Additive CNS depression with alcohol and other CNS 
depressants
● Decreased effects of barbiturates with rifampin
● Increased effects of barbiturates with monoamine oxidase 
(MAO) inhibitors or valproic acid
● Decreased effects of the following drugs with concurrent use of 
barbiturates: anticoagulants, beta-blockers, carbamazepine, 
clonazepam, oral contraceptives, corticosteroids, digi-
toxin, doxorubicin, doxycycline, felodipine, fenoprofen, 
griseofulvin, metronidazole, phenylbutazone, quinidine, 
theophylline, chloramphenicol, and verapamil
● Concomitant use with methoxyfl urane may enhance renal 
toxicity.
Route and Dosage 
AMOBARBITAL
Sedation: Adults: IM: 30 to 50 mg, 2 or 3 times a day. 
Insomnia: Adults: IM: 65 to 200 mg at bedtime. 
NOTE: Do not inject a volume >5 mL IM at any one site 
regardless of drug concentration. Tissue irritation can occur.
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BUTABARBITAL  (Butisol) 
Daytime Sedation: Adults: PO: 15 to 30 mg, 3 or 4 times a day. 
Insomnia: Adults: PO: 50 to 100 mg at bedtime. 
Preoperative Sedation: Adults: PO: 50 to 100 mg, 60 to 
90 minutes before surgery. 
Children: PO: 2 to 6 mg/kg; maximum 100 mg. 
MEPHOBARBITAL  (Mebaral) 
Sedation: Adults: PO: 32 to 100 mg 3 or 4 times a day. Optimum 
dose: 50 mg 3 or 4 times a day.
Children: PO: 16 to 32 mg 3 or 4 times a day. 
Epilepsy: Adults: PO: 400 to 600 mg daily. 
Children <5 yr: PO: 16 to 32 mg 3 or 4 times a day.
Children >5 yr: PO: 32 to 64 mg 3 or 4 times a day. 
PENTOBARBITAL  (Nembutal) 
Sedation, Insomnia, Preanesthetic: IM: Adults: Usual 
dosage: 150 to 200 mg.
Children: 2 to 6 mg/kg as a single IM injection, not to exceed 
100 mg. 
NOTE: Inject deeply into large muscle mass. Do not exceed a vol-
ume of 5 mL at any one site because of possible tissue irritation. 
PHENOBARBITAL  (Luminal) 
Sedation: Adults: PO or IM: 30 to 120 mg/day in 2 to 3 divided 
doses not to exceed 400 mg/day
Children: PO: 2 mg/kg 3 times daily. 
Preoperative Sedation: Adults: IM only: 100 to 200 mg, 60 to 
90 minutes before the procedure
Children: PO, IM or IV: 1 to 3 mg/kg 60 to 90 minutes before 
the procedure.
Insomnia: Adults: PO: 100 to 200 mg at bedtime. 
IM or IV: 100 to 320 mg. 
Children: Route and dosage determined by age and weight.
Epilepsy: Adults: PO: 60 to 200 mg/day.
Children: PO: 3 to 6 mg/kg/day. 
SECOBARBITAL  (Seconal) 
Preoperative Sedation: Adults: PO: 200 to 300 mg 1 to 
2 hours before surgery.
Children: PO: 2 to 6 mg/kg, not to exceed 100 mg. 
Insomnia: Adults: PO: 100 mg at bedtime. 
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● CHEMICAL CLASS: MISCELLANEOUS
Examples
Generic 
(Trade) 
Name 
Controlled/
Pregnancy 
Categories
Half-life 
(hr) Indications
Available 
Forms (mg)
Chloral hydrate CIV/C 7–10 ● Sedation
● Insomnia
Caps: 500
Syrup: 250/5 mL; 
500/5 mL
Eszopiclone 
(Lunesta)
CIV/C 6 ● Insomnia Tabs: 1, 2, 3
Ramelteon 
(Rozerem)
Not controlled/ 
C
1–2.6 ● Insomnia Tabs: 8
Zaleplon (Sonata) CIV/C 1 ● Insomnia Caps: 5, 10
Zolpidem 
(Ambien)
CIV/B 2–3 ● Insomnia Tabs: 5, 10
Tabs CR: 6.25, 12.5
Tabs sublingual: 
5, 10
Spray solution, 
lingual: 5 per 
actuation
Action
Zolpidem and Zaleplon 
● Bind to GABA receptors in the CNS. Appear to be selective 
for the omega1-receptor subtype. 
Eszopiclone 
● Action as a hypnotic is unclear but thought to interact with 
GABA-receptor complexes near benzodiazepine receptors
Chloral Hydrate 
● Action unknown. Produces a calming effect through depres-
sion of the CNS.
● Has generally been replaced by safer and more effective agents.
Ramelteon 
● Ramelteon is a melatonin receptor agonist with high afﬁ nity 
for melatonin MT1 and MT2 receptors. 
Contraindications and Precautions 
Contraindicated in: • Hypersensitivity • In combination 
with other CNS depressants • Pregnancy and lactation 
Zolpidem, Zaleplon, Eszopiclone, Ramelteon 
● Children (safety not established)
Chloral Hydrate 
● Severe hepatic, renal, or cardiac impairment
● Esophagitis, gastritis, or peptic ulcer disease
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Ramelteon 
● Severe hepatic function impairment
● Concomitantly with ﬂ uvoxamine
Use Cautiously in: • Elderly or debilitated patients • De-
pressed or suicidal patients • Patients with history of drug abuse 
or dependence • Patients with hepatic, renal, or respiratory dys-
function • Patients susceptible to acute intermittent porphyria 
(chloral hydrate) 
Adverse Reactions and Side Effects
● Headache
● Drowsiness
● Dizziness
● Lethargy
● Amnesia
● Nausea
● Dry mouth
● Rash
● Paradoxical excitement
● Physical and/or psychological dependence
Chloral hydrate, eszopiclone 
● Unpleasant taste
Interactions
The effects 
of: Are increased by: Are decreased by:
Concurrent use may 
result in:
Chloral 
hydrate 
Alcohol and other 
CNS depressants 
including 
antihistamines, 
antidepressants, 
opioids, sedative/
hypnotics, 
antipsychotics
Increased effects of 
oral anticoagulants; 
symptoms of sweating, 
hot fl ashes, tachycardia, 
hypertension, weakness, 
and nausea with IV 
furosemide; decreased 
effects of phenytoin
Eszopiclone Drugs that inhibit the 
CYP3A4 enzyme 
system, including 
ketoconazole, 
itraconazole, 
clarithromycin, 
nefazodone, 
ritonavir, 
nelfi navir
Lorazepam; drugs 
that induce the 
CYP3A4 enzyme 
system, such as 
rifampin; taking 
eszopiclone with 
or immediately 
after a high-fat 
or heavy meal
Additive CNS depression 
with alcohol and other 
CNS depressants, in-
cluding antihistamines, 
antidepressants, 
opioids, sedative/
hypnotics,  
antipsychotics; 
decreased effects 
of lorazepam
Ramelteon Alcohol, azole 
antifungals, 
fl uoxetine
Rifampin; taking 
ramelteon with or 
immediately after a 
high-fat or heavy 
meal
Continued
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Route and Dosage 
CHLORAL HYDRATE 
Sedation: Adults: PO: 250 mg 3 times a day after meals. 
Maximum daily dose: 2 g.
Children: PO: 25 mg/kg/day, not to exceed 500 mg per single 
dose. May be given in divided doses. 
Insomnia: Adults: PO: 500 mg to 1 g 15 to 30 minutes before 
bedtime. 
Children: PO: 50 mg/kg/day, up to 1 g per single dose. May give 
in divided doses. 
ESZOPICLONE  (Lunesta) 
Insomnia: Adults: PO: 2 mg immediately before bedtime; may 
be increased to 3 mg if needed (3 mg dose is more effective for 
sleep maintenance).
Elderly patients: PO: 1 mg immediately before bedtime for 
patients who have difﬁ culty falling asleep; 2 mg immediately 
before bedtime for patients who have difﬁ culty staying asleep. 
RAMELTEON  (Rozerem) 
Insomnia: Adults: PO: 8 mg within 30 minutes of bedtime. 
It is recommended that ramelteon not be taken with or 
immediately after a high-fat meal. 
ZALEPLON  (Sonata) 
Insomnia: Adults: PO: 10 mg (range 5 to 20 mg) at bedtime.
Elderly and debilitated patients: PO: 5 mg at bedtime, not to 
exceed 10 mg. 
The effects 
of: Are increased by: Are decreased by:
Concurrent use may 
result in:
Zaleplon Cimetidine Drugs that induce the 
CYP3A4, enzyme 
system, including 
rifampin, phenytoin, 
carbamazepine, 
and phenobarbital; 
taking zaleplon with 
or immediately after 
a high-fat or heavy 
meal
Additive CNS depression 
with alcohol and other 
CNS depressants, in-
cluding antihistamines, 
antidepressants, 
opioids, sedative/
hypnotics, 
antipsychotics
Zolpidem Azole antifungals, 
ritonavir, SSRIs
Flumazenil; rifampin; 
administration 
with food
Risk of life-threatening 
cardiac arrhythmias with 
amiodarone; additive 
CNS depression with 
alcohol and other CNS 
depressants, including 
antihistamines, anti-
depressants, opioids, 
sedative/hypnotics, 
antipsychotics 
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ZOLPIDEM  (Ambien) 
Insomnia: Adults: PO: 10 mg at bedtime. Extended-release 
tablets: 12.5 mg at bedtime.
Elderly or debilitated patients and patients with hepatic impairment: 
PO: 5 mg at bedtime. Extended-release tablets: 6.25 mg at 
bedtime. 
●  NURSING DIAGNOSES RELATED 
TO ALL SEDATIVE-HYPNOTICS
 1. Risk for injury related to abrupt withdrawal from long-term 
use or decreased mental alertness caused by residual sedation.
 2. Disturbed sleep pattern related to situational crises, physical 
condition, or severe level of anxiety.
 3. Risk for activity intolerance related to side effects of lethargy, 
drowsiness, and dizziness.
 4. Risk for acute confusion related to action of the medication 
on the central nervous system. 
●  NURSING IMPLICATIONS 
FOR SEDATIVE-HYPNOTICS
The nursing care plan should include monitoring for the follow-
ing side effects from sedative-hypnotics. Nursing implications 
related to each side effect are designated by an asterisk (*):
 1. Drowsiness, dizziness, lethargy (most common side 
effects) 
 * Instruct client not to drive or operate dangerous machin-
ery while taking the medication. 
 2. Tolerance, physical and psychological dependence
 * Instruct client to take the medication exactly as directed. 
Do not take more than the amount prescribed because 
of the habit-forming potential. Recommended for short-
term use only. Abrupt withdrawal after long-term use 
may result in serious, even life-threatening, symptoms. 
Exception: Ramelteon is not considered to be a drug of 
abuse or dependence. It is not classiﬁ ed as a controlled 
substance. It has, however, been associated with cases of 
rebound insomnia after abrupt discontinuation following 
long-term use. 
 3. Potentiates the effects of other CNS depressants
 * Instruct client not to drink alcohol or take other medica-
tions that depress the CNS while taking this medication. 
 4. May aggravate symptoms in depressed persons
 * Assess mood daily.
 * Take necessary precautions for potential suicide. 
 5. Orthostatic hypotension, palpitations, tachycardia
 * Monitor lying and standing blood pressure and pulse 
every shift.
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 * Instruct client to arise slowly from a lying or sitting 
position.
 * Monitor pulse rate and rhythm and report any signiﬁ cant 
change to the physician. 
 6. Paradoxical excitement
 * Withhold drug and notify the physician. 
 7. Dry mouth
 * Have client take frequent sips of water or ice chips, suck on 
hard candy, or chew sugarless gum. 
 8. Nausea and vomiting
 * Have client take drug with food or milk (unless it is a drug 
in which taking with food is not recommended). 
 9. Blood dyscrasias 
 * Symptoms of sore throat, fever, malaise, easy bruising, 
or unusual bleeding should be reported to the physician 
immediately. 
●  CLIENT/FAMILY EDUCATION RELATED 
TO ALL SEDATIVE-HYPNOTICS
● Do not drive or operate dangerous machinery. Drowsiness 
and dizziness can occur.
● Do not stop taking the drug abruptly after prolonged use. Can 
produce serious withdrawal symptoms, such as depression, 
insomnia, anxiety, abdominal and muscle cramps, tremors, 
vomiting, sweating, convulsions, and delirium.
● Do not consume other CNS depressants (including alcohol).
● Do not take nonprescription medication without approval 
from physician.
● Rise slowly from the sitting or lying position to prevent a sud-
den drop in blood pressure.
● Report to physician immediately symptoms of sore throat, 
fever, malaise, easy bruising, unusual bleeding, or motor 
restlessness.
● Be aware of risks of taking these drugs during pregnancy. 
(Congenital malformations have been associated with use dur-
ing the ﬁ rst trimester.) If pregnancy is suspected or planned, 
notify the physician of the desirability to discontinue the 
drug.
● Be aware of possible side effects. Refer to written materi-
als furnished by health-care providers regarding the correct 
method of self-administration.
● Carry card or piece of paper at all times stating names of 
medications being taken.
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 INTERNET REFERENCES
 a. http://www.rxlist.com/
 b. http://www.drugguide.com/
 c. http://www.nimh.nih.gov/publicat/medicate.cfm
 d. http://www.fadavis.com/townsend
 e.  http://www.nlm.nih.gov/medlineplus/druginformation
.html
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Agents Used to Treat 
Attention-Deﬁ cit/
Hyperactivity Disorder
522
●  CHEMICAL CLASS: CENTRAL 
NERVOUS SYSTEM (CNS) 
STIMULANTS (AMPHETAMINES)
Examples
Generic 
(Trade) 
Name
Controlled/
Pregnancy
Categories Half-life (hr) Indications
Available 
Forms (mg)
Amphetamine/
dextroam-
phetamine 
mixtures 
(Adderall; 
Adderall XR)
C-II/C 9–13 ● ADHD 
● Narcolepsy
Tabs: 5, 7.5, 
10, 12.5, 15, 
20, 30
Caps (XR): 5, 10, 
15, 20, 25, 30
Dextroamphet-
amine sulfate 
(Dexedrine; 
Dextrostat)
C-II/C ~12 ● ADHD 
● Narcolepsy
Tabs: 5, 10
Caps (ER): 5, 
10, 15
Oral solu: 
5 mg/5 mL
Metham-
phetamine 
(Desoxyn)
C-II/C 4–5 ● ADHD 
● Exogenous 
obesity
Tabs: 5
Lisdexam-
fetamine 
(Vyvanse)
C-II/C <1 ● ADHD Caps: 20, 30, 40 
50, 60, 70 
Action
● Central nervous system (CNS) stimulation is mediated by re-
lease of norepinephrine from central noradrenergic neurons 
in cerebral cortex, reticular activating system, and brainstem.
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● At higher doses, dopamine may be released in the mesolimbic 
system.
● Action in the treatment of attention-deﬁ cit/hyperactivity dis-
order (ADHD) is unclear. 
Contraindications and Precautions 
Contraindicated in: • Advanced arteriosclerosis • Symptom-
atic cardiovascular disease • Moderate to severe hypertension 
• Hyperthyroidism • Hypersensitivity or idiosyncrasy to the 
sympathomimetic amines • Glaucoma • Agitated states • His-
tory of drug abuse • During or within 14 days following admin-
istration of monoamine oxidase (MAO) inhibitors (hypertensive 
crisis may occur) • Children younger than 3 years (dextroam-
phetamine, lisdexamfetamine, and mixtures) • Children 
younger than 12 years (methamphetamine) • Pregnancy and 
lactation
Use Cautiously in: • Patients with mild hypertension • Chil-
dren with psychoses (may exacerbate symptoms) • Tourette’s 
disorder (may exacerbate tics) • Anorexia • Insomnia • Elderly, 
debilitated, or asthenic patients • Patients with suicidal or homi-
cidal tendencies
Adverse Reactions and Side Effects
● Overstimulation 
● Restlessness 
● Dizziness
● Insomnia 
● Headache 
● Palpitations 
● Tachycardia 
● Elevation of blood pressure
● Anorexia 
● Weight loss 
● Dry mouth 
● Tolerance 
● New or worsened psychiatric symptoms
● Physical and psychological dependence
● Suppression of growth in children (with long-term use) 
Interactions
● Increased sensitivity to amphetamines with furazolidone
● Use of amphetamines with MAO inhibitors can result in 
hypertensive crisis.
● Increased effects of amphetamines and risk of serotonin syn-
drome with selective serotonin reuptake inhibitors (SSRIs)
● Prolonged effects of amphetamines with urinary alkalinizers
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● Hastened elimination of amphetamines with urinary acidifi ers
● Amphetamines may reverse the hypotensive effects of gua-
nethidine and other antihypertensives.
● Concomitant use of amphetamines and tricyclic antidepres-
sants may increase blood levels of both drugs.
● Patients with diabetes mellitus who take amphetamines may 
require insulin adjustment.
Route and Dosage 
AMPHETAMINE/DEXTROAMPHETAMINE MIXTURES  (Adderall; 
Adderall XR) 
ADHD: Adults and children ≥6 years: PO: Initial dose: 5 mg 1 
or 2 times a day. May be increased in increments of 5 mg at 
weekly intervals until optimal response is obtained. Maximum 
dose: 40 mg/day. Extended-release caps: Initial dosage: 10 mg 
once daily in the morning. May increase in increments of 
10 mg at weekly intervals. Maximum dose: 30 mg/day.
Children 3 to 5 years: PO: Initial dose: 2.5 mg/day. May increase 
in increments of 2.5 mg/day at weekly intervals. 
Narcolepsy: Adults and children ≥12 years: PO: Initial dose: 
10 mg/day; may increase in increments of 10 mg/day at weekly 
intervals up to a maximum of 60 mg/day. 
Children 6 to 12 years of age: PO: Narcolepsy is rare in children 
younger than 12 years. When it does occur, initial dose is 
5 mg/day. May increase in increments of 5 mg/day at weekly 
intervals up to a maximum of 60 mg/day. 
DEXTROAMPHETAMINE SULFATE  (Dexedrine; Dextrostat) 
ADHD: Adults and children ≥6 years: PO: Initial dosage: 5 mg 
once or 2 times a day. May be increased in increments of 5 mg 
at weekly intervals. More than 40 mg/day is seldom required. 
(Sustained-release capsules should not be used as initial 
therapy.)
Children 3 to 5 years: PO: Initial dose: 2.5 mg/day. May increase 
in increments of 2.5 mg/day at weekly intervals until optimal 
response is achieved. 
Narcolepsy: Adults: PO: 5 to 60 mg/day in single or divided 
doses. Sustained-release capsules should not be used as initial 
therapy.
Children ≥12 years: PO: 10 mg/day. May increase by 10 mg/day 
at weekly intervals until response is obtained or 60 mg is 
reached.
Children 6 to 12 years: PO: 5 mg/day. May increase by 5 mg/
day at weekly intervals until response is obtained or 60 mg is 
reached. 
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METHAMPHETAMINE  (Desoxyn) 
ADHD: 5 mg once or 2 times a day. May increase in increments 
of 5 mg at weekly intervals. Usual effective dose is 20 to 
25 mg/day in divided doses.
Exogenous Obesity: 5 mg 1 to 3 times/day 30 minutes before 
meals. 
LISDEXAMFETAMINE  (Vyvanse)  
ADHD: Children 6 to 12 years of age: PO: 20 or 30 mg once 
daily in the morning. Dosage may be increased in increments 
of 10 or 20 mg/day at weekly intervals. Maximum dosage: 
70 mg/day. 
●  CHEMICAL CLASS: CNS STIMULANTS 
(MISCELLANEOUS AGENTS)
Examples
ER, CD, LA=extended release forms; SR=sustained release.
Generic (Trade) 
Name
Controlled/
Pregnancy
Categories
Half-life 
(hr) Indications
Available 
Forms (mg)
Dexmethylphenidate 
(Focalin; Focalin 
XR)
C-II/C 2.2 ● ADHD Tabs: 2.5, 5, 10
Caps (ER): 5, 10, 
15, 20
Methylphenidate 
(Ritalin; Ritalin-SR; 
Ritalin LA; 
Methylin; 
Methylin ER; 
Metadate ER; 
Metadate CD; 
Concerta; 
Daytrana)
C-II/C 2–4 ● ADHD
● Narcolepsy 
(except 
Concerta, 
Metadate 
CD, and 
Ritalin LA)
Immediate Release 
Tabs (Methylin, 
Ritalin): 5, 10, 20
Chewable tabs 
(Methylin): 2.5, 
5, 10
Metadate ER, 
Methylin ER: Tabs 
10, 20
Concerta: Tabs ER: 
18, 27, 36, 54
Ritalin-SR: Tabs 
SR: 20
Metadate CD, Ritalin 
LA: Caps ER: 10, 
20, 30, 40, (50, 
60—Metadate 
CD only)
Oral Solu (Methylin): 
5/5 mL, 10/5 mL
Transdermal Patch 
(Daytrana): 10, 15, 
20, 30
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Actions
● Dexmethylphenidate blocks the reuptake of norepinephrine 
and dopamine into the presynaptic neuron and increases the 
release of these monoamines into the extraneuronal space.
● Methylphenidate activates the brain stem arousal system and 
cortex to produce its stimulant effect.
● Action in the treatment of ADHD is unknown. 
Contraindications and Precautions 
Contraindicated in: • Hypersensitivity • Pregnancy, lacta-
tion, and children younger than 6 years (safety has not been 
established) • Clients with marked anxiety, tension, or agita-
tion • History of glaucoma • Motor tics or family history or 
diagnosis of Tourette’s disorder • During or within 14 days 
of treatment with MAO inhibitors (hypertensive crisis can 
occur) • Clients with structural cardiac abnormalities, cardio-
myopathy, arrhythmias, recent myocardial infarction (MI), or 
other serious cardiac problems
Use Cautiously in: • Patients with history of seizure disorder 
and/or electroencephalographic (EEG) abnormalities • Hyper-
tension • History of drug or alcohol dependence • Emotionally 
unstable patients • Renal or hepatic insufﬁ ciency • Clients with 
preexisting psychotic disorder
Adverse Reactions and Side Effects
● Headache
● Nausea
● Rhinitis
● Fever
● Anorexia
● Insomnia
● Tachycardia; palpitations; hypertension
● Nervousness
● Abdominal pain
● Growth suppression in children (with long-term use)
● Skin redness or itching at site of transdermal patch (Daytrana) 
Interactions
● Decreased effectiveness of antihypertensive agents 
● Increased serum levels of anticonvulsants (e.g., phenobarbi-
tal, phenytoin, and primidone), tricyclic antidepressants, 
selective serotonin reuptake inhibitors [SSRIs], warfarin
● Increased effects of vasopressor agents with concurrent use
● Hypertensive crisis may occur with concurrent use (or within 
2 weeks use) of MAO inhibitors
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● Concurrent use with clonidine may result in serious electro-
cardiographic (ECG) abnormalities
● Increased sympathomimetic effects with other adrenergics, 
including vasoconstrictors and decongestants
Route and Dosage 
DEXMETHYLPHENIDATE  (Focalin; Focalin XR) 
ADHD: (Immediate release tabs): 
Adults and children ≥6 years: Patients not previously taking methyl-
phenidate: PO: 2.5 mg 2 times a day. May be increased weekly 
as needed up to 10 mg 2 times a day. Patients currently taking 
methylphenidate: Starting dose is 1⁄2 of the methylphenidate 
dose, up to 10 mg 2 times a day.
(Extended-release capsules): 
Adults: Patients not previously taking methylphenidate: PO: 10 mg 
once daily. May be increased by 10 mg after 1 week to 20 mg/
day. Patients currently taking methylphenidate: Starting dose is 
1⁄2 of the methylphenidate dose, up to 20 mg/day given as a 
single daily dose. Patients currently taking dexmethylphenidate: 
Give same daily dose as a single dose.
Children ≥6 years: PO: Patients not previously taking methylpheni-
date: 5 mg once daily. May be increased by 5 mg weekly up to 
20 mg/day. Patients currently taking methylphenidate: Starting 
dose is 1⁄2 of the methylphenidate dose, up to 20 mg/day, given 
as a single daily dose. Patients currently taking dexmethylpheni-
date: Give same daily dose as a single dose. 
METHYLPHENIDATE  (Ritalin; Ritalin-SR; Ritalin LA; 
Methylin; Methylin ER; Metadate ER; Metadate CD; 
Concerta; Daytrana) 
ADHD: (Immediate release forms): 
Adults: PO: Range 10 to 60 mg/day, in divided doses 2 or 3 times/
day, preferably 30 to 45 minutes before meals. Average dose 
is 20 to 30 mg/day. To prevent interruption of sleep, take last 
dose of the day before 6 p.m. 
Children ≥6 yr: PO: Individualize dosage. May start with low 
dose of 5 mg 2 times a day before breakfast and lunch. May 
increase dosage in 5 to 10 mg increments at weekly intervals. 
Maximum daily dosage: 60 mg. 
(Extended-release forms):
Ritalin-SR, Methylin ER, and Metadate ER: Adults and children 
≥6 years: PO: May be used in place of the immediate-release 
tablets when the 8-hour dosage corresponds to the titrated 
8-hour dosage of the immediate-release tablets. Must be swal-
lowed whole.
Ritalin LA and Metadate CD: PO: Adults and children ≥6 years: 
Initial dosage: 20 mg once daily in the morning. May increase 
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dosage in 10 to 20 mg increments at weekly intervals to a max-
imum of 60 mg taken once daily in the morning. Capsules 
may be swallowed whole with liquid or opened and contents 
sprinkled on soft food (e.g., applesauce). Ensure that entire 
contents of capsule are consumed when taken in this man-
ner. NOTE: Ritalin LA may be used in place of 2 times a day 
regimen given once daily at same total dose, or in place of SR 
product at same dose.
Concerta: Adults and children ≥6 years: PO: Should be taken 
once daily in the morning. Must be swallowed whole and not 
chewed, divided, or crushed.
Clients new to methylphenidate: 18 mg once daily in the morning. 
May adjust dosage at weekly intervals to maximum of 54 mg/
day for children 6 to 12 years, and to a maximum of 72 mg/day 
(not to exceed 2 mg/kg/day) for adolescents 13 to 17 years.
Clients currently using methylphenidate: Should use following con-
version table:
Previous Methylphenidate Dose Recommended Concerta Dose
5 mg 2 or 3 times/day or 20 mg (SR) 
10 mg 2 or 3 times/day or 40 mg (SR)
15 mg 2 or 3 times/day or 60 mg (SR)
18 mg every morning
36 mg every morning
54 mg every morning
Daytrana (Transdermal Patch): Adults and children ≥6 years: Patch 
should be applied to hip area 2 hours before an effect is needed 
and should be removed 9 hours after application. Alternate 
hips with additional doses. Dosage for patients new to meth-
ylphenidate should be titrated to desired effect according to 
the following recommended schedule: 
 Week 1 Week 2 Week 3 Week 4
Nominal delivered 
dose (mg/9 hr)
Delivery rate (based on 
9-hr wear period)
10 mg
1.1 mg/hr
15 mg
1.6 mg/hr
20 mg
2.2 mg/hr
30 mg
3.3 mg/hr
Patients converting from another formulation of methylphenidate should follow 
the above titration schedule due to differences in bioavailability of Daytrana 
compared to other products.
Narcolepsy: Adults: PO: Ritalin, Methylin, Methylin ER, Ritalin-
SR, and Metadate ER indicated for this use. 10 mg 2 to 3 times/
day. Maximum dose 60 mg/day. 
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●  CHEMICAL CLASS: ALPHA-ADRENERGIC 
AGONISTS
Examples
Generic (Trade) 
Name
Pregnancy 
Categories/ 
Half-life (hr) Indications
Available 
Forms (mg)
Clonidine (Catapres) C/12–16 ● Hypertension 
Unlabeled use:
● ADHD
Tabs: 0.1, 0.2, 0.3 
Transdermal patches: 
0.1/24 hr, 0.2/24 hr, 
0.3/24 hr
Guanfacine (Tenex; 
Intuniv)
B/16–18 ● Hypertension 
(Tenex)
● ADHD (Intuniv) 
Unlabeled use:
● ADHD (Tenex)
Tabs (Tenex): 1, 2 
Tabs (ER) (Intuniv): 1, 
2, 3, 4 
Action
● Stimulates alpha-adrenergic receptors in the brain, thereby 
reducing sympathetic outﬂ ow from the CNS resulting in de-
creases in peripheral vascular resistance, heart rate, and blood 
pressure.
● Mechanism of action in the treatment of ADHD is unknown. 
Contraindications and Precautions 
Contraindicated in: • Hypersensitivity to the drug or any of 
its inactive ingredients 
Use Cautiously in: • Coronary insufﬁ ciency • Recent myo-
cardial infarction • Cerebrovascular disease • History of hy-
potension, bradycardia, or syncope • Chronic renal or hepatic 
failure • Elderly • Pregnancy and lactation
Adverse Reactions and Side Effects
● Orthostatic hypotension
● Bradycardia
● Palpitations
● Syncope
● Dry mouth
● Constipation
● Nausea
● Fatigue
● Sedation
● Rebound syndrome with abrupt withdrawal
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Interactions
● Increased effects of clonidine with verapamil and beta-blockers
● Decreased effects of clonidine with prazosin and tricyclic 
antidepressants
● Decreased effects of levodopa with clonidine
● Additive CNS effects with CNS depressants, including 
alcohol, antihistamines, opioid analgesics, and sedative/
hypnotics
● Decreased effects of guanfacine with barbiturates, rifampin, 
or phenytoin
● Increased effects of guanfacine with ketoconazole
● Increased effects of valproic acid with guanfacine
Route and Dosage 
CLONIDINE  (Catapres) 
Hypertension: Adults: PO: Initial dosage: 0.1 mg 2 times a day. 
May increase dosage in increments of 0.1 mg/day at weekly 
intervals until desired response is achieved. Maximum dose: 
2.4 mg/day. Transdermal system: Transdermal system delivering 
0.1 mg to 0.3 mg/24 hr applied every 7 days. Initiate with 
0.1 mg/24 hr system. Dosage increments may be made every 1 
to 2 weeks when system is changed. 
ADHD: Adults and children ≥12 years: PO: Initial dosage: 
0.05 mg/day. May increase in increments of 0.05 mg at 
intervals of 3 to 7 days to a maximum dose of 0.3 mg/day in 
divided doses. 
GUANFACINE  (Tenex; Intuniv) 
Hypertension (Tenex): Adults: PO: 1 mg daily at bedtime. If 
satisfactory results are not achieved after 3 to 4 weeks, may 
increase to 2 mg. 
ADHD (Intuniv): Adults and children ≥6 years: PO: Initial 
dosage: 1 mg once daily. May increase dose in increments 
of 1 mg/day at weekly intervals until desired response is 
achieved. Maximum dose: 4 mg/day. Tablets should not be 
chewed, crushed, or broken before swallowing, and should not 
be administered with high-fat meals. 
●  CHEMICAL CLASS: MISCELLANEOUS 
AGENTS FOR ADHD
Examples
Generic (Trade) 
Name
Pregnancy 
Categories/ 
Half-life (hr) Indications
Available 
Forms (mg) 
Atomoxatine 
(Strattera)
C/5.2 hr (metabolites 
6–8 hr)
● ADHD Caps: 10, 18, 25, 40, 
60, 80, 100
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Action
● Atomoxetine selectively inhibits the reuptake of the 
neurotransmitter norepinephrine.
● Bupropion is a weak inhibitor of the neuronal uptake of 
norepinephrine, serotonin, and dopamine. 
● Action in the treatment of ADHD is unclear. 
Contraindications and Precautions 
Contraindicated in: • Hypersensitivity • Coadministration 
with or within 2 weeks after discontinuing an MAO inhibitor 
• Lactation
Atomoxetine
● Narrow-angle glaucoma
Bupropion
● Known or suspected seizure disorder
● Acute phase of myocardial infarction
● Clients with bulimia or anorexia nervosa
● Clients undergoing abrupt discontinuation of alcohol or seda-
tives (increased risk of seizures) 
Use Cautiously in: • Clients with suicidal ideation • Clients 
with urinary retention • Hypertension • Hepatic, renal, or car-
diovascular insufﬁ ciency • Pregnancy (use only if beneﬁ ts outweigh 
possible risks to fetus) • Children and adolescents (may increase sui-
cidal risk) • Elderly and debilitated patients
Atomoxetine
● Children younger than 6 years (safety not established) 
Adverse Reactions and Side Effects
● Dry mouth
● Anorexia
● Nausea and vomiting
● Constipation
● Urinary retention
● Sexual dysfunction
● Headache
● Dizziness
● Insomnia or sedation
SR = 12-hour tablets; XL = 24-hour tablets.
Generic (Trade) 
Name
Pregnancy 
Categories/ 
Half-life (hr) Indications
Available 
Forms (mg) 
Bupropion 
(Wellbutrin; 
Wellbutrin SR; 
Wellbutrin XL)
B/8–24 hr ● Depression
Unlabeled use :
● ADHD
Tabs: 75, 100
Tabs SR: 100, 150, 
200
Tabs XL: 150, 300
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● Palpitations; tachycardia
● Weight loss
● Abdominal pain
● Increased sweating
Atomoxetine
● Fatigue
● Cough
● New or worsened psychiatric symptoms
● Severe liver damage
Bupropion
● Weight gain
● Tremor
● Seizures
● Blurred vision
Interactions
The effects 
of:
Are increased 
by:
Are decreased 
by:
Concurrent use may 
result in: 
Atomoxetine Concomitant use of 
CYP2D6 inhibi-
tors (paroxetine, 
fl uoxetine, 
quinidine)
Increased risk of cardiovascu-
lar effects with albuterol 
or vasopressors; poten-
tially fatal reactions with 
concurrent use (or use 
within 2 weeks of discontin-
uation) of MAO inhibitors; 
increased cardiovascular 
effects of albuterol with 
concurrent use
Bupropion Amantadine, 
levodopa, 
cimetidine, 
triclopidine, 
guanfacine, 
ritonavir
Carbamazepine Increased risk of acute toxicity 
with MAO inhibitors; 
increased risk of hyperten-
sion with nicotine 
replacement agent; 
adverse neuropsychiatric 
events with alcohol 
(alcohol tolerance is 
reduced); increased antico-
agulant effect of warfarin; 
increased effects of drugs 
metabolized by CYP2D6 
(e.g., nortriptyline, imip-
ramine, desipramine, 
paroxetine, fl uoxetine, 
sertraline, haloperidol, 
risperidone, thioridazine, 
metoprolol, propafe-
none, and fl ecainide); 
increased risk of seizures 
with drugs that lower the 
seizure threshold (antide-
pressants, antipsychotics, 
theophylline, corticosteroids, 
stimulants/anorectics) 
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Route and Dosage 
ATOMOXETINE  (Strattera) 
ADHD: Adults, adolescents, and children weighing more than 70 kg 
(154 lb): PO: Initial dose: 40 mg/day. Increase after a minimum 
of 3 days to a target total daily dose of 80 mg, as a single dose in 
the morning or 2 evenly divided doses in the morning and late 
afternoon or early evening. After 2 to 4 weeks, total dosage 
may be increased to a maximum of 100 mg, if needed.
Children weighing 70 kg (154 lb) or less: PO: Initial dose: 0.5 mg/
kg/day. Increase after a minimum of 3 days to a target total 
daily dose of about 1.2 mg/kg taken either as a single dose in 
the morning or 2 evenly divided doses in the morning and late 
afternoon or early evening. Maximum daily dose: 1.4 mg/kg 
or 100 mg daily, whichever is less.
Adjusted Dosing: Hepatic impairment: In clients with moderate 
hepatic impairment, reduce to 50% of usual dose. In clients 
with severe hepatic impairment, reduce to 25% of usual dose. 
Adjusted dosing: Coadministration with strong CYP2D6 inhibitors:
Adults, adolescents, and children weighing more than 70 kg:
Initiate dosage at 40 mg/day and only increase to the usual 
target dose of 80 mg/day if symptoms fail to improve after 
4 weeks and the initial dose is well tolerated. 
Children and adolescents up to 70 kg: Initiate dosage at 0.5 mg/kg/day 
and only increase to the usual target dose of 1.2 mg/kg/day if 
symptoms fail to improve after 4 weeks and the initial dose is 
well tolerated. 
BUPROPION  (Wellbutrin; Wellbutrin SR; Wellbutrin XL) 
ADHD: Children and adolescents: PO: Initial dose: 3 mg/kg/
day. May titrate to a maximum dose of 6 mg/kg/day. Single 
dose should not exceed 150 mg. Usually given daily in 2 or 
3 divided doses. 
Adults: 150 to 450 mg/day. No single dose of bupropion should 
exceed 150 mg. To prevent the risk of seizures, administer 
with 4 to 6 hours between doses. 
Depression (Wellbutrin): PO: Adults (immediate release 
tabs): 100 mg 2 times/day. May increase after 3 days to 
100 mg given 3 times/day. For patients who do not show 
improvement after several weeks of dosing at 300 mg/day, 
an increase in dosage up to 450 mg/day may be considered. 
No single dose of bupropion should exceed 150 mg. To 
prevent the risk of seizures, administer with 4 to 6 hours 
between doses. 
Sustained release tabs: Give as a single 150 mg dose in the morn-
ing. May increase to twice a day (total 300 mg), with 8 hours 
between doses.
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Extended release tabs: Begin dosing at 150 mg/day, given as a 
single daily dose in the morning. May increase after 3 days to 
300 mg/day, given as a single daily dose in the morning. 
Seasonal Affective Disorder (Wellbutrin XL):  PO: 150 mg 
administered each morning beginning in the autumn prior to 
the onset of depressive symptoms. Dose may be uptitrated to 
the target dose of 300 mg/day after 1 week. Therapy should 
continue through the winter season before being tapered to 
150 mg/day for 2 weeks prior to discontinuation in early spring. 
●  NURSING DIAGNOSES RELATED 
TO AGENTS FOR ADHD
 1. Risk for injury related to overstimulation and hyperac-
tivity (CNS stimulants) or seizures (possible side effect of 
bupropion).
 2. Risk for suicide secondary to major depression related to 
abrupt withdrawal after extended use (CNS stimulants).
 3. Imbalanced nutrition, less than body requirements, related 
to side effects of anorexia and weight loss (CNS stimulants).
 4. Disturbed sleep pattern related to side effects of overstimula-
tion or insomnia.
 5. Nausea related to side effects of atomoxetine or bupropion.
 6. Pain related to side effect of abdominal pain (atomoxetine, 
bupropion) or headache (all agents).
 7. Risk for activity intolerance related to side effects of sedation 
or dizziness (atomoxetine or bupropion) 
●  NURSING IMPLICATIONS FOR ADHD 
AGENTS
The plan of care should include monitoring for the follow-
ing side effects from agents for ADHD. Nursing implications 
related to each side effect are designated by an asterisk (*).
 1. Overstimulation, restlessness, insomnia (CNS stimulants)
 * Assess mental status for changes in mood, level of activity, 
degree of stimulation, and aggressiveness.
 * Ensure that the client is protected from injury. 
 * Keep stimuli low and environment as quiet as possible to 
discourage overstimulation.
 * To prevent insomnia, administer the last dose at least 
6 hours before bedtime. Administer sustained-release 
forms in the morning.
 2. Palpitations, tachycardia (CNS stimulants; atomoxetine; 
bupropion; clonidine) or bradycardia (clonidine, guanfacine)
 * Monitor and record vital signs at regular intervals (two or 
three times a day) throughout therapy. Report signiﬁ cant 
changes to the physician immediately.
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  NOTE: The U.S. Food and Drug Administration recently 
issued warnings associated with CNS stimulants and 
atomoxetine of the risk for sudden death in patients who 
have cardiovascular disease. A careful personal and fam-
ily history of heart disease, heart defects, or hypertension 
should be obtained before these medications are prescribed. 
Careful monitoring of cardiovascular function during 
administration must be ongoing.
 3. Anorexia, weight loss (CNS stimulants; atomoxetine; 
bupropion)
 * To reduce anorexia, the medication may be administered 
immediately after meals. The client should be weighed 
regularly (at least weekly) when receiving therapy with 
CNS stimulants, atomoxetine, or bupropion because of the 
potential for anorexia and weight loss, and temporary in-
terruption of growth and development.
 4. Tolerance, physical and psychological dependence (CNS 
stimulants)
 * Tolerance develops rapidly. 
 * In children with ADHD, a drug “holiday” should be 
attempted periodically under direction of the physician to 
determine the effectiveness of the medication and the need 
for continuation.
 * The drug should not be withdrawn abruptly. To do so 
could initiate the following syndrome of symptoms: nau-
sea, vomiting, abdominal cramping, headache, fatigue, 
weakness, mental depression, suicidal ideation, increased 
dreaming, and psychotic behavior.
 5. Nausea and vomiting (atomoxetine and bupropion)
 * May be taken with food to minimize GI upset. 
 6. Constipation (atomoxetine, bupropion, clonidine, guanfacine)
 * Increase ﬁ ber and ﬂ uid in diet, if not contraindicated.
 7. Dry mouth (clonidine and guanfacine) 
 * Offer the client sugarless candy, ice, frequent sips of water
 * Strict oral hygiene is very important. 
 8. Sedation (clonidine and guanfacine) 
 * Warn client that this effect is increased by concomitant use 
of alcohol and other CNS drugs.
 * Warn clients to refrain from driving or performing haz-
ardous tasks until response has been established.
 9. Potential for seizures (bupropion) 
 * Protect client from injury if seizure should occur. Instruct 
family and signiﬁ cant others of clients on bupropion ther-
apy how to protect client during a seizure if one should 
occur. Ensure that doses of the immediate release medica-
tion are administered 4 to 6 hours apart, and doses of the 
sustained release medication at least 8 hours apart. 
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 10. Severe liver damage (with atomoxetine) 
 * Monitor for the following side effects and report to physi-
cian immediately: itching, dark urine, right upper quad-
rant pain, yellow skin or eyes, sore throat, fever, malaise.  
 11. New or worsened psychiatric symptoms (with CNS 
stimulants and atomoxetine) 
 * Monitor for psychotic symptoms (e.g., hearing voices, 
paranoid behaviors, delusions).
 * Monitor for manic symptoms, including aggressive and 
hostile behaviors.
 12. Rebound syndrome (with clonidine and guanfacine) 
 * Client should be instructed not to discontinue therapy 
abruptly. To do so may result in symptoms of nervous-
ness, agitation, headache, and tremor, and a rapid rise in 
blood pressure. Dosage should be tapered gradually under 
the supervision of the physician.
●  CLIENT/FAMILY EDUCATION RELATED 
TO AGENTS FOR ADHD
● Use caution in driving or operating dangerous machinery. 
Drowsiness, dizziness, and blurred vision can occur.
● Do not stop taking CNS stimulants abruptly. To do so could 
produce serious withdrawal symptoms. 
● Avoid taking CNS stimulants late in the day to prevent insomnia. 
Take no later than 6 hours before bedtime.
● Do not take other medications (including over-the-counter 
drugs) without physician’s approval. Many medications con-
tain substances that, in combination with agents for ADHD, 
can be harmful.
● Diabetic clients should monitor blood sugar 2 or 3 times a day 
or as instructed by the physician. Be aware of the need for 
possible alteration in insulin requirements because of changes 
in food intake, weight, and activity.
● Avoid consumption of large amounts of caffeinated products 
(coffee, tea, colas, chocolate), as they may enhance the CNS 
stimulant effect.
● Notify physician if symptoms of restlessness, insomnia, an-
orexia, or dry mouth become severe or if rapid, pounding 
heartbeat becomes evident. Report any of the following side 
effects to the physician immediately: shortness of breath, 
chest pain, jaw/left arm pain, fainting, seizures, sudden vision 
changes, weakness on one side of the body, slurred speech, 
confusion, itching, dark urine, right upper quadrant pain, 
yellow skin or eyes, sore throat, fever, malaise, increased 
hyperactivity, believing things that are not true, or hearing 
voices.
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● Be aware of possible risks of taking agents for ADHD during 
pregnancy. Safe use during pregnancy and lactation has not 
been established. Inform the physician immediately if preg-
nancy is suspected or planned.
● Be aware of potential side effects of agents for ADHD. Refer 
to written materials furnished by health-care providers for 
safe self-administration.
● Carry a card or other identiﬁ cation at all times describing 
medications being taken.
 INTERNET REFERENCES
 a. http://www.rxlist.com
 b. http://www.drugguide.com
 c. http://www.nimh.nih.gov/publicat/medicate.cfm
 d. http://www.fadavis.com/townsend 
 e.  http://www.nlm.nih.gov/medlineplus/druginformation
.html
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Age Stage Major Developmental Tasks
FREUD’S STAGES OF PSYCHOSEXUAL DEVELOPMENT
Birth–18 months Oral Relief from anxiety through 
oral gratiﬁ cation of needs
18 months–
3 years
Anal Learning independence and 
control, with focus on the 
excretory function
3–6 years Phallic Identiﬁ cation with parent 
of same gender; develop-
ment of sexual identity; 
focus is on genital organs
6–12 years Latency Sexuality is repressed; focus 
is on relationships with 
same-gender peers
13–20 years Genital Libido is reawakened as geni-
tal organs mature; focus 
is on relationships with 
members of the 
opposite gender
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STAGES OF DEVELOPMENT IN H.S. SULLIVAN’S 
INTERPERSONAL THEORY
Birth–18 months Infancy Relief from anxi-
ety through oral 
gratiﬁ cation of 
needs
18 months–
6 years
Childhood Learning to experi-
ence a delay in 
personal grati-
ﬁ cation without 
undue anxiety
6–9 years Juvenile Learning to form 
satisfactory peer 
relationships
9–12 years Preadolescence Learning to form 
satisfactory 
relationships 
with persons of 
the same gender; 
the initiation of 
feelings of affec-
tion for another 
person
12–14 years Early adolescence Learning to form 
satisfactory re-
lationships with 
persons of the 
opposite gender; 
developing a 
sense of identity
14–21 years Late adolescence Establishing self-
identity; experi-
encing satisfying 
relationships; 
working to 
develop a lasting, 
intimate op-
posite-gender 
relationship
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STAGES OF DEVELOPMENT IN ERIC
ERIKSON’S PSYCHOSOCIAL THEORY
Infancy
(Birth–18 
months) 
Trust vs. 
mistrust
To develop a basic trust in 
the mothering ﬁ gure and 
be able to generalize it 
to others
Early 
childhood
(18 months–
3 years)
Autonomy vs. 
shame and 
doubt
To gain some self-control 
and independence within 
the environment
Late 
childhood. 
(3–6 years)
Initiative vs. 
guilt
To develop a sense of pur-
pose and the ability to 
initiate and direct own 
activities
School age
(6–12 years)
Industry vs. 
inferiority
To achieve a sense of self-
conﬁ dence by learning, 
competing, performing 
successfully, and receiv-
ing recognition from 
signiﬁ cant others, peers, 
and acquaintances
Adolescence
(12–20 years)
Identity vs. 
role 
confusion
To integrate the tasks 
mastered in the previous 
stages into a secure sense 
of self
Young adult-
hood 
(20–30 years)
Intimacy vs. 
isolation
To form an intense, lasting 
relationship or a commit-
ment to another person, 
a cause, an institution, or 
a creative effort
Adulthood
while
(30–65 years)
Generativity 
vs. stagna-
tion
To achieve the life goals 
established for oneself, 
also considering the 
welfare of future 
generations
Old age
(65 years–
death)
Ego integrity 
vs. despair
To review one’s life and derive 
meaning from both posi-
tive and negative events, 
while achieving a positive 
sense of self-worth
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STAGES OF DEVELOPMENT IN M. MAHLER’S THEORY 
OF OBJECT RELATIONS
Birth–
1 month
I. Normal autism Fulﬁ llment of basic 
needs for survival 
and comfort
1–5 months II. Symbiosis Developing awareness 
of external source 
of need fulﬁ llment
III.  Separation- 
Individuation
5–10 months a. Differentiation Commencement of a 
primary recogni-
tion of separateness 
from the mothering 
ﬁ gure
10–16 
months
b. Practicing Increased independ-
ence through loco-
motor functioning; 
increased sense of 
separateness of self
16–24 
months
c.  Rapprochement  Acute awareness of 
separateness of 
self; learning to 
seek “emotional 
refueling” from 
mothering ﬁ gure to 
maintain feeling of 
security
24–36 months d. Consolidation Sense of separate-
ness established; on 
the way to object 
constancy (i.e., able 
to internalize a 
sustained image of 
loved object/person 
when it is out of 
sight); resolution of 
separation anxiety
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PIAGET’S STAGES OF COGNITIVE DEVELOPMENT
Birth–
2 years
Sensorimotor With increased mobility and 
awareness, develops a sense 
of self as separate from the 
external environment; the 
concept of object perma-
nence emerges as the abil-
ity to form mental images 
evolves
2–6 years Preopera-
tional
Learning to express self with 
language; develops under-
standing of symbolic ges-
tures; achievement of object 
permanence
6–12 years Concrete 
operations
Learning to apply logic to 
thinking; development of 
understanding of reversibil-
ity and spatiality; learning 
to differentiate and classify; 
increased socialization and 
application of rules
12–15+ years Formal 
operations
Learning to think and reason in 
abstract terms; making and 
testing hypotheses; capabil-
ity of logical thinking and 
reasoning expand and are 
reﬁ ned; cognitive maturity 
achieved
KOHLBERG’S STAGES OF MORAL DEVELOPMENT
I. Preconventional
(common from 
ages 4 to 
10 years)
1. Punishment and 
obedience 
orientation
Behavior is moti-
vated by fear of 
punishment
2. Instrumental 
relativist 
orientation
Behavior is 
motivated by 
egocentrism and 
concern for self
542 ● APPENDIX A
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KOHLBERG’S STAGES OF MORAL DEVELOPMENT
II.  Conventional 
(common from 
ages 10 to 13 
years and into
adulthood)
3. Interpersonal 
concordance 
orientation
Behavior is 
motivated by 
the expecta-
tions of others; 
strong desire 
for approval and 
acceptance
4. Law and order 
orientation
Behavior is moti-
vated by respect 
for authority
III.  Postconven-
tional (can 
occur from 
adolescence on) 
5. Social contract 
legalistic 
orientation
Behavior is moti-
vated by respect 
for universal 
laws and moral 
principles and 
guided by an 
internal set of 
values
6. Universal 
ethical principle 
orientation
Behavior is moti-
vated by internal-
ized principles 
of honor, justice, 
and respect for 
human dignity 
and guided by the 
conscience
STAGES OF DEVELOPMENT IN H. PEPLAU’S 
INTERPERSONAL THEORY
Infancy Learning to count 
on others
Learning to com-
municate in 
various ways to 
the primary care- 
giver in order 
to have comfort 
needs fulﬁ lled
Continued
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STAGES OF DEVELOPMENT IN H. PEPLAU’S 
INTERPERSONAL THEORY
Toddlerhood Learning to delay 
gratiﬁ cation
Learning the 
satisfaction of 
pleasing others 
by delaying self-
gratiﬁ cation in 
small ways
Early childhood Identifying oneself Learning appropri-
ate roles and 
behaviors by ac-
quiring the abil-
ity to perceive 
the expectations 
of others
Late childhood Developing skills in 
participation
Learning the skills 
of compromise, 
competition, and 
cooperation with 
others; establish-
ment of a more 
realistic view of 
the world and a 
feeling of one’s 
place in it. 
Source: Adapted from Townsend, M.C. (2009). Psychiatric/mental health 
nursing: Concepts of care in evidence-based practice (6th ed.). Philadelphia: 
FA Davis, pp. 33, 35, 36, 38, 40, 41, 43.
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A P P E N D I X  B
Ego Defense 
Mechanisms
Defense 
Mechanisms Example
Defense 
Mechanisms Example
Compensa-
tion:
Covering up 
a real or 
perceived 
weakness 
by empha-
sizing a 
trait one 
considers 
more desir-
able.
A physically 
handi-
capped boy 
is unable to 
participate 
in football, 
so he com-
pensates 
by becom-
ing a great 
scholar.
Rationaliza-
tion:
  Attempting 
to make 
excuses or 
formulate 
logical 
reasons to 
justify un-
acceptable 
feelings or 
behaviors.
John tells 
the rehab 
nurse, 
“I drink 
because it’s 
the only 
way I can 
deal with 
my bad 
marriage 
and my 
worse job.”
Denial:
  Refusing to 
acknowl-
edge the 
existence 
of a real 
situation or 
the feelings 
associated 
with it.
A woman 
who drinks 
alcohol 
every day 
and cannot 
stop fails to 
acknowl-
edge that 
she has a 
problem.
Reaction 
Formation:
  Preventing 
unaccept-
able or 
undesirable 
thoughts or 
behaviors 
from being 
expressed 
by exag-
gerating 
opposite 
thoughts 
or types of 
behaviors
Jane hates 
nursing. She 
attended 
nursing 
school to 
please her 
parents. 
During 
career day, 
she speaks 
to prospec-
tive students 
about the 
excellence 
of nursing 
as a career.
Continued
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Defense 
Mechanisms Example
Displace-
ment:
  The transfer 
of feelings 
from one 
target to 
another 
that is con-
sidered less 
threatening 
or that is 
neutral.
A client is 
angry at his 
physician, 
does not 
express 
it, but 
becomes 
verbally 
abusive 
with the 
nurse.
Regression:
   Retreating 
in response 
to stress to 
an ear-
lier level of 
develop-
ment and 
the comfort 
measures 
associated 
with that 
level of 
functioning.
When 2-year-
old Jay is 
hospitalized 
for tonsil-
litis he will 
drink only 
from a 
bottle, even 
though his 
mom states 
he has been 
drinking 
from a 
cup for 
6 months.
Identifi ca-
tion:
  An attempt 
to increase 
self-worth 
by acquir-
ing certain 
attributes 
and charac-
teristics of 
an indi-
vidual one 
admires.
A teen-
ager who 
required 
lengthy 
rehabilita-
tion after 
an accident 
decides to 
become a 
physical 
therapist as 
a result 
of his 
experiences.
Repression:
   Involuntar-
ily blocking 
unpleasant 
feelings and 
experiences 
from one’s 
awareness.
An accident 
victim can 
remember 
nothing 
about his 
accident.
Intellectuali-
zation:
  An attempt 
to avoid 
expressing 
actual emo-
tions asso-
ciated with 
a stressful 
situation by 
using
S’s husband 
is being 
transferred 
with his job 
to a city far 
away from 
her parents. 
She hides 
anxiety by 
explain-
ing to her 
parents the 
advantages
Sublimation:
   Rechan-
neling of 
drives or 
impulses 
that are 
personally 
or socially 
unaccept-
able into 
activities 
that are 
construc-
tive.
A mother 
whose son 
was killed 
by a drunk 
driver 
chan-
nels her 
anger and 
energy into 
being the 
president 
of the local 
chapter of
546 ● APPENDIX B
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Defense 
Mechanisms Example
the intellectu-
al processes 
of logic, 
reasoning, 
and analysis.
associated 
with the 
move.
Mothers 
Against 
Drunk 
Drivers.
Introjection:
  Integrating 
the beliefs 
and values 
of another 
individual 
into one’s 
own ego 
structure.
Children 
integrate 
their par-
ents’ value 
system 
into the 
process of 
conscience 
formation. 
A child says 
to friend, 
“Don’t 
cheat. It’s 
wrong.”
Suppression:
   The 
voluntary 
blocking of 
unpleasant 
feelings and 
experiences 
from one’s 
awareness.
Scarlett 
O’Hara 
says, “I 
don’t want 
to think 
about that 
now. I’ll 
think 
about that 
tomorrow.”
Isolation:
  Separating 
a thought 
or memory 
from the 
feeling tone 
or emotion 
associated 
with it.
A young 
woman 
describes 
being 
attacked 
and raped, 
without 
showing 
any 
emotion.
Undoing:
   Symbolical-
ly negating 
or cance-
ling out an 
experience 
that one 
ﬁ nds intol-
erable.
Joe is nervous 
about his 
new job and 
yells at his 
wife. On his 
way home 
he stops 
and buys 
her some 
ﬂ owers.
Projection
  Attributing 
feelings or 
impulses 
unacceptable 
to one’s self 
to another 
person.
Sue feels a 
strong sexual 
attraction 
to her track 
coach and 
tells her 
friend, “He’s 
coming on 
to me!”
Source: Townsend, M.C. (2009). Psychiatric/mental health nursing: 
Concepts of care in evidence-based practice (6th ed.). Philadelphia: 
FA Davis, p. 18. 
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●  PHASES OF A THERAPEUTIC 
NURSE-CLIENT RELATIONSHIP
Psychiatric nurses use interpersonal relationship development 
as the primary intervention with clients in various psychiatric 
and mental health settings. This is congruent with Peplau’s 
(1962) identiﬁ cation of counseling as the major subrole of nurs-
ing in psychiatry. If Sullivan’s (1953) belief is true, that is, that 
all emotional problems stem from difﬁ culties with interpersonal 
relationships, then this role of the nurse in psychiatry becomes 
especially meaningful and purposeful. It becomes an integral 
part of the total therapeutic regimen.
The therapeutic interpersonal relationship is the means by 
which the nursing process is implemented. Through the rela-
tionship, problems are identiﬁ ed and resolution is sought. Tasks 
of the relationship have been categorized into four phases: the 
preinteraction phase, the orientation (introductory) phase, the 
working phase, and the termination phase. Although each phase 
is presented as speciﬁ c and distinct from the others, there may 
be some overlapping of tasks, particularly when the interaction 
is limited.
The Preinteraction Phase
The preinteraction phase involves preparation for the ﬁ rst 
encounter with the client. Tasks include the following:
 1. Obtaining available information about the client from the 
chart, signiﬁ cant others, or other health-team members. 
From this information, the initial assessment is begun. From 
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this initial information, the nurse may also become aware of 
personal responses to knowledge about the client.
 2. Examining one’s feelings, fears, and anxieties about work-
ing with a particular client. For example, the nurse may have 
been reared in an alcoholic family and have ambivalent feel-
ings about caring for a client who is alcohol dependent. All 
individuals bring attitudes and feelings from prior experi-
ences to the clinical setting. The nurse needs to be aware of 
how these preconceptions may affect his or her ability to care 
for individual clients.
The Orientation (Introductory) Phase
During the orientation phase, the nurse and client become 
acquainted. Tasks include the following:
 1. Creating an environment for the establishment of trust and 
rapport
 2. Establishing a contract for intervention that details the 
expectations and responsibilities of both the nurse and client
 3. Gathering assessment information to build a strong client 
database
 4. Identifying the client’s strengths and limitations
 5. Formulating nursing diagnoses
 6. Setting goals that are mutually agreeable to the nurse and 
client
 7. Developing a plan of action that is realistic for meeting the 
established goals
 8. Exploring feelings of both the client and the nurse in terms 
of the introductory phase. Introductions are often uncom-
fortable, and the participants may experience some anxiety 
until a degree of rapport has been established. Interactions 
may remain on a superﬁ cial level until the anxiety subsides. 
Several interactions may be required to fulﬁ ll the tasks 
associated with this phase.
The Working Phase
The therapeutic work of the relationship is accomplished during 
this phase. Tasks include the following:
 1. Maintaining the trust and rapport that was established dur-
ing the orientation phase
 2. Promoting the client’s insight and perception of reality
 3. Problem-solving in an effort to bring about change in the 
client’s life
 4. Overcoming resistance behaviors on the part of the client as 
the level of anxiety rises in response to discussion of painful 
issues
 5. Continuously evaluating progress toward goal attainment
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The Termination Phase
Termination of the relationship may occur for a variety of rea-
sons: the mutually agreed-upon goals may have been reached, 
the client may be discharged from the hospital, or in the case of 
a student nurse, the clinical rotation may come to an end. Ter-
mination can be a difﬁ cult phase for both the client and nurse. 
Tasks include the following:
 1. Bringing a therapeutic conclusion to the relationship. This 
occurs when:
 a. Progress has been made toward attainment of mutually 
set goals.
 b. A plan for continuing care or for assistance during stress-
ful life experiences is mutually established by the nurse 
and client.
 c. Feelings about termination of the relationship are rec-
ognized and explored. Both the nurse and client may ex-
perience feelings of sadness and loss. The nurse should 
share his or her feelings with the client. Through these 
interactions, the client learns that it is acceptable to un-
dergo these feelings at a time of separation. Through this 
knowledge, the client experiences growth during the pro-
cess of termination.
  Note: When the client feels sadness and loss, behaviors to 
delay termination may become evident. If the nurse experi-
ences the same feelings, he or she may allow the client’s 
behaviors to delay termination. For therapeutic closure, the 
nurse must establish the reality of the separation and resist 
being manipulated into repeated delays by the client.
●  THERAPEUTIC COMMUNICATION 
TECHNIQUES
Technique
Explanation/
Rationale Examples
Using 
silence
Gives the client the 
opportunity to 
collect and organ-
ize thoughts, to 
think through a 
point, or to consider 
introducing a topic 
of greater concern 
than the one being 
discussed.
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Technique
Explanation/
Rationale Examples
Accepting Conveys an attitude 
of reception and 
regard.
“Yes, I understand what 
you said.” Eye contact; 
nodding.
Giving 
recogni-
tion
Acknowledging; 
indicating aware-
ness; better than 
complimenting, 
which reﬂ ects the 
nurse’s judgment.
“Hello, Mr. J. I notice 
that you made a ce-
ramic ash tray in OT.”  
“I see you made your 
bed.”
Offering 
self
Making oneself 
available on an 
unconditional 
basis, increasing the 
client’s feelings of 
self-worth.
“I’ll stay with you a 
while.”
“We can eat our lunch 
together.”
“I’m interested in you.”
Giving 
broad 
openings
Allows the client to 
take the initiative 
in introducing the 
topic; emphasizes 
the importance 
of the client’s role 
in the interaction.
“What would you like to 
talk about today?”
“Tell me what you are 
thinking.”
Offering 
general 
leads
Offers the client 
encouragement to 
continue.
“Yes, I see.” “Go on.”
“And after that?”
Placing the 
event in 
time or 
sequence
Clariﬁ es the relation-
ship of events in 
time so that the 
nurse and client 
can view them in 
perspective.
“What seemed to lead 
up to...?”
“Was this before or 
after...?”
“When did this 
happen?”
Making 
observa-
tions
Verbalizing what 
is observed or 
perceived. This en-
courages the client 
to recognize speciﬁ c 
behaviors and com-
pare perceptions 
with the nurse.
“You seem tense.”
“I notice you are 
pacing a lot.”
“You seem uncomfort-
able when you...”
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Technique
Explanation/
Rationale Examples
Encour-
aging 
descrip-
tion of 
percep-
tions
Asking the client to 
verbalize what is 
being perceived; 
often used with 
clients experiencing 
hallucinations.
“Tell me what is 
happening now.”
“Are you hearing the 
voices again?”
“What do the voices 
seem to be saying?”
Encourag-
ing com-
parison
Asking the client to 
compare similarities 
and differences in 
ideas, experiences, or 
interpersonal rela-
tionships. Helps the 
client recognize life 
experiences that tend 
to recur as well as 
those aspects of life 
that are changeable.
“Was this something 
like...?”
“How does this 
compare with the 
time when...?”
“What was your 
response the last 
time this situation 
occurred?”
Restating The main idea of 
what the client has 
said is repeated; 
lets the client 
know whether an 
expressed statement 
has been under-
stood and gives him 
or her the chance 
to continue, or to 
clarify if necessary.
Cl: “I can’t study. 
My mind keeps wan-
dering.”
Ns: “You have diffi culty 
concentrating.”
Cl: “I can’t take that new 
job. What if I can’t 
do it?”
Ns: “You’re afraid you 
will fail in this new 
position.”
Reﬂ ecting Questions and feel-
ings are referred 
back to the client 
so that they may 
be recognized and 
accepted and so 
that the client may 
recognize that his 
or her point of view 
has value. A good 
technique to use 
when the client asks 
the nurse for advice.
Cl: “What do you think 
I should do about 
my wife’s drinking 
problem?”
Ns: “What do you think 
you should do?”
Cl: “My sister won’t 
help a bit toward my 
mother’s care. I have 
to do it all!”
Ns: “You feel angry when 
she doesn’t help.”
Continued
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Technique
Explanation/
Rationale Examples
Focusing Taking notice of a 
single idea or even a 
single word. Works 
especially well with 
a client who is mov-
ing rapidly from one 
thought to another. 
This technique is not 
therapeutic, how-
ever, with the client 
who is very anxious. 
Focusing should 
not be pursued until 
the anxiety level has 
subsided.
“This point seems 
worth looking at more 
closely. Perhaps you 
and I can discuss it 
together.”
Exploring Delving further into a 
subject, idea, experi-
ence, or relation-
ship. Especially 
helpful with clients 
who tend to remain 
on a superﬁ cial level 
of communication. 
However, if the 
client chooses not to 
disclose further in-
formation, the nurse 
should refrain from 
pushing or prob-
ing in an area that 
obviously creates 
discomfort.
“Please explain that 
situation in more 
detail.”
“Tell me more about 
that particular 
situation.”
Seeking 
clariﬁ ca-
tion and 
validation
Striving to explain 
that which is vague 
or incomprehensible 
and searching for 
mutual understand-
ing; clarifying the 
meaning of what has 
been said facilitates 
and increases under-
standing for both 
client and nurse.
“I’m not sure that I un-
derstand. Would you 
please explain?”
“Tell me if my under-
standing agrees with 
yours.”
“Do I understand 
correctly that you 
said...?”
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Technique
Explanation/
Rationale Examples
Presenting 
reality
When the client has 
a misperception of 
the environment, 
the nurse deﬁ nes 
reality or indicates 
his or her perception 
of the situation for 
the client.
“I understand that the 
voices seem real to 
you, but I do not hear 
any voices.”
“There is no one else in 
the room but you and 
me.”
Voicing 
doubt
Expressing uncer-
tainty as to the 
reality of the client’s 
perceptions. Often 
used with clients 
experiencing delu-
sional thinking.
“I fi nd that hard to 
believe (or accept).”
“That seems rather 
doubtful to me.”
Verbal-
izing the 
implied
Putting into words 
what the client has 
only implied or said 
indirectly; can also 
be used with the 
client who is mute 
or is otherwise ex-
periencing impaired 
verbal communica-
tion. This clariﬁ es 
that which is implicit 
rather than explicit.
Cl: “It’s a waste of time 
to be here. I can’t talk 
to you or anyone.”
Ns: “Are you feeling that 
no one understands?”
Cl: (Mute)
Ns: “It must have been 
very diffi cult for you 
when your husband 
died in the fi re.”
Attempting 
to trans-
late words 
into 
feelings
When feelings are 
expressed indirectly, 
the nurse tries to 
“desymbolize” what 
has been said and 
to ﬁ nd clues to the 
underlying true 
feelings.
Cl: “I’m way out in the 
ocean.”
Ns: “You must be 
feeling very lonely 
now.”
Continued
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●  NONTHERAPEUTIC COMMUNICATION 
TECHNIQUES
Technique
Explanation/
Rationale Examples
Formulating 
a plan of 
action
When a client has a 
plan in mind for 
dealing with what is 
considered to be a 
stressful situation, it 
may serve to prevent 
anger or anxiety 
from escalating to an 
unmanageable level. 
“What could you do 
to let your anger out 
harmlessly?”
“Next time this comes 
up, what might you 
do to handle it more 
appropriately?”
Source: Adapted from Hays, J.S., and Larson, K.H. (1963). Interacting 
with patients. New York: Holt, Rinehart, and Winston.
Technique
Explanation/
Rationale Examples
Giving 
reassurance
Indicates to the client 
that there is no cause for 
anxiety, thereby devalu-
ing the client’s feelings. 
May discourage the client 
from further expression 
of feelings if he or she 
believes they will only be 
downplayed or ridiculed.
“I wouldn’t worry 
about that if I 
were you.”
“Everything will be 
all right.”
Better to say: “We 
will work on that 
together.”
Rejecting Refusing to consider or 
showing contempt for 
the client’s ideas or be-
havior. This may cause 
the client to discontin-
ue interaction with the 
nurse for fear of further 
rejection.
“Let’s not discuss...”
“I don’t want to 
hear about...”
Better to say: “Let’s 
look at that a little 
closer.”
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Technique
Explanation/
Rationale Examples
Giving 
approval 
or disap-
proval
Sanctioning or denounc-
ing the client’s ideas 
or behavior. Implies 
that the nurse has the 
right to pass judgment 
on whether the client’s 
ideas or behaviors 
are “good” or “bad,” 
and that the client is 
expected to please the 
nurse. The nurse’s ac-
ceptance of the client 
is then seen as condi-
tional depending on the 
client’s behavior.
“That’s good. I’m 
glad that you...”
“That’s bad. I’d 
rather you 
wouldn’t...”
Better to say: “Let’s 
talk about how 
your behavior 
invoked anger in 
the other clients at 
dinner.”
Agreeing/
disagreeing
Indicating accord with or 
opposition to the client’s 
ideas or opinions. Im-
plies that the nurse has 
the right to pass judg-
ment on whether the 
client’s ideas or opinions 
are “right” or “wrong.” 
Agreement prevents the 
client from later modi-
fying his or her point of 
view without admitting 
error. Disagreement 
implies inaccuracy, 
provoking the need for 
defensiveness on the 
part of the client.
“That’s right. I 
agree.”
“That’s wrong. I 
disagree.”
“I don’t believe 
that.”
Better to say: “Let’s 
discuss what 
you feel is unfair 
about the new 
community rules.”
Giving 
advice
Telling the client what to 
do or how to behave 
implies that the nurse 
knows what is best and 
that the client is incapa-
ble of any self-direction. 
It nurtures the client 
in the dependent role 
by discouraging 
independent thinking.
“I think you 
should...”
“Why don’t you...”
Better to say: “What 
do you think you 
should do?” or 
“What do you 
think would be 
best for you?”
Continued
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Technique
Explanation/
Rationale Examples
Probing Persistent questioning of 
the client. Pushing for 
answers to issues the 
client does not wish to 
discuss. This causes the 
client to feel used and 
valued only for what is 
shared with the nurse, 
and places the client on 
the defensive.
“Tell me how your 
mother abused 
you when you 
were a child.”
“Tell me how you 
feel toward your 
mother now that 
she is dead.”
“Now tell me 
about...”
Better technique: 
The nurse should 
be aware of the 
client’s response 
and discontinue 
the interaction at 
the fi rst sign of 
discomfort.
Defending Attempting to protect 
someone or something 
from verbal attack. 
To defend what the 
client has criticized is 
to imply that he or she 
has no right to express 
ideas, opinions, or feel-
ings. Defending does 
not change the client’s 
feelings and may cause 
the client to think the 
nurse is taking sides 
with those being criti-
cized and against the 
client.
“No one here would 
lie to you.”
“You have a very 
capable physician. 
I’m sure he only 
has your best in-
terests in mind.”
Better to say: “I 
will try to answer 
your questions 
and clarify some 
issues regarding 
your treatment.”
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Technique
Explanation/
Rationale Examples
Requesting 
an expla-
nation
Asking the client to 
provide the reasons 
for thoughts, feelings, 
behavior, and events. 
Asking “why” a client 
did something or feels 
a certain way can be 
very intimidating, and 
implies that the client 
must defend his or her 
behavior or feelings.
“Why do you think 
that?”
“Why do you feel 
this way?”
“Why did you do 
that?”
Better to say: 
“Describe what 
you were feeling 
just before that 
happened.”
Indicating 
the exist-
ence of an 
external 
source of 
power
Attributing the source of 
thoughts, feelings, and 
behavior to others or 
to outside inﬂ uences. 
This encourages the 
client to project blame 
for his or her thoughts 
or behaviors on others 
rather than accept-
ing the responsibility 
personally.
“What makes you 
say that?”
“What made you do 
that?”
“What made you so 
angry last night?”
Better to say: 
“You became 
angry when your 
brother insulted 
your wife.”
Belittling 
feelings 
expressed
When the nurse mis-
judges the degree of 
the client’s discomfort, 
a lack of empathy and 
understanding may be 
conveyed. The nurse 
may tell the client to 
“perk up” or “snap out 
of it.” This causes the 
client to feel insigniﬁ -
cant or unimportant. 
When one is experienc-
ing discomfort, it is 
no relief to hear that 
others are or have been 
in similar situations.
Cl: “I have nothing 
to live for. I wish I 
were dead.”
Ns: “Everybody 
gets down in the 
dumps at times. 
I feel that way my-
self sometimes.”
Better to say: “You 
must be very up-
set. Tell me what 
you are feeling 
right now.”
Continued
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Technique
Explanation/
Rationale Examples
Making 
stereo- 
typed 
comments
Cliches and trite expres-
sions are meaning-
less in a nurse-client 
relationship. For the 
nurse to make empty 
conversation is to en-
courage a like response 
from the client.
“I’m fi ne, and how 
are you?”
“Hang in there. 
It’s for your own 
good.”
“Keep your chin 
up.”
Better to say: “The 
therapy must be 
diffi cult for you 
at times. How do 
you feel about your 
progress at this 
point?”
Using denial When the nurse denies 
that a problem exists, 
he or she blocks discus-
sion with the client and 
avoids helping the cli-
ent identify and explore 
areas of difﬁ culty.
Cl: “I’m nothing.”
Ns: “Of course 
you’re something. 
Everybody is 
somebody.”
Better to say: 
“You’re feeling 
like no one cares 
about you right 
now.”
Interpreting With this technique the 
therapist seeks to make 
conscious that which is 
unconscious, to tell the 
client the meaning of 
his or her experience.
“What you really 
mean is...”
“Unconsciously 
you’re saying...”
Better to say: The 
nurse must leave 
interpretation 
of the client’s 
behavior to the 
psychiatrist. The 
nurse has not 
been prepared 
to perform this 
technique and, in 
attempting to do 
so, may endanger 
other nursing roles 
with the client.
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Technique
Explanation/
Rationale Examples
Introducing 
an unre-
lated topic
Changing the subject 
causes the nurse to take 
over the direction of the 
discussion. This may 
occur in order to get to 
something that the nurse 
wants to discuss with 
the client or to get away 
from a topic that he or 
she would prefer not to 
discuss.
Cl: “I don’t have any-
thing to live for.”
Ns: “Did you have 
visitors this 
weekend?”
Better technique: 
The nurse must re-
main open and free 
to hear the client, 
to take in all that 
is being conveyed, 
both verbally and 
nonverbally.
Source: Adapted from Hays, J.S., and Larson, K.H. (1963). Interacting 
with patients. New York: Holt, Rinehart, and Winston.
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Psychosocial 
Therapies
● GROUP THERAPY
Group therapy is a type of psychosocial therapy with a number 
of clients at one time. The group is founded in a speciﬁ c theo-
retical framework, with the goal being to encourage improve-
ment in interpersonal functioning.
Nurses often lead “therapeutic groups,” which are based to a 
lesser degree in theory. The focus of therapeutic groups is more 
on group relations, interactions among group members, and the 
consideration of a selected issue.
Types of groups include task groups, in which the function 
is to accomplish a speciﬁ c outcome or task; teaching groups, in 
which knowledge or information is conveyed to a number of 
individuals; supportive-therapeutic groups, which help prevent 
future upsets by teaching participants effective ways of dealing 
with emotional stress arising from situational or developmental 
crises; and self-help groups of individuals with similar problems 
who meet to help each other with emotional distress associated 
with those problems.
Yalom (2005) identiﬁ ed 11 curative factors that individu-
als can achieve through interpersonal interactions within the 
group. They include the following:
 1. The instillation of hope
 2. Universality (individuals come to understand that they are 
not alone in the problems they experience)
 3. The imparting of information
 4. Altruism (mutual sharing and concern for each other)
 5. The corrective recapitulation of the primary family group
 6. The development of socializing techniques
 7. Imitative behavior
 8. Interpersonal learning
 9. Group cohesiveness
 10. Catharsis (open expression of feelings)
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 11.  Existential factors (the group is able to help individual mem-
bers take direction of their own lives and to accept respon-
sibility for the quality of their existence)
● PSYCHODRAMA
Psychodrama is a specialized type of therapeutic group that em-
ploys a dramatic approach in which clients become “actors” in 
life-situation scenarios.
The group leader is called the director, group members are the 
audience, and the set, or stage, may be specially designed or may 
just be any room or part of a room selected for this purpose. Ac-
tors are members from the audience who agree to take part in 
the “drama” by role-playing a situation about which they have 
been informed by the director. Usually the situation is an issue 
with which one individual client has been struggling. The client 
plays the role of himself or herself and is called the protagonist. 
In this role, the client is able to express true feelings toward in-
dividuals (represented by group members) with whom he or she 
has unresolved conﬂ icts.
In some instances, the group leader may ask for a client to 
volunteer to be the protagonist for that session. The client may 
choose a situation he or she wishes to enact and select the audi-
ence members to portray the roles of others in the life situation. 
The psychodrama setting provides the client with a safer and 
less threatening atmosphere than the real situation in which 
to express true feelings. Resolution of interpersonal conﬂ icts is 
facilitated.
When the drama has been completed, group members from 
the audience discuss the situation they have observed, offer feed-
back, express their feelings, and relate their own similar experi-
ences. In this way, all group members beneﬁ t from the session, 
either directly or indirectly.
Nurses often serve as actors, or role players, in psychodra-
ma sessions. Leaders of psychodrama have graduate degrees in 
psychology, social work, nursing, or medicine with additional 
training in group therapy and specialty preparation to become 
a psychodramatist.
● FAMILY THERAPY
In family therapy, the nurse-therapist works with the family as 
a group to improve communication and interaction patterns. 
Areas of assessment include communication, manner of self-
concept reinforcement, family members’ expectations, handling 
differences, family interaction patterns, and the “climate” of the 
family (a blend of feelings and experiences that are the result of 
sharing and interacting).
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The Family as a System
General systems theory is a way of organizing thought accord-
ing to the holistic perspective. A system is considered greater 
than the sum of its parts. A family can be viewed as a system 
composed of various subsystems. The systems approach to fam-
ily therapy is composed of eight major concepts: (1) differentia-
tion of self, (2) triangles, (3) nuclear family emotional process, 
(4) family projection process, (5) multigenerational transmission 
process, (6) sibling position proﬁ les, (7) emotional cutoff, and 
(8) societal regression. The goal is to increase the level of dif-
ferentiation of self, while remaining in touch with the family 
system.
The Structural Model
In this model, the family is viewed as a social system within which 
the individual lives and to which the individual must adapt. The 
individual both contributes to and responds to stresses within 
the family. Major concepts include systems, subsystems, trans-
actional patterns, and boundaries. The goal of therapy is to 
facilitate change in the family structure. The therapist does this 
by joining the family, evaluating the family system, and restruc-
turing the family.
The Strategic Model
This model uses the interactional or communications approach. 
Functional families are open systems where clear and precise 
messages, congruent with the situation, are sent and received. 
Healthy communication patterns promote nurturance and indi-
vidual self-worth. In dysfunctional families, viewed as partially 
closed systems, communication is vague, and messages are often 
inconsistent and incongruent with the situation. Destructive 
patterns of communication tend to inhibit healthful nurtur-
ing and decrease individual feelings of self-worth. Concepts of 
this model include double-bind communication, pseudomutual-
ity and pseudohostility, marital schism, and marital skew. The 
goal of therapy is to create change in destructive behavior and 
communication patterns among family members. This is ac-
complished by using paradoxical intervention (prescribing the 
symptom) and reframing (changing the setting or viewpoint 
in relation to which a situation is experienced and placing it in 
another more positive frame of reference).
● MILIEU THERAPY
In psychiatry, milieu therapy, or a therapeutic community, con-
stitutes a manipulation of the environment in an effort to create 
behavioral changes and to improve the psychological health and 
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functioning of the individual. The goal of therapeutic commu-
nity is for the client to learn adaptive coping, interaction, and 
relationship skills that can be generalized to other aspects of his 
or her life. The community environment itself serves as the pri-
mary tool of therapy.
According to Skinner (1979), a therapeutic community is 
based on seven basic assumptions:
 1. The health in each individual is to be realized and encour-
aged to grow.
 2. Every interaction is an opportunity for therapeutic 
intervention.
 3. The client owns his or her own environment.
 4. Each client owns his or her behavior.
 5. Peer pressure is a useful and a powerful tool.
 6. Inappropriate behaviors are dealt with as they occur.
 7. Restrictions and punishment are to be avoided. 
Since the goals of milieu therapy relate to helping the client 
learn to generalize that which is learned to other aspects of his 
or her life, the conditions that promote a therapeutic commu-
nity in the hospital setting are similar to the types of conditions 
that exist in real-life situations. They include the following:
 1. The fulﬁ llment of basic physiological needs.
 2. Physical facilities that are conducive to the achievement of 
the goals of therapy.
 3. The existence of a democratic form of self-government.
 4. The assignment of unit responsibilities according to client 
capabilities.
 5. A structured program of social and work-related activities.
 6. The inclusion of community and family in the program of 
therapy in an effort to facilitate discharge from the hospital.
The program of therapy on the milieu unit is conducted by 
the interdisciplinary treatment (IDT) team. The team includes 
some, or all, of the following disciplines and may include oth-
ers that are not speciﬁ ed here: psychiatrist, clinical psychologist, 
psychiatric clinical nurse specialist, psychiatric nurse, mental 
health technician, psychiatric social worker, occupational thera-
pist, recreational therapist, art therapist, music therapist, psy-
chodramatist, dietitian, and chaplain.
Nurses play a crucial role in the management of a therapeutic 
milieu. They are involved in the assessment, diagnosis, outcome 
identiﬁ cation, planning, implementation, and evaluation of all 
treatment programs. They have signiﬁ cant input into the IDT 
plans that are developed for all clients. They are responsible 
for ensuring that clients’ basic needs are fulﬁ lled, for continual 
assessment of physical and psychosocial status, for medication 
administration, for the development of trusting relationships, 
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for setting limits on unacceptable behaviors, for client educa-
tion, and ultimately, for helping clients, within the limits of 
their capability, become productive members of society.
Milieu therapy came into its own during the 1960s through 
the early 1980s. During this period, psychiatric inpatient treat-
ment provided sufﬁ cient time to implement programs of ther-
apy that were aimed at social rehabilitation. Currently, care in 
inpatient psychiatric facilities is shorter and more biologically 
based, limiting clients’ beneﬁ t from the socialization that occurs 
in a milieu as treatment program. Although strategies for mi-
lieu therapy are still used, they have been modiﬁ ed to conform 
to the short-term approach to care or to outpatient treatment 
programs.
● CRISIS INTERVENTION
A crisis is “a sudden event in one’s life that disturbs homeo-
stasis, during which usual coping mechanisms cannot resolve 
the problem” (Lagerquist, 2006). All individuals experience 
crises at one time or another. This does not necessarily indi-
cate psychopathology.
Crises are precipitated by speciﬁ c, identiﬁ able events and are 
determined by an individual’s personal perception of the situa-
tion. They are acute, not chronic, and generally last no longer 
than 4 to 6 weeks.
Crises occur when an individual is exposed to a stressor 
and previous problem-solving techniques are ineffective. This 
causes the level of anxiety to rise. Panic may ensue when new 
techniques are employed and resolution fails to occur.
Six types of crises have been identiﬁ ed. They include disposi-
tional crises, crises of anticipated life transitions, crises resulting 
from traumatic stress, maturational or developmental crises, cri-
ses reﬂ ecting psychopathology, and psychiatric emergencies. The 
type of crisis determines the method of intervention selected.
Crisis intervention is designed to provide rapid assistance for 
individuals who have an urgent need. Aguilera (1998) suggests 
that the “focus is on the supportive, with the restoration of the 
individual to his precrisis level of functioning or possibly to a 
higher level of functioning.”
Nurses regularly respond to individuals in crisis in all types 
of settings. Nursing process is the vehicle by which nurses assist 
individuals in crisis with a short-term problem-solving approach 
to change. A four-phase technique is used: assessment/analysis, 
planning of therapeutic intervention, intervention, and evalua-
tion of crisis resolution and anticipatory planning. Through this 
structured method of assistance, nurses assist individuals in cri-
sis to develop more adaptive coping strategies for dealing with 
stressful situations in the future.
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● RELAXATION THERAPY
Stress is a part of our everyday lives. It can be positive or nega-
tive, but it cannot be eliminated. Keeping stress at a manageable 
level is a lifelong process.
Individuals under stress respond with a physiological arousal 
that can be dangerous over long periods. Indeed, the stress re-
sponse has been shown to be a major contributor, either directly 
or indirectly, to coronary heart disease, cancer, lung ailments, 
accidental injuries, cirrhosis of the liver, and suicide—six of the 
leading causes of death in the United States.
Relaxation therapy is an effective means of reducing the 
stress response in some individuals. The degree of anxiety that 
an individual experiences in response to stress is related to cer-
tain predisposing factors, such as characteristics of temperament 
with which he or she was born, past experiences resulting in 
learned patterns of responding, and existing conditions, such as 
health status, coping strategies, and adequate support systems.
Deep relaxation can counteract the physiological and be-
havioral manifestations of stress. Various methods of relaxation 
include the following:
Deep-Breathing Exercises: Tension is released when the 
lungs are allowed to breathe in as much oxygen as pos-
sible. Deep-breathing exercises involve inhaling slowly 
and deeply through the nose, holding the breath for a few 
seconds, then exhaling slowly through the mouth, pursing 
the lips as if trying to whistle.
Progressive Relaxation: This method of deep-muscle re-
laxation is based on the premise that the body responds 
to anxiety-provoking thoughts and events with muscle 
tension. Each muscle group is tensed for 5 to 7 seconds 
and then relaxed for 20 to 30 seconds, during which time 
the individual concentrates on the difference in sensa-
tions between the two conditions. Soft, slow background 
music may facilitate relaxation. A modiﬁ ed version of this 
technique (called passive progressive relaxation) involves re-
laxation of the muscles by concentrating on the feeling of 
relaxation within the muscle, rather than the actual tens-
ing and relaxing of the muscle.
Meditation: The goal of meditation is to gain mastery over 
attention. It brings on a special state of consciousness as 
attention is concentrated solely on one thought or object. 
During meditation, as the individual becomes totally pre-
occupied with the selected focus, the respiration rate, heart 
rate, and blood pressure decrease. The overall metabolism 
declines, and the need for oxygen consumption is reduced.
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Mental Imagery: Mental imagery uses the imagination in an 
effort to reduce the body’s response to stress. The frame of 
reference is very personal, based on what each individual 
considers to be a relaxing environment. The relaxing sce-
nario is most useful when taped and played back at a time 
when the individual wishes to achieve relaxation.
Biofeedback: Biofeedback is the use of instrumentation to 
become aware of processes in the body that usually go un-
noticed and to help bring them under voluntary control. 
Biological conditions, such as muscle tension, skin surface 
temperature, blood pressure, and heart rate, are monitored 
by the biofeedback equipment. With special training, the 
individual learns to use relaxation and voluntary control 
to modify the biological condition, in turn indicating a 
modiﬁ cation of the autonomic function it represents. Bio-
feedback is often used together with other relaxation tech-
niques such as deep breathing, progressive relaxation, and 
mental imagery.
● ASSERTIVENESS TRAINING
Assertive behavior helps individuals feel better about themselves 
by encouraging them to stand up for their own basic human 
rights. These rights have equal representation for all individu-
als. But along with rights comes an equal number of respon-
sibilities. Part of being assertive includes living up to these 
responsibilities.
Assertive behavior increases self-esteem and the ability 
to develop satisfying interpersonal relationships. This is ac-
complished through honesty, directness, appropriateness, and 
respecting one’s own rights, as well as the rights of others.
Individuals develop patterns of responding in various ways, 
such as role modeling, by receiving positive or negative rein-
forcement, or by conscious choice. These patterns can take 
the form of nonassertiveness, assertiveness, aggressiveness, or 
passive-aggressiveness.
Nonassertive individuals seek to please others at the expense 
of denying their own basic human rights. Assertive individuals 
stand up for their own rights while protecting the rights of oth-
ers. Those who respond aggressively defend their own rights by 
violating the basic rights of others. Individuals who respond in a 
passive-aggressive manner defend their own rights by expressing 
resistance to social and occupational demands.
Some important behavioral considerations of assertive be-
havior include eye contact, body posture, personal distance, 
physical contact, gestures, facial expression, voice, ﬂ uency, tim-
ing, listening, thoughts, and content. Various techniques have 
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been developed to assist individuals in the process of becoming 
more assertive. Some of these include the following:
 1. Standing up for one’s basic human rights. 
Example: “I have the right to express my opinion.” 
 2. Assuming responsibility for one’s own statements. 
Example: “I don’t want to go out with you tonight,” instead of 
“I can’t go out with you tonight.” The latter implies a lack 
of power or ability. 
 3. Responding as a “broken record.” Persistently repeating in 
a calm voice what is wanted. 
Example: Telephone salesperson: “I want to help you save 
money by changing long-distance services.”
 Assertive response:  “I don’t want to change my long-
distance service.”
 Telephone salesperson:  “I can’t believe you don’t want to 
save money!”
 Assertive response:  “I don’t want to change my long-
distance service.” 
 4. Agreeing assertively. Assertively accepting negative aspects 
about oneself. Admitting when an error has been made. 
Example:
 Ms. Jones:  “You sure let that meeting get out of hand. 
What a waste of time.”
 Ms. Smith:  “Yes, I didn’t do a very good job of conduct-
ing the meeting today.” 
 5. Inquiring assertively. Seeking additional information about 
critical statements. 
Example:
 Male board member:  “You made a real fool of yourself at 
the board meeting last night.”
 Female board member:  “Oh, really? Just what about my 
behavior offended you?”
 Male board member:  “You were so damned pushy!”
 Female board member:  “Were you offended that I spoke up 
for my beliefs, or was it because my 
beliefs are in direct opposition to 
yours?” 
 6. Shifting from content to process. Changing the focus of 
the communication from discussing the topic at hand to ana-
lyzing what is actually going on in the interaction. 
 Example:
 Wife:  “Would you please call me if you will be late for 
dinner?”
 Husband:  “Why don’t you just get off my back! I always 
have to account for every minute of my time 
with you!”
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 Wife:  “Sounds to me like we need to discuss some 
other things here. What are you really angry 
about?” 
 7. Clouding/fogging. Concurring with the critic’s argu-
ment without becoming defensive and without agreeing to 
change. 
 Example:
 Nurse No. 1:  “You make so many mistakes. I don’t know 
how you ever got this job!”
 Nurse No. 2:  “You’re right. I have made some mistakes 
since I started this job.” 
 8. Defusing. Putting off further discussion with an angry in-
dividual until he or she is calmer. 
 Example:
 “You are very angry right now. I don’t want to discuss this 
matter with you while you are so upset. I will discuss it with 
you in my ofﬁ ce at 3 o’clock this afternoon.” 
 9. Delaying assertively. Putting off further discussion with 
another individual until one is calmer. 
 Example:
 “That’s a very challenging position you have taken, 
Mr. Brown. I’ll need time to give it some thought. I’ll call 
you later this afternoon.” 
 10. Responding assertively with irony. 
 Example:
 Man:  “I bet you’re one of them so-called ‘women’s 
libbers,’ aren’t you?”
 Woman: “Yes, thank you for noticing.” 
● COGNITIVE THERAPY
Cognitive therapy, developed by Aaron Beck, is commonly used 
in the treatment of mood disorders. In cognitive therapy, the in-
dividual is taught to control thought distortions that are consid-
ered to be a factor in the development and maintenance of mood 
disorders. In the cognitive model, depression is characterized 
by a triad of negative distortions related to expectations of the 
environment, self, and future. The environment and activities 
within it are viewed as unsatisfying, the self is unrealistically 
devalued, and the future is perceived as hopeless. In the same 
model, mania is characterized by a positive cognitive triad—the 
self is seen as highly valued and powerful, experiences within the 
environment are viewed as overly positive, and the future is seen 
as one of unlimited opportunity.
The general goals in cognitive therapy are to obtain symp-
tom relief as quickly as possible, to assist the client in identifying 
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dysfunctional patterns of thinking and behaving, and to guide 
the client to evidence and logic that effectively test the valid-
ity of the dysfunctional thinking. Therapy focuses on changing 
“automatic thoughts” that occur spontaneously and contribute 
to the distorted affect. Examples of “automatic thoughts” in 
depression include the following:
 1. Personalizing:  “I’m the only one who failed.”
 2. All or nothing:  “I’m a complete failure.”
 3. Mind reading:  “He thinks I’m foolish.”
 4. Discounting positives: “The other questions were so easy. 
Any dummy could have gotten them right.”
Examples of “automatic thoughts” in mania include the 
following:
 1. Personalizing:  “She’s this happy only when she’s with me.”
 2. All or nothing:  “Everything I do is great.”
 3. Mind reading:  “She thinks I’m wonderful.”
 4. Discounting negatives:  “None of those mistakes are really 
important.”
The client is asked to describe evidence that both supports 
and disputes the automatic thought. The logic underlying the 
inferences is then reviewed with the client. Another technique 
involves evaluating what would most likely happen if the client’s 
automatic thoughts were true. Implications of the consequences 
are then discussed.
Clients should not become discouraged if one technique 
seems not to be working. There is no single technique that 
works with all clients. He or she should be reassured that there 
are a number of techniques that may be used, and both therapist 
and client may explore these possibilities. Cognitive therapy 
has been shown to be an effective treatment for mood disor-
ders, particularly in conjunction with psychopharmacological 
intervention.
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A P P E N D I X  G
Electroconvulsive 
Therapy
● DEFINED 
Electroconvulsive therapy (ECT) is a type of somatic treatment 
in which electric current is applied to the brain through elec-
trodes placed on the temples. The current is sufﬁ cient to induce 
a grand mal seizure, from which the desired therapeutic effect 
is achieved.
● INDICATIONS 
 ECT is primarily used in the treatment of severe depression. It 
is sometimes administered in conjunction with antidepressant 
medication, but most physicians prefer to perform this treat-
ment only after an unsuccessful trial of drug therapy. 
ECT may also be used as a fast-acting treatment for very 
hyperactive manic clients in danger of physical exhaustion, and 
with individuals who are extremely suicidal.
ECT was originally attempted in the treatment of schizo-
phrenia, but with little success in most instances. There has 
been evidence, however, of its effectiveness in the treatment of 
acute schizophrenia, particularly if it is accompanied by cata-
tonic or affective (depression or mania) symptomatology (Black 
& Andreasen, 2011).
● CONTRAINDICATIONS 
ECT should not be used if there is increased intracranial pressure 
(resulting from a brain tumor, recent cardiovascular accident, or 
other cerebrovascular lesion). Other conditions, although not 
considered absolute contraindications, may render clients at high 
risk for the treatment. They are largely cardiovascular in nature 
and include myocardial infarction or cerebrovascular accident 
within the preceding 3 months, aortic or cerebral aneurysm, 
severe underlying hypertension, and congestive heart failure.
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● MECHANISM OF ACTION 
The exact mechanism of action is unknown. However, it is 
thought that ECT produces biochemical changes in the brain—
an increase in the levels of norepinephrine, serotonin, and 
dopamine—similar to the effects of antidepressant medications.
●  SIDE EFFECTS AND NURSING 
IMPLICATIONS 
Temporary Memory Loss and Confusion
● These are the most common side effects of ECT. It is impor-
tant for the nurse to be present when the client awakens, to 
alleviate the fears that accompany this loss of memory.
● Provide reassurance that memory loss is only temporary.
● Describe to client what has occurred.
● Reorient client to time and place.
● Allow client to verbalize fears and anxieties related to receiv-
ing ECT.
● To minimize confusion, provide a good deal of structure for 
client’s routine activities.
● RISKS ASSOCIATED WITH ECT 
 1. Death. The mortality rate from ECT is about 2 per 100,000 
treatments (Marangell et al., 2003; Sadock & Sadock, 2007). 
The major cause is cardiovascular complications, such as 
acute myocardial infarction or cardiac arrest.
 2. Brain Damage. Brain damage is considered to be a risk, but 
evidence is largely unsubstantiated.
 3. Permanent Memory Loss. Most individuals report no 
problems with their memory, aside from the time imme-
diately surrounding the ECT treatments. However, some 
clients have reported retrograde amnesia extending back to 
months before treatment. In rare instances, more extensive 
amnesia has occurred, resulting in memory gaps dating back 
years (Joska & Stein, 2008), Black and Andreasen (2011) sug-
gest that all clients receiving ECT should be informed of the 
possibility of permanent memory loss. 
Although the potential for these effects appears to be mini-
mal, the client must be made aware of the risks involved before 
consenting to treatment.
●  POTENTIAL NURSING DIAGNOSES 
ASSOCIATED WITH ECT 
 1. Risk for injury related to certain risks associated with ECT.
 2. Risk for aspiration related to altered level of consciousness 
immediately following treatment.
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 3. Decreased cardiac output related to vagal stimulation occur-
ring during the ECT.
 4. Disturbed thought processes related to side effects of tempo-
rary memory loss and confusion.
 5. Deﬁ cient knowledge related to necessity for, and side effects 
and risks of, ECT.
 6. Anxiety (moderate to severe) related to impending therapy.
 7. Self-care deﬁ cit related to incapacitation during postictal 
stage.
 8. Risk for activity intolerance related to post-ECT confusion 
and memory loss.
●  NURSING INTERVENTIONS FOR CLIENT 
RECEIVING ECT 
 1. Ensure that physician has obtained informed consent and 
that a signed permission form is on the chart.
 2. Ensure that most recent laboratory reports (complete blood 
count [CBC], urinalysis) and results of ECG and x-ray 
examination are available.
 3. Client should receive nothing by mouth (NPO) on the 
morning of the treatment.
 4. Prior to the treatment, client should void, dress in night 
clothes (or other loose clothing), and remove dentures and 
eyeglasses or contact lenses. Bedrails should be raised.
 5. Take baseline vital signs and blood pressure.
 6. Administer cholinergic blocking agent (e.g., atropine sul-
fate, glycopyrrolate) approximately 30 minutes before treat-
ment, as ordered by the physician, to decrease secretions 
and increase heart rate (which is suppressed in response to 
vagal stimulation caused by the ECT).
 7. Assist physician and/or anesthesiologist as necessary in the 
administration of intravenous medications. A short-acting 
anesthetic, such as methohexital sodium (Brevital sodium), 
is given along with the muscle relaxant succinylcholine 
chloride (Anectine).
 8. Administer oxygen and provide suctioning as required.
 9. After the procedure, take vital signs and blood pressure 
every 15 minutes for the ﬁ rst hour. Position client on side to 
prevent aspiration.
 10. Stay with client until he or she is fully awake.
 11. Allow client to verbalize fears and anxieties associated with 
the treatment.
 12. Reassure client that memory loss and confusion are only 
temporary. 
2506_Appendix_G_580-582.indd   582 10/1/10   9:30:53 AM
A P P E N D I X  H
Medication Assessment 
Tool
583
2506_Appendix_H_583-587.indd   583 10/1/10   9:31:01 AM
584 ● APPENDIX H
D
at
e 
 
 
C
lie
nt
’s 
N
am
e 
 
 
 
 
A
ge
 
 
 
 
M
ar
it
al
 S
ta
tu
s 
 
 
 
 C
hi
ld
re
n 
 
 
 
 
 
 
 
O
cc
up
at
io
n 
 
 
 
 
 
 
 
 
 
 
P
re
se
nt
in
g 
Sy
m
pt
om
s 
(s
ub
je
ct
iv
e 
&
 o
bj
ec
ti
ve
)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D
ia
gn
os
is
 (
D
SM
-I
V
-T
R
)  
 
 
 
 
 
 
 
 
 
C
ur
re
nt
 V
it
al
 S
ig
ns
: B
lo
od
 P
re
ss
ur
e:
 S
it
ti
ng
  
/ 
 ; 
St
an
di
ng
  
/ 
; P
ul
se
 
  ;
 R
es
pi
ra
ti
on
s 
 
C
U
R
R
E
N
T
/P
A
ST
 U
SE
 O
F 
P
R
E
SC
R
IP
T
IO
N
 D
R
U
G
S 
(I
nd
ic
at
e 
w
it
h 
“c
” 
or
 “
p”
 b
es
id
e 
na
m
e 
of
 d
ru
g 
w
he
th
er
 c
ur
re
nt
 o
r 
pa
st
 u
se
):
 N
am
e 
D
os
ag
e 
H
ow
 L
on
g 
U
se
d 
W
hy
 P
re
sc
ri
be
d 
 
B
y 
W
ho
m
 
Si
de
 E
ff
ec
ts
/R
es
ul
ts
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2506_Appendix_H_583-587.indd   584 10/1/10   9:31:01 AM
APPENDIX H ● 585
C
U
R
R
E
N
T
/P
A
ST
 U
SE
 O
F 
O
V
E
R
-T
H
E
-C
O
U
N
T
E
R
 D
R
U
G
S 
(I
nd
ic
at
e 
w
it
h 
“c
” 
or
 “
p”
 b
es
id
e 
na
m
e 
of
 d
ru
g 
w
he
th
er
 c
ur
re
nt
 o
r 
pa
st
 u
se
):
 N
am
e 
D
os
ag
e 
H
ow
 L
on
g 
U
se
d 
W
hy
 P
re
sc
ri
be
d 
 
B
y 
W
ho
m
 
Si
de
 E
ff
ec
ts
/R
es
ul
ts
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C
U
R
R
E
N
T
/P
A
ST
 U
SE
 O
F 
ST
R
E
E
T
 D
R
U
G
S,
 A
L
C
O
H
O
L
, 
N
IC
O
T
IN
E
, 
A
N
D
/O
R
 C
A
F
F
E
IN
E
 (
In
di
ca
te
 w
it
h 
“c
” 
or
 “
p”
 b
es
id
e 
na
m
e 
of
 d
ru
g 
w
he
th
er
 c
ur
re
nt
 o
r 
pa
st
 u
se
):
 N
am
e 
A
m
ou
nt
 U
se
d 
 
H
ow
 O
ft
en
 U
se
d 
 
W
he
n 
L
as
t U
se
d 
E
ff
ec
ts
/P
ro
du
ce
d
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A
ny
 a
lle
rg
ie
s 
to
 fo
od
 o
r 
dr
ug
s?
  
A
ny
 s
pe
ci
al
 d
ie
t c
on
si
de
ra
ti
on
s?
  
2506_Appendix_H_583-587.indd   585 10/1/10   9:31:02 AM
586 ● APPENDIX H
D
o 
yo
u 
ha
ve
 (o
r 
ha
ve
 y
ou
 e
ve
r 
ha
d)
 a
ny
 o
f t
he
 fo
llo
w
in
g?
 I
f y
es
, p
ro
vi
de
 e
xp
la
na
ti
on
 o
n 
th
e 
ba
ck
 o
f t
hi
s 
sh
ee
t.
 
Ye
s 
N
o 
Ye
s 
N
o 
 
Ye
s 
N
o
  1
. D
if
ﬁ c
ul
ty
 s
w
al
lo
w
in
g 
 
 
   
  2
. D
el
ay
ed
 w
ou
nd
 h
ea
li
ng
  
 
   
  3
. C
on
st
ip
at
io
n 
pr
ob
le
m
s 
 
 
   
  4
. U
ri
na
ti
on
 p
ro
bl
em
s 
 
 
   
  5
. R
ec
en
t c
ha
ng
e 
in
 e
li
m
in
at
io
n
   
   
pa
tt
er
ns
  
 
   
  6
. W
ea
kn
es
s 
or
 t
re
m
or
s 
 
   
  7
. S
ei
zu
re
s 
 
 
   
  8
. H
ea
da
ch
es
  
 
   
  9
. D
iz
zi
ne
ss
  
 
   
10
. H
ig
h 
bl
oo
d 
pr
es
su
re
 
 
   
11
. P
al
pi
ta
ti
on
s 
 
   
12
. C
he
st
 p
ai
n 
 
   
13
. B
lo
od
 c
lo
ts
/p
ai
n 
in
 le
gs
 
 
   
14
. F
ai
nt
in
g 
sp
el
ls
 
 
   
15
. S
w
ol
le
n 
an
kl
es
/l
eg
s/
ha
nd
s 
 
   
16
. A
st
hm
a 
 
 
   
17
. V
ar
ic
os
e 
ve
in
s 
 
 
   
18
. N
um
bn
es
s/
ti
ng
li
ng
 
   
   
(l
oc
at
io
n?
) 
 
 
   
19
. U
lc
er
s 
 
 
   
20
. N
au
se
a/
vo
m
it
in
g 
 
 
   
21
. P
ro
bl
em
s 
w
it
h 
di
ar
rh
ea
  
 
   
22
. S
ho
rt
ne
ss
 o
f b
re
at
h 
 
 
   
23
. S
ex
ua
l d
ys
fu
nc
ti
on
 
 
   
24
. L
um
ps
 in
 y
ou
r 
br
ea
st
s 
 
 
   
25
. B
lu
rr
ed
 o
r 
do
ub
le
 v
is
io
n 
 
   
26
. R
in
gi
ng
 in
 t
he
 e
ar
s 
 
   
27
. I
ns
om
ni
a 
 
   
28
. S
ki
n 
ra
sh
es
 
 
   
29
. D
ia
be
te
s 
 
   
30
. H
ep
at
it
is
 (o
r 
ot
he
r 
   
   
liv
er
 d
is
ea
se
) 
 
   
31
. K
id
ne
y 
di
se
as
e 
 
   
32
. G
la
uc
om
a 
 
   
2506_Appendix_H_583-587.indd   586 10/1/10   9:31:02 AM
APPENDIX H ● 587
A
re
 y
ou
 p
re
gn
an
t o
r 
br
ea
st
 fe
ed
in
g?
  
 
 D
at
e 
of
 la
st
 m
en
se
s 
 
 
   
   
   
 T
yp
e 
of
 c
on
tr
ac
ep
ti
on
 u
se
d 
 
 
 
D
es
cr
ib
e 
an
y 
re
st
ri
ct
io
ns
/l
im
it
at
io
ns
 t
ha
t m
ig
ht
 in
te
rf
er
e 
w
it
h 
yo
ur
 u
se
 o
f m
ed
ic
at
io
n 
fo
r 
yo
ur
 c
ur
re
nt
 p
ro
bl
em
. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
P
re
sc
ri
pt
io
n 
or
de
rs
: 
 
 
 
 
 
 
P
at
ie
nt
 te
ac
hi
ng
 r
el
at
ed
 to
 m
ed
ic
at
io
ns
 p
re
sc
ri
be
d:
 L
ab
 w
or
k 
or
de
re
d:
 
 
 
 
 
   
   
   
   
   
   
   
  
 
 
 
 
 
 
N
ur
se
’s 
Si
gn
at
ur
e 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
C
lie
nt
’s 
Si
gn
at
ur
e
2506_Appendix_H_583-587.indd   587 10/1/10   9:31:02 AM
A P P E N D I X  I
Cultural Assessment 
Tool
588
Client’s Name   Ethnic Origin  
Address   Birth Date  
Name of Signiﬁ cant Other   Relationship  
Primary Language Spoken  
Second Language Spoken   
How does client usually communicate with people who speak a 
different language?  
Is an interpreter required?  
Available?  
Highest level of education achieved  
Occupation  
Presenting Problem  
Has this problem ever occurred before?  
If so, in what manner was it handled previously?  
What is client’s usual manner of coping with stress?  
Who is(are) the client’s main support system(s)?  
Describe the family living arrangements  
Who is the major decision maker in the family?  
Describe client’s/family members’ roles within the 
family  
Describe religious beliefs and practices  
Are there any religious requirements or restrictions that place 
limitations on the client’s care?  
If so, describe  
Who in the family takes responsibility for health concerns? 
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Describe any special health beliefs and practices that may 
vary from the conventional   
From whom does family usually seek medical assistance in time 
of need?   
Describe client’s usual emotional/behavioral response to:    
 
Anxiety  
Anger   
Loss/change/failure  
Pain  
Fear  
Describe any topics that are particularly sensitive or that the 
client is unwilling to discuss (because of cultural taboos)
 
Describe any activities in which the client is unwilling to par-
ticipate (because of cultural customs or taboos)  
What are the client’s personal feelings regarding touch?  
        
What are the client’s personal feelings regarding eye contact?
 
What is the client’s personal orientation to time? (past, present, 
future)  
Describe any particular illnesses to which the client may be bio-
culturally susceptible (e.g., hypertension and sickle cell anemia 
in African Americans)  
Describe any nutritional deﬁ ciencies to which the client may be 
bioculturally susceptible (e.g., lactose intolerance in Native and 
Asian Americans)  
Describe client’s favorite foods  
Are there any foods the client requests or refuses because of 
cultural beliefs related to this illness? (e.g., “hot” and “cold” 
foods for Hispanic and Asian Americans). If so, please describe
 
Describe client’s perception of the problem and expectations of 
health care  
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The DSM-IV-TR 
Multiaxial Evaluation 
System
590
The American Psychiatric Association (APA, 2000) endorses 
case evaluation on a multiaxial system, “to facilitate comprehen-
sive and systematic evaluation with attention to the various men-
tal disorders and general medical conditions, psychosocial and 
environmental problems, and level of functioning that might 
be overlooked if the focus were on assessing a single presenting 
problem.” Each individual is evaluated on ﬁ ve axes. They are 
deﬁ ned by the Diagnostic and Statistical Manual of Mental Disor-
ders, Fourth Edition, Text Revision (DSM-IV-TR) in the following 
manner:
Axis I—Clinical Disorders and Other Conditions That May 
Be a Focus of Clinical Attention
These include all mental disorders (except personality disor-
ders and mental retardation).
Axis II—Personality Disorders and Mental Retardation
These disorders usually begin in childhood or adolescence 
and persist in a stable form into adult life.
Axis III—General Medical Conditions
These include any current general medical condition that is 
potentially relevant to the understanding or management 
of the individual’s mental disorder.
Axis IV—Psychosocial and Environmental Problems
These are problems that may affect the diagnosis, treatment, 
and prognosis of mental disorders named on axes I and II. 
Examples include: problems related to primary support 
group, social environment, education, occupation, housing, 
economics, access to health care services, interaction with 
the legal system or crime, and other types of psychosocial 
and environmental problems.
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Axis V—Global Assessment of Functioning
This allows the clinician to rate the individual’s overall function-
ing on the Global Assessment of Functioning (GAF) Scale. 
This scale represents in global terms a single measure of the 
individual’s psychological, social, and occupational function-
ing. A copy of the GAF Scale appears in Appendix K.
Source: From the Diagnostic and Statistical Manual of Mental Disorders, 
4th Edition, Text Revision, 2000. Used with permission from the American 
Psychiatric Association.
Example of a psychiatric diagnosis using the 
Multiaxial Evaluation System:
Axis I 300.4 Dysthymic Disorder
Axis II 301.6 Dependent Personality Disorder
Axis III 244.9 Hypothyroidism
Axis IV  Unemployed
Axis V GAF = 65
 (current)
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Global Assessment 
of Functioning (GAF) 
Scale
592
Consider psychological, social, and occupational functioning 
on a hypothetical continuum of mental health-illness. Do not 
include impairment in functioning due to physical (or environ-
mental) limitations.
Code (Note: Use intermediate codes when appropriate, 
e.g., 45, 68, 72)
100–91 Superior functioning in a wide range of activities, 
life’s problems never seem to get out of hand, is 
sought out by others because of his or her many 
positive qualities. No symptoms.
  90–81 Absent or minimal symptoms (e.g., mild anxiety 
before an exam), good functioning in all areas, in-
terested and involved in a wide range of activities, 
socially effective, generally satisﬁ ed with life, no 
more than everyday problems or concerns (e.g., 
an occasional argument with family members).
  80–71 If symptoms are present, they are transient and 
expectable reactions to psychosocial stres-
sors (e.g., difﬁ culty concentrating after family 
argument); no more than slight impairment in 
social, occupational, or school functioning (e.g., 
temporarily falling behind in schoolwork).
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70–61 Some mild symptoms (e.g., depressed mood and 
mild insomnia) OR some difﬁ culty in social, oc-
cupational, or school functioning (e.g., occasional 
truancy, or theft within the household), but gen-
erally functioning pretty well, has some meaning-
ful interpersonal relationships.
60–51 Moderate symptoms (e.g., ﬂ at affect and circum-
stantial speech, occasional panic attacks) OR 
moderate difﬁ culty in social, occupational, or 
school functioning (e.g., few friends, conﬂ icts 
with peers or co-workers).
50–41 Serious symptoms (e.g., suicidal ideation, severe 
obsessional rituals, frequent shoplifting) OR any 
serious impairment in social, occupational, or 
school functioning (e.g., no friends, unable to 
keep a job).
40–31 Some impairment in reality testing or communi-
cation (e.g., speech is at times illogical, obscure, 
or irrelevant) OR major impairment in several 
areas, such as work or school, family relations, 
judgment, thinking, or mood (e.g., depressed 
man avoids friends, neglects family, and is 
unable to work; child frequently beats up 
younger children, is deﬁ ant at home, and is 
failing at school).
30–31 Behavior is considerably inﬂ uenced by delusions 
or hallucinations OR serious impairment in 
communication or judgment (e.g., sometimes 
incoherent, acts grossly inappropriately, suicidal 
preoccupation) OR inability to function in 
almost all areas (e.g., stays in bed all day; no job, 
home, or friends). 
20–11 Some degree of hurting self or others (e.g., suicide 
attempts without clear expectation of death; fre-
quently violent; manic excitement) OR occasion-
ally fails to maintain minimal personal hygiene 
(e.g., smears feces) OR gross impairment in com-
munication (e.g., largely incoherent or mute).
Continued
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10–1 Persistent danger of severely hurting self or others 
(e.g., recurrent violence) OR persistent inability 
to maintain minimal personal hygiene OR seri-
ous suicidal act with clear expectation of death. 
   0 Inadequate information.
Source: Diagnostic and Statistical Manual of Mental Disorders (4th ed.). 
Text Revision. Washington, DC: American Psychiatric Publishing (2000). 
With permission.
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DSM-IV-TR 
Classiﬁ cation: Axes 
I and II Categories 
and Codes
595
●  DISORDERS USUALLY FIRST 
DIAGNOSED IN INFANCY, CHILDHOOD, 
OR ADOLESCENCE
Mental Retardation
Note: These are coded on Axis II.
317 Mild Mental Retardation
318.0 Moderate Retardation
318.1 Severe Retardation
318.2 Profound Mental Retardation
319 Mental Retardation, Severity Unspeciﬁ ed
Learning Disorders
315.00 Reading Disorder
315.1 Mathematics Disorder
315.2 Disorder of Written Expression
315.9 Learning Disorder Not Otherwise Speciﬁ ed (NOS) 
Motor Skills Disorder
315.4 Developmental Coordination Disorder
Reprinted with permission from the. Diagnostic and Statistical Manual 
of Mental Disorders, Fourth Edition, Text Revision. Copyright 2000, 
American Psychiatric Publishing.
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Communication Disorders
315.31 Expressive Language Disorder
315.32 Mixed Receptive-Expressive Language Disorder
315.39 Phonological Disorder
307.0 Stuttering
307.9 Communication Disorder NOS
Pervasive Developmental Disorders
299.00 Autistic Disorder
299.80 Rett’s Disorder
299.10 Childhood Disintegrative Disorder
299.80 Asperger’s Disorder
299.80 Pervasive Developmental Disorder NOS
Attention-Deﬁ cit and Disruptive Behavior 
Disorders
314.xx Attention-Deﬁ cit/Hyperactivity Disorder
314.01     Combined Type
314.00     Predominantly Inattentive Type
314.01     Predominantly Hyperactive-Impulsive Type
314.9 Attention-Deﬁ cit/Hyperactivity Disorder NOS
312.xx Conduct Disorder
     .81     Childhood-Onset Type
     .82     Adolescent-Onset Type
     .89     Unspeciﬁ ed Onset  
313.81 Oppositional Deﬁ ant Disorder
312.9 Disruptive Behavior Disorder NOS
Feeding and Eating Disorders of Infancy 
or Early Childhood
307.52 Pica
307.53 Rumination Disorder
307.59 Feeding Disorder of Infancy or Early Childhood
Tic Disorders
307.23 Tourette’s Disorder
307.22 Chronic Motor or Vocal Tic Disorder
307.21 Transient Tic Disorder
307.20 Tic Disorder NOS
Elimination Disorders
 — Encopresis
787.6     With Constipation and Overﬂ ow Incontinence
307.7     Without Constipation and Overﬂ ow Incontinence
307.6 Enuresis (Not Due to a General Medical Condition) 
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Other Disorders of Infancy, Childhood, 
or Adolescence
309.21 Separation Anxiety Disorder
313.23 Selective Mutism
313.89  Reactive Attachment Disorder of Infancy or Early 
Childhood
307.3 Stereotypic Movement Disorder
313.9 Disorder of Infancy, Childhood, or Adolescence NOS
●  DELIRIUM, DEMENTIA, AND AMNESTIC 
AND OTHER COGNITIVE DISORDERS
Delirium
293.0  Delirium Due to... (Indicate the General Medical Condition)
 —  Substance Intoxication Delirium (refer to Substance-
Related Disorders for substance-speciﬁ c codes)
 —  Substance Withdrawal Delirium (refer to Substance-
Related Disorders for substance-speciﬁ c codes)
 —  Delirium Due to Multiple Etiologies (code each of the 
speciﬁ c etiologies)
780.09 Delirium NOS
Dementia
294.xx Dementia of the Alzheimer’s Type, With Early Onset
      .10     Without Behavioral Disturbance
      .11     With Behavioral Disturbance
294.xx Dementia of the Alzheimer’s Type, With Late Onset
     .10     Without Behavioral Disturbance
     .11     With Behavioral Disturbance
290.xx Vascular Dementia
     .40     Uncomplicated
     .41     With Delirium
     .42     With Delusions
     .43     With Depressed Mood
294.1x Dementia Due to HIV Disease
294.1x Dementia Due to Head Trauma
294.1x Dementia Due to Parkinson’s Disease
294.1x Dementia Due to Huntington’s Disease
294.1x Dementia Due to Pick’s Disease
294.1x Dementia Due to Creutzfeldt-Jakob Disease
294.1x  Dementia Due to (Indicate the General Medical 
Condition not listed above)
 —  Substance-Induced Persisting Dementia (refer to 
Substance-Related Disorders for substance-speciﬁ c codes)
 —  Dementia Due to Multiple Etiologies (code each of the 
speciﬁ c etiologies)
294.8 Dementia NOS
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Amnestic Disorders
294.0  Amnestic Disorder Due to (Indicate the General Medical 
Condition)
   —   Substance-Induced Persisting Amnestic Disorder (refer 
to Substance-Related Disorders for substance-speciﬁ c codes)
294.8 Amnestic Disorder NOS
Other Cognitive Disorders
294.9 Cognitive Disorder NOS
●  MENTAL DISORDERS DUE TO A GENERAL 
MEDICAL CONDITION NOT ELSEWHERE 
CLASSIFIED
293.89  Catatonic Disorder Due to (Indicate the General Medical 
Condition)
310.1  Personality Change Due to (Indicate the General Medical 
Condition)
293.9  Mental Disorder NOS Due to (Indicate the General 
Medical Condition) 
● SUBSTANCE-RELATED DISORDERS
Alcohol-Related Disorders
Alcohol Use Disorders
303.90 Alcohol Dependence
305.00 Alcohol Abuse
Alcohol-Induced Disorders
303.00 Alcohol Intoxication
291.81 Alcohol Withdrawal
291.0 Alcohol Intoxication Delirium
291.0 Alcohol Withdrawal Delirium
291.2 Alcohol-Induced Persisting Dementia
291.1 Alcohol-Induced Persisting Amnestic Disorder
291.x Alcohol-Induced Psychotic Disorder
      .5     With Delusions
      .3     With Hallucinations
291.89 Alcohol-Induced Mood Disorder
291.89 Alcohol-Induced Anxiety Disorder
291.89 Alcohol-Induced Sexual Dysfunction
291.89 Alcohol-Induced Sleep Disorder
291.9 Alcohol Related Disorder NOS
Amphetamine (or Amphetamine-Like)-Related 
Disorders
Amphetamine Use Disorders
304.40 Amphetamine Dependence
305.70 Amphetamine Abuse
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Amphetamine-Induced Disorders
292.89 Amphetamine Intoxication
292.0 Amphetamine Withdrawal
292.81 Amphetamine Intoxication Delirium
292.xx Amphetamine-Induced Psychotic Disorder
      .11     With Delusions
      .12     With Hallucinations
292.84 Amphetamine-Induced Mood Disorder
292.89 Amphetamine-Induced Anxiety Disorder
292.89 Amphetamine-Induced Sexual Dysfunction
292.89 Amphetamine-Induced Sleep Disorder
292.9 Amphetamine-Related Disorder NOS
Caffeine-Related Disorders
Caffeine-Induced Disorders
305.90 Caffeine Intoxication
292.89 Caffeine-Induced Anxiety Disorder
292.89 Caffeine-Induced Sleep Disorder
292.9 Caffeine-Related Disorder NOS
Cannabis-Related Disorders
Cannabis Use Disorders
304.30 Cannabis Dependence
305.20 Cannabis Abuse
Cannabis-Induced Disorders
292.89 Cannabis Intoxication
292.81 Cannabis Intoxication Delirium
292.xx Cannabis-Induced Psychotic Disorder
      .11     With Delusions
      .12     With Hallucinations
292.89 Cannabis-Induced Anxiety Disorder
292.9 Cannabis-Related Disorder NOS
Cocaine-Related Disorders
Cocaine Use Disorders
304.20 Cocaine Dependence
305.60 Cocaine Abuse
Cocaine-Induced Disorders
292.89 Cocaine Intoxication
292.0 Cocaine Withdrawal
292.81 Cocaine Intoxication Delirium
292.xx Cocaine-Induced Psychotic Disorder
     .11     With Delusions
     .12     With Hallucinations
292.84 Cocaine-Induced Mood Disorder
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292.89 Cocaine-Induced Anxiety Disorder
292.89 Cocaine-Induced Sexual Dysfunction
292.89 Cocaine-Induced Sleep Disorder
292.9 Cocaine-Related Disorder NOS
Hallucinogen-Related Disorders
Hallucinogen Use Disorders
304.50 Hallucinogen Dependence
305.30 Hallucinogen Abuse
Hallucinogen-Induced Disorders
292.89 Hallucinogen Intoxication
292.89  Hallucinogen Persisting Perception Disorder 
(Flashbacks)
292.81 Hallucinogen Intoxication Delirium
292.xx Hallucinogen-Induced Psychotic Disorder
      .11     With Delusions
      .12     With Hallucinations
292.84 Hallucinogen-Induced Mood Disorder
292.89 Hallucinogen-Induced Anxiety Disorder
292.9 Hallucinogen-Related Disorder NOS
Inhalant-Related Disorders
Inhalant Use Disorders
304.60 Inhalant Dependence
305.90 Inhalant Abuse
Inhalant-Induced Disorders
292.89 Inhalant Intoxication
292.81 Inhalant Intoxication Delirium
292.82 Inhalant-Induced Persisting Dementia
292.xx Inhalant-Induced Psychotic Disorder
      .11     With Delusions
      .12     With Hallucinations
292.84 Inhalant-Induced Mood Disorder
292.89 Inhalant-Induced Anxiety Disorder
292.9 Inhalant-Related Disorder NOS
Nicotine-Related Disorders
Nicotine Use Disorders
305.1 Nicotine Dependence
Nicotine-Induced Disorders
292.0 Nicotine Withdrawal
292.9 Nicotine-Related Disorder NOS
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Opioid-Related Disorders
Opioid Use Disorders
304.00 Opioid Dependence
305.50 Opioid Abuse
Opioid-Induced Disorders
292.89 Opioid Intoxication
292.0 Opioid Withdrawal
292.81 Opioid Intoxication Delirium
292.xx Opioid-Induced Psychotic Disorder
      .11     With Delusions
      .12     With Hallucinations
292.84 Opioid-Induced Mood Disorder
292.89 Opioid-Induced Sexual Dysfunction
292.89 Opioid-Induced Sleep Disorder
292.9 Opioid-Related Disorder NOS
Phencyclidine (or Phencyclidine-Like)-Related 
Disorders
Phencyclidine Use Disorders
304.60 Phencyclidine Dependence
305.90 Phencyclidine Abuse
Phencyclidine-Induced Disorders
292.89 Phencyclidine Intoxication
292.81 Phencyclidine Intoxication Delirium
292.xx Phencyclidine-Induced Psychotic Disorder
     .11     With Delusions
     .12     With Hallucinations
292.84 Phencyclidine-Induced Mood Disorder
292.89 Phencyclidine-Induced Anxiety Disorder
292.9 Phencyclidine-Related Disorder NOS
Sedative-, Hypnotic-, or Anxiolytic-Related 
Disorders
Sedative, Hypnotic, or Anxiolytic Use Disorders
304.10 Sedative, Hypnotic, or Anxiolytic Dependence
305.40 Sedative, Hypnotic, or Anxiolytic Abuse
Sedative-, Hypnotic-, or Anxiolytic-Induced 
Disorders
292.89 Sedative, Hypnotic, or Anxiolytic Intoxication
292.0 Sedative, Hypnotic, or Anxiolytic Withdrawal
292.81  Sedative, Hypnotic, or Anxiolytic Intoxication 
Delirium
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292.81  Sedative, Hypnotic, or Anxiolytic Withdrawal 
Delirium
292.82  Sedative-, Hypnotic-, or Anxiolytic-Induced Persisting 
Dementia
292.83  Sedative-, Hypnotic-, or Anxiolytic-Induced Persisting 
Amnestic Disorder
292.xx  Sedative-, Hypnotic-, or Anxiolytic-Induced Psychotic 
Disorder
      .11     With Delusions
      .12     With Hallucinations
292.84  Sedative-, Hypnotic-, or Anxiolytic-Induced Mood 
Disorder
292.89  Sedative-, Hypnotic-, or Anxiolytic-Induced Anxiety 
Disorder
292.89  Sedative-, Hypnotic-, or Anxiolytic-Induced Sexual 
Dysfunction
292.89  Sedative-, Hypnotic-, or Anxiolytic-Induced Sleep 
Disorder
292.9  Sedative-, Hypnotic-, or Anxiolytic-Related Disorder 
NOS
Polysubstance-Related Disorder
304.80 Polysubstance Dependence
Other (or Unknown) Substance-Related 
Disorders
Other (or Unknown) Substance Use Disorders
304.90 Other (or Unknown) Substance Dependence
305.90 Other (or Unknown) Substance Abuse
Other (or Unknown) Substance-Induced 
Disorders
292.89 Other (or Unknown) Substance Intoxication
292.0 Other (or Unknown) Substance Withdrawal
292.81 Other (or Unknown) Substance-Induced Delirium
292.82  Other (or Unknown) Substance-Induced Persisting 
Dementia
292.83  Other (or Unknown) Substance-Induced Persisting 
Amnestic Disorder
292.xx  Other (or Unknown) Substance-Induced Psychotic 
Disorder
      .11     With Delusions
      .12     With Hallucinations
292.84 Other (or Unknown) Substance-Induced Mood Disorder
292.89  Other (or Unknown) Substance-Induced Anxiety 
Disorder
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292.89  Other (or Unknown) Substance-Induced Sexual 
Dysfunction
292.89  Other (or Unknown) Substance-Induced Sleep Disorder
292.9  Other (or Unknown) Substance-Related Disorder NOS
●  SCHIZOPHRENIA AND OTHER PSYCHOTIC 
DISORDERS
295.xx Schizophrenia
      .30     Paranoid type
      .10     Disorganized type
      .20     Catatonic type
      .90     Undifferentiated type
      .60     Residual type
295.40 Schizophreniform Disorder
295.70 Schizoaffective Disorder 
297.1 Delusional Disorder
298.8 Brief Psychotic Disorder
297.3 Shared Psychotic Disorder 
293.xx  Psychotic Disorder Due to (Indicate the General Medical 
Condition)
     .81     With Delusions
     .82     With Hallucinations
       —  Substance-Induced Psychotic Disorder (refer to 
Substance-Related Disorders for substance-speciﬁ c codes)
298.9 Psychotic Disorder NOS
●  MOOD DISORDERS
(Code current state of Major Depressive Disorder or Bipolar 
I Disorder in ﬁ fth digit: 0 = unspeciﬁ ed; 1 = mild; 2 = moderate; 
3 = severe, without psychotic features; 4 = severe, with psychotic 
features; 5 = in partial remission; 6 = in full remission.)
Depressive Disorders
296.xx Major Depressive Disorder
     .2x     Single episode
     .3x     Recurrent
300.4 Dysthymic Disorder
311 Depressive Disorder NOS
Bipolar Disorders
296.xx Bipolar I Disorder
     .0x     Single Manic Episode
     .40     Most Recent Episode Hypomanic
     .4x     Most Recent Episode Manic
     .6x     Most Recent Episode Mixed
     .5x     Most Recent Episode Depressed
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     .7     Most Recent Episode Unspeciﬁ ed
296.89  Bipolar II Disorder (Specify current or most recent episode: 
Hypomanic or Depressed)
301.13 Cyclothymic Disorder
296.80 Bipolar Disorder NOS
293.83  Mood Disorder Due to (Indicate the General Medical 
Condition)
       —  Substance-Induced Mood Disorder (refer to Substance-
Related Disorders for substance-speciﬁ c codes)
296.90 Mood Disorder NOS
● ANXIETY DISORDERS
300.01 Panic Disorder Without Agoraphobia
300.21 Panic Disorder With Agoraphobia
300.22 Agoraphobia Without History of Panic Disorder
300.29 Speciﬁ c Phobia
300.23 Social Phobia
300.3 Obsessive-Compulsive Disorder
309.81 Posttraumatic Stress Disorder
308.3 Acute Stress Disorder
300.02 Generalized Anxiety Disorder
293.89  Anxiety Disorder Due to (Indicate the General Medical 
Condition)
      —  Substance-Induced Anxiety Disorder (refer to 
Substance-Related Disorders for substance-speciﬁ c codes)
300.00 Anxiety Disorder NOS
● SOMATOFORM DISORDERS
300.81 Somatization Disorder
300.82 Undifferentiated Somatoform Disorder
300.11 Conversion Disorder
307.xx Pain Disorder
     .80     Associated with Psychological Factors
     .89      Associated with Both Psychological Factors and a 
General Medical Condition
300.7 Hypochondriasis
300.7 Body Dysmorphic Disorder
300.82 Somatoform Disorder NOS
● FACTITIOUS DISORDERS
300.xx Factitious Disorder
     .16      With Predominantly Psychological Signs and 
Symptoms
     .19     With Predominantly Physical Signs and Symptoms
     .19      With Combined Psychological and Physical Signs 
and Symptoms
300.19 Factitious Disorder NOS
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● DISSOCIATIVE DISORDERS
300.12 Dissociative Amnesia
300.13 Dissociative Fugue
300.14 Dissociative Identity Disorder
300.6 Depersonalization Disorder
300.15 Dissociative Disorder NOS
●  SEXUAL AND GENDER IDENTITY 
DISORDERS
Sexual Dysfunctions
Sexual Desire Disorders
302.71 Hypoactive Sexual Desire Disorder
302.79 Sexual Aversion Disorder
Sexual Arousal Disorders
302.72 Female Sexual Arousal Disorder
302.72 Male Erectile Disorder
Orgasmic Disorders
302.73 Female Orgasmic Disorder
302.74 Male Orgasmic Disorder
302.75 Premature Ejaculation
Sexual Pain Disorders
302.76  Dyspareunia (Not Due to a General Medical 
Condition)
306.51  Vaginismus (Not Due to a General Medical 
Condition) 
Sexual Dysfunction Due to a General Medical 
Condition
625.8  Female Hypoactive Sexual Desire Disorder Due to 
(Indicate the General Medical Condition)
608.89  Male Hypoactive Sexual Desire Disorder Due to 
(Indicate the General Medical Condition)
607.84  Male Erectile Disorder Due to (Indicate the General 
Medical Condition)
625.0  Female Dyspareunia Due to (Indicate the General 
Medical Condition)
608.89  Male Dyspareunia Due to (Indicate the General Medical 
Condition)
625.8  Other Female Sexual Dysfunction Due to (Indicate the 
General Medical Condition)
608.89  Other Male Sexual Dysfunction Due to (Indicate the 
General Medical Condition)
      —  Substance-Induced Sexual Dysfunction (refer to 
Substance-Related Disorders for substance-speciﬁ c codes)
302.70 Sexual Dysfunction NOS
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Paraphilias
302.4 Exhibitionism
302.81 Fetishism
302.89 Frotteurism
302.2 Pedophilia
302.83 Sexual Masochism
302.84 Sexual Sadism
302.3 Transvestic Fetishism
302.82 Voyeurism
302.9 Paraphilia NOS
Gender Identity Disorders
302.xx Gender Identity Disorder
     .6     In Children
     .85     In Adolescents or Adults
302.6 Gender Identity Disorder NOS
302.9 Sexual Disorder NOS
● EATING DISORDERS
307.1 Anorexia Nervosa
307.51 Bulimia Nervosa
307.50 Eating Disorder NOS
● SLEEP DISORDERS
Primary Sleep Disorders
Dyssomnias
307.42 Primary Insomnia
307.44 Primary Hypersomnia
347 Narcolepsy
780.59 Breathing-Related Sleep Disorder
307.45 Circadian Rhythm Sleep Disorder
307.47 Dyssomnia NOS
Parasomnias
307.47 Nightmare Disorder
307.46 Sleep Terror Disorder
307.46 Sleepwalking Disorder
307.47 Parasomnia NOS
Sleep Disorders Related to Another Mental 
Disorder
307.42  Insomnia Related to (Indicate the Axis I or Axis II 
Disorder)
307.44  Hypersomnia Related to (Indicate the Axis I or Axis II 
Disorder)
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Other Sleep Disorders
780.xx  Sleep Disorder Due to (Indicate the General Medical 
Condition)
     .52     Insomnia type
     .54     Hypersomnia type
     .59     Parasomnia type
     .59     Mixed type
  —  Substance-Induced Sleep Disorder (refer to Substance-
Related Disorders for substance-speciﬁ c codes)
●  IMPULSE CONTROL DISORDERS NOT 
ELSEWHERE CLASSIFIED
312.34 Intermittent Explosive Disorder
312.32 Kleptomania
312.33 Pyromania
312.31 Pathological Gambling
312.39 Trichotillomania
312.30 Impulse Control Disorder NOS
● ADJUSTMENT DISORDERS
309.xx Adjustment Disorder
     .0     With Depressed Mood
     .24     With Anxiety
     .28     With Mixed Anxiety and Depressed Mood
     .3     With Disturbance of Conduct
     .4     With Mixed Disturbance of Emotions and Conduct
     .9     Unspeciﬁ ed
● PERSONALITY DISORDERS
Note: These are coded on Axis II.
301.0 Paranoid Personality Disorder
301.20 Schizoid Personality Disorder
301.22 Schizotypal Personality Disorder
301.7 Antisocial Personality Disorder
301.83 Borderline Personality Disorder
301.50 Histrionic Personality Disorder
301.81 Narcissistic Personality Disorder
301.82 Avoidant Personality Disorder
301.6 Dependent Personality Disorder
301.4 Obsessive-Compulsive Personality Disorder
301.9 Personality Disorder NOS
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●  OTHER CONDITIONS THAT MAY BE A 
FOCUS OF CLINICAL ATTENTION
Psychological Factors Affecting Medical 
Condition
316 Choose name based on nature of factors:
   Mental Disorder Affecting Medical Condition
  Psychological Symptoms Affecting Medical Condition
   Personality Traits or Coping Style Affecting Medical 
Condition
   Maladaptive Health Behaviors Affecting Medical 
Condition
   Stress-Related Physiological Response Affecting Medical 
Condition
   Other or Unspeciﬁ ed Psychological Factors Affecting 
Medical Condition
Medication-Induced Movement Disorders
332.1 Neuroleptic-Induced Parkinsonism
333.92 Neuroleptic Malignant Syndrome
333.7 Neuroleptic-Induced Acute Dystonia
333.99 Neuroleptic-Induced Acute Akathisia
333.82 Neuroleptic-Induced Tardive Dyskinesia
333.1 Medication-Induced Postural Tremor
333.90 Medication-Induced Movement Disorder NOS
Other Medication-Induced Disorder
995.2 Adverse Effects of Medication NOS
Relational Problems
V61.9  Relational Problem Related to a Mental Disorder or 
General Medical Condition
V61.20 Parent-Child Relational Problem
V61.10 Partner Relational Problem
V61.8 Sibling Relational Problem
V62.81 Relational Problem NOS
Problems Related to Abuse or Neglect
V61.21 Physical Abuse of Child
V61.21 Sexual Abuse of Child
V61.21 Neglect of Child
       — Physical Abuse of Adult
V61.12 (if by partner)
V62.83 (if by person other than partner)
       — Sexual Abuse of Adult
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V61.12 (if by partner)
V62.83 (if by person other than partner) 
Additional Conditions That May Be a Focus 
of Clinical Attention
V15.81 Noncompliance with Treatment
V65.2 Malingering
V71.01 Adult Antisocial Behavior
V71.02 Childhood or Adolescent Antisocial Behavior
V62.89 Borderline Intellectual Functioning (coded on Axis II)
 780.9 Age-Related Cognitive Decline
V62.82 Bereavement
V62.3 Academic Problem
V62.2 Occupational Problem
 313.82 Identity Problem
V62.89 Religious or Spiritual Problem
V62.4 Acculturation Problem
V62.89 Phase of Life Problem
● ADDITIONAL CODES
 300.9 Unspeciﬁ ed Mental Disorder (nonpsychotic)
V71.09 No Diagnosis or Condition on Axis I
 799.9 Diagnosis or Condition Deferred on Axis I
V71.09 No Diagnosis on Axis II
 799.9 Diagnosis Deferred on Axis II
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Gathering the correct information about the client’s mental sta-
tus is essential to the development of an appropriate plan of care. 
The mental status examination is a description of all the areas of 
the client’s mental functioning. The following are the compo-
nents that are considered critical in the assessment of a client’s 
mental status. Examples of interview questions and criteria for 
assessment are included.
● IDENTIFYING DATA
 1. Name
 2. Gender
 3. Age 
 a. How old are you?
 b. When were you born? 
 4. Race/culture
 a. What country did you (your ancestors) come from? 
 5. Occupational/ﬁ nancial status
 a. How do you make your living?
 b. How do you obtain money for your needs? 
 6. Educational level
 a. What was the highest grade level you completed in 
school? 
 7. Signiﬁ cant other
 a. Are you married?
 b. Do you have a signiﬁ cant relationship with another 
person? 
 8. Living arrangements
 a. Do you live alone?
 b. With whom do you share your home? 
 9. Religious preference
 a. Do you have a religious preference? 
A P P E N D I X  M
Mental Status 
Assessment
610
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 10. Allergies
 a. Are you allergic to anything?
 b. Foods? Medications? 
 11. Special diet considerations
 a. Do you have any special diet requirements?
 b. Diabetic? Low sodium? 
 12. Chief complaint
 a. For what reason did you come for help today?
 b. What seems to be the problem? 
 13. Medical diagnosis
● GENERAL DESCRIPTION
Appearance
 1. Grooming and dress
 a. Note unusual modes of dress.
 b. Evidence of soiled clothing?
 c. Use of makeup
 d. Neat; unkempt
 2. Hygiene
 a. Note evidence of body or breath odor.
 b. Condition of skin, ﬁ ngernails
 3. Posture
 a. Note if standing upright, rigid, slumped over.
 4. Height and weight 
 a. Perform accurate measurements. 
 5. Level of eye contact
 a. Intermittent?
 b. Occasional and ﬂ eeting?
 c. Sustained and intense?
 d. No eye contact? 
 6. Hair color and texture
 a. Is hair clean and healthy-looking?
 b. Greasy, matted, tangled? 
 7. Evidence of scars, tattoos, or other distinguishing skin 
marks 
 a. Note any evidence of swelling or bruises.
 b. Birth marks?
 c. Rashes? 
 8. Evaluation of client’s appearance compared with chronologi-
cal age.
Motor Activity
 1. Tremors
 a. Do hands or legs tremble? 
 • Continuously?
 • At speciﬁ c times? 
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 2. Tics or other stereotypical movements
 a. Any evidence of facial tics?
 b. Jerking or spastic movements? 
 3. Mannerisms and gestures
 a. Speciﬁ c facial or body movements during conversation?
 b. Nail biting?
 c. Covering face with hands?
 d. Grimacing? 
 4. Hyperactivity 
 a. Gets up and down out of chair
 b. Paces
 c. Unable to sit still 
 5. Restlessness or agitation 
 a. Lots of ﬁ dgeting
 b. Clenching hands
 6. Aggressiveness
 a. Overtly angry and hostile
 b. Threatening
 c. Uses sarcasm
 7. Rigidity
 a. Sits or stands in a rigid position
 b. Arms and legs appear stiff and unyielding
 8. Gait patterns
 a. Any evidence of limping?
 b. Limitation of range of motion?
 c. Ataxia?
 d. Shufﬂ ing? 
 9. Echopraxia
 a. Evidence of mimicking the actions of others? 
 10. Psychomotor retardation
 a. Movements are very slow.
 b. Thinking and speech are very slow.
 c. Posture is slumped. 
 11. Freedom of movement (range of motion) 
 a. Note any limitation in ability to move. 
Speech Patterns
 1. Slowness or rapidity of speech
 a. Note whether speech seems very rapid or slower than 
normal. 
 2. Pressure of speech
 a. Note whether speech seems frenzied.
 b. Unable to be interrupted? 
 3. Intonation
 a. Are words spoken with appropriate emphasis?
 b. Are words spoken in monotone, without emphasis? 
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 4. Volume 
 a. Is speech very loud? Soft?
 b. Is speech low-pitched? High-pitched? 
 5. Stuttering or other speech impairments
 a. Hoarseness?
 b. Slurred speech? 
 6. Aphasia
 a. Difﬁ culty forming words
 b. Use of incorrect words
 c. Difﬁ culty thinking of speciﬁ c words
 d. Making up words (neologisms) 
General Attitude
 1. Cooperative/uncooperative
 a. Answers questions willingly
 b. Refuses to answer questions
 2. Friendly/hostile/defensive
 a. Is sociable and responsive
 b. Is sarcastic and irritable
 3. Uninterested/apathetic
 a. Refuses to participate in interview process
 4. Attentive/interested
 a. Actively participates in interview process
 5. Guarded/suspicious
 a. Continuously scans the environment
 b. Questions motives of interviewer
 c. Refuses to answer questions
● EMOTIONS
Mood
 1. Depressed; despairing 
 a. An overwhelming feeling of sadness
 b. Loss of interest in regular activities
 2. Irritable
 a. Easily annoyed and provoked to anger
 3. Anxious
 a. Demonstrates or verbalizes feeling of apprehension
 4. Elated
 a. Expresses feelings of joy and intense pleasure
 b. Is intensely optimistic  
 5. Euphoric
 a. Demonstrates a heightened sense of elation
 b. Expresses feelings of grandeur (“Everything is wonderful!”) 
 6. Fearful
 a. Demonstrates or verbalizes feeling of apprehension asso-
ciated with real or perceived danger 
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 7. Guilty 
 a. Expresses a feeling of discomfort associated with real or 
perceived wrongdoing
 b. May be associated with feelings of sadness and despair
 8. Labile
 a. Exhibits mood swings that range from euphoria to 
depression or anxiety
Affect
 1. Congruence with mood
 a. Outward emotional expression is consistent with mood 
(e.g., if depressed, emotional expression is sadness, eyes 
downcast, may be crying) 
 2. Constricted or blunted 
 a. Minimal outward emotional expression is observed
 3. Flat
 a. There is an absence of outward emotional expression
 4. Appropriate 
 a. The outward emotional expression is what would be 
expected in a certain situation (e.g., crying upon hearing 
of a death) 
 5. Inappropriate 
 a. The outward emotional expression is incompatible with 
the situation (e.g., laughing upon hearing of a death) 
● THOUGHT PROCESSES
Form of Thought
 1. Flight of ideas
 a. Verbalizations are continuous and rapid, and ﬂ ow from 
one to another
 2. Associative looseness
 a. Verbalizations shift from one unrelated topic to another
 3. Circumstantiality
 a. Verbalizations are lengthy and tedious, and because of 
numerous details, are delayed reaching the intended 
point
 4. Tangentiality  
 a. Verbalizations that are lengthy and tedious, and never 
reach an intended point 
 5. Neologisms 
 a. The individual is making up nonsensical-sounding words, 
which only have meaning to him or her
 6. Concrete thinking
 a. Thinking is literal; elemental
 b. Absence of ability to think abstractly
 c. Unable to translate simple proverbs
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 7. Clang associations
 a. Speaking in puns or rhymes; using words that sound alike 
but have different meanings
 8. Word salad
 a. Using a mixture of words that have no meaning together; 
sounding incoherent
 9. Perseveration 
 a. Persistently repeating the last word of a sentence spo-
ken to the client. (e.g., Nurse: “George, it’s time to go to 
lunch.” George: “lunch, lunch, lunch, lunch”) 
 10. Echolalia
 a. Persistently repeating what another person says
 11. Mutism
 a. Does not speak (either cannot or will not) 
 12. Poverty of speech 
 a. Speaks very little; may respond in monosyllables 
 13. Ability to concentrate and disturbance of attention
 a. Does the person hold attention to the topic at hand?
 b. Is the person easily distractible?
 c. Is there selective attention (e.g., blocks out topics that 
create anxiety)? 
Content of Thought
 1. Delusions (Does the person have unrealistic ideas or 
beliefs?) 
 a. Persecutory: A belief that someone is out to get him or 
her in some way (e.g., “The FBI will be here at any time to 
take me away.”).
 b. Grandiose: An idea that he or she is all-powerful or of 
great importance (e.g., “I am the king...and this is my 
kingdom! I can do anything!”).
 c. Reference: An idea that whatever is happening in the en-
vironment is about him or her (e.g., “Just watch the movie 
on TV tonight. It is about my life.”).
 d. Control or inﬂ uence: A belief that his or her behavior and 
thoughts are being controlled by external forces (e.g., “I 
get my orders from Channel 27. I do only what the forces 
dictate.”).
 e. Somatic: A belief that he or she has a dysfunctional body 
part (e.g., “My heart is at a standstill. It is no longer beat-
ing.”).
 f. Nihilistic: A belief that he or she, or a part of the body, or 
even the world does not exist or has been destroyed (e.g., 
“I am no longer alive.”). 
 2. Suicidal or homicidal ideas
 a. Is the individual expressing ideas of harming self or others? 
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 3. Obsessions
 a. Is the person verbalizing about a persistent thought or 
feeling that he or she is unable to eliminate from their 
consciousness? 
 4. Paranoia/suspiciousness
 a. Continuously scans the environment
 b. Questions motives of interviewer
 c. Refuses to answer questions  
 5. Magical thinking 
 a. Is the client speaking in a way that indicates his or her 
words or actions have power? (e.g., “If you step on a crack, 
you break your mother’s back!”) 
 6. Religiosity 
 a. Is the individual demonstrating obsession with religious 
ideas and behavior? 
 7. Phobias
 a. Is there evidence of irrational fears (of a speciﬁ c object, or 
a social situation)? 
 8. Poverty of content
 a. Is little information conveyed by the client because of 
vagueness or stereotypical statements or clichés? 
● PERCEPTUAL DISTURBANCES
 1. Hallucinations (Is the person experiencing unrealistic sen-
sory perceptions?) 
 a. Auditory (Is the individual hearing voices or other sounds 
that do not exist?)
 b. Visual (Is the individual seeing images that do not exist?)
 c. Tactile (Does the individual feel unrealistic sensations on 
the skin?)
 d. Olfactory (Does the individual smell odors that do not 
exist?)
 e. Gustatory (Does the individual have a false perception of 
an unpleasant taste?) 
 2. Illusions 
 a. Does the individual misperceive or misinterpret real 
stimuli within the environment? (Sees something and 
thinks it is something else?) 
 3. Depersonalization (altered perception of the self) 
 a. The individual verbalizes feeling “outside the body;” visu-
alizing him- or herself from afar. 
 4. Derealization (altered perception of the environment) 
 a. The individual verbalizes that the environment feels 
“strange or unreal.” A feeling that the surroundings have 
changed. 
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● SENSORIUM AND COGNITIVE ABILITY
 1. Level of alertness/consciousness
 a. Is the individual clear-minded and attentive to the 
environment?
 b. Or is there disturbance in perception and awareness of the 
surroundings? 
 2. Orientation. Is the person oriented to the following? 
 a. Time
 b. Place
 c. Person
 d. Circumstances 
 3. Memory 
 a. Recent (Is the individual able to remember occurrences of 
the past few days?)
 b. Remote (Is the individual able to remember occurrences 
of the distant past?)
 c. Confabulation (Does the individual ﬁ ll in memory gaps 
with experiences that have no basis in fact?) 
 4. Capacity for abstract thought 
 a. Can the individual interpret proverbs correctly? 
 • “What does ‘no use crying over spilled milk’ mean?”
● IMPULSE CONTROL
 1. Ability to control impulses. (Does psychosocial history 
reveal problems with any of the following?) 
 a. Aggression
 b. Hostility
 c. Fear
 d. Guilt
 e. Affection
 f. Sexual feelings
● JUDGMENT AND INSIGHT
 1. Ability to solve problems and make decisions 
 a. What are your plans for the future?
 b. What do you plan to do to reach your goals? 
 2. Knowledge about self 
 a. Awareness of limitations
 b. Awareness of consequences of actions
 c. Awareness of illness  
 • “Do you think you have a problem?”
 • “Do you think you need treatment?” 
 3. Adaptive/maladaptive use of coping strategies and ego 
defense mechanisms (e.g., rationalizing maladaptive behav-
iors, projection of blame, displacement of anger)
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Behaviors NANDA Nursing Diagnoses
Aggression; hostility Risk for injury; Risk for other-
directed violence
Anorexia or refusal to eat Imbalanced nutrition: Less than 
body requirements
Anxious behavior  Anxiety (Specify level)
Confusion; memory loss Confusion, acute/chronic; 
Disturbed thought processes;
Impaired memory
Delusions Disturbed thought processes
Denial of problems Ineffective denial
Depressed mood or anger 
turned inward
Complicated grieving
Detoxiﬁ cation; withdrawal 
from substances
Risk for injury
A P P E N D I X  N
Assigning Nursing 
Diagnoses to Client 
Behaviors
618
Following is a list of client behaviors and the NANDA nursing 
diagnoses that correspond to the behaviors and that may be used 
in planning care for the client exhibiting the speciﬁ c behavioral 
symptoms.
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Behaviors NANDA Nursing Diagnoses
Difﬁ culty accepting new 
diagnosis or recent 
change in health status
Risk-prone health behavior
Difﬁ culty making impor-
tant life decision
Decisional conﬂ ict (specify)
Difﬁ culty sleeping Insomnia; Disturbed sleep 
pattern
Difﬁ culty with interper-
sonal relationships
Impaired social interaction
Disruption in capability to 
perform usual
responsibilities
Ineffective role performance
Dissociative behaviors 
(depersonalization; 
derealization)
Disturbed sensory perception 
(kinesthetic)
Expresses feelings of 
disgust about body or 
body part
Disturbed body image 
Expresses anger at God Spiritual distress
Expresses lack of control 
over personal situation
Powerlessness
Fails to follow prescribed 
therapy
Ineffective self-health manage-
ment; Noncompliance
Flashbacks, nightmares, 
obsession with traumatic 
experience
Posttrauma syndrome
Hallucinations Disturbed sensory perception 
(auditory; visual)
Highly critical of self or 
others
Low self-esteem (chronic; 
situational)
HIV-positive; altered 
immunity
Ineffective protection
Continued
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Behaviors NANDA Nursing Diagnoses
Inability to meet basic 
needs
Self-care deﬁ cit (feeding; bath-
ing; dressing; toileting)
Loose associations or ﬂ ight 
of ideas
Impaired verbal communication
Loss of a valued entity, 
recently experienced
Risk for complicated grieving
Manic hyperactivity Risk for injury
Manipulative behavior Ineffective coping
Multiple personalities; gen-
der identity disturbance
Disturbed personal identity 
Orgasm, problems with; 
lack of sexual desire; 
erectile dysfunction
Sexual dysfunction
Overeating, compulsive Risk for imbalanced nutrition: 
More than body requirements 
Phobias Fear
Physical symptoms as cop-
ing behavior
Ineffective coping
Potential or anticipated 
loss of signiﬁ cant entity
Grieving
Projection of blame; 
rationalization of fail-
ures; denial of personal 
responsibility
Defensive coping
Ritualistic behaviors Anxiety (severe); Ineffective 
coping
Seductive remarks; inap-
propriate sexual behav-
iors
Impaired social interaction
Self-inﬂ icted injuries (non-
life-threatening)
Self-mutilation; Risk for 
self-mutilation
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Behaviors NANDA Nursing Diagnoses
Sexual behaviors (difﬁ culty, 
limitations, or changes in; 
reported dissatisfaction)
Ineffective sexuality pattern
Stress from caring for 
chronically ill person
Caregiver role strain
Stress from locating to new 
environment
Relocation stress syndrome
Substance use as a coping 
behavior
Ineffective coping
Substance use (denies use is 
a problem)
Ineffective denial
Suicidal gestures/threats; 
suicidal ideation
Risk for suicide; Risk for 
self-directed violence
Suspiciousness Disturbed thought processes; 
Ineffective coping
Vomiting, excessive, 
self-induced
Risk for deﬁ cient ﬂ uid volume
Withdrawn behavior Social isolation
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A P P E N D I X  O
Brief Mental Status 
Evaluation
622
Area of Mental Function 
Evaluated Evaluation Activity
Orientation to time “What year is it? What month is 
it? What day is it? (3 points)
Orientation to place “Where are you now?” (1 point)
Attention and immediate 
recall
“Repeat these words now: bell, 
book, & candle” (3 points)
“Remember these words and I 
will ask you to repeat them in a 
few minutes.”
Abstract thinking “What does this mean: No use 
crying over spilled milk.” 
(3 points)
Recent memory “Say the 3 words I asked you to 
remember earlier.” (3 points)
Naming objects Point to eyeglasses and ask, 
“What is this?” Repeat with 
1 other item (e.g., calendar, 
watch, pencil). (2 points 
possible)
Ability to follow simple 
verbal command
“Tear this piece of paper in half 
and put it in the trash container.” 
(2 points)
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Ability to follow simple 
written command
Write a command on a piece of 
paper (e.g., TOUCH YOUR 
NOSE), give the paper to the 
patient and say, “Do what it 
says on this paper.” (1 point for 
correct action)
Ability to use language 
correctly
Ask the patient to write a sen-
tence. (3 points if sentence has a 
subject and a verb, and has valid 
meaning).
Ability to concentrate “Say the months of the year in re-
verse, starting with December.” 
(1 point each for correct an-
swers from November through 
August. 4 points possible.)
Understanding spatial 
relationships
Draw a clock; put in all the num-
bers; and set the hands on 
3 o’clock. (clock circle = 1 point; 
numbers in correct sequence = 
1 point; numbers placed on clock 
correctly = 1 point; two hands on 
the clock = 1 point; hands set at 
correct time = 1 point. 5 points 
possible.) 
Scoring: 30 to 21 = normal; 20 to 11 = mild cognitive impairment; 10 to 0 = severe 
cognitive impairment (scores are not absolute and must be considered within 
the comprehensive diagnostic assessment). 
Sources: The Merck manual of health and aging (2005); Folstein, Folstein, 
and McHugh (1975); Kaufman and Zun (1995); Kokman et al. (1991); and 
Pfeiffer (1975).
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A P P E N D I X  P
U.S. Food and Drug 
Administration (FDA) 
Pregnancy Categories
624
Category A Adequate, well-controlled studies in 
pregnant women have not shown an 
increased risk of fetal abnormalities.
Category B Animal studies have revealed no evi-
dence of harm to the fetus; however, 
there are no adequate and well-
controlled studies in pregnant women. 
OR  Animal studies have shown an 
adverse effect, but adequate and 
well-controlled studies in pregnant 
women have failed to demonstrate a 
risk to the fetus.
Category C Animal studies have shown an adverse 
effect and there are no adequate and 
well-controlled studies in pregnant 
women.  
OR No animal studies have been con-
ducted and there are no adequate and 
well-controlled studies in pregnant 
women.
Category D Studies, adequate well-controlled or 
observational, in pregnant women 
have demonstrated a risk to the fetus. 
However, the beneﬁ ts of therapy may 
outweigh the potential risk.
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Category X Studies, adequate well-controlled or 
observational, in animals or pregnant 
women have demonstrated positive 
evidence of fetal abnormalities. The 
use of the product is contraindicated 
in women who are or may become 
pregnant. 
Source:  From Deglin, J.H., & Vallerand, A.H. (2009).  Davis’s drug guide for 
nurses (11th ed.).  Philadelphia:  F.D. Davis.  With permission. 
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U.S. Drug Enforcement 
Agency (DEA) 
Controlled Substances 
Schedules
626
Classes or schedules are determined by the DEA, an arm of 
the U.S. Justice Department, and are based on the potential 
for abuse and dependence liability (physical and psychological) 
of the medication. Some states may have stricter prescription 
regulations. Physicians, dentists, podiatrists, and veterinarians 
may prescribe controlled substances. Nurse practitioners and 
physician’s assistants may prescribe controlled substances with 
certain limitations.
Schedule I (C-I) 
Potential for abuse is so high as to be unacceptable. May be used 
for research with appropriate limitations. Examples are LSD 
and heroin.
Schedule II (C-II) 
High potential for abuse and extreme liability for physical and 
psychological dependence (amphetamines, opioid analgesics, 
dronabinol, certain barbiturates). Outpatient prescriptions must 
be in writing. In emergencies, telephone orders may be accept-
able if a written prescription is provided within 72 hours. No 
reﬁ lls are allowed.
Schedule III (C-III) 
Intermediate potential for abuse (less than C-II) and intermediate 
liability for physical and psychological dependence (certain non-
barbiturate sedatives, certain nonamphetamine CNS stimulants, 
and limited dosages of certain opioid analgesics). Outpatient 
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prescriptions can be reﬁ lled 5 times within 6 months from 
date of issue if authorized by prescriber. Telephone orders are 
acceptable.
Schedule IV (C-IV) 
Less abuse potential than Schedule III with minimal liability for 
physical or psychological dependence (certain sedative/hypnotics, 
certain antianxiety agents, some barbiturates, benzodiazepines, 
chloral hydrate, pentazocine, and propoxyphene). Outpatient 
prescriptions can be reﬁ lled 6 times within 6 months from 
date of issue if authorized by prescriber. Telephone orders are 
acceptable.
Schedule V (C-V) 
Minimal abuse potential. Number of outpatient reﬁ lls deter-
mined by prescriber. Some products (cough suppressants with 
small amounts of codeine, antidiarrheals containing paregoric) 
may be available without prescription to patients at least 18 years 
of age.
Source: From Deglin, J.H., & Vallerand, A.H. (2009). Davis’s drug guide 
for nurses (11th ed.). Philadelphia:  F.D. Davis. With permission.
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A P P E N D I X  R
Abnormal Involuntary 
Movement Scale 
(AIMS)
628
The AIMS rating scale is a 5- to 10-minute rating scale to assess 
for tardive dyskinesia (TD). A baseline exam should be admin-
istered before instituting pharmacotherapy with antipsychotics, 
and then every 3 to 6 months thereafter.
There are two parallel procedures, the Examination Procedure, 
which tells the client what to do, and the Scoring Procedure, which 
tells the clinician how to rate what he or she observes.
Examination Procedure
Either before or after completing the Examination Procedure, 
observe the client unobtrusively, at rest (e.g., in waiting room). 
The chair to be used in this examination should be a hard, ﬁ rm 
one without arms.
 1. Ask client to remove shoes and socks.
 2. Ask client whether there is anything in his/her mouth (i.e., 
gum, candy, etc.), and if there is, to remove it.
 3. Ask client about the current condition of his/her teeth. Ask 
client if he/she wears dentures. Do teeth or dentures bother 
client now?
 4. Ask client whether he/she notices any movements in mouth, 
face, hands, or feet. If yes, ask him/her to describe and to what 
extent they currently bother client or interfere with his/her 
activities.
 5. Have client sit in chair with both hands on knees, legs slightly 
apart, and feet ﬂ at on ﬂ oor. (Look at entire body for move-
ments while in this position.)
 6. Ask client to sit with hands hanging unsupported. If male, 
between legs, if female and wearing a dress, hanging over 
knees. (Observe hands and other body areas.)
 7. Ask client to open mouth. (Observe tongue at rest within 
mouth.) Do this twice.
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 8. Ask client to protrude tongue. (Observe abnormalities of 
tongue movement.) Do this twice.
 9. Ask client to tap thumb with each ﬁ nger as rapidly as pos-
sible for 10 to 15 seconds; separately with right hand, then 
with left hand. (Observe facial and leg movements.)
 10. Flex and extend client’s left and right arms (one at a time). 
(Note any rigidity.)
 11. Ask client to stand up. (Observe in proﬁ le. Observe all body 
areas again, hips included.)
 12. Ask client to extend both arms outstretched in front with 
palms down. (Observe trunk, legs, and mouth.)
 13. Have client walk a few paces, turn, and walk back to chair. 
(Observe hands and gait.) Do this twice. 
Scoring Procedure
Instructions: Complete examination procedure before making 
ratings.
Rate highest severity observed.
Code:  0  None
 1  Minimal, may be extreme normal
 2  Mild
 3  Moderate
 4  Severe
Facial and Oral Movements
 1. Muscles of Facial Expression (e.g., movement of forehead, 
eyebrows, periorbital area, cheeks; include frowning, 
blinking, smiling, grimacing)
  0 1 2 3 4 
 2. Lips and Perioral Area (e.g., puckering, pouting, smacking)
  0 1 2 3 4
 3. Jaws (e.g., biting, clenching, chewing, mouth opening, lat-
eral movement)
  0 1 2 3 4
 4. Tongue (Rate only increase in movement both in and out 
of mouth, NOT inability to sustain movement.)
  0 1 2 3 4
Extremity Movements
 5. Upper (arms, wrists, hands, ﬁ ngers). Include choreic 
movements (i.e., rapid, objectively purposeless, irregular, 
spontaneous), athetoid movements (i.e., slow, irregular, 
complex, serpentine). Do NOT include tremor (i.e., re-
petitive, regular, rhythmic).
  0 1 2 3 4
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 6. Lower (legs, knees, ankles, toes) (e.g., lateral knee move-
ment, foot taping, heel dropping, foot squirming, inver-
sion and eversion of foot)
  0 1 2 3 4
Trunk Movements
 7. Neck, shoulders, hips (e.g., rocking, twisting, squirming, 
pelvic gyrations)
  0 1 2 3 4
Global Judgments
 8. Severity of abnormal movements:
     0 1 2 3 4 (Based on the highest single score on the above 
items.)
 9. Incapacitation due to abnormal movements:
    0 None, normal
1 Minimal
2 Mild
3 Moderate
4 Severe
 10. Client’s awareness of abnormal movements (Rate only 
client’s report)
0 No awareness
1 Aware, no distress
2 Aware, mild distress
3 Aware, moderate distress
4 Aware, severe distress
Dental Status
 11. Current problems with teeth and/or dentures
0 No
1 Yes
 12. Does client usually wear dentures?
0 No
1 Yes
Interpretation of AIMS Score
Add client scores and note areas of difﬁ culty.
Score of: 
 • 0 to 1 = low risk
 •  2 in only ONE of the areas assessed = borderline/observe 
closely
 • 2 in TWO or more of the areas assessed or 3 to 4 in ONLY 
ONE area = indicative of TD
Source: U.S. Department of Health and Human Services. Available for use 
in the public domain.
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chronic confusion, 62–64
disturbed sensory perception, 65–67
low self-esteem, 67–68
self-care deﬁ cit, 64–65
self-/other-directed violence, 60–62
trauma risk, 58–60
predisposing factors in, 52–57
substance-induced, 58
symptomatology of, 52
Amphetamines, 522–525
action of, 522–523
adverse reactions and side effects of, 523
client/family education for, 536–537
contraindications and precautions for, 523
DSM-IV-TR classiﬁ cation for, 598–599
examples of, 522t
interactions of, 523–524
Internet references on, 537
intoxication with, 81
nursing diagnoses related to, 534
nursing implications of, 534–535
route and dosage of, 524–525
use/abuse of, 73, 75t, 80, 81
withdrawal from, 81, 91
ANA (American Nurses Association), 1
ANA standards of practice, 3
Anger notebook, 31
Anorexia
SSRI-related, 424
stimulant-related, 535
Anorexia nervosa
deﬁ nition of, 218
DSM-IV-TR classiﬁ cation of, 606
Internet references on, 234–235
2506_Subject Index_639-682.indd   641 10/1/10   9:41:57 AM
642 ● SUBJECT INDEX
movie(s) involving, 235
nursing diagnoses and interventions for
anxiety, 228–229
deﬁ cient ﬂ uid volume, 224–226
disturbed body image, 229–231
imbalanced nutrition: less than body requirements, 222–224
ineffective coping, 226–227
low self-esteem, 229–231
predisposing factors in, 219–221
symptomatology of, 218–219
Anorgasmia, 204
Antianxiety agents, 406–416
antihistamines, 406–408
in antisocial personality disorder, 298
azaspirodecanediones, 413–415
benzodiazepines, 408–412
in borderline personality disorder, 284
carbamate derivative, 412–413
client/family education for, 416
in disruptive behavior disorders, 31
DSM-IV-TR classiﬁ cation related to, 601–602
in eating disorders, 229
Internet references on, 416
intoxication with, 89t
nursing diagnoses related to, 415
nursing implications of, 415–416
use/abuse of, 85, 89t
withdrawal from, 89t
Anticholinergic effects, antiparkinsonian agent-related, 508
Anticholinergics, 502–505
action of, 503
adverse reactions and side effects of, 503
client/family education for, 509–510
contraindications and precautions for, 503
examples of, 502t
nursing diagnoses related to, 507
nursing implications of, 508
route and dosage for, 504–505
Anticonvulsants, 449–457
action of, 451
contraindications and precautions for, 451
examples of, 449t–450t
interactions of, 452t–453t
route and dosage for, 454–457
Antidepressants, 417–446
alpha-2 receptor antagonists, 435–436
client/family education for, 444–446
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Internet references on, 446
monoamine oxidase inhibitors, 437–439
norepinephrine-dopamine reuptake inhibitors, 428–430
nursing diagnoses related to, 440
nursing implications of, 440–444
psychotherapeutic combinations, 439–440
serotonin-2 antagonists/reuptake inhibitors, 433–435
serotonin-norepinephrine reuptake inhibitors, 430–432
serotonin reuptake inhibitors, 422–427
tricyclic antidepressants, 417–422
Antihistamines, 406–408
actions of, 406
adverse reactions and side effects of, 407
contraindications and precautions for, 407
examples of, 406t
indications for, 406
interactions of, 407
route and dosage of, 407–408
Antimanics, 447–448
contraindications and precautions for, 447
example of, 447t
interactions of, 448
route and dosage for, 448
Antiparkinsonian agents, 502–510
anticholinergics, 502–505
client/family education for, 509–510
dopaminergic agonists, 505–507
interactions, 506
Internet references on, 510
nursing diagnoses related to, 507
nursing implications of, 507–509
Antipsychotics, 472–501
action of, 460
adverse reactions and side effects of, 460–462
benzisoxazole, 487–489
client/family education for, 470–471, 500–501
contraindications and precautions for, 460–462
dibenzepines, 481–487
dibenzo-oxepino pyrrole, 492–493
dihydroindolones, 480–481
examples of, 459t–460t, 472t, 476t, 477t–488t, 480t, 
481t–482t, 487t, 490t
interactions of, 464–465
Internet references on, 501
as mood-stabilizers, 459–468
nursing diagnoses related to, 468, 493
nursing implications of, 468–470, 494–500
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phenothiazines, 472–476
phenylbutylpiperadines, 477–480
route and dosage for, 465–468
side effects of, 495t–496t
thioxanthenes, 476–477
in Tourette’s disorder, 45
Antisocial personality disorder, 276, 294–296
deﬁ nition of, 294
nursing diagnoses and interventions for
defensive coping, 301–303
deﬁ cient knowledge, 307–309
impaired social interaction, 305–307
ineffective coping, 299–301
low self-esteem, 303–305
other-directed violence risk, 297–299
predisposing factors in, 294–296
symptomatology of, 296
Anxiety. See also Anxiety disorders; Separation anxiety disorder
in adjustment disorder, 236
levels of, 549t–551t
mild, 549t
moderate, 549t–550t
moderate to severe
in adjustment disorder, 241–243
in disruptive behavior disorders, 39–40
in eating disorders, 228–229
panic, in anxiety disorders, 165–167
in psychiatric home nursing care, 354
severe, 550t
in separation anxiety disorder, 49–51
severe to panic, in borderline personality disorder, 
285–286
in sexual assault, 362
Anxiety disorders, 161–175
categories of, 162–163
DSM-IV-TR classiﬁ cation of, 604
generalized, 162–163
Internet references on, 175
medical condition and, 163
nursing diagnoses and interventions for
anxiety (panic), 165–167
fear, 167–168
ineffective coping, 169–170
powerlessness, 170–172
self-care deﬁ cit, 173–175
social isolation, 172–173
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predisposing factors in, 163–164
substance-induced, 163
symptomatology of, 164–165
Anxiolytics. See Antianxiety agents
Arrhythmias, antidepressant-related, 442
Ascites, 79
Assertiveness training, 576–578
Associative looseness, in psychotic disorders, 109
Attention-deﬁ cit/hyperactivity disorder, 26–27
deﬁ nition of, 26
drug treatment for, 522–537
DSM-IV-TR classiﬁ cation of, 26, 596
Internet references on, 53
nursing diagnoses and interventions for
anxiety, 39–40
defensive coping, 32–34
impaired social interaction, 34–35
ineffective coping, 35–37
low self-esteem, 37–38
noncompliance, 40–42
self-/other-directed violence risk, 30–32
predisposing factors in, 26
symptomatology of, 26–27
Autism, in psychotic disorders, 108
Autistic disorder, 20–25
deﬁ nition of, 20
Internet references on, 53
movie(s) involving, 53
nursing diagnoses and interventions for
disturbed personal identity, 24–25
impaired social interaction, 22–23
impaired verbal communication, 23–24
self-mutilation risk, 21–22
predisposing factors in, 20
symptomatology of, 20–21
Avoidant personality disorder, 277
Azaspirodecanediones, 413–415
contraindications and precautions for, 414
example of, 413t
indications for, 414
route and dosage for, 415
Barbiturates, 73, 75t, 513–515
action of, 513
adverse reactions and side effects of, 514
client/family education for, 520
contraindications and precautions for, 513–514
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examples of, 513t
interactions of, 514
nursing diagnoses related to, 519
nursing implications of, 519–520
route and dosage for, 514–515
Behavior, disruptive. See Disruptive behavior disorders
Benzisoxazole, 487–489
action of, 487
adverse reactions and side effects of, 488
contraindications and precautions for, 487–488
example of, 487t
interactions of, 488
route and dosage for, 489–490
Benzodiazepines, 408–412
action of, 409
adverse reactions and side effects of, 409
contraindications and precautions for, 409
examples of, 408t–409t
interactions of, 410
route and dosage for, 410–412
sedative-hypnotic use of, 511–513, 511t
Bereavement. See Grief response; Grieving, complicated; Loss 
and bereavement
Bereavement overload, 401
Beta-blockers, in premenstrual dysphoric disorder, 324t
Biochemical factors
in abuse and neglect, 311
in anxiety disorders, 163
in attention-deﬁ cit/hyperactivity disorder, 26
in bipolar disorder, 146
in borderline personality disorder, 278–279
in dysthymic disorder, 126
in pain disorder, 177
in premenstrual dysphoric disorder, 320
in substance-related disorders, 78
in Tourette’s disorder, 43
Biofeedback, 576
Biological factors, in paraphilias, 203
Bipolar disorder, mania, 146–159
deﬁ nition of, 145
DSM-IV-TR classiﬁ cation of, 603–604
movie(s) involving, 160
nursing diagnoses and interventions for
disturbed sensory perception, 155–156
disturbed thought processes, 153–155
imbalanced nutrition: less than body requirements, 
152–153
2506_Subject Index_639-682.indd   646 10/1/10   9:41:57 AM
SUBJECT INDEX ● 647
impaired social interaction, 157–158
injury risk, 148–149
insomnia, 158–159
self-/other-directed violence risk, 150–152
predisposing factors in, 146–147
substance-induced, 147
symptomatology of, 147–148
Birth temperament
in antisocial personality disorder, 295
in conduct disorder, 27
in separation anxiety disorder, 48
Black cohosh, 372t
Blood dyscrasias, sedative-hypnotic-related, 520
Blood transfusion, HIV disease with, 331
Body dysmorphic disorder, 177
Body image, disturbed, nursing diagnoses and interventions for
in eating disorders, 229–231
in obesity, 231–233
in somatoform disorders, 183–185
Body mass index, 221
Borderline personality disorder, 257–294, 276
deﬁ nition of, 278
nursing diagnoses and interventions for
anxiety, 285–286
complicated grieving, 286–288
disturbed personal identity, 290–292
impaired social interaction, 289–290
low self-esteem, 292–294
self-mutilation risk, 282–284
self-/other-directed violence risk, 282–284
predisposing factors in, 278–280
symptomatology of, 280–282
Bowlby model of grief response, 392–393, 553t–556t
Brain, alterations in
in abuse and neglect, 312
in psychotic disorders, 107
in Tourette’s disorder, 43
Brief mental status assessment, 622–623
Brief psychotic disorders, 106
Bulimia nervosa
deﬁ nition of, 219
Internet references on, 234–235
movie(s) involving, 235
nursing diagnoses and interventions for
anxiety, 228–229
deﬁ cient ﬂ uid volume, 224–226
disturbed body image, 229–231
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imbalanced nutrition: less than body requirements, 
222–224
ineffective coping, 226–227
low self-esteem, 229–231
predisposing factors in, 219–221
symptomatology of, 219
Caffeine, 73
DSM-IV-TR classiﬁ cation related to, 599
intoxication with, 87t
use/abuse of, 87t
withdrawal from, 87t
Calcium, 382t
Calcium channel blockers, 458–459
contraindications and precautions for, 458
example of, 458t
in premenstrual dysphoric disorder, 324t
route and dosage for, 459
Cancer, in HIV disease, 330–331
Cannabinols, 77t
DSM-IV-TR classiﬁ cation related to, 599
intoxication with, 81, 88t
use/abuse of, 74, 81, 87t
withdrawal from, 87t, 90
Carbamate derivative, as antianxiety agents, 412–413
Carbohydrates, intake of, 384
Cardiomyopathy, alcoholic, 79
Caregiver role strain, nursing diagnoses and interventions for
in delirium, dementia and amnestic disorders, 68–70
in psychiatric home nursing care, 356–357
Cascara sagrada, 372t
Catatonic schizophrenia, 105
Central nervous system depressants
use/abuse of, 73, 75t
withdrawal from, 91
Central nervous system stimulants. See Stimulants
Chamomile, 373t
Children
abuse and neglect of. See Abuse and neglect
concepts of death in, 399–401
disorders ﬁ rst diagnosed in, 14–53
assessment data, 14–15
autistic disorder, 20–25
disruptive behavior disorders, 26–42
DSM-IV-TR classiﬁ cation related to, 595–597
Internet references, 53
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mental retardation, 15–20
separation anxiety disorder, 48–53
Tourette’s disorder, 42–48
physical abuse of, 310, 317–318
sexual abuse of, 310–311, 313
Chiropractic medicine, 385–386
Cigarette smoking, 84, 88t
Circumstantiality, in psychotic disorders, 109
Cirrhosis, 79
Clang associations, in psychotic disorders, 109
Claustrophobia, 162
Client/family education
on amphetamines, 536–537
on antianxiety agents, 416
on antidepressants, 444–446
on mood-stabilizing drugs, 470–471
for sedative-hypnotics, 520
on stimulants, 536–537
Clinging behavior, in borderline personality disorder, 281
Clonidine (Catapres), in Tourette’s disorder, 45
CNS stimulants. See Stimulants
Cocaine
DSM-IV-TR classiﬁ cation related to, 599–600
intoxication with, 82, 88t
use/abuse of, 73, 76t, 81–82, 88t
withdrawal from, 82, 88t
Cognition
disorders of. See also Delirium; Dementia; Thought processes, 
disturbed
DSM-IV-TR classiﬁ cation related to, 597–598
impairment of, in dysthymic disorder, 127
Cognitive factors, in anxiety disorders, 164
Cognitive therapy, 578–579
Communication techniques
nontherapeutic, 564t–569t
therapeutic, 559t–564t
Compensation (ego defense), 545t
Complementary therapies, 370–389
acupressure, 376–377
acupuncture, 376–377
chiropractic medicine, 385–386
diet and nutrition, 377–379, 378t–383t, 384–385
herbal medicine, 371–372, 372t–376t
Internet references on, 389
massage, 386–387
pet therapy, 387–388
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therapeutic touch, 386
yoga, 387
Concept mapping, 3–4
Concrete thinking, in psychotic disorders, 109
Conduct disorder, 27–29
deﬁ nition of, 27
movie(s) involving, 53
nursing diagnoses and interventions for
anxiety, 39–40
defensive coping, 32–34
impaired social interaction, 34–35
ineffective coping, 35–37
low self-esteem, 37–38
noncompliance, 40–42
self-/other-directed violence risk, 30–32
predisposing factors in, 27–28
symptomatology of, 28–29
Confusion, chronic, in delirium, dementia, and amnestic 
disorders, 62–64
Confusion, sedative-hypnotic-related, 519
Constipation
antidepressant-related, 441
antiparkinsonian agent-related, 508
antipsychotic-related, 494
Conversion disorder, 177, 178
Coping. See Defensive coping; Ineffective coping
Correctional facilities, 362–363
nursing diagnoses and interventions for
complicated grieving, 365–367
defensive coping, 363–365
injury risk, 367–369
Creutzfeldt-Jakob disease, dementia in, 56
Crisis intervention, 574
Cultural Assessment Tool, 588–589
Cultural factors
in psychotic disorders, 108
in somatoform disorders, 178–719
Cyclothymic disorder, 145
Death
concepts of, 399–401
in adolescents, 400
in adults, 401
in children, 399–400
in elderly persons, 401
emergency room, 359–360
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Deep-breathing exercises, 575
Defensive coping, nursing diagnoses and interventions for
in antisocial personality disorder, 301–303
in correctional facilities, 363–365
in disruptive behavior disorders, 32–34
Deinstitutionalization, in homelessness, 342
Delirium
alcohol withdrawal, 80
deﬁ nition of, 54
DSM-IV-TR classiﬁ cation of, 597
nursing diagnoses and interventions for
caregiver role strain, 68–70
chronic confusion, 62–64
disturbed sensory perception, 65–67
low self-esteem, 67–68
self-care deﬁ cit, 64–65
self-/other-directed violence, 60–62
trauma risk, 58–60
predisposing factors in, 54–55
substance-induced, 54–55
symptomatology of, 55
Delusional disorder, 106
movie(s) involving, 124
Delusion(s)
in bipolar disorder, 147
in psychotic disorders, 109–110
Dementia
deﬁ nition of, 55
DSM-IV-TR classiﬁ cation of, 597
HIV-associated, 56
Internet references on, 70
nursing diagnoses and interventions for
caregiver role strain, 68–70
chronic confusion, 62–64
disturbed sensory perception, 65–67
low self-esteem, 67–68
self-care deﬁ cit, 64–65
self-/other-directed violence, 60–62
trauma risk, 58–60
persisting, substance induced, 57
predisposing factors in, 55–57
symptomatology of, 57–58
Denial
in grief response, 391
ineffective, nursing diagnoses and interventions for, in 
substance-related disorders, 92–93
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Denial (ego defense), 545t
Dependent personality disorder, 277
Depersonalization disorder, 192
Depression. See also Major depressive disorder
benzodiazepine effects on, 410, 415
chronic, in borderline personality disorder, 281
in grief response, 392
in HIV disease, 331
Internet references, 144
movie(s) involving, 144
in premenstrual dysphoric disorder, 326
sedative-hypnotic effects on, 519
substance-induced, 126, 146
vs. grief response, 399, 402t
Depressive disorders, 125–126. See also Major depressive disorder
Desensitization, for anxiety disorders, 168
Detoxiﬁ cation. See Withdrawal, substance
Development, impairment of, in adjustment disorder, 237
Developmental model, in adjustment disorder, 237
Development theory, 538–544
Diabetes mellitus, antipsychotic-related, 499–500
Dibenzepines, 481–487
action of, 482
adverse reactions and side effects of, 484
contraindications and precautions for, 483
examples of, 481t–482t
interactions of, 485
route and dosage for, 486–487
Dibenzo-oxepino pyrrole, 492–493
Diet. See Nutrition
Dihydroindolones, 480–481
action of, 480
adverse reactions and side effects of, 481
contraindications and precautions for, 480
examples of, 480t
interactions of, 481
route and dosage for, 481
Discontinuation syndrome, antidepressant-related, 441
Disorganized schizophrenia, 105
Displacement (ego defense), 545t
Disruptive behavior disorders, 26–42
attention-deﬁ cit/hyperactivity disorder, 26–27
conduct disorder, 27–29
nursing diagnoses and interventions for
anxiety, 39–40
defensive coping, 32–34
impaired social interaction, 34–35
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ineffective coping, 35–37
low self-esteem, 37–38
noncompliance, 40–42
self-/other-directed violence risk, 30–32
oppositional deﬁ ant disorder, 29
Dissociation, in borderline personality disorder, 282
Dissociative amnesia, 191
Dissociative disorders, 191–200
categories of, 191–192
DSM-IV-TR classiﬁ cation of, 605
Internet references on, 200
movie(s) involving, 200
nursing diagnoses and interventions for
disturbed personal identity, 196–198
disturbed sensory perception, 198–200
disturbed thought processes, 195–196
ineffective coping, 193–195
predisposing factors for, 192–193
symptomatology of, 193
Dissociative fugue, 191–192
Dissociative identity disorder, 192
Distancing behavior, in borderline personality disorder, 281
Diuretics, in premenstrual dysphoric disorder, 324t
Dizziness
antiparkinsonian agent-related, 508
sedative-hypnotic-related, 519
Domestic violence. See also Abuse and neglect; Physical abuse
in homelessness, 342
movie(s) involving, 319
Dopamine hypothesis, in psychotic disorders, 107–108
Dopaminergic agonists, 505–507
action of, 505
adverse reactions and side effects of, 506
client/family education for, 509–510
contraindications and precautions for, 505–506
examples of, 505t
interactions of, 506t
nursing diagnoses related to, 507
nursing implications of, 507–509
route and dosage for, 507
Downward drift hypothesis, in psychotic disorders, 108
Drowsiness
antiparkinsonian agent-related, 508
sedative-hypnotic-related, 519
Drugs. See also Substance-related disorders; speciﬁ c classes of 
drugs
amnestic disorders with, 58
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DEA controlled, 626–627
delirium with, 54–55
FDA pregnancy categories of, 624–625
Dry mouth
antidepressant-related, 440
antiparkinsonian agent-related, 508
antipsychotic-related, 494
sedative-hypnotic-related, 520
DSM-IV-TR classiﬁ cation, 595–609
DSM-IV-TR multiaxial evaluation system, 590–591
Dyspareunia, 204
Dysthymic disorder, 126
nursing diagnoses and interventions for
complicated grieving, 131–133
disturbed sleep pattern, 142–143
disturbed thought processes, 139–140
imbalanced nutrition: less than body requirements, 140–142
low self-esteem, 131–133
powerlessness, 137–139
suicide risk, 129–131
predisposing factors in, 127–127
symptomatology of, 128–129
Dystonia, antipsychotic-related, 499
Eating disorders, 218–235
deﬁ nition of, 218, 219
DSM-IV-TR classiﬁ cation of, 606
Internet references on, 234–235
movie(s) involving, 235
nursing diagnoses and interventions for
anxiety, 228–229
deﬁ cient ﬂ uid volume, 224–226
disturbed body image, 229–231
imbalanced nutrition: less than body requirements, 222–224
imbalanced nutrition: more than body requirements, 231–233
ineffective coping, 226–227
low self-esteem, 229–231
predisposing factors in, 219–221
symptomatology of, 218–219
Echinacea, 373t
Echolalia, in psychotic disorders, 109
Echopraxia, in psychotic disorders, 109
Education. See Client/family education
Ego defense mechanisms, 545t–547t
Ejaculation
premature, 204
retarded, 204
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Elderly persons
concepts of death in, 401
home care for. See Psychiatric home nursing care
Electroconvulsive therapy, 580–582
contraindications to, 580
deﬁ nition of, 580
indications for, 580
mechanism of action of, 581
nursing diagnoses for, 581–582
nursing interventions for, 582
risks of, 581
side effects of, 581
Elimination disorders, DSM-IV-TR classiﬁ cation related to, 
596
Emotional ambivalence, in psychotic disorders, 109
Emotional response pattern, in psychological factors affecting 
medical condition, 265
Encephalopathy, hepatic, 79
Engel model of grief response, 393, 553t–556t
Environmental factors
in abuse and neglect, 312
in attention-deﬁ cit/hyperactivity disorder, 26
in psychotic disorders, 108
in somatoform disorders, 178–719
Epilepsy, anticonvulsants in, 454–456
Erikson, E., psychosocial theory of, 540
Esophageal varices, alcohol-related, 79
Esophagitis, alcohol-related, 79
Evidence, preservation of, 359, 361, 362
Excitement, paradoxical, sedative-hypnotic-related, 520
Exhibitionism, 201
Extrapyramidal symptoms, antipsychotic-related, 499
Factitious disorders,. DSM-IV-TR classiﬁ cation of, 604
Failure, dysthymic disorder and, 127
Family dynamics
in alcoholism, 101–104
in antisocial personality disorder, 295–296
in conduct disorder, 28
in eating disorders, 220
in gender identity disorders, 212
in impulse control disorders, 258
in oppositional deﬁ ant disorder, 29
in psychological factors affecting medical condition, 
266
in separation anxiety disorder, 48–49
in somatoform disorders, 178
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Family processes
dysfunctional, in alcoholism, 101–104
interrupted, in HIV disease, 335–336
Family therapy, 572
Fats, intake of, 384
FDA pregnancy categories of drugs, 624–625
Fear, nursing diagnoses and interventions for, 167–168
Female orgasmic disorder, 204, 205
Female sexual arousal disorder, 204, 206
predisposing factors in, 205
Fennel, 373t
Fetishism, 201–202
Feverfew, 373t
Fire setting, 257
Flight of ideas, 147
Fluid volume, deﬁ cient, in eating disorders, 224–226
Folic acid, 382t
Folie à deux, 106
Forensic nursing, 358–360
correctional facilities, 362–363
nursing diagnoses and interventions for
complicated grieving, 365–367
defensive coping, 363–365
injury risk, 367–369
deﬁ nition of, 358
Internet references on, 369
in posttrauma syndrome, 360–363
in trauma care, 358–360
Freud, S., psychosexual development theory of, 538
Frotteurism, 202
Fugue, dissociative, 191
movie(s) involving, 200
GAF (Global Assessment of Functioning) Scale, 
592–594
Gambling, pathological, 257
Gastritis, alcohol-related, 79
Gastrointestinal upset
antiparkinsonian agent-related, 508
antipsychotic agent-related, 494
Gender identity disorders, 211–213
DSM-IV-TR classiﬁ cation of, 606
Internet references on, 217
nursing diagnoses and interventions for
disturbed personal identity, 213–214
impaired social interaction, 214–216
low self-esteem, 216–217
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predisposing factors in, 212
symptomatology of, 212–213
Genetic factors
in abuse and neglect, 311–312
in antisocial personality disorder, 295
in anxiety disorders, 163
in attention-deﬁ cit/hyperactivity disorder, 26
in autistic disorder, 20–21
in bipolar disorder, 146
in borderline personality disorder, 279
in conduct disorder, 27
in dissociative disorders, 192
in dysthymic disorder, 116
in eating disorders, 219–220
in impulse control disorders, 257
in obesity, 221
in psychotic disorders, 107
in separation anxiety disorder, 48
in somatoform disorders, 177
in substance-related disorders, 74
in Tourette’s disorder, 43
Ginger, 374t
Ginkgo, 374t
Ginseng, 374t
Global Assessment of Functioning (GAF) Scale, 592–594
Grandeur, delusions of, 147
Grief, deﬁ nition of, 390
Grief response
anticipatory, 397
chronic/prolonged, 398–399
deﬁ nition of, 390
delayed/inhibited, 397–398
distorted/exaggerated, 398
length of, 396–397
models of
Bowlby, 392–393, 553t–556t
Engel, 393, 553t–556t
Kübler-Ross, 391–393, 553t–556t
Worden, 393–395, 553t–556t
stages of, 391–395
vs. depression, 399–402t
Grieving, complicated, nursing diagnoses and interventions for, 
247–249
in borderline personality disorder, 286–288
in correctional facilities, 365–367
in dysthymic disorder, 131–133
in loss and bereavement, 401–404
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Group therapy, 570–571
in antisocial personality disorder, 306
Growth and development, delayed, nursing diagnoses and 
interventions for, in abuse and neglect, 317–318
Hallucinations. See also Sensory perception, disturbed
in psychotic disorders, 110
Hallucinogens
intoxication with, 83
use/abuse of, 73–74, 77t, 82–83
withdrawal from, 91
Headache, antidepressant-related, 442
Head injury, dementia after, 56
Health care availability, homelessness and, 342
Health maintenance, ineffective, in homelessness, 343–345
Hepatic encephalopathy, 79
Hepatitis, alcoholic, 79
Herbal medicine, 371–372, 372t–376t
in premenstrual dysmorphic disorder, 324t–325t
Hippocampus, in psychotic disorders, 107
Histrionic personality disorder, 276–277
HIV disease. See AIDS/HIV disease
Homelessness, 341–347
epidemiology of, 341
Internet references on, 347
mental illness and, 341
movie(s) involving, 347
nursing diagnoses and interventions for
ineffective health maintenance, 343–345
powerlessness, 345–346
predisposing factors in, 342–343
symptomatology of, 343
Hops, 374t
Hormonal effects, antipsychotic-related, 497
Housing shortage, in homelessness, 342
Huntington’s disease, dementia in, 56
Hyperactivity. See Attention-deﬁ cit/hyperactivity disorder
Hyperglycemia, antipsychotic-related, 499–500
Hypertensive crisis, MAOI-related, 443
Hypnotics. See Sedative-hypnotics
Hypoactive sexual desire disorder, 204
Hypochondriasis, 177, 178
movie(s) involving, 190
Hypotension, orthostatic
antidepressant-related, 441
antiparkinsonian agent-related, 509
antipsychotic-related, 494, 497
sedative-hypnotic-related, 519–520
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Identiﬁ cation (ego defense), 546t
Identity disorder. See also Gender identity disorders; Personal 
identity, disturbed
dissociative, 192
movie(s) involving, 200
Ileus, paralytic, antiparkinsonian agent-related, 508
Immune response, in AIDS/HIV disease, 329
Impulse control disorders
categories of, 256–257
deﬁ nition of, 256
DSM-IV-TR classiﬁ cation of, 607
Internet references on, 263
nursing diagnoses and interventions for
ineffective coping, 261–263
other-directed violence risk, 258–260
self-mutilation risk, 260–261
predisposing factors in, 257–258
symptomatology of, 258
Impulsivity
in attention-deﬁ cit/hyperactivity disorder, 26
in borderline personality disorder, 282
Inattention. See Attention-deﬁ cit/hyperactivity disorder
Ineffective coping, nursing diagnoses and interventions for
in adjustment disorder, 243–245
in anxiety disorders, 169–170
in disruptive behavior disorders, 35–37
in dissociative disorders, 193–195
in eating disorders, 226–227
in impulse control disorders, 261–263
in psychological factors affecting the medical condition, 
267–269
in psychotic disorders, 114–115
in separation anxiety disorder, 51–52
in somatoform disorders, 181–183
in substance-related disorders, 94–95
Infancy. See also Newborns
disorders ﬁ rst diagnosed in, 14–15
autistic disorder, 20–25
DSM-IV-TR classiﬁ cation related to, 595–597
mental retardation, 15–20
Tourette’s disorder, 42–48
feeding and eating disorders of, DSM-IV-TR classiﬁ cation of, 
596
Infection, in HIV disease, 330
Inhalants
intoxication with, 83
use/abuse of, 74, 77t, 83
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Injury risk. See also Violence, risk for, self-/other-directed
nursing diagnoses and interventions for
in bipolar disorder, 148–149
in correctional facilities, 367–369
in mental retardation, 16–17
in substance-related disorders, 86, 90–92
Insomnia
antidepressant-related, 442
nursing diagnoses and interventions for
in bipolar disorder, 158–159
in dysthymic disorder, 142–143
in psychotic disorders, 122–123
stimulant-related, 534
Intellectualization (ego defense), 546t–547t
Intelligence quotient, deﬁ cit in. See Mental retardation
Intermittent explosive disorder, 256
Internet references
abuse and neglect, 318–319
adjustment disorder, 255
alcohol use/abuse, 104
Alzheimer’s disease, 70
amphetamines, 537
anorexia nervosa, 234–235
antianxiety agents, 416
antidepressants, 446
antiparkinsonian agents, 510
antipsychotics, 501
anxiety disorders, 175
attention-deﬁ cit/hyperactivity disorder, 53
autistic disorder, 53
bulimia nervosa, 234–235
complementary therapies, 389
depressive disorders, 144
disorders ﬁ rst diagnosed in childhood, 53
dissociative disorders, 200
eating disorders, 234–235
forensic nursing, 369
gender identity disorders, 217
HIV disease, 340
homelessness, 347
impulse control disorders, 263
loss and bereavement, 405
mood disorders, 159–160
mood-stabilizing drugs, 471
nursing, 4
obesity, 234–235
personality disorders, 309
psychiatric home nursing care, 357
2506_Subject Index_639-682.indd   660 10/1/10   9:42:00 AM
SUBJECT INDEX ● 661
schizophrenia, 123
sedative-hypnotics, 520
sexual abuse, 318–319
somatoform disorders, 190
stimulants, 537
substance-related disorders, 104
Intoxication. See Substance intoxication
Introjection (ego defense), 547t
Iodine, 383t
Iron, 383t
Isolation (ego defense), 547t
Kava-kava, 374t
Kleptomania, 257
Knowledge, deﬁ cient, nursing diagnoses and interventions for
in HIV disease, 337–339
in psychological factors affecting the medical condition, 
272–274
in somatoform disorders, 188–190
in substance-related disorders, 99–100
Kohlberg’s stages of moral development, 542–543
Kübler-Ross model of grief response, 391–393, 553t–556t
La belle indifference, 179
Learned helplessness, depression and, 127
Learning disorders, DSM-IV-TR classiﬁ cation of, 595
Learning theory
in abuse and neglect, 312
in psychological factors affecting medical condition, 266
Lethargy, sedative-hypnotic-related, 519
Lewy body disease, dementia due to, 56
Liver, nefazodone-related failure of, 444
Loneliness, in borderline personality disorder, 281
Loquaciousness, 147
Loss and bereavement, 390–405. See also Grief response; 
Grieving, complicated
forms of, 390
Internet references on, 405
maladaptive response to, 397–399
nursing diagnoses and interventions for
complicated grieving, 401–404
spiritual distress risk, 404–405
Lymphadenopathy, in HIV disease, 330
Lysergic acid diethylamide (LSD), 74, 77t
Magnesium, 382t
Magnetic resonance imaging, in bipolar disorder, 146
Mahler, M., object relations theory of, 541
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Major depressive disorder
deﬁ nition of, 125–126
DSM-IV-TR classiﬁ cation of, 603
nursing diagnoses and interventions for
grieving, complicated, 131-133
impaired social interaction, 135–137
nutrition, imbalanced: less than body requirements, 140-142
powerlessness, 137-139
self-esteem, low, 133-135
sleep pattern, disturbed, 142-143
social isolation, 135–137
suicide, risk for, 129-131
thought processes, disturbed, 127, 135, 139-140
Male erectile disorder, 204
predisposing factors in, 205
Male orgasmic disorder, 204, 205
Mania. See also Bipolar disorder, mania, 146
Manipulation, in borderline personality disorder, 281–282
MAOIs. See Monoamine oxidase inhibitors
Marijuana. See Cannabinols
Masochism, sexual, 202
movie(s) involving, 217
Massage, 386–387
Medical condition
amnestic disorder with, 57–58
anxiety disorder with, 163
delirium with, 54
dementia with, 57
depressive disorder due to, 126
mood disorder with, 126, 146
psychological factors affecting, 264–274
deﬁ nition of, 265
DSM-IV-TR classiﬁ cation of, 608
Internet references on, 274
nursing diagnoses and interventions for
deﬁ ciency knowledge, 272–274
ineffective coping, 267–269
ineffective role performance, 271–272
low self-esteem, 267–269
predisposing factors in, 265–266
symptomatology of, 266
psychotic disorder with, 107
Medication Assessment Tool, 583–587
Medication-induced movement disorders, DSM-IV-TR 
classiﬁ cation of, 608
Medications, depressive syndrome with, 127
Meditation, 575
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Melancholia, 127. See also Major depressive disorder
Memory, disorders of. See Amnestic disorders
Mental imagery, 576
Mental retardation, 15–20
deﬁ nition of, 15
DSM-IV-TR classiﬁ cation of, 595
movie(s) involving, 53
nursing diagnoses and interventions for
impaired social interaction, 19–20
impaired verbal communication, 18–19
injury risk, 16–17
self-care deﬁ cit, 17–18
predisposing factors in, 15
symptomatology of, 15–16
Mental state, in HIV disease, 331
Mental status assessment, 610–617
brief, 622–623
Milieu therapy, 572–574
Minerals, 382t–384t
Monoamine oxidase inhibitors, 437–439
action of, 437
adverse reactions and side effects of, 437–438
client/patient education for, 445
contraindications and precautions for, 437
examples of, 436t–437t
interactions of, 438
nursing implications of, 443
route and dosage of, 438–439
Mood, deﬁ nition of, 125, 145
Mood disorders, 125–127
bipolar disorders, 145–146
movie(s) involving, 160
nursing diagnoses and interventions for
disturbed sensory perception, 155–156
disturbed thought processes, 153–155
imbalanced nutrition: less than body requirements, 
152–153
impaired social interaction, 157–158
injury risk, 148–149
insomnia, 158–159
self-/other-directed violence risk, 150–152
cyclothymic, 145
depressive disorders, 125–126
deﬁ nition of, 125–126
Internet references, 144
movie(s) involving, 144
nursing diagnoses and interventions for
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complicated grieving, 131–133
disturbed sleep pattern, 142–143
disturbed thought processes, 139–140
imbalanced nutrition: less than body requirements, 
140–142
impaired social interaction, 135–137
low self-esteem, 133–135
powerlessness, 137–139
social isolation, 135–137
suicide risk, 129–131
predisposing factors in, 127–127
substance-induced, 126
symptomatology of, 128–129
DSM-IV-TR classiﬁ cation of, 603–604
dysthymic, 126
substance-induced, 126, 146
Mood-stabilizing drugs, 447–471
anticonvulsants, 449–457
antimanic, 447–448
antipsychotics, 459–468
calcium channel blockers, 458–459
client/family education on, 470–471
Internet references on, 471
nursing diagnoses related to, 468
nursing implications for, 468–470
Motor skills disorder, DSM-IV-TR classiﬁ cation of, 595
Mourning, 390. See also Grief response; Grieving, complicated
Mutism, in psychotic disorders, 109
Narcissistic personality disorder, 277
Narcotics. See Opioids
National Center for Complementary Medicine and Alternative 
Medicine, 370
Nausea
antidepressant-related, 441
antiparkinsonian agent-related, 508
antipsychotic-related, 494
in HIV disease, 333
sedative-hypnotic-related, 520
Needle stick, HIV disease with, 332
Neglect. See Abuse and neglect
Neologisms, in psychotic disorders, 109
Neuroendocrine disturbances
in dysthymic disorder, 126–127
in eating disorders, 220
Neuroleptic malignant syndrome, antipsychotic-related, 
499
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Neurological factors
in abuse and neglect, 311
in aggressive impulses, 311
in autistic disorder, 20–21
in bipolar disorder, 146
in dissociative disorders, 192
in eating disorders, 220
Neuropathy, alcohol-related, 79
Neurotransmitters, in Tourette’s disorder, 43
Newborns
HIV in, 332
temperament of
antisocial personality disorder and, 295
conduct disorder and, 27
separation anxiety disorder and, 48
Nicotine
dependence on, 83–84
DSM-IV-TR classiﬁ cation related to, 600
use/abuse of, 88t
withdrawal from, 84, 88t
Noncompliance, in disruptive behavior disorders, 40–42
Nonsteroidal anti-inﬂ ammatory drugs, in premenstrual 
dysphoric disorder, 324t
Norepinephrine-dopamine reuptake inhibitors, 428–430
action of, 428
adverse reactions and side effects of, 428–429
contraindications and precautions for, 428
example of, 428t
interactions of, 429
route and dosage for, 429–430
Nursing. See also Forensic nursing; Psychiatric home nursing care, 1
Nursing diagnosis, 2, 2f
client behavior assignment to, 618–621
Nursing history and assessment tool, 4–13
Nursing process, 1–4, 2f
Nutrition, 348–357
essential vitamins and minerals for, 380t–384t
food groups for, 384–385
in HIV disease, 333–334
imbalanced: less than body requirements, nursing diagnoses 
and interventions for
in bipolar disorder, 152–153
in dysthymic disorder, 140–142
in eating disorders, 222–224
in substance-related disorders, 95–97
imbalanced: more than body requirements, nursing diagnoses 
and interventions for, in obesity, 231–233
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in premenstrual dysphoric disorder, 320
USDA food guide for, 378t–379t
Obesity
deﬁ nition of, 221
Internet references on, 234–235
nursing diagnoses and interventions for
disturbed body image, 231–233
imbalanced nutrition: more than body requirements, 
231–233
low self-esteem, 231–233
Object loss theory, 127
Object relations theory, 279–280, 541
Obsessive-compulsive disorder, 162
Obsessive-compulsive personality disorder, 277
Oculogyric crisis, antipsychotic-related, 499
Opioids
intoxication with, 84, 89t
use/abuse of, 73, 76t, 84, 89t
withdrawal from, 84, 89t
Oppositional deﬁ ant disorder, 29
deﬁ nition of, 29
nursing diagnoses and interventions for
anxiety, 39–40
defensive coping, 32–34
impaired social interaction, 34–35
ineffective coping, 35–37
low self-esteem, 37–38
noncompliance, 40–42
self-/other-directed violence risk, 30–32
predisposing factors in, 29
symptomatology of, 29
Orgasmic disorders, 205
deﬁ nition of, 205
DSM-IV-TR classiﬁ cation of, 605
predisposing factors in, 205, 206
Other-directed violence, risk for. See Violence, risk for
Overstimulation, stimulant-related, 534
Pain
acute, in premenstrual dysphoric disorder, 321–323, 324t, 
325t
chronic, nursing diagnoses and interventions, in somatoform 
disorders, 180–181
Pain disorder, 176–177. See also Sexual pain disorders
Palpitations
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sedative-hypnotic-related, 519–520
stimulant-related, 534–535
Pancreatitis, alcohol-related, 79
Panic, 551t
Panic (anxiety), nursing diagnoses and interventions for, 
165–167
Panic disorder, 161
Paradoxical excitement, sedative-hypnotic-related, 520
Paralytic ileus
anticholinergic-related, 508
antiparkinsonian agent-related, 508
Paranoid personality disorder, 276
Paranoid schizophrenia, 105
movie(s) involving, 124
Paraphilias
deﬁ nition of, 201–203
DSM-IV-TR classiﬁ cation of, 606
nursing diagnoses and interventions for, ineffective sexuality 
patterns, 210–211
predisposing factors in, 203
symptomatology of, 203
Parkinson’s disease, dementia in, 56
Passion ﬂ ower, 375t
Passive-aggressive personality disorder, 277–278
Pedophilia, 202
movie(s) involving, 217
Peer relationships, in conduct disorder, 28
Peplau, H., interpersonal theory of, 543–544
Peppermint, 375t
Perinatal factors, in attention-deﬁ cit/hyperactivity disorder, 26
Peripheral neuropathy, alcohol-related, 79
Persecution, delusions of, 147
Perseveration, in psychotic disorders, 109
Personal identity, disturbed, nursing diagnoses and interventions for
in autistic disorder, 24–25
in borderline personality disorder, 290–292
in dissociative disorders, 196–198
in gender identity disorders, 213–214
Personality disorders, 275–309
antisocial. See Antisocial personality disorder
borderline. See Borderline personality disorder
clusters of, 275–278
DSM-IV-TR classiﬁ cation of, 607
Internet references on, 309
Personality traits, in psychological factors affecting medical 
condition, 265
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Pet therapy, 387–388
Phencyclidine (PCP)
intoxication with, 89t
use/abuse of, 85, 89t
withdrawal from, 89t
Phenothiazines, 472–476
action of, 473
adverse reactions and side effects of, 473–474
contraindications and precautions for, 473
examples of, 472t
interactions of, 474
route and dosage for, 474–476
Phenylbutylpiperadines, 477–480
action of, 478
adverse reactions and side effects of, 478–479
contraindications and precautions for, 478
examples of, 477t–478t
interactions of, 479
route and dosage for, 479–480
Phobias, 161–162
Phosphorus, 382t
Photosensitivity
antidepressant-related, 442
antipsychotic-related, 497
Physical abuse
adult, 311
in antisocial personality disorder, 295–296
child, 310, 317–318
DSM-IV-TR classiﬁ cation of, 608
Internet references on, 318–319
symptomatology of, 312
Physical activity, 379, 384
Physical factors
in impulse control disorders, 257
in obesity, 221
in psychological factors affecting medical condition, 265
Physiological factors
in abuse and neglect, 311–312
in adjustment disorder, 237
in anxiety disorders, 163
in attention-deﬁ cit/hyperactivity disorder, 26
in autistic disorder, 20–21
in bipolar disorder, 146
in borderline personality disorder, 278–279
in conduct disorder, 27
in dissociative disorders, 192
in dysthymic disorder, 127
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in eating disorders, 219–220
in gender identity disorders, 212
in impulse control disorders, 257
in mental retardation, 15
in obesity, 221
in oppositional deﬁ ant disorder, 29
in paraphilias, 203
in premenstrual dysphoric disorder, 320
in psychological factors affecting medical condition, 265
in psychotic disorders, 107–108
in separation anxiety disorder, 48
in sexual dysfunction, 205–206
in somatoform disorders, 177–179
in Tourette’s disorder, 43
Pick’s disease, dementia in, 56
Piget’s, J., cognitive development theory, 542
Portal hypertension, 79
Postnatal factors, in attention-deﬁ cit/hyperactivity disorder, 26
Posttrauma syndrome, forensic nursing for, 360–363
Posttraumatic stress disorder, 162
Poverty, in homelessness, 342
Powerlessness, nursing diagnoses and interventions for
in abuse and neglect, 315–317
in anxiety disorders, 170–172
in dysthymic disorder, 137–139
in homelessness, 345–346
Pregnancy, sexual assault and, 361
Premature ejaculation, 204
Premenstrual dysphoric disorder, 320–328
deﬁ nition of, 320
Internet references on, 328
nursing diagnoses and interventions for
acute pain, 321–323, 324t, 325t
ineffective coping, 325–328
predisposing factors in, 320
symptomatology of, 321
Prenatal factors, in attention-deﬁ cit/hyperactivity disorder, 26
Priapism, trazodone-related, 444
Progressive relaxation, 575
Projection (ego defense), 547t
Protection, ineffective, nursing diagnoses and interventions for, 
in HIV disease, 332–335
Pseudoparkinsonism, antipsychotic-related, 498
Psychiatric home nursing care, 348–357
consultation for, 350, 352t
deﬁ nition of, 348
Internet references on, 357
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nursing diagnoses and interventions for
caregiver role strain risk, 356–357
impaired adjustment, 352–354
ineffective self-help management, 351–352
social isolation, 354–356
predisposing factors in, 348–349
reimbursement for, 349
symptomatology in, 349–351
Psychoanalytical theory
in adjustment disorder, 237
in dysthymic disorder, 127
in gender identity disorders, 212
in obesity, 222
in paraphilias, 203
Psychodrama, 571
Psychodynamic theory
in abuse and neglect, 312
in anxiety disorders, 163–164
in dissociative disorders, 192
in eating disorders, 220–221
in somatoform disorders, 178
in substance-related disorders, 78
Psychological factors affecting medical condition. See Medical 
condition, psychological factors affecting
Psychological trauma, in dissociative disorders, 192–193
Psychomotor retardation, in dysthymic disorder, 128
Psychosocial factors
in abuse and neglect, 312
in adjustment disorder, 237–238
in antisocial personality disorder, 295–296
in anxiety disorders, 164
in attention-deﬁ cit/hyperactivity disorder, 26
in borderline personality disorder, 279–280
in conduct disorder, 28
in dissociative disorders, 192–193
in eating disorders, 221
in gender identity disorders, 212
in impulse control disorders, 258
in mental retardation, 15
in obesity, 222
in oppositional deﬁ ant disorder, 29
in paraphilias, 203
in psychological factors affecting medical condition, 265–266
in separation anxiety disorder, 48–49
in sexual dysfunction, 205–206
in somatoform disorders, 178–719
in Tourette’s disorder, 43
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Psychosocial therapy, 570–579
assertiveness training, 576–578
cognitive therapy, 578–579
crisis intervention, 574
family, 572
group, 570–571
milieu, 572–574
psychodrama, 571
relaxation, 575–576
Psychotherapeutic combinations, 439–440
Psychotic disorders, 105–123
antiparkinsonian agent effects on, 508–509
categories of, 105–107
DSM-IV-TR classiﬁ cation of, 603
Internet references on, 123
nursing diagnoses and interventions for
disturbed sensory perception: auditory/visual, 
116–117
disturbed thought processes, 117–119
impaired verbal communication, 119–120
ineffective coping, 114–115
insomnia, 122–123
self-care deﬁ cit, 121–122
self-/other-directed violence risk, 110–112
social isolation, 112–114
predisposing factors in, 108
symptomatology of, 108–110
Psyllium, 375t
PTSD (posttraumatic stress disorder), 162
Pyridoxine (Vitamin B6), 381t
Pyromania, 257
Rage reaction, in borderline personality disorder, 282
Rape-trauma syndrome, nursing diagnoses and interventions for, 
313–315
Rationalization (ego defense), 545t
Reaction formation (ego defense), 545t
Regression, in psychotic disorders, 110
Regression (ego defense), 546t
Relaxation therapy, 575–576
Religiosity, in psychotic disorders, 110
Relocation stress syndrome, nursing diagnoses and interventions 
for, 253–255
Repression (ego defense), 546t
Residual schizophrenia, 106
Restlessness, stimulant-related, 534
Restraints
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in adjustment disorder, 240–241
in antisocial personality disorder, 298–299
in bipolar disorder, 151–152
in borderline personality disorder, 284
in psychotic disorders, 111–112
Retarded ejaculation, 204
Riboﬂ avin (Vitamin B2), 381t
Risk-prone health behavior, nursing diagnoses 
and interventions for
in adjustment disorder, 245–247
in psychiatric home nursing care, 352–354
Role performance, ineffective, nursing diagnoses and 
interventions for, in psychological factors affecting the 
medical condition, 271–272
Sadism, sexual, 202
movie(s) involving, 217
Salt, intake of, 384
Schizoaffective schizophrenia, 106
Schizoid personality disorder, 276
Schizophrenia
categories of, 105–107
DSM-IV-TR classiﬁ cation of, 603
Internet references on, 123
movie(s) involving, 124
nursing diagnoses and interventions for
disturbed sensory perception: auditory/visual, 116–117
disturbed thought processes, 117–119
impaired verbal communication, 119–120
ineffective coping, 114–115
insomnia, 122–123
self-care deﬁ cit, 121–122
self-/other-directed violence risk, 110–112
social isolation, 112–114
predisposing factors in, 108
symptomatology of, 108–110
Schizophreniform disorder, 106
Schizotypal personality disorder, 276
Scullcap, 375t
Seasonal pattern, in major depressive disorder, 126
Sedation
antidepressant-related, 441
antiparkinsonian agent-related, 508
antipsychotic-related, 494
Sedative-hypnotics, 511–521
barbiturates, 513–515
benzodiazepines, 511–513
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client/family education for, 520
interactions of, 517t–518t
Internet references on, 521
intoxication with, 89t
nursing diagnoses for, 519
nursing implications of, 519–520
route and dosage for, 518–519
use/abuse of, 85, 89t
withdrawal from, 89t
Seizures
antidepressant-related, 442
bupropion-related, 535
Selective serotonin reuptake inhibitors, 422–427
action of, 424
adverse reactions and side effects of, 424
contraindications and precautions for, 424
examples of, 422t–423t
interactions of, 424–425
nursing implications of, 442–443
in premenstrual dysphoric disorder, 324t
route and dosage for, 425–427
Selenium, 383t
Self-care deﬁ cit, nursing diagnoses and interventions for
in anxiety disorders, 173–175
in delirium, dementia, and amnestic disorders, 64–65
in mental retardation, 17–18
in psychotic disorders, 121–122
in somatoform disorders, 187–188
Self-directed violence, risk for. See Violence, risk for, 
self-/other-directed
Self-esteem, low
chronic, in substance-related disorders, 97–99
nursing diagnoses and interventions for
in adjustment disorder, 249–251
in borderline personality disorder, 292–294
in delirium, dementia, and amnestic disorders, 67–68
in disruptive behavior disorders, 37–38
in dysthymic disorder, 133–135
in eating disorders, 229–231
in gender identity disorders, 216–217
in obesity, 231–233
in psychological factors affecting the medical condition, 
267–269
in Tourette’s disorder, 47–48
Self-health management, ineffective, in psychiatric home 
nursing care, 351–352
Self-mutilation
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in borderline personality disorder, 282
risk for, nursing diagnoses and interventions for
in autistic disorder, 21–22
in borderline personality disorder, 282–284
in impulse control disorders, 260–261
Sensory perception
disturbed: auditory/visual, nursing diagnoses and 
interventions for, in psychotic disorders, 116–117
disturbed, nursing diagnoses and interventions for
in bipolar disorder, 155–156
in delirium, dementia, and amnestic disorders, 
65–67
in dissociative disorders, 198–200
in somatoform disorders, 185–186
Separation anxiety disorder, 48–53
deﬁ nition of, 48
nursing diagnoses and interventions for
anxiety, 49–51
impaired social interaction, 52–53
ineffective coping, 51–52
predisposing factors in, 48–49
symptomatology of, 49
Serotonin-2 antagonists/reuptake inhibitors, 433–435
action of, 433
adverse reactions and side effects of, 434
contraindications and precautions for, 433
examples of, 433t
interactions of, 434
route and dosage for, 434–435
Serotonin-norepinephrine reuptake inhibitors, 430–432
action of, 431
adverse reactions and side effects of, 431
contraindications and precautions for, 431
examples of, 430t
interactions of, 431–432
route and dosage for, 432
Serotonin syndrome, 424, 442–443
Sexual abuse
adult, 311
forensic nursing for, 361
Internet references on, 318–319
symptomatology of, 313
in borderline personality disorder, 279
child, 310–311, 313
DSM-IV-TR classiﬁ cation of, 608
Internet references on, 318–319
movie(s) involving, 319
symptomatology of, 312–313
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Sexual arousal disorders, 204
DSM-IV-TR classiﬁ cation of, 605
predisposing factors in, 205
Sexual aversion disorder, 204
Sexual desire disorders, 204, 205
DSM-IV-TR classiﬁ cation of, 605
predisposing factors in, 205
Sexual dysfunctions, 204–207
antidepressant-related, 442
antipsychotic-related, 497
DSM-IV-TR classiﬁ cation of, 605–606
nursing diagnoses and interventions for, 207–209
ineffective sexuality patterns, 209–213
in paraphilias, 210–211
predisposing factors in, 205–206
symptomatology of, 206–207
types of, 204–207
Sexual masochism, 202
movie(s) involving, 217
Sexual pain disorders, 204, 205
DSM-IV-TR classiﬁ cation of, 605
predisposing factors in, 205
Sexual sadism, 202
movie(s) involving, 217
Shared psychotic disorder, 106
Skin rash, antipsychotic-related, 494
Sleep disorders
DSM-IV-TR classiﬁ cation of, 606–607
insomnia. See Insomnia
Sleep pattern, disturbed, in dysthymic disorder, 142–143
Social interaction, impaired, nursing diagnoses and interventions 
for
in adjustment disorder, 251–253
in autistic disorder, 22–23
in bipolar disorder, 157–158
in borderline personality disorder, 289–290
in disruptive behavior disorders, 34–35
in dysthymic disorder, 135–137
in gender identity disorders, 214–216
in mental retardation, 19–20
in separation anxiety disorder, 52–53
in Tourette’s disorder, 46–47
Social isolation, nursing diagnoses and interventions for
in anxiety disorders, 172–173
in dysthymic disorder, 135–137
in psychiatric home nursing care, 354–356
in psychotic disorders, 112–114
Social learning theory, and substance use/abuse, 78
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Social phobia, 161–162
Sociocultural factors
in aggressive behavior, 312
in psychotic disorders, 108
in somatoform disorders, 178
Sodium chloride, intake of, 384
Somatization disorder, 176
Somatoform disorders, 176–177
background assessment data, 176
DSM-IV-TR classiﬁ cation of, 604
Internet references on, 190
nursing diagnoses and interventions for
chronic pain, 180–181
deﬁ cient knowledge, 188–190
disturbed body image, 183–185
disturbed sensory perception, 185–186
ineffective coping, 181–183
self-care deﬁ cit, 187–188
predisposing factors for, 177–179
symptomatology of, 179
Speciﬁ c phobia, 162
Spiritual distress, risk for, nursing diagnoses and interventions 
for, 404–405
Splitting, 280, 281
SSRIs. See Selective serotonin reuptake inhibitors
St. John’s wort, 375t
Stimulants, 522–525. See also Amphetamines
client/family education for, 536–537
dexmethylphenidate, 525–528
Internet references on, 537
methylphenidate, 525–528
nursing diagnoses related to, 534
nursing implications of, 534–535
use/abuse of, 73, 75t, 87t
withdrawal from, 87t, 91
Stress
acute, 162
posttraumatic, 162
in premenstrual dysphoric disorder, 327
relocation stress syndrome, nursing diagnoses and 
interventions for, 253–255
Stress-adaptation model, in adjustment disorder, 237–238
Stressful events
in psychotic disorders, 108
in separation anxiety disorder, 48
Sublimation (ego defense), 546t–547t
Substance abuse, 65
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Substance dependence, 71–72
Substance-induced disorders, 72
depressed mood disorder, 126, 146
Substance intoxication
alcohol, 79
amphetamine, 81
anxiolytic, 85
cannabis, 81
cocaine, 82
deﬁ nition of, 72
hallucinogen, 83
inhalant, 83
opioid, 84
PCP, 85
sedative-hypnotic, 85
Substance-related disorders, 71–104. See also Withdrawal, substance
amnestic, 58
anxiety, 163
DEA substance schedule and, 626–627
depressive, 146
DSM-IV-TR classiﬁ cation of, 598–602
in homelessness, 343
manic, 147
movie(s) involving, 104
nursing diagnoses and interventions for
chronic low self-esteem, 97–99
deﬁ cient knowledge, 99–100
dysfunctional family processes, 101–104
imbalanced nutrition: less than body requirement, 95–97
ineffective coping, 94–95
ineffective denial, 92–93
injury risk, 86, 90–92
Internet references on, 104
patterns of use
alcohol, 78–80, 87t
amphetamine, 81, 87t
anxiolytic, 85, 89t
caffeine, 87t
cannabis, 81, 88t
cocaine, 82, 88t
hallucinogen, 82–83
hypnotic, 85, 89t
inhalant, 83, 88t
nicotine, 83–84, 88t
opioid, 84, 89t
phencyclidine, 85, 89t
sedative, 85, 89t
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predisposing factors in, 78
psychotic, 107
substance classiﬁ cation in, 72–74
Substance-use disorders, 71–72
Suicidal behavior/suicide
in disruptive behavior disorders, 30–32
in dysthymic disorder, 129–131
in premenstrual dysphoric disorder, 327
Sullivan, H.S., interpersonal theory of development theory of, 539
Suppression (ego defense), 547t
Tachycardia
anticholinergic-related, 508
antidepressant-related, 442
antiparkinsonian agent-related, 508
sedative-hypnotic-related, 519–520
stimulant-related, 534–535
Tangentiality, in psychotic disorders, 109
Tardive dyskinesia, antipsychotic-related, 499
Temperament
in antisocial personality disorder, 295
in conduct disorder, 27
in separation anxiety disorder, 48
Therapeutic nurse-client relationship
communication techniques for, 559t–564t
orientation (introductory) phase of, 558
preinteraction phase of, 557–558
termination phase of, 559
working phase of, 558
Therapeutic touch, 386
Thiamine (Vitamin B1), 381t
Thioxanthenes, 476–477, 476t
Thought processes, disturbed, nursing diagnoses and 
interventions for
in bipolar disorder, 153–155
in dissociative disorders, 195–196
in dysthmic disorder, 139–140
in psychotic disorders, 117–119
Tolerance
sedative-hypnotic-related, 519
stimulant-related, 535
substance, 71–72
Touch, therapeutic, 386
Tourette’s disorder, 42–48
deﬁ nition of, 43
movie(s) involving, 53
nursing diagnoses and interventions for
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impaired social interaction, 46–47
low self-esteem, 47–48
self-/other-directed violence, 44–45
predisposing factors in, 43
symptomatology of, 43
Trauma. See also Violence
childhood, in borderline personality disorder, 279
forensic nursing care in, 358–360
risk for, nursing diagnoses and interventions for, in delirium, 
dementia, and amnestic disorders, 58–60
Trichotillomania, 257
Tricyclic antidepressants, 417–422
action of, 418
adverse reactions and side effects of, 418
contraindications and precautions for, 418–419
examples of, 417t–418t
interactions of, 419
route and dosage of, 420–422
Undifferentiated schizophrenia, 105
Undoing (ego defense), 547t
Urinary retention
anticholinergic-related, 508
antidepressant-related, 441
antiparkinsonian agent-related, 508
antipsychotic-related, 494
Vaginismus, 204, 205
Valerian, 376t
Vascular dementia, 56
Verbal communication
impaired, nursing diagnoses and interventions for
in autistic disorder, 23–24
in mental retardation, 18–19
in psychotic disorders, 119–120
nontherapeutic techniques of, 564t–569t
therapeutic technqiues of, 559t–564t
Violence
domestic. See also Abuse and neglect
in homelessness, 342
movie(s) involving, 319
risk for
other-directed, nursing diagnoses and interventions for
in antisocial personality disorder, 297–299
in impulse control disorders, 258–260
self-/other-directed, nursing diagnoses and interventions for
in adjustment disorder, 238–241
2506_Subject Index_639-682.indd   679 10/1/10   9:42:03 AM
680 ● SUBJECT INDEX
in bipolar disorder, 150–152
in borderline personality disorder, 282–284
in delirium, dementia, and amnestic disorders, 60–62
in disruptive behavior disorders, 30–32
in psychotic disorders, 110–112
in Tourette’s disorder, 44–45
Vision, blurred
anticholinergic-related, 508
antidepressant-related, 441
antiparkinsonian agent-related, 508
antipsychotic-related, 494
Vitamin A, 380t
Vitamin B1, 381t
Vitamin B2, 381t
Vitamin B3, 381t
Vitamin B6, 381t
Vitamin B12, 381t
Vitamin C, 380t
Vitamin D, 380t
Vitamin E, 380t
Vitamin K, 380t
Vomiting
in bulimia nervosa, 219
in HIV disease, 333
sedative-hypnotic-related, 521
Voyeurism, 202–203
Wasting, in HIV disease, 330
Weight. See also Eating disorders; Obesity
gain of, antipsychotic-related, 497
loss of
antidepressant-related, 442
stimulant-related, 535
management of, 379
Wernicke-Korsakoff syndrome, 79
Withdrawal, substance, 90–91
alcohol, 80, 87t, 90–91
amphetamine, 81, 87t, 90
anxiolytic, 86, 89t
cannabinols, 88t, 90
CNS depressant, 91
cocaine, 82, 88t
deﬁ nition of, 72
delirium with, 55
hallucinogen, 91
hypnotic, 86, 89t
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inhalant, 88t
nicotine, 84, 88t
opioid, 84, 89t
phencyclidine, 89t
sedative, 86, 89t
Worden model of grief response, 393–395, 553t–556t
Word salad, in psychotic disorders, 109
Wound, trauma, examination of, 359
Yoga, 387
Zinc, 383t
Zoophobia, 162
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Drug Index
Note: Page numbers followed by followed by “t” indicate tabular 
material. Trade names appear in bold.
Abilify (aripiprazole), 459t, 461, 462, 464t, 466, 490–491, 490t, 
496t
Adderall/Adderal XR (amphetamine/dextroamphetamine 
mixtures), 522t, 524
Advil (ibuprofen), 324t
Akineton (biperiden), 502t, 504
Alleve (naproxen), 324t
Almotriptan (Axert), 324t
Alprazolam (Xanax), 408t, 410
Amantadine (Symmetrel), 505t, 506, 506t, 507
Ambien (zolpidem), 516, 516t, 518, 519
Amerge (naratriptan), 324t
Amitriptyline, 417t, 420
Amitriptyline-chlordiazepoxide (Limbitrol), 439t
Amitriptyline HCI and perphenazine (Etrafon), 439t
Amobarbital (Amytal), 513t, 514
Amoxapine, 418t, 422
Amphetamine/dextroamphetamine mixtures (Adderall/Adderal 
XR), 522t, 524
Amytal (amobarbital), 513t, 514
Anafranil (clomipramine), 417t, 420
Aripiprazole (Abilify), 459t, 461, 462, 464t, 466, 490–491, 490t, 
496t
Asenapine (Saphris), 460t, 463, 465t, 468, 492–493, 492t, 496t
Ativan (lorazepam), 409t, 412
Atomoxetine (Strattera), 530–534, 530t, 532t
Aventyl (nortriptyline), 418t, 421
Axert (almotriptan), 324t
Benadryl (diphenhydramine), 502t, 504–505
Benztropine (Cogentin), 502t, 504
Biperiden (Akineton), 502t, 504
Black cohosh (Cimicifuga racemosa), 324t, 372t
Bromocriptine (Parlodel), 324t, 505t, 506, 506t
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Bugleweed (Lycopus virginicus), 324t
Buprenorphine (Subutex), 91
Bupropion (Wellbutrin/Wellbutrin SR/Wellbutrin XL/
Zyban), 428–430, 428t, 530–534, 531t, 532t
BuSpar (buspirone HCl), 413–415, 413t
Buspirone HC1 (BuSpar), 413–415, 413t
Butabarbital (Butisol), 513t, 515
Butisol (butabarbital), 513t, 515
Calan (verapamil), 458–459, 458t
Capsella bursa-pastoris (shepherd’s purse), 325t, 418t
Carbamazepine (Tegretol/Epitol/Carbatrol/Equetro/Teril/
Tegretol-XR), 449t, 451, 452t, 454
Carbatrol (carbamazepine), 449t, 451, 452t, 454
Cascara sagrada (Rhamnus purshiana), 372t
Catapres (clonidine), 45, 529t, 530
Celexa (citalopram), 422t, 425
Chamomile (Matricaria chamomilla), 373t
Chaste tree (Vitex agnus-castus), 324t
Chloral hydrate, 516, 516t, 518
Chlordiazepoxide-amitriptyline (Limbitrol), 439t
Chlordiazepoxide (Librium), 91, 408t, 410
Chlorpromazine (Thorazine), 149, 459t, 461, 462–463, 464t, 
466–467, 472t, 474–475, 495t
Cimicifuga racemosa (black cohosh), 324t, 372t
Citalopram (Celexa), 422t, 425
Clomipramine (Anafranil), 417t, 420
Clonazepam (Klonopin), 408t, 410–411, 449t, 451, 453, 453t, 
454–455
Clonidine (Catapres), 45, 529t, 530
Clorazepate (Tranxene), 408t, 411
Clozapine (Clozaril), 481t, 482, 483, 484, 485t, 486, 496t
Clozaril (clozapine), 481t, 482, 483, 484, 485t, 486, 496t
Cogentin (benztropine), 502t, 504
Compazine (prochlorperazine), 472t, 475–476, 495t
Concerta (methylphenidate), 525t, 527–528
Cymbalta (duloxetine), 430t, 432
Dalmane (ﬂ urazepam), 511t, 512
Darvon (propoxyphene), 91
Depakene (valproic acid), 449t, 451, 452, 453t, 455
Depakote (valproic acid), 449t, 451, 452, 453t, 455
Desipramine (Norpramin), 91, 417t, 420
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Desoxyn (methamphetamine), 522t, 525
Desvenlafaxine (Pristiq), 430t, 432
Desyrel (trazodone), 433t, 435
Dexmethylphenidate (Focalin/Focalin XR), 525t, 527
Dexedrine (dextroamphetamine sulfate), 522t, 524
Dextroamphetamine sulfate (Dexedrine/Dextrostat), 522t, 
523, 524
Dextrostat (dextroamphetamine sulfate), 522t, 523, 524
Diazepam (Valium), 408t, 411–412
Diphenhydramine (Benadryl), 502t, 504–505
Dolophine (methadone), 91
Doral (quazepam), 511t, 512
Doxepin (Sinequan), 418t, 420–421
Duloxetine (Cymbalta), 430t, 432
Echinacea (Echinacea angustifolia; Echniacea purpurea), 373t
Effexor (venlafaxine), 430t, 432
Eletriptan (Relpax), 324t
Emsam (selegiline transdermal system), 437t, 439
Epitol (carbamazepine), 449t, 451, 452t, 454
Equetro (carbamazepine), 449t, 451, 452t, 454
Escitalopram (Lexapro), 422t, 425
Eskalith (lithium carbonate), 447–448, 447t
Estazolam (ProSom), 511t, 512
Eszopiclone (Lunesta), 516, 516t, 517t, 518
Etrafon (perphenazine-amitriptyline HCI), 439t
Evening primrose (Oenothera beinnis), 325t
Ezide (hydrochlorothiazide), 324t
Fanapt (iloperidone), 487t, 489, 496t
Fennel (Foeniculum vulgare; Foeniculum ofﬁ cinale), 373t
Feverfew (Tanacetum parthenium), 373t
Fluoxetine (Prozac/Sarafem), 324t, 423t, 425–426
Fluphenazine (Prolixin), 472t, 475, 495t
Flurazepam (Dalmane), 511t, 512
Fluvoxamine (Luvox), 423t, 426
Focalin/Focalin XR (dexmethylphenidate), 525t, 527
Foeniculum vulgare; Foeniculum ofﬁ cinale (fennel), 373t
Frova (frovatriptan), 324t
Frovatriptan (Frova), 324t
Furosemide (Lasix), 324t
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Gabapentin (Neurontin/Gabarone), 450t, 451, 452, 453t, 456
Gabarone (gabapentin), 450t, 451, 452, 453t, 456
Geodon (ziprasidone), 45, 460t, 461–462, 463, 465t, 467–468, 
487t, 490, 496t
Ginger (Zingiber ofﬁ cinale), 373t
Ginkgo (Ginkgo biloba), 374t
Ginseng (Panax ginseng), 374t
Guanfacine (Tenex, Intuniv), 529t, 530
Halcion (triazolam), 511t, 513
Haldol (haloperidol), 45, 91, 149, 477t, 479–480, 495t
Haloperidol (Haldol), 45, 91, 149, 477t, 479–480, 495t
Hops (Humulus lupulus), 374t
Hydrochlorothiazide (Ezide/Esidrix/HydroDIURIL), 324t
HydroDIURIL (hydrochlorothiazide), 324t
Hydroxyzine (Vistaril), 406–408, 406t
Hypericum perforatum (St. John’s wort), 375t
Ibuprofen (Advil/ Motrin/ Nuprin), 324t
Iloperidone (Fanapt), 487t, 489, 496t
Imipramine (Tofranil), 418t, 421
Imitrex (sumatriptan), 324t
Inderal (propranolol), 324t
Intuniv (guanfacine), 529t, 530
Invega (paliperidone), 487t, 489, 496t
Isocarboxazid (Marplan), 436t, 438
Isoptin (verapamil), 324t, 458–459, 458t
Kava-kava (Piper methylsticum), 374t
Klonopin (clonazepam), 408t, 410–411, 449t, 451, 453, 453t, 
454–455
Lamictal (lamotrigine), 450t, 451, 452, 453t, 455–456
Lamotrigine (Lamictal), 450t, 451, 452, 453t, 455–456
Lasix (furosemide), 324t
Lexapro (escitalopram), 422t, 425
Librium (chlordiazepoxide), 91, 408t, 410
Limbitrol (chlordiazepoxide-amitriptyline), 439t
Lisdexamfetamine (Vyvanse) 472t, 522t, 523
Lithane (lithium carbonate), 447–448, 447t
Lithium carbonate (Eskalith/Lithane/Lithobid), 447–448, 447t
Lithium citrate, 447–448, 447t
Lithobid (lithium carbonate), 447–448, 447t
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Lorazepam (Ativan), 409t, 412
Loxapine (Loxitane), 481t, 482, 483, 484, 485t, 486, 495t
Loxitane (loxapine), 481t, 482, 483, 484, 485t, 486, 495t
Luminal (phenobarbital), 91, 513t, 515
Lunesta (eszopiclone), 516, 516t, 517t, 518
Luvox (ﬂ uvoxamine), 423t, 426
Lycopus virginicus (bugleweed), 324t
Maprotiline, 418t, 422
Marplan (isocarboxazid), 436t, 438
Matricaria chamomilla (chamomile), 373t
Maxalt (rizatriptan), 324t
Mebaral (mephobarbital), 513t, 515
Mentha piperita (peppermint), 375t
Mephobarbital (Mebaral), 513t, 515
Meprobamate, 412t, 413
Metadate ER/Metadate CD (methylphenidate), 525t, 527–528
Methadone (Dolophine), 91
Methamphetamine (Desoxyn), 522t, 525
Methylin/Methylin ER (methylphenidate), 525t, 527–528
Methylphenidate (Ritalin/Ritalin-SR/Ritalin LA/Methylin/
Methylin ER/Metadate ER/Metadate CD/Concerta), 
525t, 527–528
Mirtazapine (Remeron), 435–436, 435t
Moban (molindone), 480–481, 480t, 495t
Molindone (Moban), 480–481, 480t, 495t
Motrin (ibuprofen), 324t
Nalmefene (Revex), 91
Naloxone (Narcan), 91
Naltrexone (ReVia), 91
Naprosyn (naproxen), 324t
Naproxen (Naprosyn/Aleve), 324t
Naratriptan (Amerge), 324t
Narcan (naloxone), 91
Nardil (phenelzine), 436t, 439
Navane (thiothixene), 476–477, 476t, 495t
Nefazodone, 433t, 434–435
Nembutal (pentobarbital), 513t
Neurontin (gabapentin), 450t, 451, 452, 453t, 456
Norpramin (desipramine), 91, 417t, 420
Nortriptyline (Aventyl/Pamelor), 418t, 421
Nuprin (ibuprofen), 324t
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Oenothera beinnis (evening primrose), 325t
Olanzapine and ﬂ uoxetine (Symbyax), 439t, 440, 459t, 466
Olanzapine (Zyprexa), 45, 149, 459t, 460, 462, 464t, 465, 482, 
482t, 484, 485t, 486, 496t
Orap (pimozide), 45, 478t, 480, 495t
Oxazepam (Serax), 409t, 412
Oxcarbazepine (Trileptal), 450t, 453, 457
Paliperidone (Invega), 487t, 489, 496t
Pamelor (nortriptyline), 418t, 421
Panax ginseng (ginseng), 374t
Parlodel (bromocriptine), 324t, 505t, 506, 506t
Parnate (tranylcypromine), 437t, 439
Paroxetine (Paxil), 324t, 423t, 426–427
Passion ﬂ ower (Passiﬂ ora incarnata), 375t
Paxil (paroxetine), 324t, 423t, 426–427
Pentobarbital (Nembutal), 513t
Peppermint (Mentha piperita), 375t
Perphenazine, 472t, 475, 495t
Perphenazine-amitriptyline HCI (Etrafon), 439t
Phenelzine (Nardil), 436t, 439
Phenobarbital (Luminal), 91, 513t, 515
Pimozide (Orap), 45, 478t, 480, 495t
Piper methylsticum (kava-kava), 374t
Plantago ovata (psyllium), 375t
Potenilla (Potentilla anserine), 325t
Pristiq (desvenlafaxine), 430t, 432
Prochlorperazine (Compazine), 472t, 475–476, 495t
Prolixin (ﬂ uphenazine), 472t, 475, 495t
Propoxyphene (Darvon), 91
Propranolol (Inderal), 324t
ProSom (estazolam), 511t, 512
Protriptyline (Vivactil), 418t, 421
Prozac (ﬂ uoxetine), 423t, 425–426
Psyllium (Plantago ovata), 375t
Quazepam (Doral), 511t, 512
Quetiapine (Seroquel), 460t, 461, 463, 464t, 467, 482, 482t, 
483, 484, 485t, 487, 496t
Ramelteon (Rozerem), 516, 516t, 518, 518t
Relpax (eletriptan), 324t
Remeron (mirtazapine), 435–436, 435t
Restoril (temazepam), 511t, 513
2506_Drug Index_683-690.indd   688 10/1/10   9:41:09 AM
DRUG INDEX ● 689
Revex (nalmefene), 91
ReVia (naltrexone), 91
Rhamnus purshiana (cascara sagrada), 372t
Risperdal (risperidone), 45, 460t, 461, 463, 464t, 467, 487–489, 
487t, 496t
Risperidone (Risperdal), 45, 460t, 461, 463, 464t, 467, 487–489, 
487t, 496t
Ritalin/Ritalin-SR/Ritalin LA (methylphenidate), 525t, 
527–528
Rizatriptan (Maxalt), 324t
Rozerem (ramelteon), 516, 516t, 518, 518t
Saphris (asenapine), 460t, 463, 465t, 468, 492–493, 492t, 496t
Sarafem (ﬂ uoxetine), 324t, 423t, 425–426
Scullcap (Scutellaria lateriﬂ ora), 375t
Scutellaria lateriﬂ ora (scullcap), 375t
Secobarbital (Seconal), 513t, 515
Seconal (secobarbital), 513t, 515
Selegiline transdermal system (Emsan), 437t, 439
Serax (oxazepam), 409t, 412
Seroquel (quetiapine), 460t, 461, 463, 464t, 467, 482, 482t, 483, 
484, 485t, 487, 496t
Sertraline (Zoloft), 324t, 423t, 427
Shepherd’s purse (Capsella bursa-pastoris), 325t, 418t
Sinequan (doxepin), 418t, 420–421
Sonata (zaleplon), 516, 516t, 518, 518t
St. John’s wort (Hypericum perforatum), 375t
Stelazine (triﬂ uoperazine), 472t, 476, 495t
Strattera (atomoxetine), 530–534, 530t, 532t
Subutex (buprenorphine), 91
Sumatriptan (Imitrex), 324t
Surmontil (trimipramine), 418t, 421
Symbyax (olanzapine and ﬂ uoxetine), 439t, 440, 459t, 466
Symmetrel (amantadine), 505t, 506, 506t, 507
Tanacetum parthenium (feverfew), 373t
Tegretol/Tegretol-XR (carbamazepine), 449t, 451, 452t, 454
Temazepam (Restoril), 511t, 513
Tenex (guanfacine), 529t, 530
Teril (carbamazepine), 449t, 451, 452t, 454
Thioridazine, 472t, 476, 495t
Thiothixene (Navane), 476–477, 476t, 495t
Thorazine (chlorpromazine), 149, 459t, 461, 462–463, 464t, 
466–467, 472t, 474–475, 495t
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Tofranil (imipramine), 418t, 421
Topamax (topriamate), 450t, 451, 453t, 456–457
Topriamate (Topamax), 450t, 451, 453t, 456–457
Tranxene (clorazepate), 408t, 411
Tranylcypromine (Parnate), 437t, 439
Trazodone (Desyrel), 433t, 435
Triazolam (Halcion), 511t, 513
Triﬂ uoperazine (Stelazine), 472t, 476, 495t
Trihexyphenidyl, 502t, 504
Trileptal (oxcarbazepine), 450t, 453, 457
Trimipramine (Surmontil), 418t, 421
Valerian (Valeriana ofﬁ cinalis), 325t
Valerian (Valeriana ofﬁ cinals), 375t
Valium (diazepam), 408t, 411–412
Valproic acid (Depakene/Depakote), 449t, 451, 452, 453t, 455
Venlafaxine (Effexor), 430t, 432
Verapamil (Calan/Isoptin), 458–459, 458t
Verapamil (Isoptin), 324t
Vistaril (hydroxyzine), 406–408, 406t
Vitex agnus-castus (chaste tree), 324t
Vivactil (protriptyline), 418t, 421
Vyvanse (Lisdexamfetamine) 472t, 522t, 523
Wellbutrin (bupropion), 428–430, 428t, 530–534, 531t, 532t
Xanax (alprazolam), 408t, 410
Zaleplon (Sonata), 516, 516t, 518, 518t
Zingiber ofﬁ cinale (ginger), 373t
Ziprasidone (Geodon), 45, 460t, 461–462, 463, 465t, 467–468, 
487t, 490, 496t
Zolmitriptan (Zomig), 324t
Zoloft (sertraline), 324t, 423t, 427
Zolpidem (Ambien), 516, 516t, 518, 519
Zomig (zolmitriptan), 324t
Zyban (bupropion), 428–430, 428t
Zyprexa (olanzapine), 45, 149, 459t, 460, 462, 464t, 465, 482, 
482t, 484, 485t, 486, 496t
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Nursing Diagnoses 
Index
Activity intolerance, risk for
antianxiety agents and, 415
antiparkinsonian agents and, 507
CNS stimulants and, 534
mood-stabilizing drugs and, 468
sedative-hypnotics and, 519
Anxiety
moderate to severe
in adjustment disorder, 241–243
client behavior leading to diagnosis of, 618
in disruptive behavior disorders, 39–40
in eating disorders, 228–229
panic, in anxiety disorders, 165–167
severe
client behavior leading to diagnosis of, 618, 620
in separation anxiety disorder, 49–51
severe to panic
borderline personality disorder, 285–286
client behavior leading to diagnosis of, 618
Body image, disturbed
client behavior leading to diagnosis of, 619
in eating disorders, 229–231
in obesity, 233–234
in somatoform disorders, 183–185
Caregiver role strain, risk for
client behavior leading to diagnosis of, 621
in delirium, dementia and amnestic disorders, 69–70
in psychiatric home nursing care, 356–357
Confusion, risk for
antianxiety agents and, 415
client behavior leading to diagnosis of, 618
sedative-hypnotics and, 519
Constipation, antidepressants and, 440
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Decisional conﬂ ict, client behavior leading to diagnosis of, 619
Defensive coping
in antisocial personality disorder, 301–303
client behavior leading to diagnosis of, 620
in correctional facilities, 363–365
in disruptive behavior disorders, 32–34
Denial, ineffective
client behavior leading to diagnosis of, 618, 621
in substance-related disorders, 92–93
Family processes
dysfunctional, in alcoholism, 101–104
interrupted, in HIV disease, 335–336
Fear
in anxiety disorders, 167–168
client behavior leading to diagnosis of, 620
Fluid volume, deﬁ cient
client behavior leading to diagnosis of, 621
in eating disorders, 224–226
Grieving, complicated, 247–249
in borderline personality disorder, 286–288
client behavior leading to diagnosis of, 618, 620
in correctional facilities, 365–367
in loss and bereavement, 401–404
in major depressive disorder, 131–133
Growth and development, delayed, in abuse and neglect, 317–318
Health maintenance, ineffective, in homelessness, 343–345
Hyperthermia, antiparkinsonian agents and, 507
Ineffective coping
in adjustment disorder, 243–245
in antisocial personality disorder, 299–301
in anxiety disorders, 169–170
client behavior leading to diagnosis of, 620, 621
in disruptive behavior disorders, 35–37
in dissociative disorders, 194–195
in eating disorders, 226–227
in impulse control disorders, 261–263
in premenstrual dysphoric disorder, 325–328
in psychological factors affecting the medical condition, 267–269
in psychotic disorders, 114–115
in separation anxiety disorder, 51–52
in somatoform disorders, 181–183
in substance-related disorders, 94–95
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Injury, risk for
antianxiety agents and, 415
antidepressants and, 440
antiparkinsonian agents and, 507
antipsychotic agents and, 493
in bipolar disorder, 148–149
client behavior leading to diagnosis of, 618, 619
CNS stimulants and, 534
in correctional facilities, 367–369
in mental retardation, 16–17
mood-stabilizing drugs and, 468
sedative-hypnotics and, 519
in substance-related disorders, 86, 90–92
Insomnia
antianxiety agents and, 415
in bipolar disorder, 158–159
client behavior leading to diagnosis of, 620
CNS stimulants and, 534
in psychotic disorders, 122–123
sedative-hypnotics and, 519
Knowledge, deﬁ cient
antianxiety agents and, 415
antiparkinsonian agents and, 507
in antisocial personality disorder, 307–309
in HIV disease, 337–339
in psychological factors affecting the medical condition, 272–274
in somatoform disorders, 189–190
in substance-related disorders, 99–100
Nausea, CNS stimulants and, 534
Noncompliance
antipsychotic agents and, 493
in disruptive behavior disorders, 40–42
Nutrition
imbalanced: less than body requirements
in bipolar disorder, 152–153
client behavior leading to diagnosis of, 618
CNS stimulants and, 534
in eating disorders, 222–224
in major depressive disorder, 140–142
in substance-related disorders, 95–97
imbalanced: more than body requirements
client behavior leading to diagnosis of, 620
in obesity, 231–233
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Pain
acute, in premenstrual dysphoric disorder, 321–323, 324t–325t
chronic, in somatoform disorders, 180–181
CNS stimulants and, 534
Personal identity, disturbed
in autistic disorder, 24–25
in borderline personality disorder, 290–292
client behavior leading to diagnosis of, 620
in dissociative disorders, 196–198
in gender identity disorders, 213–214
Post-trauma syndrome
client behavior leading to diagnosis of, 619
in forensic nursing, 360–363
Powerlessness
in abuse and neglect, 315–317
in anxiety disorders, 170–172
client behavior leading to diagnosis of, 619
in homelessness, 345–346
in major depressive disorder, 137–139
Protection, ineffective
client behavior leading to diagnosis of, 619
in HIV disease, 332–335
Rape-trauma syndrome, 313–315
Relocation stress syndrome
in adjustment disorder, 253–255
client behavior leading to diagnosis of, 621
Risk-prone health behavior
in adjustment disorder, 245–247
client behavior leading to diagnosis of, 619
in psychiatric home nursing care, 352–354
Role performance, ineffective
client behavior leading to diagnosis of, 619
in psychological factors affecting the medical condition, 
271–272
Self-care deﬁ cit
in anxiety disorders, 173–175
client behavior leading to diagnosis of, 620
in delirium, dementia, and amnestic disorders, 64–65
in mental retardation, 17–18
in psychotic disorders, 121–122
in somatoform disorders, 187–188
Self-esteem, low
in adjustment disorder, 249–251
in antisocial personality disorder, 303–305
in borderline personality disorder, 292–294
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chronic, in substance-related disorders, 97–99
client behavior leading to diagnosis of, 619
in delirium, dementia, and amnestic disorders, 67–68
in disruptive behavior disorders, 37–38
in eating disorders, 229–231
in gender identity disorders, 216–217
in major depressive disorder, 133–135
in obesity, 233–234
in psychological factors affecting the medical condition, 
269–270
in sexual and gender identity disorders, 216–217
in Tourette’s disorder, 47–48
Self-health, ineffective management, in psychiatric home 
nursing care, 351–352
Self-mutilation, risk for
in autistic disorder, 21–22
in borderline personality disorder, 282–284
client behavior leading to diagnosis of, 620
in impulse control disorders, 260–261
Sensory perception
disturbed
in bipolar disorder, 155–156
client behavior leading to diagnosis of, 619
in delirium, dementia, and amnestic disorders, 65–67
in dissociative disorders, 198–200
in somatoform disorders, 185–186
disturbed: auditory/visual
client behavior leading to diagnosis of, 619
in psychotic disorders, 116–117
Sexual dysfunction
client behavior leading to diagnosis of, 620
nursing interventions for, 207–209
ineffective sexuality patterns, 209–213
Sexuality patterns, ineffective
client behavior leading to diagnosis of, 620
in paraphilias, 209–213
Sleep pattern, disturbed, in major depressive disorder, 142–143
Social interaction, impaired
in adjustment disorder, 251–253
in antisocial personality disorder, 305–307
in autistic disorder, 22–23
in bipolar disorder, 157–158
in borderline personality disorder, 289–290
client behavior leading to diagnosis of, 619, 620
in disruptive behavior disorders, 34–35
in gender identity disorders, 214–216
in major depressive disorder, 135–137
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in mental retardation, 19–20
in separation anxiety disorder, 52–53
in Tourette’s disorder, 46–47
Social isolation
antidepressants and, 440
in anxiety disorders, 172–173
client behavior leading to diagnosis of, 621
in major depressive disorder, 135–137
in psychiatric home nursing care, 354–356
in psychotic disorders, 112–114
Spiritual distress, risk for, in loss and bereavement, 404–405
Suicide, risk for
antidepressants and, 440
client behavior leading to diagnosis of, 621
CNS stimulants and, 534
in major depressive disorder, 129–131
Therapeutic regimen, ineffective management , client behavior 
leading to diagnosis of, 619
Thought processes, disturbed
in bipolar disorder, 154–155
client behavior leading to diagnosis of, 618, 621
in delirium, dementia, and amnestic disorders, 62–64
in dissociative disorders, 195–196
in major depressive disorder, 139–140
in psychotic disorders, 117–119
Trauma, risk of, in delirium, dementia, and amnestic disorders, 
58–60
Verbal communication, impaired
in autistic disorder, 23–24
client behavior leading to diagnosis of, 620
in mental retardation, 18–19
in psychotic disorders, 119–120
Violence, risk for, self-/other-directed
in adjustment disorder, 238–241
antipsychotic agents and, 493
in bipolar disorder, 150–152
in borderline personality disorder, 282–284
client behavior leading to diagnosis of, 618, 621
in delirium, dementia, and amnestic disorders, 60–62
in disruptive behavior disorders, 30–32
in impulse control disorders, 258–260
mood-stabilizing drugs and, 468
in psychotic disorders, 102–112
in Tourette’s disorder, 44–45
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